PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Poinar, H; Fiedel, S; King, CE; Devault, AM; Bos, K; Kuch, M; Debruyne, R				Poinar, Hendrik; Fiedel, Stuart; King, Christine E.; Devault, Alison M.; Bos, Kirsti; Kuch, Melanie; Debruyne, Regis			Comment on "DNA from Pre-Clovis Human Coprolites in Oregon, North America"	SCIENCE			English	Editorial Material							ANCIENT DNA; IDENTIFICATION; DIVERSITY; PROTEINS; RESIDUES; TOOLS	Gilbert et al. (Reports, 9 May 2008, p. 786) analyzed DNA from radiocarbon-dated paleofecal remains from Paisley Cave, Oregon, which ostensibly demonstrate a human presence in North America predating the well-established Clovis complex. We question the authenticity of their DNA results and argue that in the absence of intact stratigraphy and diagnostic artifacts, and in view of carbon isotope anomalies, the radiocarbon dates of the oldest specimens are unreliable.	[Poinar, Hendrik; King, Christine E.; Devault, Alison M.; Bos, Kirsti; Kuch, Melanie; Debruyne, Regis] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L9, Canada; [Fiedel, Stuart] Louis Berger Grp, Richmond, VA 23219 USA	McMaster University	Poinar, H (corresponding author), McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, 1280 Main St W, Hamilton, ON L8S 4L9, Canada.	poinarh@mcmaster.ca	Debruyne, Régis/G-7839-2011	Debruyne, Régis/0000-0002-7002-3940; Bos, Kirsten/0000-0003-2937-3006; Berna, Francesco/0000-0002-3839-4012				Anovitz LM, 1999, J ARCHAEOL SCI, V26, P735, DOI 10.1006/jasc.1998.0342; Brandt E, 2002, INT J OSTEOARCHAEOL, V12, P307, DOI 10.1002/oa.624; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; Cooper A, 2000, SCIENCE, V289, P1139; DOWNS EF, 1995, J ARCHAEOL SCI, V22, P11, DOI 10.1016/S0305-4403(95)80160-X; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; EISELE JA, 1995, ANTIQUITY, V69, P36, DOI 10.1017/S0003598X00064280; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Leach JD, 1998, J ARCHAEOL SCI, V25, P171, DOI 10.1006/jasc.1997.0237; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066	17	47	51	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937								10.1126/science.1168182	http://dx.doi.org/10.1126/science.1168182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468FK	19589984				2022-12-28	WOS:000267802000022
J	Goldberg, P; Berna, F; Macphail, RI				Goldberg, Paul; Berna, Francesco; Macphail, Richard I.			Comment on "DNA from Pre-Clovis Human Coprolites in Oregon, North America"	SCIENCE			English	Editorial Material							PARTICLE-SIZE; MICROMORPHOLOGY; SOIL	Gilbert et al. (Reports, 9 May 2008, p. 786) presented DNA analysis of coprolites recovered from an Oregon cave as evidence for a human presence in North America before the Clovis culture. Results of our micromorphological and Fourier transform infrared spectroscopy analyses of one of the reported coprolites are difficult to reconcile with the DNA results identifying the coprolite as human.	[Goldberg, Paul; Berna, Francesco; Macphail, Richard I.] Boston Univ, Dept Archaeol, Boston, MA 02215 USA; [Goldberg, Paul] Univ Tubingen, Zentrum Nat Wissensch Archaol, D-72070 Tubingen, Germany; [Berna, Francesco] Univ Milan, Dipartimento Sci Terra Ardito Desio, I-20133 Milan, Italy; [Macphail, Richard I.] UCL, Inst Archaeol, London WC1 0PY, England	Boston University; Eberhard Karls University of Tubingen; University of Milan; University of London; University College London	Goldberg, P (corresponding author), Boston Univ, Dept Archaeol, 675 Commonwealth Ave, Boston, MA 02215 USA.	paulberg@bu.edu	Debruyne, Régis/G-7839-2011	Debruyne, Régis/0000-0002-7002-3940; Bos, Kirsten/0000-0003-2937-3006; Berna, Francesco/0000-0002-3839-4012				Akeret O, 2001, GEOARCHAEOLOGY, V16, P687, DOI 10.1002/gea.1016; Altemiiller HJ, 1990, SOIL MICROMORPHOLOGY, P565; Caroline J, 2003, PAK J BIOL SCI, V6, P1564, DOI DOI 10.3923/PJBS.2003.1564.1573; Clauss M, 2002, OECOLOGIA, V131, P343, DOI 10.1007/s00442-002-0894-8; Courty M.A., 1989, SOILS MICROMORPHOLOG; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; JENKINS DG, COMMUNICATION; Macphail R.I., 2000, POTTERNE 1982 5 ANIM, P47; Macphail RI, 2004, J ARCHAEOL SCI, V31, P175, DOI 10.1016/j.jas.2003.07.005; MACPHAIL RI, 1990, ENDEAVOUR, V14, P163, DOI 10.1016/0160-9327(90)90039-T; Shahack-Gross R, 2003, J ARCHAEOL SCI, V30, P439, DOI 10.1006/jasc.2002.0853; SHAVER RD, 1988, J DAIRY SCI, V71, P1566, DOI 10.3168/jds.S0022-0302(88)79720-9; White R.E., 1987, INTRO PRINCIPLES PRA	13	47	51	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937								10.1126/science.1167531	http://dx.doi.org/10.1126/science.1167531			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468FK	19589984				2022-12-28	WOS:000267802000024
J	Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gotzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ; Kleijnen, J; Moher, D				Liberati, Alessandro; Altman, Douglas G.; Tetzlaff, Jennifer; Mulrow, Cynthia; Gotzsche, Peter C.; Ioannidis, John P. A.; Clarke, Mike; Devereaux, P. J.; Kleijnen, Jos; Moher, David			The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; CRITICALLY-ILL PATIENTS; OUTCOME SELECTION BIAS; CLINICAL-TRIALS; PUBLICATION BIAS; PHARMACEUTICAL-INDUSTRY; DUPLICATE PUBLICATION; INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS	Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and transparency of these reports, however, are not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (quality of reporting of meta-analysis) statement-a reporting guideline published in 1999-there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realising these issues, an international group that included experienced authors and methodologists developed PRISMA (preferred reporting items for systematic reviews and meta-analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this explanation and elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA statement, this document, and the associated website (www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.	[Liberati, Alessandro] Univ Modena & Reggio Emilia, Modena, Italy; [Liberati, Alessandro] Ist Ric Farmacol Mario Negri, Ctr Cochrane Italiano, Milan, Italy; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Tetzlaff, Jennifer; Moher, David] Ottawa Hosp, Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada; [Mulrow, Cynthia] Annals Internal Med, Philadelphia, PA USA; [Gotzsche, Peter C.] Nord Cochrane Ctr, Copenhagen, Denmark; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Clarke, Mike] UK Cochrane Ctr, Oxford, England; [Clarke, Mike] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; [Devereaux, P. J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Kleijnen, Jos] Kleijnen Systemat Reviews, York, N Yorkshire, England; [Kleijnen, Jos] Univ Maastricht, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Universita di Modena e Reggio Emilia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Ioannina; Cochrane Centre; Trinity College Dublin; McMaster University; McMaster University; Kleijnen Systematic Reviews; Maastricht University; University of Ottawa	Liberati, A (corresponding author), Univ Modena & Reggio Emilia, Modena, Italy.	alesslib@mailbase.it	Taiar, Redha/Q-6769-2016; Obando, Juan C/I-9629-2016; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021; Ioannidis, John P. A./G-9836-2011; Altman, Douglas G/A-9714-2012; Moja, Pasquale Lorenzo/CAH-0318-2022	Taiar, Redha/0000-0002-0227-3884; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Devereaux, PJ/0000-0003-2935-637X; Moher, David/0000-0003-2434-4206				Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; ALEJANDRIA MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090; Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Altman DG, 2005, MED CLIN-BARCELONA, V125, P8, DOI 10.1016/S0025-7753(05)72203-X; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Atkins D, 2005, ANN INTERN MED, V142, P1035, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00002; Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Barker A, 2007, LANCET, V370, P329, DOI 10.1016/S0140-6736(07)61163-5; BERGERHOFF K, 2004, OTT ONT CAN 12 COCHR; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bobat R, 2005, LANCET, V366, P1862, DOI 10.1016/S0140-6736(05)67756-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046; Briel M, 2004, AM J MED, V117, P596, DOI 10.1016/j.amjmed.2004.04.022; BRUNTON G, 2008, COCHRANE HDB SYSTEMA, pCH2; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; *CAN I HLTH RES, 2006, RAND CONTR TRIALS RE; Centre for Reviews Dissemination, 2009, SYST REV CRD GUID UN; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke Lorcan, 2007, J Health Serv Res Policy, V12, P101, DOI 10.1258/135581907780279648; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; COOPER H, 1989, KNOWLEDGE, V10, P179, DOI 10.1177/107554708901000301; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Critchley J, 2005, INT J EPIDEMIOL, V34, P1425, DOI 10.1093/ije/dyi195; *CTR REV DISS, 2009, RES PROJ; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; Davies P, 2001, BRIT MED J, V323, P294, DOI 10.1136/bmj.323.7308.294; DeCamp LR, 2008, ARCH PEDIAT ADOL MED, V162, P858, DOI 10.1001/archpedi.162.9.858; Deeks J, 2001, SYSTEMATIC REV HLTH, P313, DOI [DOI 10.1002/9780470693926.CH15, DOI 10.1002/9780470693926.CH16]; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Duffett M, 2007, CRIT CARE, V11, DOI 10.1186/cc5944; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Flores-Mir C, 2006, AM J ORTHOD DENTOFAC, V130, P214, DOI 10.1016/j.ajodo.2006.02.028; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; FROOM P, 1993, J CLIN EPIDEMIOL, V46, P591, DOI 10.1016/0895-4356(93)90029-Z; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; Gonzalez R, 2008, ANN INTERN MED, V149, P109, DOI 10.7326/0003-4819-149-2-200807150-00007; Gotzsche PC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000193.pub2; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; GREEN S, 2008, COCHRANE HDB SYSTEMA, pCH1; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; GUYATT G, 2002, USERS GUIDES MED LIT, P55; GUYATT GH, 2002, USERS GUIDES MED LIT, P267; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Hartley J, 1996, J INFORM SCI, V22, P349, DOI 10.1177/016555159602200503; Hartley J, 2000, B MED LIBR ASSOC, V88, P332; Haynes R Brian, 2002, ACP J Club, V136, pA11; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; HELFAND M, 2009, J CLIN EPID IN PRESS; Hemels MEH, 2004, CURR MED RES OPIN, V20, P477, DOI 10.1185/030079904125003197; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hind D, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-49; HODSON EM, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003774.PUB3; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2001, INT J TECHNOL ASSESS, V17, P601, DOI 10.1017/S0266462301107142; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; *J BRIGGS I, 2009, PROT WORK PROGR; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; JIN W, 2008, J CLIN EPIDEMIOL, V61, P770; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Jones M, 2004, CANCER-AM CANCER SOC, V101, P1720, DOI 10.1002/cncr.20569; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Last JM., 2001, DICT EPIDEMIOLOGY; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; LIBERATI A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000022.PUB2; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Major MP, 2006, J AM DENT ASSOC, V137, P1252, DOI 10.14219/jada.archive.2006.0382; Major Michael P, 2007, Evid Based Dent, V8, P66, DOI 10.1038/sj.ebd.6400504; MCDONAGH M, 2000, SYSTEMATIC REV PUBLI; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613; O'Connor D, 2008, COCHRANE HDB SYSTEMA, P81, DOI DOI 10.1002/9780470712184.CH5; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Pakos EE, 2004, INT J RADIAT ONCOL, V60, P888, DOI 10.1016/j.ijrobp.2003.11.015; Palfreyman S, 2007, BMJ-BRIT MED J, V335, P244, DOI 10.1136/bmj.39248.634977.AE; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rosmarakis ES, 2005, FASEB J, V19, P673, DOI 10.1096/fj.04-3140lfe; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saunders Y, 2004, PALLIATIVE MED, V18, P418, DOI 10.1191/0269216304pm914ra; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schroth R J, 2004, Cochrane Database Syst Rev, pCD003775, DOI 10.1002/14651858.CD003775.pub2; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Shekelle P G, 2004, Evid Rep Technol Assess (Summ), P1; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Sutton A J, 1998, Health Technol Assess, V2, P1; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson SG, 2001, STAT METHODS MED RES, V10, P375, DOI 10.1191/096228001682157616; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Uitterhoeve RJ, 2004, BRIT J CANCER, V91, P1050, DOI 10.1038/sj.bjc.6602103; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Villar J, 2001, STAT MED, V20, P3635, DOI 10.1002/sim.1096; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8; Zhang J, 2006, T NONFERR METAL SOC, V16, P1, DOI 10.1016/S1003-6326(06)60001-0	218	20581	21084	114	243	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2009	339								b2700	10.1136/bmj.b2700	http://dx.doi.org/10.1136/bmj.b2700			37	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475II	19622512	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000268351400023
J	Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gotzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ; Kleijnen, J; Moher, D				Liberati, Alessandro; Altman, Douglas G.; Tetzlaff, Jennifer; Mulrow, Cynthia; Gotzsche, Peter C.; Ioannidis, John P. A.; Clarke, Mike; Devereaux, P. J.; Kleijnen, Jos; Moher, David			The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration	PLOS MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; CRITICALLY-ILL PATIENTS; OUTCOME SELECTION BIAS; CLINICAL-TRIALS; PUBLICATION BIAS; PHARMACEUTICAL-INDUSTRY; DUPLICATE PUBLICATION; INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS	Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement-a reporting guideline published in 1999-there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA ( Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (http://www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and metaanalyses.	[Liberati, Alessandro] Univ Modena & Reggio Emilia, Modena, Italy; [Liberati, Alessandro] Ist Ric Farmacol Mario Negri, Ctr Cochrane Italiano, Milan, Italy; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Tetzlaff, Jennifer; Moher, David] Ottawa Hosp, Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada; [Mulrow, Cynthia] Annals Internal Med, Philadelphia, PA USA; [Gotzsche, Peter C.] Nord Cochrane Ctr, Copenhagen, Denmark; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Clarke, Mike] UK Cochrane Ctr, Oxford, England; [Clarke, Mike] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; [Devereaux, P. J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Devereaux, P. J.] McMaster Univ, Dept Biostat, Hamilton, ON, Canada; [Kleijnen, Jos] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; [Kleijnen, Jos] Univ Maastricht, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Universita di Modena e Reggio Emilia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Ioannina; Cochrane Centre; Trinity College Dublin; McMaster University; McMaster University; McMaster University; Kleijnen Systematic Reviews; Maastricht University; University of Ottawa	Liberati, A (corresponding author), Univ Modena & Reggio Emilia, Modena, Italy.	alesslib@mailbase.it	Taiar, Redha/Q-6769-2016; Obando, Juan C/I-9629-2016; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021; Ioannidis, John P. A./G-9836-2011; Altman, Douglas G/A-9714-2012; Moja, Pasquale Lorenzo/CAH-0318-2022	Taiar, Redha/0000-0002-0227-3884; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Devereaux, PJ/0000-0003-2935-637X; Moher, David/0000-0003-2434-4206	Canadian Institutes of Health Research; Universita di Modena e Reggio Emilia, Italy; Cancer Research UK; Clinical Evidence BMJ Knowledge; Cochrane Collaboration; GlaxoSmithKline, Canada; Italian Ministry of University [COFIN-PRIN 2002 prot. 2002061749, COFIN-PRIN 2006 prot. 2006062298]; University of Ottawa Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Universita di Modena e Reggio Emilia, Italy; Cancer Research UK(Cancer Research UK); Clinical Evidence BMJ Knowledge; Cochrane Collaboration; GlaxoSmithKline, Canada(GlaxoSmithKline); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); University of Ottawa Research Chair	PRISMA was funded by the Canadian Institutes of Health Research; Universita di Modena e Reggio Emilia, Italy; Cancer Research UK; Clinical Evidence BMJ Knowledge; The Cochrane Collaboration; and GlaxoSmithKline, Canada. AL is funded, in part, through grants of the Italian Ministry of University (COFIN-PRIN 2002 prot. 2002061749 and COFIN-PRIN 2006 prot. 2006062298). DGA is funded by Cancer Research UK. DM is funded by a University of Ottawa Research Chair. None of the sponsors had any involvement in the planning, execution, or write-up of the PRISMA documents. Additionally, no funder played a role in drafting the manuscript.	Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; ALEJANDRIA MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090; Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ALTMAN DG, 2001, BMJ RAPID RESPONSE; Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Altman DG, 2005, MED CLIN-BARCELONA, V125, P8, DOI 10.1016/S0025-7753(05)72203-X; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 2009, SYSTEMATIC REV CRDS; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Atkins D, 2005, ANN INTERN MED, V142, P1035, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00002; Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Barker A, 2007, LANCET, V370, P329, DOI 10.1016/S0140-6736(07)61163-5; BERGERHOFF K, 2004, 12 COCHR C 2 6 OCT; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bobat R, 2005, LANCET, V366, P1862, DOI 10.1016/S0140-6736(05)67756-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046; Briel M, 2004, AM J MED, V117, P596, DOI 10.1016/j.amjmed.2004.04.022; BRUNTON G, 2008, COCHRANE HDB SYSTEMA, pCH2; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; *CAN I HLTH RES, 2006, RAND CONTR TRIALS RE; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke Lorcan, 2007, J Health Serv Res Policy, V12, P101, DOI 10.1258/135581907780279648; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; COOPER H, 1989, KNOWLEDGE, V10, P179, DOI 10.1177/107554708901000301; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Critchley J, 2005, INT J EPIDEMIOL, V34, P1425, DOI 10.1093/ije/dyi195; *CTR REV DISS, 2009, RES PROJ; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; Davies P, 2001, BRIT MED J, V323, P294, DOI 10.1136/bmj.323.7308.294; DeCamp LR, 2008, ARCH PEDIAT ADOL MED, V162, P858, DOI 10.1001/archpedi.162.9.858; Deeks J, 2001, SYSTEMATIC REV HLTH, P313, DOI [DOI 10.1002/9780470693926.CH15, DOI 10.1002/9780470693926.CH16]; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Duffett M, 2007, CRIT CARE, V11, DOI 10.1186/cc5944; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Flores-Mir C, 2006, AM J ORTHOD DENTOFAC, V130, P214, DOI 10.1016/j.ajodo.2006.02.028; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; FROOM P, 1993, J CLIN EPIDEMIOL, V46, P591, DOI 10.1016/0895-4356(93)90029-Z; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; GHERSI D, 2006, THESIS U SYDNEY; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; Gonzalez R, 2008, ANN INTERN MED, V149, P109, DOI 10.7326/0003-4819-149-2-200807150-00007; Gotzsche PC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000193.pub2; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; GREEN S, 2008, COCHRANE HDB SYSTEMA, pCH1; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; GUYATT GH, 2002, THERAPY USERS GUIDES, P55; GUYATT GH, 2002, USERS GUIDES MED LIT, P267; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Hartley J, 1996, J INFORM SCI, V22, P349, DOI 10.1177/016555159602200503; Hartley J, 2000, B MED LIBR ASSOC, V88, P332; Haynes R Brian, 2002, ACP J Club, V136, pA11; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; HELFAND M, 2009, J CLIN EPID IN PRESS; Hemels MEH, 2004, CURR MED RES OPIN, V20, P477, DOI 10.1185/030079904125003197; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hind D, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-49; HODSON EM, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003774.PUB3; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2001, INT J TECHNOL ASSESS, V17, P601, DOI 10.1017/S0266462301107142; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; JIN W, 2008, J CLIN EPIDEMIOL, V61, P770; *JOANN BRIGGS I, 2009, PROT WORK PROGR; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Jones M, 2004, CANCER-AM CANCER SOC, V101, P1720, DOI 10.1002/cncr.20569; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Last JM., 2001, DICT EPIDEMIOLOGY; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; LIBERATI A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000022.PUB2; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Major MP, 2006, J AM DENT ASSOC, V137, P1252, DOI 10.14219/jada.archive.2006.0382; Major Michael P, 2007, Evid Based Dent, V8, P66, DOI 10.1038/sj.ebd.6400504; MCDONAGH M, 2000, SYSTEMATIC REV PUBLI; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613; O'Connor D, 2008, COCHRANE HDB SYSTEMA, P81, DOI DOI 10.1002/9780470712184.CH5; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Pakos EE, 2004, INT J RADIAT ONCOL, V60, P888, DOI 10.1016/j.ijrobp.2003.11.015; Palfreyman S, 2007, BMJ-BRIT MED J, V335, P244, DOI 10.1136/bmj.39248.634977.AE; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rosmarakis ES, 2005, FASEB J, V19, P673, DOI 10.1096/fj.04-3140lfe; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; SAMPSON M, 2009, J CLIN EPIDEMIO 0218; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saunders Y, 2004, PALLIATIVE MED, V18, P418, DOI 10.1191/0269216304pm914ra; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schroth R J, 2004, Cochrane Database Syst Rev, pCD003775, DOI 10.1002/14651858.CD003775.pub2; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Shekelle P G, 2004, Evid Rep Technol Assess (Summ), P1; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Sutton A J, 1998, Health Technol Assess, V2, P1; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson SG, 2001, STAT METHODS MED RES, V10, P375, DOI 10.1191/096228001682157616; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Uitterhoeve RJ, 2004, BRIT J CANCER, V91, P1050, DOI 10.1038/sj.bjc.6602103; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Villar J, 2001, STAT MED, V20, P3635, DOI 10.1002/sim.1096; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Xin Zhang, 2006, Journal of Cosmology and Astroparticle Physics, V2006, DOI 10.1088/1475-7516/2006/01/003; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	219	20581	21084	114	243	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	JUL	2009	6	7							e1000100	10.1371/journal.pmed.1000100	http://dx.doi.org/10.1371/journal.pmed.1000100			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476OR	19622512	Green Published, gold, Green Submitted			2022-12-28	WOS:000268452400006
J	Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gotzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ; Kleijnen, J; Moher, D				Liberati, Alessandro; Altman, Douglas G.; Tetzlaff, Jennifer; Mulrow, Cynthia; Gotzsche, Peter C.; Ioannidis, John P. A.; Clarke, Mike; Devereaux, P. J.; Kleijnen, Jos; Moher, David			The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; CRITICALLY-ILL PATIENTS; OUTCOME SELECTION BIAS; CLINICAL-TRIALS; PUBLICATION BIAS; PHARMACEUTICAL-INDUSTRY; DUPLICATE PUBLICATION; INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS	Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement-a reporting guideline published in 1999-there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (www.prisma-statement.org) should be helpful resources to improve reporting of systematic reviews and meta-analyses.	[Liberati, Alessandro] Univ Modena & Reggio Emilia, Ctr Cochrane Italiano, Ist Ric Farmacol Mario Negri, Via La Masa 19, I-20156 Milan, Italy; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; UK Cochrane Ctr, Oxford, England; Univ Ottawa, Ottawa, ON, Canada; [Moher, David] Ottawa Hosp, Ottawa Methods Ctr, Res Inst, Ottawa, ON, Canada; [Mulrow, Cynthia] Annals Internal Med, Philadelphia, PA 19106 USA; [Gotzsche, Peter C.] Nord Cochrane Ctr, Copenhagen, Denmark; Univ Ioannina, Sch Med, GR-45110 Ioannina, Greece; [Clarke, Mike] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; McMaster Univ, Hamilton, ON, Canada; Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; Univ Maastricht, Maastricht, Netherlands; Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [Tetzlaff, Jennifer] Ottawa Hosp, Ottawa Methods Ctr, Ottawa Hosp Res Inst, Crit Care Wing Eye Inst, Gen Campus,6th Floor,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada; [Ioannidis, John P. A.] Univ Ioannina Sch Med, Dept Hyg & Epidemiol, Univ Campus, Ioannina 45110, Greece; [Devereaux, P. J.] McMaster Univ, Hlth Sci Ctr, Clin Epidemiol & Biostatist, Room 2C8 1200 Main St W, Hamilton, ON L8N 3Z5, Canada; [Kleijnen, Jos] Kleijnen Systemat Reviews Ltd, Westminister Business Ctr, 10 Great N Way,Nether Poppleton, York YO26 6RB, N Yorkshire, England	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universita di Modena e Reggio Emilia; University of Oxford; Cochrane Centre; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ioannina; Trinity College Dublin; McMaster University; Kleijnen Systematic Reviews; Maastricht University; Maastricht University; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Kleijnen Systematic Reviews	Liberati, A (corresponding author), Univ Modena & Reggio Emilia, Ctr Cochrane Italiano, Ist Ric Farmacol Mario Negri, Via La Masa 19, I-20156 Milan, Italy.	alesslib@mailbase.it	Taiar, Redha/Q-6769-2016; Obando, Juan C/I-9629-2016; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021; Ioannidis, John P. A./G-9836-2011; Altman, Douglas G/A-9714-2012; Moja, Pasquale Lorenzo/CAH-0318-2022	Taiar, Redha/0000-0002-0227-3884; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Devereaux, PJ/0000-0003-2935-637X; Moher, David/0000-0003-2434-4206	Canadian Institutes of Health Research; Universita di Modena e Reggio Emilia, Italy; Cancer Research UK; Clinical Evidence BMJ Knowledge; Cochrane Collaboration; GlaxoSmithKline, Canada; Italian Ministry of University [COFIN-PRIN 2002 prot. 2002061749, COFIN-PRIN 2006 prot. 2006062298]; University of Ottawa Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Universita di Modena e Reggio Emilia, Italy; Cancer Research UK(Cancer Research UK); Clinical Evidence BMJ Knowledge; Cochrane Collaboration; GlaxoSmithKline, Canada(GlaxoSmithKline); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); University of Ottawa Research Chair	PRISMA was funded by the Canadian Institutes of Health Research; Universita di Modena e Reggio Emilia, Italy; Cancer Research UK; Clinical Evidence BMJ Knowledge; The Cochrane Collaboration; and GlaxoSmithKline, Canada. Dr. Liberati is funded, in part, through grants of the Italian Ministry of University ( COFIN-PRIN 2002 prot. 2002061749 and COFIN-PRIN 2006 prot. 2006062298). Dr. Altman is funded by Cancer Research UK. Dr. Moher is funded by a University of Ottawa Research Chair. None of the sponsors had any involvement in the planning, execution, or write-up of the PRISMA documents. Additionally, no funder played a role in drafting the manuscript.	Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; ALBILLOS A, 2008, ANN INTERN MED, V149, P109; ALEJANDRIA MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090; Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ALTMAN DG, NEED INDIVIDUAL TRIA; Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Altman DG, 2005, MED CLIN-BARCELONA, V125, P8, DOI 10.1016/S0025-7753(05)72203-X; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 2009, SYSTEMATIC REV CRDS; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Atkins D, 2005, ANN INTERN MED, V142, P1035, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00002; Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Barker A, 2007, LANCET, V370, P329, DOI 10.1016/S0140-6736(07)61163-5; BERGERHOFF K, 2004, 12 COCHR C OTT ONT C; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bobat R, 2005, LANCET, V366, P1862, DOI 10.1016/S0140-6736(05)67756-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046; Briel M, 2004, AM J MED, V117, P596, DOI 10.1016/j.amjmed.2004.04.022; BRUNTON G, COCHRANE HDB SYSTEMA; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; *CAN I HLTH RES, 2009, RAND CONTR TRIALS RE; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke Lorcan, 2007, J Health Serv Res Policy, V12, P101, DOI 10.1258/135581907780279648; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; COOPER H, 1989, KNOWLEDGE, V10, P179, DOI 10.1177/107554708901000301; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Critchley J, 2005, INT J EPIDEMIOL, V34, P1425, DOI 10.1093/ije/dyi195; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; Davies P, 2001, BRIT MED J, V323, P294, DOI 10.1136/bmj.323.7308.294; DeCamp LR, 2008, ARCH PEDIAT ADOL MED, V162, P858, DOI 10.1001/archpedi.162.9.858; Deeks J, 2001, SYSTEMATIC REV HLTH, P313, DOI [DOI 10.1002/9780470693926.CH15, DOI 10.1002/9780470693926.CH16]; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Duffett M, 2007, CRIT CARE, V11, DOI 10.1186/cc5944; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eggers Douglas M., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P53; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Flores-Mir C, 2006, AM J ORTHOD DENTOFAC, V130, P214, DOI 10.1016/j.ajodo.2006.02.028; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; FROOM P, 1993, J CLIN EPIDEMIOL, V46, P591, DOI 10.1016/0895-4356(93)90029-Z; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; GHERSI D, 2006, THESIS U SYDNEY SYDN; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Green S., COCHRANE HDB SYSTEMA; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; GUYATT G, 2002, USERS GUIDES MED LIT, P55; GUYATT GH, 2002, USERS GUIDES MED LIT, P267; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Hartley J, 1996, J INFORM SCI, V22, P349, DOI 10.1177/016555159602200503; Hartley J, 2000, B MED LIBR ASSOC, V88, P332; Haynes R Brian, 2002, ACP J Club, V136, pA11; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; HELFAND M, 2009, J CLIN EPID IN PRESS; Hemels MEH, 2004, CURR MED RES OPIN, V20, P477, DOI 10.1185/030079904125003197; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hind D, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-49; Hodson EM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002290.pub3; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2001, INT J TECHNOL ASSESS, V17, P601, DOI 10.1017/S0266462301107142; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hrobjartsson A, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003974.pub2, DOI 10.1002/14651858.CD003974.PUB2]; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; *J BRIGGS I PROT, 2009, J BRIGGS I PROT WORK; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Jones M, 2004, CANCER-AM CANCER SOC, V101, P1720, DOI 10.1002/cncr.20569; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; LIBERATI A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000022.PUB2; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Major MP, 2006, J AM DENT ASSOC, V137, P1252, DOI 10.14219/jada.archive.2006.0382; Major Michael P, 2007, Evid Based Dent, V8, P66, DOI 10.1038/sj.ebd.6400504; MCDONAGH M, 2000, SYSTEMATIC REV PUBLI; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613; O'Connor D, COCHRANE HDB SYSTEMA; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Pakos EE, 2004, INT J RADIAT ONCOL, V60, P888, DOI 10.1016/j.ijrobp.2003.11.015; Palfreyman S, 2007, BMJ-BRIT MED J, V335, P244, DOI 10.1136/bmj.39248.634977.AE; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rosmarakis ES, 2005, FASEB J, V19, P673, DOI 10.1096/fj.04-3140lfe; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saunders Y, 2004, PALLIATIVE MED, V18, P418, DOI 10.1191/0269216304pm914ra; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schroth R J, 2004, Cochrane Database Syst Rev, pCD003775, DOI 10.1002/14651858.CD003775.pub2; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; SHEKELLE PG, 2004, PHARM SURG TREATMENT, P1; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Sterne J, COCHRANE HDB SYSTEMA; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Sutton A J, 1998, Health Technol Assess, V2, P1; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson SG, 2001, STAT METHODS MED RES, V10, P375, DOI 10.1191/096228001682157616; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; *U YORK, 2009, CTR REV DISS RES PRO; Uitterhoeve RJ, 2004, BRIT J CANCER, V91, P1050, DOI 10.1038/sj.bjc.6602103; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Villar J, 2001, STAT MED, V20, P3635, DOI 10.1002/sim.1096; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wen J, 2008, J CLIN EPIDEMIOL, V61, P770, DOI 10.1016/j.jclinepi.2007.10.008; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8; Zhang J, 2006, T NONFERR METAL SOC, V16, P1, DOI 10.1016/S1003-6326(06)60001-0	218	20581	21084	114	243	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					W65	W94		10.7326/0003-4819-151-4-200908180-00136	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00136			30	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19622512	Green Submitted, Green Published			2022-12-28	WOS:000269038900004
J	Kelly, TN; Bazzano, LA; Fonseca, VA; Thethi, TK; Reynolds, K; He, J				Kelly, Tanika N.; Bazzano, Lydia A.; Fonseca, Vivian A.; Thethi, Tina K.; Reynolds, Kristi; He, Jiang			Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY HEART-DISEASE; GLYCEMIC CONTROL; MULTIFACTORIAL INTERVENTION; MELLITUS; COMPLICATIONS; METAANALYSIS; MORTALITY; RISK; VETERANS; OUTCOMES	Background: Results from clinical trials examining the effect of intensive glucose control on cardiovascular disease have been conflicting. Purpose: To summarize clinical benefits and harms of intensive versus conventional glucose control for adults with type 2 diabetes. Data Sources: Studies were retrieved by systematically searching the MEDLINE database (January 1950 to April 2009) with no language restrictions. Study Selection: Two independent reviewers screened abstracts or full-text articles to identify randomized trials that compared clinical outcomes in patients with type 2 diabetes receiving intensive glucose control and those receiving conventional glucose control. Data Extraction: Two investigators independently abstracted data on study variables and outcomes, including severe hypoglycemia, cardiovascular disease, and all-cause mortality. Data Synthesis: 5 trials involving 27 802 adults were included. Intensive glucose targets were lower in the 3 most recent trials. Summary analyses showed that compared with conventional control, intensive glucose control reduced the risk for cardiovascular disease (relative risk [RR], 0.90 [95% CI, 0.83 to 0.98]; risk difference per 1000 patients per 5 years [RD], -15 [CI, -24 to -5]) but not cardiovascular death (RR, 0.97 [CI, 0.76 to 1.24]; RD, -3 [CI, -14 to 7]) or all-cause mortality (RR, 0.98 [CI, 0.84 to 1.15]; RD, -4 [CI, -17 to 10]). Intensive glucose control increased the risk for severe hypoglycemia (RR, 2.03 [CI, 1.46 to 2.81]; RD, 39 [CI, 7 to 71]). As was seen in the overall analyses, pooled findings from the early and more recent trials showed that intensive glucose control reduced the risk for cardiovascular disease and increased the risk for severe hypoglycemia. Limitation: Summary rather than individual data were pooled across trials. Conclusion: Intensive glucose control reduced the risk for some cardiovascular disease outcomes (such as nonfatal myocardial infarction), did not reduce the risk for cardiovascular death or allcause mortality, and increased the risk for severe hypoglycemia.	[Kelly, Tanika N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Kaiser Permanente So Calif, Pasadena, CA USA	Tulane University; Tulane University; Kaiser Permanente	Kelly, TN (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Suite 2000, New Orleans, LA 70112 USA.	tkelly@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	National Heart, Lung, and Blood Institute [1K08HL091108]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091108] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Bazzano was supported by career development award 1K08HL091108 from the National Heart, Lung, and Blood Institute. Dr. Thethi was supported by award K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; ROSENGREN A, 1989, BRIT MED J, V299, P1127, DOI 10.1136/bmj.299.6708.1127; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shichiri M, 2000, DIABETES CARE, V23, pB21; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	34	257	272	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					394	W130		10.7326/0003-4819-151-6-200909150-00137	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00137			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19620144				2022-12-28	WOS:000270390100004
J	Fang, YL; Jayaram, H; Shane, T; Kolmakova-Partensky, L; Wu, F; Williams, C; Xiong, Y; Miller, C				Fang, Yiling; Jayaram, Hariharan; Shane, Tania; Kolmakova-Partensky, Ludmila; Wu, Fang; Williams, Carole; Xiong, Yong; Miller, Christopher			Structure of a prokaryotic virtual proton pump at 3.2 angstrom resolution	NATURE			English	Article							EXTREME ACID RESISTANCE; ESCHERICHIA-COLI; TRANSPORTER SUPERFAMILY; AGMATINE ANTIPORTER; CRYSTAL-STRUCTURE; RECOGNITION SITE; APC SUPERFAMILY; MOLECULAR-BASIS; ARGININE; MECHANISM	To reach the mammalian gut, enteric bacteria must pass through the stomach. Many such organisms survive exposure to the harsh gastric environment (pH 1.5-4) by mounting extreme acid-resistance responses, one of which, the arginine-dependent system of Escherichia coli, has been studied at levels of cellular physiology, molecular genetics and protein biochemistry(1-7). This multiprotein system keeps the cytoplasm above pH 5 during acid challenge by continually pumping protons out of the cell using the free energy of arginine decarboxylation. At the heart of the process is a 'virtual proton pump' 8 in the inner membrane, called AdiC(3,4), that imports L-arginine from the gastric juice and exports its decarboxylation product agmatine. AdiC belongs to the APC superfamily of membrane proteins(6,7,9), which transports amino acids, polyamines and organic cations in a multitude of biological roles, including delivery of arginine for nitric oxide synthesis(10), facilitation of insulin release from pancreatic beta-cells(11), and, when inappropriately over-expressed, provisioning of certain fast-growing neoplastic cells with amino acids(12,13). High-resolution structures and detailed transport mechanisms of APC transporters are currently unknown. Here we describe a crystal structure of AdiC at 3.2 angstrom resolution. The protein is captured in an outward-open, substrate-free conformation with transmembrane architecture remarkably similar to that seen in four other families of apparently unrelated transport proteins.	[Fang, Yiling; Jayaram, Hariharan; Shane, Tania; Kolmakova-Partensky, Ludmila; Wu, Fang; Williams, Carole; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; [Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Brandeis University; Howard Hughes Medical Institute; Yale University	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu			NIH [T32 NS 07292]; Advanced Photon Source [GM-CAT, 23-ID]; Advanced Light Source [8.2.1, 8.2.2]; National Synchrotron Light Source [X-25, X-29A]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031768, R01GM089688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Photon Source; Advanced Light Source; National Synchrotron Light Source; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Y. F. was supported by NIH grant T32 NS 07292. We appreciate the support of the beamline scientists at the Advanced Photon Source (GM-CAT, 23-ID), Advanced Light Source (8.2.1, 8.2.2) and National Synchrotron Light Source (X-25, X-29A). We are also grateful to J. Berry for help in hybridoma sequencing, B. Bowman for crystallographic advice, E. Gouaux for sharing information about an APC homologue, and P. DeWeer, D. P. Krummel, H. H. Lim, K. Piasta and J. Robertson for suggestions on the manuscript.	Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; MALONEY PC, 1994, CURR OPIN CELL BIOL, V6, P571, DOI 10.1016/0955-0674(94)90079-5; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Smith PA, 1997, J PHYSIOL-LONDON, V499, P625, DOI 10.1113/jphysiol.1997.sp021955; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8	31	182	183	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1040	1043		10.1038/nature08201	http://dx.doi.org/10.1038/nature08201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19578361	Green Accepted			2022-12-28	WOS:000269085500040
J	Gallagher, TH				Gallagher, Thomas H.			A 62-Year-Old Woman With Skin Cancer Who Experienced Wrong-Site Surgery Review of Medical Error	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; COMMUNICATION-SKILLS; STANDARDIZED PATIENTS; PHYSICIANS ATTITUDES; RISK-MANAGEMENT; PATIENT SAFETY; DISCLOSURE; PREVENTION; MISTAKES; INJURY	After a life-threatening complication of an injection for neck pain several years ago, Ms W experienced a wrong-site surgery to remove a squamous cell lesion from her nose, followed by pain, distress, and shaken trust in clinicians. Her experience highlights the challenges of communicating with patients after errors. Harmful medical errors occur relatively frequently. Gaps exist between patients' expectations for disclosure and apology and physicians' ability to deliver disclosures well. This discrepancy reflects clinicians' fear of litigation, concern that disclosure might harm patients, and lack of confidence in disclosure skills. Many institutions are developing disclosure programs, and some are reporting success in coupling disclosures with early offers of compensation to patients. However, much has yet to be learned about effective disclosure strategies. Important future developments include increased emphasis on institutions' responsibility for disclosure, involving trainees and other team members in disclosure, and strengthening the relationship between disclosure and quality improvement. JAMA. 2009; 302(6):669-677 www.jama.com	[Gallagher, Thomas H.] Univ Washington, Dept Med, Seattle, WA USA; [Gallagher, Thomas H.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gallagher, TH (corresponding author), UWMC Roosevelt Commons, Box 354981,4311 11th Ave NE,Ste 230, Seattle, WA 98105 USA.	thomasg@u.washington.edu			Robert Wood Johnson Foundation Investigator Award in Health Policy Research Program; Agency for Healthcare Research and Quality [1U18HS01665801, 1R01HS1650601]; Greenwall Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016506] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Investigator Award in Health Policy Research Program(Robert Wood Johnson Foundation (RWJF)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Gallagher is supported by the Robert Wood Johnson Foundation Investigator Award in Health Policy Research Program, the Agency for Healthcare Research and Quality ( grants 1U18HS01665801 and 1R01HS1650601), and the Greenwall Foundation.	Agency for Healthcare Research and Quality, 2007, NAT HEALTHC DISP REP; AMORI G, 2006, PEARLS DISCLOSURE AD; Aspegren K, 1999, MED TEACH, V21, P563, DOI 10.1080/01421599978979; Banja J., 2004, MED ERRORS MED NARCI; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berlinger N., 2005, HARM MED ERROR ETHIC; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Boothman Richard C, 2009, J Health Life Sci Law, V2, P125; Buerhaus PI, 2007, HEALTH AFFAIR, V26, pW687, DOI 10.1377/hlthaff.26.6.w687; Chan DV, 2005, SURGERY, V138, P851, DOI 10.1016/j.surg.2005.04.015; Clinton HR, 2006, NEW ENGL J MED, V354, P2205, DOI 10.1056/NEJMp068100; Cohen Jonathan, 2000, FORDHAM URBAN LAW J, V27, P1447; DELBANCO T, 2006, THINGS GO WRONG VOIC; Delbanco T, 2007, NEW ENGL J MED, V357, P1682, DOI 10.1056/NEJMp078104; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fein SP, 2007, J GEN INTERN MED, V22, P755, DOI 10.1007/s11606-007-0157-9; Full Disclosure Working Group, 2006, THINGS GO WRONG RESP; Gallagher TH, 2005, ARCH INTERN MED, V165, P1819, DOI 10.1001/archinte.165.16.1819; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; GALLAGHER TH, 2006, J HEALTHC RISK MANAG, V26, P11; GALLAGHER TH, 2006, WHAT DO UNANTICIPATE; GALLAGHER TH, 2005, J CLIN OUTCOMES MANA, V12, P253; GALLAGHER TH, 2007, J PATIENT SAF, V3, P158; Gallagher TH, 2007, NEW ENGL J MED, V356, P2713, DOI 10.1056/NEJMra070568; Gallagher TH, 2006, ARCH INTERN MED, V166, P1585, DOI 10.1001/archinte.166.15.1585; Gallagher TH, 2006, ARCH INTERN MED, V166, P1605, DOI 10.1001/archinte.166.15.1605; Garbutt J, 2007, ARCH PEDIAT ADOL MED, V161, P179, DOI 10.1001/archpedi.161.2.179; Ghaleb MA, 2006, ANN PHARMACOTHER, V40, P1766, DOI 10.1345/aph.1G717; Gibson R., 2003, WALL SILENCE UNTOLD; Hevia A, 2003, ANN EMERG MED, V42, P565, DOI 10.1067/S0196-0644(03)00399-8; Hingorani M, 1999, BRIT MED J, V318, P640, DOI 10.1136/bmj.318.7184.640; Hobgood C, 2002, ACAD EMERG MED, V9, P1156, DOI 10.1111/j.1553-2712.2002.tb01570.x; *I MED COMM QUAL H, 2000, ERR IS HUM BUILD SAF; Iedema R, 2008, INT J QUAL HEALTH C, V20, P421, DOI 10.1093/intqhc/mzn043; *JOINT COMM, FACTS UN PROT PREV W; *JOINT COMM RES, 2007, HOSP ACCR STAND 2007; Kachalia Allen, 2003, Jt Comm J Qual Saf, V29, P503; Kachalia AB, 2008, SOC SCI MED, V66, P387, DOI 10.1016/j.socscimed.2007.08.020; Kaiser Family Foundation/Agency for Healthcare Research and Quality/Harvard School of Public Health, 2004, NAT SURV CONS EXP PA; Kaldjian LC, 2007, J GEN INTERN MED, V22, P988, DOI 10.1007/s11606-007-0227-z; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; Kwaan MR, 2006, ARCH SURG-CHICAGO, V141, P353, DOI 10.1001/archsurg.141.4.353; Lamb RM, 2003, HEALTH AFFAIR, V22, P73, DOI 10.1377/hlthaff.22.2.73; Lazare A, 2006, JAMA-J AM MED ASSOC, V296, P1401, DOI 10.1001/jama.296.11.1401; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LEVINSON W, 1989, JAMA-J AM MED ASSOC, V261, P2252, DOI 10.1001/jama.261.15.2252; Liang B. A., 2004, ACCOUNTABILITY PATIE, P59; LO B, 2005, RESOLVING ETHICAL DI; Loren DJ, 2008, ARCH PEDIAT ADOL MED, V162, P922, DOI 10.1001/archpedi.162.10.922; MACDONALD T, QUAL SAF HL IN PRESS; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; MAY ML, 1990, LAW SOC REV, V24, P105, DOI 10.2307/3053788; May T, 2001, KENNEDY INST ETHIC J, V11, P135, DOI 10.1353/ken.2001.0014; Mazor KM, 2006, J GEN INTERN MED, V21, P704, DOI 10.1111/j.1525-1497.2006.00465.x; Mazor KM, 2004, ARCH INTERN MED, V164, P1690, DOI 10.1001/archinte.164.15.1690; Mazor KM, 2004, ANN INTERN MED, V140, P409, DOI 10.7326/0003-4819-140-6-200403160-00006; MCDONALD T, 2009, FOCUS PATIENT SAF, V11, P1; McDonnell WM, 2008, ANN INTERN MED, V149, P811, DOI 10.7326/0003-4819-149-11-200812020-00007; Mechanic D, 1998, J HEALTH POLIT POLIC, V23, P661; Merry A., 2001, ERRORS MED LAW; MILLER WI, 2003, FAKING IT; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; National Quality Forum, 2009, SAF PRACT BETT HEALT; *PENNS PAT SAF AUT, 2008, PA PATIENT SAF ADVIS, V5, P31; Pinkus RL, 2000, MARGIN ERROR ETHICS; Popp Pamela L, 2003, J Healthc Risk Manag, V23, P5; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Quest TE, 2002, ACAD EMERG MED, V9, P1326, DOI 10.1111/j.1553-2712.2002.tb01595.x; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Robbennolt JK, 2003, MICH LAW REV, V102, P460, DOI 10.2307/3595367; Robins L, 2008, J INTERPROF CARE, V22, P325, DOI 10.1080/13561820801886438; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; SACK K, 2008, NY TIMES        0518, pA1; Schoen C, 2005, HLTH AFF MILLWOOD S; Shannon SE, 2009, JT COMM J QUAL PATIE, V35, P5, DOI 10.1016/S1553-7250(09)35002-3; SHAPIRO E, DISCLOSING MED ERROR; Sharpe V. A, 2004, ACCOUNTABILITY PATIE; STILLMAN PL, 1983, J MED EDUC, V58, P941; Studdert DM, 2007, HEALTH AFFAIR, V26, P215, DOI 10.1377/hlthaff.26.1.215; Studdert DM, 2004, NEW ENGL J MED, V350, P283, DOI 10.1056/NEJMhpr035470; Surbone A, 2003, J CLIN ETHIC, V14, P183; Taft L., 2005, DEPAUL LAW REV, V55, P601; Vincent JL, 1998, INTENS CARE MED, V24, P1251, DOI 10.1007/s001340050758; Waterman AD, 2006, J GEN INTERN MED, V21, P367, DOI 10.1111/j.1525-1497.2005.00385.x; Waterman AD, 2007, JT COMM J QUAL PATIE, V33, P467, DOI 10.1016/S1553-7250(07)33050-X; Wayman Karen I, 2007, J Healthc Qual, V29, P12; Wei M., 2006, J HLTH LAW, V39; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; Weissman JS, 2005, JAMA-J AM MED ASSOC, V293, P1359, DOI 10.1001/jama.293.11.1359; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; White A., 2008, JCOM, V15, P240; Whitlatch NL, 2008, AM J HEMATOL, V83, P256, DOI 10.1002/ajh.21079; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Wu AW, 1999, ANN INTERN MED, V131, P970, DOI 10.7326/0003-4819-131-12-199912210-00012; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x; Yeston N, 2006, ARCH SURG-CHICAGO, V141, P357; Zimmerman Theresa M, 2007, J Healthc Risk Manag, V27, P27, DOI 10.1002/jhrm.5600270206	98	43	43	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					669	677		10.1001/jama.2009.1011	http://dx.doi.org/10.1001/jama.2009.1011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481ZI	19584321				2022-12-28	WOS:000268852300025
J	Iglehart, JK				Iglehart, John K.			A Bumpy Road for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Balz D., 2009, WASHINGTON POST 1202, pA1; CORTESE D, 2009, CHICAGO TRIBUNE 0719; WAXMAN HA, 2009, COMMUNICATION   0721	3	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6								10.1056/NEJMp0906578	http://dx.doi.org/10.1056/NEJMp0906578			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19625709				2022-12-28	WOS:000268667300004
J	Smith, AD; Tapsoba, P; Peshu, N; Sanders, EJ; Jaffe, HW				Smith, Adrian D.; Tapsoba, Placide; Peshu, Norbert; Sanders, Eduard J.; Jaffe, Harold W.			Men who have sex with men and HIV/AIDS in sub-Saharan Africa	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; MIDDLE-INCOME COUNTRIES; HIV-INFECTION; RISK-FACTORS; TRANSMISSION; YOUNG; EPIDEMIOLOGY; PREVALENCE; BEHAVIOR; MOMBASA	Globally, men who have sex with men (MSM) continue to bear a high burden of HIV infection. In sub-Saharan Africa, same-sex behaviours have been largely neglected by HIV research up to now. The results from recent studies, however, indicate the widespread existence of MSM groups across Africa, and high rates of HIV infection, HIV risk behaviour, and evidence of behavioural links between MSM and heterosexual networks have been reported. Yet most African MSM have no safe access to relevant HIV/AIDS information and services, and many African states have not begun to recognise or address the needs of these men in the context of national HIV/AIDS prevention and control programmes. The HIV/AIDS community now has considerable challenges in clarifying and addressing the needs of MSM in sub-Saharan Africa; homosexuality is illegal in most countries, and political and social hostility are endemic. An effective response to HIV/AIDS requires improved strategic information about all risk groups, including MSM. The belated response to MSM with HIV infection needs rapid and sustained national and international commitment to the development of appropriate interventions and action to reduce structural and social barriers to make these accessible.	[Smith, Adrian D.; Jaffe, Harold W.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Tapsoba, Placide] Populat Council, Accra, Ghana; [Peshu, Norbert; Sanders, Eduard J.] Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Sanders, Eduard J.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LF, England	University of Oxford; Kenya Medical Research Institute; University of Oxford	Smith, AD (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus, Oxford OX3 7LF, England.	adrian.smith@dphpc.ox.ac.uk	Smith, Adrian D/A-6336-2009; Franzeck, Fabian C/B-5055-2011	Smith, Adrian/0000-0003-0036-1490	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	EJS is financially supported by the International AIDS Vaccine Initiative. We thank Kevin De Cock and Ying-Ru Lo (Department of HIV/AIDS, WHO, Geneva, Switzerland) for comments a.bout the Review. This Review was published with the permission of the Director of KEMRI, Kenya.	ADEBAJO S, 2008, AIDS 2008 17 INT AID; amfAR, 2008, MSM HIV ROAD UN ACC; Angala P, 2006, AIDS 2006 16 INT AID; [Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; [Anonymous], INT DAT BAS IDB; ATTIPOE D, 2004, REVEALING PANDORA BO; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; BEYRER C, 2009, 16 C RETR OPP INF MO; BIGGAR RJ, 1986, LANCET, V1, P79; BURRELL E, COMP SEXUAL RISK BEH; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Chimphambano C, 2007, TROP DOCT, V37, P226, DOI 10.1258/004947507782333189; COLVIN M, 2008, AIDS 2008 17 INT AID; DIALLO MO, 1992, AIDS, V6, P581, DOI 10.1097/00002030-199206000-00010; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; DIOPNDIAYE H, 2009, 16 C RETR OPP INF MO; ELRASHIED S, 2006, AIDS 2006 16 INT AID; ELRASHIED S, 2008, AIDS 2008 17 INT AID; EPPRECHT M, 1998, BOY WIVES FEMALE HUS; Epprecht Marc., 2008, HETEROSEXUAL AFRICA; *FED REP NIG, 2008, HIV STI INT BIOL BEH; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; HRDY DB, 1987, REV INFECT DIS, V9, P1109; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; JOHNSON JE, 1988, TUMOR DIAGNOSIS ELEC, V2, P1; JOHNSTON L, 2008, AIDS 2008 17 INT AID; Lane T, 2006, AIDS, V20, P123, DOI 10.1097/01.aids.0000198083.55078.02; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; Mazzola Priscila G, 2006, BMC INFECT DIS, V6, DOI [DOI 10.1186/1471-2334-8-33, 10.1186/1471-2334-6-131, DOI 10.1186/1471-2334-6-131]; Mbugua GG, 1995, E AFR MED J, V72, P515; MOREAU A, 2007, IMPLEMENTING STI HIV; Morgan R, 2003, CULT HEALTH SEX, V5, P375, DOI 10.1080/1369105011000064146; Murray S. O., 1998, BOY WIVES FEMALE HUS; Mwakagile D, 2001, SEX TRANSM INFECT, V77, P255, DOI 10.1136/sti.77.4.255; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Onyango-Ouma W, 2005, UNDERSTANDING HIV ST; Ottosson Daniel, 2009, STATE SPONSORED HOMO; Pew Global Attitudes Project, 2007, WORLD PUBL WELC GLOB; PIOT P, 1984, LANCET, V2, P65; PIOT P, 1988, BRIT MED BULL, V44, P68, DOI 10.1093/oxfordjournals.bmb.a072247; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; *RAPP NAT COT IV, 2008, REP COT IV MIN LUTT; *REP GHAN, 2008, NAT REP PROGR UN GEN; *REP ISL MAUR, 2008, REP UNGASS 2008 MAUR; RYDER RW, 1990, AIDS, V4, P725, DOI 10.1097/00002030-199008000-00002; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sandfort TGM, 2008, SEX TRANSM INFECT, V84, P425, DOI 10.1136/sti.2008.031500; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; Simooya OO, 2001, AIDS, V15, P1741, DOI 10.1097/00002030-200109070-00023; TAPSOBA P, 2004, AIDS 2004 15 INT AID; TOVANABUTRA S, 2008, 15 INT WORKSH HIV DY, P1; UMAR E, 2008, AIDS 2008 17 INT AID; UNAIDS, 2009, UNAIDS ACT FRAM UN A; UNAIDS, 2008, REP GLOB AIDS EP; *UNAIDS WHO, AIDS EP UPD 2007; *UNGASS, 2007, MON DECL COMM HIV AI; VANDEPERRE P, 1984, LANCET, V2, P62; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; VICTORAHUCHOGA J, 2008, AIDS 2008 17 INT AID; WADE A, 2008, AIDS 2008 17 INT AID; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; *WHO UNDP UNAIDS, 2009, PREV TREATM HIV OTH; Wilson, 1951, GOOD CO STUDY NYAKYU; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; ZULU K, 2006, AIDS 2006 16 INT AID; 2009, BBC NEWS        0108	73	234	239	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					416	422		10.1016/S0140-6736(09)61118-1	http://dx.doi.org/10.1016/S0140-6736(09)61118-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19616840				2022-12-28	WOS:000268815200026
J	Cruickshank, M; Murray, G; Parkin, D; Smart, L; Walker, E; Waugh, N; Avis, M; Chilvers, C; Fielding, K; Hammond, R; Jenkins, D; Johnson, J; Neal, K; Russell, I; Seth, R; Whynes, D; Duncan, I; Robertson, A; Little, J; Sharp, L; Russell, I; Walker, L; Anthony, B; Bell, S; Bowie, A; Brown, K; Brown, J; Chew, K; Cochran, C; Cotton, S; Dean, J; Dunn, K; Edwards, J; Evans, D; Fenty, J; Finlayson, A; Gallagher, M; Gray, N; Heddle, M; Innes, A; Jobson, D; Keillor, M; MacGregor, J; Mackenzie, S; Mackie, A; McPherson, G; Okorocha, I; Reilly, M; Rodgers, J; Thornton, A; Yeats, R; Alexander, L; Buchanan, L; Henderson, S; Iterbeke, T; Lucas, S; Manderson, G; Nicol, S; Reid, G; Robinson, C; Sandilands, T; Adrian, M; Al-Sahab, A; Bentley, E; Brook, H; Bushby, C; Cannon, R; Cooper, B; Dowell, R; Dunderdale, M; Guo, L; Heideman, L; Jones, S; Lawson, S; Philips, Z; Platt, C; Prabhakaran, S; Rippin, J; Thompson, R; Williams, E; Woolley, C; Boroujerdi, M; Cotton, S; Harrild, K; Norrie, J; Day, N; Marteau, T; Parmar, M; Patnick, J; Woodman, C; Altman, D; Moss, S; Wells, M; Sharp, L; Cruickshank, M; Little, J; Cotton, S; Harrild, K; Cochran, C; Duncan, I; Gray, N; Hammond, R; Smart, L; Thornton, A; Waugh, N; Woolley, C				Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman; Avis, Mark; Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave; Duncan, Ian; Robertson, Alistair; Little, Julian; Sharp, Linda; Russell, Ian; Walker, Leslie; Anthony, Breda; Bell, Sarah; Bowie, Adrienne; Brown, Katrina; Brown, Joe; Chew, Kheng; Cochran, Claire; Cotton, Seonaidh; Dean, Jeannie; Dunn, Kate; Edwards, Jane; Evans, David; Fenty, Julie; Finlayson, Al; Gallagher, Marie; Gray, Nicola; Heddle, Maureen; Innes, Alison; Jobson, Debbie; Keillor, Mandy; MacGregor, Jayne; Mackenzie, Sheona; Mackie, Amanda; McPherson, Gladys; Okorocha, Ike; Reilly, Morag; Rodgers, Joan; Thornton, Alison; Yeats, Rachel; Alexander, Lindyanne; Buchanan, Lindsey; Henderson, Susan; Iterbeke, Tine; Lucas, Susanneke; Manderson, Gillian; Nicol, Sheila; Reid, Gael; Robinson, Carol; Sandilands, Trish; Adrian, Marg; Al-Sahab, Ahmed; Bentley, Elaine; Brook, Hazel; Bushby, Claire; Cannon, Rita; Cooper, Brenda; Dowell, Ruth; Dunderdale, Mark; Guo, Li; Heideman, Lisa; Jones, Steve; Lawson, Salli; Philips, Zoe; Platt, Christopher; Prabhakaran, Shakuntala; Rippin, John; Thompson, Rose; Williams, Elizabeth; Woolley, Claire; Boroujerdi, Massoud; Cotton, Seonaidh; Harrild, Kirsten; Norrie, John; Day, Nicholas; Marteau, Theresa; Parmar, Mahesh; Patnick, Julietta; Woodman, Ciaran; Altman, Doug; Moss, Sue; Wells, Michael; Sharp, Linda; Cruickshank, Maggie; Little, Julian; Cotton, Seonaidh; Harrild, Kirsten; Cochran, Claire; Duncan, Ian; Gray, Nicola; Hammond, Rob; Smart, Louise; Thornton, Alison; Waugh, Norman; Woolley, Claire			Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIRECTED PUNCH BIOPSY; SQUAMOUS INTRAEPITHELIAL LESIONS; TREATMENT TOO SOON; SEE-AND-TREAT; TRANSFORMATION ZONE; FOLLOW-UP; LONG-TERM; NEOPLASIA; DIAGNOSIS; BORDERLINE	Objectives To compare the effectiveness of punch biopsy and selective recall for treatment versus a policy of immediate treatment by large loop excision in the management of women with low grade abnormal cervical cytology referred for colposcopy. Design Multicentre individually randomised controlled trial, nested within the NHS cervical screening programmes. Setting Grampian, Tayside, and Nottingham. Participants 1983 women, aged 20-59, with cytology showing borderline nuclear abnormalities or mild dyskaryosis, October 1999-October 2002. Interventions Immediate large loop excision or up to four targeted punch biopsies taken immediately with recall for treatment (by large loop excision) if these showed cervical intraepithelial neoplasia grade II or III or worse. Participants were followed for three years, concluding with an exit colposcopy. Main outcome measures Clinical end points: cumulative incidence of cervical intraepithelial neoplasia grade II or worse and grade III or worse at three years. Clinically significant anxiety and depression and self reported after effects assessed six weeks after colposcopy, biopsies, or large loop excision. Results 879 women (44%) had a normal transformation zone at colposcopy and had no further procedures at that time. Colposcopists were less likely to classify the transformation zone as abnormal when the allocation was large loop excision (603 (60%) in the biopsy and selective recall group; 501 (51%) in the immediate large loop excision group). Of women randomised to biopsy and recall, 157 (16%) required a second clinic visit for treatment. Specimens from almost 60% (n=296) of women who underwent immediate large loop excision showed no cervical intraepithelial neoplasia (31%; n=156) or showed cervical intraepithelial neoplasia grade I (28%; n=140). The percentages of women diagnosed with grade II or worse up to and including the exit examination were 22% (n=216) in the biopsy and recall arm and 23% (n=228) in the immediate large loop excision arm. There was no significant difference between the arms in cumulative incidence of cervical intraepithelial neoplasia grade II or worse (adjusted relative for risk large loop excision v biopsy 1.04, 95% confidence interval 0.86 to 1.25) or grade III or worse (1.03, 0.79 to 1.34). A greater proportion of disease was detected at initial investigation and less during follow-up and at exit in the immediate large loop excision arm, but time of detection did not differ significantly between arms. Levels of anxiety and depression and reported pain did not differ between arms. Higher proportions of women randomised to large loop excision reported moderate or more severe bleeding and discharge. Conclusion A policy of targeted punch biopsies with subsequent treatment for cervical intraepithelial neoplasia grade II or III and cytological surveillance for grade I or less provides the best balance between benefits and harms for the management of women with low grade abnormal cytology referred for colposcopy. Immediate large loop excision results in overtreatment and more after effects and should not be recommended.	[Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman] Univ Aberdeen & NHS Grampian, Aberdeen, Scotland; [Avis, Mark; Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave] Univ Nottingham & Nottingham NHS, Nottingham, England; [Duncan, Ian; Robertson, Alistair] Univ Dundee & NHS Tayside, Dundee, Tayside, Scotland; [Little, Julian] Univ Ottawa, Ottawa, ON, Canada; [Sharp, Linda] Natl Canc Registry, Cork, Ireland; [Russell, Ian] Bangor Univ, Bangor, Gwynedd, Wales; [Walker, Leslie] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Aberdeen; University of Nottingham; University of Dundee; University of Ottawa; Bangor University; University of Hull	Sharp, L (corresponding author), Natl Canc Registry, Bldg 6800,Cork Airport Business Pk,Kinsale Rd, Cork, Ireland.	linda.sharp@ncri.ie	Little, Julian/AAR-6117-2020; Russell, Ian T/H-1181-2012; Chahchahi, Sarah/Q-6499-2016	Little, Julian/0000-0001-5026-5531; Marteau, Theresa/0000-0003-3025-1129	Medical Research Council [G9700808]; NHS in England and Scotland; MRC [G9700808] Funding Source: UKRI; Chief Scientist Office [HSRU1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS in England and Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office	This study was funded by the Medical Research Council (grant No G9700808) and the NHS in England and Scotland.	Allard Jay E, 2005, J Low Genit Tract Dis, V9, P36, DOI 10.1097/00128360-200501000-00008; Balasubramani L, 2007, BJOG-INT J OBSTET GY, V114, P39, DOI 10.1111/j.1471-0528.2006.01160.x; BONARDI R, 1992, OBSTET GYNECOL, V80, P1020; BOSCH FX, 2005, AETIOLOGY CERVICAL C; BUXTON EJ, 1991, BRIT J OBSTET GYNAEC, V98, P1273, DOI 10.1111/j.1471-0528.1991.tb15401.x; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Cotton SC, 2006, CONTEMP CLIN TRIALS, V27, P449, DOI 10.1016/j.cct.2006.04.001; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cruickshank M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2549; DENNY LA, 1995, BRIT J OBSTET GYNAEC, V102, P545, DOI 10.1111/j.1471-0528.1995.tb11358.x; DOYLE M, 1992, BRIT J OBSTET GYNAEC, V99, P1023, DOI 10.1111/j.1471-0528.1992.tb13714.x; Duncan ID, 2007, BJOG-INT J OBSTET GY, V114, P777, DOI 10.1111/j.1471-0528.2007.01368.x; Dunn Terry S, 2003, J Low Genit Tract Dis, V7, P104, DOI 10.1097/00128360-200304000-00006; Etherington LJ, 1997, BRIT J OBSTET GYNAEC, V104, P1380, DOI 10.1111/j.1471-0528.1997.tb11007.x; Ferris Daron G, 2005, J Low Genit Tract Dis, V9, P29, DOI 10.1097/00128360-200501000-00007; FLANNELLY G, 1994, BRIT MED J, V308, P1399, DOI 10.1136/bmj.308.6941.1399; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Guido RS, 2005, AM J OBSTET GYNECOL, V193, P1331, DOI 10.1016/j.ajog.2005.05.008; Holschneider CH, 1999, OBSTET GYNECOL, V94, P377, DOI 10.1016/S0029-7844(99)00337-3; HOWE DT, 1991, BRIT J OBSTET GYNAEC, V98, P588, DOI 10.1111/j.1471-0528.1991.tb10376.x; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; KITCHENER HC, 1995, BRIT J OBSTET GYNAEC, V102, P549, DOI 10.1111/j.1471-0528.1995.tb11359.x; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LUESLEY DM, 2002, HDB COLPOSCOPY, pCH4; Massad LS, 1996, GYNECOL ONCOL, V60, P400, DOI 10.1006/gyno.1996.0062; *NCI, 2004, TREATM INF HLTH PROF; *NHS CERV SCREEN P, 2004, NHSCSP PUBL, V20; *NHS CERV SCREEN P, 1996, NHSCSP PUBL, V2; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141; Raffle AE, 2007, SCREENING EVIDENCE P; Rana DN, 2004, CYTOPATHOLOGY, V15, P263, DOI 10.1111/j.1365-2303.2004.00194.x; Sadan O, 2007, EUR J OBSTET GYN R B, V131, P73, DOI 10.1016/j.ejogrb.2005.12.025; Scheungraber C, 2004, BRIT J CANCER, V90, P975, DOI 10.1038/sj.bjc.6601415; Smith MCG, 2006, BJOG-INT J OBSTET GY, V113, P1321, DOI 10.1111/j.1471-0528.2006.01065.x; *TOMBOLA GROUP, 2009, BR J OBSTET GYN 0707; *TOMBOLA GROUP, 2006, J LOW GENIT TRACT DI, V10, P26; *TOMBOLA GROUP, 2009, BMJ-BRIT MED J, V389, pB2546; van Hamont D, 2006, INT J GYNECOL CANCER, V16, P615, DOI 10.1111/j.1525-1438.2006.00404.x; WALKER EM, 1986, LANCET, V2, P672; Woolley C, 2007, INT J TECHNOL ASSESS, V23, P232, DOI 10.1017/S026646230707016X; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; CERVICAL CYTOLOGY WO; CERVICAL SCREENING P	47	33	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2548	10.1136/bmj.b2548	http://dx.doi.org/10.1136/bmj.b2548			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PG	19638647	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000268672800002
J	Sasieni, P; Castanon, A; Cuzick, J				Sasieni, Peter; Castanon, Alejandra; Cuzick, Jack			Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							YOUNG-WOMEN; CANCER; TRENDS; MORTALITY; AMERICAN; BENEFIT; AUDIT	Objective To study the effect of cervical screening on incidence of cervical cancer as a function of age with particular focus on women screened under the age of 25. Design Population based case-control study with prospectively recorded data on cervical screening. Setting Selected centres in the United Kingdom. Participants 4012 women aged 20-69 with invasive cancer diagnosed in participating centres and two controls per case individually matched on age and area of residence. Main outcome measures Odds ratios for strength of association between cervical cancer and screening at particular ages. Results There is no evidence that screening women aged 22-24 reduced the incidence of cervical cancer at ages 2529 (odds ratio 1.11, 95% confidence interval 0.83 to 1.50). Similar results were seen for cancers restricted to squamous carcinoma or FIGO (International Federation of Gynaecology and Obstetrics) stage IB or worse, but the numbers are insufficient to provide narrow confidence intervals. Screening was associated with a 60% reduction of cancers in women aged 40, increasing to 80% at age 64. Screening was particularly effective in preventing advanced stage cancers. Conclusions Cervical screening in women aged 20-24 has little or no impact on rates of invasive cervical cancer up to age 30. Some uncertainly still exists regarding its impact on advanced stage tumours in women under age 30. By contrast, screening older women leads to a substantial reduction in incidence of and mortality from cervical cancer. These data should help policy makers balance the impact of screening on cancer rates against its harms, such as overtreatment of lesions with little invasive potential.	[Sasieni, Peter; Castanon, Alejandra; Cuzick, Jack] Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London EC1M 6BQ, England	Cancer Research UK; University of London; Queen Mary University London	Sasieni, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London EC1M 6BQ, England.	p.sasieni@qmul.ac.uk	; Castanon, Alejandra/G-1506-2013	Sasieni, Peter/0000-0003-1509-8744; Castanon, Alejandra/0000-0002-1101-6548	Cancer Research UK [C8162/A6127, C8162/A9481]; NHS	Cancer Research UK(Cancer Research UK); NHS	This work was supported by Cancer Research UK (C8162/A6127 and C8162/A9481) and previously by the NHS cervical screening programme. Neither organisation had any input in the analysis or interpretation of the data or the writing of the paper.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; [Anonymous], 1986, IARC Sci Publ, P15; Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.3.CO;2-E; Bano F, 2008, EUR J OBSTET GYN R B, V139, P86, DOI 10.1016/j.ejogrb.2007.08.020; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P677, DOI 10.1158/1055-9965.EPI-04-0569; Crocetti E, 2007, EUR J CANCER PREV, V16, P564, DOI 10.1097/CEJ.0b013e3280145c14; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Fiander AN, 2008, J FAM PLAN REPROD H, V34, P19, DOI 10.1783/147118908783332104; Herbert A, 2008, J FAM PLAN REPROD H, V34, P21, DOI 10.1783/147118908783332078; *HLTH SOC CAR INF, 2006, CERV SCREEN PROGR EN; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Nair MS, 2007, J OBSTET GYNAECOL, V27, P706, DOI 10.1080/01443610701612532; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; Rieck GC, 2006, J MED SCREEN, V13, P64, DOI 10.1258/096914106777589551; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Sigurdsson K, 2007, EUR J CANCER, V43, P769, DOI 10.1016/j.ejca.2006.11.017; Yang BH, 2008, CANCER CAUSE CONTROL, V19, P569, DOI 10.1007/s10552-008-9118-9; Zappa M, 2004, BRIT J CANCER, V90, P1784, DOI 10.1038/sj.bjc.6601754	22	107	114	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2968	10.1136/bmj.b2968	http://dx.doi.org/10.1136/bmj.b2968			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PG	19638651	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000268672800010
J	Bascompte, J				Bascompte, Jordi			Disentangling the Web of Life	SCIENCE			English	Editorial Material							MUTUALISTIC NETWORKS; FOOD; ARCHITECTURE; INCREASES; GRAPHS	Biodiversity research typically focuses on species richness and has often neglected interactions, either by assuming that such interactions are homogeneously distributed or by addressing only the interactions between a pair of species or a few species at a time. In contrast, a network approach provides a powerful representation of the ecological interactions among species and highlights their global interdependence. Understanding how the responses of pairwise interactions scale to entire assemblages remains one of the great challenges that must be met as society faces global ecosystem change.	CSIC, Estac Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, Calle Amer Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008	Bascompte, Jordi/0000-0002-0108-6411				Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; [Anonymous], 1861, ORIGIN SPECIES MEANS; Aparicio JP, 2007, P ROY SOC B-BIOL SCI, V274, P505, DOI 10.1098/rspb.2006.0057; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Holt RD, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P333; Kondoh M, 2008, P NATL ACAD SCI USA, V105, P16631, DOI 10.1073/pnas.0805870105; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; PIMM SL, 1982, FOOD WEBS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Sugihara G., 1982, THESIS PRINCETON U P; Thompson J.N., 2005, INTERSPEC INTERACT; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2	31	291	301	4	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					416	419		10.1126/science.1170749	http://dx.doi.org/10.1126/science.1170749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628856				2022-12-28	WOS:000268255100040
J	Maines, TR; Jayaraman, A; Belser, JA; Wadford, DA; Pappas, C; Zeng, H; Gustin, KM; Pearce, MB; Viswanathan, K; Shriver, ZH; Raman, R; Cox, NJ; Sasisekharan, R; Katz, JM; Tumpey, TM				Maines, Taronna R.; Jayaraman, Akila; Belser, Jessica A.; Wadford, Debra A.; Pappas, Claudia; Zeng, Hui; Gustin, Kortney M.; Pearce, Melissa B.; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Cox, Nancy J.; Sasisekharan, Ram; Katz, Jacqueline M.; Tumpey, Terrence M.			Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice	SCIENCE			English	Article							INCREASED VIRULENCE; PANDEMIC INFLUENZA; HEMAGGLUTININ	Recent reports of mild to severe influenza-like illness in humans caused by a novel swine-origin 2009 A(H1N1) influenza virus underscore the need to better understand the pathogenesis and transmission of these viruses in mammals. In this study, selected 2009 A(H1N1) influenza isolates were assessed for their ability to cause disease in mice and ferrets and compared with a contemporary seasonal H1N1 virus for their ability to transmit to naive ferrets through respiratory droplets. In contrast to seasonal influenza H1N1 virus, 2009 A(H1N1) influenza viruses caused increased morbidity, replicated to higher titers in lung tissue, and were recovered from the intestinal tract of intranasally inoculated ferrets. The 2009 A(H1N1) influenza viruses exhibited less efficient respiratory droplet transmission in ferrets in comparison with the highly transmissible phenotype of a seasonal H1N1 virus. Transmission of the 2009 A(H1N1) influenza viruses was further corroborated by characterizing the binding specificity of the viral hemagglutinin to the sialylated glycan receptors (in the human host) by use of dose-dependent direct receptor-binding and human lung tissue-binding assays.	[Maines, Taronna R.; Belser, Jessica A.; Wadford, Debra A.; Pappas, Claudia; Zeng, Hui; Gustin, Kortney M.; Pearce, Melissa B.; Cox, Nancy J.; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Jayaraman, Akila; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jayaraman, Akila; Viswanathan, Karthik; Shriver, Zachary H.; Raman, Rahul; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tft9@cdc.gov		Wadford, Debra/0000-0002-8630-427X	Singapore-MIT Alliance for Research and Technology; National Institute of General Medical Sciences of the NIH [GM 57073, U54 GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, R37GM057073, U54GM062116] Funding Source: NIH RePORTER	Singapore-MIT Alliance for Research and Technology; National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Blair (Naval Health Research Center, San Diego), G. J. Demmler (Texas Childrens Hospital, Houston), C. Alpuche-Aranda [Instituto de Diagnostico y Referencia Epidemiologicos, Mexico], and the WHO Collaborating Centre for Reference and Research on Influenza (Melbourne) for facilitating access to viruses. We also thank X. Lu and A. Balish for preparation of viruses and V. Veguilla for statistical analysis. R.S. acknowledges the consortium for functional glycomics for providing glycan standards and support from the Singapore-MIT Alliance for Research and Technology and the National Institute of General Medical Sciences of the NIH (GM 57073 and U54 GM62116). Confocal microscopy of the human lung tissue sections was performed at the W. M. Keck Foundation Biological Imaging Facility at the Whitehead Institute. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; DAWOOD FS, 2009, J MED, V360, P2605; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; TUMPEY TM, 2009, ANNU REV MICROBIOL, V63, P252; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	21	523	563	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					484	487		10.1126/science.1177238	http://dx.doi.org/10.1126/science.1177238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574347	Green Accepted, Green Submitted			2022-12-28	WOS:000268255100059
J	Karlsson, J; Bystrom, P; Ask, J; Ask, P; Persson, L; Jansson, M				Karlsson, Jan; Bystrom, Par; Ask, Jenny; Ask, Per; Persson, Lennart; Jansson, Mats			Light limitation of nutrient-poor lake ecosystems	NATURE			English	Article							DISSOLVED ORGANIC-CARBON; CLEAR-WATER LAKES; PHOSPHORUS LIMITATION; FOOD WEBS; BIOMASS; EUTROPHICATION; IMPACT; EXPORT	Productivity denotes the rate of biomass synthesis in ecosystems and is a fundamental characteristic that frames ecosystem function and management. Limitation of productivity by nutrient availability is an established paradigm for lake ecosystems(1-3). Here, we assess the relevance of this paradigm for a majority of the world's small, nutrient-poor lakes, with different concentrations of coloured organic matter(4,5). By comparing small unproductive lakes along a water colour gradient, we show that coloured terrestrial organic matter controls the key process for new biomass synthesis (the benthic primary production) through its effects on light attenuation. We also show that this translates into effects on production and biomass of higher trophic levels (benthic invertebrates and fish). These results are inconsistent with the idea that nutrient supply primarily controls lake productivity, and we propose that a large share of the world's unproductive lakes, within natural variations of organic carbon and nutrient input, are limited by light and not by nutrients. We anticipate that our result will have implications for understanding lake ecosystem function and responses to environmental change. Catchment export of coloured organic matter is sensitive to short-term natural variability and long-term, large-scale changes, driven by climate and different anthropogenic influences(6,7). Consequently, changes in terrestrial carbon cycling will have pronounced effects on most lake ecosystems by mediating changes in light climate and productivity of lakes.	[Karlsson, Jan] Umea Univ, Dept Ecol & Environm Sci, CIRC, SE-98107 Abisko, Sweden; [Bystrom, Par; Ask, Jenny; Ask, Per; Persson, Lennart; Jansson, Mats] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden	Umea University; Umea University	Karlsson, J (corresponding author), Umea Univ, Dept Ecol & Environm Sci, CIRC, Box 62, SE-98107 Abisko, Sweden.	Jan.Karlsson@emg.umu.se	Persson, Lennart/B-2885-2012; Ask, Jenny/AGL-6833-2022	Ask, Jenny/0000-0003-2156-4908	Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas)	The study was part of the research environment LEREC (Lake Ecosystem Response to Environmental Change), financially supported by Formas (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning). We thank the Abisko Scientific Research Station, the Swedish Meteorological and Hydrological Institute and the Umea Marine Sciences Centre for providing PAR data, M. Morth and J. Johansson for chemical analysis and C. Hein for language editing.	Ask J, 2009, ECOLOGY, V90, P1923, DOI 10.1890/07-1855.1; Blenckner T, 2004, BOREAL ENVIRON RES, V9, P371; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Carpenter SR, 1998, LIMNOL OCEANOGR, V43, P73, DOI 10.4319/lo.1998.43.1.0073; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; ELORANTA P, 1978, Holarctic Ecology, V1, P362; HANSON JM, 1982, CAN J FISH AQUAT SCI, V39, P257, DOI 10.1139/f82-036; HANSSON LA, 1992, LIMNOL OCEANOGR, V37, P322, DOI 10.4319/lo.1992.37.2.0322; HOPE D, 1994, ENVIRON POLLUT, V84, P301, DOI 10.1016/0269-7491(94)90142-2; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Karlsson J, 2005, LIMNOL OCEANOGR, V50, P538, DOI 10.4319/lo.2005.50.2.0538; Karlsson J, 2003, LIMNOL OCEANOGR, V48, P269, DOI 10.4319/lo.2003.48.1.0269; Karlsson J, 2002, ECOLOGY, V83, P2902, DOI 10.1890/0012-9658(2002)083[2902:SRBPPA]2.0.CO;2; MCCAULEY E., 1984, MANUAL METHODS ASSES, P228, DOI DOI 10.1002/IROH.19860710218; McQuarrie A. D, 1998, REGRESSION TIME SERI; MEILI M, 1992, HYDROBIOLOGIA, V229, P23, DOI 10.1007/BF00006988; Mulholland P.J., 2003, AQUATIC ECOSYSTEMS I, P139, DOI [10.1016/B978-012256371-3/50007-X, 10.1016/b978-012256371-3/50007-x]; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; SVARDSON G, 1976, 56 I FRESHW RES, P144; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2	30	523	534	19	470	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 23	2009	460	7254					506	U80		10.1038/nature08179	http://dx.doi.org/10.1038/nature08179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626113				2022-12-28	WOS:000268257000037
J	Thompson, DM; Parker, R				Thompson, Debrah M.; Parker, Roy			Stressing Out over tRNA Cleavage	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CELL-PROLIFERATION; OXIDATIVE STRESS; ANGIOGENIN; RIBONUCLEASE; APOPTOSIS; TUMOR; EXPRESSION; STARVATION	A conserved response to stress involves endonucleolytic cleavage of cytoplasmic transfer RNAs (tRNAs) by ribonucleases that are normally secreted or sequestered. Ribonuclease activation or release is an intriguing new aspect of cellular stress responses, with a potential impact on translation, apoptosis, cancer, and disease progression.	[Thompson, Debrah M.; Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Acquati F, 2005, INT J ONCOL, V26, P1159; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; ARDELT W, 1991, J BIOL CHEM, V266, P245; BOREK E, 1977, CANCER RES, V37, P3362; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Iordanov MS, 2000, CANCER RES, V60, P1983; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; LEVITZ R, 1990, EMBO J, V9, P1383, DOI 10.1002/j.1460-2075.1990.tb08253.x; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Smirnoff P, 2006, CANCER-AM CANCER SOC, V107, P2760, DOI 10.1002/cncr.22327; SPEER J, 1979, CANCER, V44, P2120, DOI 10.1002/1097-0142(197912)44:6<2120::AID-CNCR2820440623>3.0.CO;2-6; STCLAIR DK, 1988, BIOCHEMISTRY-US, V27, P7263, DOI 10.1021/bi00419a013; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	40	296	310	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					215	219		10.1016/j.cell.2009.07.001	http://dx.doi.org/10.1016/j.cell.2009.07.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632169	Bronze			2022-12-28	WOS:000268277000001
J	Djousse, L; Driver, JA; Gaziano, JM				Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael			Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; DIETARY LINOLENIC ACID; UNITED-STATES; PHYSICIANS HEALTH; CARDIOVASCULAR HEALTH; ALCOHOL-CONSUMPTION; PRIMARY PREVENTION; NATIONAL-HEART; BLOOD-PRESSURE; TRENDS	Context The lifetime risk of heart failure at age 40 years is approximately 1 in 5 in the general population; however, little is known about the association between modifiable lifestyle factors and the remaining lifetime risk of heart failure. Objective To examine the association between modifiable lifestyle factors and the lifetime risk of heart failure in a large cohort of men. Design, Setting, and Participants Prospective cohort study using data from 20 900 men (mean age at baseline, 53.6 years) from the Physicians' Health Study I (19822008) who were apparently healthy at baseline. Six modifiable lifestyle factors were assessed: body weight, smoking, exercise, alcohol intake, consumption of breakfast cereals, and consumption of fruits and vegetables. Main Outcome Measure Lifetime risk of heart failure. Results During a mean follow-up of 22.4 years, 1200 men developed heart failure. Overall, the lifetime risk of heart failure was 13.8% (95% confidence interval [CI], 12.9%-14.7%) at age 40 years. Lifetime risk remained constant in men who survived free of heart failure through age 70 years and reached 10.6% (95% CI, 9.4%-11.7%) at age 80 years. Lifetime risk of heart failure was higher in men with hypertension than in those without hypertension. Healthy lifestyle habits (normal body weight, not smoking, regular exercise, moderate alcohol intake, consumption of breakfast cereals, and consumption of fruits and vegetables) were individually and jointly associated with a lower lifetime risk of heart failure, with the highest risk in men adhering to none of the 6 lifestyle factors (21.2%; 95% CI, 16.8%-25.6%) and the lowest risk in men adhering to 4 or more desirable factors (10.1%; 95% CI, 7.9%-12.3%). Conclusion In this cohort of apparently healthy men, adherence to healthy lifestyle factors is associated with a lower lifetime risk of heart failure. JAMA. 2009;302(4):394-400	[Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Boston, MA 02120 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] MAVERIC, Boston, MA USA; [Djousse, Luc; Driver, Jane A.; Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Res Ctr GRECC, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center	Djousse, L (corresponding author), Brigham & Womens Hosp, Div Aging, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	ldjousse@rics.bwh.harvard.edu	Djousse, Luc/F-5033-2017	Djousse, Luc/0000-0002-9902-3047	National Cancer Institute [CA-34944, CA-40360, CA097193]; National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-26490, HL-34595]; NATIONAL CANCER INSTITUTE [R01CA040360, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Physicians' Health Study (PHS) is supported by grants CA-34944, CA-40360, and CA097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Djousse L, 2005, CIRCULATION, V111, P2921, DOI 10.1161/CIRCULATIONAHA.104.489534; Djousse L, 2001, AM J CLIN NUTR, V74, P612; Djousse L, 2007, CURR CARDIOVASC RISK, V1, P330, DOI 10.1007/s12170-007-0053-1; Djousse L, 2007, AM HEART J, V154, P855, DOI 10.1016/j.ahj.2007.07.004; Djousse L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; GARG R, 1993, J AM COLL CARDIOL  S, V22, P3; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; Goldberg RJ, 2005, AM J MED, V118, P728, DOI 10.1016/j.amjmed.2005.04.013; Goldberg RJ, 2005, AM J CARDIOL, V95, P1324, DOI 10.1016/j.amjcard.2005.01.076; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; HO KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kochar J, 2007, OBESITY, V15, P3039, DOI 10.1038/oby.2007.362; Koelling TM, 2004, AM HEART J, V147, P74, DOI 10.1016/j.ahj.2003.07.021; Lazarevic AM, 2000, J AM COLL CARDIOL, V35, P1599, DOI 10.1016/S0735-1097(00)00565-9; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Massie BM, 1997, AM HEART J, V133, P703, DOI 10.1016/S0002-8703(97)70173-X; Moore LL, 2005, EPIDEMIOLOGY, V16, P4, DOI 10.1097/01.ede.0000147106.32027.3e; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Piano MR, 2002, CHEST, V121, P1638, DOI 10.1378/chest.121.5.1638; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Shahar E, 2004, J CARD FAIL, V10, P374, DOI 10.1016/j.cardfail.2004.02.003; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	46	285	297	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					394	400		10.1001/jama.2009.1062	http://dx.doi.org/10.1001/jama.2009.1062			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622818	Green Accepted, Bronze			2022-12-28	WOS:000268139200022
J	Chan, WS; Lee, A; Spencer, FA; Crowther, M; Rodger, M; Ramsay, T; Ginsberg, JS				Chan, Wee-Shian; Lee, Agnes; Spencer, Frederick A.; Crowther, Mark; Rodger, Marc; Ramsay, Tim; Ginsberg, Jeffrey S.			Predicting Deep Venous Thrombosis in Pregnancy: Out in "LEFt" Field?	ANNALS OF INTERNAL MEDICINE			English	Article							VEIN THROMBOSIS; D-DIMER; PULMONARY-EMBOLISM; DIAGNOSTIC MANAGEMENT; CLINICAL-ASSESSMENT; THROMBOEMBOLISM; RISK; HISTORY; TRIAL; WOMEN	Background: Clinicians' assessment of pretest probability, based on subjective criteria or prediction rules, is central to the diagnosis of deep venous thrombosis (DVT). Pretest probability assessment for DVT diagnosis has never been evaluated in pregnant women. Objective: To evaluate the accuracy of clinicians' subjective assessment of pretest probability for DVT diagnosis and identify prediction variables that could be used for pretest probability assessment in pregnant women with suspected DVT. Design: A cross-sectional study conducted over 7 years (March 2000 to April 2007). Setting: 5 university-affiliated, tertiary care centers in Canada. Patients: 194 unselected pregnant women with suspected first DVT. Intervention: Diagnosis of DVT was established with abnormal compression ultrasonography at presentation or on serial imaging. Pretest probability by subjective assessment was recorded by thrombosis experts for each patient before knowledge of results. Measurements: The sensitivity, specificity, negative predictive value, and likelihood ratios of subjective pretest probability assessment and their corresponding 95% CIs were calculated on the basis of the diagnosis of DVT. Patients were DVT positive if they had diagnostic compression ultrasonography at initial or serial testing or symptomatic venous thromboembolism on follow-up. Patients were DVT negative if they had negative compression ultrasonography at presentation and no venous thromboembolism on follow-up. A prediction rule for assessing DVT was derived, and an internal validation study was done to explore its performance. Results: The prevalence of DVT was 8.8%. Clinicians' subjective assessment of pretest probability categorized patients into 2 groups: low pretest probability (two thirds of patients) with a low prevalence of DVT (1.5% [95% CI, 0.4% to 5.4%]) and a negative predictive value of 98.5% (CI, 94.6% to 99.6%), and nonlow pretest probability with a higher prevalence of DVT (24.6% [CI, 15.5% to 36.7%]). Three variables (symptoms in the left leg [L], calf circumference difference >= 2 cm [E], and first trimester presentation [Ft]) were highly predictive of DVT in pregnant patients. Limitations: Few outcomes occurred. Altogether, 17 events were diagnosed during the study. The prediction rule derived should be validated on an independent sample before applying it to clinical practice. Conclusion: Subjective assessment of pretest probability seems to exclude DVT when the pretest probability is low. Moreover, 3 objective variables ("LEFt") may improve the accuracy of the diagnosis of DVT in pregnancy. Prospective validation studies are needed.	[Chan, Wee-Shian] Womens Coll Hosp, Dept Med, Toronto, ON M5G 1B2, Canada; McMaster Univ, Med Ctr, Hamilton Hlth Sci Corp, Ottawa, ON L8V 1C3, Canada; St Josephs Hosp, Hamilton, ON L8N 4A6, Canada; Ottawa Hosp, Ottawa, ON K1H 8L6, Canada; Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; McMaster University; McGill University; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Chan, WS (corresponding author), Womens Coll Hosp, Dept Med, 76 Grenville St, Toronto, ON M5G 1B2, Canada.	wee-shian.chan@wchospital.ca	ginsberg, jeffrey s/ABC-1065-2020	Chan, Wee-Shian/0000-0002-2513-0480; Ramsay, Tim/0000-0001-8478-8170; Rodger, Marc/0000-0001-8166-3487	Heart and Stroke Foundation of Ontario [NA 5048]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Partial funding by the Heart and Stroke Foundation of Ontario ( grant NA 5048) to recruit half of the patients in the cohort.	Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bernardi E, 1998, BRIT MED J, V317, P1037; Brill-Edwards P, 2000, NEW ENGL J MED, V343, P1439, DOI 10.1056/NEJM200011163432002; Chan WS, 2002, THROMB RES, V107, P85, DOI 10.1016/S0049-3848(02)00105-6; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Motulsky H., 1995, INTUITIVE BIOSTATIST; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x; Rathbun SW, 2004, ANN INTERN MED, V141, P839, DOI 10.7326/0003-4819-141-11-200412070-00007; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	19	86	89	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					85	W22		10.7326/0003-4819-151-2-200907210-00004	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620161				2022-12-28	WOS:000268605300002
J	Usherwood, T				Usherwood, Tim			Review: Differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Usherwood, T (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.							Malhi GS, 2009, ACTA PSYCHIAT SCAND, V119, P8, DOI 10.1111/j.1600-0447.2009.01382.x	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-10	10.7326/0003-4819-151-2-200907210-02010	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620154				2022-12-28	WOS:000268605300018
J	Cooper, TA				Cooper, Thomas A.			Neutralizing Toxic RNA	SCIENCE			English	Editorial Material							MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; PROTEINS; BINDING		[Cooper, Thomas A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	tcooper@bcm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060733, R01AR045653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076493] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL045565] Funding Source: Medline; NIAMS NIH HHS [R01 AR045653, R01 AR060733] Funding Source: Medline; NIGMS NIH HHS [R01 GM076493] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Bonetta L, 2009, CELL, V136, P581, DOI 10.1016/j.cell.2009.02.010; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Harper PS, 2001, MYOTONIC DYSTROPHY; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Rudnick SI, 2008, P NATL ACAD SCI USA, V105, P13787, DOI 10.1073/pnas.0805781105; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Townsend D, 2008, MOL THER, V16, P832, DOI 10.1038/mt.2008.52; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110	16	9	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					272	273		10.1126/science.1177452	http://dx.doi.org/10.1126/science.1177452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608901				2022-12-28	WOS:000268036600028
J	Lobo-Checa, J; Matena, M; Muller, K; Dil, JH; Meier, F; Gade, LH; Jung, TA; Stohr, M				Lobo-Checa, Jorge; Matena, Manfred; Mueller, Kathrin; Dil, Jan Hugo; Meier, Fabian; Gade, Lutz H.; Jung, Thomas A.; Stoehr, Meike			Band Formation from Coupled Quantum Dots Formed by a Nanoporous Network on a Copper Surface	SCIENCE			English	Article							SCANNING TUNNELING SPECTROSCOPY; METAL-SURFACE; BINARY SUPERLATTICES; CONFINEMENT; STATES; METAMATERIALS; MOLECULES; ELECTRONS; INDEX	The properties of crystalline solids can to a large extent be derived from the scale and dimensionality of periodic arrays of coupled quantum systems such as atoms and molecules. Periodic quantum confinement in two dimensions has been elusive on surfaces, mainly because of the challenge to produce regular nanopatterned structures that can trap electronic states. We report that the two-dimensional free electron gas of the Cu(111) surface state can be trapped within the pores of an organic nanoporous network, which can be regarded as a regular array of quantum dots. Moreover, a shallow dispersive electronic band structure is formed, which is indicative of electronic coupling between neighboring pore states.	[Lobo-Checa, Jorge; Matena, Manfred; Stoehr, Meike] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Mueller, Kathrin; Jung, Thomas A.] Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, Switzerland; [Dil, Jan Hugo; Meier, Fabian] Univ Zurich, Inst Phys, CH-8057 Zurich, Switzerland; [Dil, Jan Hugo; Meier, Fabian] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Gade, Lutz H.] Heidelberg Univ, Inst Anorgan Chem, D-69120 Heidelberg, Germany	University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Ruprecht Karls University Heidelberg	Lobo-Checa, J (corresponding author), Ctr Invest Nanociencia & Nanotecnol, Barcelona 08193, Spain.	jorge.lobo@cin2.es; thomas.jung@psi.ch; meike.stoehr@unibas.ch	Stoehr, Meike/A-3832-2008; Lobo-Checa, Jorge/D-3570-2009; Jung, Thomas A/C-9672-2010; Dil, Hugo/F-6995-2012; Küster, Kathrin/H-1902-2011; Jung, Thomas/AAE-3580-2019	Stoehr, Meike/0000-0002-1478-6118; Lobo-Checa, Jorge/0000-0003-2698-2543; Jung, Thomas A/0000-0003-0717-9886; Dil, Hugo/0000-0002-6016-6120; Küster, Kathrin/0000-0002-3185-6982; Jung, Thomas/0000-0003-0717-9886	Swiss National Science Foundation; National Center of Competence in Research; European Union; Marie Curie Research Training Network PRAIRIES; Wolfermann-Nageli-Stiftung; Bundesministerum fur Bildung und Forschung (BMBF); Swiss Federal Commission for Technology and Innovation (CTI)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research(Swiss National Science Foundation (SNSF)); European Union(European Commission); Marie Curie Research Training Network PRAIRIES(European Commission); Wolfermann-Nageli-Stiftung; Bundesministerum fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Swiss Federal Commission for Technology and Innovation (CTI)	We thank H.-J. Guntherodt for continuous support; J. Osterwalder and T. Greber for fruitful discussions and providing access to the ARPES experimental station, hosted at the Surface and Interface Spectroscopy beamline of the Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland; and Nanonis for fruitful collaboration on the STM/STS data acquisition system. Supported by the Swiss National Science Foundation, the National Center of Competence in Research "Nanoscale Science," the European Union through the Marie Curie Research Training Network PRAIRIES, the Wolfermann-Nageli-Stiftung, the Bundesministerum fur Bildung und Forschung (BMBF) Cluster "Forum Organic Electronics" (Heidelberg), and the Swiss Federal Commission for Technology and Innovation (CTI).	Ashcroft N.W., 1976, SOLID STATE PHYS; BISCHLER U, 1993, PHYS REV LETT, V71, P2296, DOI 10.1103/PhysRevLett.71.2296; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Dil H, 2008, SCIENCE, V319, P1824, DOI 10.1126/science.1154179; Gross L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.056103; HASEGAWA Y, 1993, PHYS REV LETT, V71, P1071, DOI 10.1103/PhysRevLett.71.1071; HERRON N, 1995, J INCLUS PHENOM MOL, V21, P283; Jensen H, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155417; Kiebele A, 2006, CHEMPHYSCHEM, V7, P1462, DOI 10.1002/cphc.200600186; Kliewer J, 2001, NEW J PHYS, V3, DOI 10.1088/1367-2630/3/1/322; Li JT, 1998, PHYS REV LETT, V80, P3332, DOI 10.1103/PhysRevLett.80.3332; Lobo J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137602; Mugarza A, 2003, J PHYS-CONDENS MAT, V15, pS3281, DOI 10.1088/0953-8984/15/47/006; Pennec Y, 2007, NAT NANOTECHNOL, V2, P99, DOI 10.1038/nnano.2006.212; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Reinert F, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115415; Rogach AL, 2004, ANGEW CHEM INT EDIT, V43, P148, DOI 10.1002/anie.200301704; SANCHEZ O, 1995, PHYS REV B, V52, P7894, DOI 10.1103/PhysRevB.52.7894; Schlickum U, 2007, NANO LETT, V7, P3813, DOI 10.1021/nl072466m; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Stohr M, 2005, ANGEW CHEM INT EDIT, V44, P7394, DOI 10.1002/anie.200502316; Stohr M, 2007, SMALL, V3, P1336, DOI 10.1002/smll.200700099; Theobald JA, 2003, NATURE, V424, P1029, DOI 10.1038/nature01915; Walser RM, 2001, PROC SPIE, V4467, P1, DOI 10.1117/12.432921; Wiesendanger R., 1994, SCANNING PROBE MICRO	29	113	113	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					300	303		10.1126/science.1175141	http://dx.doi.org/10.1126/science.1175141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608913	Green Accepted, Green Submitted			2022-12-28	WOS:000268036600040
J	Kahn, JA				Kahn, Jessica A.			HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-6; CANCER-SOCIETY GUIDELINE; PARTICLE VACCINE; DOUBLE-BLIND; YOUNG-WOMEN; INFECTION; EFFICACY; RISK; IMMUNOGENICITY; IMPACT	A sexually active 18-year-old woman presents to her internist for an annual examination. During the review of her family history, she notes that her mother recently received a diagnosis of "pre-cervical cancer" and underwent a loop electrosurgical excision procedure. The patient's mother has advised her to get the "cervical-cancer shot." Should this patient receive a human papillomavirus (HPV) vaccine, and how effective would vaccination be in preventing cervical cancer?	Cincinnati Childrens Hosp Med Ctr, Div Adolescent Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Kahn, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Adolescent Med, MLC 4000,3333 Burnet Ave, Cincinnati, OH 45229 USA.	jessica.kahn@cchmc.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Kahn reports being coprincipal investigator in a clinical trial of HPV vaccination that is funded by the National Institutes of Health; Merck is providing immunogenicity testing and vaccine, but no salary or other support, for this trial. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P118; [Anonymous], 2010, REP HLTH CONC FOLL H; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Bergler WF, 2000, EUR ARCH OTO-RHINO-L, V257, P263, DOI 10.1007/s004050050236; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bocchini JA, 2007, PEDIATRICS, V120, P666, DOI 10.1542/peds.2007-1735; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Brewer NT, 2007, ANN BEHAV MED, V34, P95, DOI 10.1007/BF02879925; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; *CDCP, SUMM TABL CERV CANC; *CDCP, 2009 CHILD AD IMM SC; *CDCP, HPV VACC INF YOUNG W; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; *FOOD DRUG ADM, 2008, PROD APPR INF HUM PA; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Friedman LS, 2006, J ADOLESCENT HEALTH, V39, P620, DOI 10.1016/j.jadohealth.2006.07.013; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GIULIANO AR, 2008, EUROGIN EUR RES ORG; HARPER D, 2008, 39 ANN M SOC GYN ONC; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Heideman DAM, 2008, BJOG-INT J OBSTET GY, V115, P938, DOI 10.1111/j.1471-0528.2008.01779.x; *HJ KAIS FAM FDN, 2008, HPV VACC IMPL FIN PO; Horner M, SEER CANC STAT REV 1; Insinga RP, 2008, CANCER EPIDEM BIOMAR, V17, P1611, DOI 10.1158/1055-9965.EPI-07-2922; Insinga RP, 2006, WOMEN HEALTH ISS, V16, P236, DOI 10.1016/j.whi.2006.06.005; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kiviat NB, 2008, JNCI-J NATL CANCER I, V100, P290, DOI 10.1093/jnci/djn038; Kollar LM, 2008, CURR OPIN OBSTET GYN, V20, P479, DOI 10.1097/GCO.0b013e32830d0cf6; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; LEHTINEN M, 2006, VACCINE S3, V24; LUNA J, 2007, 24 INT PAP C BEIJ NO; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Myers E, 2008, GYNECOL ONCOL, V109, pS31, DOI 10.1016/j.ygyno.2008.02.001; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Paavonen J, 2007, LANCET, V370, P1414; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; PALEFSKY JM, 2006, VACCINE S3, V24; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; SCHWARZ TF, 2006, P AN M AM SOC CLIN, V24, P1008; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stoler MH, 2003, CANCER J, V9, P360, DOI 10.1097/00130404-200309000-00005; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wheeler CM, 2008, VACCINE, V26, P686, DOI 10.1016/j.vaccine.2007.11.043; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Wright TC, 2008, GYNECOL ONCOL, V109, pS40, DOI 10.1016/j.ygyno.2008.02.002; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	62	71	82	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					271	278		10.1056/NEJMct0806938	http://dx.doi.org/10.1056/NEJMct0806938			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19605832				2022-12-28	WOS:000267976100008
J	Zhou, Y; Zheng, HJ; Chen, YY; Zhang, L; Wang, K; Guo, J; Huang, Z; Zhang, B; Huang, W; Jin, K; Dou, TH; Hasegawa, M; Wang, L; Zhang, Y; Zhou, J; Tao, L; Cao, ZW; Li, YX; Vinar, T; Brejova, B; Brown, D; Li, M; Miller, DJ; Blair, D; Zhong, Y; Chen, Z; Hu, W; Wang, ZQ; Zhang, QH; Song, HD; Chen, SJ; Xu, XN; Xu, B; Ju, C; Huang, YC; Brindley, PJ; McManus, DP; Feng, Z; Han, ZG; Lu, G; Ren, SX; Wang, YZ; Gu, WY; Kang, H; Chen, J; Chen, XY; Chen, ST; Wang, LJ; Yan, J; Wang, BY; Lv, XY; Jin, L; Wang, BF; Pu, SY; Zhang, XL; Zhang, W; Hu, QP; Zhu, GF; Wang, J; Yu, J; Wang, J; Yang, HM; Ning, ZM; Beriman, M; Wei, CL; Ruan, YJ; Zhao, GP; Wang, SY; Liu, F; Wang, ZQ; Zheng, HJ; Zhang, QH; Wang, SY; Han, ZG				Zhou, Yan; Zheng, Huajun; Chen, Yangyi; Zhang, Lei; Wang, Kai; Guo, Jing; Huang, Zhen; Zhang, Bo; Huang, Wei; Jin, Ke; Dou, Tonghai; Hasegawa, Masami; Wang, Li; Zhang, Yuan; Zhou, Jie; Tao, Lin; Cao, Zhiwei; Li, Yixue; Vinar, Tomas; Brejova, Brona; Brown, Dan; Li, Ming; Miller, David J.; Blair, David; Zhong, Yang; Chen, Zhu; Hu, Wei; Wang, Zhi-Qin; Zhang, Qin-Hua; Song, Huai-Dong; Chen, Saijuan; Xu, Xuenian; Xu, Bin; Ju, Chuan; Huang, Yucheng; Brindley, Paul J.; McManus, Donald P.; Feng, Zheng; Han, Ze-Guang; Lu, Gang; Ren, Shuangxi; Wang, Yuezhu; Gu, Wenyi; Kang, Hui; Chen, Jie; Chen, Xiaoyun; Chen, Shuting; Wang, Lijun; Yan, Jie; Wang, Biyun; Lv, Xinyan; Jin, Lei; Wang, Bofei; Pu, Shiyin; Zhang, Xianglin; Zhang, Wei; Hu, Qiuping; Zhu, Genfeng; Wang, Jun; Yu, Jun; Wang, Jian; Yang, Huanming; Ning, Zemin; Beriman, Matthew; Wei, Chia-Lin; Ruan, Yijun; Zhao, Guoping; Wang, Shengyue; Liu, Feng; Wang, Zhi-Qin; Zheng, Huajun; Zhang, Qin-hua; Wang, Shengyue; Han, Ze-Guang		Schistosoma Japonicum Genome Seque	The Schistosoma japonicum genome reveals features of host-parasite interplay	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SNP MAP; IDENTIFICATION; CLONING; MANSONI; LOCALIZATION; EVOLUTIONARY; ECDYSTEROIDS; METAANALYSIS; SENSITIVITY	Schistosoma japonicum is a parasitic flatworm that causes human schistosomiasis, which is a significant cause of morbidity in China and the Philippines. Here we present a draft genomic sequence for the worm. The genome provides a global insight into the molecular architecture and host interaction of this complex metazoan pathogen, revealing that it can exploit host nutrients, neuroendocrine hormones and signalling pathways for growth, development and maturation. Having a complex nervous system and a well-developed sensory system, S. japonicum can accept stimulation of the corresponding ligands as a physiological response to different environments, such as fresh water or the tissues of its intermediate and mammalian hosts. Numerous proteases, including cercarial elastase, are implicated in mammalian skin penetration and haemoglobin degradation. The genomic information will serve as a valuable platform to facilitate development of new interventions for schistosomiasis control.	[Zhou, Yan; Zheng, Huajun; Chen, Yangyi; Zhang, Lei; Wang, Kai; Guo, Jing; Huang, Zhen; Zhang, Bo; Huang, Wei; Chen, Zhu; Wang, Zhi-Qin; Han, Ze-Guang; Lu, Gang; Ren, Shuangxi; Wang, Yuezhu; Gu, Wenyi; Kang, Hui; Chen, Jie; Chen, Xiaoyun; Chen, Shuting; Wang, Lijun; Yan, Jie; Wang, Biyun; Lv, Xinyan; Jin, Lei; Wang, Bofei; Pu, Shiyin; Zhang, Xianglin; Zhang, Wei; Hu, Qiuping; Zhu, Genfeng; Zhao, Guoping; Wang, Shengyue; Liu, Feng; Wang, Zhi-Qin; Zheng, Huajun; Wang, Shengyue; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Zhou, Yan; Zheng, Huajun; Jin, Ke; Dou, Tonghai; Hasegawa, Masami; Wang, Li; Zhang, Yuan; Zhou, Jie; Zhong, Yang; Zhao, Guoping; Liu, Feng; Zheng, Huajun] Fudan Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Li; Tao, Lin; Cao, Zhiwei; Li, Yixue; Zhong, Yang] Shanghai Ctr Bioinformat Technol, Shanghai 200235, Peoples R China; [Vinar, Tomas; Brejova, Brona; Brown, Dan; Li, Ming] Univ Waterloo, Cheriton Sch Comp Sci, Waterloo, ON N2L 3G1, Canada; [Miller, David J.; Blair, David] James Cook Univ, Sch Trop Biol, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Chen, Zhu; Song, Huai-Dong; Chen, Saijuan; Lu, Gang] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Chen, Zhu; Song, Huai-Dong; Chen, Saijuan; Lu, Gang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Hu, Wei; Xu, Xuenian; Xu, Bin; Ju, Chuan; Huang, Yucheng; Feng, Zheng] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Zhang, Qin-Hua; Zhang, Qin-hua] Shanghai Ctr Biochip Engn, Shanghai 201203, Peoples R China; [Brindley, Paul J.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [McManus, Donald P.] Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld 4006, Australia; [Wang, Jun; Yu, Jun; Wang, Jian; Yang, Huanming] Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China; [Ning, Zemin; Beriman, Matthew; Zhao, Guoping] Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Hinxton CB10 1SA, England; [Wei, Chia-Lin; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Fudan University; Chinese Academy of Sciences; University of Waterloo; James Cook University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; George Washington University; QIMR Berghofer Medical Research Institute; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Wellcome Trust Sanger Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, Y (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, 250 Bi Bo Rd, Shanghai 201203, Peoples R China.		McManus, Donald P./G-2678-2013; Blair, David/G-6052-2011; Zheng, Huajun/AAN-4973-2020; Wang, Jun/A-7261-2013; Vinar, Tomas/I-3695-2014; HU, Wei/F-1004-2012; McManus, Don/AAC-5394-2020; 郑, 征/C-8514-2011; Brejova, Brona/I-3718-2014; Song, Huai-Dong/G-8961-2011; Blair, David/O-2786-2019; Ning, Zemin/D-2411-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Blair, David/0000-0002-4658-3251; Vinar, Tomas/0000-0003-3898-3447; McManus, Don/0000-0001-6443-1449; Brejova, Brona/0000-0002-9483-1766; Blair, David/0000-0002-4658-3251; Wang, Jun/0000-0002-8540-8931; Zhao, Guo-Ping/0000-0002-7621-6620; Brown, Dan/0000-0002-5205-5762; Ning, Zemin/0000-0003-4359-776X; Zhang, Bo/0000-0001-8890-8416; Tao, Lin/0000-0001-7494-4758; Wang, Jun/0000-0002-2113-5874; Han, Ze-Guang/0000-0002-1018-1752; WANG, kai/0000-0002-6194-0480; Brindley, Paul J./0000-0003-1765-0002	Chinese National High-Tech Program [2004AA2Z1010, 2006AA02Z335, 2006AA02Z318, 2007AA02Z153]; Chinese National Key Project for Basic Research [2006CB708510, 2007CB513100]; Chinese Academy of Sciences; Shanghai Municipal Commission for Science and Technology [04DZ14010, 055407031, 06JC14059, 07QA14043, 07DZ22915]; National Natural Science Foundation of China; US National Institute of Allergy and Infectious Diseases [AI39461]; National Science and Engineering Research Council of Canada [OGP0046506]; National Health and Medical Research Council of Australia; Wellcome Trust, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI039461] Funding Source: NIH RePORTER	Chinese National High-Tech Program(National High Technology Research and Development Program of China); Chinese National Key Project for Basic Research; Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was mainly supported by the Chinese National High-Tech Program (863 Program) (2004AA2Z1010, 2006AA02Z335, 2006AA02Z318, 2007AA02Z153), the Chinese National Key Project for Basic Research (973 Project) (2006CB708510, 2007CB513100), the Chinese Academy of Sciences, the Shanghai Municipal Commission for Science and Technology (04DZ14010, 055407031, 06JC14059, 07QA14043, 07DZ22915), and the National Natural Science Foundation of China. Support from the US National Institute of Allergy and Infectious Diseases (award number AI39461), the National Science and Engineering Research Council of Canada (OGP0046506), a International Collaborative Research Grants award from the National Health and Medical Research Council of Australia, and the Wellcome Trust, UK, is also gratefully acknowledged. The Shanghai Supercomputer Center kindly provided computational facilities for some of the data analysis. The authors wish to thank P. De Jong and his colleagues for the BAC libraries construction of S. japonicum and N. M. El-Sayed for his contribution on the collaboration between the S. japonicum and S. mansoni sequencing consortia.	Abouel-Nour M. F., 2005, Journal of the Egyptian Society of Parasitology, V35, P147; Adamson P B, 1976, Med Hist, V20, P176; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BASCH PF, 1986, COMP BIOCHEM PHYS A, V83, P199, DOI 10.1016/0300-9629(86)90108-8; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergquist R, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000244; BERRIMAN M, NATURE IN PRESS, DOI DOI 10.1038/NATURE08160; Brejova B, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp052; COHEN LM, 1980, J PARASITOL, V66, P362, DOI 10.2307/3280843; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Dvorak J, 2005, INT J PARASITOL, V35, P895, DOI 10.1016/j.ijpara.2005.02.018; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FOSTER JM, 1992, TROP MED PARASITOL, V43, P239; Gamulin V, 2000, BIOL J LINN SOC, V71, P821, DOI [10.1111/j.1095-8312.2000.tb01293.x, 10.1006/bijl.2000.0476]; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grosjean Y, 2003, J NEUROBIOL, V55, P1, DOI 10.1002/neu.10208; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766; Hillyer GV, 2005, J HELMINTHOL, V79, P241, DOI 10.1079/JOH2005304; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Hoffmann KF, 2001, MOL BIOCHEM PARASIT, V112, P113, DOI 10.1016/S0166-6851(00)00352-2; Holmes SP, 2003, INSECT MOL BIOL, V12, P27, DOI 10.1046/j.1365-2583.2003.00384.x; Hu W, 2004, TRENDS MOL MED, V10, P217, DOI 10.1016/j.molmed.2004.03.002; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Koehler JW, 2007, MEM I OSWALDO CRUZ, V102, P83, DOI 10.1590/S0074-02762007000100014; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; Mone H, 2004, ADV PARASIT, V57, P89, DOI 10.1016/S0065-308X(04)57002-1; Mousley A, 2005, PARASITOLOGY, V131, pS143, DOI 10.1007/S0031182005008553; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; NEWPORT GR, 1988, J BIOL CHEM, V263, P13179; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Robert D, 2002, J INSECT PHYSIOL, V48, P189, DOI 10.1016/S0022-1910(01)00163-9; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Scholler S, 2005, BIOCHEM BIOPH RES CO, V327, P29, DOI 10.1016/j.bbrc.2004.11.139; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; SMART D, 1995, PARASITOLOGY, V110, P87, DOI 10.1017/S0031182000081087; SMART D, 1994, J COMP NEUROL, V347, P426, DOI 10.1002/cne.903470308; Sobreira TJP, 2006, BIOINFORMATICS, V22, P361, DOI 10.1093/bioinformatics/bti809; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STRICKLIN SL, 2005, WORMBOOK, V25, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; XU YZ, 1990, EXP PARASITOL, V70, P124, DOI 10.1016/0014-4894(90)90093-R; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	69	518	543	5	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					345	U56		10.1038/nature08140	http://dx.doi.org/10.1038/nature08140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606140	hybrid, Green Accepted			2022-12-28	WOS:000267979000028
J	Brook, I				Brook, Itzhak			Rediscovering My Voice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ib6@georgetown.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					236	236		10.1001/jama.2009.981	http://dx.doi.org/10.1001/jama.2009.981			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602676				2022-12-28	WOS:000267948100001
J	Fielding, JE; Teutsch, SM				Fielding, Jonathan E.; Teutsch, Steven M.			Integrating Clinical Care and Community Health Delivering Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REDUCE; INTERVENTIONS; REVIEWS		[Fielding, Jonathan E.; Teutsch, Steven M.] Univ Calif Los Angeles, Los Angeles Cty Dept Publ Hlth, Los Angeles, CA 90012 USA; [Fielding, Jonathan E.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90012 USA; [Fielding, Jonathan E.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90012 USA	Los Angeles County Department of Public Health; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Teutsch, SM (corresponding author), Univ Calif Los Angeles, Los Angeles Cty Dept Publ Hlth, 313 N Figueroa St,Room 708, Los Angeles, CA 90012 USA.	steutsch@ph.lacounty.gov						Agency for Healthcare Research and Quality, US PREV SERV TASK FO; [Anonymous], STAT HLTH CAR QUAL; *COMM GUID WEB PAG, GUID COMM PREV SERV; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Gilliland FD, 2009, PEDIATRICS, V123, pS168, DOI 10.1542/peds.2008-2233G; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Teutsch SM, 2005, PEDIATRICS, V116, P240, DOI 10.1542/peds.2005-0383; Trust for America's Health, 2008, BLUEPR HEALTH AM MOD	11	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					317	319		10.1001/jama.2009.1025	http://dx.doi.org/10.1001/jama.2009.1025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602692				2022-12-28	WOS:000267948100026
J	O'Brien, E				O'Brien, Eoin			Is systolic blood pressure all that matters? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTENSION; MORTALITY		Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	University College Dublin	O'Brien, E (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.	eobrien@iol.ie						Banegas JR, 2007, HYPERTENSION, V49, P62, DOI 10.1161/01.HYP.0000250557.63490.55; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dolan E, 2006, HYPERTENSION, V47, P365, DOI 10.1161/01.HYP.0000200699.74641.c5; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Jones DW, 2008, HYPERTENSION, V51, P1249, DOI 10.1161/HYPERTENSIONAHA.108.113746; Mancia G, 2007, HYPERTENSION, V49, P17, DOI 10.1161/01.HYP.0000250560.27738.72; O'Brien E, 2008, HYPERTENSION, V51, P1435, DOI 10.1161/HYPERTENSIONAHA.107.100008; Pickering TG, 2002, HYPERTENSION, V40, P795, DOI 10.1161/01.HYP.0000038733.08436.98; PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Salles GF, 2008, ARCH INTERN MED, V168, P2340, DOI 10.1001/archinte.168.21.2340; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2009	339								b2669	10.1136/bmj.b2669	http://dx.doi.org/10.1136/bmj.b2669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LC	19592406				2022-12-28	WOS:000267898700003
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gregory, KD; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Schwartz, JS; Wilt, T				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							INTRAOCULAR-LENS IMPLANTATION; RANDOMIZED-TRIAL; UNITED-STATES; CATARACT-EXTRACTION; PREVALENCE; PEOPLE; VISION; FALLS	Description: Update of the 1996 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for visual impairment. Methods: The USPSTF reviewed evidence published since its last review on screening adults 65 years or older in the primary care setting for visual acuity impairment associated with uncorrected refractive errors, cataracts, and age-related macular degeneration. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for visual acuity for the improvement of outcomes in older adults. (I statement).	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Arizona State Univ, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; [Isham, George] Hlth Partners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Moyer, Virginia A.] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA; [Wilt, Timothy] Univ Minnesota, Dept Med, Denver, CO USA; [US Preventive Serv Task Force] Agcy Healthcare Res & Qual, Rockville, MD USA	Colorado Department of Public Health & Environment; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University System of Georgia; Augusta University; Arizona State University; Arizona State University-Downtown Phoenix; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; Agency for Healthcare Research & Quality	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013		Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	ACOG Committee on Gynecologic Practice, 2006, Obstet Gynecol, V108, P1615; *AM AC OPHTH PREF, 2005, PREF PRACT PATT GUID; *AM OPT ASS CONS P, 2005, OPT CLIN PRACT GUID; Centers for Disease Control and Prevention, 2006, IMPR NAT VIS HLTH CO; Chou R., 2009, AHRQ PUBLICATION; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Eekhof JAH, 2000, FAM PRACT, V17, P329, DOI 10.1093/fampra/17.4.329; Evans JR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub2; Lord SR, 2002, J AM GERIATR SOC, V50, P1760, DOI 10.1046/j.1532-5415.2002.50502.x; McGwin G, 2003, OPHTHALMIC EPIDEMIOL, V10, P107, DOI 10.1076/opep.10.2.107.13900; Meads C, 2003, Health Technol Assess, V7, pv; Meads C, 2003, HEALTH TECHNOL ASSES, V7, p[v, 1], DOI [10.3310/hta7090, DOI 10.3310/hta7090]; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; MURRAY A, SYSTEMATIC REV SAFET; Owsley C, 2002, JAMA-J AM MED ASSOC, V288, P841, DOI 10.1001/jama.288.7.841; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P228, DOI 10.1001/archopht.1994.01090140104032; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3; Smeeth L, 2003, BMJ-BRIT MED J, V327, P1027, DOI 10.1136/bmj.327.7422.1027; *US PREV SERV TASK, 1996, SCREEN VIS IMP GUID; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Virgili G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004763.pub2; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Wormald R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002030.pub3	27	14	15	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					37	U56		10.7326/0003-4819-151-1-200907070-00007	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19581645	Green Published			2022-12-28	WOS:000267946100005
J	Missoni, E; Tediosi, F; Pacileo, G; Borgonovi, E				Missoni, Eduardo; Tediosi, Fabrizio; Pacileo, Guglielmo; Borgonovi, Elio			G8 Summit 2009: what approach will Italy take to health?	LANCET			English	Editorial Material									[Missoni, Eduardo; Tediosi, Fabrizio; Pacileo, Guglielmo; Borgonovi, Elio] Univ Bocconi, Ctr Res Hlth & Social Care Management CERGAS, I-20136 Milan, Italy	Bocconi University	Missoni, E (corresponding author), Univ Bocconi, Ctr Res Hlth & Social Care Management CERGAS, I-20136 Milan, Italy.	eduardo.missoni@unibocconi.it	Borgonovi, Elio/AAH-8707-2020; Tediosi, Fabrizio/ABC-7880-2020; Tediosi, Fabrizio/AAD-4805-2022	Tediosi, Fabrizio/0000-0001-8671-9400				*I IT STAT CONS NA, 2008, 1 I IT STAT CONS NAZ; *OECD DEV ASS COMM, ODA DON OECD STAT EX; *OECD DEV ASS COMM, 2004, PEER REV IT; *REP IT, 2008, INSTR ANN MULT STAT; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					9	10		10.1016/S0140-6736(09)61216-2	http://dx.doi.org/10.1016/S0140-6736(09)61216-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467UO	19577679				2022-12-28	WOS:000267768800008
J	Parmacek, MS; Epstein, JA				Parmacek, Michael S.; Epstein, Jonathan A.			Cardiomyocyte Renewal.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REGENERATION; CELLS		[Parmacek, Michael S.; Epstein, Jonathan A.] Univ Penn, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Parmacek, MS (corresponding author), Univ Penn, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.			Epstein, Jonathan/0000-0001-8637-4465; Parmacek, Michael/0000-0003-1449-4665	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075215] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL075215] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857	5	48	50	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					86	88		10.1056/NEJMcibr0903347	http://dx.doi.org/10.1056/NEJMcibr0903347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571289	Green Accepted			2022-12-28	WOS:000267533100016
J	Shah, AS; Ben-Shahar, Y; Moninger, TO; Kline, JN; Welsh, MJ				Shah, Alok S.; Ben-Shahar, Yehuda; Moninger, Thomas O.; Kline, Joel N.; Welsh, Michael J.			Motile Cilia of Human Airway Epithelia Are Chemosensory	SCIENCE			English	Article							CELLS; MUTATION; DEFECTS	Cilia are microscopic projections that extend from eukaryotic cells. There are two general types of cilia; primary cilia serve as sensory organelles, whereas motile cilia exert mechanical force. The motile cilia emerging from human airway epithelial cells propel harmful inhaled material out of the lung. We found that these cells express sensory bitter taste receptors, which localized on motile cilia. Bitter compounds increased the intracellular calcium ion concentration and stimulated ciliary beat frequency. Thus, airway epithelia contain a cell-autonomous system in which motile cilia both sense noxious substances entering airways and initiate a defensive mechanical mechanism to eliminate the offending compound. Hence, like primary cilia, classical motile cilia also contain sensors to detect the external environment.	[Shah, Alok S.; Ben-Shahar, Yehuda; Moninger, Thomas O.; Kline, Joel N.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Ben-Shahar, Yehuda; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		kline, joel/0000-0002-5523-8855; Welsh, Michael/0000-0002-1646-6206	National Heart, Lung, and Blood Institute [HL51670]; Cystic Fibrosis Foundation [R458-CR02, ENGLH9850]; National Institute of Diabetes and Digestive and Kidney Disease [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759, R01DK051315] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Yin for assistance and discussions and P. Karp, T. Nesselhauf, P. Hughes, and the In Vitro Models and Cell Culture Core [supported in part by the National Heart, Lung, and Blood Institute (HL51670), Cystic Fibrosis Foundation (R458-CR02 and ENGLH9850), and the National Institute of Diabetes and Digestive and Kidney Disease (DK54759)] for assistance. Y.B.-S. was an Associate and M.J.W. is an Investigator of the Howard Hughes Medical Institute.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; BOITANO S, 1994, J CELL SCI, V107, P3037; Braiman A, 2008, RESP PHYSIOL NEUROBI, V163, P202, DOI 10.1016/j.resp.2008.05.010; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Horvath G, 2008, CELL MOTIL CYTOSKEL, V65, P469, DOI 10.1002/cm.20273; Iomini C, 2006, CURR BIOL, V16, P1147, DOI 10.1016/j.cub.2006.04.035; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Merigo F, 2005, CELL TISSUE RES, V319, P211, DOI 10.1007/s00441-004-1007-2; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SISSON JH, 1994, AM J RESP CRIT CARE, V149, P205, DOI 10.1164/ajrccm.149.1.8111584; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005	30	480	496	5	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1131	1134		10.1126/science.1173869	http://dx.doi.org/10.1126/science.1173869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628819	Green Accepted			2022-12-28	WOS:000269382300042
J	Pocock, SJ; Smeeth, L				Pocock, Stuart J.; Smeeth, Liam			Insulin glargine and malignancy: an unwarranted alarm	LANCET			English	Editorial Material							RANDOMIZED-TRIALS		[Pocock, Stuart J.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Liam.Smeeth@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [082178] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; HEMKENS LG, 2009, DIABETOLOGIA, DOI DOI 10.1007/S00125-009-1418.4; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; *SDRN EP GROUP, US INS GLARG CANC IN; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	9	102	105	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					511	513		10.1016/S0140-6736(09)61307-6	http://dx.doi.org/10.1016/S0140-6736(09)61307-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19616841				2022-12-28	WOS:000269019400009
J	Adler, SL; Bassi, A				Adler, Stephen L.; Bassi, Angelo			Is Quantum Theory Exact?	SCIENCE			English	Editorial Material							REDUCTION; SYSTEMS		[Adler, Stephen L.] Inst Adv Study, Princeton, NJ 08540 USA; [Bassi, Angelo] Univ Trieste, Dept Theoret Phys, I-34014 Trieste, Italy; [Bassi, Angelo] Ist Nazl Fis Nucl, I-34127 Trieste, Italy	Institute for Advanced Study - USA; University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN)	Adler, SL (corresponding author), Inst Adv Study, Einstein Dr, Princeton, NJ 08540 USA.	adler@ias.edu; bassi@ts.infn.it		Bassi, Angelo/0000-0001-7500-387X				Adler S., 2004, QUANTUM THEORY EMERG, DOI [10.1017/CBO9780511535277, DOI 10.1017/CBO9780511535277]; Adler SL, 2007, J PHYS A-MATH THEOR, V40, P15083, DOI 10.1088/1751-8113/40/50/012; Adler SL, 2007, J PHYS A-MATH THEOR, V40, P13395, DOI 10.1088/1751-8113/40/44/017; Adler SL, 2007, J PHYS A-MATH THEOR, V40, P2935, DOI 10.1088/1751-8113/40/12/S03; Adler SL, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/39/395308; Arndt M, 1999, NATURE, V401, P680, DOI 10.1038/44348; Bassi A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.030401; Bassi A, 2003, PHYS REP, V379, P257, DOI 10.1016/S0370-1573(03)00103-0; Fu QJ, 1997, PHYS REV A, V56, P1806, DOI 10.1103/PhysRevA.56.1806; GHIRARDI GC, 1986, PHYS REV D, V34, P470, DOI 10.1103/PhysRevD.34.470; GHIRARDI GC, 1990, PHYS REV A, V42, P78, DOI 10.1103/PhysRevA.42.78; Leggett AJ, 2005, SCIENCE, V307, P871, DOI 10.1126/science.1109541; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; PEARLE P, 1976, PHYS REV D, V13, P857, DOI 10.1103/PhysRevD.13.857; Pearle P., 1999, Open systems and measurement in relativistic quantum theory. Proceedings, P195	15	105	105	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					275	276		10.1126/science.1176858	http://dx.doi.org/10.1126/science.1176858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608904				2022-12-28	WOS:000268036600031
J	Bhala, N; Usherwood, T; George, J				Bhala, Neeraj; Usherwood, Tim; George, Jacob			10-Minute Consultation Non-alcoholic fatty liver disease	BRITISH MEDICAL JOURNAL			English	Editorial Material							NAFLD		[George, Jacob] Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2145, Australia; [Usherwood, Tim; George, Jacob] Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney		neeraj.bhala@ctsu.ox.ac.uk	George, jacob/P-1496-2014	Bhala, Neeraj/0000-0003-2502-1177				*AM LIV FDN, VOL NONPR HLTH AG US; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; *BRIT LIV TRUST, NONPR MED RES CHAR U; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094	5	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 16	2009	339								b2474	10.1136/bmj.b2474	http://dx.doi.org/10.1136/bmj.b2474			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BX	19608620				2022-12-28	WOS:000268105200001
J	Zahn, R				Zahn, Rainer			CLIMATE CHANGE Beyond the CO2 connection	NATURE			English	Editorial Material							NORTH-ATLANTIC OCEAN; CIRCULATION; PLEISTOCENE		[Zahn, Rainer] Univ Autonoma Barcelona, ICREA, Inst Ciencia & Tecnol Ambientals, E-08193 Bellaterra, Spain; [Zahn, Rainer] Univ Autonoma Barcelona, Dept Geol, E-08193 Bellaterra, Spain	Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona	Zahn, R (corresponding author), Univ Autonoma Barcelona, ICREA, Inst Ciencia & Tecnol Ambientals, E-08193 Bellaterra, Spain.	rainer.zahn@uab.cat			ICREA Funding Source: Custom	ICREA(ICREA)		Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; Dickson RR, 2003, PHILOS T R SOC A, V361, P1917, DOI 10.1098/rsta.2003.1237; DUPLESSY JC, 1991, OCEANOL ACTA, V14, P311; Franzese AM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001706; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; MIX AC, 1985, EARTH PLANET SC LETT, V73, P231, DOI 10.1016/0012-821X(85)90072-X; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; van Sebille E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036614; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2	13	17	19	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					335	336		10.1038/460335a	http://dx.doi.org/10.1038/460335a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606136				2022-12-28	WOS:000267979000024
J	Morch, LS; Lokkegaard, E; Andreasen, AH; Kruger-Kjaer, S; Lidegaard, O				Morch, Lina Steinrud; Lokkegaard, Ellen; Andreasen, Anne Helms; Kruger-Kjaer, Susanne; Lidegaard, Ojvind			Hormone Therapy and Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPLACEMENT THERAPY; SWEDISH WOMEN; RISK; DENMARK; REGISTRY; HEALTH	Context Studies have suggested an increased risk of ovarian cancer among women taking postmenopausal hormone therapy. Data are sparse on the differential effects of formulations, regimens, and routes of administration. Objective To assess risk of ovarian cancer in perimenopausal and postmenopausal women receiving different hormone therapies. Design and Setting Nationwide prospective cohort study including all Danish women aged 50 through 79 years from 1995 through 2005 through individual linkage to Danish national registers. Redeemed prescription data from the National Register of Medicinal Product Statistics provided individually updated exposure information. The National Cancer Register and Pathology Register provided ovarian cancer incidence data. Information on confounding factors and effect modifiers was from other national registers. Poisson regression analyses with 5-year age bands included hormone exposures as time-dependent covariates. Participants A total of 909 946 women without hormone-sensitive cancer or bilateral oophorectomy. Main Outcome Measure Ovarian cancer. Results In an average of 8.0 years of follow-up (7.3 million women-years), 3068 incident ovarian cancers, of which 2681 were epithelial cancers, were detected. Compared with women who never took hormone therapy, current users of hormones had incidence rate ratios for all ovarian cancers of 1.38 (95% confidence interval [CI], 1.26-1.51) and 1.44 ( 95% CI, 1.30-1.58) for epithelial ovarian cancer. The risk declined with years since last use: 0 to 2 years, 1.22 ( 95% CI, 1.02-1.46); more than 2 to 4 years, 0.98 ( 95% CI, 0.75-1.28); more than 4 to 6 years, 0.72 ( 95% CI, 0.50-1.05), and more than 6 years, 0.63 ( 95% CI, 0.41-0.96). For current users the risk of ovarian cancer did not differ significantly with different hormone therapies or duration of use. The incidence rates in current and never users of hormones were 0.52 and 0.40 per 1000 years, respectively, ie, an absolute risk increase of 0.12 ( 95% CI, 0.01-0.17) per 1000 years. This approximates 1 extra ovarian cancer for roughly 8300 women taking hormone therapy each year. Conclusion Regardless of the duration of use, the formulation, estrogen dose, regimen, progestin type, and route of administration, hormone therapy was associated with an increased risk of ovarian cancer. JAMA. 2009; 302(3):298-305 www.jama.com	[Morch, Lina Steinrud; Lidegaard, Ojvind] Univ Copenhagen, Gynaecol Clin, Rigshosp, DK-2100 Copenhagen, Denmark; [Lokkegaard, Ellen] Univ Copenhagen, Hillerod Hosp, Gynaecol Obstetr Dept, Copenhagen, Denmark; [Morch, Lina Steinrud; Andreasen, Anne Helms] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Kruger-Kjaer, Susanne] Danish Canc Soc, Dept Virus Hormones & Canc, Inst Canc Epidemiol, Osterbro, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Danish Cancer Society	Morch, LS (corresponding author), Univ Copenhagen, Gynaecol Clin, Rigshosp, Sect 3341,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	linamorch@yahoo.dk		Kjaer, Susanne/0000-0002-8347-1398; Andreasen, Anne Helms/0000-0002-2350-9884; Lokkegaard, Ellen/0000-0003-4149-5663; Morch, Lina/0000-0001-6506-2569	Danish Cancer Society [DP05006]	Danish Cancer Society(Danish Cancer Society)	This study was supported by grant J No. DP05006 from the Danish Cancer Society.	Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Danforth KN, 2007, BRIT J CANCER, V96, P151, DOI 10.1038/sj.bjc.6603527; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Hammar M, 1996, MATURITAS, V25, P193, DOI 10.1016/S0378-5122(96)01065-1; Hundrup YA, 2000, ACTA OBSTET GYN SCAN, V79, P194, DOI 10.1080/j.1600-0412.2000.079003194.x; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Kjaerbye-Thygesen Anette, 2007, Ugeskr Laeger, V169, P50; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lokkegaard E, 2007, ACTA OBSTET GYN SCAN, V86, P1342, DOI 10.1080/00016340701505523; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Soegaard M, 2007, CANCER EPIDEM BIOMAR, V16, P1160, DOI 10.1158/1055-9965.EPI-07-0089; STORM HH, 1988, INT J EPIDEMIOL, V17, P44, DOI 10.1093/ije/17.1.44; Storm HH, 1997, DAN MED BULL, V44, P535	16	139	144	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					298	305		10.1001/jama.2009.1052	http://dx.doi.org/10.1001/jama.2009.1052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602689	Bronze			2022-12-28	WOS:000267948100023
J	Baskin, JL; Pui, CH; Reiss, U; Wilimas, JA; Metzger, ML; Ribeiro, RC; Howard, SC				Baskin, Jacquelyn L.; Pui, Ching-Hon; Reiss, Ulrike; Wilimas, Judith A.; Metzger, Monika L.; Ribeiro, Raul C.; Howard, Scott C.			Management of occlusion and thrombosis associated with long-term indwelling central venous catheters	LANCET			English	Review							TISSUE-PLASMINOGEN ACTIVATOR; DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; PEDIATRIC ONCOLOGY PATIENTS; PLACEBO-CONTROLLED TRIAL; LOW-DOSE WARFARIN; CANCER-PATIENTS; ACCESS DEVICES; POSTTHROMBOTIC SYNDROME; DOUBLE-BLIND	Long-term central venous catheters (CVCs) are important instruments in the care of patients with chronic illnesses, but catheter occlusions and catheter-related thromboses are common complications that can result from their use. in this Review, we summarise management of these complications. Mechanical CVC occlusions need cause-specific treatment, whereas thrombotic occlusions usually resolve with thrombolytic treatment, such as alteplase. Prophylaxis with thrombolytic flushes might prevent CVC infections and catheter-related thromboses, but confirmatory studies and cost-effectiveness analysis of this approach are needed. Risk factors for catheter-related thromboses include previous catheter infections, malposition of the catheter tip, and prothrombotic states. Catheter-related thromboses can lead to catheter infection, pulmonary embolism, and post-thrombotic syndrome. Catheter-related thromboses are usually diagnosed by Doppler ultrasonography or venography and treated with anticoagulation therapy for 6 weeks to a year, dependent on the extent of the thrombus, response to initial therapy, and whether thrombophilic factors persist. Prevention of catheter-related thromboses includes proper positioning of the CVC and prevention of infections; anticoagulation prophylaxis is not currently recommended.	[Baskin, Jacquelyn L.; Pui, Ching-Hon; Wilimas, Judith A.; Metzger, Monika L.; Ribeiro, Raul C.; Howard, Scott C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Baskin, Jacquelyn L.; Pui, Ching-Hon; Wilimas, Judith A.; Metzger, Monika L.; Ribeiro, Raul C.; Howard, Scott C.] St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA; [Reiss, Ulrike] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Baskin, Jacquelyn L.] Childrens Hosp Los Angeles, Dept Hematol & Oncol, Los Angeles, CA 90027 USA; [Pui, Ching-Hon; Reiss, Ulrike; Wilimas, Judith A.; Metzger, Monika L.; Ribeiro, Raul C.; Howard, Scott C.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Coll Med, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Children's Hospital Los Angeles; University of Tennessee System; University of Tennessee Health Science Center	Howard, SC (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	scott.howard@stjude.org	Pui, Ching-Hon/N-8076-2018; Howard, Scott C/K-3401-2013	Pui, Ching-Hon/0000-0003-0303-5658; Howard, Scott C/0000-0003-2244-1686	National Institutes of Health [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Carolyn Chesney, Marianne van de Wetering, Menno Huisman, and Janna Journeycake for critical review of the manuscript and Betsy Williford for graphic design. This work was supported in part by grant CA21765 from the National Institutes of Health and by the American Lebanese Syrian Associated Charities (ALSAC).	AKINWANDE KI, 1995, ANN PHARMACOTHER, V29, P707, DOI 10.1177/106002809502907-811; ANDRIS DA, 1994, JPEN-PARENTER ENTER, V18, P531, DOI 10.1177/0148607194018006531; Baarslag HJ, 2002, ANN INTERN MED, V136, P865, DOI 10.7326/0003-4819-136-12-200206180-00007; Bagnall-Reeb H A, 1990, Oncol Nurs Forum, V17, P677; BALESTRERI L, 1995, EUR J RADIOL, V20, P108, DOI 10.1016/0720-048X(95)00633-2; Barnacle A, 2008, PEDIATR RADIOL, V38, P363, DOI 10.1007/s00247-007-0610-2; BARZAGHI A, 1995, PEDIATR HEMAT ONCOL, V12, P243, DOI 10.3109/08880019509029565; BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; Blaney M, 2006, J VASC INTERV RADIOL, V17, P1745, DOI 10.1097/01.RVI.0000241542.71063.83; Boersma RS, 2008, ANN ONCOL, V19, P433, DOI 10.1093/annonc/mdm350; Bona RD, 1999, SEMIN THROMB HEMOST, V25, P147, DOI 10.1055/s-2007-994916; Boraks P, 1998, BRIT J HAEMATOL, V101, P483, DOI 10.1046/j.1365-2141.1998.00732.x; BREAUX CW, 1987, J PEDIATR SURG, V22, P829, DOI 10.1016/S0022-3468(87)80648-6; Chaukiyal P, 2008, THROMB HAEMOSTASIS, V99, P38, DOI 10.1160/TH07-07-0446; Chesler L, 2002, J PEDIAT HEMATOL ONC, V24, P653, DOI 10.1097/00043426-200211000-00010; Choi M, 2001, J PEDIATR-US, V139, P152, DOI 10.1067/mpd.2001.115019; Couban S, 2005, J CLIN ONCOL, V23, P4063, DOI 10.1200/JCO.2005.10.192; Danek G D, 1992, Pediatr Nurs, V18, P111; Deitcher SR, 2005, PATHOPHYSIOL HAEMO T, V34, P215, DOI 10.1159/000092427; Deitcher SR, 2004, J VASC INTERV RADIOL, V15, P575, DOI 10.1097/01.RVI.0000124950.24134.19; Deitcher SR, 2002, J CLIN ONCOL, V20, P317, DOI 10.1200/JCO.20.1.317; Dillon PW, 2004, J CLIN ONCOL, V22, P2718, DOI 10.1200/JCO.2004.07.019; Elman EE, 2006, THROMB RES, V117, P609, DOI 10.1016/j.thromres.2005.05.029; Fazeny-Dorner B, 2003, BONE MARROW TRANSPL, V31, P927, DOI 10.1038/sj.bmt.1704022; Fisher Amy A, 2004, J Infus Nurs, V27, P171, DOI 10.1097/00129804-200405000-00006; Fratino G, 2005, ANN ONCOL, V16, P648, DOI 10.1093/annonc/mdi111; GILLIES H, 1985, BRIT MED J, V290, P1708, DOI 10.1136/bmj.290.6483.1708; Glaser DW, 2001, J PEDIATR-US, V138, P255, DOI 10.1067/mpd.2001.111272; Goldenberg NA, 2005, CURR OPIN HEMATOL, V12, P370, DOI 10.1097/01.moh.0000160754.55131.14; GOODE CJ, 1991, NURS RES, V40, P324; Gupta H, 2007, PEDIATR BLOOD CANCER, V48, P527, DOI 10.1002/pbc.20875; Haire WD, 2004, THROMB HAEMOSTASIS, V92, P575, DOI 10.1160/TH03-11-0686; HAIRE WD, 1994, THROMB HAEMOSTASIS, V72, P543; Hanslik A, 2008, PEDIATRICS, V122, P1284, DOI 10.1542/peds.2007-3852; Hirsh J, 2001, CHEST, V119, p1S, DOI 10.1378/chest.119.1_suppl.1S; Holcombe B J, 1992, J Intraven Nurs, V15, P36; Hooke C, 2000, J Pediatr Oncol Nurs, V17, P174, DOI 10.1053/jpon.2000.8065; HOSHAL VL, 1971, ARCH SURG-CHICAGO, V102, P353; Jacobs BR, 2001, J PEDIATR-US, V139, P593, DOI 10.1067/mpd.2001.118195; Joffe HV, 2004, CIRCULATION, V110, P1605, DOI 10.1161/01.CIR.0000142289.94369.D7; Journeycake JM, 2003, CURR OPIN HEMATOL, V10, P369, DOI 10.1097/00062752-200309000-00008; Kahn SR, 2002, BLOOD REV, V16, P155, DOI 10.1016/S0268-960X(02)00008-5; Kalmanti M, 2002, PEDIATR HEMAT ONCOL, V19, P173, DOI 10.1080/088800102753541323; Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kerner JA, 2006, JPEN-PARENTER ENTER, V30, pS73, DOI 10.1177/01486071060300S1S73; Kethireddy S, 2008, J VASC ACCESS, V9, P51, DOI 10.1177/112972980800900109; Kuhle S, 2003, THROMB RES, V111, P227, DOI 10.1016/j.thromres.2003.09.008; Kuo YS, 2005, CANCER INVEST, V23, P582, DOI 10.1080/07357900500276923; Lagro SWJ, 2000, BONE MARROW TRANSPL, V26, P1103, DOI 10.1038/sj.bmt.1702675; LeDuc K, 1997, J Emerg Nurs, V23, P306, DOI 10.1016/S0099-1767(97)90216-6; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; LICHTMAN MA, 2006, WILLIAMS HEMATOLOGY, P286; Liu CY, 2004, J VASC INTERV RADIOL, V15, P39, DOI 10.1097/01.RVI.0000106385.63463.EC; LOKICH JJ, 1985, J CLIN ONCOL, V3, P710, DOI 10.1200/JCO.1985.3.5.710; Luciani A, 2001, RADIOLOGY, V220, P655, DOI 10.1148/radiol.2203001181; Male C, 2005, THROMB HAEMOSTASIS, V94, P516, DOI 10.1160/TH03-02-0091; Male C, 2003, BLOOD, V101, P4273, DOI 10.1182/blood-2002-09-2731; Male C, 2002, THROMB HAEMOSTASIS, V87, P593, DOI 10.1055/s-0037-1613054; Manco-Johnson MJ, 2006, ACTA HAEMATOL-BASEL, V115, P207, DOI 10.1159/000090937; Manco-Johnson MJ, 2006, BLOOD, V107, P21, DOI 10.1182/blood-2004-11-4211; Massicotte MP, 1998, J PEDIATR-US, V133, P770, DOI 10.1016/S0022-3476(98)70149-0; Massicotte P, 2003, THROMB RES, V109, P101, DOI 10.1016/S0049-3848(03)00099-9; McCloskey Donna Jo, 2002, Pediatr Nurs, V28, P97; Mehall JR, 2002, CRIT CARE MED, V30, P908, DOI 10.1097/00003246-200204000-00033; Moll S, 2006, J CLIN ONCOL, V24, P3056, DOI 10.1200/JCO.2006.05.8438; Monagle P, 2000, PEDIATR RES, V47, P763, DOI 10.1203/00006450-200006000-00013; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Monreal M, 1996, THROMB HAEMOSTASIS, V75, P251; MONREAL M, 1994, THROMB HAEMOSTASIS, V72, P548; MONREAL M, 1991, CHEST, V99, P280, DOI 10.1378/chest.99.2.280; Mustafa BO, 2002, ARCH INTERN MED, V162, P401, DOI 10.1001/archinte.162.4.401; Ng R, 2004, J VASC INTERV RADIOL, V15, P45, DOI 10.1097/01.RVI.000099538.29957.F7; Niers TMH, 2007, J THROMB HAEMOST, V5, P1878, DOI 10.1111/j.1538-7836.2007.02660.x; Owens L, 2002, AM J HEALTH-SYST PH, V59, P1638, DOI 10.1093/ajhp/59.17.1638; *OXF CTR EV BAS ME, LEV EV; PENNINGTON CR, 1987, JPEN-PARENTER ENTER, V11, P507, DOI 10.1177/0148607187011005507; Ponec D, 2001, J VASC INTERV RADIOL, V12, P951, DOI 10.1016/S1051-0443(07)61575-9; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; RAAD II, 1994, JAMA-J AM MED ASSOC, V271, P1014, DOI 10.1001/jama.271.13.1014; Ragni MV, 2008, HAEMOPHILIA, V14, P30, DOI 10.1111/j.1365-2516.2007.01599.x; Rosovsky RP, 2005, HEMATOL ONCOL CLIN N, V19, P183, DOI 10.1016/j.hoc.2004.09.007; RUBIN RN, 1983, J CLIN ONCOL, V1, P572, DOI 10.1200/JCO.1983.1.9.572; Ruud E, 2006, ACTA PAEDIATR, V95, P1053, DOI 10.1080/08035250600729092; Sajid MS, 2007, ACTA HAEMATOL-BASEL, V118, P10, DOI 10.1159/000101700; Sharathkumar AA, 2008, J PEDIAT HEMATOL ONC, V30, P261, DOI 10.1097/MPH.0b013e318162bcf5; Shen V, 2003, J PEDIAT HEMATOL ONC, V25, P38, DOI 10.1097/00043426-200301000-00009; SHULMAN RJ, 1988, JPEN-PARENTER ENTER, V12, P509, DOI 10.1177/0148607188012005509; Skinner R, 2008, PEDIATR BLOOD CANCER, V50, P826, DOI 10.1002/pbc.21332; SMITH S, 1991, AM J PEDIAT HEMATOL, V13, P141; Stephens LC, 1997, TRANSFUS SCI, V18, P187; STEPHENS LC, 1995, JPEN-PARENTER ENTER, V19, P75, DOI 10.1177/014860719501900175; Svoboda P, 2004, CRIT CARE MED, V32, P1990, DOI 10.1097/01.CCM.0000142706.01717.EB; Terrill KR, 2003, J PEDIAT HEMATOL ONC, V25, P864, DOI 10.1097/00043426-200311000-00008; Tesselaar MET, 2004, EUR J CANCER, V40, P2253, DOI 10.1016/j.ejca.2004.06.023; TSCHIRHART JM, 1988, AM SURGEON, V54, P326; Van Rooden CJ, 2005, J THROMB HAEMOST, V3, P2409, DOI 10.1111/j.1538-7836.2005.01398.x; van Rooden CJ, 2005, J CLIN ONCOL, V23, P2655, DOI 10.1200/JCO.2005.05.002; van Rooden CJ, 2003, BRIT J HAEMATOL, V123, P507, DOI 10.1046/j.1365-2141.2003.04638.x; Verso M, 2005, J CLIN ONCOL, V23, P4057, DOI 10.1200/JCO.2005.06.084; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; WERLIN SL, 1995, JPEN-PARENTER ENTER, V19, P416, DOI 10.1177/0148607195019005416; Wiliams JA, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.2.e7	103	231	247	1	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					159	169		10.1016/S0140-6736(09)60220-8	http://dx.doi.org/10.1016/S0140-6736(09)60220-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19595350	Green Accepted			2022-12-28	WOS:000268111600033
J	Quaas, J				Quaas, Johannes			Smoke and Climate Change	SCIENCE			English	Editorial Material							AEROSOLS		Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Max Planck Society	Quaas, J (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	johannes.quaas@zmaw.de	Quaas, Johannes/I-2656-2013	Quaas, Johannes/0000-0001-7057-194X				Anderson TL, 2003, SCIENCE, V300, P1103, DOI 10.1126/science.1084777; Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Bellouin N, 2005, NATURE, V438, P1138, DOI 10.1038/nature04348; Bellouin N, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009385; Brasseur GP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023902; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kaufman YJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023125; Myhre G, 2009, SCIENCE, V325, P187, DOI 10.1126/science.1174461; QUAAS J, 2009, ATMOS CHEM PHYS DISC, V9, P12731; Quaas J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008962; Schulz M, 2006, ATMOS CHEM PHYS, V6, P5225, DOI 10.5194/acp-6-5225-2006; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215	12	3	3	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					153	154		10.1126/science.1176991	http://dx.doi.org/10.1126/science.1176991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589987				2022-12-28	WOS:000267802000029
J	Neilson, EG; Farris, AB				Neilson, Eric G.; Farris, Alton B.			A Woman with Abdominal Pain, Weight Loss, and Renal Failure Acute and chronic tubulointerstitial nephritis associated with uveitis (TINU or Dobrin's syndrome).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYARTERITIS-NODOSA; HELICOBACTER-PYLORI; INTERSTITIAL NEPHRITIS; FANCONI-SYNDROME; AUTOANTIBODIES; VASCULITIS; DIAGNOSIS; CELLS		[Neilson, Eric G.] Vanderbilt Univ Sch Med, Nashville, TN USA; [Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Farris, Alton B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Farris, Alton B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Neilson, EG (corresponding author), Vanderbilt Univ Sch Med, Nashville, TN USA.		Farris, Alton Brad/S-6041-2017	Farris, Alton Brad/0000-0001-5534-7763				Abed L, 2008, NEPHROL DIAL TRANSPL, V23, P1452, DOI 10.1093/ndt/gfm890; Baker RJ, 2004, NEPHROL DIAL TRANSPL, V19, P8, DOI 10.1093/ndt/gfg464; Bley TA, 2007, CLIN EXP RHEUMATOL, V25, pS60; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Chen M, 2005, KIDNEY INT, V68, P2225, DOI 10.1111/j.1523-1755.2005.00679.x; DOBRIN RS, 1975, AM J MED, V59, P325, DOI 10.1016/0002-9343(75)90390-3; Ezzikouri S, 2008, INFECT GENET EVOL, V8, P306, DOI 10.1016/j.meegid.2008.01.010; GLADZIWA U, 1993, NEPHROL DIAL TRANSPL, V8, P301; Goda C, 2005, AM J OPHTHALMOL, V140, P637, DOI 10.1016/j.ajo.2005.04.019; Guillevin L, 2005, MEDICINE, V84, P313, DOI 10.1097/01.md.0000180792.80212.5e; Herlitz LC, 2007, KIDNEY INT, V72, P1554, DOI 10.1038/sj.ki.5002410; Izzedine H, 2008, NEPHROL DIAL TRANSPL, V23, P1095, DOI 10.1093/ndt/gfm940; Jennette JC, 2007, CLIN EXP RHEUMATOL, V25, pS52; Koike K, 2007, CLIN NEPHROL, V67, P255; LESSARD M, 1989, AM J KIDNEY DIS, V13, P158, DOI 10.1016/S0272-6386(89)80136-2; Levine SM, 2002, AM J MED, V112, P386, DOI 10.1016/S0002-9343(01)01131-7; Luqmani RA, 2007, CLIN EXP RHEUMATOL, V25, pS57; Mandeville JTH, 2001, SURV OPHTHALMOL, V46, P195, DOI 10.1016/S0039-6257(01)00261-2; NADASDY T, 2007, HEPTINSTALLS PATHOLO, V2, P1083; Nardone G, 2005, HELICOBACTER, V10, P53, DOI 10.1111/j.1523-5378.2005.00291.x; Preddie DC, 2006, CLIN J AM SOC NEPHRO, V1, P718, DOI 10.2215/CJN.01711105; SALU P, 1990, BRIT J OPHTHALMOL, V74, P53, DOI 10.1136/bjo.74.1.53; Segelmark M, 2007, CURR OPIN RHEUMATOL, V19, P33, DOI 10.1097/BOR.0b013e328011cb6f; Shimazaki K, 2008, OCUL IMMUNOL INFLAMM, V16, P51, DOI 10.1080/09273940801899772; Simunic M, 2005, ANN SAUDI MED, V25, P425, DOI 10.5144/0256-4947.2005.425; Smith JR, 2007, NAT CLIN PRACT RHEUM, V3, P219, DOI 10.1038/ncprheum0454; Takemura T, 1999, AM J KIDNEY DIS, V34, P1016, DOI 10.1016/S0272-6386(99)70006-5; TAKEMURA T, 2000, AM J KIDNEY DIS, V35, P572; Wakaki H, 2001, PEDIATRICS, V107, P1443, DOI 10.1542/peds.107.6.1443; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593	30	3	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					179	187		10.1056/NEJMcpc0810841	http://dx.doi.org/10.1056/NEJMcpc0810841			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587344				2022-12-28	WOS:000267748900013
J	Arts, MP; Brand, R; van den Akker, ME; Koes, BW; Bartels, RHMA; Peul, WC				Arts, Mark P.; Brand, Ronald; van den Akker, M. Elske; Koes, Bart W.; Bartels, Ronald H. M. A.; Peul, Wilco C.		Leiden-The Hague Spine Interventio	Tubular Diskectomy vs Conventional Microdiskectomy for Sciatica A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUMBAR DISC HERNIATION; LOW-BACK-PAIN; MICROENDOSCOPIC DISKECTOMY; CONSERVATIVE TREATMENT; LEARNING-CURVE; MICRODISCECTOMY; QUESTIONNAIRE; OUTCOMES	Context Conventional microdiskectomy is the most frequently performed surgery for patients with sciatica due to lumbar disk herniation. Transmuscular tubular diskectomy has been introduced to increase the rate of recovery, although evidence is lacking of its efficacy. Objective To determine outcomes and time to recovery in patients treated with tubular diskectomy compared with conventional microdiskectomy. Design, Setting, and Patients The Sciatica Micro-Endoscopic Diskectomy randomized controlled trial was conducted among 328 patients aged 18 to 70 years who had persistent leg pain (>8 weeks) due to lumbar disk herniations at 7 general hospitals in the Netherlands from January 2005 to October 2006. Patients and observers were blinded during the follow-up, which ended 1 year after final enrollment. Interventions Tubular diskectomy (n = 167) vs conventional microdiskectomy (n = 161). Main Outcome Measures The primary outcome was functional assessment on the Roland-Morris Disability Questionnaire (RDQ) for sciatica (score range: 0-23, with higher scores indicating worse functional status) at 8 weeks and 1 year after randomization. Secondary outcomes were scores on the visual analog scale for leg pain and back pain (score range: 0-100 mm) and patient's self-report of recovery (measured on a Likert 7-point scale). Results Based on intention-to-treat analysis, the mean RDQ score during the first year after surgery was 6.2 (95% confidence interval [CI], 5.6 to 6.8) for tubular diskectomy and 5.4 (95% CI, 4.6 to 6.2) for conventional microdiskectomy (between-group mean difference, 0.8; 95% CI, -0.2 to 1.7). At 8 weeks after surgery, the RDQ mean (SE) score was 5.8 (0.4) for tubular diskectomy and 4.9 (0.5) for conventional microdiskectomy (between-group mean difference, 0.8; 95% CI, -0.4 to 2.1). At 1 year, the RDQ mean (SE) score was 4.7 (0.5) for tubular diskectomy and 3.4 (0.5) for conventional microdiskectomy (between-group mean difference, 1.3; 95% CI, 0.03 to 2.6) in favor of conventional microdisketomy. On the visual analog scale, the 1-year between-group mean difference in improvement was 4.2 mm (95% CI, 0.9 to 7.5 mm) for leg pain and 3.5 mm (95% CI, 0.1 to 6.9 mm) for back pain in favor of conventional microdiskectomy. At 1 year, 107 of 156 patients (69%) assigned to tubular diskectomy reported a good recovery vs 120 of 151 patients (79%) assigned to conventional microdiskectomy (odds ratio, 0.59 [95% CI, 0.35 to 0.99]; P = .05). Conclusions Use of tubular diskectomy compared with conventional microdiskectomy did not result in a statistically significant improvement in the Roland-Morris Disability Questionnaire score. Tubular diskectomy resulted in less favorable results for patient self-reported leg pain, back pain, and recovery. Trial Registration isrctn.org Identifier: ISRCTN51857546 JAMA. 2009;302(2):149-158	[Arts, Mark P.; Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, NL-2512 VA The Hague, Netherlands; [Arts, Mark P.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Brand, Ronald] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Koes, Bart W.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [van den Akker, M. Elske] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Bartels, Ronald H. M. A.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 ED Nijmegen, Netherlands	Haaglanden Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Arts, MP (corresponding author), Med Ctr Haaglanden, Dept Neurosurg, Lijnbaan 32, NL-2512 VA The Hague, Netherlands.	m.arts@mchaaglanden.nl	Koes, Bart w/K-4614-2016; Bartels, Ronald HMA/L-4184-2015	Koes, Bart w/0000-0002-0450-9969; Bartels, Ronald HMA/0000-0002-8638-4660; van den Akker-van Marle, M. Elske/0000-0002-5269-509X	Dutch Health Care Insurance Board	Dutch Health Care Insurance Board	This study was funded by the Dutch Health Care Insurance Board.	Arts MP, 2008, J NEUROSURG-SPINE, V9, P32, DOI 10.3171/SPI/2008/9/7/032; Arts MP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-42; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brock M, 2008, EUR SPINE J, V17, P518, DOI 10.1007/s00586-008-0604-2; Caspar W, 1977, LUMBAR DISC ADULT HY, V4; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Foley K.T., 1997, TECH NEUROSURG, V3, P301; Hofstee DJ, 2002, J NEUROSURG, V96, P45, DOI 10.3171/spi.2002.96.1.0045; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; McGirt MJ, 2009, NEUROSURGERY, V64, P338, DOI 10.1227/01.NEU.0000337574.58662.E2; McLoughlin GS, 2008, CAN J NEUROL SCI, V35, P75, DOI 10.1017/S0317167100007599; Mixter W.J., 1934, NEW ENGL J MED, V211, P210, DOI [10.1056/NEJM193408022110506, DOI 10.1056/NEJM193408022110506]; Muramatsu K, 2001, SPINE, V26, P1599, DOI 10.1097/00007632-200107150-00022; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Parikh K, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E14; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; PROLO DJ, 1986, SPINE, V11, P601, DOI 10.1097/00007632-198607000-00012; Righesso O, 2007, NEUROSURGERY, V61, P545, DOI 10.1227/01.NEU.0000290901.00320.F5; Ryang YM, 2008, NEUROSURGERY, V62, P174, DOI 10.1227/01.NEU.0000311075.56486.C5; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Yasargil MG, 1977, ADV NEUROSURG, V4, P81	24	153	165	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					149	158		10.1001/jama.2009.972	http://dx.doi.org/10.1001/jama.2009.972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584344				2022-12-28	WOS:000267696500024
J	Park, JI; Venteicher, AS; Hong, JY; Choi, J; Jun, S; Shkreli, M; Chang, W; Meng, ZJ; Cheung, P; Ji, H; McLaughlin, M; Veenstra, TD; Nusse, R; McCrea, PD; Artandi, SE				Park, Jae-Il; Venteicher, Andrew S.; Hong, Ji Yeon; Choi, Jinkuk; Jun, Sohee; Shkreli, Marina; Chang, Woody; Meng, Zhaojing; Cheung, Peggie; Ji, Hong; McLaughlin, Margaret; Veenstra, Timothy D.; Nusse, Roel; McCrea, Pierre D.; Artandi, Steven E.			Telomerase modulates Wnt signalling by association with target gene chromatin	NATURE			English	Article							BETA-CATENIN; REVERSE-TRANSCRIPTASE; ANTEROPOSTERIOR AXIS; TRANSIENT ACTIVATION; GROWTH; PROLIFERATION; EXPRESSION; OVEREXPRESSION; DYSFUNCTION; REGULATORS	Stem cells are controlled, in part, by genetic pathways frequently dysregulated during human tumorigenesis. Either stimulation of Wnt/beta-catenin signalling or overexpression of telomerase is sufficient to activate quiescent epidermal stem cells in vivo, although the mechanisms by which telomerase exerts these effects are not understood. Here we show that telomerase directly modulates Wnt/beta-catenin signalling by serving as a cofactor in a beta-catenin transcriptional complex. The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (also called SMARCA4), a SWI/SNF-related chromatin remodelling protein, and activates Wnt-dependent reporters in cultured cells and in vivo. TERT serves an essential role in formation of the anterior-posterior axis in Xenopus laevis embryos, and this defect in Wnt signalling manifests as homeotic transformations in the vertebrae of Tert(-/-) mice. Chromatin immunoprecipitation of the endogenous TERT protein from mouse gastrointestinal tract shows that TERT physically occupies gene promoters of Wnt-dependent genes. These data reveal an unanticipated role for telomerase as a transcriptional modulator of the Wnt/beta-catenin signalling pathway.	[Park, Jae-Il; Venteicher, Andrew S.; Choi, Jinkuk; Jun, Sohee; Shkreli, Marina; Chang, Woody; Cheung, Peggie; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Choi, Jinkuk; Artandi, Steven E.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Hong, Ji Yeon; Ji, Hong; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [McLaughlin, Margaret] MIT, Koch Inst Integrat Canc Biol, Cambridge, MA 02139 USA; [McLaughlin, Margaret] MIT, Dept Biol, Cambridge, MA 02139 USA; [Nusse, Roel] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	park, jaeil/AAS-5894-2021; Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; PARK, JAE-IL/0000-0002-0737-2654; Choi, Jinkuk/0000-0002-2449-8291	Stanford Comprehensive Cancer Center Fellowship; NCI [CA111691, CA125453]; California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [P30CA124435, R01CA125453, R01CA111691] Funding Source: NIH RePORTER	Stanford Comprehensive Cancer Center Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Chu of the Stanford Comparative Medicine Histology Research Core Laboratory for technical assistance. Wethank F. Ishikawa for Xenopus TERT plasmid, G. Crabtree for antibodies and plasmids, T. Jacks for ROSACreER T2 mice, and K. Park for constructive comments. J.-I. P. was supported by a Stanford Comprehensive Cancer Center Fellowship. This work was supported by NCI grants CA111691 and CA125453 and by a grant from the California Breast Cancer Research Program to S. E. A.	Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Rajaraman S, 2007, P NATL ACAD SCI USA, V104, P17747, DOI 10.1073/pnas.0706485104; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	50	482	506	0	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					66	U77		10.1038/nature08137	http://dx.doi.org/10.1038/nature08137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571879	Green Accepted			2022-12-28	WOS:000267545200030
J	Turk, MJ; Abel, T; O'Shea, B				Turk, Matthew J.; Abel, Tom; O'Shea, Brian			The Formation of Population III Binaries from Cosmological Initial Conditions	SCIENCE			English	Article							LAMBDA-CDM UNIVERSE; ROTATING GAS CLOUDS; 1ST STARS; PRIMORDIAL STAR; MASS FUNCTION; HII REGION; METAL-FREE; FRAGMENTATION; ACCRETION; FEEDBACK	Previous high-resolution cosmological simulations predicted that the first stars to appear in the early universe were very massive and formed in isolation. Here, we discuss a cosmological simulation in which the central 50 M(circle dot) (where M(circle dot) is the mass of the Sun) clump breaks up into two cores having a mass ratio of two to one, with one fragment collapsing to densities of 10(-8) grams per cubic centimeter. The second fragment, at a distance of similar to 800 astronomical units, is also optically thick to its own cooling radiation from molecular hydrogen lines but is still able to cool via collision-induced emission. The two dense peaks will continue to accrete from the surrounding cold gas reservoir over a period of similar to 10(5) years and will likely form a binary star system.	[Turk, Matthew J.; Abel, Tom] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Menlo Pk, CA 94025 USA; [O'Shea, Brian] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Stanford University; Michigan State University	Turk, MJ (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	mturk@slac.stanford.edu		Abel, Tom/0000-0002-5969-1251	U.S. Department of Energy (DOE) [20051325PRD4]; Stanford Linear Accelerator Center [DE-AC02-76SF00515]; NASA [NNX08AH26G]; NSF [AST-0807312]; National Nuclear Security Administration of the DOE at Los Alamos National Laboratory (LANL) [DE-AC52-06NA25396]; LANL Directors Postdoctoral Fellowship	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Stanford Linear Accelerator Center; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); National Nuclear Security Administration of the DOE at Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); LANL Directors Postdoctoral Fellowship	This work was partially supported by the U.S. Department of Energy (DOE) contract to Stanford Linear Accelerator Center no. DE-AC02-76SF00515, NASA Astrophysics Theory and Fundamental Physics grant NNX08AH26G, and NSF AST-0807312. B.W.O. and M.J.T. carried out this work in part under the auspices of the National Nuclear Security Administration of the DOE at Los Alamos National Laboratory (LANL) under contract no. DE-AC52-06NA25396. B.W.O. was partially supported by a LANL Directors Postdoctoral Fellowship (DOE LDRD grant 20051325PRD4).	Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Abel T, 2007, ASTROPHYS J, V659, pL87, DOI 10.1086/516820; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2004, NEW ASTRON, V9, P353, DOI 10.1016/j.newast.2003.12.006; Glover S, 2008, AIP CONF PROC, V990, P25; HACHISU I, 1988, ASTROPHYS J SUPPL S, V66, P315, DOI 10.1086/191259; HACHISU I, 1987, ASTROPHYS J, V323, P592, DOI 10.1086/165856; Machida MN, 2008, ASTROPHYS J, V677, P813, DOI 10.1086/533434; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; O'Shea BW, 2008, ASTROPHYS J, V673, P14, DOI 10.1086/524006; O'Shea BW, 2007, ASTROPHYS J, V654, P66, DOI 10.1086/509250; O'Shea BW, 2005, ASTROPHYS J, V628, pL5, DOI 10.1086/432683; Omukai K, 2003, ASTROPHYS J, V599, P746, DOI 10.1086/379319; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; OSHEA BW, 2004, ADAPTIVE MESH REFINE; Ostriker EC, 1999, ASTROPHYS J, V513, P252, DOI 10.1086/306858; Ripamonti E, 2004, MON NOT R ASTRON SOC, V348, P1019, DOI 10.1111/j.1365-2966.2004.07422.x; Saigo K, 2004, ASTROPHYS J, V615, pL65, DOI 10.1086/426389; Tan JC, 2004, ASTROPHYS J, V603, P383, DOI 10.1086/381490; Tumlinson J, 2006, ASTROPHYS J, V641, P1, DOI 10.1086/500383; Turk MJ, 2008, AIP CONF PROC, V990, P16; Wise JH, 2008, ASTROPHYS J, V685, P40, DOI 10.1086/590417; Yoshida N, 2003, ASTROPHYS J, V592, P645, DOI 10.1086/375810; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978	29	293	293	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					601	605		10.1126/science.1173540	http://dx.doi.org/10.1126/science.1173540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19589964	Green Submitted			2022-12-28	WOS:000268493000047
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Who will pay and who will say no?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 29	2009	339								b3042	10.1136/bmj.b3042	http://dx.doi.org/10.1136/bmj.b3042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479PH	19640934				2022-12-28	WOS:000268672900003
J	Tattersall, GJ; Andrade, DV; Abe, AS				Tattersall, Glenn J.; Andrade, Denis V.; Abe, Augusto S.			Heat Exchange from the Toucan Bill Reveals a Controllable Vascular Thermal Radiator	SCIENCE			English	Article							SURFACE-TEMPERATURE; VASOMOTION; SLEEP; BIRDS	The toco toucan (Ramphastos toco), the largest member of the toucan family, possesses the largest beak relative to body size of all birds. This exaggerated feature has received various interpretations, from serving as a sexual ornament to being a refined adaptation for feeding. However, it is also a significant surface area for heat exchange. Here we show the remarkable capacity of the toco toucan to regulate heat distribution by modifying blood flow, using the bill as a transient thermal radiator. Our results indicate that the toucan's bill is, relative to its size, one of the largest thermal windows in the animal kingdom, rivaling elephants' ears in its ability to radiate body heat.	[Tattersall, Glenn J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Andrade, Denis V.; Abe, Augusto S.] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil	Brock University; Universidade Estadual Paulista	Tattersall, GJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.		Fisiologia comparada, Inct/I-2427-2013; Tattersall, Glenn J/D-3469-2009; Andrade, Denis/A-9145-2013	Tattersall, Glenn J/0000-0002-6591-6760; Andrade, Denis/0000-0002-7662-2848	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao para o Desenvolvimento da Unesp (FUNDUNESP); Natural Sciences and Engineering Research Council of Canada	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao para o Desenvolvimento da Unesp (FUNDUNESP); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to A.S.A. and D.V.A., from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao para o Desenvolvimento da Unesp (FUNDUNESP) to D.V.A., and the Natural Sciences and Engineering Research Council of Canada to G.J.T. M. Symonds kindly commented on the manuscript, and D. Skandalis, V. Cadena, and M. da Silva assisted with experiments.	ALFOLDI P, 1990, PFLUG ARCH EUR J PHY, V417, P336, DOI 10.1007/BF00371001; ALVARENGA H, 2004, TOUCANS AM; BUFFON GLL, 1780, HIST NATURELLE GEN P; Darwin C., 1871, P475; HAGAN AA, 1980, J THERM BIOL, V5, P95, DOI 10.1016/0306-4565(80)90006-6; HELLER HC, 1988, CAN J ZOOL, V66, P61, DOI 10.1139/z88-008; JONES JS, 1985, NATURE, V315, P182, DOI 10.1038/315182b0; KLIR JJ, 1990, COMP BIOCHEM PHYS A, V96, P141, DOI 10.1016/0300-9629(90)90055-W; Lancaster WC, 1997, J THERM BIOL, V22, P109, DOI 10.1016/S0306-4565(96)00039-3; McNab BK, 2001, AUK, V118, P916, DOI 10.1642/0004-8038(2001)118[0916:EOTABA]2.0.CO;2; MIDTGARD U, 1984, ZOOMORPHOLOGY, V104, P323, DOI 10.1007/BF00312014; PHILLIPS PK, 1994, J THERM BIOL, V19, P423, DOI 10.1016/0306-4565(94)90042-6; PHILLIPS PK, 1992, COMP BIOCHEM PHYS A, V101, P693, DOI 10.1016/0300-9629(92)90345-Q; Scott GR, 2008, J EXP BIOL, V211, P1326, DOI 10.1242/jeb.015958; Sick H, 2001, ORNITOLOGIA BRASILEI; SKUTCH ALEXANDER F., 1958, CONDOR, V60, P201, DOI 10.2307/1365190; Tattersall GJ, 2003, J EXP BIOL, V206, P33, DOI 10.1242/jeb.00057; TRAILL TS, 1815, T LINN SOC LOND, V11, P288; TUCKER VA, 1968, J EXP BIOL, V48, P67; Ulrich H, 1997, TROPICAL BIODIVERSIT, P305; Van Tyne J., 1929, LIFE HIST TOUCAN RAM; WALSBERG GE, 1978, J EXP BIOL, V76, P185; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	23	156	162	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					468	470		10.1126/science.1175553	http://dx.doi.org/10.1126/science.1175553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628866				2022-12-28	WOS:000268255100054
J	Perez, JC; Groisman, EA				Perez, J. Christian; Groisman, Eduardo A.			Evolution of Transcriptional Regulatory Circuits in Bacteria	CELL			English	Review							COMPLETE GENOME SEQUENCE; LATERAL GENE-TRANSFER; FACTOR-BINDING SITES; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; YERSINIA-PESTIS; NETWORK MOTIFS; VIBRIO-CHOLERAE; RNA-POLYMERASE; FEEDBACK LOOP	Related organisms typically respond to a given cue by altering the level or activity of orthologous transcription factors, which, paradoxically, often regulate expression of distinct gene sets. Although promoter rewiring of shared genes is primarily responsible for regulatory differences among related eukaryotic species, in bacteria, species-specific genes are often controlled by ancestral transcription factors, and regulatory circuit evolution has been further shaped by horizontal gene transfer. Modifications in transcription factors and in promoter structure also contribute to divergence in bacterial regulatory circuits.	[Perez, J. Christian; Groisman, Eduardo A.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu		Perez, J. Christian/0000-0001-5790-1481	National Institutes of Health [49561, 42236]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Schroer for help with the figures. Our research on bacterial regulatory circuits is supported, in part, by grants 49561 and 42236 from the National Institutes of Health. E. A. G. is a Howard Hughes Medical Institute investigator.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Balaji S, 2007, BIOESSAYS, V29, P625, DOI 10.1002/bies.20600; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Cabeza ML, 2007, J BACTERIOL, V189, P7335, DOI 10.1128/JB.00801-07; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Davidson E.H., 2006, REGULATORY GENOME; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Harrison-McMonagle P, 1999, J MOL BIOL, V285, P555, DOI 10.1006/jmbi.1998.2375; Hershberg R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r62; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jeon J, 2008, J BACTERIOL, V190, P7326, DOI 10.1128/JB.00903-08; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Krukonis ES, 2003, MOL CELL, V12, P157, DOI 10.1016/S1097-2765(03)00222-3; Lintner RE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-60; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Lozada-Chavez I, 2008, J MOL BIOL, V379, P627, DOI 10.1016/j.jmb.2008.04.008; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Martinez-Antonio A, 2006, TRENDS MICROBIOL, V14, P22, DOI 10.1016/j.tim.2005.11.002; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mitrophanov AY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000233; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Quinones M, 2006, J BIOL CHEM, V281, P39407, DOI 10.1074/jbc.M609694200; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ruiz N, 2001, J BACTERIOL, V183, P5974, DOI 10.1128/JB.183.20.5974-5981.2001; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Winfield MD, 2005, J BIOL CHEM, V280, P14765, DOI 10.1074/jbc.M413900200; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	93	118	119	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					233	244		10.1016/j.cell.2009.07.002	http://dx.doi.org/10.1016/j.cell.2009.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632175	Green Accepted, Bronze			2022-12-28	WOS:000268277000007
J	Stein, A; Weber, G; Wahl, MC; Jahn, R				Stein, Alexander; Weber, Gert; Wahl, Markus C.; Jahn, Reinhard			Helical extension of the neuronal SNARE complex into the membrane	NATURE			English	Article							JUXTAMEMBRANE REGION; SYNAPTIC EXOCYTOSIS; MOLECULAR-DYNAMICS; FUSION; SYNAPTOTAGMIN; PROTEINS; DETERMINANTS; MECHANISMS; ENDOSOMES; SYNTAXIN	Neurotransmission relies on synaptic vesicles fusing with the membrane of nerve cells to release their neurotransmitter content into the synaptic cleft, a process requiring the assembly of several members of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family. SNAREs represent an evolutionarily conserved protein family that mediates membrane fusion in the secretory and endocytic pathways of eukaryotic cells(1-3). On membrane contact, these proteins assemble in trans between the membranes as a bundle of four alpha-helices, with the energy released during assembly being thought to drive fusion(4-6). However, it is unclear how the energy is transferred to the membranes and whether assembly is conformationally linked to fusion. Here, we report the X-ray structure of the neuronal SNARE complex, consisting of rat syntaxin 1A, SNAP-25 and synaptobrevin 2, with the carboxy-terminal linkers and transmembrane regions at 3.4 angstrom resolution. The structure shows that assembly proceeds beyond the already known core SNARE complex(7), resulting in a continuous helical bundle that is further stabilized by side-chain interactions in the linker region. Our results suggest that the final phase of SNARE assembly is directly coupled to membrane merger.	[Stein, Alexander; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Max Planck Inst Biophys Chem, Res Grp Xray Crystallog, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Fachbereich Biol, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society; Free University of Berlin	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Stein, Alexander/I-4950-2012; Wahl, Markus C./D-6365-2017; Weber, Gert/I-1800-2013	Stein, Alexander/0000-0002-2696-0611; Wahl, Markus C./0000-0002-2811-5307; Weber, Gert/0000-0003-3624-1060; Jahn, Reinhard/0000-0003-1542-3498	NIGMS NIH HHS [P01 GM072694, P01 GM072694-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelham HRB, 1995, COLD SPRING HARB SYM, V60, P105, DOI 10.1101/SQB.1995.060.01.013; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Su ZL, 2008, STRUCTURE, V16, P1138, DOI 10.1016/j.str.2008.03.018; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Van Komen JS, 2005, EUKARYOT CELL, V4, P2017, DOI 10.1128/EC.4.12.2017-2028.2005; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	296	301	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					525	U105		10.1038/nature08156	http://dx.doi.org/10.1038/nature08156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19571812	Green Accepted, Green Published			2022-12-28	WOS:000268257000041
J	Swackhamer, K				Swackhamer, Kathy			Ashes in Eyes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kswackhamer@cox.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					357	358		10.1001/jama.2009.990	http://dx.doi.org/10.1001/jama.2009.990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622806				2022-12-28	WOS:000268139200001
J	Palella, FJ; Armon, C; Buchacz, K; Cole, SR; Chmiel, JS; Novak, RM; Wood, K; Moorman, AC; Brooks, JT				Palella, Frank J., Jr.; Armon, Carl; Buchacz, Kate; Cole, Stephen R.; Chmiel, Joan S.; Novak, Richard M.; Wood, Kathleen; Moorman, Anne C.; Brooks, John T.		HOPS HIV Outpatient Study	The Association of HIV Susceptibility Testing With Survival Among HIV-Infected Patients Receiving Antiretroviral Therapy: A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHENOTYPIC DRUG-RESISTANCE; MARGINAL STRUCTURAL MODELS; SOCIETY-USA PANEL; DISEASE PROGRESSION; RECOMMENDATIONS; PREVALENCE; MANAGEMENT; INHIBITORS; EVOLUTION	Background: HIV-1 genotypic and phenotypic susceptibility testing (GPT) optimizes antiretroviral selection, but its effect on survival is unknown. Objective: To evaluate the association between GPT and survival. Design: Cohort study. Setting: 10 U.S. HIV clinics. Patients: 2699 HIV-infected patients eligible for GPT (plasma HIV RNA level > 1000 copies/mL) seen from 1999 through 2005. Measurements: Demographic characteristics, clinical factors, GPT use, all-cause mortality, and crude and adjusted hazard ratios (HRs) for the association of GPT with survival. Results: Patients were followed for a median of 3.3 years; 915 (34%) had GPT. Patients who had GPT had lower mortality rates than those who did not (2.0 vs. 2.7 deaths per 100 person-years). In standard Cox models, GPT was associated with improved survival (adjusted HR, 0.69 [95% CI, 0.51 to 0.94]; P = 0.017) after controlling for demographic characteristics, CD4(+) cell count, HIV RNA level, and intensity of clinical follow-up. In subgroup analyses, GPT was associated with improved survival for the 2107 highly active antiretroviral therapy (HAART)-experienced patients (2.2 vs. 3.2 deaths per 100 person-years for patients who had GPT vs. those who did not have GPT; adjusted HR, 0.60 [CI, 0.43 to 0.82]; P = 0.002) and for the 921 triple antiretroviral class -experienced patients (2.1 vs. 3.1 deaths per 100 person-years; adjusted HR, 0.61 [CI 0.40 to 0.93]; P = 0.022). Marginal structural models supported associations between GPT and improved survival in the overall cohort (adjusted HR, 0.54; P = 0.001) and in the HAART-experienced group (adjusted HR, 0.56; P = 0.003). Limitations: Use of GPT was not randomized. Residual confounding may exist. Conclusion: Use of GPT was independently associated with improved survival among HAART-experienced patients.	[Palella, Frank J., Jr.; Chmiel, Joan S.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; [Buchacz, Kate; Brooks, John T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; [Armon, Carl; Wood, Kathleen] Cerner Corp, Vienna, VA USA; [Novak, Richard M.] Univ Illinois, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Centers for Disease Control & Prevention - USA; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Palella, FJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Infect Dis, 645 N Michigan Ave,Suite 900, Chicago, IL 60611 USA.	f-palella@northwestern.edu		Moorman, Anne/0000-0003-2411-2798	Centers for Disease Control and Prevention [200-2006-18797]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By the Centers for Disease Control and Prevention ( contract no. 200-2006-18797).	*AIDS ED TRAIN CTR, 2006, CLIN MAN MAN HIV INF; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Brown AJL, 2000, J VIROL, V74, P10269, DOI 10.1128/JVI.74.22.10269-10273.2000; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Hales G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010018; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Little SJ, 2001, BRIT MED J, V322, P1074, DOI 10.1136/bmj.322.7294.1074; Lucas GM, 2004, AIDS, V18, P1539, DOI 10.1097/01.aids.0000131339.68666.1a; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; Martinez-Picado J, 2005, J VIROL, V79, P5907, DOI 10.1128/JVI.79.10.5907-5913.2005; Miller V, 2001, AIDS, V15, P309, DOI 10.1097/00002030-200102160-00003; Moorman AC, 1999, ANN EPIDEMIOL, V9, P349, DOI 10.1016/S1047-2797(99)00005-8; *PAN ANT GUID AD A, 2008, PAN ANT GUID AD AD G; Patel K, 2008, CLIN INFECT DIS, V46, P1751, DOI 10.1086/587900; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Sarmati L, 2002, J CLIN MICROBIOL, V40, P335, DOI 10.1128/JCM.40.2.335-340.2002; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; *SURV RISK ASS DIV, 2005, HIV 1 STRAIN PRIM DR; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916	27	38	40	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					73	W21		10.7326/0003-4819-151-2-200907210-00003	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620160				2022-12-28	WOS:000268605300001
J	Maladen, RD; Ding, Y; Li, C; Goldman, DI				Maladen, Ryan D.; Ding, Yang; Li, Chen; Goldman, Daniel I.			Undulatory Swimming in Sand: Subsurface Locomotion of the Sandfish Lizard	SCIENCE			English	Article								The desert-dwelling sandfish (Scincus scincus) moves within dry sand, a material that displays solid and fluidlike behavior. High-speed x-ray imaging shows that below the surface, the lizard no longer uses limbs for propulsion but generates thrust to overcome drag by propagating an undulatory traveling wave down the body. Although viscous hydrodynamics can predict swimming speed in fluids such as water, an equivalent theory for granular drag is not available. To predict sandfish swimming speed, we developed an empirical model by measuring granular drag force on a small cylinder oriented at different angles relative to the displacement direction and summing these forces over the animal movement profile. The agreement between model and experiment implies that the noninertial swimming occurs in a frictional fluid.	[Maladen, Ryan D.; Goldman, Daniel I.] Georgia Inst Technol, Interdisciplinary Bioengn Program, Atlanta, GA 30332 USA; [Ding, Yang; Li, Chen; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Goldman, DI (corresponding author), Georgia Inst Technol, Interdisciplinary Bioengn Program, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu	Li, Chen/A-4003-2013; Ding, Yang/A-9885-2013; Ding, Yang/A-9885-2013	Li, Chen/0000-0001-7516-3646; Ding, Yang/0000-0002-8252-2421; Ding, Yang/0000-0001-8161-2743	NSF [PHY-0749991]; Burroughs Wellcome Fund	NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by NSF Physics of Living Systems grant PHY-0749991 and the Burroughs Wellcome Fund. We thank R. Full and T. Papenfuss for helpful discussion. We thank S. Steinmetz and N. Gravish for experimental assistance and P. Umbanhowar for discussion of the drag model and careful reading of the manuscript.	Albert I, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061303; Albert R, 1999, PHYS REV LETT, V82, P205, DOI 10.1103/PhysRevLett.82.205; Alexander RM., 2003, PRINCIPLES ANIMAL LO; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Baumgartner W, 2007, J BIONIC ENG, V4, P1, DOI 10.1016/S1672-6529(07)60006-7; Baumgartner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003309; Biewener AA, 1999, J EXP BIOL, V202, P3387; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DICKINSON WW, 1994, J SEDIMENT RES A, V64, P226; Dorgan KM, 2005, NATURE, V433, P475, DOI 10.1038/433475a; Ezcurra E., 2006, GLOBAL DESERTS OUTLO; GANS C, 1975, AM ZOOL, V15, P455; GRAY J, 1964, J EXP BIOL, V41, P135; Jaeger HM, 1996, PHYS TODAY, V49, P32, DOI 10.1063/1.881494; Korta J, 2007, J EXP BIOL, V210, P2383, DOI 10.1242/jeb.004572; Lauder GV, 2002, NEWS PHYSIOL SCI, V17, P235, DOI 10.1152/nips.01398.2002; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moon BR, 1998, J EXP BIOL, V201, P2669; Nedderman R. M., 1992, STAT KINEMATICS GRAN; Schofield A.N., 1968, CRITICAL STATE SOIL; TRUEMAN ER, 1970, J EXP BIOL, V53, P701; Vogel S, 1994, LIFE MOVING FLUIDS; White CR, 2001, AUST J ZOOL, V49, P663, DOI 10.1071/ZO00076; WIEGHARDT K, 1975, ANNU REV FLUID MECH, V7, P89, DOI 10.1146/annurev.fl.07.010175.000513	26	264	268	11	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					314	318		10.1126/science.1172490	http://dx.doi.org/10.1126/science.1172490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608917				2022-12-28	WOS:000268036600044
J	Dyer, C				Dyer, Clare			Assisted suicide: the fight goes on	BRITISH MEDICAL JOURNAL			English	Editorial Material												ClareDyer@aol.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 16	2009	339								b2868	10.1136/bmj.b2868	http://dx.doi.org/10.1136/bmj.b2868			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BX	19608622				2022-12-28	WOS:000268105200003
J	Wolff, T; Leupold, J; Nuesch, R				Wolff, Thomas; Leupold, Judith; Nueesch, Reto			Bang! The smoker with suprapubic pain	LANCET			English	Editorial Material							BRUCELLOSIS		[Nueesch, Reto] Hirslanden Klin St Anna, Div Infect Dis, CH-6006 Luzern, Switzerland; [Leupold, Judith] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Wolff, Thomas] Univ Basel Hosp, Div Vasc Surg, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Nuesch, R (corresponding author), Hirslanden Klin St Anna, Div Infect Dis, St Anna Str 32, CH-6006 Luzern, Switzerland.	reto.nuesch@hirslanden.ch						Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pappas G, 2005, EXPERT OPIN PHARMACO, V6, P201, DOI 10.1517/14656566.6.2.201; Quaniers J, 2005, ACTA CHIR BELG, V105, P93; Reddy DJ, 2000, VASCULAR SURG, P1383; Taleski V, 2002, VET MICROBIOL, V90, P147, DOI 10.1016/S0378-1135(02)00250-X	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					174	174		10.1016/S0140-6736(09)60869-2	http://dx.doi.org/10.1016/S0140-6736(09)60869-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19595351				2022-12-28	WOS:000268111600035
J	Barrette, RW; Metwally, SA; Rowland, JM; Xu, LZ; Zaki, SR; Nichol, ST; Rollin, PE; Towner, JS; Shieh, WJ; Batten, B; Sealy, TK; Carrillo, C; Moran, KE; Bracht, AJ; Mayr, GA; Sirios-Cruz, M; Catbagan, DP; Lautner, EA; Ksiazek, TG; White, WR; McIntosh, MT				Barrette, Roger W.; Metwally, Samia A.; Rowland, Jessica M.; Xu, Lizhe; Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Carrillo, Consuelo; Moran, Karen E.; Bracht, Alexa J.; Mayr, Gregory A.; Sirios-Cruz, Magdalena; Catbagan, Davinio P.; Lautner, Elizabeth A.; Ksiazek, Thomas G.; White, William R.; McIntosh, Michael T.			Discovery of Swine as a Host for the Reston ebolavirus	SCIENCE			English	Article							VIRUS; BATS; PHILIPPINES; RESERVOIRS; INFECTION; VIRULENCE; EMERGENCE	Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic fatal outbreaks of disease in humans and nonhuman primates have given impetus to identification of host tropisms and potential reservoirs. Domestic swine in the Philippines, experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome, have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member of Filoviridae that has not been associated with disease in humans, its emergence in the human food chain is of concern. REBOV isolates were found to be more divergent from each other than from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been circulating since, and possibly before, the initial discovery of REBOV in monkeys.	[Barrette, Roger W.; Metwally, Samia A.; Rowland, Jessica M.; Xu, Lizhe; Carrillo, Consuelo; Moran, Karen E.; Bracht, Alexa J.; Mayr, Gregory A.; Lautner, Elizabeth A.; White, William R.; McIntosh, Michael T.] USDA, Plum Isl Anim Dis Ctr, US Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs,Foreign Anim Dis Diagnost Lab, Greenport, NY 11944 USA; [Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Ksiazek, Thomas G.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; [Zaki, Sherif R.; Nichol, Stuart T.; Rollin, Pierre E.; Towner, Jonathan S.; Shieh, Wun-Ju; Batten, Brigid; Sealy, Tara K.; Ksiazek, Thomas G.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA 30333 USA; [Sirios-Cruz, Magdalena; Catbagan, Davinio P.] Dept Agr, Bur Anim Ind, Quezon City 1101, Philippines	United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Metwally, SA (corresponding author), USDA, Plum Isl Anim Dis Ctr, US Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs,Foreign Anim Dis Diagnost Lab, Greenport, NY 11944 USA.	samia.a.metwally@aphis.usda.gov; michael.t.mcintosh@aphis.usda.gov	Towner, Jonathan/ABC-3780-2020	Rollin, Pierre/0000-0002-4608-2641	USDA; APHIS; Department of Homeland Security	USDA(United States Department of Agriculture (USDA)); APHIS(United States Department of Agriculture (USDA)); Department of Homeland Security(United States Department of Homeland Security (DHS))	We thank members of the Diagnostic Services Section of FADDL (H. Petrowski, F. Mohamed, and M. Berninger), the CDC Special Pathogens Branch (D. Cannon, A. Comer, S. Dickerson, C. Manning, D. Miller, and Z. Reed), and the CDC Infectious Disease Pathology Branch (C. Paddock, P. Adem, and C. Goldsmith) for expert technical assistance. We are also grateful to P. Hauer (APHIS, USDA) for critical review of the manuscript and to T. Gomez and J. Willnow (USDA) for facilitating conversations between U.S. agencies and the Philippines. We thank G. Risatti for protocols for PRRSV RT-PCR. This work was funded by the USDA as part of an ongoing foreign animal disease diagnostic investigation. Support for microarray development and implementation is sponsored by the APHIS Science Fellows Program, USDA, and the Department of Homeland Security. R.W.B. is an award recipient of the APHIS Science Fellows Program. PRRSV NSP2 sequences are available at GenBank (accession numbers FJ641193, FJ641194, and FJ641195), as are Reston08-A, Reston08-C, and Reston08-E sequences (accession numbers FJ621583, FJ621584, and FJ621585, respectively). Microarray data and analyses are available for download from NCBI Gene Expression Omnibus (accession GSE15687 [NCBI GEO] ) at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15687. All authors declare that they have no competing interests.	Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Jahrling PB, 1996, ARCH VIROL, P115; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li YF, 2008, ARCH VIROL, V153, P1877, DOI 10.1007/s00705-008-0207-6; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Morikawa S, 2007, COMP IMMUNOL MICROB, V30, P391, DOI 10.1016/j.cimid.2007.05.005; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Peters CJ, 1999, J INFECT DIS, V179, pIX; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Strong JE, 2008, P NATL ACAD SCI USA, V105, P17982, DOI 10.1073/pnas.0809698105; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	21	255	282	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					204	206		10.1126/science.1172705	http://dx.doi.org/10.1126/science.1172705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590002	Green Published			2022-12-28	WOS:000267802000048
J	Rieppel, O				Rieppel, Olivier			How Did the Turtle Get Its Shell?	SCIENCE			English	Editorial Material							BODY PLAN; EVOLUTION; CARAPACE; ORIGIN		Field Museum Nat Hist, Dept Geol, Rowe Family Curator Evolutionary Biol, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Rieppel, O (corresponding author), Field Museum Nat Hist, Dept Geol, Rowe Family Curator Evolutionary Biol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	orieppel@fieldmuseum.org						BURKE AC, 1991, AM ZOOL, V31, P616; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; CARROLL RL, 1988, VERTEBRATE PALEONTOL, P210; Cebra-Thomas J, 2005, J EXP ZOOL PART B, V304B, P558, DOI 10.1002/jez.b.21059; DARWIN C, 1859, ORIGIN SPECIES, P8; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Joyce WG, 2009, P ROY SOC B-BIOL SCI, V276, P507, DOI 10.1098/rspb.2008.1196; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; LEE MSY, 1993, SCIENCE, V261, P1716, DOI 10.1126/science.261.5129.1716; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Nagashima H, 2009, SCIENCE, V325, P193, DOI 10.1126/science.1173826; Reisz RR, 2008, NATURE, V456, P450, DOI 10.1038/456450a	12	8	9	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					154	155		10.1126/science.1177446	http://dx.doi.org/10.1126/science.1177446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589988				2022-12-28	WOS:000267802000030
J	Svendsen, JM; Smogorzewska, A; Sowa, ME; O'Connell, BC; Gygi, SP; Elledge, SJ; Harper, JW				Svendsen, Jennifer M.; Smogorzewska, Agata; Sowa, Mathew E.; O'Connell, Brenda C.; Gygi, Steven P.; Elledge, Stephen J.; Harper, J. Wade			Mammalian BTBD12/SLX4 Assembles A Holliday Junction Resolvase and Is Required for DNA Repair	CELL			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; SACCHAROMYCES-CEREVISIAE; MEIOTIC CROSSOVERS; MUS81-EME1; IDENTIFICATION; RESOLUTION; MECHANISM; PROTEINS; DAMAGE; YEAST	Structure-specific endonucleases mediate cleavage of DNA structures formed during repair of collapsed replication forks and double-strand breaks (DSBs). Here, we identify BTBD12 as the human ortholog of the budding yeast DNA repair factor Slx4p and D. melanogaster MUS312. Human SLX4 forms a multiprotein complex with the ERCC4(XPF)-ERCC1, MUS81-EME1, and SLX1 endonucleases and also associates with MSH2/MSH3 mismatch repair complex, telomere binding complex TERF2(TRF2)-TERF2IP(RAP1), the protein kinase PLK1 and the uncharacterized protein C20orf94. Depletion of SLX4 causes sensitivity to mitomycin C and camptothecin and reduces the efficiency of DSB repair in vivo. SLX4 complexes cleave 3' flap, 5' flap, and replication fork structures; yet unlike other endonucleases associated with SLX4, the SLX1-SLX4 module promotes symmetrical cleavage of static and migrating Holliday junctions (HJs), identifying SLX1-SLX4 as a HJ resolvase. Thus, SLX4 assembles a modular toolkit for repair of specific types of DNA lesions and is critical for cellular responses to replication fork failure.	[Svendsen, Jennifer M.; Sowa, Mathew E.; O'Connell, Brenda C.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Med, Div Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Smogorzewska, Agata/B-8891-2011	Smogorzewska, Agata/0000-0001-6285-1562; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health; Centers for Medical Countermeasures Against Radiation; Stewart Trust; Burroughs Wellcome Fund; American Cancer Society;  [T32CA09216]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Medical Countermeasures Against Radiation; Stewart Trust; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Clare McGowan, Richard Wood, Orlando Scharer, Joyce Reardon, Laura Niedernhofer, Maria Jasin, Steve West, and Guang Hu for reagents, John Rouse, Jim Haber, Jeff Sekelsky, Monica Colaiacovo, and Pierre- Henri Gaillard for communicating results prior to publication, and Alberto Ciccia and Maria Jasin for discussions. This work was supported by grants from the National Institutes of Health to S.J.E., S.P.G., and J.W.H., a Centers for Medical Countermeasures Against Radiation grant to S.J.E., and by a grant from the Stewart Trust to J.W.H.A.S. is supported by T32CA09216 to the Pathology Department at the Massachusetts General Hospital and by an award from the Burroughs Wellcome Fund. B.C.O. is supported by a postdoctoral fellowship from the American Cancer Society. S.J.E. is an investigator of the Howard Hughes Medical Institute.	Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Coulon S, 2004, MOL BIOL CELL, V15, P71, DOI 10.1091/mbc.E03-08-0586; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FEKAIRI S, 2009, CELL IN PRESS; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; SOWA ME, 2009, CELL IN PRESS, DOI DOI 10.1016/J.CELL.2009.04.042; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; WEST SC, 1995, NATURE, V373, P27, DOI 10.1038/373027a0; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	34	348	362	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					63	77		10.1016/j.cell.2009.06.030	http://dx.doi.org/10.1016/j.cell.2009.06.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596235	Green Accepted, Bronze			2022-12-28	WOS:000267848600015
J	Kim, JI; Ju, YS; Park, H; Kim, S; Lee, S; Yi, JH; Mudge, J; Miller, NA; Hong, D; Bell, CJ; Kim, HS; Chung, IS; Lee, WC; Lee, JS; Seo, SH; Yun, JY; Woo, HN; Lee, H; Suh, D; Lee, S; Kim, HJ; Yavartanoo, M; Kwak, M; Zheng, Y; Lee, MK; Park, H; Kim, JY; Gokcumen, O; Mills, RE; Zaranek, AW; Thakuria, J; Wu, X; Kim, RW; Huntley, JJ; Luo, S; Schroth, GP; Wu, TD; Kim, H; Yang, KS; Park, WY; Kim, H; Church, GM; Lee, C; Kingsmore, SF; Seo, JS				Kim, Jong-Il; Ju, Young Seok; Park, Hansoo; Kim, Sheehyun; Lee, Seonwook; Yi, Jae-Hyuk; Mudge, Joann; Miller, Neil A.; Hong, Dongwan; Bell, Callum J.; Kim, Hye-Sun; Chung, In-Soon; Lee, Woo-Chung; Lee, Ji-Sun; Seo, Seung-Hyun; Yun, Ji-Young; Woo, Hyun Nyun; Lee, Heewook; Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Lee, Mi Kyeong; Park, Hyunjun; Kim, Jeong Yeon; Gokcumen, Omer; Mills, Ryan E.; Zaranek, Alexander Wait; Thakuria, Joseph; Wu, Xiaodi; Kim, Ryan W.; Huntley, Jim J.; Luo, Shujun; Schroth, Gary P.; Wu, Thomas D.; Kim, HyeRan; Yang, Kap-Seok; Park, Woong-Yang; Kim, Hyungtae; Church, George M.; Lee, Charles; Kingsmore, Stephen F.; Seo, Jeong-Sun			A highly annotated whole-genome sequence of a Korean individual	NATURE			English	Article							MESSENGER-RNA	Recent advances in sequencing technologies have initiated an era of personal genome sequences. To date, human genome sequences have been reported for individuals with ancestry in three distinct geographical regions: a Yoruba African, two individuals of northwest European origin, and a person from China(1-4). Here we provide a highly annotated, whole-genome sequence for a Korean individual, known as AK1. The genome of AK1 was determined by an exacting, combined approach that included whole-genome shot-gun sequencing (27.8x coverage), targeted bacterial artificial chromosome sequencing, and high-resolution comparative genomic hybridization using custom microarrays featuring more than 24 million probes. Alignment to the NCBI reference, a composite of several ethnic clades(5,6), disclosed nearly 3.45 million single nucleotide polymorphisms ( SNPs), including 10,162 non-synonymous SNPs, and 170,202 deletion or insertion polymorphisms (indels). SNP and indel densities were strongly correlated genome-wide. Applying very conservative criteria yielded highly reliable copy number variants for clinical considerations. Potential medical phenotypes were annotated for non-synonymous SNPs, coding domain indels, and structural variants. The integration of several human whole-genome sequences derived from several ethnic groups will assist in understanding genetic ancestry, migration patterns and population bottlenecks.	[Kim, Jong-Il; Ju, Young Seok; Park, Hansoo; Yi, Jae-Hyuk; Hong, Dongwan; Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Park, Hyunjun; Kim, Jeong Yeon; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea; [Kim, Jong-Il; Ju, Young Seok; Suh, Dongwhan; Lee, Seungbok; Yavartanoo, Maryam; Kwak, Minhye; Zheng, Ying; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Coll Med, Dept Biochem & Mol Biol, Seoul 110799, South Korea; [Suh, Dongwhan; Lee, Seungbok; Kim, Hyun-Jin; Park, Woong-Yang; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Jong-Il; Kim, Sheehyun; Lee, Seonwook; Kim, Hye-Sun; Chung, In-Soon; Lee, Woo-Chung; Lee, Ji-Sun; Woo, Hyun Nyun; Lee, Heewook; Kim, HyeRan; Yang, Kap-Seok; Kim, Hyungtae; Seo, Jeong-Sun] Macrogen Inc, Seoul 153023, South Korea; [Kim, Jong-Il; Park, Hansoo; Seo, Seung-Hyun; Yun, Ji-Young; Lee, Mi Kyeong; Seo, Jeong-Sun] Psoma Therapeut Inc, Seoul 110799, South Korea; [Mudge, Joann; Miller, Neil A.; Bell, Callum J.; Mills, Ryan E.; Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Gokcumen, Omer; Mills, Ryan E.; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zaranek, Alexander Wait; Thakuria, Joseph; Wu, Xiaodi; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Huntley, Jim J.; Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Macrogen, Inc.; National Center for Genome Resources (NCGR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Illumina; Roche Holding; Genentech	Seo, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea.	jeongsun@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; Ju, Young Seok/E-1324-2012; park, woongyang/D-5727-2012; Lee, Mi Kyeong/C-3046-2017; KIM, JONG-IL/D-1019-2011; Mills, Ryan/F-4225-2010; Gokcumen, Omer/J-6984-2013	Ju, Young Seok/0000-0002-5514-4189; Lee, Mi Kyeong/0000-0002-3036-3684; KIM, JONG-IL/0000-0002-7240-3744; Mills, Ryan/0000-0003-3425-6998; Mudge, Joann/0000-0002-2972-1640; kingsmore, stephen/0000-0002-3758-4631; Seungbok, Lee/0000-0002-3145-8714; Gokcumen, Omer/0000-0003-4371-679X; Hong, Dongwan/0000-0002-7816-1299; church, george/0000-0001-6232-9969; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655; Kingsmore, Stephen/0000-0001-7180-2527; Kim, Sheehyun/0000-0002-4347-4420	Korean Ministry of Education, Science, and Technology [M10305030000]; Green Cross Therapeutics [0411-20080023]; Macrogen Inc. [MG2009001]; National Institutes of Health (NIH) [RR016480, HG004221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Green Cross Therapeutics; Macrogen Inc.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. Yi for her help during this work. We would like to thank D. Bentley and M. Ross for providing genotypes of NA18507, and S. Ham for his comment on BAC analysis. This work has been supported by the Korean Ministry of Education, Science, and Technology ( grant M10305030000), Green Cross Therapeutics ( 0411-20080023), and Macrogen Inc. (MG2009001). This work was also supported in part by National Institutes of Health (NIH) grants RR016480 ( S. F. K.) and HG004221 ( C. L.). We acknowledge G. D. May, J. E. Woodward and L. E. Clendenen for generation of some of the sequence data, and T. Ramaraj for assistance with data analysis.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen R, 2004, GENOME RES, V14, P679, DOI 10.1101/gr.2171704; Frijters ACJ, 1997, THEOR APPL GENET, V94, P390, DOI 10.1007/s001220050428; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Longman-Jacobsen N, 2003, GENE, V312, P257, DOI 10.1016/S0378-1119(03)00621-8; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Silva JC, 2002, TRENDS GENET, V18, P544, DOI 10.1016/S0168-9525(02)02757-9; Sokal R.R., 2012, BIOMETRY; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	22	242	259	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1011	U96		10.1038/nature08211	http://dx.doi.org/10.1038/nature08211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19587683	Green Accepted, hybrid			2022-12-28	WOS:000269085500034
J	Cordes, KR; Sheehy, NT; White, MP; Berry, EC; Morton, SU; Muth, AN; Lee, TH; Miano, JM; Ivey, KN; Srivastava, D				Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Lee, Ting-Hein; Miano, Joseph M.; Ivey, Kathryn N.; Srivastava, Deepak			miR-145 and miR-143 regulate smooth muscle cell fate and plasticity	NATURE			English	Article							SERUM RESPONSE FACTOR; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; PROGENITOR CELLS; VASCULAR INJURY; MICRORNA; DIFFERENTIATION; MYOCARDIN; ACTIVATION; PROLIFERATION	MicroRNAs (miRNAs) are regulators of myriad cellular events, but evidence for a single miRNA that can efficiently differentiate multipotent stem cells into a specific lineage or regulate direct reprogramming of cells into an alternative cell fate has been elusive. Here we show that miR-145 and miR-143 are co-transcribed in multipotent murine cardiac progenitors before becoming localized to smooth muscle cells, including neural crest stem-cell-derived vascular smooth muscle cells. miR-145 and miR-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated in injured or atherosclerotic vessels containing proliferating, less differentiated smooth muscle cells. miR-145 was necessary for myocardin-induced reprogramming of adult fibroblasts into smooth muscle cells and sufficient to induce differentiation of multipotent neural crest stem cells into vascular smooth muscle. Furthermore, miR-145 and miR-143 cooperatively targeted a network of transcription factors, including Klf4 (Kruppel-like factor 4), myocardin and Elk-1 (ELK1, member of ETS oncogene family), to promote differentiation and repress proliferation of smooth muscle cells. These findings demonstrate that miR-145 can direct the smooth muscle fate and that miR-145 and miR-143 function to regulate the quiescent versus proliferative phenotype of smooth muscle cells.	[Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94543 USA; [Cordes, Kimberly R.; Sheehy, Neil T.; White, Mark P.; Berry, Emily C.; Morton, Sarah U.; Muth, Alecia N.; Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Lee, Ting-Hein; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Rochester	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	; Miano, Joseph/L-5634-2018	Metzler, Kimberly/0000-0002-9043-3357; Morton, Sarah/0000-0002-7816-2646; Miano, Joseph/0000-0001-7522-3207	NHLBI/NIH [HL62572, HL091168]; California Institute for Regenerative Medicine (CIRM); NIH/NCRR [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Blelloch for DGCR8-null EBs; R. J. Schwartz for SRF-null ES cells; I. Charo and N. Saederup for RNA from atherosclerotic tissue; J. Maurer for JoMa neural crest cell line; L. Qian and Y. Huang for providing mouse cardiac infarct RNA; C. Tsou for help with calcium flux assays; E. N. Olson for the myocardin expression plasmid; P. Swinton for generation of transgenic mice; J. Fish and C. Miller for histopathology support; S. Ordway and G. Howard for scientific editing; B. Taylor for manuscript preparation. We also thank members of the Srivastava laboratory for discussions. J. M. M. was supported by HL62572 and HL091168 from NHLBI/NIH. D. S. was supported by grants from the NHLBI/NIH and the California Institute for Regenerative Medicine (CIRM) and was an Established Investigator of the American Heart Association. This work was also supported by NIH/NCRR grant C06 RR018928 to the Gladstone Institutes.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Mishra-Gorur K, 2002, AM J PATHOL, V161, P1893, DOI 10.1016/S0002-9440(10)64465-3; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamamoto M, 1998, EXP CELL RES, V240, P349, DOI 10.1006/excr.1998.3999; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	1214	1326	8	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					705	U80		10.1038/nature08195	http://dx.doi.org/10.1038/nature08195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19578358	Green Accepted, Green Submitted			2022-12-28	WOS:000268670300031
J	Chandra, D; Parisini, E; Mozaffarian, D				Chandra, Divay; Parisini, Emilio; Mozaffarian, Dariush			Meta-analysis: Travel and Risk for Venous Thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Review							DEEP-VEIN THROMBOSIS; LONG-HAUL FLIGHTS; AIR-TRAVEL; PULMONARY-EMBOLISM; RANDOMIZED-TRIAL; HYPOBARIC HYPOXIA; ELASTIC STOCKINGS; CLINICAL-TRIALS; HUMAN-BEINGS; COAGULATION	Background: The potential risk for travel-related venous thromboembolism (VTE) has become an important public health concern because of rapid increases in long-distance travel; however, previous studies on this relationship are surprisingly contradictory. Purpose: To estimate the risk for VTE in travelers, determine whether a dose-response relationship exists, and identify reasons for the contradictory results of previous studies. Data Sources: MEDLINE, EMBASE, BIOSIS, CINAHL, grey-literature sources, contact with investigators, and reference lists of studies, without language restrictions. Study Selection: Reports were selected if they investigated the association between travel and VTE for persons who used any mode of transportation and if nontraveling persons were included for comparison. Data Extraction: Data on study and patient characteristics, risk estimates, and quality were independently extracted by 2 investigators. Pooled effect estimates were obtained by using random-effect meta-analysis. Data Synthesis: Of 1560 identified abstracts, 14 studies (11 case-control, 2 cohort, and 1 case-crossover) met inclusion criteria, including 4055 cases of VTE. Compared with nontravelers, the overall pooled relative risk for VTE in travelers was 2.0 (95% CI, 1.5 to 2.7). Significant heterogeneity was present because of the method for selecting control participants (P = 0.008): whether the studies used control participants who had been referred for VTE evaluation or nonreferred control participants. When the studies that used referred control participants were excluded, the pooled relative risk for VTE in travelers was 2.8 (CI, 2.2 to 3.7), without significant heterogeneity. A dose-response relationship was identified, with an 18% higher risk for VTE for each 2-hour increase in duration of travel by any mode (P = 0.010) and a 26% higher risk for every 2 hours of air travel (P = 0.005). Limitation: All available studies were from Western countries; generalizability to non-Western populations is expected but needs confirmation. Conclusion: Travel is associated with a nearly 3-fold higher risk for VTE, with a dose-response relationship of 18% higher risk for each 2-hour increase in travel duration. Heterogeneity in results of previous studies was due to selection bias toward the null from use of referred control participants.	[Chandra, Divay] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Chandra, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	dchandra@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008		Agency for Healthcare Research and Quality; U. S. Department of Health and Human Services [290-02-0022]; Tufts Medical Center/Pfizer	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U. S. Department of Health and Human Services; Tufts Medical Center/Pfizer(Pfizer)	Grant Support: By the Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services (contract 290-02-0022). Dr. Alsheikh-Ali received an unrestricted faculty development award from Tufts Medical Center/Pfizer.	Adi Yaser, 2004, BMC Cardiovasc Disord, V4, P7; Arya R, 2002, BRIT J HAEMATOL, V116, P653, DOI 10.1046/j.0007-1048.2001.03330.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belcaro G, 2003, CLIN APPL THROMB-HEM, V9, P197, DOI 10.1177/107602960300900303; Belcaro G, 2002, ANGIOLOGY, V53, P635, DOI 10.1177/000331970205300603; Belcaro G, 2001, ANGIOLOGY, V52, P369, DOI 10.1177/000331970105200601; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Cannegieter SC, 2006, PLOS MED, V3, P1258, DOI 10.1371/journal.pmed.0030307; Cesarone MR, 2003, ANGIOLOGY, V54, P143, DOI 10.1177/000331970305400202; Cesarone MR, 2003, ANGIOLOGY, V54, P1, DOI 10.1177/000331970305400101; Crosby A, 2003, LANCET, V361, P2207, DOI 10.1016/S0140-6736(03)13777-4; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimberg LA, 2001, J TRAVEL MED, V8, P127, DOI 10.2310/7060.2001.24399; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Hosoi Y, 2002, EUR J VASC ENDOVASC, V24, P235, DOI 10.1053/ejvs.2002.1719; Jacobson BF, 2003, SAMJ S AFR MED J, V93, P522; Joseph CLM, 2000, CHEST, V117, P1336, DOI 10.1378/chest.117.5.1336; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kelman CW, 2003, BRIT MED J, V327, P1072, DOI 10.1136/bmj.327.7423.1072; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; Kuipers S, 2007, J INTERN MED, V262, P615, DOI 10.1111/j.1365-2796.2007.01867.x; Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Martinelli I, 2003, ARCH INTERN MED, V163, P2771, DOI 10.1001/archinte.163.22.2771; OPATRNY L, 2004, THESIS MCGILL U MONT; Parkin L, 2006, THROMB HAEMOSTASIS, V95, P807, DOI 10.1160/TH05-12-0813; Perez-Rodriguez E, 2003, ARCH INTERN MED, V163, P2766, DOI 10.1001/archinte.163.22.2766; ROTHMAN KJ, 2002, EPIDEMIOLOGY INTRO, P73; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Schobersberger W, 2004, BLOOD COAGUL FIBRIN, V15, P419, DOI 10.1097/01.mbc.0000114438.81125.cf; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6; Stricker H, 2006, J THROMB HAEMOST, V4, P900, DOI 10.1111/j.1538-7836.2006.01855.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sturmer T, 2000, J Epidemiol Biostat, V5, P125; Tardy B, 1996, THROMB RES, V83, P153, DOI 10.1016/0049-3848(96)00116-8; ten Wolde M, 2003, THROMB HAEMOSTASIS, V89, P499, DOI 10.1055/s-0037-1613380; TERKUILE A, 2008, INT CIVIL AVIATION O, V63, P36; Toff WD, 2006, JAMA-J AM MED ASSOC, V295, P2251, DOI 10.1001/jama.295.19.2251; Trujillo-Santos AJ, 2008, ANN HEMATOL, V87, P79, DOI 10.1007/s00277-007-0373-8; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; World Health Organization, 2007, RES GLOB HAZ TRAV WR	44	112	117	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					180	W42		10.7326/0003-4819-151-3-200908040-00129	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00129			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19581633				2022-12-28	WOS:000268947800005
J	Honnappa, S; Gouveia, SM; Weisbrich, A; Damberger, FF; Bhavesh, NS; Jawhari, H; Grigoriev, I; van Rijssel, FJA; Buey, RM; Lawera, A; Jelesarov, I; Winkler, FK; Wuthrich, K; Akhmanova, A; Steinmetz, MO				Honnappa, Srinivas; Gouveia, Susana Montenegro; Weisbrich, Anke; Damberger, Fred F.; Bhavesh, Neel S.; Jawhari, Hatim; Grigoriev, Ilya; van Rijssel, Frederik J. A.; Buey, Ruben M.; Lawera, Aleksandra; Jelesarov, Ilian; Winkler, Fritz K.; Wuethrich, Kurt; Akhmanova, Anna; Steinmetz, Michel O.			An EB1-Binding Motif Acts as a Microtubule Tip Localization Signal	CELL			English	Article							PLUS-END-TRACKING; CAP-GLY DOMAINS; NMR-SPECTROSCOPY; IN-VITRO; PROTEIN; EB1; DYNAMICS; MCAK; RECOGNITION; NETWORKS	Microtubules are filamentous polymers essential for cell viability. Microtubule plus-end tracking proteins (+TIPs) associate with growing microtubule plus ends and control microtubule dynamics and interactions with different cellular structures during cell division, migration, and morphogenesis. EB1 and its homologs are highly conserved proteins that play an important role in the targeting of +TIPs to microtubule ends, but the underlying molecular mechanism remains elusive. By using live cell experiments and in vitro reconstitution assays, we demonstrate that a short polypeptide motif, Ser-x-Ile-Pro (SxIP), is used by numerous +TIPs, including the tumor suppressor APC, the transmembrane protein STIM1, and the kinesin MCAK, for localization to microtubule tips in an EB1-dependent manner. Structural and biochemical data reveal the molecular basis of the EB1-SxIP interaction and explain its negative regulation by phosphorylation. Our findings establish a general "microtubule tip localization signal'' (MtLS) and delineate a unifying mechanism for this subcellular protein targeting process.	[Gouveia, Susana Montenegro; Grigoriev, Ilya; van Rijssel, Frederik J. A.; Lawera, Aleksandra; Akhmanova, Anna] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Honnappa, Srinivas; Weisbrich, Anke; Jawhari, Hatim; Buey, Ruben M.; Winkler, Fritz K.; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Damberger, Fred F.; Bhavesh, Neel S.; Wuethrich, Kurt] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Jelesarov, Ilian] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Wuethrich, Kurt] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Scripps Research Institute; Scripps Research Institute	Akhmanova, A (corresponding author), Erasmus MC, Dept Cell Biol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.akhmanova@erasmusmc.nl; michel.steinmetz@psi.ch	Martinez-Buey, Ruben/K-4296-2014; Bhavesh, Neel Sarovar/F-3127-2015; Akhmanova, Anna S/B-8896-2011; Steinmetz, Michel O/AAA-3349-2022; Damberger, Fred F/A-8938-2011	Martinez-Buey, Ruben/0000-0003-1263-0221; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Akhmanova, Anna S/0000-0002-9048-8614; Steinmetz, Michel O/0000-0001-6157-3687; Damberger, Fred F/0000-0002-8457-3409; gouveia, susana/0000-0003-1220-410X	Swiss National Science Foundation; Netherlands Organization for Scientific Research; Fundacao para a Ciencia e a Tecnologia; FEBS; ETH Zurich through the NCCR ""Structural Biology''	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEBS; ETH Zurich through the NCCR ""Structural Biology''(ETH Zurich)	We are indebted to A. Blanc, D. Desbouis, and C. Muller for excellent technical assistance, to N. Olieric for cloning of human MCAK, to A. Mussachio for critical reading and comments on the manuscript, and to R. Lewis, D. Compton, and L. Wordeman for the generous gift of materials. X-ray data were collected at beamline X06SA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). This work was supported by the Swiss National Science Foundation (to M.O.S.), by the Netherlands Organization for Scientific Research (to A. A.), by Fundacao para a Ciencia e a Tecnologia fellowship (to S. M. G.), by a FEBS fellowship to R. M. B., and by the Swiss National Science Foundation and the ETH Zurich through the NCCR ""Structural Biology'' (to I. J., F. K. W., and K. W.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Keller R., 2004, COMPUTER AIDED RESON, V1; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	38	456	472	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					366	376		10.1016/j.cell.2009.04.065	http://dx.doi.org/10.1016/j.cell.2009.04.065			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632184	Green Accepted, Bronze			2022-12-28	WOS:000268277000017
J	Ritchie, DS; Smyth, MJ				Ritchie, David S.; Smyth, Mark J.			A New Therapeutic Target for Leukemia Comes to the Surface	CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA	Expression of the cell-surface protein CD47 allows some normal cells to avoid phagocytosis by macrophages. In this issue, Jaiswal et al. (2009) and Majeti et al. (2009) show that elevated CD47 expression by leukemic stem cells inhibits macrophage activity and is an indicator of poor prognosis for patients with acute myeloid leukemia.	[Ritchie, David S.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Ritchie, David S.] Univ Melbourne, Dept Med Dent & Hlth Sci, Parkville, Vic 3010, Australia; [Smyth, Mark J.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Ritchie, DS (corresponding author), Peter MacCallum Canc Ctr, Div Haematol & Med Oncol, Melbourne, Vic 3002, Australia.	david.ritchie@petermac.org; mark.smyth@petermac.org	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240				Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; van den Berg TK, 2008, TRENDS IMMUNOL, V29, P203, DOI 10.1016/j.it.2008.02.004	6	12	16	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					226	228		10.1016/j.cell.2009.07.005	http://dx.doi.org/10.1016/j.cell.2009.07.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632173	Bronze			2022-12-28	WOS:000268277000005
J	Klein, HL; Symington, LS				Klein, Hannah L.; Symington, Lorraine S.			Breaking Up Just Got Easier to Do	CELL			English	Editorial Material							DNA-REPAIR; YEAST	The SLX4 protein functions as a platform for catalytic subunits of structure-specific endonucleases. Findings reported in Cell (Fekairi et al., 2009; Svendsen et al., 2009) and in Molecular Cell (Andersen et al., 2009; Mu oz et al., 2009) now identify the human SLX4 and show that in association with the SLX1 endonuclease it directs the symmetric cleavage and resolution of Holliday junctions.	[Klein, Hannah L.] NYU, Langone Med Ctr, Dept Biochem, New York, NY 10016 USA; [Symington, Lorraine S.] Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	New York University; NYU Langone Medical Center; Columbia University	Klein, HL (corresponding author), NYU, Langone Med Ctr, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	hannah.klein@nyumc.org; lss5@columbia.edu		Klein, Hannah/0000-0003-4228-8535	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041784, R01 GM041784-21] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN SL, 2009, MOL CELL IN PRESS, V35; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104; Mullen JR, 2001, GENETICS, V157, P103; MUNOZ IM, 2009, MOL CELL IN PRESS, V35	8	20	20	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					20	22		10.1016/j.cell.2009.06.039	http://dx.doi.org/10.1016/j.cell.2009.06.039			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596231	Bronze			2022-12-28	WOS:000267848600010
J	Cooke, J; Sullivan, M; Barton, EJ; Bullock, JS; Carlberg, RG; Gal-Yam, A; Tollerud, E				Cooke, Jeff; Sullivan, Mark; Barton, Elizabeth J.; Bullock, James S.; Carlberg, Ray G.; Gal-Yam, Avishay; Tollerud, Erik			Type IIn supernovae at redshift z approximate to 2 from archival data	NATURE			English	Article							GALAXIES; Z-SIMILAR-TO-3; TELESCOPE; EPOCH	Supernovae have been confirmed to redshift z approximate to 1.7 (refs 1, 2) for type Ia (thermonuclear detonation of a white dwarf) and to z approximate to 0.7 (refs 1, 3-5) for type II (collapse of the core of the star). The subclass type IIn (ref. 6) supernovae are luminous(7-9) core-collapse explosions of massive stars(8-11) and, unlike other types, are very bright in the ultraviolet(12-15), which should enable them to be found optically at redshifts z approximate to 2 and higher(14,16). In addition, the interaction of the ejecta with circumstellar material creates strong, long-lived emission lines that allow spectroscopic confirmation of many events of this type at z approximate to 2 for 3-5 years after explosion (ref. 14). Here we report three spectroscopically confirmed type IIn supernovae, at redshifts z = 0.808, 2.013 and 2.357, detected in archival data using a method(14) designed to exploit these properties at z approximate to 2. Type IIn supernovae directly probe the formation of massive stars at high redshift. The number found to date is consistent with the expectations of a locally measured(17) stellar initial mass function, but not with an evolving initial mass function proposed(18-20) to explain independent observations at low and high redshift.	[Cooke, Jeff; Barton, Elizabeth J.; Bullock, James S.; Tollerud, Erik] Univ Calif Irvine, Dept Phys & Astron, Ctr Cosmol, Irvine, CA 92697 USA; [Sullivan, Mark] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Carlberg, Ray G.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Gal-Yam, Avishay] Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel	University of California System; University of California Irvine; University of Oxford; University of Toronto; Weizmann Institute of Science	Cooke, J (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Ctr Cosmol, Irvine, CA 92697 USA.	cooke@uci.edu	Carlberg, Raymond G/I-6947-2012; Bullock, James/K-1928-2015	Carlberg, Raymond G/0000-0002-7667-0081; Bullock, James/0000-0003-4298-5082; Tollerud, Erik/0000-0002-9599-310X; Sullivan, Mark/0000-0001-9053-4820	NSERC; Royal Society; NSF [AST-0071048]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Society(Royal Society of London); NSF(National Science Foundation (NSF))	J. C. thanks D. Leonard for discussions. This work was made possible by support from the Gary McCue postdoctoral fellowship and the Center for Cosmology at the University of California, Irvine. We acknowledge support from NSERC and the Royal Society. The analysis pipeline used to reduce the DEIMOS data was developed at UC Berkeley with support from the NSF (grant AST-0071048). The CFHT-LS relies on observations with MegaCam, a joint project of CFHT and CEA/DAPNIA, at the CFHT. We used data products from the Canadian Astronomy Data Centre as part of the CFHT-LS. Both CFHT and the W. M. Keck Observatory are located near the summit of Mauna Kea, Hawai'i. We acknowledge the cultural role that the summit of Mauna Kea has within the indigenous Hawaiian community.	Botticella MT, 2008, ASTRON ASTROPHYS, V479, P49, DOI 10.1051/0004-6361:20078011; BROWN P, 2008, ULTRAVIOLET LIGHT CU; Chary RR, 2008, ASTROPHYS J, V680, P32, DOI 10.1086/587737; Cooke J, 2005, ASTROPHYS J, V621, P596, DOI 10.1086/427685; Cooke J, 2008, ASTROPHYS J, V677, P137, DOI 10.1086/526490; Dahlen T, 1999, ASTRON ASTROPHYS, V350, P349; Dave R, 2008, MON NOT R ASTRON SOC, V385, P147, DOI 10.1111/j.1365-2966.2008.12866.x; Della Valle M, 2006, ASTROPHYS J, V642, pL103, DOI 10.1086/504636; Faber SM, 2003, P SOC PHOTO-OPT INS, V4841, P1657, DOI 10.1117/12.460346; Fransson C, 2005, ASTROPHYS J, V622, P991, DOI 10.1086/426495; Fransson C, 2002, ASTROPHYS J, V572, P350, DOI 10.1086/340295; Gal-Yam A, 2007, ASTROPHYS J, V656, P372, DOI 10.1086/510523; Kotak R, 2006, ASTRON ASTROPHYS, V460, pL5, DOI 10.1051/0004-6361:20065800; Le Fevre O, 2003, PROC SPIE, V4834, P173, DOI 10.1117/12.457547; McCarthy JK, 1998, P SOC PHOTO-OPT INS, V3355, P81, DOI 10.1117/12.316831; Neill JD, 2006, ASTRON J, V132, P1126, DOI 10.1086/505532; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Poznanski D, 2007, MON NOT R ASTRON SOC, V382, P1169, DOI 10.1111/j.1365-2966.2007.12424.x; Richardson D, 2002, ASTRON J, V123, P745, DOI 10.1086/338318; Riess AG, 2001, ASTROPHYS J, V560, P49, DOI 10.1086/322348; Riess AG, 2004, ASTROPHYS J, V600, pL163, DOI 10.1086/378311; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Smith N, 2008, ASTROPHYS J, V686, P467, DOI 10.1086/591021; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Soderberg AM, 2006, ASTROPHYS J, V636, P391, DOI 10.1086/498009; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Steidel CC, 2004, ASTROPHYS J, V604, P534, DOI 10.1086/381960; van Dokkum PG, 2008, ASTROPHYS J, V674, P29, DOI 10.1086/525014	30	36	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					237	239		10.1038/nature08082	http://dx.doi.org/10.1038/nature08082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587765	Green Submitted			2022-12-28	WOS:000267761000036
J	Morris, J				Morris, Jane			Endgames Case report A maths student with psychiatric symptoms	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Edinburgh & Associated Hosp, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh	Morris, J (corresponding author), Royal Edinburgh & Associated Hosp, Edinburgh EH10 5HF, Midlothian, Scotland.	jane.morris@nshlothian.scot.nhs.uk						*BRIT PSYCH SOC RO, 2006, OBS COMP DIS COR INT	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2009	339								b2639	10.1136/bmj.b2639	http://dx.doi.org/10.1136/bmj.b2639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KY	19586973				2022-12-28	WOS:000267898300004
J	Halliday, AN; Wood, BJ				Halliday, Alex N.; Wood, Bernard J.			How Did Earth Accrete?	SCIENCE			English	Editorial Material							TERRESTRIAL MAGMA OCEAN; FORMING GIANT IMPACT; CORE FORMATION; CONSTRAINTS; METEORITES; EQUILIBRATION; TIMESCALE; PLANETS		[Halliday, Alex N.; Wood, Bernard J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Halliday, AN (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	alex.halliday@earth.ox.ac.uk	Wood, Bernard J/E-8173-2010	Wood, Bernard J/0000-0003-1038-7301	NERC [NE/F018266/1] Funding Source: UKRI; STFC [ST/F001940/1, PP/D001250/1] Funding Source: UKRI; Natural Environment Research Council [NE/F018266/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/F001940/1, PP/D001250/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Canup RM, 2008, PHILOS T R SOC A, V366, P4061, DOI 10.1098/rsta.2008.0101; CHEN JH, 1990, GEOCHIM COSMOCHIM AC, V54, P1729, DOI 10.1016/0016-7037(90)90404-9; Halliday AN, 2008, PHILOS T R SOC A, V366, P4163, DOI 10.1098/rsta.2008.0209; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Kegler P, 2008, EARTH PLANET SC LETT, V268, P28, DOI 10.1016/j.epsl.2007.12.020; Markowski A, 2006, EARTH PLANET SC LETT, V242, P1, DOI 10.1016/j.epsl.2005.11.048; Ogihara M, 2007, ICARUS, V188, P522, DOI 10.1016/j.icarus.2006.12.006; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Polyakov VB, 2009, SCIENCE, V323, P912, DOI 10.1126/science.1166329; RINGWOOD AE, 1966, GEOCHIM COSMOCHIM AC, V30, P41, DOI 10.1016/0016-7037(66)90090-1; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Wetherill G. W, 1986, ORIGIN MOON, P519; Wood BJ, 2008, PHILOS T R SOC A, V366, P4339, DOI 10.1098/rsta.2008.0115; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	15	19	20	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					44	45		10.1126/science.1172587	http://dx.doi.org/10.1126/science.1172587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574377				2022-12-28	WOS:000267594000026
J	Rubin, GJ; Amlot, R; Page, L; Wessely, S				Rubin, G. James; Amlot, Richard; Page, Lisa; Wessely, Simon			Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: cross sectional telephone survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE RESPIRATORY SYNDROME; HONG-KONG; RESPONSES; LONDON; IMPACT; STATE; SARS	Objective To assess whether perceptions of the swine flu outbreak predicted changes in behaviour among members of the public in England, Scotland, and Wales. Design Cross sectional telephone survey using random digit dialling. Setting Interviews by telephone between 8 and 12 May. Participants 997 adults aged 18 or more who had heard of swine flu and spoke English. Main outcome measures Recommended change in behaviour (increases in hand washing and surface cleaning or plans made with a "flu friend") and avoidance behaviours (engaged in one or more of six behaviours such as avoiding large crowds or public transport). Results 37.8% of participants (n=377) reported performing any recommended behaviour change "over the past four days... because of swine flu." 4.9% (n=49) had carried out any avoidance behaviour. Controlling for personal details and anxiety, recommended changes were associated with perceptions that swine flu is severe, that the risk of catching it is high risk, that the outbreak will continue for a long time, that the authorities can be trusted, that good information has been provided, that people can control their risk of catching swine flu, and that specific behaviours are effective in reducing the risk. Being uncertain about the outbreak and believing that the outbreak had been exaggerated were associated with a lower likelihood of change. The strongest predictor of behaviour change was ethnicity, with participants from ethnic minority groups being more likely to make recommended changes (odds ratio 3.2, 95% confidence interval 2.0 to 5.3) and carry out avoidance behaviours (4.1, 2.0 to 8.4). Conclusions The results support efforts to inform the public about specific actions that can reduce the risks from swine flu and to communicate about the government's plans and resources. Tackling the perception that the outbreak has been "over-hyped" may be difficult but worthwhile. Additional research is required into differing reactions to the outbreak among ethnic groups.	[Page, Lisa; Wessely, Simon] Kings Coll London, Inst Psychiat, Dept Psychol Med, Weston Educ Ctr, London SE5 9RJ, England	University of London; King's College London		g.rubin@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929	National Institute for Health Researc; NIHR Biomedical Research Centre for Mental Health; South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research [CDF/01/024] Funding Source: researchfish	National Institute for Health Researc(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the National Institute for Health Research, as part of a career development research training fellowship awarded to GJR. RA is supported as a full time employee of the Health Protection Agency. SW is funded by the NIHR Biomedical Research Centre for Mental Health, the South London and Maudsley NHS Foundation Trust, and the Institute of Psychiatry, King's College London. The funders played no part in the study design; the collection, analysis, or interpretation of the data; the writing of the report; or the decision to submit the manuscript for publication. The views expressed in this publication are those of the authors and not necessarily those of their funders or employers.	Brahmbhatt M., 2008, SARS TYPE EC EFFECTS; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Eisenman DP, 2009, AM J PUBLIC HEALTH, V99, P168, DOI 10.2105/AJPH.2007.124206; ERIKSON K, 1990, HARVARD BUS REV, V68, P118; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; *NHS, 2009, IMP INF SWIN FLU LEA; *NHS CHOIC, 2009, AL IMP INF SWIN FLU; Page L, 2008, BIOSECUR BIOTERROR, V6, P309, DOI 10.1089/bsp.2008.0043; Petrie KJ, 2002, BRIT MED J, V324, P690, DOI 10.1136/bmj.324.7339.690; Rubin GJ, 2007, BMJ-BRIT MED J, V335, P1143, DOI 10.1136/bmj.39367.455243.BE; Rubin GJ, 2008, INT J METH PSYCH RES, V17, pS29, DOI 10.1002/mpr.270; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Sandman PM, 2009, NATURE, V459, P322, DOI 10.1038/459322a; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Uzun S, 2008, J CLIN NURS, V17, P602, DOI 10.1111/j.1365-2702.2007.02018.x; World Health Organization, 2009, CURR WHO PHAS PAND; Wray RJ, 2008, AM J PUBLIC HEALTH, V98, P2214, DOI 10.2105/AJPH.2006.107102; ZEIGLER DJ, 1981, GEOGR REV, V71, P1, DOI 10.2307/214548	27	630	634	6	116	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2009	339								b2651	10.1136/bmj.b2651	http://dx.doi.org/10.1136/bmj.b2651			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QZ	19574308	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267678700008
J	Abdo, AA; Ackermann, M; Ajello, M; Anderson, B; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Bignami, GF; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Cutini, S; Dermer, CD; de Angelis, A; de Luca, A; de Palma, F; Digel, SW; Dormody, M; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Farnier, C; Favuzzi, C; Fegan, SJ; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giommi, P; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Gwon, C; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hughes, RE; Johannesson, G; Johnson, RP; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Marelli, M; Mazziotta, MN; McConville, W; McEnery, JE; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Pierbattista, M; Piron, F; Porter, TA; Primack, JR; Raino, S; Rando, R; Ray, PS; Razzano, M; Rea, N; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, LS; Rodriguez, AY; Romani, RW; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Starck, JL; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JG; Thompson, DJ; Tibaldo, L; Tibolla, O; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Van Etten, A; Vasileiou, V; Vilchez, N; Vitale, V; Waite, AP; Wang, P; Watters, K; Winer, BL; Wolff, MT; Wood, KS; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Anderson, B.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Bignami, G. F.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Cutini, S.; Dermer, C. D.; de Angelis, A.; de Luca, A.; de Palma, F.; Digel, S. W.; Dormody, M.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giommi, P.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Gwon, C.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hughes, R. E.; Johannesson, G.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Marelli, M.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Pierbattista, M.; Piron, F.; Porter, T. A.; Primack, J. R.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Rea, N.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Romani, R. W.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Starck, J. -L.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Tibolla, O.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wang, P.; Watters, K.; Winer, B. L.; Wolff, M. T.; Wood, K. S.; Ylinen, T.; Ziegler, M.			Detection of 16 Gamma-Ray Pulsars Through Blind Frequency Searches Using the Fermi LAT	SCIENCE			English	Article							LARGE-AREA TELESCOPE; TIME-DIFFERENCING TECHNIQUE; UNIDENTIFIED EGRET SOURCES; X-RAY; SUPERNOVA REMNANT; 3EG J1835+5918; RADIO; GEMINGA; CATALOG; COUNTERPART	Pulsars are rapidly rotating, highly magnetized neutron stars emitting radiation across the electromagnetic spectrum. Although there are more than 1800 known radio pulsars, until recently only seven were observed to pulse in gamma rays, and these were all discovered at other wavelengths. The Fermi Large Area Telescope (LAT) makes it possible to pinpoint neutron stars through their gamma-ray pulsations. We report the detection of 16 gamma-ray pulsars in blind frequency searches using the LAT. Most of these pulsars are coincident with previously unidentified gamma-ray sources, and many are associated with supernova remnants. Direct detection of gamma-ray pulsars enables studies of emission mechanisms, population statistics, and the energetics of pulsar wind nebulae and supernova remnants.	[Anderson, B.; Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Primack, J. R.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Abdo, A. A.; Dermer, C. D.; Grove, J. E.; Gwon, C.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Ray, P. S.; Strickman, M. S.; Wolff, M. T.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Waite, A. P.; Wang, P.; Watters, K.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Waite, A. P.; Wang, P.; Watters, K.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Axelsson, M.; Conrad, J.; Meurer, C.; Ryde, F.; Ylinen, T.] Oskar Klein Ctr Cosmo Particle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Pierbattista, M.; Starck, J. -L.] Univ Paris Diderot, Lab AIM, CEA Saclay, CEA IRFU,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35121 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bignami, G. F.; de Luca, A.] Ist Univ Studi Super, I-27100 Pavia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caraveo, P. A.; Marelli, M.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Celik, Oe; Cheung, C. C.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Ritz, S.; Thompson, D. J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Conrad, J.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Cutini, S.; Gasparrini, D.; Giommi, P.; Giordano, F.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, Ctr Etud Nucl Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Fukazawa, Y.; Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.; McConville, W.] Univ Maryland, College Pk, MD 20742 USA; [Guiriec, S.] Univ Alabama, Huntsville, AL 35899 USA; [Kataoka, J.] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Kawai, N.] Inst Phys & Chem Res RIKEN, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Knoedlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Rea, N.] Sterrekundig Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Rea, N.; Rodriguez, A. Y.; Torres, D. F.] Inst Ciencies Espai IEEC CSIC, Barcelona 08193, Spain; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Takahashi, T.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Tibolla, O.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Vasileiou, V.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Vasileiou, V.] Univ Maryland, Baltimore, MD 21250 USA; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Anderson, B.; Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Primack, J. R.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy	University of California System; University of California Santa Cruz; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Oskar Klein Centre; Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Royal Institute of Technology; Stockholm University; Agenzia Spaziale Italiana (ASI); University of Udine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Hiroshima University; University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Huntsville; Waseda University; RIKEN; Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Max Planck Society; ICREA; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore; University of Rome Tor Vergata; Linnaeus University; University of Kalmar; University of California System; University of California Santa Cruz; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN)	Dormody, M (corresponding author), Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA.	dormody@scipp.ucsc.edu; paul.ray@nrl.navy.mil; pablo@scipp.ucsc.edu; ziegler@scipp.ucsc.edu	Thompson, David J/D-2939-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; Sgrò, Carmelo/K-3395-2016; Baldini, Luca/E-5396-2012; lubrano, pasquale/F-7269-2012; Reimer, Olaf/A-3117-2013; Giglietto, Nicola/Y-2425-2019; Rando, Riccardo/M-7179-2013; McEnery, Julie E/D-6612-2012; Gasparrini, Dario/X-6699-2019; Gargano, Fabio/AAD-5121-2021; Tajima, Hiroyasu/I-6228-2014; Fukazawa, Yasushi/G-2081-2017; Funk, Stefan/AAI-1568-2021; giglietto, nicola/I-8951-2012; Takahashi, Hiromitsu H/T-2713-2017; Kuss, Michael W/H-8959-2012; Morselli, Aldo/G-6769-2011; Harding, Alice K/D-3160-2012; Starck, Jean-Luc/D-9467-2011; Reimer, Anita/K-5822-2015; Jóhannesson, Guðlaugur/O-8741-2015; Rando, Riccardo/O-1302-2019; Cutini, Sara/ABB-1787-2020; tramacere, andrea/B-9424-2012; Loparco, Francesco/O-8847-2015; Torres, Diego F./AAF-7931-2019; Bastieri, Denis/AAC-5917-2020; Parkinson, Pablo Miguel Saz/I-7980-2013; Funk, Stefan/B-7629-2015; cohen-tanugi, Johann/ABB-1481-2021; Moskalenko, Igor V/A-1301-2007; Rea, Nanda/I-2853-2015; Johnson, Neil/G-3309-2014; Caraveo, Patrizia/AAL-5708-2020; Torres, Diego F/ABD-7940-2020; Gehrels, Neil/D-2971-2012; Mazziotta, Mario N/O-8867-2015; Tosti, Gino/E-9976-2013; Torres, Diego F./O-9422-2016; Hays, Elizabeth/D-3257-2012; Nolan, Patrick L/A-5582-2009; Gargano, Fabio/O-8934-2015; Orlando, Elena/R-5594-2016; giommi, paolo/L-1006-2018	Thompson, David J/0000-0001-5217-9135; Jóhannesson, Guðlaugur/0000-0003-1458-7036; lubrano, pasquale/0000-0003-0221-4806; Reimer, Olaf/0000-0001-6953-1385; Giglietto, Nicola/0000-0002-9021-2888; Gasparrini, Dario/0000-0002-5064-9495; Gargano, Fabio/0000-0002-5055-6395; Tajima, Hiroyasu/0000-0002-1721-7252; Fukazawa, Yasushi/0000-0002-0921-8837; Funk, Stefan/0000-0002-2012-0080; giglietto, nicola/0000-0002-9021-2888; Takahashi, Hiromitsu H/0000-0001-6314-5897; Morselli, Aldo/0000-0002-7704-9553; Starck, Jean-Luc/0000-0003-2177-7794; Reimer, Anita/0000-0001-8604-7077; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Rando, Riccardo/0000-0001-6992-818X; Cutini, Sara/0000-0002-1271-2924; tramacere, andrea/0000-0002-8186-3793; Loparco, Francesco/0000-0002-1173-5673; Torres, Diego F./0000-0002-1522-9065; Bastieri, Denis/0000-0002-6954-8862; Funk, Stefan/0000-0002-2012-0080; cohen-tanugi, Johann/0000-0001-9022-4232; Moskalenko, Igor V/0000-0001-6141-458X; Rea, Nanda/0000-0003-2177-6388; Caraveo, Patrizia/0000-0003-2478-8018; Mazziotta, Mario N/0000-0001-9325-4672; Torres, Diego F./0000-0002-1522-9065; Gargano, Fabio/0000-0002-5055-6395; Pesce-Rollins, Melissa/0000-0003-1790-8018; Sgro', Carmelo/0000-0001-5676-6214; Orlando, Elena/0000-0001-6406-9910; De Angelis, Alessandro/0000-0002-3288-2517; De Luca, Andrea/0000-0001-6739-687X; Omodei, Nicola/0000-0002-5448-7577; Fusco, Piergiorgio/0000-0002-9383-2425; Spandre, Gloria/0000-0003-0802-3453; Tibaldo, Luigi/0000-0001-7523-570X; Ray, Paul/0000-0002-5297-5278; SANCHEZ, David/0000-0002-7210-4496; Ciprini, Stefano/0000-0002-0712-2479; Giordano, Francesco/0000-0002-8651-2394; Ackermann, Markus/0000-0001-8952-588X; Anderson, Brandon/0000-0003-0009-7976; Katagiri, Hideaki/0000-0003-2347-8819; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Kerr, Matthew/0000-0002-0893-4073; Baldini, Luca/0000-0002-9785-7726; Tanaka, Takaaki/0000-0002-4383-0368; Grenier, Isabelle/0000-0003-3274-674X; giommi, paolo/0000-0002-2265-5003; Tibolla, Omar/0000-0002-9074-0584; Pepe, Monica/0000-0001-5624-4010; Cecchi, Claudia/0000-0002-2192-8233; de Palma, Francesco/0000-0001-5898-2834; Cheung, Chi (Teddy)/0000-0002-4377-0174; Bignami, Giovanni/0000-0001-9582-2450; Cameron, Robert/0000-0003-0942-2747; Casandjian, Jean-Marc/0000-0003-1404-0524; Johnson, Tyrel/0000-0002-2771-472X; Porter, Troy/0000-0002-2621-4440; Berenji, Bijan/0000-0002-4551-772X	NASA; U.S. Department of Energy; Commissariat a l Energie Atomique and CNRS/Institut National de Physique Nucleaire et de Physique des Particules (France); Agenzia Spaziale Italiana; Istituto Nazionale di Astrofisica (Italy); Ministry of Education, Culture, Sports, Science and Technology; High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency (Japan); K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy(United States Department of Energy (DOE)); Commissariat a l Energie Atomique and CNRS/Institut National de Physique Nucleaire et de Physique des Particules (France); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Istituto Nazionale di Astrofisica (Italy)(Istituto Nazionale Astrofisica (INAF)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); Japan Aerospace Exploration Agency (Japan); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board (Sweden); ICREA(ICREA)	The Fermi LAT Collaboration is supported by NASA and the U.S. Department of Energy; the Commissariat a l Energie Atomique and CNRS/Institut National de Physique Nucleaire et de Physique des Particules (France); the Agenzia Spaziale Italiana, Istituto Nazionale di Fisica Nucleare, and Istituto Nazionale di Astrofisica (Italy); the Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (Japan); and the K. A. Wallenberg Foundation, Swedish Research Council, and National Space Board (Sweden). Much of this work was carried out on the Pleiades supercomputer at the Department of Astronomy, University of California, Santa Cruz. This work made extensive use of the ATNF pulsar database. We thank N. Gehrels for granting Swift/XRT time to explore the LAT error circles, the Swift MOC staff for performing the observations, F. Camilo and S. Ransom for contributions, and M. Roberts for useful discussions.	Abdo AA, 2008, SCIENCE, V322, P1218, DOI 10.1126/science.1165572; Abdo AA, 2009, SCIENCE, V325, P848, DOI 10.1126/science.1176113; Abdo AA, 2009, ASTROPHYS J SUPPL S, V183, P46, DOI 10.1088/0067-0049/183/1/46; Abdo AA, 2009, ASTROPHYS J, V700, P1059, DOI 10.1088/0004-637X/700/2/1059; Abdo AA, 2009, ASTROPHYS J, V696, P1084, DOI 10.1088/0004-637X/696/2/1084; Abdo AA, 2009, ASTROPHYS J LETT, V695, pL72, DOI 10.1088/0004-637X/695/1/L72; Atwood WB, 2006, ASTROPHYS J, V652, pL49, DOI 10.1086/510018; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Bignami GF, 1996, ANNU REV ASTRON ASTR, V34, P331, DOI 10.1146/annurev.astro.34.1.331; BIGNAMI GF, 1983, ANNU REV ASTRON ASTR, V21, P67, DOI 10.1146/annurev.aa.21.090183.000435; Braje TM, 2002, ASTROPHYS J, V565, pL91, DOI 10.1086/339419; Brazier KTS, 1996, MON NOT R ASTRON SOC, V281, P1033, DOI 10.1093/mnras/281.3.1033; Brazier KTS, 1999, MON NOT R ASTRON SOC, V305, P671, DOI 10.1046/j.1365-8711.1999.02490.x; Chandler AM, 2001, ASTROPHYS J, V556, P59, DOI 10.1086/321573; Faherty J, 2007, ASTROPHYS SPACE SCI, V308, P225, DOI 10.1007/s10509-007-9368-0; Halpern JP, 2007, ASTROPHYS J, V668, P1154, DOI 10.1086/521355; Halpern JP, 2004, ASTROPHYS J, V612, P398, DOI 10.1086/422409; Halpern JP, 2002, ASTROPHYS J, V573, pL41, DOI 10.1086/341967; Harding AK, 2008, ASTROPHYS J, V680, P1378, DOI 10.1086/588037; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; HELFAND DJ, 1994, MON NOT R ASTRON SOC, V267, P490, DOI 10.1093/mnras/267.3.490; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; LEAHY DA, 1986, MON NOT R ASTRON SOC, V220, P501, DOI 10.1093/mnras/220.3.501; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Mukherjee R, 2003, ASTROPHYS J, V589, P487, DOI 10.1086/374641; MUKHERJEE R, 1995, ASTROPHYS J, V441, pL61, DOI 10.1086/187790; Ng CY, 2005, ASTROPHYS J, V627, P904, DOI 10.1086/430632; Ransom S.M., 2001, THESIS HARVARD U; Reimer O, 2001, MON NOT R ASTRON SOC, V324, P772, DOI 10.1046/j.1365-8711.2001.04397.x; Roberts MSE, 2001, ASTROPHYS J SUPPL S, V133, P451, DOI 10.1086/320352; Standish EM, 1998, ASTRON ASTROPHYS, V336, P381; SWANENBURG BN, 1981, ASTROPHYS J, V243, pL69, DOI 10.1086/183445; Thompson DJ, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/11/116901; Watters KP, 2009, ASTROPHYS J, V695, P1289, DOI 10.1088/0004-637X/695/2/1289; Weisskopf MC, 2006, ASTROPHYS J, V652, P387, DOI 10.1086/508339; YADIGAROGLU IA, 1995, ASTROPHYS J, V449, P211, DOI 10.1086/176047; Ziegler M, 2008, ASTROPHYS J, V680, P620, DOI 10.1086/587024	37	244	246	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					840	844		10.1126/science.1175558	http://dx.doi.org/10.1126/science.1175558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19574346	Green Submitted			2022-12-28	WOS:000269242400037
J	Wolf, SJ; Bebarta, VS; Bonnett, CJ; Pons, PT; Cantrill, SV				Wolf, Stephen J.; Bebarta, Vikhyat S.; Bonnett, Carl J.; Pons, Peter T.; Cantrill, Stephen V.			Blast injuries	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; OPERATION-IRAQI-FREEDOM; SUICIDE BOMBING ATTACKS; LUNG INJURY; COMPARTMENT SYNDROME; AIR-EMBOLISM; PERMISSIVE HYPERCAPNIA; COMPUTED-TOMOGRAPHY	Health-care providers are increasingly faced with the possibility of needing to care for people injured in explosions, but can often, however, feel undertrained for the unique aspects of the patient's presentation and management. Although most blast-related injuries (eg, fragmentation injuries from improvised explosive devices and standard military explosives) can be managed in a similar manner to typical penetrating or blunt traumatic injuries, injuries caused by the blast pressure wave itself cannot. The blast pressure wave exerts forces mainly at air-tissue interfaces within the body, and the pulmonary, gastrointestinal, and auditory systems are at greatest risk. Arterial air emboli arising from severe pulmonary injury can cause ischaemic complications-especially in the brain, heart, and intestinal tract. Attributable, in part, to the scene chaos that undoubtedly exists, poor triage and missed diagnosis of blast injuries are substantial concerns because injuries can be subtle or their presentation can be delayed. Management of these injuries can be a challenge, compounded by potentially conflicting treatment goals. This Seminar aims to provide a thorough overview of these unique primary blast injuries and their management.	[Wolf, Stephen J.; Bonnett, Carl J.; Pons, Peter T.; Cantrill, Stephen V.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Bebarta, Vikhyat S.] Wilford Hall USAF Med Ctr, Div Med Toxicol, Dept Emergency Med, San Antonio, TX 78236 USA; [Wolf, Stephen J.; Bonnett, Carl J.; Pons, Peter T.; Cantrill, Stephen V.] Univ Colorado Denver, Sch Med, Aurora, CO 80045 USA; [Pons, Peter T.; Cantrill, Stephen V.] Denver Hlth Med Ctr, Dept Emergency Med, BNICE Training Ctr, Denver, CO 80249 USA	Denver Health Medical Center; United States Department of Defense; United States Air Force; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Wolf, SJ (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St MC 0108, Denver, CO 80204 USA.	stephen.wolf@dhha.org		Wolf, Stephen/0000-0003-0398-9785				Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; Alfici R, 2006, MIL MED, V171, P1155, DOI 10.7205/MILMED.171.12.1155; Almogy G, 2006, ANN SURG, V243, P541, DOI 10.1097/01.sla.0000206418.53137.34; Almogy G, 2005, ARCH SURG-CHICAGO, V140, P390, DOI 10.1001/archsurg.140.4.390; ANDERSEN RC, 2006, J AM ACAD ORTHOP S10, V14, P24; [Anonymous], BBC NEWS; [Anonymous], 2004, CHEM EXPLOSIVES; Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Arnold Jeffrey L, 2003, Prehosp Disaster Med, V18, P220; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Banning AP, 1997, HEART, V78, P226, DOI 10.1136/hrt.78.3.226; Beekley AC, 2004, AM J SURG, V187, P652, DOI 10.1016/j.amjsurg.2004.02.001; Beekley AC, 2007, SURG CLIN N AM, V87, P157, DOI 10.1016/j.suc.2006.09.008; BELLAMY RF, 1991, TXB MILITARY MED MED, P1; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BITTERMAN H, 1993, ISRAEL J MED SCI, V29, P22; Blackbourne LH, 2008, CRIT CARE MED, V36, pS304, DOI 10.1097/CCM.0b013e31817e2854; BLOCK EFJ, 1995, J TRAUMA, V39, P787, DOI 10.1097/00005373-199510000-00036; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; *BROOK I, IR IND TRACK VAR REC; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; Butela ST, 2001, AM J ROENTGENOL, V176, P129, DOI 10.2214/ajr.176.1.1760129; CASEBY NG, 1976, INJURY, V8, P1, DOI 10.1016/0020-1383(76)90002-4; Casler J D, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P13; CATRON PW, 1991, NEUROLOGY, V41, P314, DOI 10.1212/WNL.41.2_Part_1.314; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cereda M, 1996, CHEST, V109, P480, DOI 10.1378/chest.109.2.480; Cereda M, 2000, CRIT CARE MED, V28, P1269, DOI 10.1097/00003246-200005000-00002; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chait R H, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P9; Chaloner E, 2005, BRIT MED J, V331, P119, DOI 10.1136/bmj.331.7509.119; Clouse WD, 2007, J AM COLL SURGEONS, V204, P625, DOI 10.1016/j.jamcollsurg.2007.01.040; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Cooper PW., 1996, EXPLOSIVES ENG; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crabtree J, 2006, J BURN CARE RES, V27, P576, DOI 10.1097/01.BCR.0000235459.60000.A5; Cripps NPJ, 1997, BRIT J SURG, V84, P1298; Cruz E, 1985, J Med Soc N J, V82, P641; Davis T.L., 1972, CHEM POWDER EXPLOSIV; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eckert MJ, 2006, ARCH SURG-CHICAGO, V141, P806, DOI 10.1001/archsurg.141.8.806; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Ennis JL, 2008, J TRAUMA, V64, pS146, DOI 10.1097/TA.0b013e318160b44c; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Frank JA, 2005, CRIT CARE MED, V33, P181, DOI 10.1097/01.CCM.0000150663.45778.C4; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; FRYKBERG ER, 1987, MIL MED, V152, P563; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; Halpern Pinchas, 2003, Prehosp Disaster Med, V18, P235; Harrison CH, 2006, ANN EMERG MED, V48, pS102; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; Hirshberg B, 1999, CHEST, V116, P1683, DOI 10.1378/chest.116.6.1683; Ho AMH, 1999, ANESTHESIOLOGY, V90, P564, DOI 10.1097/00000542-199902000-00033; Ho AMH, 2002, MED HYPOTHESES, V59, P611, DOI 10.1016/S0306-9877(02)00153-6; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hull JB, 1996, J TRAUMA, V40, pS198, DOI 10.1097/00005373-199603001-00044; HULL JB, 1994, BRIT J SURG, V81, P1132, DOI 10.1002/bjs.1800810815; HULL JB, 1992, BRIT J SURG, V79, P1303, DOI 10.1002/bjs.1800791220; HULLER T, 1970, ARCH SURG-CHICAGO, V100, P24; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kauvar DS, 2006, BURNS, V32, P853, DOI 10.1016/j.burns.2006.03.008; KINDWALL EP, 1992, CLEV CLIN J MED, V59, P517, DOI 10.3949/ccjm.59.5.517; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; Kluger Y, 2004, Scand J Surg, V93, P11; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Kosir R, 2007, J TRAUMA, V63, P268, DOI 10.1097/TA.0b013e318074fe15; Krishnamurthy R, 2006, J Clin Forensic Med, V13, P311, DOI 10.1016/j.jcfm.2006.06.020; KRONENBERG J, 1993, AM J OTOL, V14, P92; Lasak John M, 2006, Ear Nose Throat J, V85, P724; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Leissner KB, 2006, J CARDIOTHOR VASC AN, V20, P872, DOI 10.1053/j.jvca.2006.01.020; Li XJ, 2002, BURNS, V28, P787, DOI 10.1016/S0305-4179(02)00190-0; LIU M, 1993, J TRAUMA, V35, P267, DOI 10.1097/00005373-199308000-00016; MA OJ, 1995, J TRAUMA, V38, P879; Martins MJ, 2004, TEST-SPAIN, V13, P113; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Mehta S, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-16; Mellor S G, 1988, Br J Hosp Med, V39, P536; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; MELLOR SG, 1992, WORLD J SURG, V16, P893, DOI 10.1007/BF02066988; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Ohnishi M, 2001, EXP PHYSIOL, V86, P357, DOI 10.1113/eph8602145; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Paran H, 1996, J TRAUMA, V40, P472, DOI 10.1097/00005373-199603000-00029; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; PHILLIPS YY, 1991, TCB MILITARY MED CON, P295; PHILLIPS YY, 1991, TXB MILITARY MED CON, P221; Pizov R, 1999, CHEST, V115, P165, DOI 10.1378/chest.115.1.165; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; *RAND MEM I PREV T, RAND MIPT TERR INC D; *REUT AL, LOND BOMB US EV MAT; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Ritenour AE, 2008, J TRAUMA, V64, pS153, DOI 10.1097/TA.0b013e3181607750; Sadan O, 1991, ACTA OBSTET GYN SCAN, V70, P511, DOI 10.3109/00016349109007171; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; SCHARDIN H, 2005, PHYS PRINCIPLES EFFE, P1207; Schwartz R, 2007, CURR PROB SURG, V44, P496, DOI 10.1067/j.cpsurg.2007.05.002; Sebesta J, 2006, SURG CLIN N AM, V86, P711, DOI 10.1016/j.suc.2006.03.002; Severance Harry W, 2002, N C Med J, V63, P242; Shackford SR, 1999, J TRAUMA, V46, P553, DOI 10.1097/00005373-199904000-00003; SHARPNACK DD, 1991, TXB MILITARY MED, P271; SHERCK J, 1994, AM J SURG, V168, P670, DOI 10.1016/S0002-9610(05)80142-4; Sorkine P, 1998, J TRAUMA, V45, P35, DOI 10.1097/00005373-199807000-00006; Stafford RE, 1999, ARCH SURG-CHICAGO, V134, P622, DOI 10.1001/archsurg.134.6.622; Stansbury LG, 2008, J ORTHOP TRAUMA, V22, P43, DOI 10.1097/BOT.0b013e31815b35aa; STAPCZYNSKI JS, 1982, ANN EMERG MED, V11, P687, DOI 10.1016/S0196-0644(82)80268-0; Stuhmiller J. H., 1991, CONVENTIONAL WARFARE, P241; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; TOWNSEND M, 2006, OBSERVER LONDON 0507, P16; Tremblay LN, 2002, J TRAUMA, V53, P833, DOI 10.1097/00005373-200211000-00005; TUMAN KJ, 1987, ANESTHESIOLOGY, V67, P952, DOI 10.1097/00000542-198712000-00013; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weiss YG, 1999, J CLIN ANESTH, V11, P132, DOI 10.1016/S0952-8180(99)00006-9; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; WILDEGGERGAISSM.AE, 2003, ADF HLTH, V4, P3; Wilson Clay, 2007, IMPROVISED EXPLOSIVE; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yang ZH, 1996, J TRAUMA, V40, pS81, DOI 10.1097/00005373-199603001-00019; Yazbeck-Karam VG, 2004, ANESTHESIOLOGY, V100, P448, DOI 10.1097/00000542-200402000-00040; ZIV M, 1973, MIL MED, V138, P811, DOI 10.1093/milmed/138.12.811; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246; Zuckerman S, 1940, LANCET, V2, P219	135	223	264	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					405	415		10.1016/S0140-6736(09)60257-9	http://dx.doi.org/10.1016/S0140-6736(09)60257-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19631372				2022-12-28	WOS:000268815200025
J	Stocker, R; Durham, WM				Stocker, Roman; Durham, William M.			Tumbling for Stealth?	SCIENCE			English	Editorial Material							MOTILITY; CILIA		[Stocker, Roman; Durham, William M.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; 				BAUM GL, 1998, CILIA MUCUS MUCOCILI; Berg H. C., 2004, COLI MOTION; Flores H, 2005, B MATH BIOL, V67, P137, DOI 10.1016/j.bulm.2004.06.006; Huygens Ch., 1673, PENDULUM CLOCK; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; TAMM SL, 1984, J EXP BIOL, V113, P401; TAMM SL, 1970, PROC R SOC SER B-BIO, V175, P219, DOI 10.1098/rspb.1970.0020; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Visser AW, 2007, J PLANKTON RES, V29, P447, DOI 10.1093/plankt/fbm029; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Vogel G, 2005, SCIENCE, V310, P216, DOI 10.1126/science.310.5746.216	12	22	22	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					400	402		10.1126/science.1177269	http://dx.doi.org/10.1126/science.1177269			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628846				2022-12-28	WOS:000268255100030
J	O'Dowd, A				O'Dowd, Adrian			A/H1N1 influenza update	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2009	339								b2977	10.1136/bmj.b2977	http://dx.doi.org/10.1136/bmj.b2977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475IN	19628526				2022-12-28	WOS:000268351900003
J	Sabin, LR; Zhou, R; Gruber, JJ; Lukinova, N; Bambina, S; Berman, A; Lau, CK; Thompson, CB; Cherry, S				Sabin, Leah R.; Zhou, Rui; Gruber, Joshua J.; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Lau, Chi-Kong; Thompson, Craig B.; Cherry, Sara			Ars2 Regulates Both miRNA- and siRNA-Dependent Silencing and Suppresses RNA Virus Infection in Drosophila	CELL			English	Article							CAP-BINDING COMPLEX; ANTIVIRAL IMMUNITY; ARGONAUTE PROTEINS; DISTINCT ROLES; MESSENGER-RNA; SERRATE; DICER-2; PATHWAY; INTERFERENCE; INITIATION	Intrinsic immune responses autonomously inhibit viral replication and spread. One pathway that restricts viral infection in plants and insects is RNA interference (RNAi), which targets and degrades viral RNA to limit infection. To identify additional genes involved in intrinsic antiviral immunity, we screened Drosophila cells for modulators of viral infection using an RNAi library. We identified Ars2 as a key component of Drosophila antiviral immunity. Loss of Ars2 in cells, or in flies, increases susceptibility to RNA viruses. Consistent with its antiviral properties, we found that Ars2 physically interacts with Dcr-2, modulates its activity in vitro, and is required for siRNA-mediated silencing. Furthermore, we show that Ars2 plays an essential role in miRNA-mediated silencing, interacting with the Microprocessor and stabilizing pri-miRNAs. The identification of Ars2 as a player in these small RNA pathways provides new insight into the biogenesis of small RNAs that may be extended to other systems.	[Sabin, Leah R.; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Zhou, Rui] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gruber, Joshua J.; Lau, Chi-Kong; Thompson, Craig B.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gruber, Joshua J.; Lau, Chi-Kong; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu	Lau, Terrence/ABB-7900-2021	Lau, Terrence/0000-0002-7505-7306; Sabin, Leah/0000-0003-1757-7415; cherry, sara/0000-0003-3956-6610	Leukemia and Lymphoma Society; NIH [T32 GM-07229, RO1AI07451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074951, R01AI074951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Bonini and M. Tudor for critically reading the manuscript; members of the Cherry laboratory for technical advice and helpful discussions; S. Poethig and M. Y. Park for technical advice; J. Rose for VSV-eGFP; D. Lyles for anti-VSV M; P. Ahlquist for anti-FHV B2; R. Hardy for SlN/GFP; R. Doms for Vaccinia; Harvard and VDRC for Ars2 transgenic flies; and The Bloomington Stock center for other fly stocks. R.Z. is supported by the Leukemia and Lymphoma Society. L. R. S. is supported by NIH training grant T32 GM-07229 and NIH grant RO1AI07451 to S. C.	ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DAMON IK, 2007, FIELDS VIROLOGY, P2948; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Friesen PD., 2007, FIELDS VIROLOGY, V1, P707; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lyles D, 2007, FIELDS VIROLOGY, P1364; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	48	162	169	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					340	351		10.1016/j.cell.2009.04.045	http://dx.doi.org/10.1016/j.cell.2009.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632183	Green Accepted, Bronze			2022-12-28	WOS:000268277000015
J	Lyketsos, CG; Chisolm, MS				Lyketsos, Constantine G.; Chisolm, Margaret S.			The Trap of Meaning A Public Health Tragedy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lyketsos, Constantine G.; Chisolm, Margaret S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Chisolm, MS (corresponding author), Johns Hopkins Bayview Med Ctr, 5300 Alpha Commons Dr,Alpha Commons Bldg,4th Floo, Baltimore, MD 21224 USA.	mchisol1@jhmi.edu	Chisolm, Margaret/C-3255-2008	Chisolm, Margaret/0000-0001-7424-919X				[Anonymous], GLOB BURD DIS 2004 U; DOUGHERTY C, 2009, NY TIMES        0106; Greer J, 2004, J PSYCHOSOM RES, V57, P521, DOI 10.1016/j.jpsychores.2004.02.020; Hamilton, 1968, GEN PSYCHOPATHOLOGY; Higgins E S, 1994, Arch Fam Med, V3, P908, DOI 10.1001/archfami.3.10.908; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LEHMANNHAUPT CC, 2009, NY TIMES        0128; McHugh PR, 2005, JAMA-J AM MED ASSOC, V293, P2526, DOI 10.1001/jama.293.20.2526; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; WHITEHORN J C, 1947, Am J Psychiatry, V104, P289	10	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					432	433		10.1001/jama.2009.1059	http://dx.doi.org/10.1001/jama.2009.1059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622823				2022-12-28	WOS:000268139200027
J	Green, RC; Roberts, JS; Cupples, LA; Relkin, NR; Whitehouse, PJ; Brown, T; Eckert, SL; Butson, M; Sadovnick, AD; Quaid, KA; Chen, C; Cook-Deegan, R; Farrer, LA				Green, Robert C.; Roberts, J. Scott; Cupples, L. Adrienne; Relkin, Norman R.; Whitehouse, Peter J.; Brown, Tamsen; Eckert, Susan LaRusse; Butson, Melissa; Sadovnick, A. Dessa; Quaid, Kimberly A.; Chen, Clara; Cook-Deegan, Robert; Farrer, Lindsay A.		REVEAL Study Grp	Disclosure of APOE Genotype for Risk of Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; 1ST-DEGREE RELATIVES; EVENT SCALE; PSYCHOMETRIC PROPERTIES; PSYCHOLOGIC DISTRESS; AFRICAN-AMERICANS; COLORECTAL-CANCER; BREAST-CANCER; IMPACT; METAANALYSIS	Background The apolipoprotein E (APOE) genotype provides information on the risk of Alzheimer's disease, but the genotyping of patients and their family members has been discouraged. We examined the effect of genotype disclosure in a prospective, randomized, controlled trial. Methods We randomly assigned 162 asymptomatic adults who had a parent with Alzheimer's disease to receive the results of their own APOE genotyping (disclosure group) or not to receive such results (nondisclosure group). We measured symptoms of anxiety, depression, and test-related distress 6 weeks, 6 months, and 1 year after disclosure or nondisclosure. Results There were no significant differences between the two groups in changes in time-averaged measures of anxiety (4.5 in the disclosure group and 4.4 in the nondisclosure group, P = 0.84), depression (8.8 and 8.7, respectively; P = 0.98), or test-related distress (6.9 and 7.5, respectively; P = 0.61). Secondary comparisons between the nondisclosure group and a disclosure subgroup of subjects carrying the APOE epsilon 4 allele (which is associated with increased risk) also revealed no significant differences. However, the epsilon 4-negative subgroup had a significantly lower level of test-related distress than did the epsilon 4-positive subgroup (P = 0.01). Subjects with clinically meaningful changes in psychological outcomes were distributed evenly among the nondisclosure group and the epsilon 4-positive and epsilon 4-negative subgroups. Baseline scores for anxiety and depression were strongly associated with post-disclosure scores of these measures (P<0.001 for both comparisons). Conclusions The disclosure of APOE genotyping results to adult children of patients with Alzheimer's disease did not result in significant short-term psychological risks. Test-related distress was reduced among those who learned that they were APOE epsilon 4-negative. Persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure. (ClinicalTrials.gov number, NCT00571025.)	[Green, Robert C.; Brown, Tamsen; Farrer, Lindsay A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Green, Robert C.; Cupples, L. Adrienne; Chen, Clara; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Green, Robert C.] Harvard Univ, Sch Med, Genet Training Program, Boston, MA USA; [Roberts, J. Scott] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Relkin, Norman R.] Weill Cornell Med Coll, New York, NY USA; [Whitehouse, Peter J.; Butson, Melissa] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Eckert, Susan LaRusse] Columbia Univ, Sch Med, New York, NY USA; [Sadovnick, A. Dessa] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Sadovnick, A. Dessa] Hlth Sci Ctr, Vancouver, BC, Canada; [Quaid, Kimberly A.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Cook-Deegan, Robert] Duke Univ, Durham, NC USA	Boston University; Boston University; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Cornell University; Case Western Reserve University; Columbia University; University of British Columbia; University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; Indiana University System; Indiana University-Purdue University Indianapolis; Duke University	Green, RC (corresponding author), Boston Univ, Sch Med, 715 Albany St,L-320, Boston, MA 02118 USA.	rcgreen@bu.edu	Obisesan, Thomas O/D-4184-2011; Farrer, Lindsay/AAS-1035-2020; Roter, Debra L/N-8830-2014	Cook-Deegan, Robert/0000-0002-8251-4237; Cupples, L. Adrienne/0000-0003-0273-7965; Linnenbringer, Erin/0000-0002-3883-0013; Farrer, Lindsay/0000-0001-5533-4225	Ethical, Legal and Social Implications (ELSI) Branch of the National Human Genome Research Institute [R01-HG/AG02213, R01-AG09029]; National Institute on Aging (NIA); NIA Mentoring Award [K24 AG027841]; Boston University Alzheimer's Disease Center [P30-AG13846]; Boston University General Clinical Research Center [M01-RR00533]; Centers of Excellence in ELSI Research [P50HG003391]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391, R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009029, P30AG013846, K24AG027841] Funding Source: NIH RePORTER	Ethical, Legal and Social Implications (ELSI) Branch of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA Mentoring Award; Boston University Alzheimer's Disease Center; Boston University General Clinical Research Center; Centers of Excellence in ELSI Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (R01-HG/AG02213, to Dr. Green; and R01-AG09029, to Dr. Farrer) from the Ethical, Legal and Social Implications (ELSI) Branch of the National Human Genome Research Institute and the National Institute on Aging (NIA); by an NIA Mentoring Award (K24 AG027841, to Dr. Green); by a grant (P30-AG13846) from the Boston University Alzheimer's Disease Center; by a grant (M01-RR00533) from the Boston University General Clinical Research Center; and by a grant (P50HG003391, to Duke University) from the Centers of Excellence in ELSI Research.	Beck A.T., 1987, BECK DEPRESSION INVE; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Chase GA, 2002, GENET MED, V4, P297, DOI 10.1097/00125817-200207000-00008; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cupples LA, 2004, GENET MED, V6, P192, DOI 10.1097/01.GIM.0000132679.92238.58; DudokdeWit AC, 1998, J MED GENET, V35, P745, DOI 10.1136/jmg.35.9.745; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hipps YG, 2003, GENET TEST, V7, P39, DOI 10.1089/109065703321560921; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Jones, 1996, BRIT MED J, V313, P550; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Julian-Reynier C, 2003, EUR J HUM GENET, V11, P725, DOI 10.1038/sj.ejhg.5201037; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; McConnell LM, 1998, NAT MED, V4, P757, DOI 10.1038/nm0798-757; Meiser B, 2004, CLIN GENET, V66, P502, DOI 10.1111/j.1399-0004.2004.00339.x; Meiser B, 2002, EUR J CANCER, V38, P2025, DOI 10.1016/S0959-8049(02)00264-2; Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519; Neumann PJ, 2001, HEALTH AFFAIR, V20, P252, DOI 10.1377/hlthaff.20.5.252; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353; Payne K, 2008, VALUE HEALTH, V11, P497, DOI 10.1111/j.1524-4733.2007.00259.x; Petersen RC, 2007, SEMIN NEUROL, V27, P22, DOI 10.1055/s-2006-956752; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; Roberts JS, 2000, GERONTOLOGIST, V40, P43; Roberts JS, 2004, GENET MED, V6, P197, DOI 10.1097/01.GIM.0000132688.55591.77; Roberts JS, 2003, ALZ DIS ASSOC DIS, V17, P86, DOI 10.1097/00002093-200304000-00006; Roberts JS, 2003, ALZ DIS ASSOC DIS, V17, P19, DOI 10.1097/00002093-200301000-00003; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Schwartz MD, 2002, J CLIN ONCOL, V20, P514, DOI 10.1200/JCO.20.2.514; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Smith CO, 2004, ARCH NEUROL-CHICAGO, V61, P875, DOI 10.1001/archneur.61.6.875; Thewes B, 2001, PSYCHO-ONCOLOGY, V10, P459, DOI 10.1002/pon.533; Vernon SW, 1997, HEALTH PSYCHOL, V16, P73, DOI 10.1037/0278-6133.16.1.73; Wolfberg AJ, 2006, NEW ENGL J MED, V355, P543, DOI 10.1056/NEJMp068079; ZILBERG NJ, 1982, J CONSULT CLIN PSYCH, V50, P407, DOI 10.1037/0022-006X.50.3.407	41	342	346	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					245	254		10.1056/NEJMoa0809578	http://dx.doi.org/10.1056/NEJMoa0809578			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19605829	Green Accepted			2022-12-28	WOS:000267976100005
J	Harrison, DE; Strong, R; Sharp, ZD; Nelson, JF; Astle, CM; Flurkey, K; Nadon, NL; Wilkinson, JE; Frenkel, K; Carter, CS; Pahor, M; Javors, MA; Fernandez, E; Miller, RA				Harrison, David E.; Strong, Randy; Sharp, Zelton Dave; Nelson, James F.; Astle, Clinton M.; Flurkey, Kevin; Nadon, Nancy L.; Wilkinson, J. Erby; Frenkel, Krystyna; Carter, Christy S.; Pahor, Marco; Javors, Martin A.; Fernandez, Elizabeth; Miller, Richard A.			Rapamycin fed late in life extends lifespan in genetically heterogeneous mice	NATURE			English	Article							TOR; PATHWAY; DESIGN; TARGET; YEAST	Inhibition of the TOR signalling pathway by genetic or pharmacological intervention extends lifespan in invertebrates, including yeast, nematodes and fruitflies(1-5); however, whether inhibition of mTOR signalling can extend lifespan in a mammalian species was unknown. Here we report that rapamycin, an inhibitor of the mTOR pathway, extends median and maximal lifespan of both male and female mice when fed beginning at 600 days of age. On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. The effect was seen at three independent test sites in genetically heterogeneous mice, chosen to avoid genotype-specific effects on disease susceptibility. Disease patterns of rapamycin-treated mice did not differ from those of control mice. In a separate study, rapamycin fed to mice beginning at 270 days of age also increased survival in both males and females, based on an interim analysis conducted near the median survival point. Rapamycin may extend lifespan by postponing death from cancer, by retarding mechanisms of ageing, or both. To our knowledge, these are the first results to demonstrate a role for mTOR signalling in the regulation of mammalian lifespan, as well as pharmacological extension of lifespan in both genders. These findings have implications for further development of interventions targeting mTOR for the treatment and prevention of age-related diseases.	[Harrison, David E.; Astle, Clinton M.; Flurkey, Kevin] Jackson Lab, Bar Harbor, ME 04609 USA; [Strong, Randy; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Strong, Randy; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Res Serv, Dept Pharmacol, San Antonio, TX 78229 USA; [Strong, Randy; Sharp, Zelton Dave; Nelson, James F.; Fernandez, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Sharp, Zelton Dave] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Nadon, Nancy L.] NIA, Div Aging Biol, Bethesda, MD 20892 USA; [Wilkinson, J. Erby] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Frenkel, Krystyna] NYU, Sch Med, New York, NY 10016 USA; [Carter, Christy S.; Pahor, Marco] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Gerontol & Geriatr Winston Salem, Winston Salem, NC 27157 USA; [Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	Jackson Laboratory; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; New York University; Wake Forest University; University of Texas System; University of Texas Health San Antonio; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	david.harrison@jax.org	Longo, Kenneth A/A-5631-2010; Carter, Christy/E-6630-2011; Carter, Christy/A-6828-2011		NIA [AG022303, AG025707, AG022308, AG022307, AG13319]; Department of Veterans Affairs; DoD [W81XWH-07-1-0605]; NATIONAL INSTITUTE ON AGING [P30AG028740, P30AG013319, U01AG022307, U01AG022308, U01AG022303, P30AG025707] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); DoD(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA grants AG022303 (R. A. M.), AG025707 and AG022308 (D. E. H.), AG022307 (R. S.) and AG13319 (J. F. N. and R. S.), and the Department of Veterans Affairs (R. A. M. and R. S.) and DoD W81XWH-07-1-0605 (Z. D. S.). We wish to thank P. J. Krason, P. J. Harrison, E. Adler, V. Diaz, J. Sewald, L. Burmeister, B. Kohler, M. Han, M. Lauderdale and D. Jones for reliable technical assistance, S. Pletcher and A. Galecki for statistical assistance, and H. Warner and S. N. Austad for scientific counsel.	Archer JR, 1996, J GERONTOL A-BIOL, V51, pB448, DOI 10.1093/gerona/51A.6.B448; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Garber K, 2001, J NATL CANCER I, V93, P1517, DOI 10.1093/jnci/93.20.1517; Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Klebanov S, 2001, EXP BIOL MED, V226, P854, DOI 10.1177/153537020122600908; KOHN RR, 1978, PRINCIPLES MAMMALIAN; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Nadon NL, 2008, AGE, V30, P187, DOI 10.1007/s11357-008-9048-1; Olshansky SJ, 2006, SCIENTIST, V20, P28; Petroulakis E, 2007, Br J Cancer, V96 Suppl, pR11; PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; RODERICK TH, 1963, GENETICS, V48, P205; SCHNEIDER EL, 1985, NEW ENGL J MED, V312, P1159, DOI 10.1056/NEJM198505023121805; SCHNEIDER EL, 1998, BROCKELHURSTS TXB GE, P193; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	30	2446	2568	14	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					392	U108		10.1038/nature08221	http://dx.doi.org/10.1038/nature08221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19587680	Green Submitted, Green Accepted			2022-12-28	WOS:000267979000038
J	John, S				John, Sajeev			PHOTONICS Light control at will	NATURE			English	Editorial Material									Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	University of Toronto	John, S (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	john@physics.utoronto.ca						Bauer J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.013819; Chutinan A, 2006, OPT EXPRESS, V14, P1266, DOI 10.1364/OE.14.001266; Ishizaki K, 2009, NATURE, V460, P367, DOI 10.1038/nature08190; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Vujic D, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063814	7	11	12	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					337	337		10.1038/460337a	http://dx.doi.org/10.1038/460337a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606137	Bronze			2022-12-28	WOS:000267979000025
J	Ewing, RC; von Hippel, FN				Ewing, Rodney C.; von Hippel, Frank N.			Nuclear Waste Management in the United States-Starting Over	SCIENCE			English	Editorial Material									[Ewing, Rodney C.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [von Hippel, Frank N.] Princeton Univ, Program Sci & Global Secur, Princeton, NJ 08542 USA	University of Michigan System; University of Michigan; Princeton University	Ewing, RC (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	rodewing@umich.edu; fvhippel@princeton.edu		Ewing, Rodney/0000-0001-9472-4031				DOE, 2008, DOERW0591; MacFarlane Allison, 2006, UNCERTAINTY UNDERGRO; National Research Council, 2006, GOING DIST SAF TRANS; National Research Council, 1995, TECHN BAS YUCC MOUNT; National Research Council, 1996, NUCL WASTES TECHNOLO; *OFF MAN BUDG, 2009, NEW ER RESP REN AM P, P63; *ORG EC COOP DEV, 2003, PUBL INF CONS INV RE; Perkovich George, 1999, INDIAS NUCL BOMB, p[28, 55]; VONHIPPEL FN, 2009, COSTS BENEFITS REPRO; 2008, FED REG, V73, P59551	10	82	84	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					151	152		10.1126/science.1174594	http://dx.doi.org/10.1126/science.1174594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468FK	19589986				2022-12-28	WOS:000267802000028
J	Furuyama, T; Henikoff, S				Furuyama, Takehito; Henikoff, Steven			Centromeric Nucleosomes Induce Positive DNA Supercoils	CELL			English	Article							HISTONE (H3-H4)(2) TETRAMER; SACCHAROMYCES-CEREVISIAE; CENP-A; YEAST CENTROMERE; BUDDING YEAST; FISSION YEAST; CHROMOSOME SEGREGATION; ARCHAEAL NUCLEOSOMES; CHROMATIN-STRUCTURE; COPY NUMBER	Centromeres of higher eukaryotes are epigenetically maintained; however, the mechanism that underlies centromere inheritance is unknown. Centromere identity and inheritance require the assembly of nucleosomes containing the CenH3 histone variant in place of canonical H3. Although H3 nucleosomes wrap DNA in a left-handed manner and induce negative supercoils, we show here that CenH3 nucleosomes reconstituted from Drosophila histones induce positive supercoils. Furthermore, we show that CenH3 likewise induces positive supercoils in functional centromeres in vivo, using a budding yeast minichromosome system and temperature-sensitive mutations in kinetochore proteins. The right-handed wrapping of DNA around the histone core implied by positive supercoiling indicates that centromere nucleosomes are unlikely to be octameric and that the exposed surfaces holding the nucleosome together would be available for kinetochore protein recruitment. The mutual incompatibility of nucleosomes with opposite topologies could explain how centromeres are efficiently maintained as unique loci on chromosomes.	[Furuyama, Takehito; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alilat M, 1999, J MOL BIOL, V291, P815, DOI 10.1006/jmbi.1999.2988; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bates A. D., 2005, DNA TOPOLOGY; BLOOM K, 1984, MOL BIOL CYTOSKELETO, P175; BLOOM KS, 1982, CELL, V29, P305, DOI 10.1016/0092-8674(82)90147-7; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HOOSER AV, 2001, J CELL SCI, V114, P3529; JEHN B, 1991, MOL CELL BIOL, V11, P5212, DOI 10.1128/MCB.11.10.5212; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malcolm A D, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P323; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; NELSON RG, 1979, P NATL ACAD SCI USA, V76, P6515, DOI 10.1073/pnas.76.12.6515; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pereira SL, 1997, P NATL ACAD SCI USA, V94, P12633, DOI 10.1073/pnas.94.23.12633; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; RESNICK MA, 1990, CHROMOSOMA, V99, P281, DOI 10.1007/BF01731704; SAAVEDRA RA, 1986, CELL, V45, P65, DOI 10.1016/0092-8674(86)90538-6; Sandman K, 1998, CELL MOL LIFE SCI, V54, P1350, DOI 10.1007/s000180050259; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; Tomonaga T, 2003, CANCER RES, V63, P3511; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	55	166	167	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					104	113		10.1016/j.cell.2009.04.049	http://dx.doi.org/10.1016/j.cell.2009.04.049			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596238	Green Accepted, Bronze			2022-12-28	WOS:000267848600018
J	Nagashima, H; Sugahara, F; Takechi, M; Ericsson, R; Kawashima-Ohya, Y; Narita, Y; Kuratani, S				Nagashima, Hiroshi; Sugahara, Fumiaki; Takechi, Masaki; Ericsson, Rolf; Kawashima-Ohya, Yoshie; Narita, Yuichi; Kuratani, Shigeru			Evolution of the Turtle Body Plan by the Folding and Creation of New Muscle Connections	SCIENCE			English	Article							CARAPACIAL RIDGE; SHELL; EMBRYOS; GENES; ORIGIN	The turtle shell offers a fascinating case study of vertebrate evolution, based on the modification of a common body plan. The carapace is formed from ribs, which encapsulate the scapula; this stands in contrast to the typical amniote body plan and serves as a key to understanding turtle evolution. Comparative analyses of musculoskeletal development between the Chinese soft-shelled turtle and other amniotes revealed that initial turtle development conforms to the amniote pattern; however, during embryogenesis, lateral rib growth results in a shift of elements. In addition, some limb muscles establish new turtle-specific attachments associated with carapace formation. We propose that the evolutionary origin of the turtle body plan results from heterotopy based on folding and novel connectivities.	[Nagashima, Hiroshi; Sugahara, Fumiaki; Takechi, Masaki; Ericsson, Rolf; Kawashima-Ohya, Yoshie; Narita, Yuichi; Kuratani, Shigeru] RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan; [Sugahara, Fumiaki] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	RIKEN; Kobe University	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Sugahara, Fumiaki/ABA-7542-2021; Sugahara, Fumiaki/C-5379-2017; Kuratani, Shigeru/J-4146-2014	Sugahara, Fumiaki/0000-0001-8445-1703; Kuratani, Shigeru/0000-0001-9717-7221				Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Baer v., 1828, ENTWICKLUNGSGESCHICH; BURKE AC, 1991, AM ZOOL, V31, P616; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cebra-Thomas J, 2005, J EXP ZOOL PART B, V304B, P558, DOI 10.1002/jez.b.21059; Evans DJR, 2006, ANAT EMBRYOL, V211, pS43, DOI 10.1007/s00429-006-0121-1; Geoffroy Saint-Hilaire, 1818, PHILOS ANATOMIQUE, V1; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Haeckel E., 1875, JENAISCHE Z FR NATUR, V9, P402; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Lee MSY, 1996, NATURE, V379, P812, DOI 10.1038/379812a0; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Loredo GA, 2001, J EXP ZOOL, V291, P274, DOI 10.1002/jez.1103; Moustakas JE, 2008, EVOL DEV, V10, P29, DOI 10.1111/j.1525-142X.2007.00210.x; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Nagashima H, 2007, DEVELOPMENT, V134, P2219, DOI 10.1242/dev.002618; Ohya YK, 2005, J EXP ZOOL PART B, V304B, P107, DOI 10.1002/jez.b.21027; Prols F, 2004, DEV BIOL, V275, P315, DOI 10.1016/j.ydbio.2004.08.003; Reisz RR, 2008, NATURE, V456, P450, DOI 10.1038/456450a; Rieppel O, 2001, BIOESSAYS, V23, P987, DOI 10.1002/bies.1143; Romer AS, 1977, VERTEBRATE BODY, V5th; RUCKES H, 1929, ANN NY ACAD SCI, V31, P81, DOI DOI 10.1111/J.1749-6632.1929.TB55192.X; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Vincent C, 2003, DEV GENES EVOL, V213, P464, DOI 10.1007/s00427-003-0347-3; WALKER WF, 1947, J MORPHOL, V80, P195, DOI 10.1002/jmor.1050800204	28	99	101	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					193	196		10.1126/science.1173826	http://dx.doi.org/10.1126/science.1173826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590000				2022-12-28	WOS:000267802000045
J	Franzdottir, SR; Engelen, D; Yuva-Aydemir, Y; Schmidt, I; Aho, A; Klambt, C				Franzdottir, Sigridur Rut; Engelen, Daniel; Yuva-Aydemir, Yeliz; Schmidt, Imke; Aho, Annukka; Klaembt, Christian			Switch in FGF signalling initiates glial differentiation in the Drosophila eye	NATURE			English	Article							RECEPTOR TYROSINE KINASE; CELL MIGRATION; GROWTH-FACTOR; MESSENGER-RNA; RAP1; ACTIVATION; MESODERM; EMBRYO; MORPHOGENESIS; NEUREGULIN-1	The formation of a complex nervous system requires the intricate interaction of neurons and glial cells. Glial cells generally migrate over long distances before they initiate their differentiation, which leads to wrapping and insulation of axonal processes(1,2). The molecular pathways coordinating the switch from glial migration to glial differentiation are largely unknown(3). Here we demonstrate that, within the Drosophila eye imaginal disc, fibroblast growth factor (FGF) signalling coordinates glial proliferation, migration and subsequent axonal wrapping. Glial differentiation in the Drosophila eye disc requires a succession from glia-glia interaction to glia-neuron interaction(4). The neuronal component of the fly eye develops in the peripheral nervous system within the eye-antennal imaginal disc, whereas glial cells originate from a pool of central-nervous-system-derived progenitors and migrate onto the eye imaginal disc(5-8). Initially, glial-derived Pyramus, an FGF8-like ligand, modulates glial cell number and motility. A switch to neuronally expressed Thisbe, a second FGF8-like ligand, then induces glial differentiation. This switch is accompanied by an alteration in the intracellular signalling pathway through which the FGF receptor channels information into the cell. Our findings reveal how a switch from glia-glia interactions to glia-neuron interactions can trigger formation of glial membrane around axonal trajectories. These results disclose an evolutionarily conserved control mechanism of axonal wrapping(2), indicating that Drosophila might serve as a model to understand glial disorders in humans.	[Franzdottir, Sigridur Rut; Engelen, Daniel; Yuva-Aydemir, Yeliz; Schmidt, Imke; Aho, Annukka; Klaembt, Christian] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	klaembt@uni-muenster.de	Franzdottir, Sigridur/M-2534-2015		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Muller for providing flies and advice, M. Leptin, M. Freeman, the Bloomington stock centre and the Vienna Drosophila RNAi Center (VDRC) for sending flies and antibodies, H. Aberle, S. Bogdan, T. Hummel, E. Raz, M. Silies and R. Stephan for discussions. The work was funded through grants of the Deutsche Forschungsgemeinschaft.	Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Cafferty P, 2007, NEURON GLIA BIOL, V3, P45, DOI 10.1017/S1740925X07000634; CHOI KW, 1994, NEURON, V12, P423, DOI 10.1016/0896-6273(94)90282-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Edenfeld G, 2006, NEURON, V52, P969, DOI 10.1016/j.neuron.2006.10.029; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Meinertzhagen Ian A., 1993, P1363; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shishido E, 1997, DEVELOPMENT, V124, P2119; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stork T, 2009, DEVELOPMENT, V136, P1251, DOI 10.1242/dev.032847; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wolff Tanya, 1993, P1277; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	32	99	100	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					758	U106		10.1038/nature08167	http://dx.doi.org/10.1038/nature08167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19597479				2022-12-28	WOS:000268670300043
J	Knauth, LP; Kennedy, MJ				Knauth, L. Paul; Kennedy, Martin J.			The late Precambrian greening of the Earth	NATURE			English	Article							STABLE ISOTOPIC EVIDENCE; CARBONATE CEMENTATION; OXYGEN; LAND; LIMESTONES; COMPLEX; ROCKS; LIFE	Many aspects of the carbon cycle can be assessed from temporal changes in the C-13/C-12 ratio of oceanic bicarbonate. C-13/C-12 can temporarily rise when large amounts of C-13-depleted photosynthetic organic matter are buried at enhanced rates(1), and can decrease if phytomass is rapidly oxidized(2) or if low C-13 is rapidly released from methane clathrates(3). Assuming that variations of the marine C-13/C-12 ratio are directly recorded in carbonate rocks, thousands of carbon isotope analyses of late Precambrian examples have been published to correlate these otherwise undatable strata and to document perturbations to the carbon cycle just before the great expansion of metazoan life. Low C-13/C-12 in some Neoproterozoic carbonates is considered evidence of carbon cycle perturbations unique to the Precambrian. These include complete oxidation of all organic matter in the ocean(2) and complete productivity collapse such that low-C-13/C-12 hydrothermal CO2 becomes the main input of carbon(4). Here we compile all published oxygen and carbon isotope data for Neoproterozoic marine carbonates, and consider them in terms of processes known to alter the isotopic composition during transformation of the initial precipitate into limestone/dolostone. We show that the combined oxygen and carbon isotope systematics are identical to those of well-understood Phanerozoic examples that lithified in coastal pore fluids, receiving a large groundwater influx of photosynthetic carbon from terrestrial phytomass. Rather than being perturbations to the carbon cycle, widely reported decreases in C-13/C-12 in Neoproterozoic carbonates are more easily interpreted in the same way as is done for Phanerozoic examples. This influx of terrestrial carbon is not apparent in carbonates older than similar to 850 Myr, so we infer an explosion of photosynthesizing communities on late Precambrian land surfaces. As a result, biotically enhanced weathering generated carbon-bearing soils on a large scale and their detrital sedimentation sequestered carbon(5). This facilitated a rise in O-2 necessary for the expansion of multicellular life.	[Knauth, L. Paul] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Kennedy, Martin J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92557 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California Riverside	Knauth, LP (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	Knauth@asu.edu		Kennedy, Martin/0000-0002-1330-6864	NASA Exobiology [NG04GJ47G, NNX08AT72G, NNG04GJ42G]; NSF [EAR 0345207]	NASA Exobiology(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank K. McFadden for help compiling the data. L. P. K. was funded by NASA Exobiology grants NG04GJ47G and NNX08AT72G. M. J. K. was funded by NASA Exobiology NNG04GJ42G and NSF EAR 0345207.	BANNER JL, 1990, GEOCHIM COSMOCHIM AC, V54, P3123, DOI 10.1016/0016-7037(90)90128-8; Bristow TF, 2008, GEOLOGY, V36, P863, DOI 10.1130/G24968A.1; Brooks SM, 1997, EARTH SURF PROC LAND, V22, P45, DOI 10.1002/(SICI)1096-9837(199701)22:1&lt;45::AID-ESP686&gt;3.0.CO;2-P; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; FAIRCHILD IJ, 1990, GEOL SOC SPEC PUBL, V53, P201, DOI 10.1144/GSL.SP.1990.053.01.11; Fayek M, 2001, J SEDIMENT RES, V71, P444, DOI 10.1306/2DC40954-0E47-11D7-8643000102C1865D; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GROSS MG, 1966, SCIENCE, V151, P1082, DOI 10.1126/science.151.3714.1082; HATHAWAY JC, 1979, SCIENCE, V206, P515, DOI 10.1126/science.206.4418.515; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hendry JP, 2000, J SEDIMENT RES, V70, P227, DOI 10.1306/2DC4090D-0E47-11D7-8643000102C1865D; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; KAUFMAN AJ, 1992, GEOLOGY, V20, P181, DOI 10.1130/0091-7613(1992)020<0181:BACCON>2.3.CO;2; Kennedy M, 2006, SCIENCE, V311, P1446, DOI 10.1126/science.1118929; Land L.S., 1986, US GEOLOGICAL SURVEY, V1578, P129; Lenton TM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018802; Melim L.A., 2001, SUBSURFACE GEOLOGY P, V70, P137; Moore WS, 2008, NAT GEOSCI, V1, P309, DOI 10.1038/ngeo183; Muehlenbachs K, 1998, CHEM GEOL, V145, P263, DOI 10.1016/S0009-2541(97)00147-2; Pokrovskii BG, 2006, LITHOL MINER RESOUR+, V41, P576, DOI 10.1134/S002449020606006X; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; QUINN TM, 1991, J SEDIMENT PETROL, V61, P681; SCHOLLE PA, 1980, AAPG BULL, V64, P67, DOI DOI 10.1306/2F91892D-16CE-11D7-8645000102C1865D; Schwartzman D., 1999, LIFE TEMPERATURE EAR; Taylor KG, 2000, J SEDIMENT RES, V70, P360, DOI 10.1306/2DC40916-0E47-11D7-8643000102C1865D; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	28	419	441	8	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					728	732		10.1038/nature08213	http://dx.doi.org/10.1038/nature08213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19587681				2022-12-28	WOS:000268670300036
J	Kalantry, S; Purushothaman, S; Bowen, RB; Starmer, J; Magnuson, T				Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry			Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation	NATURE			English	Article							DOSAGE COMPENSATION; LINKED GENES; MAMMALIAN X; EXPRESSION; METHYLATION; EED	XX female mammals undergo transcriptional silencing of most genes on one of their two X chromosomes to equalize X-linked gene dosage with XY males in a process referred to as X-chromosome inactivation (XCI). XCI is an example of epigenetic regulation(1). Once enacted in individual cells of the early female embryo, XCI is stably transmitted such that most descendant cells maintain silencing of that X chromosome(2). In eutherian mammals, XCI is thought to be triggered by the expression of the non-coding Xist RNA from the future inactive X chromosome (Xi)(3-5); Xist RNA in turn is proposed to recruit protein complexes that bring about heterochromatinization of the Xi(6,7). Here we test whether imprinted XCI, which results in preferential inactivation of the paternal X chromosome (Xp), occurs in mouse embryos inheriting an Xp lacking Xist. We find that silencing of Xp-linked genes can initiate in the absence of paternal Xist; Xist is, however, required to stabilize silencing along the Xp. Xp-linked gene silencing associated with mouse imprinted XCI, therefore, can initiate in the embryo independently of Xist RNA.	[Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Kalantry, Sundeep; Purushothaman, Sonya; Bowen, Randall Bryant; Starmer, Joshua; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu			American Cancer Society; US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD024462, K99HD055333] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Jaenisch for Xist<SUP>2lox</SUP> mice and G. Martin for Zp3 -Cre mice (Supplementary Methods). Wealso thank A. Fedoriw and K. Huynh, for advice on allele-specific RT -PCR, and are grateful to S. Malpani and L. Williams, for discussions; M. Calabrese, R. Chandler, D. Ciavatta, A. Fedoriw, C. Griffin, S. Malpani, J. Mugford, M. Pohlers, K. Shpargel and L. Williams, for critically reading the manuscript. We also acknowledge the Michael Hooker Microscopy Facility at the University of North Carolina at Chapel Hill for the use of their LeicaSP2 confocal microscope. This work was supported in part by an American Cancer Society Postdoctoral Fellowship to S. K. and by grants from the US National Institutes of Health to S. K. and T. M.	BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; COOPER DW, 1971, NATURE, V230, P292, DOI 10.1038/230292a0; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; SAMOLLOW PB, 1987, GENETICS, V115, P185; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Wallis MC, 2008, CELL MOL LIFE SCI, V65, P3182, DOI 10.1007/s00018-008-8109-z; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	30	106	114	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					647	651		10.1038/nature08161	http://dx.doi.org/10.1038/nature08161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19571810	Green Accepted, Green Submitted			2022-12-28	WOS:000268454300054
J	Acciari, VA; Aliu, E; Arlen, T; Bautista, M; Beilicke, M; Benbow, W; Bradbury, SM; Buckley, JH; Bugaev, V; Butt, Y; Byrum, K; Cannon, A; Celik, O; Cesarini, A; Chow, YC; Ciupik, L; Cogan, P; Cui, W; Dickherber, R; Fegan, SJ; Finley, JP; Fortin, P; Fortson, L; Furniss, A; Gall, D; Gillanders, GH; Grube, J; Guenette, R; Gyuk, G; Hanna, D; Holder, J; Horan, D; Hui, CM; Humensky, TB; Imran, A; Kaaret, P; Karlsson, N; Kieda, D; Kildea, J; Konopelko, A; Krawczynski, H; Krennrich, F; Lang, MJ; LeBohec, S; Maier, G; McCann, A; McCutcheon, M; Millis, J; Moriarty, P; Ong, RA; Otte, AN; Pandel, D; Perkins, JS; Petry, D; Pohl, M; Quinn, J; Ragan, K; Reyes, LC; Reynolds, PT; Roache, E; Roache, E; Rose, HJ; Schroedter, M; Sembroski, GH; Smith, AW; Swordy, SP; Theiling, M; Toner, JA; Varlotta, A; Vincent, S; Wakely, SP; Ward, JE; Weekes, TC; Weinstein, A; Williams, DA; Wissel, S; Wood, M; Walker, RC; Davies, F; Hardee, PE; Junor, W; Ly, C; Aharonian, F; Akhperjanian, AG; Anton, G; de Almeida, UB; Bazer-Bachi, AR; Becherini, Y; Behera, B; Bernlohr, K; Bochow, A; Boisson, C; Bolmont, J; Borrel, V; Brucker, J; Brun, F; Brun, P; Buhler, R; Bulik, T; Busching, I; Boutelier, T; Chadwick, PM; Charbonnier, A; Chaves, RCG; Cheesebrough, A; Chounet, LM; Clapson, AC; Coignet, G; Dalton, M; Daniel, MK; Davids, ID; Degrange, B; Deil, C; Dickinson, HJ; Djannati-Atai, A; Domainko, W; Drury, LO; Dubois, F; Dubus, G; Dyks, J; Dyrda, M; Egberts, K; Emmanoulopoulos, D; Espigat, P; Farnier, C; Feinstein, F; Fiasson, A; Forster, A; Fontaine, G; Fussling, M; Gabici, S; Gallant, YA; Gerard, L; Gerbig, D; Giebels, B; Glicenstein, JF; Gluck, B; Goret, P; Gohring, D; Hauser, D; Hauser, M; Heinz, S; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hoffmann, A; Hofmann, W; Holleran, M; Hoppe, S; Horns, D; Jacholkowska, A; de Jager, OC; Jahn, C; Jung, I; Katarzynski, K; Katz, U; Kaufmann, S; Kendziorra, E; Kerschhaggl, M; Khangulyan, D; Khelifi, B; Keogh, D; Kluzniak, W; Kneiske, T; Komin, N; Kosack, K; Lamanna, G; Lenain, JP; Lohse, T; Marandon, V; Martin, JM; Martineau-Huynh, O; Marcowith, A; Maurin, D; McComb, TJL; Medina, MC; Moderski, R; Moulin, E; Naumann-Godo, M; de Naurois, M; Nedbal, D; Nekrassov, D; Nicholas, B; Niemiec, J; Nolan, SJ; Ohm, S; Olive, JF; Wilhelmi, ED; Orford, KJ; Ostrowski, M; Panter, M; Arribas, MP; Pedaletti, G; Pelletier, G; Petrucci, PO; Pita, S; Raue, M; Rayner, SM; Renaud, M; Rieger, F; Ripken, J; Rob, L; Rosier-Lees, S; Rowell, G; Rudak, B; Rulten, CB; Ruppel, J; Sahakian, V; Santangelo, A; Schlickeiser, R; Schock, FM; Schroder, R; Schwanke, U; Schwarzburg, S; Schwemmer, S; Shalchi, A; Sikora, M; Skilton, JL; Sol, H; Spangler, D; Stawarz, L; Steenkamp, R; Stegmann, C; Stinzing, F; Superina, G; Szostek, A; Tam, PH; Tavernet, JP; Terrier, R; Tibolla, O; Tluczykont, M; van Eldik, C; Vasileiadis, G; Venter, C; Venter, L; Vialle, JP; Vincent, P; Vivier, M; Volk, HJ; Volpe, F; Wagner, SJ; Ward, M; Zdziarski, AA; Zech, A; Anderhub, H; Antonelli, LA; Antoranz, P; Backes, M; Baixeras, C; Balestra, S; Barrio, JA; Bastieri, D; Gonzlez, JB; Becker, JK; Bednarek, W; Berger, K; Bernardini, E; Biland, A; Bock, RK; Bonnoli, G; Bordas, P; Tridon, DB; Bosch-Ramon, V; Bose, D; Braun, I; Bretz, T; Britvitch, I; Camara, M; Carmona, E; Commichau, S; Contreras, JL; Cortina, J; Costado, MT; Covino, S; Curtef, V; Dazzi, F; De Angelis, A; Del Pozo, ED; Mendez, CD; De los Reyes, R; De Lotto, B; De Maria, M; De Sabata, F; Dominguez, A; Dorner, D; Doro, M; Elsaesser, D; Errando, M; Ferenc, D; Fernandez, E; Firpo, R; Fonseca, MV; Font, L; Galante, N; Lopez, RJG; Garczarczyk, M; Gaug, M; Goebel, F; Hadasch, D; Hayashida, M; Herrero, A; Hildebrand, D; Hohne-Monch, D; Hose, J; Hsu, CC; Jogler, T; Kranich, D; La Barbera, A; Laille, A; Leonardo, E; Lindfors, E; Lombardi, S; Longo, F; Lopez, M; Lorenz, E; Majumdar, P; Maneva, G; Mankuzhiyil, N; Mannheim, K; Maraschi, L; Mariotti, M; Martinez, M; Mazin, D; Meucci, M; Miranda, JM; Mirzoyan, R; Miyamoto, H; Moldon, J; Moles, M; Moralejo, A; Nieto, D; Nilsson, K; Ninkovic, J; Oya, I; Paoletti, R; Paredes, JM; Pasanen, M; Pascoli, D; Pauss, F; Pegna, RG; Perez-Torres, MA; Persic, M; Peruzzo, L; Prada, F; Prandini, E; Puchades, N; Reichardt, I; Rhode, W; Ribo, M; Rico, J; Rissi, M; Robert, A; Rugamer, S; Saggion, A; Saito, TY; Salvati, M; Sanchez-Conde, M; Satalecka, K; Scalzotto, V; Scapin, V; Schweizer, T; Shayduk, M; Shore, SN; Sidro, N; Sierpowska-Bartosik, A; Sillanpaa, A; Sitarek, J; Sobczynska, D; Spanier, F; Stamerra, A; Stark, LS; Takalo, L; Tavecchio, F; Temnikov, P; Tescaro, D; Teshima, M; Torres, DF; Turini, N; Vankov, H; Wagner, RM; Zabalza, V; Zandanel, F; Zanin, R; Zapatero, J				Acciari, V. A.; Aliu, E.; Arlen, T.; Bautista, M.; Beilicke, M.; Benbow, W.; Bradbury, S. M.; Buckley, J. H.; Bugaev, V.; Butt, Y.; Byrum, K.; Cannon, A.; Celik, O.; Cesarini, A.; Chow, Y. C.; Ciupik, L.; Cogan, P.; Cui, W.; Dickherber, R.; Fegan, S. J.; Finley, J. P.; Fortin, P.; Fortson, L.; Furniss, A.; Gall, D.; Gillanders, G. H.; Grube, J.; Guenette, R.; Gyuk, G.; Hanna, D.; Holder, J.; Horan, D.; Hui, C. M.; Humensky, T. B.; Imran, A.; Kaaret, P.; Karlsson, N.; Kieda, D.; Kildea, J.; Konopelko, A.; Krawczynski, H.; Krennrich, F.; Lang, M. J.; LeBohec, S.; Maier, G.; McCann, A.; McCutcheon, M.; Millis, J.; Moriarty, P.; Ong, R. A.; Otte, A. N.; Pandel, D.; Perkins, J. S.; Petry, D.; Pohl, M.; Quinn, J.; Ragan, K.; Reyes, L. C.; Reynolds, P. T.; Roache, E.; Roache, E.; Rose, H. J.; Schroedter, M.; Sembroski, G. H.; Smith, A. W.; Swordy, S. P.; Theiling, M.; Toner, J. A.; Varlotta, A.; Vincent, S.; Wakely, S. P.; Ward, J. E.; Weekes, T. C.; Weinstein, A.; Williams, D. A.; Wissel, S.; Wood, M.; Walker, R. C.; Davies, F.; Hardee, P. E.; Junor, W.; Ly, C.; Aharonian, F.; Akhperjanian, A. G.; Anton, G.; de Almeida, U. Barres; Bazer-Bachi, A. R.; Becherini, Y.; Behera, B.; Bernloehr, K.; Bochow, A.; Boisson, C.; Bolmont, J.; Borrel, V.; Brucker, J.; Brun, F.; Brun, P.; Buehler, R.; Bulik, T.; Buesching, I.; Boutelier, T.; Chadwick, P. M.; Charbonnier, A.; Chaves, R. C. G.; Cheesebrough, A.; Chounet, L. -M.; Clapson, A. C.; Coignet, G.; Dalton, M.; Daniel, M. K.; Davids, I. D.; Degrange, B.; Deil, C.; Dickinson, H. J.; Djannati-Atai, A.; Domainko, W.; Drury, L. O'C; Dubois, F.; Dubus, G.; Dyks, J.; Dyrda, M.; Egberts, K.; Emmanoulopoulos, D.; Espigat, P.; Farnier, C.; Feinstein, F.; Fiasson, A.; Foerster, A.; Fontaine, G.; Fuessling, M.; Gabici, S.; Gallant, Y. A.; Gerard, L.; Gerbig, D.; Giebels, B.; Glicenstein, J. F.; Glueck, B.; Goret, P.; Goehring, D.; Hauser, D.; Hauser, M.; Heinz, S.; Heinzelmann, G.; Henri, G.; Hermann, G.; Hinton, J. A.; Hoffmann, A.; Hofmann, W.; Holleran, M.; Hoppe, S.; Horns, D.; Jacholkowska, A.; de Jager, O. C.; Jahn, C.; Jung, I.; Katarzynski, K.; Katz, U.; Kaufmann, S.; Kendziorra, E.; Kerschhaggl, M.; Khangulyan, D.; Khelifi, B.; Keogh, D.; Kluzniak, W.; Kneiske, T.; Komin, Nu.; Kosack, K.; Lamanna, G.; Lenain, J. -P.; Lohse, T.; Marandon, V.; Martin, J. M.; Martineau-Huynh, O.; Marcowith, A.; Maurin, D.; McComb, T. J. L.; Medina, M. C.; Moderski, R.; Moulin, E.; Naumann-Godo, M.; de Naurois, M.; Nedbal, D.; Nekrassov, D.; Nicholas, B.; Niemiec, J.; Nolan, S. J.; Ohm, S.; Olive, J. -F.; Wilhelmi, E. de Ona; Orford, K. J.; Ostrowski, M.; Panter, M.; Arribas, M. Paz; Pedaletti, G.; Pelletier, G.; Petrucci, P. -O.; Pita, S.; Raue, M.; Rayner, S. M.; Renaud, M.; Rieger, F.; Ripken, J.; Rob, L.; Rosier-Lees, S.; Rowell, G.; Rudak, B.; Rulten, C. B.; Ruppel, J.; Sahakian, V.; Santangelo, A.; Schlickeiser, R.; Schoeck, F. M.; Schroeder, R.; Schwanke, U.; Schwarzburg, S.; Schwemmer, S.; Shalchi, A.; Sikora, M.; Skilton, J. L.; Sol, H.; Spangler, D.; Stawarz, L.; Steenkamp, R.; Stegmann, C.; Stinzing, F.; Superina, G.; Szostek, A.; Tam, P. H.; Tavernet, J. -P.; Terrier, R.; Tibolla, O.; Tluczykont, M.; van Eldik, C.; Vasileiadis, G.; Venter, C.; Venter, L.; Vialle, J. P.; Vincent, P.; Vivier, M.; Voelk, H. J.; Volpe, F.; Wagner, S. J.; Ward, M.; Zdziarski, A. A.; Zech, A.; Anderhub, H.; Antonelli, L. A.; Antoranz, P.; Backes, M.; Baixeras, C.; Balestra, S.; Barrio, J. A.; Bastieri, D.; Gonzlez, J. Becerra; Becker, J. K.; Bednarek, W.; Berger, K.; Bernardini, E.; Biland, A.; Bock, R. K.; Bonnoli, G.; Bordas, P.; Tridon, D. Borla; Bosch-Ramon, V.; Bose, D.; Braun, I.; Bretz, T.; Britvitch, I.; Camara, M.; Carmona, E.; Commichau, S.; Contreras, J. L.; Cortina, J.; Costado, M. T.; Covino, S.; Curtef, V.; Dazzi, F.; De Angelis, A.; Del Pozo, E. De Cea; Mendez, C. Delgado; De los Reyes, R.; De Lotto, B.; De Maria, M.; De Sabata, F.; Dominguez, A.; Dorner, D.; Doro, M.; Elsaesser, D.; Errando, M.; Ferenc, D.; Fernandez, E.; Firpo, R.; Fonseca, M. V.; Font, L.; Galante, N.; Lopez, R. J. Garcia; Garczarczyk, M.; Gaug, M.; Goebel, F.; Hadasch, D.; Hayashida, M.; Herrero, A.; Hildebrand, D.; Hoehne-Moench, D.; Hose, J.; Hsu, C. C.; Jogler, T.; Kranich, D.; La Barbera, A.; Laille, A.; Leonardo, E.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, M.; Lorenz, E.; Majumdar, P.; Maneva, G.; Mankuzhiyil, N.; Mannheim, K.; Maraschi, L.; Mariotti, M.; Martinez, M.; Mazin, D.; Meucci, M.; Miranda, J. M.; Mirzoyan, R.; Miyamoto, H.; Moldon, J.; Moles, M.; Moralejo, A.; Nieto, D.; Nilsson, K.; Ninkovic, J.; Oya, I.; Paoletti, R.; Paredes, J. M.; Pasanen, M.; Pascoli, D.; Pauss, F.; Pegna, R. G.; Perez-Torres, M. A.; Persic, M.; Peruzzo, L.; Prada, F.; Prandini, E.; Puchades, N.; Reichardt, I.; Rhode, W.; Ribo, M.; Rico, J.; Rissi, M.; Robert, A.; Ruegamer, S.; Saggion, A.; Saito, T. Y.; Salvati, M.; Sanchez-Conde, M.; Satalecka, K.; Scalzotto, V.; Scapin, V.; Schweizer, T.; Shayduk, M.; Shore, S. N.; Sidro, N.; Sierpowska-Bartosik, A.; Sillanpaa, A.; Sitarek, J.; Sobczynska, D.; Spanier, F.; Stamerra, A.; Stark, L. S.; Takalo, L.; Tavecchio, F.; Temnikov, P.; Tescaro, D.; Teshima, M.; Torres, D. F.; Turini, N.; Vankov, H.; Wagner, R. M.; Zabalza, V.; Zandanel, F.; Zanin, R.; Zapatero, J.		VERITAS Collaboration; VLBA 43 Ghz M87 Monitoring Team; HESS Collaboration; MAGIC Collaboration	Radio Imaging of the Very-High-Energy gamma-Ray Emission Region in the Central Engine of a Radio Galaxy	SCIENCE			English	Article							SUPERMASSIVE BLACK-HOLE; TEV EMISSION; M87 JET; CRAB-NEBULA; INNER JET; VARIABILITY; HST-1; BASE; M-87; SITE	The accretion of matter onto a massive black hole is believed to feed the relativistic plasma jets found in many active galactic nuclei (AGN). Although some AGN accelerate particles to energies exceeding 10(12) electron volts and are bright sources of very-high-energy (VHE) gamma-ray emission, it is not yet known where the VHE emission originates. Here we report on radio and VHE observations of the radio galaxy Messier 87, revealing a period of extremely strong VHE gamma-ray flares accompanied by a strong increase of the radio flux from its nucleus. These results imply that charged particles are accelerated to very high energies in the immediate vicinity of the black hole.	[Acciari, V. A.; Benbow, W.; Kildea, J.; Perkins, J. S.; Theiling, M.; Weekes, T. C.] Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA; [Aliu, E.; Holder, J.; Roache, E.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Aliu, E.; Holder, J.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Arlen, T.; Celik, O.; Chow, Y. C.; Fegan, S. J.; Ong, R. A.; Weinstein, A.; Wood, M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bautista, M.; Cogan, P.; Guenette, R.; Hanna, D.; Maier, G.; McCann, A.; McCutcheon, M.; Ragan, K.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Beilicke, M.; Buckley, J. H.; Bugaev, V.; Dickherber, R.; Krawczynski, H.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Bradbury, S. M.; Rose, H. J.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Butt, Y.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Byrum, K.; Smith, A. W.] Argonne Natl Lab, Argonne, IL 60439 USA; [Cannon, A.; Grube, J.; Quinn, J.; Ward, J. E.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Cesarini, A.; Gillanders, G. H.; Lang, M. J.; Toner, J. A.] Natl Univ Ireland, Sch Phys, Galway, Ireland; [Ciupik, L.; Fortson, L.; Gyuk, G.; Karlsson, N.] Adler Planetarium & Astron Museum, Dept Astron, Chicago, IL 60605 USA; [Cui, W.; Finley, J. P.; Gall, D.; Sembroski, G. H.; Varlotta, A.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Fortin, P.] Columbia Univ, Dept Phys & Astron, Barnard Coll, New York, NY 10027 USA; [Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Horan, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Hui, C. M.; Kieda, D.; LeBohec, S.; Vincent, S.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Humensky, T. B.; Swordy, S. P.; Wakely, S. P.; Wissel, S.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Imran, A.; Krennrich, F.; Pohl, M.; Schroedter, M.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Kaaret, P.; Pandel, D.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Konopelko, A.] Pittsburg State Univ, Dept Phys, Pittsburg, KS 66762 USA; [Millis, J.] Anderson Univ, Dept Phys, Anderson, IN 46012 USA; [Moriarty, P.] Galway Mayo Inst Technol, Dept Life & Phys Sci, Galway, Ireland; [Petry, D.] European So Observ, D-85748 Garching, Germany; [Reyes, L. C.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Reynolds, P. T.] Cork Inst Technol, Dept Appl Phys & Instrumentat, Cork, Ireland; [Walker, R. C.; Davies, F.] NRAO, Socorro, NM 87801 USA; [Davies, F.] New Mexico Inst Min & Technol, Dept Phys, Socorro, NM 87801 USA; [Hardee, P. E.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Junor, W.] Los Alamos Natl Lab, MS D436, ISR 2, Los Alamos, NM USA; [Ly, C.] Univ Calif Los Angeles, Dept Astron, Los Angeles, CA 90095 USA; [Aharonian, F.; Bernloehr, K.; Bochow, A.; Buehler, R.; Chaves, R. C. G.; Clapson, A. C.; Deil, C.; Domainko, W.; Egberts, K.; Hoffmann, A.; Hofmann, W.; Hoppe, S.; Khangulyan, D.; Kosack, K.; Nekrassov, D.; Ohm, S.; Panter, M.; Rieger, F.; Tibolla, O.; van Eldik, C.; Voelk, H. J.; Volpe, F.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Akhperjanian, A. G.; Sahakian, V.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Bazer-Bachi, A. R.; Borrel, V.; Olive, J. -F.] Ctr Etud Spatiale Rayonnements, CNRS, UPS, F-31029 Toulouse 4, France; [Horns, D.; Kneiske, T.; Ripken, J.; Tluczykont, M.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Bernloehr, K.; Dalton, M.; Fuessling, M.; Kerschhaggl, M.; Lohse, T.; Arribas, M. Paz; Schwanke, U.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Boisson, C.; Lenain, J. -P.; Martin, J. M.; Medina, M. C.; Sol, H.; Venter, L.] Univ Paris Diderot, CNRS, Observ Paris, Lab Univers & Theories, F-92190 Meudon, France; [Brun, F.; Glicenstein, J. F.; Goret, P.; Komin, Nu.; Moulin, E.; Vivier, M.] Commissariat Energie Atom CE Saclay, Inst Rech Lois Fondamentales Univers, Direct Sci Mat, F-91191 Gif Sur Yvette, France; [de Almeida, U. Barres; Chadwick, P. M.; Cheesebrough, A.; Daniel, M. K.; Dickinson, H. J.; Keogh, D.; McComb, T. J. L.; Nolan, S. J.; Orford, K. J.; Rulten, C. B.; Spangler, D.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Buesching, I.; Davids, I. D.; de Jager, O. C.; Venter, C.] North West Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; [Chounet, L. -M.; Degrange, B.; Fontaine, G.; Giebels, B.; Khelifi, B.; Naumann-Godo, M.; Superina, G.; Volpe, F.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Coignet, G.; Dubois, F.; Lamanna, G.; Rosier-Lees, S.; Vialle, J. P.] Lab Annecy Le Vieux Phys Particules, CNRS, IN2P3, F-74941 Annecy Le Vieux, France; [Becherini, Y.; Djannati-Atai, A.; Gerard, L.; Marandon, V.; Wilhelmi, E. de Ona; Pita, S.; Terrier, R.] Univ Paris 07, CNRS, Observ Paris, CEA,UMR 7164, F-75205 Paris 13, France; [Aharonian, F.; Drury, L. O'C; Gabici, S.] Dublin Inst Adv Studies, Dublin 2, Ireland; [Behera, B.; Emmanoulopoulos, D.; Espigat, P.; Gallant, Y. A.; Hauser, D.; Hauser, M.; Heinz, S.; Heinzelmann, G.; Henri, G.; Hoffmann, A.; Kaufmann, S.; Kendziorra, E.; Kerschhaggl, M.; Pedaletti, G.; Pelletier, G.; Raue, M.; Rayner, S. M.; Renaud, M.; Rieger, F.; Schwemmer, S.; Shalchi, A.; Sikora, M.; Tam, P. H.; Tibolla, O.; Wagner, S. J.; Ward, M.; Zdziarski, A. A.; Zech, A.; Anderhub, H.] Heidelberg Univ, D-69117 Heidelberg, Germany; [Farnier, C.; Feinstein, F.; Fiasson, A.; Gallant, Y. A.; Marcowith, A.; Vasileiadis, G.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier 5, France; [Anton, G.; Brucker, J.; Glueck, B.; Goehring, D.; Jahn, C.; Jung, I.; Katz, U.; Schoeck, F. M.; Stegmann, C.; Stinzing, F.] Univ Erlangen Nurnberg, Inst Phys, D-91058 Erlangen, Germany; [Boutelier, T.; Dubus, G.; Pelletier, G.; Petrucci, P. -O.; Szostek, A.] Univ Grenoble 1, CNRS, Astrophys Lab, Inst Natl Sci Univers, F-38041 Grenoble 9, France; [Santangelo, A.; Schwarzburg, S.] Univ Tubingen, Inst Astron & Astrophys, D-72076 Tubingen, Germany; [Bolmont, J.; Brun, F.; Charbonnier, A.; Jacholkowska, A.; Martineau-Huynh, O.; Maurin, D.; de Naurois, M.; Tavernet, J. -P.; Vincent, P.] Univ Paris 07, CNRS, Univ Paris 06, Lab Phys Nucl & Hautes,IN2P3, F-75252 Paris 5, France; [Nedbal, D.; Rob, L.] Charles Univ Prague, Fac Math & Phys, Inst Particle & Nucl Phys, CR-18000 Prague, Czech Republic; [Gerbig, D.; Kluzniak, W.; Ruppel, J.; Schlickeiser, R.; Schroeder, R.] Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; [Davids, I. D.; Steenkamp, R.] Univ Namibia, Windhoek, Namibia; [Ostrowski, M.; Stawarz, L.; Szostek, A.] Uniwersytet Jagiellonski, Obserwatorium Astron, PL-30244 Krakow, Poland; [Bulik, T.; Dyks, J.; Moderski, R.; Rudak, B.; Sikora, M.] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Hinton, J. A.; Skilton, J. L.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Nicholas, B.; Rowell, G.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Katarzynski, K.] Nicholas Copernicus Univ, Torun Ctr Astron, PL-87100 Torun, Poland; [Baixeras, C.; Font, L.; Hadasch, D.; Robert, A.; Zapatero, J.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Bastieri, D.; Bock, R. K.; Doro, M.; Lombardi, S.; Lopez, M.; Mariotti, M.; Pascoli, D.; Saggion, A.; Scalzotto, V.] Univ Padua, I-35131 Padua, Italy; [Gonzlez, J. Becerra; Costado, M. T.; Mendez, C. Delgado; Lopez, R. J. Garcia; Gaug, M.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Bednarek, W.; Berger, K.; Sitarek, J.; Sobczynska, D.] Univ Lodz, PL-90236 Lodz, Poland; [Bernardini, E.; Majumdar, P.; Satalecka, K.] DESY, D-15738 Zeuthen, Germany; [Bock, R. K.; Tridon, D. Borla; Carmona, E.; Galante, N.; Goebel, F.; Hayashida, M.; Hsu, C. C.; Jogler, T.; Lorenz, E.; Mirzoyan, R.; Miyamoto, H.; Ninkovic, J.; Saito, T. Y.; Schweizer, T.; Shayduk, M.; Sitarek, J.; Teshima, M.; Wagner, R. M.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Bonnoli, G.; Leonardo, E.; Paoletti, R.; Pegna, R. G.; Stamerra, A.; Turini, N.] Univ Siena, I-53100 Siena, Italy; [Bordas, P.; Bosch-Ramon, V.; Moldon, J.; Paredes, J. M.; Ribo, M.; Zabalza, V.] Univ Barcelona, IEEC, Inst Ciencias Cosmos, E-08028 Barcelona, Spain; [Bretz, T.; Elsaesser, D.; Mannheim, K.; Ruegamer, S.; Spanier, F.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Cortina, J.; Errando, M.; Fernandez, E.; Firpo, R.; Garczarczyk, M.; Martinez, M.; Moralejo, A.; Puchades, N.; Reichardt, I.; Rico, J.; Sidro, N.; Tescaro, D.; Zanin, R.] Univ Autonoma Barcelona, Inst Fis Altes Energies, E-08193 Barcelona, Spain; [Costado, M. T.; Lopez, R. J. Garcia] Dept Astrofis, E-38206 Tenerife, Spain; [Dazzi, F.; De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Scapin, V.] Univ Udine, I-33100 Udine, Italy; [Del Pozo, E. De Cea; Sierpowska-Bartosik, A.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, E-08193 Barcelona, Spain; [Dominguez, A.; Moles, M.; Perez-Torres, M. A.; Sanchez-Conde, M.; Zandanel, F.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Ferenc, D.; Laille, A.] Univ Calif Davis, Davis, CA 95616 USA; [Lindfors, E.; Nilsson, K.; Pasanen, M.; Sillanpaa, A.; Takalo, L.] Turku Univ, Tuorla Observ, FI-21500 Piikkio, Finland; [Maneva, G.; Temnikov, P.; Vankov, H.] Inst Nucl Energy Res, BG-1784 Sofia, Bulgaria; [Persic, M.] INAF, Osservatorio Astron, I-34143 Trieste, Italy; [Rico, J.; Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, E-08010 Barcelona, Spain; [Shore, S. N.] Univ Pisa, I-56126 Pisa, Italy; [Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Bastieri, D.; Bock, R. K.; Doro, M.; Lombardi, S.; Paoletti, R.; Persic, M.; Peruzzo, L.; Prandini, E.; Saggion, A.; Scalzotto, V.] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Bonnoli, G.; Leonardo, E.; Paoletti, R.; Stamerra, A.; Turini, N.] Ist Nazl Fis Nucl, I-53100 Siena, Italy; [Dazzi, F.; De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Scapin, V.] Ist Nazl Fis Nucl, I-33100 Udine, Italy; [Persic, M.] Ist Nazl Fis Nucl, I-34143 Trieste, Italy; [Shore, S. N.] Ist Nazl Fis Nucl, I-56126 Pisa, Italy; [Backes, M.; Becker, J. K.; Curtef, V.; Rhode, W.] Tech Univ Dortmund, D-44221 Dortmund, Germany	Harvard University; Smithsonian Institution; University of Delaware; University of Delaware; University of California System; University of California Los Angeles; McGill University; Washington University (WUSTL); University of Leeds; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; United States Department of Energy (DOE); Argonne National Laboratory; University College Dublin; Ollscoil na Gaillimhe-University of Galway; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Columbia University; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Utah System of Higher Education; University of Utah; University of Chicago; Iowa State University; University of Iowa; Pittsburg State University; Galway Mayo Institute of Technology; European Southern Observatory; University of Chicago; Cork Institute of Technology; National Radio Astronomy Observatory (NRAO); New Mexico Institute of Mining Technology; University of Alabama System; University of Alabama Tuscaloosa; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Los Angeles; Max Planck Society; Yerevan Physics Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg; Humboldt University of Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Durham University; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Dublin Institute for Advanced Studies; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Charles University Prague; Ruhr University Bochum; University of Namibia; Jagiellonian University; Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; University of Leeds; University of Adelaide; Nicolaus Copernicus University; Autonomous University of Barcelona; University of Padua; Instituto de Astrofisica de Canarias; University of Lodz; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Siena; Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; University of Wurzburg; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); University of Udine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of California System; University of California Davis; University of Turku; Bulgarian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); ICREA; University of Pisa; University of California System; University of California Santa Cruz; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Dortmund University of Technology	Beilicke, M (corresponding author), Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA.	beilicke@physics.wustl.edu; krawcz@wuphys.wustl.edu; cwalker@aoc.nrao.edu; phardee@bama.ua.edu; martin.raue@mpi-hd.mpg.de; mazin@ifae.es; robert.wagner@mpp.mpg.de	Ribó, Marc/B-3579-2015; Barrio, Juan A/L-3227-2014; Ninkovic, Jelena/G-5005-2012; Niemiec, Jacek/R-5432-2017; Kildea, John/AFR-7973-2022; CAMARA, Mamadou Bailo/F-5785-2019; Dominguez, Alberto/J-4429-2016; Horns, Dieter/ABE-9516-2020; Cortina, Juan/C-2783-2017; Torres, Diego F./O-9422-2016; Costado, M. Teresa/ABB-2702-2020; Herrero, Artemio/H-7312-2015; Fontaine, Gerard/D-6420-2014; Temnikov, Petar P./L-6999-2016; Otte, Adam Nepomuk/L-4638-2019; Cui, Wei/Y-3279-2019; Satalecka, Konstancja/AAT-1309-2020; Jung-Richardt, Ira/AAT-8884-2020; Bretz, Thomas/AAK-8726-2020; Venter, Christo/E-6884-2011; Bosch-Ramon, Valenti/E-5274-2016; de Ona Wilhelmi, Emma/U-5587-2017; Olaizola, Abelardo Moralejo/M-2916-2014; Mannheim, Karl/F-6705-2012; Katz, Uli F/E-1925-2013; Delgado, Carlos/K-7587-2014; Hadasch, Daniela/N-7819-2016; Weinstein, Amanda/D-1445-2019; Drury, Luke O'C/B-1916-2017; Nieto, Daniel/J-7250-2015; Mazin, Daniel/N-8038-2016; Backes, Michael/N-5126-2016; González, María Victoria Fonseca/E-8093-2019; Torres, Diego F./AAF-7931-2019; Katarzyński, Krzysztof/G-4528-2014; Rico, Javier/K-8004-2014; Gaug, Markus/L-2340-2014; van Eldik, Christopher/C-3901-2013; Horns, Dieter/C-9727-2011; Fernández, Ester/K-9734-2014; Font, Lluís/L-4197-2014; Covino, Stefano/AAQ-5188-2021; Maneva, Galina M/L-7120-2016; Daniel, Michael K/A-2903-2010; Khangulyan, Dmitry/AAH-1940-2019; Anton, Gisela/C-4840-2013; González, Jose Luis Contreras/K-7255-2014; Fernandez, Enrique/L-5387-2014; Torres, Diego F/ABD-7940-2020; Braun, Isabel V/C-9373-2012; López-Moya, Marcos/L-2304-2014; Marcowith, Alexandre/ABH-1254-2020; Coma, Pol Bordas/AAA-2332-2020; Bernardini, Elisa/AAA-4810-2020; Reichardt, Ignasi/P-7478-2016; Bastieri, Denis/AAC-5917-2020; Doro, Michele/F-9458-2012; Tjus, Julia/G-8145-2012; Gonzalez, María Victoria Fonseca MV Fonseca/I-2004-2015; Moderski, Rafal/ABG-8777-2020; Djannati-Atai, Arache/ABA-9249-2021; Pohl, Martin/P-4920-2017; Ly, Chun/AAV-7439-2021; Bulik, Tomasz/AAJ-6742-2020; Gonzalez, Josefa Becerra/AAH-6071-2019; Barres de Almeida, Ulisses/V-4025-2019; Antoranz, Pedro/H-5095-2015; Cesarini, Andrea/AAS-9877-2020; Pühlhofer, Gerd/Q-2336-2018; Moldon, Javier/GPP-0784-2022; Martinez Rodriguez, Manel/C-2539-2017; Lombardi, Saverio/Q-2818-2018; Moulin, Emmanuel/B-5959-2017; Miranda, Jose Miguel/F-2913-2013; ZANIN, Roberta/B-2316-2018	Ribó, Marc/0000-0002-9931-4557; Barrio, Juan A/0000-0002-0965-0259; Niemiec, Jacek/0000-0001-6036-8569; Kildea, John/0000-0002-7084-1425; Dominguez, Alberto/0000-0002-3433-4610; Horns, Dieter/0000-0003-1945-0119; Cortina, Juan/0000-0003-4576-0452; Torres, Diego F./0000-0002-1522-9065; Costado, M. Teresa/0000-0002-2672-4061; Fontaine, Gerard/0000-0002-6443-5025; Temnikov, Petar P./0000-0002-9559-3384; Otte, Adam Nepomuk/0000-0002-5955-6383; Cui, Wei/0000-0002-6324-5772; Satalecka, Konstancja/0000-0002-7669-266X; Bretz, Thomas/0000-0002-3800-5531; Venter, Christo/0000-0002-2666-4812; Bosch-Ramon, Valenti/0000-0002-6043-5079; de Ona Wilhelmi, Emma/0000-0002-5401-0744; Olaizola, Abelardo Moralejo/0000-0002-1344-9080; Katz, Uli F/0000-0002-7063-4418; Delgado, Carlos/0000-0002-7014-4101; Hadasch, Daniela/0000-0001-8663-6461; Weinstein, Amanda/0000-0002-2126-2419; Drury, Luke O'C/0000-0002-9257-2270; Nieto, Daniel/0000-0003-3343-0755; Mazin, Daniel/0000-0002-2010-4005; Backes, Michael/0000-0002-9326-6400; González, María Victoria Fonseca/0000-0003-2235-0725; Torres, Diego F./0000-0002-1522-9065; Katarzyński, Krzysztof/0000-0002-8806-4863; Rico, Javier/0000-0003-4137-1134; Gaug, Markus/0000-0001-8442-7877; van Eldik, Christopher/0000-0001-9669-645X; Font, Lluís/0000-0003-2109-5961; Covino, Stefano/0000-0001-9078-5507; Maneva, Galina M/0000-0002-5959-4179; Daniel, Michael K/0000-0002-8053-7910; Khangulyan, Dmitry/0000-0002-7576-7869; Anton, Gisela/0000-0003-2039-4724; González, Jose Luis Contreras/0000-0001-7282-2394; Fernandez, Enrique/0000-0002-6405-9488; Braun, Isabel V/0000-0002-9389-0502; López-Moya, Marcos/0000-0002-8791-7908; Marcowith, Alexandre/0000-0002-3971-0910; Coma, Pol Bordas/0000-0002-0266-8536; Bernardini, Elisa/0000-0003-3108-1141; Reichardt, Ignasi/0000-0003-3694-3820; Bastieri, Denis/0000-0002-6954-8862; Doro, Michele/0000-0001-9104-3214; Tjus, Julia/0000-0002-1748-7367; Gonzalez, María Victoria Fonseca MV Fonseca/0000-0003-2235-0725; Moderski, Rafal/0000-0002-8663-3882; Pohl, Martin/0000-0001-7861-1707; Ly, Chun/0000-0002-4245-2318; Gonzalez, Josefa Becerra/0000-0002-6729-9022; Barres de Almeida, Ulisses/0000-0001-7909-588X; Antoranz, Pedro/0000-0002-3015-3601; Cesarini, Andrea/0000-0002-8611-8610; Ninkovic, Jelena/0000-0003-1523-3635; Rowell, Gavin/0000-0002-9516-1581; Hsu, Ching-Cheng/0000-0001-9406-2023; Martinez Rodriguez, Manel/0000-0002-9763-9155; De Lotto, Barbara/0000-0003-3624-4480; Persic, Massimo/0000-0003-1853-4900; Lombardi, Saverio/0000-0002-6336-865X; Sikora, Marek/0000-0003-1667-7334; Rudak, Bronislaw/0000-0003-0452-3805; Hermann, German/0000-0002-4595-1032; Oya, Igor/0000-0002-3881-9324; Turini, Nicola/0000-0002-9395-5230; Sobczynska, Dorota/0000-0003-4973-7903; Prandini, Elisa/0000-0003-4502-9053; Moulin, Emmanuel/0000-0003-4007-0145; Bonnoli, Giacomo/0000-0003-2464-9077; Punch, Michael/0000-0002-4710-2165; Clapson, Andre-Claude/0000-0002-6327-1073; De Angelis, Alessandro/0000-0002-3288-2517; Puchades, Neus/0000-0001-7816-8119; Martineau-Huynh, Olivier/0000-0001-5334-8244; Sanchez-Conde, Miguel/0000-0002-3849-9164; LA BARBERA, ANTONINO/0000-0002-5880-8913; Dazzi, Francesco/0000-0001-5409-6544; Wissel, Stephanie/0000-0003-0569-6978; de los Reyes Lopez, Raquel/0000-0003-0485-9552; Spanier, Felix/0000-0001-6802-4744; Bose, Debanjan/0000-0003-1071-5854; Rieger, Frank/0000-0003-1334-2993; Bednarek, Wlodek/0000-0003-0605-108X; Quinn, John/0000-0002-4855-2694; Stamerra, Antonio/0000-0002-9430-5264; Paredes, Josep M./0000-0002-1566-9044; Miranda, Jose Miguel/0000-0002-1472-9690; Zdziarski, Andrzej/0000-0002-0333-2452; ZANIN, Roberta/0000-0001-6320-1801; Kneiske, Tanja M./0000-0002-3210-6200; Sitarek, Julian/0000-0002-1659-5374; Tibolla, Omar/0000-0002-9074-0584; Kieda, David/0000-0003-4785-0101; leonardo, elvira/0000-0003-0271-7673; Lang, Mark/0000-0003-4641-4201; Chadwick, Paula/0000-0002-1468-2685; Hui, Chiumun/0000-0002-0468-6025	ETH [TH 34/043]; Polish MniSzW [N N203 390834]; Young Investigators Program of the Helmholtz Gemeinschaft; U.S. Department of Energy; NSF; Smithsonian Institution; Natural Sciences and Engineering Research Council of Canada; Science Foundation Ireland; STFC, U.K; STFC [ST/F002963/1, ST/G003084/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002963/1, PP/E001319/1, ST/G003084/1] Funding Source: researchfish; ICREA Funding Source: Custom; Direct For Mathematical & Physical Scien [0908040] Funding Source: National Science Foundation	ETH(ETH Zurich); Polish MniSzW; Young Investigators Program of the Helmholtz Gemeinschaft; U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); STFC, U.K(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was also supported by ETH research grant TH 34/043, the Polish MniSzW grant N N203 390834, and the Young Investigators Program of the Helmholtz Gemeinschaft. VERITAS: This research is supported by grants from the U.S. Department of Energy, NSF, the Smithsonian Institution, the Natural Sciences and Engineering Research Council of Canada, Science Foundation Ireland, and the STFC in the U.K. We acknowledge the excellent work of the technical support staff at the Fred Lawrence Whipple Observatory and the collaborating institutions in the construction and operation of the instrument. VLBA: The Very Long Baseline Array is operated by the National Radio Astronomy Observatory, a facility of NSF, operated under cooperative agreement by Associated Universities, Inc.	Acciari VA, 2008, ASTROPHYS J, V679, P397, DOI 10.1086/587458; Acciari VA, 2008, ASTROPHYS J, V679, P1427, DOI 10.1086/587736; Aharonian F, 2006, SCIENCE, V314, P1424, DOI 10.1126/science.1134408; Aharonian F, 2006, ASTRON ASTROPHYS, V457, P899, DOI 10.1051/0004-6361:20065351; Aharonian F, 2003, ASTRON ASTROPHYS, V403, pL1, DOI 10.1051/0004-6361:20030372; Albert J, 2008, ASTROPHYS J, V674, P1037, DOI 10.1086/525270; Albert J, 2008, ASTROPHYS J LETT, V685, pL23, DOI 10.1086/592348; Baltz EA, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.023514; Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; Cheung CC, 2007, ASTROPHYS J, V663, pL65, DOI 10.1086/520510; Gaidos JA, 1996, NATURE, V383, P319, DOI 10.1038/383319a0; GEBHARDT K, 2009, ASTROPHYS J IN PRESS; Georganopoulos M, 2005, ASTROPHYS J, V634, pL33, DOI 10.1086/498714; Harris DE, 2009, ASTROPHYS J, V699, P305, DOI 10.1088/0004-637X/699/1/305; Harris DE, 2006, ASTROPHYS J, V640, P211, DOI 10.1086/500081; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; Kovalev YY, 2007, ASTROPHYS J, V668, pL27, DOI 10.1086/522603; Lenain JP, 2008, ASTRON ASTROPHYS, V478, P111, DOI 10.1051/0004-6361:20077995; Ly C, 2007, ASTROPHYS J, V660, P200, DOI 10.1086/512846; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; McKinney JC, 2006, MON NOT R ASTRON SOC, V368, P1561, DOI 10.1111/j.1365-2966.2006.10256.x; NAPIER PJ, 1994, P IEEE, V82, P658, DOI 10.1109/5.284733; Neronov A, 2007, ASTROPHYS J, V671, P85, DOI 10.1086/522199; Owen FN, 2000, ASTROPHYS J, V543, P611, DOI 10.1086/317151; Perlman ES, 2007, ASTROPHYS J, V663, P808, DOI 10.1086/518781; Pfrommer C, 2003, ASTRON ASTROPHYS, V407, pL73, DOI 10.1051/0004-6361:20031088; Reimer A, 2004, ASTRON ASTROPHYS, V419, P89, DOI 10.1051/0004-6361:20034231; Rieger FM, 2008, INT J MOD PHYS D, V17, P1569, DOI 10.1142/S0218271808013169; Tavecchio F, 2008, MON NOT R ASTRON SOC, V385, pL98, DOI 10.1111/j.1745-3933.2008.00441.x; Walker GAH, 2008, J PHYS CONF SER, V118, DOI 10.1088/1742-6596/118/1/012013; Wilson AS, 2002, ASTROPHYS J, V568, P133, DOI 10.1086/338887	31	172	172	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					444	448		10.1126/science.1175406	http://dx.doi.org/10.1126/science.1175406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574351	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000268255100048
J	Declercq, W; Vanden Berghe, T; Vandenabeele, P				Declercq, Wim; Vanden Berghe, Tom; Vandenabeele, Peter			RIP Kinases at the Crossroads of Cell Death and Survival	CELL			English	Review							NECROSIS-FACTOR RECEPTOR-1; KAPPA-B ACTIVATION; TNF-ALPHA; PATHWAY; IDENTIFICATION; NECROSTATINS; DOMAIN; SIGNAL	Protein kinases of the receptor interacting protein (RIP) family collaborate with death receptor proteins to regulate cell death. Recent studies (Cho et al., 2009; He et al., 2009; Zhang et al., 2009) reveal that the RIP3 kinase functions with RIP1 at the crossroads of apoptosis, necroptosis, and cell survival.	[Declercq, Wim; Vanden Berghe, Tom; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; [Declercq, Wim; Vanden Berghe, Tom; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.ugent.be	Vandenabeele, Peter/AAD-5793-2022; Vanden Berghe, Tom/C-4916-2009; Vandenabeele, Peter/C-8597-2009; Berghe, Tom Vanden/N-2902-2019	Vandenabeele, Peter/0000-0002-6669-8822; Vanden Berghe, Tom/0000-0002-1633-0974; Berghe, Tom Vanden/0000-0002-1633-0974	VIB; UGhent; FP6 ApopTrain [MRTN-CT-035624]; FP6 Epistem [LSHB-CT-2005-019067]; Apo-Sys [FP7-200767, IAP 6/18]; FWO-Vlaanderen [3G.0218.06, G.0226.09];  [BOF-GOA-12.0505.02]	VIB; UGhent; FP6 ApopTrain; FP6 Epistem; Apo-Sys(European CommissionEuropean Commission Joint Research Centre); FWO-Vlaanderen(FWO); 	We thank A. Bredan and M. Bertrand. P. V. is supported by VIB, UGhent, FP6 ApopTrain, MRTN-CT-035624; FP6 Epistem, LSHB-CT-2005-019067; Apo-Sys FP7-200767, IAP 6/18, FWO-Vlaanderen (3G.0218.06 and G.0226.09), and BOF-GOA-12.0505.02. T. V. B. holds a grant of the FWO and P. V. holds a Methusalem grant.	Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Vandenabeele P, 2008, TRENDS BIOCHEM SCI, V33, P352, DOI 10.1016/j.tibs.2008.05.007; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	18	360	384	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					229	232		10.1016/j.cell.2009.07.006	http://dx.doi.org/10.1016/j.cell.2009.07.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632174	Green Submitted, Bronze			2022-12-28	WOS:000268277000006
J	Dunn, A				Dunn, Andrew			Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WARFARIN		Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Sch Med, New York, NY USA.							Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-4	10.7326/0003-4819-151-2-200907210-02004	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620148				2022-12-28	WOS:000268605300012
J	Andreasen, R; Sharma, M				Andreasen, Rasmus; Sharma, Mukul			Comment on "Neodymium-142 Evidence for Hadean Mafic Crust"	SCIENCE			English	Editorial Material							ISOTOPE FRACTIONATION; MASS-SPECTROMETRY; TERRESTRIAL ROCKS; DIFFERENTIATION; MANTLE; EARTH	O'Neil et al. (Reports, 26 September 2008, p. 1828) presented neodymium-142 data for rocks from northern Quebec, Canada, and suggested that these rocks may represent the oldest preserved crustal section on Earth. We argue that the age of the rocks is based on a spurious correlation between rocks that are probably not co-genetic and negative Nd-142 anomalies that may be the result of an analytical artifact.	[Andreasen, Rasmus] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Kensington SW7 2AZ, England; [Sharma, Mukul] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	Imperial College London; Dartmouth College	Andreasen, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Kensington SW7 2AZ, England.	r.andreasen@imperial.ac.uk	Andreasen, Rasmus/J-8837-2019	Andreasen, Rasmus/0000-0001-9737-1243				Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Andreasen R, 2004, GEOCHIM COSMOCHIM AC, V68, pA747; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Habfast K, 1998, INT J MASS SPECTROM, V176, P133, DOI 10.1016/S1387-3806(98)14030-7; MOORBATH S, 1986, CHEM GEOL, V57, P63, DOI 10.1016/0009-2541(86)90094-X; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; Sharma M, 2004, PRECAMBRIAN RES, V135, P315, DOI 10.1016/j.precamres.2004.09.003; Upadhyay D, 2008, J ANAL ATOM SPECTROM, V23, P561, DOI 10.1039/b715585a	12	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938								10.1126/science.1169604	http://dx.doi.org/10.1126/science.1169604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608899				2022-12-28	WOS:000268036600023
J	Charron, DJ				Charron, Dominique J.			Jean Dausset (1916-2009) OBITUARY	NATURE			English	Biographical-Item									[Charron, Dominique J.] Hop St Louis, Lab Jean Dausset, F-75010 Paris, France; [Charron, Dominique J.] Inst Univ Hematol, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Charron, DJ (corresponding author), Hop St Louis, Lab Jean Dausset, F-75010 Paris, France.	dominique.charron@sls.aphp.fr							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					338	338		10.1038/460338a	http://dx.doi.org/10.1038/460338a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606138				2022-12-28	WOS:000267979000026
J	Monaghan, TM; Thomas, JD; Goddard, W				Monaghan, Tanya M.; Thomas, James D.; Goddard, William			Picture quiz A painful rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWEETS-SYNDROME; CROHNS-DISEASE; ASSOCIATION		[Monaghan, Tanya M.] Univ Nottingham, Queens Med Ctr, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England; [Thomas, James D.] Queens Med Ctr, Dept Radiol, Nottingham NG7 2UH, England; [Goddard, William] Derby City Gen Hosp, Derby Digest Dis Ctr, Derby DE22 3NE, England	University of Nottingham; University of Nottingham; University of Nottingham	Monaghan, TM (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England.	tanyamonaghan@gmail.com		Monaghan, Tanya/0000-0001-7622-3997				BURROWS NP, 1995, CLIN EXP DERMATOL, V20, P279, DOI 10.1111/j.1365-2230.1995.tb01324.x; Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34; Cohen PR, 2007, INT J DERMATOL, V46, P106, DOI 10.1111/j.1365-4632.2006.02605.x; Cohen Philip R, 2002, Am J Clin Dermatol, V3, P117, DOI 10.2165/00128071-200203020-00005; Cohen PR, 2004, INT J DERMATOL, V43, P772, DOI 10.1111/j.1365-4632.2004.02197.x; Cohen PR, 2003, INT J DERMATOL, V42, P761, DOI 10.1046/j.1365-4362.2003.01891.x; Cohen PR, 2000, CLIN DERMATOL, V18, P265, DOI 10.1016/S0738-081X(99)00129-7; Decisier M, 2009, GUT, V58, P67, DOI 10.1136/gut.2008.156737; el-Azhary RA, 2008, MAYO CLIN PROC, V83, P1026, DOI 10.4065/83.9.1026; Foster Erina N, 2005, Clin Dev Immunol, V12, P145, DOI 10.1080/17402520500134254; Mustafa Nadia M, 2008, J Med Case Rep, V2, P221, DOI 10.1186/1752-1947-2-221; Rahier JF, 2005, ACTA GASTRO-ENT BELG, V68, P376; Rappaport A, 2001, DIS COLON RECTUM, V44, P1526, DOI 10.1007/BF02234611; SWEET RD, 1964, BRIT J DERMATOL, V76, P349, DOI 10.1111/j.1365-2133.1964.tb14541.x; Travis S, 1997, EUR J GASTROEN HEPAT, V9, P715, DOI 10.1097/00042737-199707000-00013; Vaz A, 2000, POSTGRAD MED J, V76, P713, DOI 10.1136/pmj.76.901.713	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2009	339								b2293	10.1136/bmj.b2293	http://dx.doi.org/10.1136/bmj.b2293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BV	19605450				2022-12-28	WOS:000268105000001
J	Hargreaves, DC; Horng, T; Medzhitov, R				Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan			Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation	CELL			English	Article							RNA-POLYMERASE-II; NF-KAPPA-B; BROMODOMAIN PROTEIN BRD4; P-TEFB; CHROMATIN MODIFICATIONS; ACETYLATION CODE; ACTIVATION; DROSOPHILA; GENOME; CELLS	Most inducible transcriptional programs consist of primary and secondary response genes (PRGs and SRGs) that differ in their kinetics of expression and in their requirements for new protein synthesis and chromatin remodeling. Here we show that many PRGs, in contrast to SRGs, have preassembled RNA polymerase II (Pol II) and positive histone modifications at their promoters in the basal state. Pol II at PRGs generates low levels of full-length unspliced transcripts but fails to make mature, protein-coding transcripts in the absence of stimulation. Induction of PRGs is controlled at the level of transcriptional elongation and mRNA processing, through the signal-dependent recruitment of P-TEFb. P-TEFb is in turn recruited by the bromodomain-containing protein Brd4, which detects H4K5/8/12Ac inducibly acquired at PRG promoters. Our findings suggest that the permissive structure of PRGs both stipulates their unique regulation in the basal state by corepressor complexes and enables their rapid induction in multiple cell types.	[Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Hargreaves, Diana C.; Horng, Tiffany; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Horng, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	thorng@hsph.harvard.edu; ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute; NIH [AI046688-08, U01 AI061360]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R37AI046688, U01AI061360] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. Klaus Rajewsky for NEMOflox/flox cells, Dr. Steven Smale for discussions and communication of unpublished results, and Drs. Tian Chi, David Schatz, and Sankar Ghosh for helpful discussions and suggestions. This work was supported by the Howard Hughes Medical Institute and grants from the NIH (AI046688-08 and U01 AI061360).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; KODAMA T, 2008, TIME COURSE GENE EXP; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lis JT, 2000, GENE DEV, V14, P792; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nishiyama A, 2008, FEBS LETT, V582, P1501, DOI 10.1016/j.febslet.2008.03.044; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sharma M, 2007, J BIOL CHEM, V282, P20887, DOI 10.1074/jbc.M701420200; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	47	491	515	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					129	145		10.1016/j.cell.2009.05.047	http://dx.doi.org/10.1016/j.cell.2009.05.047			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596240	Bronze, Green Accepted			2022-12-28	WOS:000267848600020
J	Bosch, X; Poch, E; Grau, JM				Bosch, Xavier; Poch, Esteban; Grau, Josep M.			Current Concepts: Rhabdomyolysis and Acute Kidney Injury.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-RENAL-FAILURE; TRAUMATIC RHABDOMYOLYSIS; FLUID RESUSCITATION; LIPID-PEROXIDATION; CREATINE-KINASE; MYOGLOBIN; MANNITOL; MECHANISMS; SERUM; PATHOPHYSIOLOGY		[Bosch, Xavier; Grau, Josep M.] Univ Barcelona, Muscle Res Unit, Dept Internal Med, Hosp Clin,Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Poch, Esteban] Univ Barcelona, Dept Nephrol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Grau, JM (corresponding author), Univ Barcelona, Muscle Res Unit, Dept Internal Med, Hosp Clin,Inst Invest Biomed August Pi & Sunyer, Villarroel 170, E-08036 Barcelona, Spain.	epoch@clinic.ub.es; jmgrau@clinic.ub.es	Guthoff, Martina/D-3960-2018	Guthoff, Martina/0000-0002-4294-980X	Fondo Investigaciones Sanatarias [FIS 05/0015, FIS 04/0464]; Instituto de Salud Carlos III; Red Renal de Investigacion Cooperativa [ISCIII-Retic- RD06]; Suport Grup de Recerca [05/300]; Center for Biomedical Research on Rare Diseases; Instituto de Salud Carlos III, Barcelona	Fondo Investigaciones Sanatarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Red Renal de Investigacion Cooperativa; Suport Grup de Recerca; Center for Biomedical Research on Rare Diseases; Instituto de Salud Carlos III, Barcelona(Instituto de Salud Carlos III)	Supported by grants from Fondo Investigaciones Sanatarias (FIS 05/0015, to Dr. Poch; and FIS 04/0464, to Dr. Grau), Instituto de Salud Carlos III, Red Renal de Investigacion Cooperativa (ISCIII-Retic- RD06, to Dr. Poch), Suport Grup de Recerca (05/300, to Dr. Grau), and the Center for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III, Barcelona (to Dr. Grau).	AKMAL M, 1986, J CLIN ENDOCR METAB, V63, P137, DOI 10.1210/jcem-63-1-137; Allison RC, 2003, AM J MED SCI, V326, P79, DOI 10.1097/00000441-200308000-00005; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; BETTER OS, 1990, NEW ENGL J MED, V322, P825; Better OS, 1997, KIDNEY INT, V52, P886, DOI 10.1038/ki.1997.409; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Brown CVR, 2004, J TRAUMA, V56, P1191, DOI 10.1097/01.TA.0000130761.78627.10; Cho YS, 2007, EMERG MED J, V24, P276, DOI 10.1136/emj.2006.043265; CORWIN HL, 1984, ARCH INTERN MED, V144, P981, DOI 10.1001/archinte.144.5.981; de Meijer AR, 2003, INTENS CARE MED, V29, P1121, DOI 10.1007/s00134-003-1800-5; Evans Kimberley J, 2005, J Intensive Care Med, V20, P272, DOI 10.1177/0885066605278969; FERNANDEZSOLA J, 1988, MED CLIN-BARCELONA, V90, P199; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Giannoglou GD, 2007, EUR J INTERN MED, V18, P90, DOI 10.1016/j.ejim.2006.09.020; GROSSMAN RA, 1974, NEW ENGL J MED, V291, P807, DOI 10.1056/NEJM197410172911601; Gunal AI, 2004, J AM SOC NEPHROL, V15, P1862, DOI 10.1097/01.asn.0000129336.09976.73; Hatamizadeh P, 2006, AM J KIDNEY DIS, V47, P428, DOI 10.1053/j.ajkd.2005.11.019; Heyman SN, 1997, EXP NEPHROL, V5, P210; Ho AMH, 2001, J TRAUMA, V51, P173, DOI 10.1097/00005373-200107000-00033; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Homsi E, 1997, RENAL FAILURE, V19, P283, DOI 10.3109/08860229709026290; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Kellum, 1997, Crit Care, V1, P53, DOI 10.1186/cc103; KNOCHEL JP, 1982, ANNU REV MED, V33, P435, DOI 10.1146/annurev.me.33.020182.002251; Lameire N, 2005, LANCET, V365, P417; Melli G, 2005, MEDICINE, V84, P377, DOI 10.1097/01.md.0000188565.48918.41; Mikkelsen TS, 2005, ACTA ANAESTH SCAND, V49, P859, DOI 10.1111/j.1399-6576.2005.00577.x; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; OH MS, 1993, NEPHRON, V63, P255, DOI 10.1159/000187206; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Richards JR, 2000, J EMERG MED, V19, P51, DOI 10.1016/S0736-4679(00)00180-3; RON D, 1984, ARCH INTERN MED, V144, P277, DOI 10.1001/archinte.144.2.277; Ronco C, 2005, CRIT CARE, V9, P141, DOI 10.1186/cc3055; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Shimazu T, 1997, J TRAUMA, V42, P641, DOI 10.1097/00005373-199704000-00010; SIEB JP, 2004, MYOLOGY BASIC CLIN, P1677; Simerville A, 2006, AM FAM PHYSICIAN, V74, P1096; Szpirt WM, 1997, J CARDIOVASC SURG, V38, P557; TEIN I, 1992, HDB CLIN NEUROLOGY, V62, P553; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; VEENSTRA J, 1994, NEPHROL DIAL TRANSPL, V9, P637, DOI 10.1093/ndt/9.6.637; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WAKABAYASHI Y, 1994, INTENS CARE MED, V20, P109, DOI 10.1007/BF01707664; WARD MM, 1988, ARCH INTERN MED, V148, P1553, DOI 10.1001/archinte.148.7.1553; Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053; WOODROW G, 1995, RENAL FAILURE, V17, P467, DOI 10.3109/08860229509037610; WROGEMANN K, 1976, LANCET, V1, P672; ZAGER RA, 1989, LAB INVEST, V60, P619; ZAGER RA, 1992, J CLIN INVEST, V89, P989, DOI 10.1172/JCI115682; ZAGER RA, 1989, AM J PHYSIOL, V256, pF446, DOI 10.1152/ajprenal.1989.256.3.F446; ZAGER RA, 1991, J AM SOC NEPHROL, V2, P848	52	753	811	6	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					62	72		10.1056/NEJMra0801327	http://dx.doi.org/10.1056/NEJMra0801327			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571284				2022-12-28	WOS:000267533100010
J	Hao, HX; Khalimonchuk, O; Schraders, M; Dephoure, N; Bayley, JP; Kunst, H; Devilee, P; Cremers, CWRJ; Schiffman, JD; Bentz, BG; Gygi, SP; Winge, DR; Kremer, H; Rutter, J				Hao, Huai-Xiang; Khalimonchuk, Oleh; Schraders, Margit; Dephoure, Noah; Bayley, Jean-Pierre; Kunst, Henricus; Devilee, Peter; Cremers, Cor W. R. J.; Schiffman, Joshua D.; Bentz, Brandon G.; Gygi, Steven P.; Winge, Dennis R.; Kremer, Hannie; Rutter, Jared			SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; COMPLEX-II; FLAVOPROTEIN SUBUNIT; MUTATIONS; PREVALENCE; SEQUENCE; DISEASES; CARRIER; FAD	Mammalian mitochondria contain about 1100 proteins, nearly 300 of which are uncharacterized. Given the well-established role of mitochondrial defects in human disease, functional characterization of these proteins may shed new light on disease mechanisms. Starting with yeast as a model system, we investigated an uncharacterized but highly conserved mitochondrial protein (named here Sdh5). Both yeast and human Sdh5 interact with the catalytic subunit of the succinate dehydrogenase (SDH) complex, a component of both the electron transport chain and the tricarboxylic acid cycle. Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor). Germline loss-of-function mutations in the human SDH5 gene, located on chromosome 11q13.1, segregate with disease in a family with hereditary paraganglioma, a neuroendocrine tumor previously linked to mutations in genes encoding SDH subunits. Thus, a mitochondrial proteomics analysis in yeast has led to the discovery of a human tumor susceptibility gene.	[Hao, Huai-Xiang; Khalimonchuk, Oleh; Winge, Dennis R.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Schiffman, Joshua D.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Schiffman, Joshua D.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Bentz, Brandon G.] Univ Utah, Sch Med, Dept Surg, Div Otolaryngol Head & Neck Surg, Salt Lake City, UT 84112 USA; [Schraders, Margit; Kunst, Henricus; Cremers, Cor W. R. J.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Donders Ctr Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bayley, Jean-Pierre; Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu	Cremers, C.W.R.J./L-4254-2015; Kunst, Henricus P.M./J-6456-2012; DEVILEE, PETER/ABR-2140-2022; Dephoure, Noah/N-7818-2014; Schraders, Margit/A-1607-2016; Khalimonchuk, Oleh/AAM-1194-2021; Kremer, Hannie/F-5126-2010; Devilee, Peter/GXV-8005-2022	Kunst, Henricus P.M./0000-0003-1162-6394; Dephoure, Noah/0000-0001-5802-2657; Khalimonchuk, Oleh/0000-0002-3972-8678; Kremer, Hannie/0000-0002-0841-8693; 	NIH [DK071962, GM087346]; Dutch Cancer Society [UL 2002-2723]; European Union 6th Framework Program [518200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071962, R56DK071962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); European Union 6th Framework Program(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rutter laboratory for helpful discussions; the J. Shaw and J. Kaplan laboratories for antibodies and technical assistance; J.-M. Heo, T. Smith, E. Taylor, E. van Wijk, S. van der Velde-Visser, and C. Beumer for technical assistance; B. Lemire for the antibodies to Sdh1 and Sdh2; C. Outten for the antiserum to Tim10; and J. Lindsley for critical reading of the manuscript. This work was funded by NIH grants DK071962 and GM087346 (to J.R.), by the Dutch Cancer Society (grant UL 2002-2723), and by the European Union 6th Framework Program, Project No. 518200 (to P.D.). J.R. and H.H. plan to file a patent related to genetic testing of the hSDH5 gene.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; CASCON A, 2009, HORM METAB RES  0402; CHAPMAN KB, 1992, GENE, V118, P131, DOI 10.1016/0378-1119(92)90260-V; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; GHEZZI D, 2009, NAT GENET       0524; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; McWhinney SR, 2007, NEW ENGL J MED, V357, P1054, DOI 10.1056/NEJMc071191; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; Robinson KM, 1996, J BIOL CHEM, V271, P4061; Romano JD, 2005, J BACTERIOL, V187, P940, DOI 10.1128/JB.187.3.940-948.2005; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; VANBAARS F, 1982, HUM GENET, V60, P305, DOI 10.1007/BF00569208; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	28	522	541	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1139	1142		10.1126/science.1175689	http://dx.doi.org/10.1126/science.1175689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628817	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000269382300044
J	Tiihonen, J; Lonnqvist, J; Wahlbeck, K; Klaukka, T; Niskanen, L; Tanskanen, A; Haukka, J				Tiihonen, Jari; Lonnqvist, Jouko; Wahlbeck, Kristian; Klaukka, Timo; Niskanen, Leo; Tanskanen, Antti; Haukka, Jari			11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)	LANCET			English	Article							ANTIPSYCHOTIC-DRUGS; NATIONWIDE COHORT; CLOZAPINE; DIAGNOSES; DISORDER; SUICIDE; TRIAL	Background The introduction of second-generation antipsychotic drugs during the 1990s is widely believed to have adversely affected mortality of patients with schizophrenia. Our aim was to establish the long-term contribution of antipsychotic drugs to mortality in such patients. Methods Nationwide registers in Finland were used to compare the cause-specific mortality in 66 881 patients versus the total population (5.2 million) between 1996, and 2006, and to link these data with the use of antipsychotic drugs. We measured the all-cause mortality of patients with schizophrenia in outpatient care during current and cumulative exposure to any antipsychotic drug versus no use of these drugs, and exposure to the six most frequently used antipsychotic drugs compared with perphenazine use. Findings Although the proportional use of second-generation antipsychotic drugs rose from 13% to 64% during follow-up the gap in life expectancy between patients with schizophrenia and the general popullation did not widen between 1996 (25 years), and 2006 (22.5 years). Compared with current use of perphenazine, the highest risk for overall mortality was recorded for quetiapine (adjusted hazard ratio [HR] 1.41, 95% CI 1.09-1.82), and the lowest risk for clozapine (0.74, 0.60-0.91; p=0.0045 for the difference between clozapine vs perphenazine, and p<0.0001 for an other antipsychotic drugs). Long-term cumulative exposure (7-11 years) to any antipsychotic treatment was associated with lower mortality than was no drug use (0.81, 0.77-0.84). In patients with one or more filled prescription for an antipsychotic drug, an inverse relation between mortality and duration of cumulative use was noted (HR for trend per exposure year 0.991; 0.985-0.997). Interpretation Long-term treatment with antipsychotic drugs is associated with lower mortality compared with no antipsychotic use. Second-generation drugs are a highly heterogeneous group, and clozapine seems to be associated with a substantially lower mortality than any other antipsychotics. Restrictions on the use of clozapine should be reassessed.	[Tiihonen, Jari] Univ Kuopio, Dept Forens Psychiat, FIN-70240 Kuopio, Finland; [Tiihonen, Jari] Niuvanniemi Hosp, Dept Clin Physiol, Kuopio, Finland; [Niskanen, Leo] Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland; [Tiihonen, Jari; Niskanen, Leo] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Tiihonen, Jari; Niskanen, Leo] Univ Helsinki, Cent Hosp, SF-00180 Helsinki, Finland; [Tiihonen, Jari; Lonnqvist, Jouko; Tanskanen, Antti; Haukka, Jari] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Wahlbeck, Kristian] Natl Res & Dev Ctr Welf & Hlth STAKES, Helsinki, Finland; [Klaukka, Timo] Social Insurance Inst Finland, Helsinki, Finland; [Wahlbeck, Kristian] Vaasa Cent Hosp, Psychiat Unit, Vaasa, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Vaasa Central Hospital	Tiihonen, J (corresponding author), Univ Kuopio, Dept Forens Psychiat, Niuvanniemi Hosp, FIN-70240 Kuopio, Finland.	jari.tiihonen@niuva.fi	Wahlbeck, Kristian/F-8394-2011; Tiihonen, Jari/G-3078-2012; Haukka, Jari/G-1484-2014	Wahlbeck, Kristian/0000-0003-3754-3933; Tiihonen, Jari/0000-0002-0400-6798; Haukka, Jari/0000-0003-1450-6208	Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland)	Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland)	This study was supported by funding from the Annual EVO Financing (special government subsidies from the Ministry of Health and Welfare, Finland). The researchers were independent from the funder. We thank Simo Pelanteri (STAKES information) for his work with different registers in selection of and merging of data for this project, and Aija Rasanen for secretarial assistance.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Anonym, ATC DDD INDEX 2006; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; ELIAS M, 2007, US TODAY        0503; Freedman R, 2005, NEW ENGL J MED, V353, P1286, DOI 10.1056/NEJMe058200; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Klein DF, 2007, JAMA-J AM MED ASSOC, V298, P333, DOI 10.1001/jama.298.3.333; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Makikyro T, 1998, EUR PSYCHIAT, V13, P57, DOI 10.1016/S0924-9338(98)80019-9; Mantel-Teeuwisse AK, 2001, J CLIN EPIDEMIOL, V54, P1181, DOI 10.1016/S0895-4356(01)00396-1; MCEVOY JP, 2006, AM J PSYCHIAT, V163, P463; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Parks J., MORBIDITY MORTALITY; R Development Core Team, 2005, LANG ENV STAT COMP; Ray WA, 2005, NEW ENGL J MED, V353, P2319, DOI 10.1056/NEJMp058267; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Skrbo A, 1999, Med Arh, V53, P57; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; Toson B., 2003, NATL STAT METHODOL S, V33	27	830	848	3	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					620	627		10.1016/S0140-6736(09)60742-X	http://dx.doi.org/10.1016/S0140-6736(09)60742-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486TU	19595447				2022-12-28	WOS:000269222600022
J	Avorn, J; Schneeweiss, S				Avorn, Jerry; Schneeweiss, Sebastian			Managing Drug-Risk Information - What to Do with All Those New Numbers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Avorn, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X				AVORN J, 1986, JAMA-J AM MED ASSOC, V255, P357, DOI 10.1001/jama.255.3.357; Avorn J, 2005, POWERFUL MED BENEFIT; Joffe MM, 2009, EPIDEMIOLOGY, V20, P523, DOI 10.1097/EDE.0b013e3181a82501; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Wood R, 1997, Popul Trends, P5	5	28	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					647	649		10.1056/NEJMp0905466	http://dx.doi.org/10.1056/NEJMp0905466			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482JX	19635948				2022-12-28	WOS:000268884100002
J	Callahan, D				Callahan, Daniel			Cost Control - Time to Get Serious	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		Hastings Ctr, Garrison, NY USA		Callahan, D (corresponding author), Hastings Ctr, Garrison, NY USA.							Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; *CONGR BUDG OFF, 2007, CONGR BUDG OFF PUBL, V2975; *CONGR BUDG OFF, 2008, EV COSTS BEN HLTH IN; KOLLMAN G, 2003, CRS REP C WASH DC CO, P1; White J, 2007, MILBANK Q, V85, P395, DOI 10.1111/j.1468-0009.2007.00494.x	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7								10.1056/NEJMp0905630	http://dx.doi.org/10.1056/NEJMp0905630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482JX	19641194				2022-12-28	WOS:000268884100004
J	Swanson, RC; Mosley, H; Sanders, D; Egilman, D; De Maeseneer, J; Chowdhury, M; Lanata, CF; Dearden, K; Bryant, M				Swanson, R. Chad; Mosley, Henry; Sanders, David; Egilman, David; De Maeseneer, Jan; Chowdhury, Mushtaque; Lanata, Claudio F.; Dearden, Kirk; Bryant, Malcolm			Call for global health-systems impact assessments	LANCET			English	Editorial Material							PROGRAMS		[Swanson, R. Chad; Mosley, Henry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sanders, David] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, Western Cape, South Africa; [Egilman, David] Brown Univ, Providence, RI 02912 USA; [De Maeseneer, Jan] Univ Ghent, B-9000 Ghent, Belgium; [Chowdhury, Mushtaque] BRAC Univ, Dhaka, Bangladesh; [Lanata, Claudio F.] Inst Nutr Res, Lima, Peru; [Dearden, Kirk] Boston Univ, Boston, MA 02215 USA; [Bryant, Malcolm] IDEAS Dev Inst, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of the Western Cape; Brown University; Ghent University; Bangladesh Rural Advancement Committee BRAC; BRAC University; Boston University	Swanson, RC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	ghsias@gmail.com						Atun RA, 2004, EUR J PUBLIC HEALTH, V14, P267, DOI 10.1093/eurpub/14.3.267; BENNETT S, 2003, SYSTEM WIDE EFFECTS; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Cole BL, 2005, AM J PREV MED, V28, P382, DOI 10.1016/j.amepre.2005.01.010; *HLTH SYST ACT NET, 2005, GLOB LEAD VIEWS HSS; Islam M., 2007, HLTH SYSTEMS ASSESSM; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Marchal B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000059; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; OECD, 2003, HARM DON PRACT EFF A; Oomman N., 2008, SEIZING OPPORTUNITY; Pfeiffer J, 2003, SOC SCI MED, V56, P725, DOI 10.1016/S0277-9536(02)00068-0; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; *WHO, 2008, HLTH SYST TOP; *WHO, 2009, TOOLKL MON HLTH SYST; GLOBAL HIV AIDS INIT	17	13	13	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					433	435		10.1016/S0140-6736(09)61212-5	http://dx.doi.org/10.1016/S0140-6736(09)61212-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19577289				2022-12-28	WOS:000268898400007
J	Malmstrom, J; Beck, M; Schmidt, A; Lange, V; Deutsch, EW; Aebersold, R				Malmstroem, Johan; Beck, Martin; Schmidt, Alexander; Lange, Vinzenz; Deutsch, Eric W.; Aebersold, Ruedi			Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans	NATURE			English	Article							TANDEM MASS-SPECTROMETRY; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; ABSOLUTE QUANTIFICATION; SALMONELLA-TYPHIMURIUM; TOMOGRAPHY; EXPRESSION; PEPTIDES; COMPLEX; MS	Mass-spectrometry-based methods for relative proteome quantification have broadly affected life science research. However, important research directions, particularly those involving mathematical modelling and simulation of biological processes, also critically depend on absolutely quantitative data-that is, knowledge of the concentration of the expressed proteins as a function of cellular state. Until now, absolute protein concentration measurements of a considerable fraction of the proteome (73%) have only been derived from genetically altered Saccharomyces cerevisiae cells(1), a technique that is not directly portable from yeast to other species. Here we present a mass-spectrometry-based strategy to determine the absolute quantity, that is, the average number of protein copies per cell in a cell population, for a large fraction of the proteome in genetically unperturbed cells. Applying the technology to the human pathogen Leptospira interrogans, a spirochete responsible for leptospirosis(2), we generated an absolute protein abundance scale for 83% of the mass-spectrometry-detectable proteome, from cells at different states. Taking advantage of the unique cellular dimensions of L. interrogans, we used cryo-electron tomography morphological measurements to verify, at the single-cell level, the average absolute abundance values of selected proteins determined by mass spectrometry on a population of cells. Because the strategy is relatively fast and applicable to any cell type, we expect that it will become a cornerstone of quantitative biology and systems biology.	[Malmstroem, Johan; Beck, Martin; Schmidt, Alexander; Lange, Vinzenz; Aebersold, Ruedi] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Schmidt, Alexander; Lange, Vinzenz; Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Deutsch, Eric W.; Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich	Aebersold, R (corresponding author), ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch	Beck, Martin/B-5589-2011; Schmidt, Alexander/C-5122-2009; Malmström, Johan A/B-7660-2009; Lange, Vinzenz/I-1077-2019; Schmidt, Alexander/D-6426-2011; Deutsch, Eric/AAF-5912-2020	Beck, Martin/0000-0002-7397-1321; Malmström, Johan A/0000-0002-2889-7169; Lange, Vinzenz/0000-0002-6442-9573; Schmidt, Alexander/0000-0002-3149-2381; Deutsch, Eric/0000-0001-8732-0928	ETH Zurich; Swiss National Science Foundation [31000-10767]; National Heart, Lung and Blood Institute; National Institutes of Health [N01-HV-28179]; ERC; Swedish Society for Medical Research; European Molecular Biology Organization; Marie Curie fellowship of the European Commission; Competence Center for Systems Physiology and Metabolic Diseases; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Swedish Society for Medical Research; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie fellowship of the European Commission(European Commission); Competence Center for Systems Physiology and Metabolic Diseases; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project has been funded in part by ETH Zurich, the Swiss National Science Foundation (grant 31000-10767), federal funds from the National Heart, Lung and Blood Institute, the National Institutes of Health (contract no. N01-HV-28179), SystemsX. ch, the Swiss initiative for systems biology, in part by the PROSPECTS (proteomics in time and space) European network of excellence, and with funds from the ERC project Proteomics V3.0' for R. A. J. M. was supported by a fellowship from the Swedish Society for Medical Research (SSMF), M. B. was supported by a long-term fellowship of the European Molecular Biology Organization and a Marie Curie fellowship of the European Commission, A. S. and V. L. were supported by the Competence Center for Systems Physiology and Metabolic Diseases. We thank O. Medalia and the electron microscopy facility of ETH Zurich (EMEZ) for support, and D. A. Haake for critical reading of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Briegel A, 2008, MOL MICROBIOL, V69, P30, DOI 10.1111/j.1365-2958.2008.06219.x; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Heller M, 2005, J PROTEOME RES, V4, P2273, DOI 10.1021/pr050193v; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; SHALIT I, 1989, ANTIMICROB AGENTS CH, V33, P788, DOI 10.1128/AAC.33.5.788; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SOSINSKY GE, 1992, P NATL ACAD SCI USA, V89, P4801, DOI 10.1073/pnas.89.11.4801; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150	33	335	338	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					762	U112		10.1038/nature08184	http://dx.doi.org/10.1038/nature08184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19606093	Green Accepted			2022-12-28	WOS:000268670300044
J	Mayer-Schonberger, V				Mayer-Schonberger, Viktor			Can We Reinvent the Internet?	SCIENCE			English	Editorial Material									Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 259772, Singapore	National University of Singapore	Mayer-Schonberger, V (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 259772, Singapore.	Viktor_MS@nus.edu.sg						Baldwin C. Y., 2000, DESIGN RULES POWER M; BAUMOL W, 2007, RP0708 AM ENT I PUBL; BENKLER Y, 2006, WEALTH NETWORKS; Burt R. L., 2005, BROKERAGE CLOSURE IN; Burt R. S, 1992, STRUCTURAL HOLES; DALRYMPLE J, 2009, CNET            0612; ELY A, 2008, INFORM WEEK     1220; Evans P, 2005, HARVARD BUS REV, V83, P96; Lakhani KR, 2003, RES POLICY, V32, P923, DOI 10.1016/S0048-7333(02)00095-1; Lerner J, 2002, J IND ECON, V50, P197, DOI 10.1111/1467-6451.00174; Loch CH, 1999, MANAGE SCI, V45, P160, DOI 10.1287/mnsc.45.2.160; MEYER D, 2009, ZDNET           0506; Page SE, 2007, DIFFERENCE POWER DIV; SALTZER JH, 1984, ACM T COMPUT SYST, V2, P277, DOI 10.1145/357401.357402; van Schewick Barbara, 2007, J TELECOMM HIGH TECH, V5, P329; Varian H., 1998, INFORM RULES STRATEG; Weber Steven, 2004, SUCCESS OPEN SOURCE; Zittrain JL, 2006, HARVARD LAW REV, V119, P1974; 2007, HUFFINGTON POST 1029; 2009, SEATTLE TIMES   0608	20	10	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					396	397		10.1126/science.1178418	http://dx.doi.org/10.1126/science.1178418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474AR	19628843				2022-12-28	WOS:000268255100027
J	Ozgul, A; Tuljapurkar, S; Benton, TG; Pemberton, JM; Clutton-Brock, TH; Coulson, T				Ozgul, Arpat; Tuljapurkar, Shripad; Benton, Tim G.; Pemberton, Josephine M.; Clutton-Brock, Tim H.; Coulson, Tim			The Dynamics of Phenotypic Change and the Shrinking Sheep of St. Kilda	SCIENCE			English	Article							CLIMATE-CHANGE; BODY-SIZE; QUANTITATIVE TRAIT; NATURAL-SELECTION; RAPID EVOLUTION; POPULATION; ENVIRONMENT; RESPONSES; GROWTH; TRENDS	Environmental change, including climate change, can cause rapid phenotypic change via both ecological and evolutionary processes. Because ecological and evolutionary dynamics are intimately linked, a major challenge is to identify their relative roles. We exactly decomposed the change in mean body weight in a free-living population of Soay sheep into all the processes that contribute to change. Ecological processes contribute most, with selection-the underpinning of adaptive evolution-explaining little of the observed phenotypic trend. Our results enable us to explain why selection has so little effect even though weight is heritable, and why environmental change has caused a decline in the body size of Soay sheep.	[Ozgul, Arpat; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Benton, Tim G.] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Imperial College London; Stanford University; University of Leeds; University of Edinburgh; University of Cambridge	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Coulson, Tim/AAL-8148-2021; Benton, Tim G/C-6493-2009; Pemberton, Josephine M/F-3100-2010; Ozgul, Arpat/K-2032-2012	Coulson, Tim/0000-0001-9371-9003; Benton, Tim G/0000-0002-7448-1973; Ozgul, Arpat/0000-0001-7477-2642; Tuljapurkar, Shripad/0000-0001-5549-4245	Natural Environment Research Council [NE/E015921/1]; National Institute of Aging [P01/AG/22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; Natural Environment Research Council [NER/A/S/2003/00461] Funding Source: researchfish; NERC [NE/E015921/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/E015921/1 and National Institute of Aging grant P01/AG/22500.	Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2008, AM NAT, V172, P599, DOI 10.1086/591693; Falconer D.S., 1960, INTRO QUANTITATIVE G, P1, DOI [10.2307/2985722, DOI 10.2307/2985722]; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gratten J, 2008, SCIENCE, V319, P318, DOI 10.1126/science.1151182; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Heywood JS, 2005, EVOLUTION, V59, P2287, DOI 10.1111/j.0014-3820.2005.tb00939.x; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kruuk LEB, 2003, TRENDS ECOL EVOL, V18, P207, DOI 10.1016/S0169-5347(03)00073-9; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z	25	227	231	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					464	467		10.1126/science.1173668	http://dx.doi.org/10.1126/science.1173668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574350	Green Accepted			2022-12-28	WOS:000268255100053
J	Wiedemann, N; Meisinger, C; Pfanner, N				Wiedemann, Nils; Meisinger, Chris; Pfanner, Nikolaus			Connecting Organelles	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; OUTER-MEMBRANE; MITOCHONDRIAL-MEMBRANES; YEAST; PROTEIN; MMM1P; DNA; NUCLEOIDS; STABILITY; MDM12P		[Wiedemann, Nils] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79104 Freiburg, Germany; Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Wiedemann, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Wiedemann, Nils/0000-0001-8305-6728				Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740	15	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					403	404		10.1126/science.1178016	http://dx.doi.org/10.1126/science.1178016			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628848				2022-12-28	WOS:000268255100032
J	Hart, LS; El-Deiry, WS				Hart, Lori S.; El-Deiry, Wafik S.			Cell Death: A New Par-4 the TRAIL	CELL			English	Editorial Material							GRP78/BIP; APOPTOSIS	The protein Par-4 acts in the cytoplasm to trigger cell death signaling via caspase activation and the mitochondrial release of cytochrome c. Burikhanov et al. (2009) now provide surprising evidence that Par-4 can also promote apoptosis from outside the cell, after its secretion in response to endoplasmic reticulum stress.	[El-Deiry, Wafik S.] Univ Penn, Sch Med,Lab Mol Oncol & Cell Cycle Regulat, Inst Translat Med & Therapeut, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	El-Deiry, WS (corresponding author), Univ Penn, Sch Med,Lab Mol Oncol & Cell Cycle Regulat, Inst Translat Med & Therapeut, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA.	wafik@mail.med.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266				Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Boehrer S, 2006, LEUKEMIA RES, V30, P597, DOI 10.1016/j.leukres.2005.09.003; Garcia-Cao I, 2005, EMBO REP, V6, P577, DOI 10.1038/sj.embor.7400421; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Zhao YM, 2007, CANCER RES, V67, P9276, DOI 10.1158/0008-5472.CAN-07-2124	9	6	8	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					220	222		10.1016/j.cell.2009.07.007	http://dx.doi.org/10.1016/j.cell.2009.07.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632170	Bronze			2022-12-28	WOS:000268277000002
J	Jackson, PK				Jackson, Peter K.			Navigating the Deubiquitinating Proteome with a CompPASS	CELL			English	Editorial Material							ENZYMES	Deubiquitinating enzymes (DUBs) act on ubiquitinated substrates to regulate their modification and stability. In this issue, Sowa et al. (2009) present a comprehensive proteomic analysis of DUB interacting proteins in humans and a new quantitative scoring system for hits (CompPASS), providing a resource that links DUBs to biological pathways.	Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA	Roche Holding; Genentech	Jackson, PK (corresponding author), Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA.	pjackson@gene.com		Jackson, Peter/0000-0002-1742-2539				CHEESEMAN IM, 2005, SCI STKE, V211; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873	6	4	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					222	224		10.1016/j.cell.2009.07.008	http://dx.doi.org/10.1016/j.cell.2009.07.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632171	Bronze			2022-12-28	WOS:000268277000003
J	Sur, D; Ochiai, RL; Bhattacharya, SK; Ganguly, NK; Ali, M; Manna, B; Dutta, S; Donner, A; Kanungo, S; Park, JK; Puri, MK; Kim, DR; Dutta, D; Bhaduri, B; Acosta, CJ; Clemens, JD				Sur, Dipika; Ochiai, R. Leon; Bhattacharya, Sujit K.; Ganguly, Nirmal K.; Ali, Mohammad; Manna, Byomkesh; Dutta, Shanta; Donner, Allan; Kanungo, Suman; Park, Jin Kyung; Puri, Mahesh K.; Kim, Deok Ryun; Dutta, Dharitri; Bhaduri, Barnali; Acosta, Camilo J.; Clemens, John D.			A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS IMMUNIZATION CAMPAIGN; POLYSACCHARIDE VACCINE; CAPSULAR POLYSACCHARIDE; SALMONELLA-TYPHI; FEVER; CHILDREN; IMMUNOGENICITY; EFFICACY; SHIGELLOSIS; COUNTRIES	Background Typhoid fever remains an important cause of illness and death in the developing world. Uncertainties about the protective effect of Vi polysaccharide vaccine in children under the age of 5 years and about the vaccine's effect under programmatic conditions have inhibited its use in developing countries. Methods We conducted a phase 4 effectiveness trial in which slum-dwelling residents of Kolkata, India, who were 2 years of age or older were randomly assigned to receive a single dose of either Vi vaccine or inactivated hepatitis A vaccine, according to geographic clusters, with 40 clusters in each study group. The subjects were then followed for 2 years. Results A total of 37,673 subjects received a dose of a study vaccine. The mean rate of vaccine coverage was 61% for the Vi vaccine clusters and 60% for the hepatitis A vaccine clusters. Typhoid fever was diagnosed in 96 subjects in the hepatitis A vaccine group, as compared with 34 in the Vi vaccine group, with no subject having more than one episode. The level of protective effectiveness for the Vi vaccine was 61% (95% confidence interval [CI], 41 to 75; P<0.001 for the comparison with the hepatitis A vaccine group). Children who were vaccinated between the ages of 2 and 5 years had a level of protection of 80% (95% CI, 53 to 91). Among unvaccinated members of the Vi vaccine clusters, the level of protection was 44% (95% CI, 2 to 69). The overall level of protection among all residents of Vi vaccine clusters was 57% (95% CI, 37 to 71). No serious adverse events that were attributed to either vaccine were observed during the month after vaccination. Conclusions The Vi vaccine was effective in young children and protected unvaccinated neighbors of Vi vaccinees. The potential for combined direct and indirect protection by Vi vaccine should be considered in future deliberations about introducing this vaccine in areas where typhoid fever is endemic. (ClinicalTrials.gov number, NCT00125008.)	[Ochiai, R. Leon; Ali, Mohammad; Park, Jin Kyung; Puri, Mahesh K.; Kim, Deok Ryun; Acosta, Camilo J.; Clemens, John D.] Int Vaccine Inst, Seoul 151919, South Korea; [Sur, Dipika; Bhattacharya, Sujit K.; Manna, Byomkesh; Dutta, Shanta; Kanungo, Suman; Dutta, Dharitri; Bhaduri, Barnali] Natl Inst Cholera & Enter Dis, Kolkata, India; [Ganguly, Nirmal K.] Indian Council Med Res, Delhi, India; [Donner, Allan] Univ Western Ontario, London, ON, Canada	International Vaccine Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); Western University (University of Western Ontario)	Clemens, JD (corresponding author), Int Vaccine Inst, SNU Res Pk,San 4-8 Bongcheon 7 Dong, Seoul 151919, South Korea.	jclemens@ivi.int	Ali, Mohammad/E-2365-2017; Kanungo, Sloka/HHM-7508-2022	Ali, Mohammad/0000-0003-1410-388X; Ochiai, Leon/0000-0002-5079-6786; Kanungo, Suman/0000-0003-4441-4443	Diseases of the Most Impoverished Program of the Bill and Melinda Gates Foundation; International Vaccine Institute; Ggovernments of the Republic of Korea; Government of Sweden; Government of Kuwait	Diseases of the Most Impoverished Program of the Bill and Melinda Gates Foundation; International Vaccine Institute; Ggovernments of the Republic of Korea; Government of Sweden; Government of Kuwait	Supported by the Diseases of the Most Impoverished Program of the Bill and Melinda Gates Foundation, coordinated by the International Vaccine Institute, and by the governments of the Republic of Korea, Sweden, and Kuwait. GlaxoSmithKline donated vaccines used in the study and performed serologic assays but provided no funding for the study. The Japanese International Cooperation Agency supplied diagnostic equipment and reagents for typhoid.	ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; Acosta CJ, 2005, TROP MED INT HEALTH, V10, P1219, DOI 10.1111/j.1365-3156.2005.01517.x; Acosta CJ, 2004, EXPERT OPIN BIOL TH, V4, P1939, DOI 10.1517/14712598.4.12.1939; Agtini MD, 2006, PUBLIC HEALTH, V120, P1081, DOI 10.1016/j.puhe.2006.06.008; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P257; [Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P1; Bopp CA, 1999, MANUAL CLIN MICROBIO, P459; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; *DEP VACC BIOL, 2003, BACKGR DOC DIAGN TRE; DeRoeck D, 2005, VACCINE, V23, P2762, DOI 10.1016/j.vaccine.2004.11.044; Engels EA, 2000, COCHRANE DB SYST REV, V2; Fraser A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub2; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use, 1996, ICH HARM TRIP GUID G; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; Khan MI, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-17; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; Lebacq E, 2001, BIODRUGS, V15, P5, DOI 10.2165/00063030-200115001-00002; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Overbosch D, 2005, J TRAVEL MED, V12, P319, DOI 10.2310/7060.2005.12604; Pelser HH, 2001, BIODRUGS, V15, P13, DOI 10.2165/00063030-200115001-00003; REID N, 1985, BIOMETRIKA, V72, P1; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Thiem Vu Dinh, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P515; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625; Yang J, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-49	32	155	161	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					335	344		10.1056/NEJMoa0807521	http://dx.doi.org/10.1056/NEJMoa0807521			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625715				2022-12-28	WOS:000268184500004
J	Wang, QB; Li, W; Zhang, Y; Yuan, X; Xu, KX; Yu, JD; Chen, Z; Beroukhim, R; Wang, HY; Lupien, M; Wu, T; Regan, MM; Meyer, CA; Carroll, JS; Manrai, AK; Janne, OA; Balk, SP; Mehra, R; Han, B; Chinnaiyan, AM; Rubin, MA; True, L; Fiorentino, M; Fiore, C; Loda, M; Kantoff, PW; Liu, XS; Brown, M				Wang, Qianben; Li, Wei; Zhang, Yong; Yuan, Xin; Xu, Kexin; Yu, Jindan; Chen, Zhong; Beroukhim, Rameen; Wang, Hongyun; Lupien, Mathieu; Wu, Tao; Regan, Meredith M.; Meyer, Clifford A.; Carroll, Jason S.; Manrai, Arjun Kumar; Janne, Olli A.; Balk, Steven P.; Mehra, Rohit; Han, Bo; Chinnaiyan, Arul M.; Rubin, Mark A.; True, Lawrence; Fiorentino, Michelangelo; Fiore, Christopher; Loda, Massimo; Kantoff, Philip W.; Liu, X. Shirley; Brown, Myles			Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer	CELL			English	Article							KALLIKREIN 2; HUMAN GENOME; HISTONE H3; CHIP-CHIP; CYCLIN-A; COMPLEX; PROGRESSION; EXPRESSION; SIGNATURES; MODEL	The evolution of prostate cancer from an androgen-dependent state to one that is androgen-independent marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in androgen-independent cancers is poorly understood. We have defined the direct AR-dependent target genes in both androgen-dependent and -independent cancer cells by generating AR-dependent gene expression profiles and AR cistromes. In contrast to what is found in androgen-dependent cells, AR selectively upregulates M-phase cell-cycle genes in androgen-independent cells, including UBE2C, a gene that inactivates the M-phase checkpoint. We find that epigenetic marks at the UBE2C enhancer, notably histone H3K4 methylation and FoxA1 transcription factor binding, are present in androgen-independent cells and direct AR-enhancer binding and UBE2C activation. Thus, the role of AR in androgen-independent cancer cells is not to direct the androgen-dependent gene expression program without androgen, but rather to execute a distinct program resulting in androgen-independent growth.	[Wang, Qianben; Xu, Kexin; Beroukhim, Rameen; Lupien, Mathieu; Fiorentino, Michelangelo; Fiore, Christopher; Loda, Massimo; Kantoff, Philip W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Tao] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wang, Qianben; Chen, Zhong] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wang, Qianben; Chen, Zhong] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Yong; Regan, Meredith M.; Meyer, Clifford A.; Manrai, Arjun Kumar; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Zhang, Yong; Regan, Meredith M.; Meyer, Clifford A.; Manrai, Arjun Kumar; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Yuan, Xin; Wang, Hongyun; Balk, Steven P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02215 USA; [Yu, Jindan; Mehra, Rohit; Han, Bo; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Beroukhim, Rameen] Harvard & MIT, Broad Inst, Cambridge, MA 02139 USA; [Carroll, Jason S.] Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Janne, Olli A.] Univ Helsinki, Inst Biomed Physiol, Biomedicum, FI-00014 Helsinki, Finland; [Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [True, Lawrence] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Helsinki; Cornell University; University of Washington; University of Washington Seattle	Wang, QB (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	qianben.wang@osumc.edu; xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Thomson, Axel/A-7893-2013; Wang, Qianben/E-4267-2011; Brown, Myles/B-6906-2008; Fiorentino, Michelangelo/AAB-8056-2022; Li, Wei/A-8544-2009; Wu, Tao/C-7533-2013; Zhang, Yong/B-4838-2011; Chen, Zhong/E-2776-2018; Brown, Myles/AAX-5332-2021	Zhang, Yong/0000-0001-6316-2734; Chen, Zhong/0000-0002-9644-1737; Brown, Myles/0000-0002-8213-1658; Lupien, Mathieu/0000-0003-0929-9478; Manrai, Arjun/0000-0001-9657-9800; Li, Wei/0000-0001-9931-5990; Rubin, Mark/0000-0002-8321-9950; Carroll, Jason/0000-0003-3643-0080; Kantoff, Philip/0000-0001-7275-0597; Fiore, Christopher/0000-0003-3151-3354	National Institutes of Health [P50 CA090381, K99 CA126160, R01 HG004069, K99 CA129565]; The Prostate Cancer Foundation; Department of Defense [W81XWH-07-1-0037, PC080665]; NATIONAL CANCER INSTITUTE [K99CA126160, P50CA090381, K99CA129565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Prostate Cancer Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health (P50 CA090381 to M. B., K99 CA126160 to Q. W., and R01 HG004069 to X. S. L., and K99 CA129565 to J.Y., The Prostate Cancer Foundation (to M. B), and Department of Defense (W81XWH-07-1-0037 to X. S. L., and PC080665 to J.Y.). We thank Drs. Roland Schule for providing KDM1 constructs; and Michael Rape for UBE2C constructs. We also thank Drs. James DeCaprio, Gustavo Leone, Tim Huang, Yun Li, and Shengjun Ren for helpful discussions; and Dr. Chunpeng Zhang and Anna Rorick for technical assistance.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Comstock CES, 2007, CELL CYCLE, V6, P1307, DOI 10.4161/cc.6.11.4353; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GROUP PCT, 2000, LANCET, V355, P1491; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lin J, 2006, NEOPLASIA, V8, P1062, DOI 10.1593/neo.05832; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thalmann GN, 2000, PROSTATE, V44, P91; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yu DC, 1999, CANCER RES, V59, P1498	48	676	695	3	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					245	256		10.1016/j.cell.2009.04.056	http://dx.doi.org/10.1016/j.cell.2009.04.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632176	Green Accepted, Bronze			2022-12-28	WOS:000268277000008
J	Saperia, J; Lakhanpaul, M; Kemp, A; Glaser, D				Saperia, Julia; Lakhanpaul, Monica; Kemp, Alison; Glaser, Danya		Guideline Dev Grp & Tech Team	Practice Guidelines When to suspect child maltreatment: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glaser, Danya] Great Ormond St Hosp Sick Children, Dept Child & Adolescent Mental Hlth, London WC1N 3JH, England; [Lakhanpaul, Monica] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Lakhanpaul, Monica] Univ Leicester, Leicester Royal Infirm, Dept Med Educ & Social Care, Leicester, Leics, England; [Kemp, Alison] Cardiff Univ, Univ Wales Hosp, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leicester; Cardiff University	Glaser, D (corresponding author), Great Ormond St Hosp Sick Children, Dept Child & Adolescent Mental Hlth, Great Ormond St, London WC1N 3JH, England.	dglaser@ich.ucl.ac.uk		Lakhanpaul, Monica/0000-0002-9855-2043				*DAT UN WAL, 2009, DAT DISS TOOL; Department for Children Schools and Families, 2008, DCSF REF ASS CHILDR; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Glaser D, 2002, CHILD ABUSE NEGLECT, V26, P697, DOI 10.1016/S0145-2134(02)00342-3; HM Government, 2018, WORKING TOGETHER SAF; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; *NAT SOC PREV CRUE, 2009, CHILD PROT REG STAT; National Institute for Health and Clinical Excellence, 2007, GUID MAN; National Institute for Health and Clinical Excellence, 2009, SUSP CHILD MALTR; Office of the United Nations High Commissioner for Human Rights, 1990, CONV RIGHTS CHILD; Welsh Assembly Government, 2005, NAT SERV FRAM CHILDR; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR; Wise J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1967	14	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2009	339								b2689	10.1136/bmj.b2689	http://dx.doi.org/10.1136/bmj.b2689			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IL	19625357	Green Published, Green Accepted			2022-12-28	WOS:000268351700020
J	Haslam, M; Hernandez-Aguilar, A; Ling, V; Carvalho, S; de la Torre, I; DeStefano, A; Du, A; Hardy, B; Harris, J; Marchant, L; Matsuzawa, T; McGrew, W; Mercader, J; Mora, R; Petraglia, M; Roche, H; Visalberghi, E; Warren, R				Haslam, Michael; Hernandez-Aguilar, Adriana; Ling, Victoria; Carvalho, Susana; de la Torre, Ignacio; DeStefano, April; Du, Andrew; Hardy, Bruce; Harris, Jack; Marchant, Linda; Matsuzawa, Tetsuro; McGrew, William; Mercader, Julio; Mora, Rafael; Petraglia, Michael; Roche, Helene; Visalberghi, Elisabetta; Warren, Rebecca			Primate archaeology	NATURE			English	Review							MONKEYS CEBUS-LIBIDINOSUS; BEARDED CAPUCHIN MONKEYS; NUT-CRACKING; TOOL USE; SAVANNA CHIMPANZEES; EARLY HOMINID; STONE TOOLS; BED-II; WILD; PAN	All modern humans use tools to overcome limitations of our anatomy and to make difficult tasks easier. However, if tool use is such an advantage, we may ask why it is not evolved to the same degree in other species. To answer this question, we need to bring a long-term perspective to the material record of other members of our own order, the Primates.	[Haslam, Michael; Hernandez-Aguilar, Adriana; Ling, Victoria; Carvalho, Susana; McGrew, William; Petraglia, Michael] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [de la Torre, Ignacio] UCL, Inst Archaeol, London WC1H 0PY, England; [DeStefano, April; Du, Andrew; Harris, Jack] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Hardy, Bruce; Warren, Rebecca] Kenyon Coll, Dept Anthropol, Gambier, OH 43022 USA; [Marchant, Linda] Miami Univ, Dept Anthropol, Oxford, OH 45056 USA; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan; [Mercader, Julio] Univ Calgary, Dept Archaeol, Calgary, AB T2N 1N4, Canada; [Mora, Rafael] Univ Autonoma Barcelona, Div Prehist, E-08193 Barcelona, Spain; [Roche, Helene] CNRS, F-92023 Paris, France; [Visalberghi, Elisabetta] Ist Sci & Tecnol Cogniz, I-00197 Rome, Italy	University of Cambridge; University of London; University College London; Rutgers State University New Brunswick; Kenyon College; University System of Ohio; Miami University; Kyoto University; University of Calgary; Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Haslam, M (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England.	mah66@cam.ac.uk	Torcal, Rafael Mora/A-2145-2009; Petraglia, Michael/ABA-9748-2021; Torcal, Rafael Mora/O-1149-2019; Matsuzawa, Tetsuro/ABE-9654-2021; Mercader, Julio/G-5182-2010; Hernandez-Aguilar, R. Adriana/K-4709-2014	Torcal, Rafael Mora/0000-0001-7824-6818; Torcal, Rafael Mora/0000-0001-7824-6818; Matsuzawa, Tetsuro/0000-0002-8147-2725; Hernandez-Aguilar, R. Adriana/0000-0002-9539-8669; Petraglia, Michael/0000-0003-2522-5727; Carvalho, Susana/0000-0003-4542-3720; Du, Andrew/0000-0002-7381-5089; de la Torre, Ignacio/0000-0002-1805-634X; Haslam, Michael/0000-0001-8234-7806; Visalberghi, Elisabetta/0000-0001-7407-5468	US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	We thank R. Foley and the US National Science Foundation Revealing Hominid Origins Initiative. The University of Cambridge, the Galton Institute and King's College, Cambridge, UK, sponsored the symposium 'Primatology Meets Palaeoanthropology 2: The Origins of Percussive Technology', held in October 2008 at the Leverhulme Centre for Human Evolutionary Studies in Cambridge.	AIELLO L, 1990, INTRO HUMAN EVOLUTIO, P191; Anderson JR, 2000, SLEEP MED REV, V4, P355, DOI 10.1053/smrv.2000.0105; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Boinski Sue, 2003, P365, DOI 10.1017/CBO9780511584022.014; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Copeland SR, 2007, J HUM EVOL, V53, P146, DOI 10.1016/j.jhevol.2007.03.002; DE A, 2004, SCIENCE, V306, P1909; de Heinzelin J, 1999, SCIENCE, V284, P625; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; FOLEY R, 1987, ANTIQUITY, V61, P380, DOI 10.1017/S0003598X00072938; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N, 2002, ACHEULIAN SITE GESHE; Hall K. R. L., 1964, Journal of Mammalogy, V45, P287, DOI 10.2307/1376994; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; HERNANDEZAGUILA.A, J HUM EVOL IN PRESS; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; INIZAN ML, 1995, TECHNOLOGIE P TAILLE; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY MD, 1971, O GORGE EXCAVATIONS; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Madden JR, 2008, ANIM COGN, V11, P1, DOI 10.1007/s10071-007-0092-5; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; Mann J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003868; Mannu M, 2009, AM J PRIMATOL, V71, P242, DOI 10.1002/ajp.20642; Marchant LF., 2005, STONE KNAPPING NECES, P341; Matsuzawa Tetsuro, 1994, P351; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 2003, J HUM EVOL, V44, P521, DOI 10.1016/S0047-2484(03)00042-3; McGrew William, 2004, CULTURED CHIMPANZEE; McGrew William C., 2001, P160; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; NISHIDA T, 1976, FOLIA PRIMATOL, V25, P277, DOI 10.1159/000155720; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Rybczynski N, 2008, PALEOBIOLOGY, V34, P389, DOI 10.1666/06085.1; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Sept J, 1998, AM J PRIMATOL, V46, P85, DOI 10.1002/(SICI)1098-2345(1998)46:1<85::AID-AJP7>3.3.CO;2-1; SEPT JM, 1992, CURR ANTHROPOL, V33, P187, DOI 10.1086/204050; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; TELEKI G, 1974, J HUM EVOL, V3, P575, DOI 10.1016/0047-2484(74)90018-9; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Toth N., 2006, OLDOWAN CASE STUDIES, P155; vanSchaik CP, 1996, NATURWISSENSCHAFTEN, V83, P186, DOI 10.1007/s001140050271; Visalberghi E, 2007, AM J PHYS ANTHROPOL, V132, P426, DOI 10.1002/ajpa.20546; Visalberghi E, 2009, PRIMATES, V50, P95, DOI 10.1007/s10329-008-0127-9; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064; WASHBURN SL, 1960, SCI AM, V203, P63; WESTERGAARD GC, 1995, WORLD ARCHAEOL, V27, P1; Whiten A, 2003, EVOL ANTHROPOL, V12, P92, DOI 10.1002/evan.10107; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wright RVS., 1972, MANKIND, V8, P296, DOI DOI 10.1111/J.1835-9310.1972.TB00451.X; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697	76	158	164	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					339	344		10.1038/nature08188	http://dx.doi.org/10.1038/nature08188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	470MO	19606139				2022-12-28	WOS:000267979000027
J	Garske, T; Legrand, J; Donnelly, CA; Ward, H; Cauchemez, S; Fraser, C; Ferguson, NM; Ghani, AC				Garske, Tini; Legrand, Judith; Donnelly, Christl A.; Ward, Helen; Cauchemez, Simon; Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.			Assessing the severity of the novel influenza A/H1N1 pandemic	BRITISH MEDICAL JOURNAL			English	Article							ACUTE-RESPIRATORY-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; CASE-FATALITY RATIO; VIRUS-INFECTIONS; EFFICACY; SAFETY; OSELTAMIVIR; ZANAMIVIR; DISEASE; TIME		[Garske, Tini; Legrand, Judith; Donnelly, Christl A.; Ward, Helen; Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England	Imperial College London	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.	t.garske@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008; Ward, Helen/A-1836-2009	Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Ward, Helen/0000-0001-8238-5036; Ghani, Azra/0000-0002-0007-4910; Donnelly, Christl/0000-0002-0195-2463	Medical Research Council [G0600719B] Funding Source: researchfish; Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armitage P., 2002, STAT METHODS MED RES; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *EUR CTR DIS PREV, ECDC SIT REP INFL A; FRASER C, 2009, SCIENCE, V117, P60; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Gigli A, 2000, STAT MED, V19, P175, DOI 10.1002/(SICI)1097-0258(20000130)19:2&lt;175::AID-SIM299&gt;3.0.CO;2-S; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Health Protection Agency, 2009, HPA WEEKL NAT INFL R; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; MAINES TR, 2009, SCIENCE, V117, P723; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; *PAN AM HLTH ORG, 2009, UPD INFL A H1N1 REG; PEREZPADILLA R, 2009, N ENGL J MED; *PUBL HLTH AG CAN, PAND H1N1 2009 OUTBR; Secretaria de Salud de Mexico, SIT ACT EP; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; *US CDCP, 2009, KEY FACTS SEAS INFL; *US CDCP, 2009, NAT LIN INFL A H1N1; *US CDCP, H1N1 FLU; *WHO, SIT UPD INFL A H1N1; Yip PSF, 2005, AM J EPIDEMIOL, V161, P700, DOI 10.1093/aje/kwi088; Yip PSF, 2005, J R STAT SOC A STAT, V168, P233, DOI 10.1111/j.1467-985X.2004.00345.x; 2003, NY TIMES        0422	26	161	165	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 14	2009	339								b2840	10.1136/bmj.b2840	http://dx.doi.org/10.1136/bmj.b2840			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602714				2022-12-28	WOS:000268104900008
J	Kerac, M; Bunin, J; Seal, A; Thindwa, M; Tomkins, A; Sadler, K; Bahwere, P; Collins, S				Kerac, Marko; Bunin, James; Seal, Andrew; Thindwa, Mariam; Tomkins, Andrew; Sadler, Kate; Bahwere, Paluku; Collins, Steve			Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi	LANCET			English	Article							SEVERE ACUTE-PANCREATITIS; MALNOURISHED CHILDREN; LACTOBACILLUS GG; HIV; MANAGEMENT; DIARRHEA; REHABILITATION; BACTEREMIA; SYNBIOTICS; CHALLENGES	Background Severe acute malnutrition affects 13 million children worldwide and causes 1-2 million deaths every year. Our aim was to assess the clinical and nutritional efficacy of a probiotic and prebiotic functional food for the treatment of severe acute malnutrition in a HIV-prevalent setting. Methods We recruited 795 Malawian children (age range 5 to 168 months [median 22, IQR 15 to 32]) from July 12, 2006, to March 7, 2007, into a double-blind, randomised, placebo-controlled efficacy trial. For generalisability, all admissions for severe acute malnutrition treatment were eligible for recruitment. After stabilisation with milk feeds, children were randomly assigned to ready-to-use therapeutic food either with (n=399) or without (n=396) Synbiotic2000 Forte. Average prescribed Synbiotic dose was 1010 colony-forming units or more of lactic acid bacteria per day for the duration of treatment (median 3.3 days). Primary outcome was nutritional cure (weight-for-height >80% of National Center for Health Statistics median on two consecutive outpatient visits). Secondary outcomes included death, weight gain, time to cure, and prevalence of clinical symptoms (diarrhoea, fever, and respiratory problems). Analysis was on an intention-to-treat basis. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN19364765. Findings Nutritional cure was similar in both Synbiotic and control groups (53.9% [215 of 399] and 51.3% [203 of 396]; p=0.40). Secondary outcomes were also similar between groups. HIV seropositivity was associated with worse outcomes overall, but did not modify or confound the negative results. Subgroup analyses showed possible trends towards reduced outpatient mortality in the Synbiotic group (p=0.06). Interpretation In Malawi, Synbiotic2000 Forte did not improve severe acute malnutrition outcomes. The observation of reduced outpatient mortality might be caused by bias, confounding, or chance, but is biologically plausible, has potential for public health impact, and should be explored in future studies.	[Kerac, Marko] UCL Ctr Int Hlth & Dev, Inst Child Hlth, London WC1N 1EH, England; [Kerac, Marko; Sadler, Kate; Bahwere, Paluku; Collins, Steve] Valid Int, Oxford, England; [Kerac, Marko; Bunin, James] Coll Med, Blantyre, Malawi; [Bunin, James] Univ Liverpool, Liverpool Sch Trop Med, Child Dev & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Thindwa, Mariam] Dist Hlth Off, Blantyre, Malawi	University of London; University College London; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Kerac, M (corresponding author), UCL Ctr Int Hlth & Dev, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	marko.kerac@gmail.com	Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022; Seal, Andrew/C-8550-2014	Kerac, Marko/0000-0002-3745-7317; Seal, Andrew/0000-0003-3656-4054	CTC research and development programme; Valid International; Concern Worldwide; National Institute for Health Research [ACF-2008-18-010] Funding Source: researchfish	CTC research and development programme; Valid International; Concern Worldwide; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank patients, carers, and staff of MOYO ward, Queen Elizabeth Central Hospital, Malawi. We also thank Elizabeth Molyneux, Therese Hesketh, Sonia Lewycka, Joseph Mfutso-Berigo, Tom Heikens, Hannah Blencowe, Michael Moore, Bfigitte Denis, Katherine Gray, Malcolm Molyneux, Medipharm Sweden (Ingrid Persson, Lennart Persson, Margot Hallin, and Eva Tykesson), James Soothill, Stig Bengmark, Mark Myatt, Tim Cole, and Atul Singhal for their help and support. This study was part of the CTC research and development programme and collaboration between Valid International and Concern Worldwide.	Allen S.J., 2004, COCHRANE DB SYST REV, pCD003048, DOI [10.1002/14651858.CD003048.pub2, DOI 10.1002/14651858.CD003048]; Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; Babirekere-Iriso E, 2006, ANN TROP PAEDIATR, V26, P319, DOI 10.1179/146532806X152845; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bhutta ZA, 2008, J PEDIATR GASTR NUTR, V47, P260, DOI 10.1097/MPG.0b013e318181b334; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Campbell DI, 2002, BRIT J NUTR, V88, P499, DOI 10.1079/BJN2002697; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; *COMM BAS MAN SEV, JOINT STAT WHO WORLD; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; ELDIOP HI, 2003, AM J CLIN NUTR, V78, P302; Fagundes-Neto U, 1982, Arq Gastroenterol, V19, P91; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Galpin L, 2005, AM J CLIN NUTR, V82, P1040, DOI 10.1093/ajcn/82.5.1040; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; *GOV MAL, 2007, INT GUID MAN AC MALN; Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; HEIKENS GT, 1993, EUR J CLIN NUTR, V47, P160; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KHARA T, 2004, ENN EMERGENCY NUTR N, V2; Kotzampassi K, 2006, WORLD J SURG, V30, P1848, DOI 10.1007/s00268-005-0653-1; Krick J, 1996, J AM DIET ASSOC, V96, P680, DOI 10.1016/S0002-8223(96)00188-5; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Manary MJ, 1998, J PEDIATR-US, V133, P789, DOI 10.1016/S0022-3476(98)70153-2; Marinella MA, 2003, NUTR REV, V61, P320, DOI 10.1301/nr.2003.sept.320-323; Ndagije F, 2007, ANN TROP PAEDIATR, V27, P269, DOI 10.1179/146532807X245652; Oberhelman RA, 1999, J PEDIATR-US, V134, P15, DOI 10.1016/S0022-3476(99)70366-5; Olah A, 2007, HEPATO-GASTROENTEROL, V54, P590; PERI IMV, 2003, ARCH GASTROENTEROHEP, V22, P65; Reed RP, 1996, ANN TROP PAEDIATR, V16, P61, DOI 10.1080/02724936.1996.11747805; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; Sadler K, 2008, J TROP PEDIATRICS, V54, P364, DOI 10.1093/tropej/fmn029; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Spindler-Vesel A, 2007, JPEN-PARENTER ENTER, V31, P119, DOI 10.1177/0148607107031002119; SULLIVAN PB, 1991, ACTA PAEDIATR SCAND, V80, P1025; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; Trois L, 2008, J TROP PEDIATRICS, V54, P19, DOI 10.1093/tropej/fmm066; *VAL INT COMM BAS, FIELD MAN; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Waterlow JC, 1992, PROTEIN ENERGY MALNU; WILCOX MH, RESULTS STUDY PROBIO; World Health Organization, 1999, MAN SEV MALN MAN PHY; MODEST GROWTH PROBIO	49	123	128	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					136	144		10.1016/S0140-6736(09)60884-9	http://dx.doi.org/10.1016/S0140-6736(09)60884-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19595348				2022-12-28	WOS:000268111600031
J	Clelland, CD; Choi, M; Romberg, C; Clemenson, GD; Fragniere, A; Tyers, P; Jessberger, S; Saksida, LM; Barker, RA; Gage, FH; Bussey, TJ				Clelland, C. D.; Choi, M.; Romberg, C.; Clemenson, G. D., Jr.; Fragniere, A.; Tyers, P.; Jessberger, S.; Saksida, L. M.; Barker, R. A.; Gage, F. H.; Bussey, T. J.			A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation	SCIENCE			English	Article							DENTATE GYRUS; MEMORY; CA3; MICE; ENSEMBLES; CELLS; TASK; RATS; BORN	The dentate gyrus (DG) of the mammalian hippocampus is hypothesized to mediate pattern separation-the formation of distinct and orthogonal representations of mnemonic information-and also undergoes neurogenesis throughout life. How neurogenesis contributes to hippocampal function is largely unknown. Using adult mice in which hippocampal neurogenesis was ablated, we found specific impairments in spatial discrimination with two behavioral assays: (i) a spatial navigation radial arm maze task and (ii) a spatial, but non-navigable, task in the mouse touch screen. Mice with ablated neurogenesis were impaired when stimuli were presented with little spatial separation, but not when stimuli were more widely separated in space. Thus, newborn neurons may be necessary for normal pattern separation function in the DG of adult mice.	[Clelland, C. D.; Clemenson, G. D., Jr.; Gage, F. H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Clelland, C. D.; Choi, M.; Fragniere, A.; Tyers, P.; Barker, R. A.] Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England; [Romberg, C.; Saksida, L. M.; Bussey, T. J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Jessberger, S.] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Saksida, L. M.; Bussey, T. J.] Univ Cambridge, MRC, Cambridge CB2 3EB, England; [Saksida, L. M.; Bussey, T. J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Barker, R. A.] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England	Salk Institute; University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; tjb1000@cam.ac.uk	Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016; Jessberger, Sebastian/AAJ-4032-2020; Clelland, Claire/AAZ-6038-2021; Choi, Minee/AAL-4769-2021	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171; Choi, Minee/0000-0001-9414-8214; Clelland, Claire/0000-0002-9112-2278; Jessberger, Sebastian/0000-0002-0056-8275; Romberg-Taylor, Carola/0000-0002-4379-3579; Barker, Roger Alistair/0000-0001-8843-7730	Lookout; Mathers Foundations; Kavli Institute for Brain and Mind; NIH [NS-050217]; Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge; MaxNetAging; NCCR Neural Plasticity and Repair; Marshalls and Jack Kent Cooke Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217] Funding Source: NIH RePORTER; Medical Research Council [G0300723B, G0001354, G0001354B] Funding Source: researchfish	Lookout; Mathers Foundations; Kavli Institute for Brain and Mind; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge(University of Cambridge); MaxNetAging; NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Marshalls and Jack Kent Cooke Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. J. Armstrong and J. B. Aimone for useful input and discussions, M. L. Gage for editorial comments, and J. Simon for assistance with figures. This work was funded in part by James S. McDonnell, Lookout, and Mathers Foundations, the Kavli Institute for Brain and Mind, and NIH (grant NS-050217) (F.H.G.), and also by the NIHR Biomedical Research Centre Award to the University of Cambridge and generous donations from patients and families to the Huntingtons and Parkinsons Disease Research Clinics at the Brain Repair Centre, University of Cambridge (R.A.B.). This work was also supported in part by MaxNetAging and NCCR Neural Plasticity and Repair Grants (S.J.) and Marshalls and Jack Kent Cooke Foundation scholarships (C.D.C.).	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; BERNSTEIN D, 1985, PHARMACOL BIOCHEM BE, V22, P301, DOI 10.1016/0091-3057(85)90395-8; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilbert PE, 1998, J NEUROSCI, V18, P804; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McTighe SM, 2009, NEUROREPORT, V20, P881, DOI 10.1097/WNR.0b013e32832c5eb2; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	30	1111	1138	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					210	213		10.1126/science.1173215	http://dx.doi.org/10.1126/science.1173215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590004	Green Accepted			2022-12-28	WOS:000267802000050
J	Singh, H				Singh, Harinder			Teeing Up Transcription on CpG Islands	CELL			English	Editorial Material							RNA-POLYMERASE-II; POLY(DA-DT)	Eukaryotic cells use elaborate molecular mechanisms to rapidly activate signal-dependent gene expression. New work provides fresh insights into these mechanisms by demonstrating that CpG islands in promoters are nucleosome-destabilizing elements and can facilitate the establishment of an unusual poised transcriptional state (Ramirez-Carrozzi et al., 2009; Hargreaves et al., 2009).	[Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hsingh@uchicago.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341	8	6	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					14	16		10.1016/j.cell.2009.06.028	http://dx.doi.org/10.1016/j.cell.2009.06.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596228	Bronze			2022-12-28	WOS:000267848600007
J	Stallings, CL; Stephanou, NC; Chu, L; Hochschild, A; Nickels, BE; Glickman, MS				Stallings, Christina L.; Stephanou, Nicolas C.; Chu, Linda; Hochschild, Ann; Nickels, Bryce E.; Glickman, Michael S.			CarD Is an Essential Regulator of rRNA Transcription Required for Mycobacterium tuberculosis Persistence	CELL			English	Article							REPAIR COUPLING FACTOR; ESCHERICHIA-COLI; DNA-REPAIR; BACILLUS-SUBTILIS; MYXOCOCCUS-XANTHUS; STRINGENT RESPONSE; STRUCTURAL BASIS; GENE-EXPRESSION; FACTOR MFD; POLYMERASE	Mycobacterium tuberculosis is arguably the world's most successful infectious agent because of its ability to control its own cell growth within the host. Bacterial growth rate is closely coupled to rRNA transcription, which in E. coli is regulated through DksA and (p) ppGpp. The mechanisms of rRNA transcriptional control in mycobacteria, which lack DksA, are undefined. Here we identify CarD as an essential mycobacterial protein that controls rRNA transcription. Loss of CarD is lethal for mycobacteria in culture and during infection of mice. CarD depletion leads to sensitivity to killing by oxidative stress, starvation, and DNA damage, accompanied by failure to reduce rRNA transcription. CarD can functionally replace DksA for stringent control of rRNA transcription, even though CarD associates with a different site on RNA polymerase. These findings highlight a distinct molecular mechanism for regulating rRNA transcription in mycobacteria that is critical for M. tuberculosis pathogenesis.	[Stallings, Christina L.; Stephanou, Nicolas C.; Chu, Linda; Glickman, Michael S.] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Memorial Sloan Kettering Cancer Center	Glickman, MS (corresponding author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	glickmam@mskcc.org	Nickels, Bryce/AAF-2549-2020	Nickels, Bryce/0000-0001-7449-8831; Glickman, Michael S/0000-0001-7918-5164	NIH [GM073829, GM44025, AI064693, AI075805]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI075805, R01AI064693, R01AI080619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM073829] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dirk Schnappinger and Sabine Ehrt for reagents and advice about the tet system, Alex Lash for assistance with bioinformatic analyses, Seth Darst for advice and design of the thermus b fragment, Nigel Savery for materials and assistance relating to the roadblock repression assays, the Genomics Core at MSKCC for microarray hybridization and processing, and Ken Marians for critical reading of the manuscript. M. smegmatis microarrays were provided by NIAID/PFGRC. This work was supported by NIH grant GM073829 to Seth Darst, GM44025 to A. H., AI064693 to M. S. G., and AI075805 to C. L. S.	ALFOLDI L, 1962, J MOL BIOL, V5, P348, DOI 10.1016/S0022-2836(62)80077-1; [Anonymous], 2009, GLOB TUB CONTR; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Avarbock D, 1999, GENE, V233, P261, DOI 10.1016/S0378-1119(99)00114-6; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dahl JL, 2005, J BACTERIOL, V187, P2439, DOI 10.1128/JB.187.7.2439-2447.2005; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; NENE V, 1983, FEBS LETT, V153, P307, DOI 10.1016/0014-5793(83)80630-9; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; NICOLAS FJ, 1994, GENE DEV, V8, P2375, DOI 10.1101/gad.8.19.2375; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Taverna P, 1996, J BACTERIOL, V178, P5105, DOI 10.1128/jb.178.17.5105-5111.1996; TEDIN K, 1992, J BIOL CHEM, V267, P2337; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	53	166	172	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					146	159		10.1016/j.cell.2009.04.041	http://dx.doi.org/10.1016/j.cell.2009.04.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596241	Green Accepted, Bronze			2022-12-28	WOS:000267848600021
J	Wender, PA; Miller, BL				Wender, Paul A.; Miller, Benjamin L.			Synthesis at the molecular frontier	NATURE			English	Article							ORGANIC-SYNTHESIS; ORIENTED SYNTHESIS; NATURAL-PRODUCTS; IN-VITRO; DISCOVERY; CHEMISTRY; ANALOGS; IDENTIFICATION; PROSTRATIN; CONVERSION		[Wender, Paul A.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Wender, Paul A.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Miller, Benjamin L.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA	Stanford University; Stanford University; University of Rochester	Wender, PA (corresponding author), Stanford Univ, Dept Chem, 333 Campus Dr, Stanford, CA 94305 USA.	wenderp@stanford.edu; Benjamin_miller@urmc.rochester.edu	Chen, Yao/AAJ-2409-2020	Miller, Benjamin/0000-0003-1647-0122	NCI NIH HHS [R37 CA031845-29, R37 CA031845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chanon M, 1998, SYNTHESIS-STUTTGART, P1559; Chappell D, 2006, ORG BIOMOL CHEM, V4, P4409, DOI 10.1039/b614011b; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Corey EJ., 2007, MOL MED; CORNFORTH JW, 1993, AUST J CHEM, V46, P157, DOI 10.1071/CH9930157; CURRAN DP, 1987, TETRAHEDRON, V43, P5653, DOI 10.1016/S0040-4020(01)87744-9; Das A, 2009, ACCOUNTS CHEM RES, V42, P631, DOI 10.1021/ar8002249; Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; Gareiss PC, 2008, J AM CHEM SOC, V130, P16254, DOI 10.1021/ja804398y; Greenbaum E, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P496, DOI 10.1109/IEDM.2002.1175888; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Horvath IT, 2007, CHEM REV, V107, P2169, DOI 10.1021/cr078380v; Johnson HE, 2008, J NAT PROD, V71, P2041, DOI 10.1021/np800295m; Kingston DGI, 2007, CURR OPIN DRUG DISC, V10, P130; Koshino M, 2008, NAT NANOTECHNOL, V3, P595, DOI 10.1038/nnano.2008.263; Krueger AT, 2009, CHEM BIOL, V16, P242, DOI 10.1016/j.chembiol.2008.12.004; LaVan DA, 2006, P NATL ACAD SCI USA, V103, P5251, DOI 10.1073/pnas.0506694103; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; McNaughton BR, 2007, J AM CHEM SOC, V129, P11306, DOI 10.1021/ja072114h; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicewicz DA, 2008, J AM CHEM SOC, V130, P17281, DOI 10.1021/ja808347q; Nicolaou KC, 2003, TETRAHEDRON, V59, P6683, DOI 10.1016/S0040-4020(03)00943-8; Padwa A, 2007, TETRAHEDRON, V63, P5341, DOI 10.1016/j.tet.2007.03.158; Reed J. W, 2007, WAY SYNTHESIS EVOLUT; REPPE W, 1948, LIEBIGS ANN CHEM, V560, P1; Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Sun MK, 2008, EUR J PHARMACOL, V584, P328, DOI 10.1016/j.ejphar.2008.02.014; Szpilman AM, 2008, ANGEW CHEM INT EDIT, V47, P4339, DOI 10.1002/anie.200800590; Thomas GL, 2008, ANGEW CHEM INT EDIT, V47, P2808, DOI 10.1002/anie.200705415; Tietze L. F., 2006, DOMINO REACTIONS ORG; Towle MJ, 2001, CANCER RES, V61, P1013; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Vilotijevic I, 2007, SCIENCE, V317, P1189, DOI 10.1126/science.1146421; Wender P. A., 1993, ORGANIC SYNTHESIS TH, V2, P27; Wender PA, 2002, PURE APPL CHEM, V74, P25, DOI 10.1351/pac200274010025; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; WENDER PA, 2007, DRUG DISCOVERY RES N, P127; Wender PA, 2008, J AM CHEM SOC, V130, P6658, DOI 10.1021/ja8015632; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Wilson RM, 2006, J ORG CHEM, V71, P8329, DOI 10.1021/jo0610053; Wulff JE, 2007, J AM CHEM SOC, V129, P4898, DOI 10.1021/ja0690971; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l	50	409	414	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 9	2009	460	7252					197	201		10.1038/460197a	http://dx.doi.org/10.1038/460197a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587760	Green Accepted			2022-12-28	WOS:000267761000029
J	Kripalani, M; Shawcross, J; Reilly, J; Main, J				Kripalani, Mukesh; Shawcross, James; Reilly, Joe; Main, John			Practice Pointer Lithium and chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reilly, Joe] Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Stockton On Tees TS17 6BH, England; [Kripalani, Mukesh] St Lukes Hosp, Tees Esk & Wear Valleys NHS Fdn Trust, Middlesbrough TS4 3AF, Cleveland, England; [Shawcross, James; Main, John] James Cook Univ Hosp, S Tees Acute Hosp NHS Trust, Middlesbrough TS4 3BW, Cleveland, England	Durham University; James Cook University Hospital	Reilly, J (corresponding author), Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Stockton On Tees TS17 6BH, England.	j.g.reilly@durham.ac.uk						Gitlin M, 1999, DRUG SAFETY, V20, P231, DOI 10.2165/00002018-199920030-00004; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; LEHMANN K, 1995, AM J KIDNEY DIS, V25, P82, DOI 10.1016/0272-6386(95)90632-0; Lepkifker E, 2004, J CLIN PSYCHIAT, V65, P850; Morriss R, 2008, BRIT J PSYCHIAT, V193, P93, DOI 10.1192/bjp.bp.108.051268; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V38; *NHS INF CTR, 2007, COR HEART DIS QUAL O; Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x; Rosa AR, 2007, PROG NEURO-PSYCHOPH, V31, P217, DOI 10.1016/j.pnpbp.2006.08.007; Schreiner A, 2000, AM J PSYCHIAT, V157, P834, DOI 10.1176/appi.ajp.157.5.834; Waring W Stephen, 2006, Toxicol Rev, V25, P221, DOI 10.2165/00139709-200625040-00003	12	24	24	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 3	2009	339								b2452	10.1136/bmj.b2452	http://dx.doi.org/10.1136/bmj.b2452			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466RB	19578086				2022-12-28	WOS:000267679000002
J	Bitton, A; Yialamas, M; Levy, BD; Katz, JT; Loscalzo, J				Bitton, Asaf; Yialamas, Maria; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph			A Fragile Balance.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OSTEOGENESIS-IMPERFECTA; STEM-CELLS; INDIVIDUALS; CHILDREN		[Bitton, Asaf; Yialamas, Maria; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Katz, JT (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021					Chamberlain JR, 2008, MOL THER, V16, P187, DOI 10.1038/sj.mt.6300339; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217; Kamel HK, 2005, DRUG AGING, V22, P741, DOI 10.2165/00002512-200522090-00003; Letocha AD, 2005, J BONE MINER RES, V20, P977, DOI 10.1359/JBMR.050109; Maasalu K, 2003, ACTA PAEDIATR, V92, P452; Marini J C, 1988, Adv Pediatr, V35, P391; Phillipi CA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005088.pub2; Prockop DJ, 2004, NEW ENGL J MED, V350, P2302, DOI 10.1056/NEJMcibr040806; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; RAUCH F, 2009, J BONE MINER RE 0303	11	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					74	79		10.1056/NEJMcps0806370	http://dx.doi.org/10.1056/NEJMcps0806370			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571286				2022-12-28	WOS:000267533100013
J	Huang, MY; Chang, WH				Huang, Ming-Yuan; Chang, Wen-Han			Telltale Triangle of Pneumoperitoneum.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Ming-Yuan; Chang, Wen-Han] Mackay Mem Hosp, Taipei 10449, Taiwan	Mackay Memorial Hospital	Huang, MY (corresponding author), Mackay Mem Hosp, Taipei 10449, Taiwan.	m.c.yuan928@gmail.com		Chang, WenHan/0000-0002-2071-7258					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					73	73		10.1056/NEJMicm0801361	http://dx.doi.org/10.1056/NEJMicm0801361			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571285				2022-12-28	WOS:000267533100011
J	Kuhlen, M; Madau, P; Silk, J				Kuhlen, Michael; Madau, Piero; Silk, Joseph			Exploring Dark Matter with Milky Way Substructure	SCIENCE			English	Article							ANNIHILATION; RAYS; HALO	The unambiguous detection of dark matter annihilation in our Galaxy would unravel one of the most outstanding puzzles in particle physics and cosmology. Recent observations have motivated models in which the annihilation rate is boosted by the Sommerfeld effect, a nonperturbative enhancement arising from a long-range attractive force. We applied the Sommerfeld correction to Via Lactea II, a high-resolution N-body simulation of a Milky Way-sized galaxy, to investigate the phase-space structure of the galactic halo. We found that the annihilation luminosity from kinematically cold substructure could be enhanced by orders of magnitude relative to previous calculations, leading to the prediction of gamma-ray fluxes from as many as several hundred dark clumps that should be detectable by the Fermi satellite.	[Kuhlen, Michael] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; [Madau, Piero] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Silk, Joseph] Univ Oxford, Dept Phys, Oxford OX1 3RH, England	Institute for Advanced Study - USA; University of California System; University of California Santa Cruz; University of Oxford	Kuhlen, M (corresponding author), Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA.	mqk@ias.edu		silk, joe/0000-0002-1566-8148; Madau, Piero/0000-0002-6336-3293	NASA [NNX08AV68G]; Institute for Advanced Study	NASA(National Aeronautics & Space Administration (NASA)); Institute for Advanced Study(Institute for Advanced Study)	Supported by NASA grant NNX08AV68G (P.M.) and by the William L. Loughlin Fellowship at the Institute for Advanced Study (M.K.). This work would not have been possible without the expertise and invaluable contributions of all the members of the Via Lactea Project team. We thank M. Lattanzi, S. Profumo, N. Arkani-Hamed, N. Weiner, P. Meade, and T. Volansky for enlightening discussions; D. Shih for help with the Sommerfeld enhancement calculations; and M. Papucci for providing gamma ray spectra.	Abdo AA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.181101; Aharonian F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.221102; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Arkani-Hamed N, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.015014; Bovy J, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.083539; Chang J, 2008, NATURE, V456, P362, DOI 10.1038/nature07477; Diemand J, 2008, NATURE, V454, P735, DOI 10.1038/nature07153; Diemand J, 2007, ASTROPHYS J, V657, P262, DOI 10.1086/510736; Hisano J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.031303; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Kuhlen M, 2008, ASTROPHYS J, V686, P262, DOI 10.1086/590337; Kuhlen M, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.123517; Lattanzi M, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.083523; Lavalle J, 2008, ASTRON ASTROPHYS, V479, P427, DOI 10.1051/0004-6361:20078723; Madau P, 2008, ASTROPHYS J LETT, V689, pL41, DOI 10.1086/595814; March-Russell J, 2009, PHYS LETT B, V676, P133, DOI 10.1016/j.physletb.2009.04.010; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Pieri L, 2008, MON NOT R ASTRON SOC, V384, P1627, DOI 10.1111/j.1365-2966.2007.12828.x; Robertson BE, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.083525; SILK J, 1984, PHYS REV LETT, V53, P624, DOI 10.1103/PhysRevLett.53.624; Vogelsberger M, 2009, MON NOT R ASTRON SOC, V395, P797, DOI 10.1111/j.1365-2966.2009.14630.x; Zemp M, 2009, MON NOT R ASTRON SOC, V394, P641, DOI 10.1111/j.1365-2966.2008.14361.x	24	59	59	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					970	973		10.1126/science.1174881	http://dx.doi.org/10.1126/science.1174881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608862	Green Submitted			2022-12-28	WOS:000269242800039
J	Senju, A; Southgate, V; White, S; Frith, U				Senju, Atsushi; Southgate, Victoria; White, Sarah; Frith, Uta			Mindblind Eyes: An Absence of Spontaneous Theory of Mind in Asperger Syndrome	SCIENCE			English	Article							FUNCTIONING AUTISM; FALSE BELIEF; ANIMATED SHAPES; MENTAL STATES; ATTRIBUTION; CHILDREN; INFANTS; BRAIN; 2-YEAR-OLDS; UNDERSTAND	Adults with Asperger syndrome can understand mental states such as desires and beliefs (mentalizing) when explicitly prompted to do so, despite having impairments in social communication. We directly tested the hypothesis that such individuals nevertheless fail to mentalize spontaneously. To this end, we used an eye-tracking task that has revealed the spontaneous ability to mentalize in typically developing infants. We showed that, like infants, neurotypical adults' (n = 17 participants) eye movements anticipated an actor's behavior on the basis of her false belief. This was not the case for individuals with Asperger syndrome (n = 19). Thus, these individuals do not attribute mental states spontaneously, but they may be able to do so in explicit tasks through compensatory learning.	[Senju, Atsushi; Southgate, Victoria] Univ London, Ctr Brain & Cognit Dev, London, England; [White, Sarah; Frith, Uta] UCL, Inst Cognit Neurosci, London, England; [Frith, Uta] Aarhus Univ, Aarhus Univ Hosp, Ctr Functionally Integrat Neurosci, DK-800 Aarhus C, Denmark	University of London; Birkbeck University London; University of London; University College London; Aarhus University	Senju, A (corresponding author), Univ London, Ctr Brain & Cognit Dev, London, England.	a.senju@bbk.ac.uk	Senju, Atsushi/C-4097-2008; White, Sarah J/C-4084-2008; Frith, Uta/C-1757-2008	Senju, Atsushi/0000-0002-8081-7170; White, Sarah J/0000-0001-6946-9155; Frith, Uta/0000-0002-9063-4466; Southgate, Victoria/0000-0001-9328-3019	Economic and Social Research Council (ESRC); Medical Research Council of UK (MRC)/ESRC; MRC [G0701484]; Aarhus Research Foundation;  [RES-063-27-0207];  [PTA 037-27-0107]; Economic and Social Research Council [ES/E003273/1, ES/G007322/1] Funding Source: researchfish; Medical Research Council [G0701484] Funding Source: researchfish; ESRC [ES/G007322/1, ES/E003273/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council of UK (MRC)/ESRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus Research Foundation; ; ; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	A.S. was supported by an Economic and Social Research Council (ESRC) Research Fellowship (RES-063-27-0207), S.W. by a Medical Research Council of UK (MRC)/ESRC fellowship (PTA 037-27-0107), and U.F. by an MRC grant (G0701484) and the Aarhus Research Foundation.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron -Cohen S., 1997, MINDBLINDNESS ESSAY; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Corkum V, 1998, DEV PSYCHOL, V34, P28, DOI 10.1037/0012-1649.34.1.28; DENNETT DC, 1978, BEHAV BRAIN SCI, V1, P568, DOI 10.1017/S0140525X00076664; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; Frith U., 2003, AUTISM EXPLAINING EN; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Klin A, 2000, J CHILD PSYCHOL PSYC, V41, P831, DOI 10.1111/1469-7610.00671; Luckett T, 2002, J AUTISM DEV DISORD, V32, P127, DOI 10.1023/A:1014844722931; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Peterson CC, 2007, J CHILD PSYCHOL PSYC, V48, P1243, DOI 10.1111/j.1469-7610.2007.01810.x; Ruffman T, 2001, J CHILD PSYCHOL PSYC, V42, P1083, DOI 10.1111/1469-7610.00807; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Shamay-Tsoory SG, 2008, J AUTISM DEV DISORD, V38, P1451, DOI 10.1007/s10803-007-0515-9; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Wellman HA, 2008, DEV PSYCHOL, V44, P618, DOI 10.1037/0012-1649.44.2.618; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x	27	427	432	7	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					883	885		10.1126/science.1176170	http://dx.doi.org/10.1126/science.1176170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19608858	Green Accepted			2022-12-28	WOS:000269242400049
J	Feinmann, J				Feinmann, Jane			Adverse events You can say sorry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						*DEP HLTH, NAT PAT SAF FOR; Gallagher TH, 2007, NEW ENGL J MED, V356, P2713, DOI 10.1056/NEJMra070568; IEDEMA R, 2009, SOC HLTH ILLNESS, V2, P262; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; LANKSHEAR AJ, 2007, BEING OPEN PATIENTS; *NAT PAT SAF AG, 2008, BEING OP COMM PAT SA; Quinn RE, 2008, CLIN OBSTET GYNECOL, V51, P709, DOI 10.1097/GRF.0b013e3181899cc2; *SORRY WORKS, ED HEALTHC REF SORR; WOJCIESZAK D, 2008, SORRY WORKS; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	10	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2009	339								b3057	10.1136/bmj.40018.430972.4D	http://dx.doi.org/10.1136/bmj.40018.430972.4D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PH	19640937				2022-12-28	WOS:000268672900006
J	Butts, CT				Butts, Carter T.			Revisiting the Foundations of Network Analysis	SCIENCE			English	Editorial Material							COMMUNICATION; FRAMEWORK; DYNAMICS	Network analysis has emerged as a powerful way of studying phenomena as diverse as interpersonal interaction, connections among neurons, and the structure of the Internet. Appropriate use of network analysis depends, however, on choosing the right network representation for the problem at hand.	[Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Irvine, CA 92697 USA; [Butts, Carter T.] Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Butts, CT (corresponding author), Univ Calif Irvine, Dept Sociol, 3151 Social Sci Plaza, Irvine, CA 92697 USA.	buttsc@uci.edu						Bollobas B., 1998, MODERN GRAPH THEORY; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; BOYD JP, 1969, J MATH PSYCHOL, V6, P139, DOI 10.1016/0022-2496(69)90032-7; Brandes U, 2005, NETWWORK ANAL METHOL; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Butts CT, 2007, J MATH SOCIOL, V31, P121, DOI 10.1080/00222500601188056; Butts CT, 2006, SOC NETWORKS, V28, P283, DOI 10.1016/j.socnet.2005.07.003; Butts CT, 2008, SOCIOL METHODOL, V38, P155, DOI 10.1111/j.1467-9531.2008.00203.x; Butts CT, 2004, J MATH SOCIOL, V28, P81, DOI 10.1080/00222500490448208; BUTTS CT, 2006, 31 ANN HAZ RES APPL; Carley KM, 1996, SOC NETWORKS, V18, P1, DOI 10.1016/0378-8733(95)00252-9; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Faust K, 2007, SOCIOL METHODOL, V37, P209, DOI 10.1111/j.1467-9531.2007.00179.x; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Handcock MS, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P229; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Monge P. R., 2003, THEORIES COMMUNICATI, DOI 10.1093/oso/9780195160369.001.0001; Moody J, 2002, SOC FORCES, V81, P25, DOI 10.1353/sof.2002.0056; Morgan DL, 1997, SOC NETWORKS, V19, P9, DOI 10.1016/S0378-8733(96)00288-2; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 2007, SEXUALLY TRANSMITTED, pCH7; Murphy M, 1996, EUR J POPUL, V12, P363, DOI 10.1007/BF01796913; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Potterat JJ, 2002, SEX TRANSM INFECT, V78, pI152, DOI 10.1136/sti.78.suppl_1.i152; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Snijders TAB, 1996, J MATH SOCIOL, V21, P149, DOI 10.1080/0022250X.1996.9990178; STRAUSS D, 1986, SIAM REV, V28, P513, DOI 10.1137/1028156; STUTBACH D, 2006, P ACM SIGCOMM; Subramanian L, 2002, IEEE INFOCOM SER, P618, DOI 10.1109/INFCOM.2002.1019307; Wasserman S, 1997, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Willer D., 1999, NETWORK EXCHANGE THE	40	309	316	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					414	416		10.1126/science.1171022	http://dx.doi.org/10.1126/science.1171022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474AR	19628855				2022-12-28	WOS:000268255100039
J	van Onna, M; van Bemmel, T; van Wensen, E; Schaar, C; Slis, H; Spronk, PE				van Onna, Marieke; van Bemmel, Thomas; van Wensen, Erik; Schaar, Cees; Slis, Hein; Spronk, Peter E.			Endgames Case report Black and blue ... and unconscious	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMATOSE PATIENT		[van Onna, Marieke; van Bemmel, Thomas; van Wensen, Erik; Schaar, Cees; Slis, Hein; Spronk, Peter E.] Gelre Hosp, Dept Intens Care Med, NL-7334 DZ Apeldoorn, Netherlands	Gelre Hospitals	Spronk, PE (corresponding author), Gelre Hosp, Dept Intens Care Med, NL-7334 DZ Apeldoorn, Netherlands.	p.spronk@gelre.nl						*CENTR BUR STAT, 2004, GEZ WELZ; Halcomb SE, 2006, EUR J EMERG MED, V13, P364, DOI 10.1097/01.mej.0000228444.55899.70; Malik K, 2002, POSTGRAD MED, V111, P38, DOI 10.3810/pgm.2002.02.1106; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; YOUNG GB, 2007, UPTODATE	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2009	339								b2864	10.1136/bmj.b2864	http://dx.doi.org/10.1136/bmj.b2864			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475IL	19625351				2022-12-28	WOS:000268351700009
J	Angell, SY; Silver, LD; Goldstein, GP; Johnson, CM; Deitcher, DR; Frieden, TR; Bassett, MT				Angell, Sonia Y.; Silver, Lynn Dee; Goldstein, Gail P.; Johnson, Christine M.; Deitcher, Deborah R.; Frieden, Thomas R.; Bassett, Mary T.			Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction	ANNALS OF INTERNAL MEDICINE			English	Article							ACID CONTENT; US ADULTS; TRENDS; GUIDELINES; DISEASE; FOOD	Decades after key modifiable risk factors were identified, cardiovascular disease remains the leading cause of preventable death, and only one quarter of persons with high cholesterol levels have attained recommended levels of control. Cholesterol control efforts have focused on consumer education and medical treatment. A powerful, complementary approach is to change the makeup of food, a route the New York City Department of Health and Mental Hygiene took when it restricted artificial trans fat-a contributor to coronary heart disease-in restaurants. The Department first undertook a voluntary campaign, but this effort did not decrease the proportion of restaurants that used artificial trans fat. In December 2006, the Board of Health required that artificial trans fat be phased out of restaurant food. To support implementation, the Department provided technical assistance to restaurants. By November 2008, the restriction was in full effect in all New York City restaurants and estimated restaurant use of artificial trans fat for frying, baking, or cooking or in spreads had decreased from 50% to less than 2%. Preliminary analyses suggest that replacement of artificial trans fat has resulted in products with more healthful fatty acid profiles. For example, in major restaurant chains, total saturated fat plus trans fat in French fries decreased by more than 50%. At 2 years, dozens of national chains had removed artificial trans fat, and 13 jurisdictions, including California, had adopted similar laws. Public health efforts that change food content to make default choices healthier enable consumers to more successfully meet dietary recommendations and reduce their cardiovascular risk.	[Angell, Sonia Y.; Silver, Lynn Dee; Goldstein, Gail P.; Johnson, Christine M.; Deitcher, Deborah R.; Frieden, Thomas R.; Bassett, Mary T.] New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Silver, LD (corresponding author), New York City Hlth Dept, 2 Lafayette St,20th Floor,CN-46, New York, NY 10007 USA.	lsilver@health.nyc.gov		Silver, Lynn/0000-0002-2680-7393; Frieden, Thomas/0000-0002-4759-2256	American Heart Association	American Heart Association(American Heart Association)	By the City of New York. The American Heart Association provided an educational grant to support the Trans Fat Help Center.	Albers MJ, 2008, J AM DIET ASSOC, V108, P367, DOI 10.1016/j.jada.2007.10.045; ALLEN RR, 1996, BAILEYS IND OIL FAT, P213; *AM MED ASS HOUS D, 2006, RED T FAT CONT AM DI; [Anonymous], 2003, DIET NUTR PREV CHRON; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Beran MS, 2008, AM J LIFESTYLE MED, V2, P75, DOI 10.1177/1559827607308805; Brunner EJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub3; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; CARUSO DB, 2008, NYC KEEPS CANNOLI DR; Chrysam M. M., 1996, BAILEYS IND OIL FAT, P65; *CTR CONS FREED, 2007, WHOS WORST NANN 2007; DORFMAN B, 2008, MCDONALDS COOKING OI; Dzisiak D, 2006, AM HEART ASS T FAT C; GARDINER J, 2005, NEW YORK SUN    0811; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; HOFFMAN B, 2005, NEW YORK POST   0811, P2; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Marantz PR, 2008, AM J PREV MED, V34, P234, DOI 10.1016/j.amepre.2007.11.017; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; *NY CIT DEP HLTH M, 2008, NOT AD REP REEN ART; *NY CIT TRANS FAT, 2009, 0 GRAMS T FAT PROD L; Ratnayake WMN, 2009, EUR J CLIN NUTR, V63, P808, DOI 10.1038/ejcn.2008.39; SANTORA M, 2005, NY TIMES        0811, V1; STARK D, 2006, AM HEART ASS T FAT C; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Tarrago-Trani MT, 2006, J AM DIET ASSOC, V106, P867, DOI 10.1016/j.jada.2006.03.010; US Departement Of Health and Human Services, 2005, HYPERCHOLESTEROLEMIA, P1; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; *US FDA, 2006, HIST GRAS LIST SCOGS; Willett W, 2001, EAT DRINK BE HLTH HA; 2006, NEW YORK POST   0928, P26; 2003, FED REG         0711, P41434; 2003, FDA CONSUM, V37, P20	38	79	81	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					129	W33		10.7326/0003-4819-151-2-200907210-00010	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620165				2022-12-28	WOS:000268605300007
J	van der Meer, V; Bakker, MJ; van den Hout, WB; Rabe, KF; Sterk, PJ; Kievit, J; Assendelft, WJJ; Sont, JK				van der Meer, Victor; Bakker, Moira J.; van den Hout, Wilbert B.; Rabe, Klaus F.; Sterk, Peter J.; Kievit, Job; Assendelft, Willem J. J.; Sont, Jacob K.		SMASHING Self-Management Asthma	Internet-Based Self-management Plus Education Compared With Usual Care in Asthma A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; CHILDREN; ADULTS; VALIDITY; OUTCOMES; PROGRAM	Background: The Internet may support patient self-management of chronic conditions, such as asthma. Objective: To evaluate the effectiveness of Internet-based asthma self-management. Design: Randomized, controlled trial. Setting: 37 general practices and 1 academic outpatient department in the Netherlands. Patients: 200 adults with asthma who were treated with inhaled corticosteroids for 3 months or more during the previous year and had access to the Internet. Measurements: Asthma-related quality of life at 12 months (minimal clinically significant difference of 0.5 on the 7-point scale), asthma control, symptom-free days, lung function, and exacerbations. Intervention: Participants were randomly assigned by using a computer-generated permuted block scheme to Internet-based self-management (n = 101) or usual care (n = 99). The Internet-based self-management program included weekly asthma control monitoring and treatment advice, online and group education, and remote Web communications. Results: Asthma-related quality of life improved by 0.56 and 0.18 points in the Internet and usual care groups, respectively (adjusted between-group difference, 0.38 [95% CI, 0.20 to 0.56]). An improvement of 0.5 point or more occurred in 54% and 27% of Internet and usual care patients, respectively (adjusted relative risk, 2.00 [CI, 1.38 to 3.04]). Asthma control improved more in the Internet group than in the usual care group (adjusted difference, -0.47 [CI, -0.64 to -0.30]). At 12 months, 63% of Internet patients and 52% of usual care patients reported symptom-free days in the previous 2 weeks (adjusted absolute difference, 10.9% [CI, 0.05% to 21.3%]). Prebronchodilator FEV1 changed with 0.24 L and -0.01 L for Internet and usual care patients, respectively (adjusted difference, 0.25 L [CI, 0.03 to 0.46 L]). Exacerbations did not differ between groups. Limitation: The study was unblinded and lasted only 12 months. Conclusion: Internet-based self-management resulted in improvements in asthma control and lung function but did not reduce exacerbations, and improvement in asthma-related quality of life was slightly less than clinically significant.	[van der Meer, Victor] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; Univ Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	van der Meer, V (corresponding author), Leiden Univ, Med Ctr, Postzone J-10-S,Room J-10-87,Albinusdreef 2,POB 9, NL-2300 RC Leiden, Netherlands.	v.van_der_meer@lumc.nl	Toussaint, Pieter/O-9523-2016; assendelft, willem/AAW-1854-2021; Sont, Jacob K/J-8071-2015; Sterk, P.J./AAK-8175-2020; Rabe, Klaus F./AAW-6296-2021; Assendelft, W.J.J./H-8008-2014	Toussaint, Pieter/0000-0001-7340-7213; assendelft, willem/0000-0002-2966-3778; Sont, Jacob K/0000-0002-5840-0651; Rabe, Klaus F./0000-0002-7020-1401; Assendelft, W.J.J./0000-0002-2966-3778; van den Hout, Wilbert B./0000-0002-6425-0135	Netherlands Organization for Health Research and Development [945-04-061, 920-03-354]; Netherlands Asthma Foundation [3.4.03.45]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Asthma Foundation	By the Netherlands Organization for Health Research and Development (ZonMw grants 945-04-061 and 920-03-354) and Netherlands Asthma Foundation ( grant 3.4.03.45).	Armour C, 2007, THORAX, V62, P496, DOI 10.1136/thx.2006.064709; ASTHMA I, 2007, AM J RESP CRIT CARE, V175, P888; Chan DS, 2007, PEDIATRICS, V119, P569, DOI 10.1542/peds.2006-1884; Dennis SM, 2000, LANCET, V355, P1675, DOI 10.1016/S0140-6736(00)02238-8; Fonseca JA, 2005, CHEST, V128, P1258, DOI 10.1378/chest.128.3.1258; Geijer R M M, 2008, Ned Tijdschr Geneeskd, V152, P1146; Gibson PG, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001117], 10.1002/14651858.CD001117]; *GLOB IN ASTHM, 1995, NIH PUBL; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Jan RL, 2007, TELEMED J E-HEALTH, V13, P257, DOI 10.1089/tmj.2006.0053; Jones A, 2000, BMJ-BRIT MED J, V321, P1507, DOI 10.1136/bmj.321.7275.1507; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Kamps AWA, 2000, PEDIATR PULM, V29, P39, DOI 10.1002/(SICI)1099-0496(200001)29:1<39::AID-PPUL7>3.0.CO;2-G; Kritikos V, 2005, J ASTHMA, V42, P795, DOI 10.1080/02770900500308627; Lamberts H., 1987, ICPC INT CLASSIFICAT; Lemaigre V, 2005, CHEST, V128, P3133, DOI 10.1378/chest.128.5.3133; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; National Asthma Education and Prevention Program, 2007, 3 NIH NAT ASTHM ED P; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; O'Byrne PM, 2006, LANCET, V368, P794, DOI 10.1016/S0140-6736(06)69289-1; Pinnock H, 2003, BMJ-BRIT MED J, V326, P477, DOI 10.1136/bmj.326.7387.477; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Rasmussen LM, 2005, J ALLERGY CLIN IMMUN, V115, P1137, DOI 10.1016/j.jaci.2005.03.030; Solberg KE, 2008, LANCET, V371, P17, DOI 10.1016/S0140-6736(08)60052-5; Thoonen BPA, 2003, THORAX, V58, P30, DOI 10.1136/thorax.58.1.30; Twisk JWR, 2003, APPL LONGITUDINAL DA; van der Meer V, 2007, CHEST, V132, P112, DOI 10.1378/chest.06-2787; van der Palen J, 2001, PATIENT EDUC COUNS, V43, P161, DOI 10.1016/S0738-3991(00)00155-5; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127	35	137	139	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					110	W31		10.7326/0003-4819-151-2-200907210-00008	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00008			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620163				2022-12-28	WOS:000268605300005
J	Wilson, JF				Wilson, Jennifer Fisher			Can Disease Prevention Save Health Reform?	ANNALS OF INTERNAL MEDICINE			English	News Item							OBESITY; MONEY					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				American Medical Association, 2004, NAT SUMM OB BUILD PL; [Anonymous], HLTH WEIGHT ITS NOT; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; DeVol R, 2007, UNHEALTHY AM EC BURD; Dubnov-Raz G, 2008, ENDOCRIN METAB CLIN, V37, P873, DOI 10.1016/j.ecl.2008.08.002; Goetzel RZ, 2009, HEALTH AFFAIR, V28, P37, DOI 10.1377/hlthaff.28.1.37; Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566; Marmor T, 2009, ANN INTERN MED, V150, P485, DOI 10.7326/0003-4819-150-7-200904070-00114; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; PEAR R, 2009, NY TIMES        0511; PEAR R, 2009, NY TIMES        0514; Rashad I., 2006, E ECON J, V32, P133; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; THORPE K, 2009, HUFFINGTON POST 0225; Trust for America's Health, 2009, PREV HLTH AM INV DIS; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	17	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					145	148		10.7326/0003-4819-151-2-200907210-00021	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00021			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	478RH	19620172				2022-12-28	WOS:000268605300010
J	Boyd, M; Emery, S; Cooper, DA				Boyd, Mark; Emery, Sean; Cooper, David A.			Antiretroviral roll-out: the problem of second-line therapy	LANCET			English	Editorial Material							PUBLIC-HEALTH APPROACH; TREATMENT FAILURE; SCALE-UP; CRITERIA; OUTCOMES; AFRICA; ADULTS		[Boyd, Mark; Emery, Sean; Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Fac Med, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute	Boyd, M (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Fac Med, Sydney, NSW 2010, Australia.	mboyd@nchecr.unsw.edu.au	Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Boyd, Mark/0000-0002-6848-3307				Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Cooper D, 2007, LANCET, V370, P7, DOI 10.1016/S0140-6736(07)61024-1; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Humphreys EH, 2007, COCHRANE DB SYST REV, V4; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; World Health Organisation, 2007, PRIOR 2 LIN ANT DRUG; World Health Organization, 2006, ANT THER HIV INF AD	11	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 18	2009	374	9685					185	186		10.1016/S0140-6736(09)61313-1	http://dx.doi.org/10.1016/S0140-6736(09)61313-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19616706				2022-12-28	WOS:000268263000009
J	Carslaw, K				Carslaw, Ken			ATMOSPHERIC PHYSICS Cosmic rays, clouds and climate	NATURE			English	Editorial Material									Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Carslaw, K (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	k.s.carslaw@leeds.ac.uk	Carslaw, Ken S/C-8514-2009	Carslaw, Ken S/0000-0002-6800-154X				Carslaw KS, 2002, SCIENCE, V298, P1732, DOI 10.1126/science.1076964; Curtius J, 2006, SPACE SCI REV, V125, P159, DOI 10.1007/s11214-006-9054-5; Harrison RG, 2008, P ROY SOC A-MATH PHY, V464, P2575, DOI 10.1098/rspa.2008.0081; Harrison RG, 2008, P ROY SOC A-MATH PHY, V464, P2561, DOI 10.1098/rspa.2008.0009; Harrison RG, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014003; Kirkby J, 2007, SURV GEOPHYS, V28, P333, DOI 10.1007/s10712-008-9030-6; Pierce JR, 2007, ATMOS CHEM PHYS, V7, P1367, DOI 10.5194/acp-7-1367-2007; Pierce JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037946; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033038	9	27	28	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					332	333		10.1038/460332a	http://dx.doi.org/10.1038/460332a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606133				2022-12-28	WOS:000267979000021
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Addressing severe acute malnutrition where it matters	LANCET			English	Editorial Material							CHILD UNDERNUTRITION; MANAGEMENT; GROWTH		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Ashraf H, 2007, J TROP PEDIATRICS, V53, P171, DOI 10.1093/tropej/fmm005; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; Bhutta ZA, 2008, LANCET, V372, P1124, DOI 10.1016/S0140-6736(08)61458-0; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Colli E, 2006, EUR UROL, V49, P82, DOI 10.1016/j.eururo.2005.08.014; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Defourny I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005455; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; NIELSEN CC, 1992, TROP GEOGR MED, V44, P346	13	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					94	96		10.1016/S0140-6736(09)61264-2	http://dx.doi.org/10.1016/S0140-6736(09)61264-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472EG	19595329				2022-12-28	WOS:000268111600005
J	O'Connor, AB				O'Connor, Alec B.			The Need for Improved Access to FDA Reviews	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETIC PERIPHERAL NEUROPATHY; DOUBLE-BLIND; PREGABALIN; PUBLICATION; RELIEF		[O'Connor, Alec B.] Univ Rochester, Sch Med & Dent, Dept Med, Hosp Med Div, Rochester, NY 14642 USA	University of Rochester	O'Connor, AB (corresponding author), Strong Mem Hosp, Box HMD-MED,601 Elmwood Ave, Rochester, NY 14642 USA.	alec_oconnor@urmc.rochester.edu		O'Connor, Alec/0000-0001-8181-5567				*CTR DRUG EV RES, 21446 CTR DRUG EV RE; *CTR DRUG EV RES, 2008, MEM; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Lesser H, 2004, NEUROLOGY, V63, P2104, DOI 10.1212/01.WNL.0000145767.36287.A1; O'Connor AB, 2008, PHARMACOECONOMICS, V26, P1045, DOI 10.2165/0019053-200826120-00007; Oxford Centre for Evidence- basedMedicine-Le- vels of Evidence, 2009, BAS MED LEV EV; Richter RW, 2005, J PAIN, V6, P253, DOI 10.1016/j.jpain.2004.12.007; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Tolle T, 2008, EUR J PAIN, V12, P203, DOI 10.1016/j.ejpain.2007.05.003; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	13	38	41	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					191	193		10.1001/jama.2009.973	http://dx.doi.org/10.1001/jama.2009.973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584349				2022-12-28	WOS:000267696500029
J	Chou, R; Dana, T; Bougatsos, C				Chou, Roger; Dana, Tracy; Bougatsos, Christina			Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; EYE CATARACT-SURGERY; MACULAR DEGENERATION; REFRACTIVE ERROR; MICROBIAL KERATITIS; HEALTH-STATUS; RISK-FACTORS; VISION; FALLS; RANIBIZUMAB	Background: Impaired visual acuity is common in older adults. Screening for impaired visual acuity could lead to interventions to improve vision, function, and quality of life. Purpose: To update the 1996 U. S. Preventive Services Task Force evidence review on benefits and harms of screening for impaired visual acuity in primary care settings in adults age 65 years or older. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews were searched for studies published in English from 1996 to July 2008. Study Selection: Randomized trials and controlled observational studies that directly evaluated screening for impaired visual acuity in older adults were selected. To evaluate indirect evidence on screening, investigators included studies of diagnostic test accuracy and systematic reviews, randomized trials, and controlled observational studies of treatments for uncorrected refractive errors, cataracts, and age-related macular degeneration (AMD). Data Extraction: Details were abstracted about the patient sample, study design, data analysis, follow-up, and results. Quality was assessed by using predefined criteria. Data Synthesis: Direct evidence on screening and evidence on accuracy of diagnostic tests were synthesized qualitatively. For benefits and harms of treatments, quantitative estimates for treatment effects from good-quality systematic reviews were reported or relative risks using a random-effects model were calculated. Direct evidence shows that screening for vision impairment in older adults in primary care settings is not associated with improved visual or other clinical outcomes and may be associated with unintended harms, such as increased falls. Effective treatments are available for uncorrected refractive error, cataracts, and AMD. A visual acuity test (for example, the Snellen eye chart) is the standard for screening for vision impairment in primary care, but its diagnostic accuracy is uncertain because no studies compare it against a clinically relevant reference standard. There remains no evidence on accuracy of funduscopic examination. Limitations: A relatively small number of primary studies and methodological shortcomings made it difficult to reach conclusions with a high degree of confidence. In addition, studies not published in English and studies of community- or home-based screening were not included. Conclusion: More research is needed to understand why direct evidence shows no benefits of screening, even though impaired visual acuity is common and effective treatments are available.	[Chou, Roger; Dana, Tracy; Bougatsos, Christina] Oregon Hlth & Sci Ctr, Portland, OR USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [HHSA-290-2007-10057-I-EPC3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract HHSA-290-2007-10057-I-EPC3, Task Order No. 3).	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], 1982, Br J Ophthalmol, V66, P745; [Anonymous], 1991, Arch Ophthalmol, V109, P1220; APPLEGATE WB, 1987, JAMA-J AM MED ASSOC, V257, P1064; Ariyasu RG, 1996, OPHTHALMOLOGY, V103, P1751, DOI 10.1016/S0161-6420(96)30431-4; Arnold J, 2001, OPHTHALMOLOGY, V108, P841; Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Arnold JJ, 2004, AM J OPHTHALMOL, V137, P683, DOI 10.1016/j.ajo.2003.11.059; AVERY RL, GOOD NEWS ANTIVEGF T; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Bressler NM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1307; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chalmers RL, 2007, OPTOMETRY VISION SCI, V84, P573, DOI 10.1097/OPX.0b013e3180dc9a12; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Chou R., 2009, AHRQ PUBLICATION; Coleman AL, 2006, J AM GERIATR SOC, V54, P883, DOI 10.1111/j.1532-5415.2006.00817.x; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; D'Amico DJ, 2006, OPHTHALMOLOGY, V113, P992, DOI 10.1016/j.ophtha.2006.02.027; Eekhof JAH, 2000, SCAND J PRIM HEALTH, V18, P203; Eekhof JAH, 2000, FAM PRACT, V17, P329, DOI 10.1093/fampra/17.4.329; Evans JR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000253.pub2; Feher J, 2005, OPHTHALMOLOGICA, V219, P154, DOI 10.1159/000085248; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; FLEMING C, 2005, 34 AG HEALTHC RES QU; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Greve MDJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P448; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; HAWKINS BS, 1990, ARCH OPHTHALMOL-CHIC, V108, P816; HILLER R, 1983, AM J PUBLIC HEALTH, V73, P93, DOI 10.2105/AJPH.73.1.93; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Ivers RQ, 2001, OPHTHALMOLOGY, V108, P968, DOI 10.1016/S0161-6420(00)00649-7; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnson AR, 2007, J UROLOGY, V177, P639, DOI 10.1016/j.juro.2006.09.047; KAISER HJ, 1995, OPHTHALMOLOGICA, V209, P302, DOI 10.1159/000310646; Kaiser PK, 2006, GRAEF ARCH CLIN EXP, V244, P1132, DOI 10.1007/s00417-005-0199-9; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Lee AG, 2001, J AM GERIATR SOC, V49, P673; Leys A, 2008, EYE, V22, P792, DOI 10.1038/sj.eye.6702900; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lord SR, 2002, J AM GERIATR SOC, V50, P1760, DOI 10.1046/j.1532-5415.2002.50502.x; Lundstrom M, 2000, J CATARACT REFR SURG, V26, P408, DOI 10.1016/S0886-3350(99)00418-6; MANGIONE CM, 1994, ARCH OPHTHALMOL-CHIC, V112, P1419, DOI 10.1001/archopht.1994.01090230033017; McDonnell PJ, 2003, OPHTHALMOLOGY, V110, P2302, DOI 10.1016/j.ophtha.2003.02.004; McGwin G, 2000, ACCIDENT ANAL PREV, V32, P735, DOI 10.1016/S0001-4575(99)00123-2; McGwin G, 2003, OPHTHAL EPIDEMIOL, V10, P303, DOI 10.1076/opep.10.5.303.17323; McGwin G, 2003, OPHTHALMIC EPIDEMIOL, V10, P107, DOI 10.1076/opep.10.2.107.13900; MCMURDO M E T, 1988, Health Bulletin (Edinburgh), V46, P327; Meads C, 2003, Health Technol Assess, V7, pv; Meads C, 2003, HEALTH TECHNOL ASSES, V7, p[v, 1], DOI [10.3310/hta7090, DOI 10.3310/hta7090]; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; MURRAY A, 2005, SYSTEMATIC REV SAFET; National Institute for Health and Clinical Excellence, 2006, GUID MAN; Nilsson Sven Erik G., 1994, CLAO Journal, V20, P225; NORRIS SL, 2008, 61 AG HEALTHC RES QU; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Owsley C, 2002, JAMA-J AM MED ASSOC, V288, P841, DOI 10.1001/jama.288.7.841; Owsley C, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.118547; Owsley C, 2007, ARCH OPHTHALMOL-CHIC, V125, P1471, DOI 10.1001/archopht.125.11.1471; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3; SCHEIN OD, 1994, OPHTHALMOLOGY, V101, P1142; Schein OD, 2001, J CATARACT REFR SURG, V27, P665, DOI 10.1016/S0886-3350(01)00844-6; Schein OD, 2005, OPHTHALMOLOGY, V112, P2172, DOI 10.1016/j.ophtha.2005.09.014; Smeeth L, 2003, BMJ-BRIT MED J, V327, P1027, DOI 10.1136/bmj.327.7422.1027; STEINBERG EP, 1994, OPHTHALMOLOGY, V101, P1131; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1232; Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613; Tahzib NG, 2005, J CATARACT REFR SURG, V31, P1943, DOI 10.1016/j.jcrs.2005.08.022; Taylor HR, 2004, INVEST OPHTH VIS SCI, V45, P2539, DOI 10.1167/iovs.03-1198; Teh RCA, 2006, J AM GERIATR SOC, V54, P370, DOI 10.1111/j.1532-5415.2005.00592_4.x; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, pCH33; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Virgili G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004763.pub2; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Wang F, 1998, Ophthalmic Epidemiol, V5, P69, DOI 10.1076/opep.5.2.69.1575; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Woods RL, 1998, OPHTHALMOLOGY, V105, P2318, DOI 10.1016/S0161-6420(98)91235-0; Wormald R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002030.pub3	92	33	34	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					44	U81		10.7326/0003-4819-151-1-200907070-00008	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00008			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19581646				2022-12-28	WOS:000267946100006
J	Wegner, DM				Wegner, Daniel M.			How to Think, Say, or Do Precisely the Worst Thing for Any Occasion	SCIENCE			English	Review							THOUGHT SUPPRESSION; MENTAL CONTROL; UNWANTED MEMORIES; SOCIAL COGNITION; IRONIC PROCESSES; CHRONIC PAIN; ACCESSIBILITY; STEREOTYPES; ACCEPTANCE; STRATEGIES	In slapstick comedy, the worst thing that could happen usually does: The person with a sore toe manages to stub it, sometimes twice. Such errors also arise in daily life, and research traces the tendency to do precisely the worst thing to ironic processes of mental control. These monitoring processes keep us watchful for errors of thought, speech, and action and enable us to avoid the worst thing in most situations, but they also increase the likelihood of such errors when we attempt to exert control under mental load ( stress, time pressure, or distraction). Ironic errors in attention and memory occur with identifiable brain activity and prompt recurrent unwanted thoughts; attraction to forbidden desires; expression of objectionable social prejudices; production of movement errors; and rebounds of negative experiences such as anxiety, pain, and depression. Such ironies can be overcome when effective control strategies are deployed and mental load is minimized.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Wegner, DM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	wegner@wjh.harvard.edu			National Institute for Mental Health [MH 49127]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049127] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute for Mental Health grant MH 49127.	Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Adams HE, 1996, J ABNORM PSYCHOL, V105, P440, DOI 10.1037/0021-843X.105.3.440; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Ansfield ME, 1996, BEHAV RES THER, V34, P523, DOI 10.1016/0005-7967(96)00031-9; Arndt J, 1997, J PERS SOC PSYCHOL, V73, P5, DOI 10.1037/0022-3514.73.1.5; Bach P, 2002, J CONSULT CLIN PSYCH, V70, P1129, DOI 10.1037//0022-006X.70.5.1129; Bakker FC, 2006, INT J SPORT PSYCHOL, V37, P265; Bargh JA, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P361; Baudoin C, 1921, SUGGESTION AUTOSUGGE; Beevers CG, 1999, CLIN PSYCHOL-SCI PR, V6, P133, DOI 10.1093/clipsy/6.2.133; Beilock SL, 2001, J SPORT EXERCISE PSY, V23, P200, DOI 10.1123/jsep.23.3.200; Bryant RA, 2006, INT J CLIN EXP HYP, V54, P488, DOI 10.1080/00207140600857002; CIOFFI D, 1993, J PERS SOC PSYCHOL, V64, P274, DOI 10.1037/0022-3514.64.2.274; Darwin, 2003, ORIGIN SPECIES MEANS; Eastwood JD, 1998, INT J CLIN EXP HYP, V46, P77, DOI 10.1080/00207149808409991; Freud S., 1950, STANDARD EDITION COM, V1, P115; Galinsky AD, 2007, J EXP SOC PSYCHOL, V43, P833, DOI 10.1016/j.jesp.2006.09.001; Goubert L, 2004, PAIN, V110, P220, DOI 10.1016/j.pain.2004.03.034; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Harvey AG, 2000, BEHAV RES THER, V38, P1117, DOI 10.1016/S0005-7967(99)00150-3; HIGGINS ET, 1999, UNINTENDED THOUGHT, P75; James W., 1879, MIND, V13, P1, DOI DOI 10.1093/MIND/OS-4.13.1; King BJ, 1998, INT J CLIN EXP HYP, V46, P295, DOI 10.1080/00207149808410009; Koster EHW, 2003, BEHAV RES THER, V41, P1113, DOI 10.1016/S0005-7967(03)00144-X; LANE JD, 1995, J PERS SOC PSYCHOL, V69, P237, DOI 10.1037/0022-3514.69.2.237; Lane LW, 2006, PSYCHOL SCI, V17, P273, DOI 10.1111/j.1467-9280.2006.01697.x; Macrae CN, 1997, J PERS SOC PSYCHOL, V72, P709; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; MACRAE CN, 1994, J PERS SOC PSYCHOL, V67, P808, DOI 10.1037/0022-3514.67.5.808; Masedo AI, 2007, BEHAV RES THER, V45, P199, DOI 10.1016/j.brat.2006.02.006; MERRON J, 2003, ANKIEL CANT SEEM CON; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Monteith M J, 1998, Pers Soc Psychol Rev, V2, P63, DOI 10.1207/s15327957pspr0201_4; Muris P, 1996, BEHAV RES THER, V34, P501, DOI 10.1016/0005-7967(96)00005-8; Najmi S, 2008, CONSCIOUS COGN, V17, P114, DOI 10.1016/j.concog.2007.01.006; Newman LS, 1997, J PERS SOC PSYCHOL, V72, P980, DOI 10.1037/0022-3514.72.5.980; Nixon RDV, 2007, PERS INDIV DIFFER, V42, P677, DOI 10.1016/j.paid.2006.08.018; Page AC, 2005, J PERS SOC PSYCHOL, V88, P421, DOI 10.1037/0022-3514.88.3.421; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; POE EA, 1845, GRAHAMS LADYS GENTLE, V28, P1; Rassin E, 2000, CLIN PSYCHOL REV, V20, P973, DOI 10.1016/S0272-7358(99)00019-7; RUBIN HB, 1976, PSYCHOPHARMACOLOGY, V47, P123, DOI 10.1007/BF00735810; Schmidt RE, 2008, CONSCIOUS COGN, V17, P714, DOI 10.1016/j.concog.2007.09.002; Smart L, 1999, J PERS SOC PSYCHOL, V77, P474, DOI 10.1037/0022-3514.77.3.474; Taylor F, 2007, BEHAV RES THER, V45, P163, DOI 10.1016/j.brat.2006.01.005; Tolin DF, 2002, BEHAV RES THER, V40, P1255, DOI 10.1016/S0005-7967(01)00095-X; WEGNER DM, 1992, ADV EXP SOC PSYCHOL, V25, P193, DOI 10.1016/S0065-2601(08)60284-1; Wegner DM, 2004, PSYCHOL SCI, V15, P232, DOI 10.1111/j.0963-7214.2004.00657.x; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1993, J PERS SOC PSYCHOL, V65, P1093, DOI 10.1037/0022-3514.65.6.1093; WEGNER DM, 1992, J PERS SOC PSYCHOL, V63, P903, DOI 10.1037/0022-3514.63.6.903; Wegner DM, 1997, BEHAV RES THER, V35, P11, DOI 10.1016/S0005-7967(96)00078-2; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wegner DM, 1998, PSYCHOL SCI, V9, P196, DOI 10.1111/1467-9280.00037; WEGNER DM, 1995, J PERS SOC PSYCHOL, V68, P782, DOI 10.1037/0022-3514.68.5.782; WEGNER DM, 1990, J PERS SOC PSYCHOL, V58, P409, DOI 10.1037/0022-3514.58.3.409; Wegner DM, 1996, J PERS SOC PSYCHOL, V71, P680, DOI 10.1037/0022-3514.71.4.680; WEGNER DM, 1994, J PERS SOC PSYCHOL, V66, P287, DOI DOI 10.1037/0022-3514.66.2.287; Wenzlaff RM, 2000, PERS SOC PSYCHOL B, V26, P1200, DOI 10.1177/0146167200262003; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001	61	99	100	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					48	50		10.1126/science.1167346	http://dx.doi.org/10.1126/science.1167346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	465NL	19574380	Green Submitted			2022-12-28	WOS:000267594000029
J	Whiteway, JA; Komguem, L; Dickinson, C; Cook, C; Illnicki, M; Seabrook, J; Popovici, V; Duck, TJ; Davy, R; Taylor, PA; Pathak, J; Fisher, D; Carswell, AI; Daly, M; Hipkin, V; Zent, AP; Hecht, MH; Wood, SE; Tamppari, LK; Renno, N; Moores, JE; Lemmon, MT; Daerden, F; Smith, PH				Whiteway, J. A.; Komguem, L.; Dickinson, C.; Cook, C.; Illnicki, M.; Seabrook, J.; Popovici, V.; Duck, T. J.; Davy, R.; Taylor, P. A.; Pathak, J.; Fisher, D.; Carswell, A. I.; Daly, M.; Hipkin, V.; Zent, A. P.; Hecht, M. H.; Wood, S. E.; Tamppari, L. K.; Renno, N.; Moores, J. E.; Lemmon, M. T.; Daerden, F.; Smith, P. H.			Mars Water-Ice Clouds and Precipitation	SCIENCE			English	Article							VAPOR; CYCLE	The light detection and ranging instrument on the Phoenix mission observed water-ice clouds in the atmosphere of Mars that were similar to cirrus clouds on Earth. Fall streaks in the cloud structure traced the precipitation of ice crystals toward the ground. Measurements of atmospheric dust indicated that the planetary boundary layer (PBL) on Mars was well mixed, up to heights of around 4 kilometers, by the summer daytime turbulence and convection. The water-ice clouds were detected at the top of the PBL and near the ground each night in late summer after the air temperature started decreasing. The interpretation is that water vapor mixed upward by daytime turbulence and convection forms ice crystal clouds at night that precipitate back toward the surface.	[Whiteway, J. A.; Komguem, L.; Dickinson, C.; Cook, C.; Illnicki, M.; Seabrook, J.; Popovici, V.; Davy, R.; Taylor, P. A.; Pathak, J.] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada; [Duck, T. J.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Fisher, D.] Nat Resources Canada, Geol Survey Canada, Natl Glaciol Grp, Ottawa, ON, Canada; [Carswell, A. I.] Optech, Vaughan, ON, Canada; [Daly, M.] MDA, Brampton, ON, Canada; [Hipkin, V.] CSA, St Hubert, PQ, Canada; [Zent, A. P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Hecht, M. H.; Tamppari, L. K.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Wood, S. E.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Renno, N.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Moores, J. E.; Smith, P. H.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Lemmon, M. T.] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX USA; [Daerden, F.] Belgian Inst Space Aeron BIRA IASB, Brussels, Belgium	York University - Canada; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Arizona; Texas A&M University System; Texas A&M University College Station	Whiteway, JA (corresponding author), York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada.	whiteway@yorku.ca	Davy, Richard/GWC-5040-2022; Davy, Richard/H-8387-2016; Lemmon, Mark/X-2333-2019; Lemmon, Mark T/E-9983-2010; Wood, Stephen/R-5592-2016; Davy, Richard/AAK-9303-2021; Daly, Michael/AAO-6623-2021; Moores, John E./AAO-6622-2021; Daerden, Frank/S-8759-2017	Davy, Richard/0000-0001-9639-5980; Davy, Richard/0000-0001-9639-5980; Lemmon, Mark/0000-0002-4504-5136; Lemmon, Mark T/0000-0002-4504-5136; Wood, Stephen/0000-0002-9330-434X; Daly, Michael/0000-0002-3733-2530; Moores, John E./0000-0001-9435-1095; Daerden, Frank/0000-0001-7433-1839; Hecht, Michael/0000-0002-4114-4583	CSA [9F007-070437/001/SR]; University of Arizona; Jet Propulsion Laboratory	CSA; University of Arizona; Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA))	This work was enabled by funding from the CSA under contract 9F007-070437/001/SR. The Phoenix mission was led by the University of Arizona, on behalf of NASA, and managed by the Jet Propulsion Laboratory.	DAVIES DW, 1979, J GEOPHYS RES, V84, P8335, DOI 10.1029/JB084iB14p08335; Davy R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010481; Field PR, 2006, ATMOS CHEM PHYS, V6, P2991, DOI 10.5194/acp-6-2991-2006; Fuchs N. A., 1964, MECH AEROSOLS; Gallagher MW, 2005, Q J ROY METEOR SOC, V131, P1143, DOI 10.1256/qj.03.138; Heymsfield AJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022742; KAHN R, 1990, J GEOPHYS RES-SOLID, V95, P14677, DOI 10.1029/JB095iB09p14677; RYAN JA, 1982, J GEOPHYS RES-OCEANS, V87, P7279, DOI 10.1029/JC087iC09p07279; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Smith PH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003083; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Titov DV, 1999, J GEOPHYS RES-PLANET, V104, P9019, DOI 10.1029/1998JE900046; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018; Whiteway J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021201; Whiteway J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003002; Zent AP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2007JE003052	16	149	149	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					68	70		10.1126/science.1172344	http://dx.doi.org/10.1126/science.1172344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574386				2022-12-28	WOS:000267594000035
J	Vaidya, B; Chakera, AJ; Dick, C				Vaidya, Bijay; Chakera, Ali J.; Dick, Catherine			Easily Missed? Addison's disease	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADRENAL INSUFFICIENCY		[Vaidya, Bijay; Chakera, Ali J.] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Dick, Catherine] Devon Primary Care Trust, Exeter EX3 0EN, Devon, England; [Vaidya, Bijay] Peninsula Med Sch, Exeter, Devon, England	University of Exeter; University of Exeter	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	bijay.vaidya@pms.ac.uk	Vaidya, Bijay/AAF-1947-2020	Vaidya, Bijay/0000-0002-2223-0494				Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Brosnan CM, 1996, BRIT MED J, V312, P1085; Hilditch K, 2000, BRIT MED J, V321, P645, DOI 10.1136/bmj.321.7261.645; Kendereski A, 1999, J ENDOCRINOL INVEST, V22, P395, DOI 10.1007/BF03343579; Likhari T, 2007, POSTGRAD MED J, V83, P420, DOI 10.1136/pgmj.2007.058321; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Murray JS, 2001, BRIT MED J, V323, P332, DOI 10.1136/bmj.323.7308.332; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; Simm PJ, 2004, J PAEDIATR CHILD H, V40, P596, DOI 10.1111/j.1440-1754.2004.00482.x; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909	10	14	14	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 2	2009	339								b2385	10.1136/bmj.b2385	http://dx.doi.org/10.1136/bmj.b2385			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QZ	19574315				2022-12-28	WOS:000267678700004
J	Hsieh, D; Xia, Y; Qian, D; Wray, L; Dil, JH; Meier, F; Osterwalder, J; Patthey, L; Checkelsky, JG; Ong, NP; Fedorov, AV; Lin, H; Bansil, A; Grauer, D; Hor, YS; Cava, RJ; Hasan, MZ				Hsieh, D.; Xia, Y.; Qian, D.; Wray, L.; Dil, J. H.; Meier, F.; Osterwalder, J.; Patthey, L.; Checkelsky, J. G.; Ong, N. P.; Fedorov, A. V.; Lin, H.; Bansil, A.; Grauer, D.; Hor, Y. S.; Cava, R. J.; Hasan, M. Z.			A tunable topological insulator in the spin helical Dirac transport regime	NATURE			English	Article							ELECTRONIC-STRUCTURE; BI2TE3; CONE	Helical Dirac fermions-charge carriers that behave as massless relativistic particles with an intrinsic angular momentum (spin) locked to its translational momentum-are proposed to be the key to realizing fundamentally new phenomena in condensed matter physics(1-9). Prominent examples include the anomalous quantization of magneto-electric coupling(4-6), half-fermion states that are their own antiparticle(7,8), and charge fractionalization in a Bose-Einstein condensate(9), all of which are not possible with conventional Dirac fermions of the graphene variety(10). Helical Dirac fermions have so far remained elusive owing to the lack of necessary spin-sensitive measurements and because such fermions are forbidden to exist in conventional materials harbouring relativistic electrons, such as graphene(10) or bismuth(11). It has recently been proposed that helical Dirac fermions may exist at the edges of certain types of topologically ordered insulators(3,4,12)-materials with a bulk insulating gap of spin-orbit origin and surface states protected against scattering by time-reversal symmetry-and that their peculiar properties may be accessed provided the insulator is tuned into the so-called topological transport regime(3-9). However, helical Dirac fermions have not been observed in existing topological insulators(13-18). Here we report the realization and characterization of a tunable topological insulator in a bismuth-based class of material by combining spin-imaging and momentum-resolved spectroscopies, bulk charge compensation, Hall transport measurements and surface quantum control. Our results reveal a spin-momentum locked Dirac cone carrying a non-trivial Berry's phase that is nearly 100 per cent spin-polarized, which exhibits a tunable topological fermion density in the vicinity of the Kramers point and can be driven to the long-sought topological spin transport regime. The observed topological nodal state is shown to be protected even up to 300 K. Our demonstration of room-temperature topological order and non-trivial spin-texture in stoichiometric Bi2Se3.M-x (M-x indicates surface doping or gating control) paves the way for future graphene-like studies of topological insulators, and applications of the observed spin-polarized edge channels in spintronic and computing technologies possibly at room temperature.	[Hsieh, D.; Xia, Y.; Qian, D.; Wray, L.; Checkelsky, J. G.; Ong, N. P.; Hasan, M. Z.] Princeton Univ, Joseph Henry Labs Phys, Dept Phys, Princeton, NJ 08544 USA; [Grauer, D.; Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Hasan, M. Z.] Princeton Univ, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA; [Hasan, M. Z.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; [Qian, D.] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200030, Peoples R China; [Dil, J. H.; Meier, F.; Patthey, L.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Dil, J. H.; Meier, F.; Osterwalder, J.] Univ Zurich Irchel, Inst Phys, CH-8057 Zurich, Switzerland; [Fedorov, A. V.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Lin, H.; Bansil, A.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Princeton University; Princeton University; Princeton University; Princeton University; Shanghai Jiao Tong University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Northeastern University	Hasan, MZ (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Dept Phys, Princeton, NJ 08544 USA.	mzhasan@Princeton.edu	Ong, N. Phuan/Z-1626-2019; Patthey, Luc/G-6130-2018; Lin, Hsin/F-9568-2012; Dil, Hugo/F-6995-2012; San Hor, Yew/S-1429-2017; Grauer, David/F-2777-2011; Qian, Dong/O-1028-2015; HASAN, M. Zahid/D-8237-2012	Patthey, Luc/0000-0001-6101-8069; Lin, Hsin/0000-0002-4688-2315; Dil, Hugo/0000-0002-6016-6120; San Hor, Yew/0000-0002-1417-4357; Ong, N. Phuan/0000-0001-7166-1058; Fedorov, Alexei/0000-0003-3510-3117; Wray, L. Andrew/0000-0001-8977-0201	Basic Energy Sciences of the US Department of Energy [DE-FG-02-05ER46200, AC03-76SF00098, DE-FG02-07ER46352]; Swiss Light Source, Paul Scherrer Institute; NSF through the Princeton Center for Complex Materials [DMR-0819860]; Princeton University; A. P. Sloan Foundation; R. H. Dicke; Kavli Institute of Theoretical Physics at Santa Barbara	Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Swiss Light Source, Paul Scherrer Institute; NSF through the Princeton Center for Complex Materials; Princeton University(Princeton University); A. P. Sloan Foundation(Alfred P. Sloan Foundation); R. H. Dicke; Kavli Institute of Theoretical Physics at Santa Barbara	We acknowledge the following people for discussions: P. W. Anderson, B. Altshuler, L. Balents, M. R. Beasley, B. A. Bernevig, C. Callan, J. C. Davis, H. Fertig, E. Fradkin, L. Fu, D. Gross, D. Haldane, K. Le Hur, B. I. Halperin, D. A. Huse, C. L. Kane, C. Kallin, E. A. Kim, R. B. Laughlin, D.- H. Lee, P. A. Lee, J. E. Moore, A. J. Millis, A. H. Castro Neto, J. Orenstein, P. Phillips, S. Sachdev, Dan C. Tsui, A. Vishwanath, F. Wilczek, X.-G. Wen and A. Yazdani. The spin- resolved and spin- integrated ARPES measurements using synchrotron X-ray facilities and theoretical computations are supported by the Basic Energy Sciences of the US Department of Energy (DE-FG-02-05ER46200, AC03-76SF00098 and DE-FG02-07ER46352) and by the Swiss Light Source, Paul Scherrer Institute. Materials growth and characterization are supported by the NSF through the Princeton Center for Complex Materials (DMR-0819860) and Princeton University. M. Z. H. acknowledges additional support from the A. P. Sloan Foundation, an R. H. Dicke fellowship research grant and the Kavli Institute of Theoretical Physics at Santa Barbara.	Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; BLACK J, 1957, J PHYS CHEM SOLIDS, V2, P240, DOI 10.1016/0022-3697(57)90090-2; Blaha P., 2001, COMPUTER CODE WIEN2K; Checkelsky JG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115434; DAY C, 2009, PHYS TODAY, V62, P12; Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; HOESCH M, 2002, THESIS U ZURICH; Hor YS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195208; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Hufner S., 1995, PHOTOELECTRON SPECTR; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Li L, 2008, SCIENCE, V321, P547, DOI 10.1126/science.1158908; Meier F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165431; Mishra SK, 1997, J PHYS-CONDENS MAT, V9, P461, DOI 10.1088/0953-8984/9/2/014; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Moore J, 2009, NAT PHYS, V5, P378, DOI 10.1038/nphys1294; NISHIDE A, 2009, DIRECT MAPPING SPIN; Noh HJ, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/57006; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Petkov V, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.092105; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; SERADJEH B, 2009, EXCITON CONDENSATION; THOMAS GA, 1992, PHYS REV B, V46, P1553, DOI 10.1103/PhysRevB.46.1553; Urazhdin S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.085313; Wang GF, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075201; WILCZEK F, 1982, PHYS REV LETT, V48, P1146, DOI 10.1103/PhysRevLett.48.1146; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhou SY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.086402	35	1542	1551	23	820	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1101	U59		10.1038/nature08234	http://dx.doi.org/10.1038/nature08234			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19620959	Green Accepted, Green Submitted			2022-12-28	WOS:000269314000032
J	Orso, G; Pendin, D; Liu, S; Tosetto, J; Moss, TJ; Faust, JE; Micaroni, M; Egorova, A; Martinuzzi, A; McNew, JA; Daga, A				Orso, Genny; Pendin, Diana; Liu, Song; Tosetto, Jessica; Moss, Tyler J.; Faust, Joseph E.; Micaroni, Massimo; Egorova, Anastasia; Martinuzzi, Andrea; McNew, James A.; Daga, Andrea			Homotypic fusion of ER membranes requires the dynamin-like GTPase Atlastin	NATURE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; DROSOPHILA; PROTEINS; RECONSTITUTION; MORPHOGENESIS; LIPOSOMES; NEURONS	Establishment and maintenance of proper architecture is essential for endoplasmic reticulum (ER) function. Homotypic membrane fusion is required for ER biogenesis and maintenance, and has been shown to depend on GTP hydrolysis. Here we demonstrate that Drosophila Atlastin-the fly homologue of the mammalian GTPase atlastin 1 involved in hereditary spastic paraplegia-localizes on ER membranes and that its loss causes ER fragmentation. Drosophila Atlastin embedded in distinct membranes has the ability to form trans-oligomeric complexes and its overexpression induces enlargement of ER profiles, consistent with excessive fusion of ER membranes. In vitro experiments confirm that Atlastin autonomously drives membrane fusion in a GTP-dependent fashion. In contrast, GTPase-deficient Atlastin is inactive, unable to form trans-oligomeric complexes owing to failure to self-associate, and incapable of promoting fusion in vitro. These results demonstrate that Atlastin mediates membrane tethering and fusion and strongly suggest that it is the GTPase activity that is required for ER homotypic fusion.	[Orso, Genny; Pendin, Diana; Tosetto, Jessica; Martinuzzi, Andrea; Daga, Andrea] Eugenio Medea Sci Inst, I-31015 Conegliano, Italy; [Liu, Song; Moss, Tyler J.; Faust, Joseph E.; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Tosetto, Jessica] Univ Padua, Dept Pharmacol, I-35131 Padua, Italy; [Micaroni, Massimo] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Egorova, Anastasia] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; [Daga, Andrea] Eugenio Medea Sci Inst, Dulbecco Telethon Inst, I-35131 Padua, Italy; [Daga, Andrea] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	IRCCS Eugenio Medea; Rice University; University of Padua; University of Queensland; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Daga, A (corresponding author), Eugenio Medea Sci Inst, I-31015 Conegliano, Italy.	mcnew@rice.edu; daga@unipd.it	daga, andrea/J-1865-2018; McNew, James/AAV-4911-2020; Martinuzzi, Andrea/AAC-3127-2022; Orso, Genny/C-6492-2016; McNew, James/ABD-8081-2020; Pendin, Diana/K-7868-2016; Liu, Song/E-2254-2011; Martinuzzi, Andrea/K-3887-2016	daga, andrea/0000-0001-8935-5489; McNew, James/0000-0001-8459-3664; Orso, Genny/0000-0002-2959-8806; Pendin, Diana/0000-0003-2827-935X; Martinuzzi, Andrea/0000-0002-0319-3579; Faust, Joseph/0000-0002-2183-8529; Micaroni, Massimo/0000-0001-6405-0451; Moss, Tyler/0000-0001-7140-9987	National Institutes of Health [GM71832]; G. Harold and Leila Mathers Charitable Foundation; Telethon-Italy; Italian Ministry of Health and the Foundation Compagnia di San Paolo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Mathers Charitable Foundation; Telethon-Italy(Fondazione Telethon); Italian Ministry of Health and the Foundation Compagnia di San Paolo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lippincott-Schwartz, R. Rikhy, M. Buszczak, M. Ramaswami and J. Kim for providing Drosophila strains, A. Gazziero for generating transgenic lines, and E. Giordano for the provision of the SympUAST vector. We thank M. G. Rossetto for support throughout the duration of the work, N. D'Elia for technical assistance, R. Polishchuck and the Telethon EM core facility, and W. Guo for help with EM analysis of negative stained Drosophila Atlastin proteoliposomes. This work was supported by grants from the National Institutes of Health (GM71832) and the G. Harold and Leila Mathers Charitable Foundation to J. A. M., and from Telethon-Italy, the Italian Ministry of Health and the Foundation Compagnia di San Paolo to A. D.	Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; BRAND AH, 1993, DEVELOPMENT, V118, P401; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Lee Y, 2008, NEUROBIOL AGING, V29, P84, DOI 10.1016/j.neurobiolaging.2006.09.004; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Polishchuk R S, 2001, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0408s11; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakefield S, 2006, CELL MOL LIFE SCI, V63, P2027, DOI 10.1007/s00018-006-6142-3; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	30	320	329	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					978	U58		10.1038/nature08280	http://dx.doi.org/10.1038/nature08280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19633650				2022-12-28	WOS:000269085500027
J	Purcell, SM; Wray, NR; Stone, JL; Visscher, PM; O'Donovan, MC; Sullivan, PF; Sklar, P; Ruderfer, DM; McQuillin, A; Morris, DW; O'Dushlaine, CT; Corvin, A; Holmans, PA; Macgregor, S; Gurling, H; Blackwood, DHR; Craddock, NJ; Gill, M; Hultman, CM; Kirov, GK; Lichtenstein, P; Muir, WJ; Owen, MJ; Pato, CN; Scolnick, EM; St Clair, D; Williams, NM; Georgieva, L; Nikolov, I; Norton, N; Williams, H; Toncheva, D; Milanova, V; Thelander, EF; Sullivan, P; Kenny, E; Quinn, EM; Choudhury, K; Datta, S; Pimm, J; Thirumalai, S; Puri, V; Krasucki, R; Lawrence, J; Quested, D; Bass, N; Crombie, C; Fraser, G; Kuan, SL; Walker, N; McGhee, KA; Pickard, B; Malloy, P; Maclean, AW; Van Beck, M; Pato, MT; Medeiros, H; Middleton, F; Carvalho, C; Morley, C; Fanous, A; Conti, D; Knowles, JA; Ferreira, CP; Macedo, A; Azevedo, MH; Kirby, AN; Ferreira, MAR; Daly, MJ; Chambert, K; Kuruvilla, F; Gabriel, SB; Ardlie, K; Moran, JL				Purcell, Shaun M.; Wray, Naomi R.; Stone, Jennifer L.; Visscher, Peter M.; O'Donovan, Michael C.; Sullivan, Patrick F.; Sklar, Pamela; Ruderfer, Douglas M.; McQuillin, Andrew; Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Holmans, Peter A.; Macgregor, Stuart; Gurling, Hugh; Blackwood, Douglas H. R.; Craddock, Nick J.; Gill, Michael; Hultman, Christina M.; Kirov, George K.; Lichtenstein, Paul; Muir, Walter J.; Owen, Michael J.; Pato, Carlos N.; Scolnick, Edward M.; St Clair, David; Williams, Nigel M.; Georgieva, Lyudmila; Nikolov, Ivan; Norton, N.; Williams, H.; Toncheva, Draga; Milanova, Vihra; Thelander, Emma F.; Sullivan, Patrick; Kenny, Elaine; Quinn, Emma M.; Choudhury, Khalid; Datta, Susmita; Pimm, Jonathan; Thirumalai, Srinivasa; Puri, Vinay; Krasucki, Robert; Lawrence, Jacob; Quested, Digby; Bass, Nicholas; Crombie, Caroline; Fraser, Gillian; Kuan, Soh Leh; Walker, Nicholas; McGhee, Kevin A.; Pickard, Ben; Malloy, Pat; Maclean, Alan W.; Van Beck, Margaret; Pato, Michele T.; Medeiros, Helena; Middleton, Frank; Carvalho, Celia; Morley, Christopher; Fanous, Ayman; Conti, David; Knowles, James A.; Ferreira, Carlos Paz; Macedo, Antonio; Azevedo, M. Helena; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly; Kuruvilla, Finny; Gabriel, Stacey B.; Ardlie, Kristin; Moran, Jennifer L.			Common polygenic variation contributes to risk of schizophrenia and bipolar disorder	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE RARE ALLELES; PSYCHIATRIC-DISORDERS; DISEASE; GENES; LOCI; TWIN	Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%(1,2). We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.	[Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Ferreira, Manuel A. R.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Scolnick, Edward M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Scolnick, Edward M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Purcell, Shaun M.; Stone, Jennifer L.; Sklar, Pamela; Ruderfer, Douglas M.; Kirby, Andrew N.; Ferreira, Manuel A. R.; Daly, Mark J.; Chambert, Kimberly; Kuruvilla, Finny; Gabriel, Stacey B.; Ardlie, Kristin; Moran, Jennifer L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wray, Naomi R.; Visscher, Peter M.; Macgregor, Stuart] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [O'Donovan, Michael C.; Holmans, Peter A.; Craddock, Nick J.; Kirov, George K.; Owen, Michael J.; Williams, Nigel M.; Georgieva, Lyudmila; Nikolov, Ivan; Norton, N.; Williams, H.] Cardiff Univ, Sch Med, Dept Psychol Med, MRC Ctr Neuropsychiat Genet & Gen, Cardiff C14 4XN, Wales; [Sullivan, Patrick F.; Sullivan, Patrick] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.; Sullivan, Patrick] Univ N Carolina, Dept Psychiat & Epidemiol, Chapel Hill, NC 27599 USA; [McQuillin, Andrew; Gurling, Hugh; Choudhury, Khalid; Datta, Susmita; Pimm, Jonathan; Puri, Vinay; Krasucki, Robert; Lawrence, Jacob; Bass, Nicholas] UCL, Sch Med, Mol Psychiat Lab, Res Dept Mental Hlth Sci,Windeyer Inst Med Sci, London W1T 4JF, England; [Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Gill, Michael; Kenny, Elaine; Quinn, Emma M.] Univ Dublin Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Morris, Derek W.; O'Dushlaine, Colm T.; Corvin, Aiden; Gill, Michael; Kenny, Elaine; Quinn, Emma M.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 2, Ireland; [Blackwood, Douglas H. R.; Muir, Walter J.; McGhee, Kevin A.; Pickard, Ben; Malloy, Pat; Maclean, Alan W.; Van Beck, Margaret] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Hultman, Christina M.; Lichtenstein, Paul; Thelander, Emma F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci, SE-75017 Uppsala, Sweden; [Pato, Carlos N.; Pato, Michele T.; Medeiros, Helena; Carvalho, Celia; Fanous, Ayman; Conti, David; Knowles, James A.] Univ So Calif, Ctr Genom Psychiat, Los Angeles, CA 90033 USA; [St Clair, David; Walker, Nicholas] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Crombie, Caroline; Fraser, Gillian] Univ Aberdeen, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Toncheva, Draga] Univ Hosp Maichin Dom, Dept Med Genet, Sofia 1431, Bulgaria; [Milanova, Vihra] Alexander Univ Hosp, Psychiat Clin 1, Dept Psychiat, Sofia 1431, Bulgaria; [Thirumalai, Srinivasa] W Berkshire NHS Trust, Reading RG3 5LR, Berks, England; [Quested, Digby] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Kuan, Soh Leh] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Middleton, Frank; Morley, Christopher] SUNY Syracuse, Upstate Med Univ Syracuse, Syracuse, NY 13210 USA; [Fanous, Ayman] Washington VA Med Ctr, Washington, DC 20422 USA; [Fanous, Ayman] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, Ayman] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Ferreira, Carlos Paz] Dept Psychiat, P-9500310 Sao Miguel, Azores, Portugal; [Macedo, Antonio; Azevedo, M. Helena] Univ Coimbra, Dept Psychiat, P-3004504 Coimbra, Portugal	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; QIMR Berghofer Medical Research Institute; Cardiff University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; UCL Medical School; Trinity College Dublin; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; Karolinska Institutet; Uppsala University; University of Southern California; University of Aberdeen; University of Aberdeen; Medical University Sofia; Medical University Sofia; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Georgetown University; Virginia Commonwealth University; Universidade de Coimbra	Sklar, P (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, 185 Cambridge St, Boston, MA 02114 USA.	shaun@pngu.mgh.harvard.edu; sklar@chgr.mgh.harvard.edu	Morris, Derek/AAW-8343-2021; macedo, antónio/AFQ-1570-2022; St Clair, David/AAN-2412-2021; Williams, Hywel/AAL-2440-2021; Fanous, Ayman H/O-1263-2017; Barreto Carvalho, Célia/AAY-8962-2021; Gurling, Hugh M/A-5029-2010; Daly, Mark J/B-2453-2017; Visscher, Peter/ABB-6151-2020; Macgregor, Stuart/C-6442-2009; McQuillin, Andrew/C-1623-2008; THOMAS, Sean C./B-6089-2008; Holmans, Peter/F-4518-2015; Morley, Christopher P./K-1907-2014; macedo santos, antónio/M-5737-2013; macedo, antónio/AFQ-1571-2022; Ruderfer, Douglas M/M-5795-2016; Ferreira, Manuel A R/D-3609-2013; blackwood, douglas/AIB-8874-2022; Wray, Naomi/C-8639-2015; Pickard, Benjamin S/K-3923-2014; Morley, Christopher P./W-5037-2019; anand, amit/A-7222-2009; O'Donovan, Michael C/P-7005-2018	Morris, Derek/0000-0002-3413-570X; macedo, antónio/0000-0003-2180-2718; Williams, Hywel/0000-0001-7758-0312; Daly, Mark J/0000-0002-0949-8752; Visscher, Peter/0000-0002-2143-8760; Macgregor, Stuart/0000-0001-6731-8142; McQuillin, Andrew/0000-0003-1567-2240; THOMAS, Sean C./0000-0002-0686-2483; Holmans, Peter/0000-0003-0870-9412; Morley, Christopher P./0000-0003-0185-7148; macedo santos, antónio/0000-0003-2180-2718; macedo, antónio/0000-0003-2180-2718; Ruderfer, Douglas M/0000-0002-2365-386X; Ferreira, Manuel A R/0000-0001-9059-1825; Wray, Naomi/0000-0001-7421-3357; Pickard, Benjamin S/0000-0002-2374-6329; Morley, Christopher P./0000-0003-0185-7148; O'Donovan, Michael C/0000-0001-7073-2379; Middleton, Frank/0000-0002-3107-7188; Walters, James/0000-0002-6980-4053; lichtenstein, paul/0000-0003-3037-5287; Quested, Digby/0000-0001-6155-3336; Toncheva, Draga/0000-0002-7451-6363; Kirov, George/0000-0002-3427-3950; Corvin, Aiden/0000-0001-6717-4089; Gill, Michael/0000-0003-0206-5337; de Oliveira Barreto Coimbra Carvalho, Celia Maria/0000-0003-4453-8139; Moran, Jennifer/0000-0002-5664-4716	Stanley Medical Research Institute; Sylvan C. Herman Foundation [MH071681]; Medical Research Council (UK) Programme; National Institutes of Mental Health (USA) [CONTE: 2 P50 MH066392-05A1]; Swedish Council for Working Life and Social Research [FO 184/2000, 2001-2368]; Stanley Medical Research Institute [MH071681, MH077139]; Narsad Young Investigator Award; Australian National Health and Medical Research Council [389892, 442915, 496688, 496674]; Science Foundation Ireland; Health Research Board (Ireland); Wellcome Trust; National Institutes of Mental Health and the Department of Veterans Affairs; MRC [G0800509, G0500791, G0801418] Funding Source: UKRI; Medical Research Council [G0801418, G0500791, G0800509] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH074027, R01MH077139, R01MH071681, R01MH080403] Funding Source: NIH RePORTER	Stanley Medical Research Institute; Sylvan C. Herman Foundation; Medical Research Council (UK) Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Mental Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stanley Medical Research Institute; Narsad Young Investigator Award(NARSAD); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (Ireland); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Mental Health and the Department of Veterans Affairs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)US Department of Veterans Affairs); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the patients and families who contributed to these studies. We also thank E. Lander, N. Patterson and members of the Medical and Population Genetics group at the Broad Institute of Harvard and Massachusetts Institute of Technology for valuable discussion, and members of the Broad Biological Samples and Genetic Analysis Platforms for sample management and genotyping. Weparticularly thank D. Levinson and P. Gejman for allowing access to the MGS samples, and J. Shi for analytic support with the MGS samples. The group at the Stanley Center for Psychiatric Research at the Broad Institute was supported by the Stanley Medical Research Institute (E. M. S.), the Sylvan C. Herman Foundation (E. M. S.), and MH071681 (P. S.). The Cardiff University group was supported by a Medical Research Council (UK) Programme grant and the National Institutes of Mental Health (USA) (CONTE: 2 P50 MH066392-05A1). The group at the Karolinska Institutet was supported by the Swedish Council for Working Life and Social Research (FO 184/2000; 2001-2368). The Massachusetts General Hospital group was supported by the Stanley Medical Research Institute (P. S.), MH071681 and MH077139 (P. S.) and a Narsad Young Investigator Award (S. M. P.). The group at the Queensland Institute of Medical Research was supported by the Australian National Health and Medical Research Council (grants 389892, 442915, 496688 and 496674) and thanks S. Gordon for data preparation. The Trinity College Dublin group was supported by Science Foundation Ireland, the Health Research Board (Ireland), the Stanley Medical Research Institute and the Wellcome Trust; Irish controls were supplied by J. McPartlin from the Trinity College Biobank. The work at the University of Aberdeen was partly funded by GlaxoSmithKline and Generation Scotland, Genetics Health Initiative. University College London clinical and control samples were collected with support from the Neuroscience Research Charitable Trust, the Camden and Islington Mental Health and Social Care Trust, East London and City Mental Heath Trust, the West Berkshire NHS Trust, the West London Mental Health Trust, Oxfordshire and Buckinghamshire Mental Health Partnership NHS Trust, South Essex Partnership NHS Foundation Trust, Gloucestershire Partnership NHS Foundation Trust, Mersey Care NHS Trust, Hampshire Partnership NHS Trust and the North East London Mental Health Trust. The collection of the University of Edinburgh cohort was supported by the Wellcome Trust Clinical Research Facility (Edinburgh) and grants from The Wellcome Trust, London and the Chief Scientist Office of the Scottish Government. The group at the University of North Carolina, Chapel Hill, was supported by MH074027, MH077139 and MH080403, the Sylvan C. Herman Foundation (P. F. S.) and the Stanley Medical Research Institute (P. F. S.). The group at the University of Southern California thanks the patients and their families for their collaboration, and acknowledges the support of the National Institutes of Mental Health and the Department of Veterans Affairs.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; FISHER RA, 1918, PHILOS T R SOC EDINB, V399, P433; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; *PSYCH GWAS CONS C, BR J PSYCHI IN PRESS, DOI DOI 10.1192/BJP.BP.108.063156; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	26	3236	3300	10	496	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					748	752		10.1038/nature08185	http://dx.doi.org/10.1038/nature08185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19571811	Green Accepted			2022-12-28	WOS:000268670300041
J	Bischoff, EWMA; Uijen, A; van der Wel, M				Bischoff, Erik W. M. A.; Uijen, Annemarie; van der Wel, Mark			10-Minute Consultation Aphthous ulcers	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bischoff, Erik W. M. A.; Uijen, Annemarie; van der Wel, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bischoff, EWMA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	e.bischoff@elg.umcn.nl	Uijen, A.A./L-4701-2015; van der Wel, M.C./L-4750-2015; Bischoff, Erik W.M.A./L-4201-2015					McBride DR, 2000, AM FAM PHYSICIAN, V62, P149; Scully C, 2000, BRIT MED J, V321, P162, DOI 10.1136/bmj.321.7254.162; Scully C, 2005, BRIT DENT J, V199, P259, DOI 10.1038/sj.bdj.4812649	3	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2009	339								b2382	10.1136/bmj.b2382	http://dx.doi.org/10.1136/bmj.b2382			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633032				2022-12-28	WOS:000268352100001
J	Robertson, DJ; Burke, CA; Welch, HG; Haile, RW; Sandler, RS; Greenberg, ER; Ahnen, DJ; Bresalier, RS; Rothstein, RI; Cole, B; Mott, LA; Baron, JA				Robertson, Douglas J.; Burke, Carol A.; Welch, H. Gilbert; Haile, Robert W.; Sandler, Robert S.; Greenberg, E. Robert; Ahnen, Dennis J.; Bresalier, Robert S.; Rothstein, Richard I.; Cole, Bernard; Mott, Leila A.; Baron, John A.			Using the Results of a Baseline and a Surveillance Colonoscopy to Predict Recurrent Adenomas With High-Risk Characteristics	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-CANCER-SOCIETY; COLORECTAL-CANCER; SCREENING COLONOSCOPY; TASK-FORCE; POLYPS; GUIDELINES; HISTORY; POLYPECTOMY; REMOVAL; TRIAL	Background: Suggested intervals for postpolypectomy surveillance colonoscopy are currently based on the adenoma findings from the most recent examination. Objective: To determine the risk for clinically significant adenoma recurrence on the basis of the results of 2 previous colonoscopies. Design: Prospective cohort study. Setting: Academic and private centers in North America. Patients: Participants in an adenoma chemoprevention trial in which all participants had 1 or more adenoma found on complete colonoscopy at entry. For this analysis, only participants whose qualifying adenoma was their first were included. All participants then underwent second and third study colonoscopies at roughly 3-year intervals. Measurements: Proportion of patients with high-risk findings at the third study colonoscopy-either at least 1 advanced (>= 1 cm or advanced histology) adenoma or multiple (>= 3) adenomas. Results: Fifty-eight of 564 participants (10.3%) had high-risk findings at the third study examination. If the second examination showed high-risk findings, then results from the first examination added no significant information about the probability of high-risk findings on the third examination (18.2% for high-risk findings on the first examination vs. 20.0% for low-risk findings on the first examination; P = 0.78). If the second examination showed no adenomas, then the results from the first examination added significant information about the probability of high-risk findings on the third examination (12.3% if the first examination had high-risk findings vs. 4.9% if the first examination had low-risk findings; P = 0.015). Limitation: This observational study cannot specifically examine adenoma recurrence risk at intervals suggested for patients with low-risk adenomas (for example, 5 years vs. 10 years). Conclusion: Information from 2 previous examinations may help identify low-risk populations that benefit little from intense surveillance. Surveillance guidelines might be tailored in selected patients to use information from 2 previous examinations, not just the most recent one.			Robertson, DJ (corresponding author), Vet Affairs Med Ctr, 215 N Main St,Sect Gastroenterol 111E, White River Jct, VT 05009 USA.	douglas.robertson@va.gov		Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health [R01 CA 59005]; NATIONAL CANCER INSTITUTE [U01CA046927, R01CA059005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Robertson's work is supported by a Veterans Affairs Health Services Research & Development Career Development Award. The parent study was supported by grant R01 CA 59005 from the National Institutes of Health.	ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Beck DE, 2000, DIS COLON RECTUM, V43, P1092; Blumberg D, 2000, DIS COLON RECTUM, V43, P1084, DOI 10.1007/BF02236554; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P497; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schoen RE, 2003, AM J GASTROENTEROL, V98, P1237, DOI 10.1016/S0002-9270(03)00271-5; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	26	52	52	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					103	W26		10.7326/0003-4819-151-2-200907210-00007	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620162	Green Accepted			2022-12-28	WOS:000268605300004
J	Imai, J; Yamada, T; Saito, T; Ishigaki, Y; Hinokio, Y; Kotake, H; Oka, Y; Katagiri, H				Imai, Junta; Yamada, Tetsuya; Saito, Tokuo; Ishigaki, Yasushi; Hinokio, Yoshinori; Kotake, Hidetoshi; Oka, Yoshitomo; Katagiri, Hideki			Eradication of insulin resistance	LANCET			English	Editorial Material							IMMUNE THROMBOCYTOPENIC PURPURA; HELICOBACTER-PYLORI		[Katagiri, Hideki] Tohoku Univ Hosp, Dept Diabet & Metab, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kotake, Hidetoshi] Japanese Red Cross Sendai Hosp, Div Diabet & Metab, Sendai, Miyagi 9828501, Japan	Tohoku University	Katagiri, H (corresponding author), Tohoku Univ Hosp, Dept Diabet & Metab, Aoba Ku, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp						Asahi A, 2008, J CLIN INVEST, V118, P2939, DOI 10.1172/JCI34496; Cicconi V, 2001, AM J MED, V111, P163, DOI 10.1016/S0002-9343(01)00738-0; GOLDFINE A, 2005, JOSLIN TXB DIABETES, P493; Stasi R, 2009, BLOOD, V113, P1231, DOI 10.1182/blood-2008-07-167155; Zentilin P, 2002, ALIMENT PHARM THERAP, V16, P1291, DOI 10.1046/j.1365-2036.2002.01284.x	5	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					264	264		10.1016/S0140-6736(09)60872-2	http://dx.doi.org/10.1016/S0140-6736(09)60872-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474DP	19616723				2022-12-28	WOS:000268263000036
J	Medley, GF; Nokes, DJ				Medley, Graham F.; Nokes, D. James			Does Viral Diversity Matter?	SCIENCE			English	Editorial Material							VACCINATION; ROTAVIRUS; DYNAMICS; PROTECTION; EPIDEMICS; ENGLAND; WALES		[Medley, Graham F.; Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Nokes, D. James] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya	University of Warwick; Kenya Medical Research Institute	Medley, GF (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	graham.medley@warwick.ac.uk	Medley, Graham/B-7289-2008	Medley, Graham/0000-0002-0030-7278	Wellcome Trust [076278, 061584] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Atchison CJ, 2009, EUROSURVEILLANCE, V14; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450	8	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					274	275		10.1126/science.1177475	http://dx.doi.org/10.1126/science.1177475			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608903				2022-12-28	WOS:000268036600030
J	Wheeler, TM; Sobczak, K; Lueck, JD; Osborne, RJ; Lin, XY; Dirksen, RT; Thornton, CA				Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.			Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA	SCIENCE			English	Article							EXPANDED CUG REPEAT; PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; CHLORIDE CHANNEL; TRINUCLEOTIDE REPEAT; MUSCLEBLIND PROTEINS; EXPANSION; TRANSCRIPTS; HAIRPINS; MODEL	Genomic expansions of simple tandem repeats can give rise to toxic RNAs that contain expanded repeats. In myotonic dystrophy, the expression of expanded CUG repeats (CUG(exp)) causes abnormal regulation of alternative splicing and neuromuscular dysfunction. We used a transgenic mouse model to show that derangements of myotonic dystrophy are reversed by a morpholino antisense oligonucleotide, CAG25, that binds to CUG(exp) RNA and blocks its interaction with muscleblind-like 1 (MBNL1), a CUG(exp)-binding protein. CAG25 disperses nuclear foci of CUG(exp) RNA and reduces the overall burden of this toxic RNA. As MBNL1 is released from sequestration, the defect of alternative splicing regulation is corrected, thereby restoring ion channel function. These findings suggest an alternative use of antisense methods, to inhibit deleterious interactions of proteins with pathogenic RNAs.	[Wheeler, Thurman M.; Sobczak, Krzysztof; Osborne, Robert J.; Lin, Xiaoyan; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Sobczak, Krzysztof; Lueck, John D.; Osborne, Robert J.; Lin, Xiaoyan; Dirksen, Robert T.; Thornton, Charles A.] Univ Rochester, Dept Physiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Thornton, CA (corresponding author), Univ Rochester, Dept Neurol, Rochester, NY 14642 USA.	charles_thornton@urmc.rochester.edu		Sobczak, Krzysztof/0000-0001-8352-9812; Lueck, John/0000-0002-1820-711X	University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center; Center for RNA Biology; NIH [AR046806, AR/NS48143, NIDCR-T32DE07202]; Muscular Dystrophy Association; Foundation for Polish Science; Run America Foundation; Saunders Family fund;  [U54NS48843]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046806, K24AR048143, R01AR049077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843, K08NS064293] Funding Source: NIH RePORTER	University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center; Center for RNA Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Run America Foundation; Saunders Family fund; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work comes from the University of Rochester Wellstone Muscular Dystrophy Cooperative Research Center (U54NS48843) and Center for RNA Biology, with support from NIH (AR046806, AR/NS48143, and NIDCR-T32DE07202 to J.D.L.), the Muscular Dystrophy Association, and a postdoctoral fellowship to K.S. from the Foundation for Polish Science, Run America Foundation, and the Saunders Family fund. We appreciate help from L. Richardson and S. Leistman. The University of Rochester has applied for a patent based partly on the work described here.	Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	26	285	303	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					336	339		10.1126/science.1173110	http://dx.doi.org/10.1126/science.1173110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608921	Green Accepted			2022-12-28	WOS:000268036600050
J	Oganov, AR; Chen, JH; Gatti, C; Ma, YZ; Ma, YM; Glass, CW; Liu, ZX; Yu, T; Kurakevych, OO; Solozhenko, VL				Oganov, Artem R.; Chen, Jiuhua; Gatti, Carlo; Ma, Yanzhang; Ma, Yanming; Glass, Colin W.; Liu, Zhenxian; Yu, Tony; Kurakevych, Oleksandr O.; Solozhenko, Vladimir L.			Ionic high-pressure form of elemental boron (vol 457, pg 863, 2009)	NATURE			English	Correction													, Carlo/B-7410-2009; Solozhenko, Vladimir L./E-1975-2011; Ma, Yanming/ABE-8450-2020; Oganov, Artem R./O-8234-2019; Oganov, Artem R./AAA-1478-2021; Kurakevych, Oleksandr O/A-5105-2008; Glass, Colin/E-2377-2014; Gatti, Carlo/AAA-8211-2020	, Carlo/0000-0002-0047-1596; Solozhenko, Vladimir L./0000-0002-0881-9761; Oganov, Artem R./0000-0001-7082-9728; Kurakevych, Oleksandr O/0000-0002-1249-5325; Glass, Colin/0000-0003-0192-1808; Ma, Yanzhang/0000-0002-8215-7962				Oganov AR, 2009, NATURE, V457, P863, DOI 10.1038/nature07736; WENTORF RH, 1965, SCIENCE, V147, P49, DOI 10.1126/science.147.3653.49	2	30	30	6	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 9	2009	460	7252					292	292		10.1038/nature08164	http://dx.doi.org/10.1038/nature08164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587770	Bronze, Green Submitted			2022-12-28	WOS:000267761000048
J	Sepkowitz, KA				Sepkowitz, Kent A.			Forever Unprepared -- The Predictable Unpredictability of Pathogens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324	3	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					120	121		10.1056/NEJMp0902373	http://dx.doi.org/10.1056/NEJMp0902373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19587337				2022-12-28	WOS:000267748900004
J	Lee, BJ; Forbes, K				Lee, Brian J.; Forbes, Ken			Practice Quality Improvement Report The role of specialists in managing the health of populations with chronic illness: the example of chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Article							STAGE RENAL-DISEASE; IMPACT; CARE; MORTALITY; OUTCOMES; RISK; NEPHROLOGIST; NEPHROPATHY; MORBIDITY; REFERRALS	Problem Specialty care has been used to manage individual patients at the discretion of generalists but not to drive improvements at the population level. Design Observational longitudinal study. Setting Kaiser Permanente Hawaii, with more than 10 000 members with documented chronic kidney disease. Key measures for improvement Rate of late referrals to nephrology care, defined as occurring within four months of end stage renal disease and the proportions of patients starting haemodialysis with a mature arteriovenous fistula and starting dialysis in the outpatient setting. Strategies for change Risk stratification of the entire population and unsolicited consultations provided by nephrologists to generalists, based on patients' risk level, enabled by an electronic population management database. Effects of change Between 2004 and 2008, the proportion of referrals occurring within four months of onset of end stage renal disease dropped from 37 of 116 (32%) to 10 of 84 (12%), P=0.001. The proportion of patients starting haemodialysis with a mature arteriovenous fistula increased from 19 of 108 (18%) to 27 of 76 (36%), P=0.006. The proportion of patients who started haemodialysis as outpatients increased from 39 of 113 (35%) to 47 of 84 (56%), P=0.003. Lessons learnt Turning the traditional referral system on its head by providing unsolicited, risk driven nephrology consultations is an effective strategy for increasing the quality of medical management of patients with chronic kidney disease in the primary care setting and improving the cost effective use of nephrology services. This approach may be broadly applicable to other specialty areas.	[Lee, Brian J.] Kaiser Permanente, Moanalua Med Ctr, Hawaii Reg, Honolulu, HI 96819 USA; [Forbes, Ken] Kaiser Permanente, Care Management Inst, Hawaii Reg, Honolulu, HI 96819 USA	Kaiser Permanente; Kaiser Permanente	Lee, BJ (corresponding author), Kaiser Permanente, Moanalua Med Ctr, Hawaii Reg, 3288 Moanalua Rd, Honolulu, HI 96819 USA.	brian.j.lee@kp.org			Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region	Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region	This work was jointly supported by the Nephrology Division and Care Management Institute of Kaiser Permanente, Hawaii Region.	Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Chen SC, 2008, NEPHROLOGY, V13, P730, DOI 10.1111/j.1440-1797.2008.01023.x; Cheng ZQ, 2009, HYBRIDOMA, V28, P33, DOI 10.1089/hyb.2008.0069; *DELF GROUP LLC, 2007, DELF PROJ SHOWC NEPH; Ellis PA, 1998, QJM-MON J ASSOC PHYS, V91, P727, DOI 10.1093/qjmed/91.11.727; Ifudu O, 1996, AM J KIDNEY DIS, V28, P841, DOI 10.1016/S0272-6386(96)90383-2; Innes A, 2008, NEPHROL DIAL TRANSPL, V23, P2571, DOI 10.1093/ndt/gfn069; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Livaudais Gerard, 2006, Perm J, V10, P72; Martinez-Ramirez HR, 2006, AM J KIDNEY DIS, V47, P78, DOI 10.1053/j.ajkd.2005.09.015; Navaneethan SD, 2008, AM J MED, V121, pE17, DOI 10.1016/j.amjmed.2008.01.008; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; Ravani P, 2005, J NEPHROL, V18, P188; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Thorp ML, 2004, AM J MANAG CARE, V10, P417; Yang XL, 2006, DIABETOLOGIA, V49, P2299, DOI 10.1007/s00125-006-0376-3; 2002, AM J KIDNEY DIS S, V39, pS1	27	34	34	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2009	339								b2395	10.1136/bmj.b2395	http://dx.doi.org/10.1136/bmj.b2395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KY	19586983				2022-12-28	WOS:000267898300002
J	Holland, GJ				Holland, Greg J.			Predicting El Nino's Impacts	SCIENCE			English	Editorial Material							SEASONAL HURRICANE FREQUENCY		NCAR, Boulder, CO 80305 USA	National Center Atmospheric Research (NCAR) - USA	Holland, GJ (corresponding author), NCAR, 1850 Table Mesa Dr, Boulder, CO 80305 USA.	gholland@ucar.edu						BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1669, DOI 10.1175/1520-0493(1984)112<1669:ASHFPI>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Kim HM, 2009, SCIENCE, V325, P77, DOI 10.1126/science.1174062; TARAZONA J, 2001, NINO LATIN AM BIOL S; Vitart F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030740; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705	7	6	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					47	47		10.1126/science.1176515	http://dx.doi.org/10.1126/science.1176515			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574379				2022-12-28	WOS:000267594000028
J	Pagani, M; Caldeira, K; Berner, R; Beerling, DJ				Pagani, Mark; Caldeira, Ken; Berner, Robert; Beerling, David J.			The role of terrestrial plants in limiting atmospheric CO2 decline over the past 24 million years	NATURE			English	Article							CARBON-CYCLE; EVOLUTION; CLIMATE; MODEL; VEGETATION; FEEDBACKS; DYNAMICS; LEAVES; MA	Environmental conditions during the past 24 million years are thought to have been favourable for enhanced rates of atmospheric carbon dioxide drawdown by silicate chemical weathering(1-7). Proxy records indicate, however, that the Earth's atmospheric carbon dioxide concentrations did not fall below about 200-250 parts per million during this period(8). The stabilization of atmospheric carbon dioxide concentrations near this minimum value suggests that strong negative feedback mechanisms inhibited further drawdown of atmospheric carbon dioxide by high rates of global silicate rock weathering. Here we investigate one possible negative feedback mechanism, occurring under relatively low carbon dioxide concentrations and in warm climates, that is related to terrestrial plant productivity and its role in the decomposition of silicate minerals(9-11). We use simulations of terrestrial and geochemical carbon cycles and available experimental evidence to show that vegetation activity in upland regions of active orogens was severely limited by near-starvation of carbon dioxide in combination with global warmth over this period. These conditions diminished biotic-driven silicate rock weathering and thereby attenuated an important long-term carbon dioxide sink. Although our modelling results are semi-quantitative and do not capture the full range of biogeochemical feedbacks that could influence the climate, our analysis indicates that the dynamic equilibrium between plants, climate and the geosphere probably buffered the minimum atmospheric carbon dioxide concentrations over the past 24 million years.	[Pagani, Mark; Berner, Robert] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Beerling, David J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Yale University; Carnegie Institution for Science; University of Sheffield	Pagani, M (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	mark.pagani@yale.edu	Beerling, David J/C-2840-2009; Caldeira, Ken/E-7914-2011; Pagani, Mark/B-3233-2008	Beerling, David J/0000-0003-1869-4314; Caldeira, Ken/0000-0002-4591-643X; 	NSF [OCE-0095734]; DOE [DE-FG02-01ER15173]; Leverhulme Trust; Natural Environment Research Council [NE/E015190/1]; Royal Society-Wolfson Research Merit Award; Yale Climate and Energy Institute; NERC [NE/E015190/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society-Wolfson Research Merit Award(Royal Society of London); Yale Climate and Energy Institute; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Conversations with C. Garzione, M. Hren. J. Berry, and C. Osborne were greatly appreciated. This work was supported, in part, by NSF grant OCE-0095734 (to M. P.) and DOE grant DE-FG02-01ER15173 (to R. A. B.). D. J. B. gratefully acknowledges funding from the Leverhulme Trust and Natural Environment Research Council (NE/E015190/1), and through a Royal Society-Wolfson Research Merit Award. M. P. acknowledges support from the Yale Climate and Energy Institute.	Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; Beerling D. J., 2001, VEGETATION TERRESTRI; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Berner E., 2003, TREATISE GEOCHEMISTR, V5, P605; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Blisniuk PM, 2005, AM J SCI, V305, P1033, DOI 10.2475/ajs.305.10.1033; Campbell CD, 2005, GLOBAL CHANGE BIOL, V11, P1956, DOI 10.1111/j.1365-2486.2005.01045.x; Chung SL, 2005, EARTH-SCI REV, V68, P173, DOI 10.1016/j.earscirev.2004.05.001; Cogne JP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001148; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; DeCelles PG, 2007, EARTH PLANET SC LETT, V253, P389, DOI 10.1016/j.epsl.2006.11.001; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Engebretson D.C., 1992, GSA TODAY, P93; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Gillis RJ, 2006, TECTONICS, V25, DOI 10.1029/2005TC001887; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; JACOBS BF, 1999, ANN MISSOURI BOT GAR, V86, P90; Kerrick DM, 1999, EARTH PLANET SC LETT, V173, P195, DOI 10.1016/S0012-821X(99)00229-0; Kerrick DM, 1998, CHEM GEOL, V145, P213, DOI 10.1016/S0009-2541(97)00144-7; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Lin GH, 1999, OECOLOGIA, V119, P97, DOI 10.1007/s004420050765; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; PEARLSTEIN RM, 1984, ADV PHOTOSYNTHESIS R, V1, P13; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; RCUSCH DN, 1998, OXFORD MONOGRAPHS GE, V38, P261; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Taylor LL, 2009, GEOBIOLOGY, V7, P171, DOI 10.1111/j.1472-4669.2009.00194.x; VOLK T, 1987, AM J SCI, V287, P763, DOI 10.2475/ajs.287.8.763; VONCAEMMERER S, 1991, AUST J PLANT PHYSIOL, V18, P287, DOI 10.1071/pp9910287; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeebe RE, 2008, NAT GEOSCI, V1, P312, DOI 10.1038/ngeo185	44	103	107	5	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					85	U94		10.1038/nature08133	http://dx.doi.org/10.1038/nature08133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571882				2022-12-28	WOS:000267545200034
J	Johnston, RJ; Poholek, AC; DiToro, D; Yusuf, I; Eto, D; Barnett, B; Dent, AL; Craft, J; Crotty, S				Johnston, Robert J.; Poholek, Amanda C.; DiToro, Daniel; Yusuf, Isharat; Eto, Danelle; Barnett, Burton; Dent, Alexander L.; Craft, Joe; Crotty, Shane			Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; GERMINAL-CENTER FORMATION; IMMUNE-RESPONSES; IN-VIVO; B-CELLS; GENE-EXPRESSION; PROVIDE HELP; INFLAMMATION; FOLLICLES; SAP	Effective B cell-mediated immunity and antibody responses often require help from CD4(+) T cells. It is thought that a distinct CD4(+) effector T cell subset, called T follicular helper cells (T-FH), provides this help; however, the molecular requirements for T-FH differentiation are unknown. We found that expression of the transcription factor Bcl6 in CD4(+) T cells is both necessary and sufficient for in vivo T-FH differentiation and T cell help to B cells in mice. In contrast, the transcription factor Blimp-1, an antagonist of Bcl6, inhibits T-FH differentiation and help, thereby preventing B cell germinal center and antibody responses. These findings demonstrate that T-FH cells are required for proper B cell responses in vivo and that Bcl6 and Blimp-1 play central but opposing roles in T-FH differentiation.	[Johnston, Robert J.; DiToro, Daniel; Yusuf, Isharat; Eto, Danelle; Barnett, Burton; Crotty, Shane] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Johnston, Robert J.; Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92037 USA; [Poholek, Amanda C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Yale University; Yale University	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, 9420 Athena Circle, La Jolla, CA 92037 USA.	shane@liai.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	LIAI institutional funds; Pew Scholar Award; Cancer Research Institute; National Institute of Allergy and Infectious Diseases [R01 072543]; NIAID [R01 063107]; Rheuminations Inc.; Arthritis Foundation; Connecticut Chapter of the Lupus Foundation of America; NIH [AR40072, AR44076, P30 AR053495]; UCSD/LIAI; NCBI Gene Expression Omnibus [GSE16697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, R01AI072543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, R01AR040072, P30AR053495, R01AR044076] Funding Source: NIH RePORTER	LIAI institutional funds; Pew Scholar Award; Cancer Research Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rheuminations Inc.; Arthritis Foundation; Connecticut Chapter of the Lupus Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD/LIAI; NCBI Gene Expression Omnibus; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by LIAI institutional funds, a Pew Scholar Award, a Cancer Research Institute Award, and National Institute of Allergy and Infectious Diseases grants R01 072543 and NIAID R01 063107 (S.C.), Rheuminations Inc., the Arthritis Foundation, the Connecticut Chapter of the Lupus Foundation of America, and NIH grants AR40072, AR44076, and P30 AR053495 (J.C.), and fellowships from the UCSD/LIAI Immunology NIH Training Grant (I.Y. and R.J.J.). R.J.J. is a member of the UCSD Biomedical Sciences (BMS) graduate program. Microarray data have been deposited at the NCBI Gene Expression Omnibus (GSE16697).	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; TSIAGBE VK, 1998, BIOL GERMINAL CTR LY, P1; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	39	1097	1151	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1006	1010		10.1126/science.1175870	http://dx.doi.org/10.1126/science.1175870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608860	Green Accepted			2022-12-28	WOS:000269242800049
J	Maziak, DE; Darling, GE; Inculet, RI; Gulenchyn, KY; Driedger, AA; Ung, YC; Miller, JD; Gu, CS; Cline, KJ; Evans, WK; Levine, MN				Maziak, Donna E.; Darling, Gail E.; Inculet, Richard I.; Gulenchyn, Karen Y.; Driedger, Albert A.; Ung, Yee C.; Miller, John D.; Gu, Chu-Shu; Cline, Kathryn J.; Evans, William K.; Levine, Mark N.			Positron Emission Tomography in Staging Early Lung Cancer A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-IMPACT	Background: Among patients with early-stage non-small cell lung cancer (NSCLC), preoperative imaging tests are important in defining surgical candidates. Objective: To assess whether whole-body positron emission tomography and computed tomography (PET-CT) plus cranial imaging correctly upstages cancer in more patients with NSCLC than does conventional staging plus cranial imaging. Design: Randomized clinical trial with recruitment from June 2004 to August 2007. The centralized, computer-generated, variable block size randomization scheme was stratified by treatment center and cancer stage. Participants, health care providers, and outcome assessors were not blinded to imaging modality assignment. Setting: 8 hospitals and 5 PET-CT centers in academic institutions. Patients: Eligible patients were older than 18 years; had histologic or cytologic proof of stage I, II, or IIIA NSCLC on the basis of chest radiography and thoracic CT; and had a tumor considered to be resectable. Intervention: PET-CT or conventional staging (abdominal CT and bone scan). All patients also had cranial imaging using CT or magnetic resonance imaging. Measurements: The primary outcome was correct upstaging, thereby avoiding stage-inappropriate surgery. Secondary outcomes were incorrect upstaging and incorrect understaging. Results: 170 patients were assigned to PET-CT and 167 to conventional staging. Eight patients (3 who had PET-CT and 5 who had conventional staging) did not have planned surgery. Disease was correctly upstaged in 23 of 167 PET-CT recipients and 11 of 162 conventional staging recipients (13.8% vs. 6.8%; difference, 7.0 percentage points [95% CI, 0.3 to 13.7 percentage points]), thereby sparing these patients from surgery. Disease was incorrectly upstaged in 8 PET-CT recipients and 1 conventional staging recipient (4.8% vs. 0.6%; difference, 4.2 percentage points [CI, 0.5 to 8.6 percentage points]), and it was incorrectly understaged in 25 and 48 patients, respectively (14.9% vs. 29.6%; difference, 14.7 percentage points [CI, 5.7 to 23.4 percentage points]). At 3 years, 52 patients who had PET-CT and 57 patients who had conventional staging had died. Limitation: The relatively small sample and the fact that some patients did not have planned surgery limited the ability to determine precise differences in clinical outcomes that were attributable to testing strategies. Conclusion: Preoperative staging with PET-CT and cranial imaging identifies more patients with mediastinal and extrathoracic disease than conventional staging, thereby sparing more patients from stage-inappropriate surgery, but the strategy also incorrectly upstaged disease in more patients.	[Maziak, Donna E.; Darling, Gail E.; Inculet, Richard I.; Gulenchyn, Karen Y.; Driedger, Albert A.; Ung, Yee C.; Miller, John D.; Gu, Chu-Shu; Cline, Kathryn J.; Evans, William K.; Levine, Mark N.] McMaster Univ, Hamilton Hlth Sci, Ontario Clin Oncol Grp, Hamilton, ON, Canada	McMaster University	Levine, MN (corresponding author), Henderson Gen Hosp, Hamilton Hlth Sci, Ontario Clin Oncol Grp, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	mlevine@mcmaster.ca			Ontario Ministry of Health and Long-Term Care [06126]; Canadian Institutes of Health Research [MCT-78777]; Cancer Care Ontario	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Care Ontario	By the Ontario Ministry of Health and Long-Term Care ( grant 06126) and the Canadian Institutes of Health Research ( grant MCT-78777), and support from Cancer Care Ontario.	Guyatt GH, 2001, ANN THORAC SURG, V71, P425; Herder GJM, 2006, J CLIN ONCOL, V24, P1800, DOI 10.1200/JCO.2005.02.4695; Hicks RJ, 2001, J NUCL MED, V42, P1596; Mac Manus MP, 2001, CANCER, V92, P886, DOI 10.1002/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Rusch VW, 2005, J CLIN ONCOL, V23, P8283, DOI 10.1200/JCO.2005.08.912; Saunders CAB, 1999, ANN THORAC SURG, V67, P790, DOI 10.1016/S0003-4975(98)01257-0; Sundaresan SR, 1998, ANN THORAC SURG, V66, P892; Ung YC, 2007, JNCI-J NATL CANCER I, V99, P1753, DOI 10.1093/jnci/djm232; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Viney RC, 2004, J CLIN ONCOL, V22, P2357, DOI 10.1200/JCO.2004.04.126; Weder W, 1998, ANN THORAC SURG, V66, P886, DOI 10.1016/S0003-4975(98)00675-4; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; 2001, ANN THORAC SURG, V71, P433	15	134	139	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					221	W48		10.7326/0003-4819-151-4-200908180-00132	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00132			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19581636				2022-12-28	WOS:000269038900001
J	McDonald, A				McDonald, Anne			A Patient's Journey Living with a benign brain tumour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												somerledmcd@btinternet.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2886	10.1136/bmj.b2886	http://dx.doi.org/10.1136/bmj.b2886			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479PG	19638372				2022-12-28	WOS:000268672800008
J	Gruber, JJ; Zatechka, DS; Sabin, LR; Yong, J; Lum, JJ; Kong, M; Zong, WX; Zhang, ZX; Lau, CK; Rawlings, J; Cherry, S; Ihle, JN; Dreyfuss, G; Thompson, CB				Gruber, Joshua J.; Zatechka, D. Steven; Sabin, Leah R.; Yong, Jeongsik; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Zhang, Zhenxi; Lau, Chi-Kong; Rawlings, Jason; Cherry, Sara; Ihle, James N.; Dreyfuss, Gideon; Thompson, Craig B.			Ars2 Links the Nuclear Cap-Binding Complex to RNA Interference and Cell Proliferation	CELL			English	Article							MESSENGER-RNA; PROTEOMIC ANALYSIS; PROTEIN; SERRATE; MICRORNAS; MIRNA; EXPORT; GENES	Here we identify a component of the nuclear RNA cap-binding complex (CBC), Ars2, that is important for miRNA biogenesis and critical for cell proliferation. Unlike other components of the CBC, Ars2 expression is linked to the proliferative state of the cell. Deletion of Ars2 is developmentally lethal, and deletion in adult mice led to bone marrow failure whereas parenchymal organs composed of nonproliferating cells were unaffected. Depletion of Ars2 or CBP80 from proliferating cells impaired miRNA-mediated repression and led to alterations in primary miRNA processing in the nucleus. Ars2 depletion also reduced the levels of several miRNAs, including miR-21, let-7, and miR-155, that are implicated in cellular transformation. These findings provide evidence for a role for Ars2 in RNA interference regulation during cell proliferation.	[Gruber, Joshua J.; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Thompson, Craig B.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Gruber, Joshua J.; Lum, Julian J.; Kong, Mei; Zong, Wei-Xing; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Zatechka, D. Steven; Rawlings, Jason; Ihle, James N.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Sabin, Leah R.; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Yong, Jeongsik; Zhang, Zhenxi; Lau, Chi-Kong; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; St Jude Children's Research Hospital; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Lau, Terrence/ABB-7900-2021; Rawlings, Jason/H-4457-2011	Dreyfuss, Gideon/0000-0001-8129-8774; Lau, Terrence/0000-0002-7505-7306; Lum, Julian/0000-0002-5624-3541; Sabin, Leah/0000-0003-1757-7415; cherry, sara/0000-0003-3956-6610	NIH; A.F.C.R.I; NATIONAL CANCER INSTITUTE [R01CA092660, K01CA098092, R01CA099179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.F.C.R.I; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Zissimos Mourelatos for helpful discussions and providing luciferase reporters. We thank Iain Mattaj for kindly providing CBC antibodies, Ramin Shiekhattar for kindly providing Flag-Dicer and Flag-Drosha plasmids, and Michael Milone for providing a pri-miR-155 plasmid. We thank Jim Alwine, Scott Poethig, and members of the Thompson and Dreyfuss laboratories for discussions and inspiration. J.J.G. and C. B. T. are supported by funds from the NIH and the A.F.C.R.I.	Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kiriakidou M, 2005, METH MOL B, V309, P295; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Oh SW, 2003, GENETICS, V163, P195; OHNO M, 1990, NUCLEIC ACIDS RES, V18, P6989, DOI 10.1093/nar/18.23.6989; Papp I, 2004, PLANT MOL BIOL, V55, P679, DOI 10.1007/s11103-004-1680-2; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rossman TG, 1999, CARCINOGENESIS, V20, P311, DOI 10.1093/carcin/20.2.311; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	38	140	152	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					328	339		10.1016/j.cell.2009.04.046	http://dx.doi.org/10.1016/j.cell.2009.04.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632182	Green Accepted, Bronze			2022-12-28	WOS:000268277000014
J	Plotkin, SR; Stemmer-Rachamimov, AO; Barker, FG; Halpin, C; Padera, TP; Tyrrell, A; Sorensen, AG; Jain, RK; di Tomaso, E				Plotkin, Scott R.; Stemmer-Rachamimov, Anat O.; Barker, Fred G., II; Halpin, Chris; Padera, Timothy P.; Tyrrell, Alex; Sorensen, A. Gregory; Jain, Rakesh K.; di Tomaso, Emmanuelle			Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACIAL-NERVE FUNCTION; PHASE-II TRIAL; VESTIBULAR-SCHWANNOMA; TUMOR VASCULATURE; ACOUSTIC NEUROMAS; KINASE INHIBITOR; ANGIOGENESIS; EXPRESSION; MANAGEMENT	Background Profound hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated with bilateral vestibular schwannomas, benign tumors that arise from the eighth cranial nerve. There is no medical treatment for such tumors. Methods We determined the expression pattern of vascular endothelial growth factor (VEGF) and three of its receptors, VEGFR-2, neuropilin-1, and neuropilin-2, in paraffin-embedded samples from 21 vestibular schwannomas associated with neurofibromatosis type 2 and from 22 sporadic schwannomas. Ten consecutive patients with neurofibromatosis type 2 and progressive vestibular schwannomas who were not candidates for standard treatment were treated with bevacizumab, an anti-VEGF monoclonal antibody. An imaging response was defined as a decrease of at least 20% in tumor volume, as compared with baseline. A hearing response was defined as a significant increase in the word-recognition score, as compared with baseline. Results VEGF was expressed in 100% of vestibular schwannomas and VEGFR-2 in 32% of tumor vessels on immunohistochemical analysis. Before treatment, the median annual volumetric growth rate for 10 index tumors was 62%. After bevacizumab treatment in the 10 patients, tumors shrank in 9 patients, and 6 patients had an imaging response, which was maintained in 4 patients during 11 to 16 months of follow-up. The median best response to treatment was a volumetric reduction of 26%. Three patients were not eligible for a hearing response; of the remaining seven patients, four had a hearing response, two had stable hearing, and one had progressive hearing loss. There were 21 adverse events of grade 1 or 2. Conclusions VEGF blockade with bevacizumab improved hearing in some, but not all, patients with neurofibromatosis type 2 and was associated with a reduction in the volume of most growing vestibular schwannomas.	[Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat O.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Padera, Timothy P.; Tyrrell, Alex; Jain, Rakesh K.; di Tomaso, Emmanuelle] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Plotkin, Scott R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA; [Sorensen, A. Gregory] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Halpin, Chris] Massachusetts Eye & Ear Infirm, Dept Audiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary	Plotkin, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Yawkey 9E,55 Fruit St, Boston, MA 02114 USA.	splotkin@partners.org	Padera, Timothy/R-2982-2019; Tyrrell, James/A-6359-2010; Jain, Rakesh K/I-1384-2017	Padera, Timothy/0000-0002-3453-9384; Jain, Rakesh K/0000-0001-7571-3548; Plotkin, Scott/0000-0002-6109-6419	Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; Children's Tumor Foundation [NF050202]; Neurofibromatosis Research Program of the Department of Defense [P01NS024279, P01CA80124]; National Institutes of Health; Federal Share/National Cancer Institute Proton Beam Program; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER	Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; Children's Tumor Foundation; Neurofibromatosis Research Program of the Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federal Share/National Cancer Institute Proton Beam Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the Harvard Medical School Center for Neurofibromatosis and Allied Disorders; Neurofibromatosis, Inc., New England; the Children's Tumor Foundation; a grant (NF050202, to Dr. Plotkin) from the Neurofibromatosis Research Program of the Department of Defense; a Claflin Award (to Dr. di Tomaso); grants (P01NS024279, to Dr. Stemmer- Rachamimov; and P01CA80124, to Dr. Jain) from the National Institutes of Health; and grants from the Federal Share/National Cancer Institute Proton Beam Program (to Drs. di Tomaso and Jain).	Babovic-Vuksanovic D, 2006, NEUROLOGY, V67, P1860, DOI 10.1212/01.wnl.0000243231.12248.67; Babovic-Vuksanovic D, 2007, PEDIATR NEUROL, V36, P293, DOI 10.1016/j.pediatrneurol.2007.01.009; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Brackmann DE, 2001, NEUROSURGERY, V49, P274, DOI 10.1097/00006123-200108000-00007; Brieger J, 2003, ACTA OTO-LARYNGOL, V123, P1040, DOI 10.1080/00016480310005101; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caye-Thomasen P, 2005, OTOL NEUROTOL, V26, P98, DOI 10.1097/00129492-200501000-00017; Caye-Thomasen P, 2007, AUDIOL NEURO-OTOL, V12, P1, DOI 10.1159/000096152; Combs SE, 2005, INT J RADIAT ONCOL, V63, P75, DOI 10.1016/j.ijrobp.2005.01.055; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; Fine HA, 2000, J CLIN ONCOL, V18, P708, DOI 10.1200/JCO.2000.18.4.708; Flickinger JC, 2001, J NEUROSURG, V94, P1, DOI 10.3171/jns.2001.94.1.0001; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Halpin C, 2006, OTOL NEUROTOL, V27, P110, DOI 10.1097/00129492-200601000-00020; Harris GJ, 2008, NEUROSURGERY, V62, P1314, DOI 10.1227/01.neu.0000333303.79931.83; Hirsh IJ, 1952, J SPEECH HEAR DISORD, V17, P321, DOI 10.1044/jshd.1703.321; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P176, DOI 10.1016/S0194-5998(95)70100-1; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Plotkin SR, 2008, NAT CLIN PRACT ONCOL, V5, P487, DOI 10.1038/ncponc1157; Plotkin SR, 2009, J NEURO-ONCOL, V93, P61, DOI 10.1007/s11060-009-9867-7; Saito K, 2003, CLIN NEUROPATHOL, V22, P30; Samii M, 1997, NEUROSURGERY, V40, P696, DOI 10.1097/00006123-199704000-00007; Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527; TAKAMIYA Y, 1994, NEUROSURGERY, V34, P869, DOI 10.1227/00006123-199405000-00013; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Uesaka T, 2007, J NEURO-ONCOL, V83, P259, DOI 10.1007/s11060-007-9336-0; Uzun C, 2003, LARYNGOSCOPE, V113, P1751, DOI 10.1097/00005537-200310000-00017	30	296	307	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					358	367		10.1056/NEJMoa0902579	http://dx.doi.org/10.1056/NEJMoa0902579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19587327	Green Accepted, Green Published			2022-12-28	WOS:000268184500006
J	Schraml, BU; Hildner, K; Ise, W; Lee, WL; Smith, WAE; Solomon, B; Sahota, G; Sim, J; Mukasa, R; Cemerski, S; Hatton, RD; Stormo, GD; Weaver, CT; Russell, JH; Murphy, TL; Murphy, KM				Schraml, Barbara U.; Hildner, Kai; Ise, Wataru; Lee, Wan-Ling; Smith, Whitney A. -E.; Solomon, Ben; Sahota, Gurmukh; Sim, Julia; Mukasa, Ryuta; Cemerski, Saso; Hatton, Robin D.; Stormo, Gary D.; Weaver, Casey T.; Russell, John H.; Murphy, Theresa L.; Murphy, Kenneth M.			The AP-1 transcription factor Batf controls T(H)17 differentiation	NATURE			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; ACTIVATOR PROTEIN-1; CELL-DIFFERENTIATION; NEGATIVE REGULATOR; TRANSGENIC MICE; TH17 CELLS; IN-VITRO; B-ATF; IL-21	Activator protein 1 (AP-1, also known as JUN) transcription factors are dimers of JUN, FOS, MAF and activating transcription factor (ATF) family proteins characterized by basic region and leucine zipper domains(1). Many AP-1 proteins contain defined transcriptional activation domains, but BATF and the closely related BATF3 (refs 2, 3) contain only a basic region and leucine zipper, and are considered to be inhibitors of AP-1 activity(3-8). Here we show that Batf is required for the differentiation of IL17-producing T helper (T(H)17) cells(9). T(H)17 cells comprise a CD4(+) T-cell subset that coordinates inflammatory responses in host defence but is pathogenic in autoimmunity(10-13). Batf(-/-) mice have normal T(H)1 and T(H)2 differentiation, but show a defect in T(H)17 differentiation, and are resistant to experimental autoimmune encephalomyelitis. Batf(-/-) T cells fail to induce known factors required for T(H)17 differentiation, such as ROR gamma t(11) (encoded by Rorc) and the cytokine IL21 (refs 14-17). Neither the addition of IL21 nor the overexpression of ROR gamma t fully restores IL17 production in Batf(-/-) T cells. The Il17 promoter is BATF-responsive, and after T(H)17 differentiation, BATF binds conserved intergenic elements in the Il17a-Il17f locus and to the Il17, Il21 and Il22 (ref. 18) promoters. These results demonstrate that the AP-1 protein BATF has a critical role in T(H)17 differentiation.	[Schraml, Barbara U.; Hildner, Kai; Ise, Wataru; Lee, Wan-Ling; Smith, Whitney A. -E.; Solomon, Ben; Cemerski, Saso; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Ise, Wataru; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Sahota, Gurmukh; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Sim, Julia; Russell, John H.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Mukasa, Ryuta; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850; Solomon, Benjamin/0000-0003-1009-7312; Weaver, Casey/0000-0002-2180-1793; Russell, John/0000-0002-3680-9587; Schraml, Barbara/0000-0002-5801-0151; Hatton, Robin/0000-0002-4797-9899	Howard Hughes Medical Institute; National Institutes of Health [HG00249, GM07200, AI035783, AR049293]; Daiichi-Sankyo Co. Ltd; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783, R21AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR049293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802, T32GM007200] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi-Sankyo Co. Ltd(Daiichi Sankyo Company Limited); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lallone for anti-BATF antibody preparation, and B. Sleckman for Cre-expressing adenovirus. This work was supported by the Howard Hughes Medical Institute (K. M. M.), and grants from the National Institutes of Health HG00249 and training grant GM07200 (G. D. S.), AI035783 (C. T. W.), AR049293 (R. D. H.), and from Daiichi-Sankyo Co. Ltd (C. T. W.).	Betti M, 2006, ANN ONCOL, V17, P235; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bower KE, 2004, ONCOGENE, V23, P8805, DOI 10.1038/sj.onc.1208109; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Thornton TM, 2006, EUR J IMMUNOL, V36, P160, DOI 10.1002/eji.200535215; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Williams KL, 2003, J IMMUNOL, V170, P2417, DOI 10.4049/jimmunol.170.5.2417; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	33	421	441	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					405	U125		10.1038/nature08114	http://dx.doi.org/10.1038/nature08114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19578362	Green Accepted			2022-12-28	WOS:000267979000041
J	Collins, J; Koplan, JP				Collins, Janet; Koplan, Jeffrey P.			Health Impact Assessment A Step Toward Health in All Policies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US		[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Collins, Janet] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, 1599 Clifton Rd NE,Ste 6101, Atlanta, GA 30322 USA.	jkoplan@emory.edu						Alston JM, 2006, REV AGR ECON, V28, P313, DOI 10.1111/j.1467-9353.2006.00292.x; *ASS PUBL HLTH OBS, HIA GAT; Bhatia R, 2008, ENVIRON HEALTH PERSP, V116, P991, DOI 10.1289/ehp.11132; Dannenberg AL, 2008, AM J PREV MED, V34, P241, DOI 10.1016/j.amepre.2007.11.015; Quigley RL, 2006, SPECIAL PUBLICATION, V5; *UCLA HLTH ASS CLE, HIA CLIC UCLA HLTH I; *UCLA HLTH IMP ASS, NEWS ANN LEG; Wismar M., 2007, EFFECTIVENESS HLTH I; *WORLD BANK, 422 WORLD BANK, pCH4	9	83	85	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					315	317		10.1001/jama.2009.1050	http://dx.doi.org/10.1001/jama.2009.1050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602691				2022-12-28	WOS:000267948100025
J	Karski, M; Forster, L; Choi, JM; Steffen, A; Alt, W; Meschede, D; Widera, A				Karski, Michal; Foerster, Leonid; Choi, Jai-Min; Steffen, Andreas; Alt, Wolfgang; Meschede, Dieter; Widera, Artur			Quantum Walk in Position Space with Single Optically Trapped Atoms	SCIENCE			English	Article								The quantum walk is the quantum analog of the well-known random walk, which forms the basis for models and applications in many realms of science. Its properties are markedly different from the classical counterpart and might lead to extensive applications in quantum information science. In our experiment, we implemented a quantum walk on the line with single neutral atoms by deterministically delocalizing them over the sites of a one-dimensional spin-dependent optical lattice. With the use of site-resolved fluorescence imaging, the final wave function is characterized by local quantum state tomography, and its spatial coherence is demonstrated. Our system allows the observation of the quantum-to-classical transition and paves the way for applications, such as quantum cellular automata.	[Karski, Michal; Foerster, Leonid; Choi, Jai-Min; Steffen, Andreas; Alt, Wolfgang; Meschede, Dieter; Widera, Artur] Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany	University of Bonn	Karski, M (corresponding author), Univ Bonn, Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany.	karski@uni-bonn.de; widera@uni-bonn.de	Widera, Artur/D-1032-2017	Widera, Artur/0000-0002-0338-9969	Deutsche Forschungsgemeinschaft; European Commission; Studienstiftung des deutschen Volkes; Korea Research Foundation; Korean Government (Ministry of Education and Human Resources Development)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Studienstiftung des deutschen Volkes; Korea Research Foundation(National Research Foundation of Korea); Korean Government (Ministry of Education and Human Resources Development)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	We acknowledge financial support from the Deutsche Forschungsgemeinschaft (research unit 635) and European Commission (Integrated Project on Scalable Quantum Computing with Light and Atoms). M.K. acknowledges support from the Studienstiftung des deutschen Volkes, and J.-M.C. received partial support from the Korea Research Foundation grant funded by the Korean Government (Ministry of Education and Human Resources Development).	Barber M., 1970, RANDOM RESTRICTED WA; Berg, 2018, RANDOM WALKS BIOL; Bouwmeester D, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.013410; CHAPMAN MS, 1995, PHYS REV LETT, V75, P3783, DOI 10.1103/PhysRevLett.75.3783; Childs AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.180501; Do B, 2005, J OPT SOC AM B, V22, P499, DOI 10.1364/JOSAB.22.000499; Du JF, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.042316; Dur W, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052319; Fama EF, 1965, FINANC ANAL J, V21, P55, DOI 10.2469/faj.v51.n1.1861; Feynman R.P., 1965, QUANTUM MECH PATH IN; Hackermuller L, 2004, NATURE, V427, P711, DOI 10.1038/nature02276; Karski M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053001; Kempe J, 2003, CONTEMP PHYS, V44, P307, DOI 10.1080/00107151031000110776; Kendon V, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.042315; Knight PL, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.020301; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; MOLLENSTEDT G, 1956, Z PHYS, V145, P377, DOI 10.1007/BF01326780; Perets HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170506; Raussendorf R, 2005, PHYS REV A, V72, DOI [10.1103/PhysRevA.72.052301, 10.1103/PhysREvA.72.052301, 10.1103/PhysRevA.72.022301]; Rosenfeld W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050504; Ryan CA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062317; Schlosshauer M, 2007, FRONT COLLECT, P1; SCHMITZ H, 2009, PREPRINT; Sension RJ, 2007, NATURE, V446, P740, DOI 10.1038/446740a; Shepherd DJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.020502; Travaglione BC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032310; Vollbrecht KGH, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012324; Weitz M, 1996, PHYS REV LETT, V77, P2356, DOI 10.1103/PhysRevLett.77.2356	29	474	480	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					174	177		10.1126/science.1174436	http://dx.doi.org/10.1126/science.1174436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589996	Green Submitted			2022-12-28	WOS:000267802000039
J	Sfeir, A; Kosiyatrakul, ST; Hockemeyer, D; MacRae, SL; Karlseder, J; Schildkraut, CL; de Lange, T				Sfeir, Agnel; Kosiyatrakul, Settapong T.; Hockemeyer, Dirk; MacRae, Sheila L.; Karlseder, Jan; Schildkraut, Carl L.; de lange, Titia			Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication	CELL			English	Article							SISTER CHROMATID EXCHANGES; DNA-BINDING DOMAIN; G4 DNA; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; CHROMOSOME ENDS; ESSENTIAL GENE; PROTEINS TRF1; POT1 PROTEINS; LENGTH	Telomeres protect chromosome ends through the interaction of telomeric repeats with shelterin, a protein complex that represses DNA damage signaling and DNA repair reactions. The telomeric repeats are maintained by telomerase, which solves the end replication problem. We report that the TTAGGG repeat arrays of mammalian telomeres pose a challenge to the DNA replication machinery, giving rise to replication-dependent defects that resemble those of aphidicolin-induced common fragile sites. Gene deletion experiments showed that efficient duplication of telomeres requires the shelterin component TRF1. Without TRF1, telomeres activate the ATR kinase in S phase and show a fragile-site phenotype in metaphase. Single-molecule analysis of replicating telomeres showed that TRF1 promotes efficient replication of TTAGGG repeats and prevents fork stalling. Two helicases implicated in the removal of G4 DNA structures, BLM and RTEL1, were required to repress the fragile-telomere phenotype. These results identify a second telomere replication problem that is solved by the shelterin component TRF1.	[Sfeir, Agnel; Hockemeyer, Dirk; MacRae, Sheila L.; Karlseder, Jan; de lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA; [Kosiyatrakul, Settapong T.; Schildkraut, Carl L.] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Hockemeyer, Dirk/0000-0002-5598-5092	NCI NIH HHS [R01 CA076027-11, R01 CA076027] Funding Source: Medline; NIA NIH HHS [R01 AG016642, R01 AG016642-10] Funding Source: Medline; NIGMS NIH HHS [R37 GM049046, R37 GM049046-17] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AK, 1996, MOL CELL BIOL, V16, P4614; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Falaschi A, 2007, CELL CYCLE, V6, P1705, DOI 10.4161/cc.6.14.4495; FEICHTINGER W, 1989, HUM GENET, V83, P145, DOI 10.1007/BF00286707; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Musio A, 1996, CYTOGENET CELL GENET, V75, P159, DOI 10.1159/000134469; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Philippe C, 1999, ANN GENET-PARIS, V42, P202; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Undarmaa B, 2004, BIOCHEM BIOPH RES CO, V315, P51, DOI 10.1016/j.bbrc.2004.01.014; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	71	691	700	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					90	103		10.1016/j.cell.2009.06.021	http://dx.doi.org/10.1016/j.cell.2009.06.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596237	Bronze, Green Accepted			2022-12-28	WOS:000267848600017
J	Wiersig, J; Gies, C; Jahnke, F; Assmann, M; Berstermann, T; Bayer, M; Kistner, C; Reitzenstein, S; Schneider, C; Hofling, S; Forchel, A; Kruse, C; Kalden, J; Hommel, D				Wiersig, J.; Gies, C.; Jahnke, F.; Assmann, M.; Berstermann, T.; Bayer, M.; Kistner, C.; Reitzenstein, S.; Schneider, C.; Hoefling, S.; Forchel, A.; Kruse, C.; Kalden, J.; Hommel, D.			Direct observation of correlations between individual photon emission events of a microcavity laser	NATURE			English	Article								Lasers are recognized for coherent light emission, the onset of which is reflected in a change in the photon statistics(1). For many years, attempts have been made to directly measure correlations in the individual photon emission events of semiconductor lasers(2,3). Previously, the temporal decay of these correlations below or at the lasing threshold was considerably faster than could be measured with the time resolution provided by the Hanbury Brown/Twiss measurement set-up(4) used. Here we demonstrate a measurement technique using a streak camera that overcomes this limitation and provides a record of the arrival times of individual photons. This allows us to investigate the dynamical evolution of correlations between the individual photon emission events. We apply our studies to micropillar lasers(5) with semiconductor quantum dots(2,3,6-8) as the active material, operating in the regime of cavity quantum electrodynamics(9). For laser resonators with a low cavity quality factor, Q, a smooth transition from photon bunching to uncorrelated emission with increasing pumping is observed; for high-Q resonators, we see a non-monotonic dependence around the threshold where quantum light emission can occur. We identify regimes of dynamical anti-bunching of photons in agreement with the predictions of a microscopic theory that includes semiconductor-specific effects.	[Wiersig, J.; Gies, C.; Jahnke, F.; Kruse, C.; Kalden, J.; Hommel, D.] Univ Bremen, Dept Phys, D-28334 Bremen, Germany; [Assmann, M.; Berstermann, T.; Bayer, M.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Kistner, C.; Reitzenstein, S.; Schneider, C.; Hoefling, S.; Forchel, A.] Univ Wurzburg, D-97074 Wurzburg, Germany	University of Bremen; Dortmund University of Technology; University of Wurzburg	Jahnke, F (corresponding author), Univ Bremen, Dept Phys, D-28334 Bremen, Germany.	jahnke@itp.uni-bremen.de; manfred.bayer@tu-dortmund.de	Wiersig, Jan/F-1410-2013; Reitzenstein, Stephan/AAG-5399-2019; Reitzenstein, Stephan/A-9184-2014; Hofling, Sven/C-3140-2013; Bayer, Manfred/I-7947-2013; Assmann, Marc/I-9754-2019; Kalden, Joachim/E-6911-2011	Reitzenstein, Stephan/0000-0002-1381-9838; Hofling, Sven/0000-0003-0034-4682; Assmann, Marc/0000-0003-4953-1286; Kalden, Joachim/0000-0003-4694-7913; Forchel, Alfred/0000-0002-9377-9935; Bayer, Manfred/0000-0002-0893-5949; Wiersig, Jan/0000-0003-2764-1660	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We would like to thank P. Gartner and I. Akimov for discussions and technical support. Funding from the Deutsche Forschungsgemeinschaft through the research group 'Quantum optics in semiconductor nanostructures' and a grant for CPU time at the Forschungszentrum Julich (Germany) is gratefully acknowledged.	Baer N, 2006, EUR PHYS J B, V50, P411, DOI 10.1140/epjb/e2006-00164-3; Benson O, 1999, PHYS REV A, V59, P4756, DOI 10.1103/PhysRevA.59.4756; Berman P., 1994, CAVITY QUANTUM ELECT; Berstermann T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165318; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Carmichael H. J., 1998, STAT METHODS QUANTUM, V1; Choi YS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2751131; Fricke J, 1996, ANN PHYS-NEW YORK, V252, P479, DOI 10.1006/aphy.1996.0142; Gies C, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013803; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; Hofmann HF, 2000, J OPT SOC AM B, V17, P1926, DOI 10.1364/JOSAB.17.001926; Hoyer W, 2004, NONEQUILIBRIUM PHYSICS AT SHORT TIME SCALES, P309; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Kira M, 1999, PROG QUANT ELECTRON, V23, P189, DOI 10.1016/S0079-6727(99)00008-7; Loudon R., 1983, QUANTUM THEORY LIGHT; MACHIDA S, 1987, PHYS REV LETT, V58, P1000, DOI 10.1103/PhysRevLett.58.1000; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Reitzenstein S, 2008, OPT EXPRESS, V16, P4848, DOI 10.1364/OE.16.004848; RICE PR, 1994, PHYS REV A, V50, P4318, DOI 10.1103/PhysRevA.50.4318; Schwab M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045323; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; Ulrich SM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043906; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wiele C, 1998, PHYS REV A, V58, pR2680, DOI 10.1103/PhysRevA.58.R2680; Xie ZG, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117401	25	180	181	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					245	U108		10.1038/nature08126	http://dx.doi.org/10.1038/nature08126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587766				2022-12-28	WOS:000267761000038
J	Winer, RA				Winer, Rachel A.			Physician by Number	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rachel.winer@mssm.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					127	128		10.1001/jama.2009.979	http://dx.doi.org/10.1001/jama.2009.979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584330				2022-12-28	WOS:000267696500001
J	Sharam, GJ; Sinclair, ARE; Turkington, R				Sharam, Gregory J.; Sinclair, A. R. E.; Turkington, Roy			Serengeti Birds Maintain Forests by Inhibiting Seed Predators	SCIENCE			English	Article							TANZANIA		[Sharam, Gregory J.; Sinclair, A. R. E.; Turkington, Roy] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Turkington, R (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	royt@interchange.ubc.ca			Natural sciences and Engineering Research Council of Canada	Natural sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural sciences and Engineering Research Council of Canada.	Chapman CA, 1999, CONSERV BIOL, V13, P1301, DOI 10.1046/j.1523-1739.1999.98229.x; Mduma SAR, 2007, J ECOL, V95, P184, DOI 10.1111/j.1365-2745.2006.01188.x; PELLEW RA, 1984, AFR J ECOL, V22, P73, DOI 10.1111/j.1365-2028.1984.tb00679.x; SHARAM G, 2005, THESIS U BRIT COLUMB; Sharam G, 2006, BIOTROPICA, V38, P599, DOI 10.1111/j.1744-7429.2006.00195.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397	6	18	18	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					51	51		10.1126/science.1173805	http://dx.doi.org/10.1126/science.1173805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574381				2022-12-28	WOS:000267594000030
J	West, JA; Viswanathan, SR; Yabuuchi, A; Cunniff, K; Takeuchi, A; Park, IH; Sero, JE; Zhu, H; Perez-Atayde, A; Frazier, AL; Surani, MA; Daley, GQ				West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Sero, Julia E.; Zhu, Hao; Perez-Atayde, Antonio; Frazier, A. Lindsay; Surani, M. Azim; Daley, George Q.			A role for Lin28 in primordial germ-cell development and germ-cell malignancy	NATURE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; TRANSGENIC MICE; DOWN-REGULATION; MOUSE; MICRORNA; LINEAGE; LET-7; SPECIFICATION; METHYLATION	The rarity and inaccessibility of the earliest primordial germ cells (PGCs) in the mouse embryo thwart efforts to investigate molecular mechanisms of germ-cell specification. stella (also called Dppa3) marks the rare founder population of the germ lineage(1,2). Here we differentiate mouse embryonic stem cells carrying a stella transgenic reporter into putative PGCs in vitro. The Stella(+) cells possess a transcriptional profile similar to embryo-derived PGCs, and like their counterparts in vivo, lose imprints in a time-dependent manner. Using inhibitory RNAs to screen candidate genes for effects on the development of Stella(+) cells in vitro, we discovered that Lin28, a negative regulator of let-7 microRNA processing(3-6), is essential for proper PGC development. Furthermore, we show that Blimp1 (also called Prdm1), a let-7 target and a master regulator of PGCspecification(7-9), can rescue the effect of Lin28 deficiency during PGC development, thereby establishing a mechanism of action for Lin28 during PGC specification. Overexpression of Lin28 promotes formation of Stella(+) cells in vitro and PGCs in chimaeric embryos, and is associated with human germ-cell tumours. The differentiation of putative PGCs from embryonic stem cells in vitro recapitulates the early stages of gamete development in vivo, and provides an accessible system for discovering novel genes involved in germ-cell development and malignancy.	[West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Frazier, A. Lindsay; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Frazier, A. Lindsay; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [West, Jason A.; Viswanathan, Srinivas R.; Yabuuchi, Akiko; Cunniff, Kerianne; Takeuchi, Ayumu; Park, In-Hyun; Zhu, Hao; Daley, George Q.] Harvard Univ, Stem Cell Inst, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sero, Julia E.; Perez-Atayde, Antonio] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Frazier, A. Lindsay] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cambridge; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	West, Jason/I-4445-2014; Zhu, Hao/L-5114-2013; Julia, Sero/J-5476-2016; Viswanathan, Srinivas/ABA-6316-2021	West, Jason/0000-0002-7252-8651; Zhu, Hao/0000-0002-8417-9698; Julia, Sero/0000-0002-0299-9212; Viswanathan, Srinivas/0000-0003-1856-3023; Surani, Azim/0000-0002-8640-4318	NIH; Harvard Stem Cell Institute; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; MRC [G0300723, G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B, G0300723] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. W. Lensch for comments on this manuscript; D. K. Gifford, G. Gerber, C. Reeder and J. Baughman for comments and input regarding microarray analysis; G. Losyev for flow cytometry expertise; and S. Winkler of the British Consulate for providing support for collaboration between the Daley and Surani laboratories. This study was supported by grants from the NIH, the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research, and by support from the germ cell program of the Harvard Stem Cell Institute. G. Q. D. is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P2006, DOI 10.1002/cncr.20566; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	40	284	304	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					909	U151		10.1038/nature08210	http://dx.doi.org/10.1038/nature08210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19578360	Green Accepted			2022-12-28	WOS:000268938300042
J	Wang, J; Alexander, P; Wu, LJ; Hammer, R; Cleaver, O; McKnight, SL				Wang, Jian; Alexander, Peter; Wu, Leeju; Hammer, Robert; Cleaver, Ondine; McKnight, Steven L.			Dependence of Mouse Embryonic Stem Cells on Threonine Catabolism	SCIENCE			English	Article							3-DEHYDROGENASE; BIOSYNTHESIS	Measurements of the abundance of common metabolites in cultured embryonic stem (ES) cells revealed an unusual state with respect to one-carbon metabolism. These findings led to the discovery of copious expression of the gene encoding threonine dehydrogenase (TDH) in ES cells. TDH-mediated catabolism of threonine takes place in mitochondria to generate glycine and acetylcoenzyme A (CoA), with glycine facilitating one-carbon metabolism via the glycine cleavage system and acetyl-CoA feeding the tricarboxylic acid cycle. Culture media individually deprived of each of the 20 amino acids were applied to ES cells, leading to the discovery that ES cells are critically dependent on one amino acid-threonine. These observations show that ES cells exist in a high-flux backbone metabolic state comparable to that of rapidly growing bacterial cells.	[Wang, Jian; Alexander, Peter; Wu, Leeju; Hammer, Robert; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Cleaver, Ondine] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Cleaver, Ondine/0000-0003-2454-6641; Hammer, Robert E./0000-0001-5487-7551	NIH; Anonymous donor; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anonymous donor; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by an NIH Directors Pioneer Award, and unrestricted funds provided to S.L.M. by an anonymous donor	Alberts B., 2015, MOL BIOL CELL, V1; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; DALE RA, 1978, BIOCHIM BIOPHYS ACTA, V544, P496, DOI 10.1016/0304-4165(78)90324-0; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; HARDY K, 1989, DEVELOPMENT, V107, P597; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; PHEAR EA, 1957, J AM CHEM SOC, V79, P3737, DOI 10.1021/ja01571a034; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; WARREN L, 1957, J BIOL CHEM, V229, P613; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318	16	255	266	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					435	439		10.1126/science.1173288	http://dx.doi.org/10.1126/science.1173288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19589965	Green Accepted			2022-12-28	WOS:000268255100046
J	Jiang, QF; Karata, K; Woodgate, R; Cox, MM; Goodman, MF				Jiang, Qingfei; Karata, Kiyonobu; Woodgate, Roger; Cox, Michael M.; Goodman, Myron F.			The active form of DNA polymerase V is UmuD ' C-2-RecA-ATP	NATURE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; RECA PROTEIN; UV-MUTAGENESIS; REPLICATION; DEFICIENT; MUTATIONS; REPAIR; UMUC; PURIFICATION	DNA-damage-induced SOS mutations arise when Escherichia coli DNA polymerase (pol) V, activated by a RecA nucleoprotein filament (RecA*), catalyses translesion DNA synthesis. Here we address two longstanding enigmatic aspects of SOS mutagenesis, the molecular composition of mutagenically active pol V and the role of RecA*. We show that RecA* transfers a single RecA-ATP stoichiometrically from its DNA 39-end to free polV (UmuD'C-2) to form an active mutasome (polV Mut) with the composition UmuD'C-2-RecA-ATP. PolV Mut catalyses TLS in the absence of RecA* and deactivates rapidly upon dissociation from DNA. Deactivation occurs more slowly in the absence of DNA synthesis, while retaining RecA-ATP in the complex. Reactivation of polV Mut is triggered by replacement of RecA-ATP from RecA*. Thus, the principal role of RecA* in SOS mutagenesis is to transfer RecA-ATP to pol V, and thus generate active mutasomal complex for translesion synthesis.	[Jiang, Qingfei; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Jiang, Qingfei; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Karata, Kiyonobu; Woodgate, Roger] NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu	JIANG, QINGFEI/K-3492-2012	JIANG, QINGFEI/0000-0002-9072-8032; Woodgate, Roger/0000-0001-5581-4616	National Institutes of Health [ES12259, R37GM21422, GM32335]; NICHD/NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, R37GM021422, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants to M. F. G. (ES12259; R37GM21422) and M. M. C. (GM32335), and funds from the NICHD/NIH Intramural Research Program to K. K. and R. W. The authors thank R. Britt for preparation of the RecA E38KDC17 protein used in this study. MALS data were collected using the USC NanoBiophysics Core Facility, with the aid and cooperation of N. Chelyapov. Wethank J. Bertram for his help in performing the MALS experiment and analysing the data. We thank J. Petruska for his comments.	Becherel OJ, 2002, DNA REPAIR, V1, P703, DOI 10.1016/S1568-7864(02)00106-4; BRIDGES BA, 1984, MOL GEN GENET, V196, P364, DOI 10.1007/BF00328073; Bruck I, 1996, J BIOL CHEM, V271, P10767, DOI 10.1074/jbc.271.18.10767; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; DUTREIX M, 1992, MOL GEN GENET, V232, P489, DOI 10.1007/BF00266254; ECHOLS H, 1990, MUTAT RES, V236, P301, DOI 10.1016/0921-8777(90)90013-U; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P463; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lenne-Samuel N, 2002, EMBO REP, V3, P45, DOI 10.1093/embo-reports/kvf007; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; SWEASY JB, 1990, J BACTERIOL, V172, P3030, DOI 10.1128/jb.172.6.3030-3036.1990; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	25	109	112	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					359	363		10.1038/nature08178	http://dx.doi.org/10.1038/nature08178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606142	Green Accepted			2022-12-28	WOS:000267979000030
J	Van Gossum, A; Navas, MM; Fernandez-Urien, I; Carretero, C; Gay, G; Delvaux, M; Lapalus, MG; Ponchon, T; Neuhaus, H; Philipper, M; Costamagna, G; Riccioni, ME; Spada, C; Petruzziello, L; Fraser, C; Postgate, A; Fitzpatrick, A; Hagenmuller, F; Keuchel, M; Schoofs, N; Deviere, J				Van Gossum, Andre; Munoz Navas, Miguel; Fernandez-Urien, Inaqui; Carretero, Cristina; Gay, Gerard; Delvaux, Michel; Lapalus, Marie Georges; Ponchon, Thierry; Neuhaus, Horst; Philipper, Michael; Costamagna, Guido; Riccioni, Maria Elena; Spada, Cristiano; Petruzziello, Lucio; Fraser, Chris; Postgate, Aymer; Fitzpatrick, Aine; Hagenmuller, Friedrich; Keuchel, Martin; Schoofs, Nathalie; Deviere, Jacques			Capsule Endoscopy versus Colonoscopy for the Detection of Polyps and Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PILLCAM COLON CAPSULE; COLORECTAL-CANCER; SCREENING COLONOSCOPY; ADVANCED NEOPLASIA; ADENOMA DETECTION; SMALL-BOWEL; IMPACT; RECOMMENDATIONS; SURVEILLANCE	Background An ingestible capsule consisting of an endoscope equipped with a video camera at both ends was designed to explore the colon. This study compared capsule endoscopy with optical colonoscopy for the detection of colorectal polyps and cancer. Methods We performed a prospective, multicenter study comparing capsule endoscopy with optical colonoscopy (the standard for comparison) in a cohort of patients with known or suspected colonic disease for the detection of colorectal polyps or cancer. Patients underwent an adapted colon preparation, and colon cleanliness was graded from poor to excellent. We computed the sensitivity and specificity of capsule endoscopy for polyps, advanced adenoma, and cancer. Results A total of 328 patients (mean age, 58.6 years) were included in the study. The capsule was excreted within 10 hours after ingestion and before the end of the lifetime of the battery in 92.8% of the patients. The sensitivity and specificity of capsule endoscopy for detecting polyps that were 6 mm in size or bigger were 64% (95% confidence interval [CI], 59 to 72) and 84% (95% CI, 81 to 87), respectively, and for detecting advanced adenoma, the sensitivity and specificity were 73% (95% CI, 61 to 83) and 79% (95% CI, 77 to 81), respectively. Of 19 cancers detected by colonoscopy, 14 were detected by capsule endoscopy (sensitivity, 74%; 95% CI, 52 to 88). For all lesions, the sensitivity of capsule endoscopy was higher in patients with good or excellent colon cleanliness than in those with fair or poor colon cleanliness. Mild-to-moderate adverse events were reported in 26 patients (7.9%) and were mostly related to the colon preparation. Conclusions The use of capsule endoscopy of the colon allows visualization of the colonic mucosa in most patients, but its sensitivity for detecting colonic lesions is low as compared with the use of optical colonoscopy. (ClinicalTrials.gov number, NCT00604162.)	[Van Gossum, Andre; Schoofs, Nathalie; Deviere, Jacques] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Gastroenterol Hepatopancreatol & Gastrointes, B-1070 Brussels, Belgium; [Munoz Navas, Miguel; Fernandez-Urien, Inaqui; Carretero, Cristina] Univ Navarra, Div Digest Dis, E-31080 Pamplona, Spain; [Gay, Gerard; Delvaux, Michel] CHU Nancy, Dept Internal Med & Digest Dis, Hop Brabois, Nancy, France; [Lapalus, Marie Georges; Ponchon, Thierry] Hop Edouard Herriot, Serv Hepatogastroenterol, Lyon, France; [Neuhaus, Horst; Philipper, Michael] Evangel Krankenhaus, Dept Internal Med, Dusseldorf, Germany; [Costamagna, Guido; Riccioni, Maria Elena; Petruzziello, Lucio] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Digest Endoscopy Unit, Rome, Italy; [Fraser, Chris; Postgate, Aymer; Fitzpatrick, Aine] Univ London Imperial Coll Sci Technol & Med, St Marks Hosp, Wolfson Unit Endoscopy, London, England; [Hagenmuller, Friedrich; Keuchel, Martin] Asklepios Klin Altona, Dept Med 1, Hamburg, Germany	Universite Libre de Bruxelles; University of Navarra; CHU de Nancy; CHU Lyon; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Imperial College London; Asklepios Klinik Altona	Van Gossum, A (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Gastroenterol Hepatopancreatol & Gastrointes, Route Lennik 808, B-1070 Brussels, Belgium.		Spada, Cristiano/AAO-8852-2020	Spada, Cristiano/0000-0002-5692-0960; riccioni, maria elena/0000-0002-9239-4312	Given Imaging; Norgine	Given Imaging; Norgine	Dr. Ponchon reports receiving grant support from Norgine; Dr. Neuhaus, consulting fees from Cook Endoscopy; Dr. Philipper, consulting fees from Given Imaging and Merckle Recordati; Dr. Costamagna, grant support from Cook Endoscopy, Boston Scientific, and Olympus; Dr. Riccioni, lecture fees from Given Imaging; and Dr. Devisre, research support from Cook Endoscopy, Boston Scientific, Satiety, and AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Ben-Horin S, 2007, AM J GASTROENTEROL, V102, P2680, DOI 10.1111/j.1572-0241.2007.01486.x; Bond JH, 2007, AM J GASTROENTEROL, V102, P2686, DOI 10.1111/j.1572-0241.2007.01483.x; Bujanda L, 2007, GUT, V56, P1714, DOI 10.1136/gut.2007.120709; Burnand B, 2006, GASTROINTEST ENDOSC, V63, P1018, DOI 10.1016/j.gie.2006.01.051; Cave DR, 2006, NAT CLIN PRACT GASTR, V3, P158, DOI 10.1038/ncpgasthep0416; Cellier C, 2008, BEST PRACT RES CL GA, V22, P329, DOI 10.1016/j.bpg.2007.12.006; Chiu HM, 2006, AM J GASTROENTEROL, V101, P2719, DOI 10.1111/j.1572-0241.2006.00868.x; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Eliakim R, 2008, CURR OPIN GASTROEN, V24, P159, DOI 10.1097/MOG.0b013e3282f3d946; Gay G, 2008, ENDOSCOPY, V40, P140, DOI 10.1055/s-2007-995419; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Leighton Jonathan A, 2006, Gastrointest Endosc Clin N Am, V16, P229, DOI 10.1016/j.giec.2006.03.004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2005, CLIN GASTROENTEROL H, V3, P798, DOI 10.1016/S1542-3565(05)00405-2; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Ponchon T, 2007, ENDOSCOPY, V39, P992, DOI 10.1055/s-2007-995347; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex DK, 2007, GASTROENTEROLOGY, V133, P42, DOI 10.1053/j.gastro.2007.04.029; Schoofs N, 2006, ENDOSCOPY, V38, P971, DOI 10.1055/s-2006-944835; Szojda MM, 2008, SCAND J GASTROENTERO, V43, P622, DOI 10.1080/00365520701843001; Thomas-Gibson S, 2006, ENDOSCOPY, V38, P456, DOI 10.1055/s-2006-925259; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Worthington J, 2008, CURR MED RES OPIN, V24, P481, DOI 10.1185/030079908X260844 	26	261	278	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					264	270		10.1056/NEJMoa0806347	http://dx.doi.org/10.1056/NEJMoa0806347			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605831	Bronze			2022-12-28	WOS:000267976100007
J	Bredel, M; Scholtens, DM; Harsh, GR; Bredel, C; Chandler, JP; Renfrow, JJ; Yadav, AK; Vogel, H; Scheck, AC; Tibshirani, R; Sikic, BI				Bredel, Markus; Scholtens, Denise M.; Harsh, Griffith R.; Bredel, Claudia; Chandler, James P.; Renfrow, Jaclyn J.; Yadav, Ajay K.; Vogel, Hannes; Scheck, Adrienne C.; Tibshirani, Robert; Sikic, Branimir I.			A Network Model of a Cooperative Genetic Landscape in Brain Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MOLECULAR CLASSIFICATION; EXPRESSION PATTERNS; MALIGNANT GLIOMAS; PROSTATE-CANCER; GLIOBLASTOMA; CELLS; SURVIVAL; GENOME; GROWTH	Context Gliomas, particularly glioblastomas, are among the deadliest of human tumors. Gliomas emerge through the accumulation of recurrent chromosomal alterations, some of which target yet-to-be-discovered cancer genes. A persistent question concerns the biological basis for the coselection of these alterations during gliomagenesis. Objectives To describe a network model of a cooperative genetic landscape in gliomas and to evaluate its clinical relevance. Design, Setting, and Patients Multidimensional genomic profiles and clinical profiles of 501 patients with gliomas (45 tumors in an initial discovery set collected between 2001 and 2004 and 456 tumors in validation sets made public between 2006 and 2008) from multiple academic centers in the United States and The Cancer Genome Atlas Pilot Project (TCGA). Main Outcome Measures Identification of genes with coincident genetic alterations, correlated gene dosage and gene expression, and multiple functional interactions; association between those genes and patient survival. Results Gliomas select for a nonrandom genetic landscape-a consistent pattern of chromosomal alterations-that involves altered regions ("territories") on chromosomes 1p, 7, 8q, 9p, 10, 12q, 13q, 19q, 20, and 22q (false-discovery rate-corrected P<.05). A network model shows that these territories harbor genes with putative synergistic, tumor-promoting relationships. The coalteration of the most interactive of these genes in glioblastoma is associated with unfavorable patient survival. A multigene risk scoring model based on 7 landscape genes (POLD2, CYCS, MYC, AKR1C3, YME1L1, ANXA7, and PDCD4) is associated with the duration of overall survival in 189 glioblastoma samples from TCGA ( global log-rank P=.02 comparing 3 survival curves for patients with 0-2, 3-4, and 5-7 dosage-altered genes). Groups of patients with 0 to 2 ( low- risk group) and 5 to 7 (high-risk group) dosage-altered genes experienced 49.24 and 79.56 deaths per 100 person-years ( hazard ratio [HR], 1.63; 95% confidence interval [CI], 1.10-2.40; Cox regression model P=.02), respectively. These associations with survival are validated using gene expression data in 3 independent glioma studies, comprising 76 ( global log-rank P=.003; 47.89 vs 15.13 deaths per 100 person-years for high risk vs low risk; Cox model HR, 3.04; 95% CI, 1.49-6.20; P=.002) and 70 (global log-rank P=.008; 83.43 vs 16.14 deaths per 100 person-years for high risk vs low risk; HR, 3.86; 95% CI, 1.59-9.35; P=.003) high-grade gliomas and 191 glioblastomas (global log-rank P=.002; 83.23 vs 34.16 deaths per 100 person-years for high risk vs low risk; HR, 2.27; 95% CI, 1.44-3.58; P<.001). Conclusions The alteration of multiple networking genes by recurrent chromosomal aberrations in gliomas deregulates critical signaling pathways through multiple, cooperative mechanisms. These mutations, which are likely due to nonrandom selection of a distinct genetic landscape during gliomagenesis, are associated with patient prognosis. JAMA. 2009; 302(3):261-275 www.jama.com	[Bredel, Markus] Northwestern Univ, Dept Neurol Surg, NW Brain Tumor Inst,Robert H Lurie Comprehens Can, Lurie Ctr Canc Genet Res,Feinberg Sch Med, Chicago, IL 60611 USA; [Bredel, Markus; Chandler, James P.; Renfrow, Jaclyn J.; Yadav, Ajay K.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Harsh, Griffith R.; Bredel, Claudia] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Bredel, Claudia; Sikic, Branimir I.] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Bredel, Claudia; Sikic, Branimir I.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Sch Med, Dept Hlth Res & Policy & Stat, Stanford, CA 94305 USA; [Bredel, Markus; Bredel, Claudia] Univ Freiburg, Dept Gen Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Markus; Bredel, Claudia] Univ Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Scheck, Adrienne C.] Barrow Neurol Inst, St Josephs Med Ctr, Ina Levine Brain Tumor Ctr, Phoenix, AZ 85013 USA	Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Freiburg; University of Freiburg; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Bredel, M (corresponding author), Northwestern Univ, Dept Neurol Surg, NW Brain Tumor Inst,Robert H Lurie Comprehens Can, Lurie Ctr Canc Genet Res,Feinberg Sch Med, 303 E Super St,Lurie Room 6-111, Chicago, IL 60611 USA.	m-bredel@northwestern.edu	Scheck, Adrienne/AAH-5040-2020	Yadav, Ajay/0000-0003-3321-4198; Scheck, Adrienne/0000-0003-3497-1895; Vogel, Otto Hannes/0000-0002-0960-3508	Illinois Excellence in Academic Medicine Program [211]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER	Illinois Excellence in Academic Medicine Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the State of Illinois Excellence in Academic Medicine Program (EAM Award 211 to Dr M. Bredel).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; COLMAN H, NEURO ONCOL IN PRESS; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furge LL, 1999, J BIOL CHEM, V274, P33504, DOI 10.1074/jbc.274.47.33504; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo QM, 2000, CANCER RES, V60, P5922; Hyman E, 2002, CANCER RES, V62, P6240; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Leighton X, 2004, CANCER LETT, V210, P239, DOI 10.1016/j.canlet.2004.01.018; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsushima-Nishiu M, 2001, CANCER RES, V61, P3741; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Mitelman F, 1995, ISCN INT SYSTEM HUMA; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nutt CL, 2003, CANCER RES, V63, P1602; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Srivastava M, 2004, CLIN CANCER RES, V10, P2344, DOI 10.1158/1078-0432.CCR-03-0278; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stears RL, 2000, PHYSIOL GENOMICS, V3, P93, DOI 10.1152/physiolgenomics.2000.3.2.93; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Torosyan Y, 2006, CANCER RES, V66, P9609, DOI 10.1158/0008-5472.CAN-06-1574; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006	47	145	150	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					261	275		10.1001/jama.2009.997	http://dx.doi.org/10.1001/jama.2009.997			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602686	Green Accepted, Bronze			2022-12-28	WOS:000267948100020
J	Besche, HC; Peth, A; Goldberg, AL				Besche, Henrike C.; Peth, Andreas; Goldberg, Alfred L.			Getting to First Base in Proteasome Assembly	CELL			English	Review							19S REGULATORY PARTICLE; 20S PROTEASOMES; PATHWAY; ATPASES; TERMINI; PROTEIN; GATE	Assembly of complex structures such as the eukaryotic 26S proteasome requires intricate mechanisms that ensure precise subunit arrangements. Recent studies have shed light on the pathway for ordered assembly of the base of the 19S regulatory particle of the 26S proteasome by identifying new precursor complexes and four dedicated chaperones involved in its assembly.	[Besche, Henrike C.; Peth, Andreas; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		Besche, Henrike/0000-0002-9841-9218	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051923-13, R01 GM051923] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	19	62	65	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					25	28		10.1016/j.cell.2009.06.035	http://dx.doi.org/10.1016/j.cell.2009.06.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596233	Green Accepted, Bronze			2022-12-28	WOS:000267848600012
J	Esfandbod, M; Malekpour, M				Esfandbod, Mohsen; Malekpour, Mahdi			Cutaneous Anthrax.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Esfandbod, Mohsen; Malekpour, Mahdi] Univ Tehran Med Sci, Tehran 1419733141, Iran	Tehran University of Medical Sciences	Esfandbod, M (corresponding author), Univ Tehran Med Sci, Tehran 1419733141, Iran.	sfandbod@sina.tums.ac.ir	Malekpour, Mahdi/B-6174-2009	Malekpour, Mahdi/0000-0002-7337-3479; Esfandbod, Mohsen/0000-0002-6497-2306					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					178	178		10.1056/NEJMicm0802093	http://dx.doi.org/10.1056/NEJMicm0802093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587343				2022-12-28	WOS:000267748900011
J	Hopkins, H; Asiimwe, C; Bell, D				Hopkins, Heidi; Asiimwe, Caroline; Bell, David			Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals	BRITISH MEDICAL JOURNAL			English	Editorial Material							MALARIA TREATMENT; COMBINATION THERAPY; FEBRILE ILLNESS; TESTS; TANZANIA; CHILDREN; AFRICA; IMPACT; POLICY; MORBIDITY		[Hopkins, Heidi; Asiimwe, Caroline] FIND, Kampala, Uganda; [Bell, David] WHO, Reg Off Western Pacific, New York, NY USA	Foundation For Innovative New Diagnostics; World Health Organization	Hopkins, H (corresponding author), FIND, Kampala, Uganda.	heidi.hopkins@finddiagnostics.org		Asiimwe, Caroline/0000-0001-6840-5985; Hopkins, Heidi/0000-0003-1076-6758				Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], MAL RAP DIAGN TESTS; [Anonymous], 2008, WORLD MAL REP 2008; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Djimde A, 1998, AM J TROP MED HYG, V59, P376, DOI 10.4269/ajtmh.1998.59.376; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Moerman F, 2003, LANCET INFECT DIS, V3, P99, DOI 10.1016/S1473-3099(03)00518-8; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *ROLL BACK MAL PAR, 2007, AFF MED FAC MAL AMFM; *ROLL BACK MAL WHO, GLOB STRAT PLAN 2005; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; United Nations, 2008, MILL DEV GOALS REP; WHO, 2006, GUID TREATM MAL; *WHO, 2008, GLOB MAL CONR EL REP; *WHO, FDN INN NEW DIAGN ME; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Zikusooka CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-176	28	29	29	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 7	2009	339								b2606	10.1136/bmj.b2606	http://dx.doi.org/10.1136/bmj.b2606			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KX	19584113				2022-12-28	WOS:000267898200003
J	Farrell, SA; Webb, NA; Barret, D; Godet, O; Rodrigues, JM				Farrell, Sean A.; Webb, Natalie A.; Barret, Didier; Godet, Olivier; Rodrigues, Joana M.			An intermediate-mass black hole of over 500 solar masses in the galaxy ESO 243-49	NATURE			English	Article							X-RAY OBSERVATIONS; ACCRETION	Ultraluminous X-ray sources are extragalactic objects located outside the nucleus of the host galaxy with bolometric luminosities(1) exceeding 10(39) erg s(-1). These extreme luminosities-if the emission is isotropic and below the theoretical (Eddington) limit, where the radiation pressure is balanced by the gravitational pressure-imply the presence of an accreting black hole with a mass of similar to 10(2)-10(5) solar masses (M-circle dot). The existence of such intermediate-mass black holes is in dispute, and though many candidates have been proposed, none are widely accepted as definitive. Here we report the detection of a variable X-ray source with a maximum 0.2-10 keV luminosity of up to 1.1 x 10(42) erg s(-1) in the edge-on spiral galaxy ESO 243-49, with an implied conservative lower limit for the mass of the black hole of similar to 500M(circle dot).	[Farrell, Sean A.; Webb, Natalie A.; Barret, Didier; Rodrigues, Joana M.] Univ Toulouse, UPS, CESR, F-31028 Toulouse 9, France; [Farrell, Sean A.; Webb, Natalie A.; Barret, Didier; Rodrigues, Joana M.] CNRS, UMR5187, F-31028 Toulouse, France; [Godet, Olivier] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Leicester	Farrell, SA (corresponding author), Univ Leicester, Dept Phys & Astron, Univ Rd, Leicester LE1 7RH, Leics, England.	saf28@star.le.ac.uk; natalie.webb@cesr.fr	Barret, Didier/AAV-2771-2020	barret, didier/0000-0002-0393-9190	ESA Member States; NASA; UK Space Agency [ST/G008655/1] Funding Source: researchfish	ESA Member States(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); UK Space Agency	We thank N. Schartel for granting an observation under the XMM-Newton project scientist discretionary time programme. We thank R. Belmont, A. King, J.-P. Lasota, K. Mukai, T. Roberts, S. Rosen, S. Sembay and M. Watson for discussions. S. A. F. acknowledges funding from the CNES. S. A. F. and O. G. acknowledge STFC funding. This work made use of the 2XMM Serendipitous Source Catalogue constructed by the XMM-Newton Survey Science Centre on behalf of ESA. We thank the Swift team for performing a TOO observation that provided justification for an additional observation with XMM-Newton. This work was based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA.	ABRAMOWICZ MA, 1990, ASTROPHYS J, V361, P470, DOI 10.1086/169211; Afonso J, 2005, ASTROPHYS J, V624, P135, DOI 10.1086/428923; Baskill DS, 2005, MON NOT R ASTRON SOC, V357, P626, DOI 10.1111/j.1365-2966.2005.08677.x; Begelman MC, 2002, ASTROPHYS J, V568, pL97, DOI 10.1086/340457; Bekki K, 2003, MON NOT R ASTRON SOC, V346, pL11, DOI 10.1046/j.1365-2966.2003.07275.x; Berghea CT, 2008, ASTROPHYS J, V687, P471, DOI 10.1086/591722; Casella P, 2008, MON NOT R ASTRON SOC, V387, P1707, DOI 10.1111/j.1365-2966.2008.13372.x; Done C, 2007, ASTRON ASTROPHYS REV, V15, P1, DOI 10.1007/s00159-007-0006-1; Freeland M, 2006, MON NOT R ASTRON SOC, V372, P630, DOI 10.1111/j.1365-2966.2006.10750.x; Giommi P., 2002, BLAZAR ASTROPHYSICS, P63; Gudel M, 2004, ASTRON ASTROPHYS REV, V12, P71, DOI 10.1007/s00159-004-0023-2; Hilton EJ, 2007, ASTRON J, V134, P1503, DOI 10.1086/521343; Hurkett CP, 2008, ASTROPHYS J, V679, P587, DOI 10.1086/586881; Immler S, 2003, LECT NOTES PHYS, V598, P91; Jonker PG, 2007, AIP CONF PROC, V983, P519; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; King AR, 2008, MON NOT R ASTRON SOC, V385, pL113, DOI 10.1111/j.1745-3933.2008.00444.x; Liu J, 2008, ASTROPHYS J LETT, V674, pL73, DOI 10.1086/529071; Miller JM, 2003, ASTROPHYS J, V585, pL37, DOI 10.1086/368373; Miniutti G, 2006, MON NOT R ASTRON SOC, V373, pL1, DOI 10.1111/j.1745-3933.2006.00224.x; Noyola E, 2008, ASTROPHYS J, V676, P1008, DOI 10.1086/529002; Roberts TP, 2007, ASTROPHYS SPACE SCI, V311, P203, DOI 10.1007/s10509-007-9547-z; TENDER R, 2006, COMPACT STELLAR XRAY, P381; Turriziani S, 2007, ASTRON ASTROPHYS, V472, P699, DOI 10.1051/0004-6361:20077114; Watson MG, 2009, ASTRON ASTROPHYS, V493, P339, DOI 10.1051/0004-6361:200810534	25	375	376	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					73	75		10.1038/nature08083	http://dx.doi.org/10.1038/nature08083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571880	Green Submitted			2022-12-28	WOS:000267545200031
J	Hwang, J; Pototschnig, M; Lettow, R; Zumofen, G; Renn, A; Gotzinger, S; Sandoghdar, V				Hwang, J.; Pototschnig, M.; Lettow, R.; Zumofen, G.; Renn, A.; Goetzinger, S.; Sandoghdar, V.			A single-molecule optical transistor	NATURE			English	Article							PHOTON; FLUORESCENCE; ATOM; SPECTROSCOPY; EXCITATION; RESONANCE; EMISSION; BLOCKADE; CAVITY; FIELDS	The transistor is one of the most influential inventions of modern times and is ubiquitous in present-day technologies. In the continuing development of increasingly powerful computers as well as alternative technologies based on the prospects of quantum information processing, switching and amplification functionalities are being sought in ultrasmall objects, such as nanotubes, molecules or atoms(1-9). Among the possible choices of signal carriers, photons are particularly attractive because of their robustness against decoherence, but their control at the nano-metre scale poses a significant challenge as conventional nonlinear materials become ineffective. To remedy this shortcoming, resonances in optical emitters can be exploited, and atomic ensembles have been successfully used to mediate weak light beams(7). However, single-emitter manipulation of photonic signals has remained elusive and has only been studied in high-finesse microcavities(10-13) or waveguides(8,14). Here we demonstrate that a single dye molecule can operate as an optical transistor and coherently attenuate or amplify a tightly focused laser beam, depending on the power of a second 'gating' beam that controls the degree of population inversion. Such a quantum optical transistor has also the potential for manipulating non-classical light fields down to the single-photon level. We discuss some of the hurdles along the road towards practical implementations, and their possible solutions.	[Hwang, J.; Pototschnig, M.; Lettow, R.; Zumofen, G.; Renn, A.; Goetzinger, S.; Sandoghdar, V.] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Hwang, J.; Pototschnig, M.; Lettow, R.; Zumofen, G.; Renn, A.; Goetzinger, S.; Sandoghdar, V.] ETH, OptETH, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sandoghdar, V (corresponding author), ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland.	vahid.sandoghdar@ethz.ch	Gotzinger, Stephan/AAX-6761-2021; Sandoghdar, Vahid/AAT-8856-2020; Goetzinger, Stephan/C-7396-2013	Gotzinger, Stephan/0000-0003-4975-0112; Sandoghdar, Vahid/0000-0003-2594-4801; 	Swiss National Foundation (SNF); ETH Zurich [PP-01 07-02]	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Foundation (SNF) and ETH Zurich (QSIT, grant no. PP-01 07-02). We thank I. Gerhardt and G. Wrigge for their contributions to this project. V. S. thanks X. S. Xie for his hospitality at Harvard University during the writing process of this manuscript.	Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Chizhik A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073002; DAVIDOVICH L, 1993, PHYS REV LETT, V71, P2360, DOI 10.1103/PhysRevLett.71.2360; Dawes AMC, 2005, SCIENCE, V308, P672, DOI 10.1126/science.1110151; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Gerhardt I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.033601; Gerhardt I, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.011402; Harris SE, 1998, PHYS REV LETT, V81, P3611, DOI 10.1103/PhysRevLett.81.3611; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Lettow R, 2007, OPT EXPRESS, V15, P15842, DOI 10.1364/OE.15.015842; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Loudon R., 2000, QUANTUM THEORY LIGHT; Lounis B, 1997, PHYS REV LETT, V78, P3673, DOI 10.1103/PhysRevLett.78.3673; Micheli A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140408; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Plakhotnik T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.183602; Rogobete L, 2007, OPT LETT, V32, P1623, DOI 10.1364/OL.32.001623; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Shen JT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153003; Stobinska M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/14007; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Vaishnav JY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.265302; Wrigge G, 2008, NAT PHYS, V4, P60, DOI 10.1038/nphys812; Zumofen G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180404	30	267	274	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					76	80		10.1038/nature08134	http://dx.doi.org/10.1038/nature08134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571881				2022-12-28	WOS:000267545200032
J	Steinbrook, R				Steinbrook, Robert			The End of Fee-for-Service Medicine? Proposals for Payment Reform in Massachusetts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*COMM MA, 2009, REC SPEC COMM HLTH C; ELMENDORF DW, 2009, COMMUNICATION   0616; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Medicare Payment Advisory Commission The (MedPac), 2009, REP C IMPR INC MED P; Steinbrook R, 2008, NEW ENGL J MED, V358, P2757, DOI 10.1056/NEJMp0804277	5	17	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1036	1038		10.1056/NEJMp0906556	http://dx.doi.org/10.1056/NEJMp0906556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492LP	19641192				2022-12-28	WOS:000269659400002
J	Steele, GA; Huttel, AK; Witkamp, B; Poot, M; Meerwaldt, HB; Kouwenhoven, LP; van der Zant, HSJ				Steele, G. A.; Huttel, A. K.; Witkamp, B.; Poot, M.; Meerwaldt, H. B.; Kouwenhoven, L. P.; van der Zant, H. S. J.			Strong Coupling Between Single-Electron Tunneling and Nanomechanical Motion	SCIENCE			English	Article							NANOTUBE QUANTUM DOTS; CARBON NANOTUBES; RESONATOR; OSCILLATIONS; BLOCKADE; STATES	Nanoscale resonators that oscillate at high frequencies are useful in many measurement applications. We studied a high-quality mechanical resonator made from a suspended carbon nanotube driven into motion by applying a periodic radio frequency potential using a nearby antenna. Single-electron charge fluctuations created periodic modulations of the mechanical resonance frequency. A quality factor exceeding 10(5) allows the detection of a shift in resonance frequency caused by the addition of a single-electron charge on the nanotube. Additional evidence for the strong coupling of mechanical motion and electron tunneling is provided by an energy transfer to the electrons causing mechanical damping and unusual nonlinear behavior. We also discovered that a direct current through the nanotube spontaneously drives the mechanical resonator, exerting a force that is coherent with the high-frequency resonant mechanical motion.	[Steele, G. A.; Huttel, A. K.; Witkamp, B.; Poot, M.; Meerwaldt, H. B.; Kouwenhoven, L. P.; van der Zant, H. S. J.] Delft Univ Technol, Kavli Inst NanoSci, NL-2600 GA Delft, Netherlands	Delft University of Technology	Steele, GA (corresponding author), Delft Univ Technol, Kavli Inst NanoSci, POB 5046, NL-2600 GA Delft, Netherlands.	g.a.steele@tudelft.nl	Hüttel, Andreas K/C-2400-2008; Poot, Menno/A-3589-2009; van der Zant, Herre S.J./J-9467-2016; Steele, Gary/D-8378-2013	Hüttel, Andreas K/0000-0001-5794-5919; Poot, Menno/0000-0002-5047-8497; van der Zant, Herre S.J./0000-0002-5385-0282; 	Dutch Organization for Fundamental Research on Matter; Netherlands Organization for Scientific Research; Nanotechnology Network Netherlands; Japan Science and Technology Agency International Cooperative Research Project	Dutch Organization for Fundamental Research on Matter; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Nanotechnology Network Netherlands; Japan Science and Technology Agency International Cooperative Research Project(Japan Science & Technology Agency (JST))	We thank Y. M. Blanter and Y. V. Nazarov for helpful discussions. This work was supported by the Dutch Organization for Fundamental Research on Matter, the Netherlands Organization for Scientific Research, the Nanotechnology Network Netherlands, and the Japan Science and Technology Agency International Cooperative Research Project.	BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; BRINK M, 2007, THESIS CORNELL U; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Chiu HY, 2008, NANO LETT, V8, P4342, DOI 10.1021/nl802181c; Cleland A. N, 2002, FDN NANOMECHANICS; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Ekinci KL, 2004, APPL PHYS LETT, V84, P4469, DOI 10.1063/1.1755417; Huttel AK, 2009, NANO LETT, V9, P2547, DOI 10.1021/nl900612h; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Lassagne B, 2008, NANO LETT, V8, P3735, DOI 10.1021/nl801982v; Leturcq R, 2009, NAT PHYS, V5, P327, DOI 10.1038/NPHYS1234; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Nayfeh A.H., 1995, NONLINEAR OSCIL; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Sapmaz S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026801; Sapmaz S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235414; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Steele GA, 2009, NAT NANOTECHNOL, V4, P363, DOI [10.1038/NNANO.2009.71, 10.1038/nnano.2009.71]; Stomp R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056802; Usmani O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195312; Witkamp B, 2006, NANO LETT, V6, P2904, DOI 10.1021/nl062206p; Woodside MT, 2002, SCIENCE, V296, P1098, DOI 10.1126/science.1069923; Zhu J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2139623; Zwanenburg FA, 2009, NANO LETT, V9, P1071, DOI 10.1021/nl803440s	27	317	319	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1103	1107		10.1126/science.1176076	http://dx.doi.org/10.1126/science.1176076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628816	Green Submitted			2022-12-28	WOS:000269382300034
J	Castle, PE; Rodriguez, AC; Burk, RD; Herrero, R; Wacholder, S; Alfaro, M; Morales, J; Guillen, D; Sherman, ME; Solomon, D; Schiffman, M				Castle, Philip E.; Cecilia Rodriguez, Ana; Burk, Robert D.; Herrero, Rolando; Wacholder, Sholom; Alfaro, Mario; Morales, Jorge; Guillen, Diego; Sherman, Mark E.; Solomon, Diane; Schiffman, Mark		PEG Grp	Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCIDENCE TRENDS; QUALITY-CONTROL; FOLLOW-UP; WOMEN; HPV; NEOPLASIA; DNA; INFECTION; ADENOCARCINOMA; ABNORMALITIES	Objective To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence of prevalently detected carcinogenic human papillomavirus (HPV). Design Population based cohort study. Setting Guanacaste, Costa Rica. Participants 2282 sexually active women actively followed after enrolment. Main outcome measures Primary end points: three year and five year cumulative incidence of histologically confirmed cervical intraepithelial neoplasia grade II+ (n=70). Cervical specimens collected at each visit tested for more than 40 HPV genotypes. HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, and 82 were considered the primary carcinogenic genotypes. Results Women who tested positive for a carcinogenic HPV at enrolment and after about one year (9-21 months) (positive/positive) had a three year cumulative incidence of cervical intraepithelial neoplasia grade II+ of 17.0% (95% confidence interval 12.1% to 22.0%). Those who tested negative/positive (3.4%, 0.1% to 6.8%), positive/negative (1.2%,-0.2% to 2.5%), and negative/negative (0.5%, 0.1% to 0.9%) were at a significantly lower risk. There was little difference in the cumulative incidence of cervical intraepithelial neoplasia grade II+ between testing positive twice for any carcinogenic HPV genotype (same genotype or different genotypes) v testing positive twice for the same carcinogenic genotype (17.0% v 21.3%, respectively). Short term persistence of HPV 16 strongly predicted cervical intraepithelial neoplasia grade II+, with a three year cumulative incidence of 40.8% (26.4% to 55.1%). Similar patterns were observed for the five year cumulative incidence of grade II+ and for three year and five year cumulative incidence of grade III+. Conclusions Short term persistence of a prevalently detected carcinogenic HPV infection, especially HPV 16, strongly predicts a subsequent diagnosis of cervical intraepithelial neoplasia II+ over the next few years.	[Castle, Philip E.; Wacholder, Sholom; Sherman, Mark E.; Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Solomon, Diane] NCI, Canc Prevent Div, NIH, DHHS, Bethesda, MD 20892 USA; [Cecilia Rodriguez, Ana; Herrero, Rolando; Alfaro, Mario; Morales, Jorge; Guillen, Diego] INCIEN SA Fdn, San Jose, Costa Rica; [Burk, Robert D.] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine	Castle, PE (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA.	castlep@mail.nih.gov	Hildesheim, Allan/B-9760-2015; Castle, Philip/AAP-6395-2020; Schiffman, Mark/B-9766-2015	Hildesheim, Allan/0000-0003-0257-2363; Castle, Philip/0000-0003-1082-6554; 	National Institutes of Health [N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP- 81023, CA78527]; National Cancer Institute; National Institutes of Health, Department of Health and Human Services; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP050535, N01CP021081, N01CP040542, N01CP033061, N01CP081023] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA078527, R01CA078527, ZIACP010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP- 81023, intramural programme, CA78527 to RB). The Guanacaste cohort was partly funded by the intramural research programme of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. ACR was supported by an appointment to the senior fellowship programme at the National Institutes of Health. The programme is administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the National Institutes of Health. The sponsors had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bratti MC, 2004, REV PANAM SALUD PUBL, V15, P75; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Bulk S, 2007, BRIT J CANCER, V96, P1234, DOI 10.1038/sj.bjc.6603693; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Carozzi FM, 2005, AM J CLIN PATHOL, V124, P716, DOI 10.1309/84E5WHJQHK83BGQD; Castle PE, 2004, AM J CLIN PATHOL, V122, P238, DOI 10.1309/BA43HMCAJ26VWQH3; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2008, AM J EPIDEMIOL, V168, P138, DOI 10.1093/aje/kwn037; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; IARC, 2005, IARC HDB CANC PREV; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	31	132	141	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2569	10.1136/bmj.b2569	http://dx.doi.org/10.1136/bmj.b2569			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PG	19638649	Green Published, hybrid			2022-12-28	WOS:000268672800004
J	Cruickshank, M; Murray, G; Parkin, D; Smart, L; Walker, E; Waugh, N; Avis, M; Chilvers, C; Fielding, K; Hammond, R; Jenkins, D; Johnson, J; Neal, K; Russell, I; Seth, R; Whynes, D; Duncan, I; Robertson, A; Little, J; Sharp, L; Russell, I; Walker, L; Anthony, B; Bell, S; Bowie, A; Brown, K; Brown, J; Chew, K; Cochran, C; Cotton, S; Dean, J; Dunn, K; Edwards, J; Evans, D; Fenty, J; Finlayson, A; Gallagher, M; Gray, N; Heddle, M; Innes, A; Jobson, D; Keillor, M; MacGregor, J; Mackenzie, S; Mackie, A; McPherson, G; Okorocha, I; Reilly, M; Rodgers, J; Thornton, A; Yeats, R; Alexander, L; Buchanan, L; Henderson, S; Iterbeke, T; Lucas, S; Manderson, G; Nicol, S; Reid, G; Robinson, C; Sandilands, T; Adrian, M; Al-Sahab, A; Bentley, E; Brook, H; Bushby, C; Cannon, R; Cooper, B; Dowell, R; Dunderdale, M; Gabrawi, E; Guo, L; Heideman, L; Jones, S; Lawson, S; Philips, Z; Platt, C; Prabhakaran, S; Rippin, J; Thompson, R; Williams, E; Woolley, C; Boroujerdi, M; Cotton, S; Harrild, K; Norrie, J; Day, N; Marteau, T; Parmar, M; Patnick, J; Woodman, C; Altman, D; Moss, S; Wells, M; Whynes, D; Philips, Z; Woolley, C; Cotton, S; Cruickshank, M; Harrild, K; Little, J; Neal, K; Sharp, L; Waugh, N				Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman; Avis, Mark; Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave; Duncan, Ian; Robertson, Alistair; Little, Julian; Sharp, Linda; Russell, Ian; Walker, Leslie; Anthony, Breda; Bell, Sarah; Bowie, Adrienne; Brown, Katrina; Brown, Joe; Chew, Kheng; Cochran, Claire; Cotton, Seonaidh; Dean, Jeannie; Dunn, Kate; Edwards, Jane; Evans, David; Fenty, Julie; Finlayson, Al; Gallagher, Marie; Gray, Nicola; Heddle, Maureen; Innes, Alison; Jobson, Debbie; Keillor, Mandy; MacGregor, Jayne; Mackenzie, Sheona; Mackie, Amanda; McPherson, Gladys; Okorocha, Ike; Reilly, Morag; Rodgers, Joan; Thornton, Alison; Yeats, Rachel; Alexander, Lindyanne; Buchanan, Lindsey; Henderson, Susan; Iterbeke, Tine; Lucas, Susanneke; Manderson, Gillian; Nicol, Sheila; Reid, Gael; Robinson, Carol; Sandilands, Trish; Adrian, Marg; Al-Sahab, Ahmed; Bentley, Elaine; Brook, Hazel; Bushby, Claire; Cannon, Rita; Cooper, Brenda; Dowell, Ruth; Dunderdale, Mark; Gabrawi, E.; Guo, Li; Heideman, Lisa; Jones, Steve; Lawson, Salli; Philips, Zoe; Platt, Christopher; Prabhakaran, Shakuntala; Rippin, John; Thompson, Rose; Williams, Elizabeth; Woolley, Claire; Boroujerdi, Massoud; Cotton, Seonaidh; Harrild, Kirsten; Norrie, John; Day, Nicholas; Marteau, Theresa; Parmar, Mahesh; Patnick, Julietta; Woodman, Ciaran; Altman, Doug; Moss, Sue; Wells, Michael; Whynes, Dave; Philips, Zoe; Woolley, Claire; Cotton, Seonaidh; Cruickshank, Maggie; Harrild, Kirsten; Little, Julian; Neal, Keith; Sharp, Linda; Waugh, Norman			Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study	BRITISH MEDICAL JOURNAL			English	Article							LIQUID-BASED CYTOLOGY; SQUAMOUS INTRAEPITHELIAL LESIONS; SEE-AND-TREAT; HUMAN-PAPILLOMAVIRUS; CONVENTIONAL CYTOLOGY; UNITED-KINGDOM; UTERINE CERVIX; CANCER; MANAGEMENT; HEALTH	Objective To estimate the cost effectiveness of alternative methods of managing low grade cervical cytological abnormalities detected at routine screening. Design Cost analysis within multicentre individually randomised controlled trial. Setting Grampian, Tayside, and Nottingham. Participants 4201 women with low grade abnormalities. Interventions Cytological surveillance or referral to colposcopy for biopsy and recall if necessary or referral to colposcopy with immediate treatment based on colposcopic appearance. Main outcome measures Data on resource use collected from participants throughout the duration of the trial (36 months), enabling the estimation of both the direct (health care) and indirect (time and travel) costs of management. Quality of life assessed at recruitment and at 12, 18, 24, and 30 months, using the EQ-5D instrument. Economic outcomes expressed as costs per case of cervical intraepithelial neoplasia (grade II or worse) detected, by trial arm, as confirmed at exit, and cost utility ratios (cost per quality adjusted life year (QALY) gained) for the three pairwise comparisons of trial arms. Results The mean three year discounted costs of surveillance, immediate treatment, and biopsy and recall were 150.20 pound ((sic)177, $249), 240.30 pound ((sic)283, $415), and 241.10 pound ((sic)284, $4000), respectively, viewed from the health service perspective. From the social perspective, mean discounted costs were 204.40 pound ((sic)241, $339), 339.90 pound ((sic)440, $563), and 327.50 pound ((sic)386, $543), respectively. Estimated at the means, the incremental cost effectiveness ratios indicated that immediate treatment was dominated by the other two management methods, although it did offer the lowest cost per case of cervical intraepithelial neoplasia detected and treated. The pronounced skews in the distributions indicated that probabilistic uncertainty analysis would offer more meaningful estimates of cost effectiveness. The observed differences in the cost effectiveness ratios between trial arms were not significant. Conclusion Judged within the time frame of the TOMBOLA evaluation, there is no compelling economic reason to favour any one follow-up method over either of the others.	[Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman] Univ Aberdeen & NHS Grampian, Aberdeen, Scotland; [Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave] Univ Nottingham & Nottingham NHS, Nottingham, England; [Duncan, Ian; Robertson, Alistair] Univ Dundee & NHS Tayside, Dundee, Tayside, Scotland; [Little, Julian] Univ Ottawa, Ottawa, ON, Canada; [Sharp, Linda] Natl Canc Registry, Cork, Ireland; [Russell, Ian] Bangor Univ, Bangor, Gwynedd, Wales; [Walker, Leslie] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Aberdeen; University of Nottingham; University of Dundee; University of Ottawa; Bangor University; University of Hull	Whynes, D (corresponding author), Univ Nottingham, Sch Econ, Nottingham NG7 2RD, England.	david.whynes@nottingham.ac.uk	Little, Julian/AAR-6117-2020; Russell, Ian T/H-1181-2012	Little, Julian/0000-0001-5026-5531; Marteau, Theresa/0000-0003-3025-1129	Medical Research Council [G9700808]; NHS in England and Scotland; Chief Scientist Office [HSRU1] Funding Source: researchfish; MRC [G9700808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS in England and Scotland; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Council (grant No G9700808) and the NHS in England and Scotland.	[Anonymous], 2005, SOC VAL JUDG PRINC D; Balasubramani L, 2007, BJOG-INT J OBSTET GY, V114, P39, DOI 10.1111/j.1471-0528.2006.01160.x; Baldauf JJ, 1998, EUR J OBSTET GYN R B, V76, P193, DOI 10.1016/S0301-2115(97)00171-1; Baltussen RMPM, 2002, INT J TECHNOL ASSESS, V18, P112; Bos JM, 2005, PHARMACOECONOMICS, V23, P639, DOI 10.2165/00019053-200523070-00001; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Bruinsma F, 2007, BJOG-INT J OBSTET GY, V114, P70, DOI 10.1111/j.1471-0528.2006.01107.x; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Cecchini S, 1997, TUMORI J, V83, P732, DOI 10.1177/030089169708300403; Cochand-Priollet B, 2005, DIAGN CYTOPATHOL, V33, P338, DOI 10.1002/dc.20283; Comber H, 2004, BRIT J CANCER, V91, P1902, DOI 10.1038/sj.bjc.6602236; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Cotton SC, 2006, CONTEMP CLIN TRIALS, V27, P449, DOI 10.1016/j.cct.2006.04.001; Curtis L., UNIT COSTS HLTH SOCI; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; *DEP HLTH, 2004, NHS REF COSTS 2003 2; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Doyle B, 2006, CYTOPATHOLOGY, V17, P60, DOI 10.1111/j.1365-2303.2006.00338.x; Fairman A, 2004, AUST NZ J OBSTET GYN, V44, P252, DOI 10.1111/j.1479-828X.2004.00223.x; Flannelly G, 1997, J PUBLIC HEALTH MED, V19, P419, DOI 10.1093/oxfordjournals.pubmed.a024671; Fung HYM, 1997, EUR J OBSTET GYN R B, V72, P199, DOI 10.1016/S0301-2115(97)02700-0; Gravelle H, 2007, HEALTH ECON, V16, P307, DOI 10.1002/hec.1168; Helms LJ, 1999, MED CARE, V37, P652, DOI 10.1097/00005650-199907000-00005; Hjelmgren J, 2001, Value Health, V4, P225, DOI 10.1046/j.1524-4733.2001.43040.x; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Holschneider CH, 1999, OBSTET GYNECOL, V94, P377, DOI 10.1016/S0029-7844(99)00337-3; *INF CTR HLTH SOC, 2005, CERV SCREEN PROGR EN; Insinga RP, 2007, MED DECIS MAKING, V27, P414, DOI 10.1177/0272989X07302128; Jones M. H., 1998, Annals Academy of Medicine Singapore, V27, P666; Karnon J, 2004, HEALTH TECHNOL ASSES, V8, P1; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Legood R, 2006, BMJ-BRIT MED J, V332, P79, DOI 10.1136/bmj.38698.458866.7C; Lindeque BG, 2005, BEST PRACT RES CL OB, V19, P545, DOI 10.1016/j.bpobgyn.2005.02.008; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; *NAT STAT, 2002, LAB MARK NEW EARN SU; National institute for health and clinical excellence, 2008, N1618 NICE; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sawaya GF, 2007, ANN INTERN MED, V147, P668, DOI 10.7326/0003-4819-147-9-200711060-00012; Scheungraber C, 2004, BRIT J CANCER, V90, P975, DOI 10.1038/sj.bjc.6601415; Scottish Intercollegiate Guideline Network, 2004, SIGN 50 GUID DEV HDB; Sherlaw-Johnson C, 2004, BRIT J CANCER, V91, P84, DOI 10.1038/sj.bjc.6601884; Taylor S, 2006, INT J CANCER, V118, P957, DOI 10.1002/ijc.21434; Waugh N, 1996, CYTOPATHOLOGY, V7, P231, DOI 10.1046/j.1365-2303.1996.39982399.x; Williams ARW, 2006, CYTOPATHOLOGY, V17, P82, DOI 10.1111/j.1365-2303.2006.00339.x; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; WOLSTENHOLME JL, 2001, THESIS U NOTTINGHAM; Woolley C, 2007, INT J TECHNOL ASSESS, V23, P232, DOI 10.1017/S026646230707016X	53	21	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 28	2009	339								b2549	10.1136/bmj.b2549	http://dx.doi.org/10.1136/bmj.b2549			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479PG	19638648	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000268672800003
J	Clement, AC; Burgman, R; Norris, JR				Clement, Amy C.; Burgman, Robert; Norris, Joel R.			Observational and Model Evidence for Positive Low-Level Cloud Feedback	SCIENCE			English	Article							CLIMATE SENSITIVITY; PACIFIC; SURFACE; OCEAN; DATASET; VARIABILITY; CIRCULATION; REGIME; TOP	Feedbacks involving low-level clouds remain a primary cause of uncertainty in global climate model projections. This issue was addressed by examining changes in low-level clouds over the Northeast Pacific in observations and climate models. Decadal fluctuations were identified in multiple, independent cloud data sets, and changes in cloud cover appeared to be linked to changes in both local temperature structure and large-scale circulation. This observational analysis further indicated that clouds act as a positive feedback in this region on decadal time scales. The observed relationships between cloud cover and regional meteorological conditions provide a more complete way of testing the realism of the cloud simulation in current-generation climate models. The only model that passed this test simulated a reduction in cloud cover over much of the Pacific when greenhouse gases were increased, providing modeling evidence for a positive low-level cloud feedback.	[Clement, Amy C.; Burgman, Robert] Univ Miami, Div Meteorol & Phys Oceanog, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Norris, Joel R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Miami; University of California System; University of California San Diego; Scripps Institution of Oceanography	Clement, AC (corresponding author), Univ Miami, Div Meteorol & Phys Oceanog, Rosenstiel Sch Marine & Atmospher Sci, MSC 362,4600 Rickenbacker Causeway, Miami, FL 33149 USA.	aclement@rsmas.miami.edu	Norris, Joel R/A-9785-2008; Burgman, Robert J/I-6424-2017	Norris, Joel R/0000-0003-4384-0977; Burgman, Robert J/0000-0002-8460-6768	National Oceanic and Atmospheric Administration Office of Global Programs [NA06OAR4310142]; NSF;  [ATM02-38527]	National Oceanic and Atmospheric Administration Office of Global Programs(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); 	Funding for this work was provided by the National Oceanic and Atmospheric Administration Office of Global Programs (grant NA06OAR4310142). An NSF CAREER award (ATM02-38527) supported the work by J.R.N.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Burgman RJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031830; Chen JY, 2008, J CLIMATE, V21, P2634, DOI 10.1175/2007JCLI2012.1; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Evan AT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028083; Hahn C. J., 1999, NDP026C CARB DIOX IN; HARTMANN DL, 1992, J CLIMATE, V5, P1281, DOI 10.1175/1520-0442(1992)005<1281:TEOCTO>2.0.CO;2; Hazeleger W, 2004, J PHYS OCEANOGR, V34, P320, DOI 10.1175/1520-0485(2004)034<0320:HCTPOH>2.0.CO;2; Jacobowitz H, 2003, B AM METEOROL SOC, V84, P785, DOI 10.1175/BAMS-84-6-785; Johns TC, 2006, J CLIMATE, V19, P1327, DOI 10.1175/JCLI3712.1; KLEIN SA, 1995, J CLIMATE, V8, P1140, DOI 10.1175/1520-0442(1995)008<1140:OTRALC>2.0.CO;2; KLEIN SA, 1993, J CLIMATE, V6, P1587, DOI 10.1175/1520-0442(1993)006<1587:TSCOLS>2.0.CO;2; Lock AP, 2000, MON WEATHER REV, V128, P3187, DOI 10.1175/1520-0493(2000)128<3187:ANBLMS>2.0.CO;2; Ma CC, 1996, J CLIMATE, V9, P1635, DOI 10.1175/1520-0442(1996)009<1635:PSCATT>2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Medeiros B, 2008, J CLIMATE, V21, P4974, DOI 10.1175/2008JCLI1995.1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller RL, 1997, J CLIMATE, V10, P409, DOI 10.1175/1520-0442(1997)010<0409:TTALCC>2.0.CO;2; Misra V, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008597; Nigam S, 1997, J CLIMATE, V10, P2447, DOI 10.1175/1520-0442(1997)010<2447:TAWTCP>2.0.CO;2; Norris JR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006183; Norris JR, 2000, J CLIMATE, V13, P245, DOI 10.1175/1520-0442(2000)013<0245:LCTOTO>2.0.CO;2; Norris JR, 2000, SPACE SCI REV, V94, P375, DOI 10.1023/A:1026704314326; Norris JR, 1999, J CLIMATE, V12, P1864, DOI 10.1175/1520-0442(1999)012<1864:OTAPAI>2.0.CO;2; NORRIS JR, 1994, J CLIMATE, V7, P1915, DOI 10.1175/1520-0442(1994)007<1915:IVISCA>2.0.CO;2; Norris JR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005600; Pavolonis MJ, 2005, J APPL METEOROL, V44, P804, DOI 10.1175/JAM2236.1; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; SEAGER R, 1995, J CLIMATE, V8, P1951, DOI 10.1175/1520-0442(1995)008<1951:AAAMLM>2.0.CO;2; Smith TM, 2003, J CLIMATE, V16, P1495, DOI 10.1175/1520-0442-16.10.1495; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Stevens B, 2007, MON WEATHER REV, V135, P985, DOI 10.1175/MWR3427.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; VOLODIN EM, 2004, RUSS METEOROL HYDROL, V12, P1; Wang YQ, 2005, J CLIMATE, V18, P934, DOI 10.1175/JCLI3302.1; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; Worley SJ, 2005, INT J CLIMATOL, V25, P823, DOI 10.1002/joc.1166; Zhang MH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025942; ZHANG Y, 1997, J CLIMATE, V10, P1020; Zhang YC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004457	44	256	259	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					460	464		10.1126/science.1171255	http://dx.doi.org/10.1126/science.1171255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628865				2022-12-28	WOS:000268255100052
J	Vespignani, A				Vespignani, Alessandro			Predicting the Behavior of Techno-Social Systems	SCIENCE			English	Editorial Material							SPREAD; EMERGENCE; SCALE	We live in an increasingly interconnected world of techno-social systems, in which infrastructures composed of different technological layers are interoperating within the social component that drives their use and development. Examples are provided by the Internet, the World Wide Web, WiFi communication technologies, and transportation and mobility infrastructures. The multiscale nature and complexity of these networks are crucial features in understanding and managing the networks. The accessibility of new data and the advances in the theory and modeling of complex networks are providing an integrated framework that brings us closer to achieving true predictive power of the behavior of techno-social systems.	[Vespignani, Alessandro] Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47408 USA; [Vespignani, Alessandro] Indiana Univ, Pervas Technol Inst, Bloomington, IN 47408 USA; [Vespignani, Alessandro] Inst Sci Interchange, Turin, Italy	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Vespignani, A (corresponding author), Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47408 USA.	alexv@indiana.edu		Vespignani, Alessandro/0000-0003-3419-4205				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Crovella M., 2006, INTERNET MEASUREMENT; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Giannotti, 2008, MOBILITY DATA MINING, DOI 10.1007/978-3-540-75177-9; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Huberman B. A., 2003, LECT NOTES PHYS; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lundberg GA, 1937, AM SOCIOL REV, V2, P318, DOI 10.2307/2084864; Massey A., 1933, EPIDEMIOLOGY RELATIO; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Murray J. D., 1993, MATH BIOL, DOI [10.1007/b98869, DOI 10.1007/B98869]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Pavliotis GA, 2008, TEXTS APPL MATH, V53, P1; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pentland A, 2009, SOCIAL COMPUTING AND BEHAVIORAL MODELING, P1, DOI 10.1007/978-1-4419-0056-2_1; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Willumsen LG, 2011, MOD TRANSP 4 ED	39	321	334	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					425	428		10.1126/science.1171990	http://dx.doi.org/10.1126/science.1171990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628859				2022-12-28	WOS:000268255100043
J	Eldar, A; Chary, VK; Xenopoulos, P; Fontes, ME; Loson, OC; Dworkin, J; Piggot, PJ; Elowitz, MB				Eldar, Avigdor; Chary, Vasant K.; Xenopoulos, Panagiotis; Fontes, Michelle E.; Loson, Oliver C.; Dworkin, Jonathan; Piggot, Patrick J.; Elowitz, Michael B.			Partial penetrance facilitates developmental evolution in bacteria	NATURE			English	Article							BACILLUS-SUBTILIS SPORULATION; REPLICATION INITIATION; GENE-EXPRESSION; SPORE FORMATION; HSP90; DNA; DIFFERENTIATION; ROBUSTNESS; SEPTATION; CAPACITOR	Development normally occurs similarly in all individuals within an isogenic population, but mutations often affect the fates of individual organisms differently(1-4). This phenomenon, known as partial penetrance, has been observed in diverse developmental systems. However, it remains unclear how the underlying genetic network specifies the set of possible alternative fates and how the relative frequencies of these fates evolve(5-8). Here we identify a stochastic cell fate determination process that operates in Bacillus subtilis sporulation mutants and show how it allows genetic control of the penetrance of multiple fates. Mutations in an intercompartmental signalling process generate a set of discrete alternative fates not observed in wild-type cells, including rare formation of two viable 'twin' spores, rather than one within a single cell. By genetically modulating chromosome replication and septation, we can systematically tune the penetrance of each mutant fate. Furthermore, signalling and replication perturbations synergize to significantly increase the penetrance of twin sporulation. These results suggest a potential pathway for developmental evolution between monosporulation and twin sporulation through states of intermediate twin penetrance. Furthermore, time-lapse microscopy of twin sporulation in wild-type Clostridium oceanicum shows a strong resemblance to twin sporulation in these B. subtilis mutants(9,10). Together the results suggest that noise can facilitate developmental evolution by enabling the initial expression of discrete morphological traits at low penetrance, and allowing their stabilization by gradual adjustment of genetic parameters.	[Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Eldar, Avigdor; Fontes, Michelle E.; Loson, Oliver C.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Chary, Vasant K.; Xenopoulos, Panagiotis; Piggot, Patrick J.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Dworkin, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Eldar, Avigdor/0000-0001-8485-9370	US National Institutes of Health (NIH) [GM43577]; NIH [R01GM079771, P50 GM068763]; US National Science Foundation CAREER Award [0644463]; Packard Foundation; International Human Frontier Science Organization; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, R01GM043577, P50GM068763] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation CAREER Award(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); International Human Frontier Science Organization; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Leadbetter and E. Matson for their help with the anaerobic species. We thank R. Losick, A. Grossman, M. Fujita and A. Arkin for strains and advice. Wethank R. Kishony, D. Jones, Wolfgang Schwarz, G. Suel, J.- G. Ojalvo, B. Shraiman, J. Levine, J. C. W. Locke, D. Sprinzak, L. Cai and other members of M. B. E. and P. J. P. labs for helpful discussions. Work in the P. J. P.'s lab was supported by Public Health Service Grant GM43577 from the US National Institutes of Health (NIH). Work in M. B. E.'s lab was supported by NIH grants R01GM079771 and P50 GM068763, US National Science Foundation CAREER Award 0644463 and the Packard Foundation. A. E. was supported by the International Human Frontier Science Organization and the European Molecular Biology Organization.	Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Angert ER, 1998, P NATL ACAD SCI USA, V95, P10218, DOI 10.1073/pnas.95.17.10218; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; COOTE JG, 1972, J GEN MICROBIOL, V71, P1; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HORVITZ HR, 1980, GENETICS, V96, P435; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095, DOI 10.1099/00207713-51-6-2095; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; KIRSCHNER M, 2005, PLAUSIBILITY LIFE RE, P71; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rutherford SL, 2003, NAT GENET, V33, P6, DOI 10.1038/ng0103-6; Rutherford S, 2007, CRIT REV BIOCHEM MOL, V42, P355, DOI 10.1080/10409230701597782; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; SMITH LD, 1970, J BACTERIOL, V103, P811, DOI 10.1128/JB.103.3.811-813.1970; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	34	97	99	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					510	U86		10.1038/nature08150	http://dx.doi.org/10.1038/nature08150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19578359	Green Accepted			2022-12-28	WOS:000268257000038
J	Somers, MJG; Sharma, A; Grant, PE; Guimaraes, AR; Schneeberger, EE				Somers, Michael J. G.; Sharma, Amita; Grant, P. Ellen; Guimaraes, Alexander R.; Schneeberger, Eveline E.			A Boy with Headache, Nausea, Seizures, and Hypertension Atypical hemolytic-uremic syndrome with complement factor H mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOTIC MICROANGIOPATHY; THROMBOCYTOPENIC PURPURA; CHILDREN; SURFACE		[Somers, Michael J. G.] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Grant, P. Ellen; Guimaraes, Alexander R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Schneeberger, Eveline E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Somers, Michael J. G.; Sharma, Amita] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Grant, P. Ellen; Guimaraes, Alexander R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Schneeberger, Eveline E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Somers, MJG (corresponding author), Childrens Hosp, Div Nephrol, Boston, MA 02115 USA.		Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013	AstraZeneca	AstraZeneca(AstraZeneca)	Dr. Guimaraes reports receiving grant support from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	ALON US, 2004, PEDIAT NEPHROLOGY, P817; Amirlak I, 2006, NEPHROLOGY, V11, P213, DOI 10.1111/j.1440-1797.2006.00556.x; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; COPPO R, 2004, PEDIAT NEPHROLOGY, P851; Garg Shveta, 2007, Turk J Haematol, V24, P69; Heinen S, 2007, J AM SOC NEPHROL, V18, P506, DOI 10.1681/ASN.2006091069; HOGG RJ, 1985, KIDNEY INT, V27, P450, DOI 10.1038/ki.1985.30; Jalanko H, 2008, AM J TRANSPLANT, V8, P216, DOI 10.1111/j.1600-6143.2007.02029.x; JARDIM HMPF, 1992, PEDIATR NEPHROL, V6, P231, DOI 10.1007/BF00878354; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kavanagh D, 2007, CLIN J AM SOC NEPHRO, V2, P591, DOI 10.2215/CJN.03270906; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; KLEIN PJ, 1977, LANCET, V2, P1024; Lapeyraque AL, 2008, PEDIATR NEPHROL, V23, P1363, DOI 10.1007/s00467-008-0803-4; Morita S, 1999, INTERNAL MED, V38, P495, DOI 10.2169/internalmedicine.38.495; Niaudet P, 1983, NEPHROLOGIE PEDIATRI, P381; Noris M, 2006, PROG INFLAM RES, P65; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Prasad N, 2007, BRIT J RADIOL, V80, P422, DOI 10.1259/bjr/81758556; Rifkin BS, 2006, MAYO CLIN PROC, V81, P593, DOI 10.4065/81.5.593; Shibagaki Y, 2005, HYPERTENS RES, V28, P89, DOI 10.1291/hypres.28.89; Skerka C, 2006, PROG INFLAM RES, P85; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Tsai HM, 2003, J THROMB HAEMOST, V1, P625, DOI 10.1046/j.1538-7836.2003.00169.x; Zhang B, 2008, HYPERTENS RES, V31, P479, DOI 10.1291/hypres.31.479	25	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					389	400		10.1056/NEJMcpc0900640	http://dx.doi.org/10.1056/NEJMcpc0900640			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625720				2022-12-28	WOS:000268184500011
J	Mokhlesi, B; Khan, M				Mokhlesi, Babak; Khan, Mohsin			Nail-gun narcolepsy	LANCET			English	Editorial Material									[Mokhlesi, Babak] Univ Chicago, Sleep Disorders Ctr, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Mokhlesi, B (corresponding author), Univ Chicago, Sleep Disorders Ctr, Chicago, IL 60637 USA.	bmokhles@medicine.bsd.uchicago.edu							0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 18	2009	374	9685					238	238		10.1016/S0140-6736(09)60310-X	http://dx.doi.org/10.1016/S0140-6736(09)60310-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19616721				2022-12-28	WOS:000268263000032
J	de Aguiar, MAM; Baranger, M; Baptestini, EM; Kaufman, L; Bar-Yam, Y				de Aguiar, M. A. M.; Baranger, M.; Baptestini, E. M.; Kaufman, L.; Bar-Yam, Y.			Global patterns of speciation and diversity	NATURE			English	Article							ADAPTIVE SPECIATION; SPECIES ABUNDANCE; SPACE	In recent years, strikingly consistent patterns of biodiversity have been identified over space, time, organism type and geographical region(1,2). A neutral theory (assuming no environmental selection or organismal interactions) has been shown to predict many patterns of ecological biodiversity(2,3). This theory is based on a mechanism by which new species arise similarly to point mutations in a population without sexual reproduction. Here we report the simulation of populations with sexual reproduction, mutation and dispersal. We found simulated time dependence of speciation rates, species-area relationships and species abundance distributions consistent with the behaviours found in nature(1-13). From our results, we predict steady speciation rates, more species in one-dimensional environments than two-dimensional environments, three scaling regimes of species-area relationships and lognormal distributions of species abundance with an excess of rare species and a tail that may be approximated by Fisher's logarithmic series. These are consistent with dependences reported for, among others, global birds(4) and flowering plants(5), marine invertebrate fossils(6), ray-finned fishes(7), British birds(8,9) and moths(10), North American songbirds(11), mammal fossils from Kansas(12) and Panamanian shrubs(13). Quantitative comparisons of specific cases are remarkably successful. Our biodiversity results provide additional evidence that species diversity arises without specific physical barriers(6,11,14). This is similar to heavy traffic flows, where traffic jams can form even without accidents or barriers(15).	[de Aguiar, M. A. M.; Baranger, M.; Kaufman, L.; Bar-Yam, Y.] New England Complex Syst Inst, Cambridge, MA 02138 USA; [de Aguiar, M. A. M.; Baptestini, E. M.] Univ Estadual Campinas, BR-13083970 Campinas, SP, Brazil; [Baranger, M.] Univ Arizona, Tucson, AZ 85719 USA; [Kaufman, L.] Boston Univ, Boston, MA 02215 USA	Universidade Estadual de Campinas; University of Arizona; Boston University	Bar-Yam, Y (corresponding author), New England Complex Syst Inst, Cambridge, MA 02138 USA.	yaneer@necsi.edu	de Aguiar, Marcus A M/C-9137-2012; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We acknowledge internal support by the New England Complex Systems Institute. M. A. M. d. A. and E. M. B. acknowledge financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and L. K. from the Marine Management Area Science Program of Conservation International and the Gordon and Betty Moore Foundation.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bar-Yam Y., 1997, DYNAMICS COMPLEX SYS; DARCY WE, 1987, FLORA PANAMA CHECKLI, V1; Dobzhansky T., 1937; Doebeli M, 2005, EVOLUTION, V59, P691; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gavrilets S, 2005, EVOLUTION, V59, P696; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gibbons D. W., 1993, NEW ATLAS BREEDING B; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREGORY RD, 1994, P ROY SOC B-BIOL SCI, V257, P299, DOI 10.1098/rspb.1994.0129; HIGGS PG, 1991, J PHYS A-MATH GEN, V24, pL985, DOI 10.1088/0305-4470/24/17/005; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Hubbell Stephen P., 2001, V32, pi; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Moyle P. B., 2003, FISHES INTRO ICHTHYO, Vfifth; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1997, SCIENCE, V277, P1622, DOI 10.1126/science.277.5332.1622; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Williams C. B., 1964, PATTERNS BALANCE NAT	30	118	122	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					384	387		10.1038/nature08168	http://dx.doi.org/10.1038/nature08168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606148				2022-12-28	WOS:000267979000036
J	Yadav, AK; Renfrow, JJ; Scholtens, DM; Xie, H; Duran, GE; Bredel, C; Vogel, H; Chandler, JP; Chakravarti, A; Robe, PA; Das, S; Scheck, AC; Kessler, JA; Soares, MB; Sikic, BI; Harsh, GR; Bredel, M				Yadav, Ajay K.; Renfrow, Jaclyn J.; Scholtens, Denise M.; Xie, Hehuang; Duran, George E.; Bredel, Claudia; Vogel, Hannes; Chandler, James P.; Chakravarti, Arnab; Robe, Pierre A.; Das, Sunit; Scheck, Adrienne C.; Kessler, John A.; Soares, Marcelo B.; Sikic, Branimir I.; Harsh, Griffith R.; Bredel, Markus			Monosomy of Chromosome 10 Associated With Dysregulation of Epidermal Growth Factor Signaling in Glioblastomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-SUPPRESSOR GENE; ANNEXIN-VII; IN-SITU; EXPRESSION; ANX7; HAPLOINSUFFICIENCY; BREAST; EGF; BENEFIT; GENOME	Context Glioblastomas-uniformly fatal brain tumors-often have both monosomy of chromosome 10 and gains of the epidermal growth factor receptor ( EGFR) gene locus on chromosome 7, an association for which the mechanism is poorly understood. Objectives To assess whether coselection of EGFR gains on 7p12 and monosomy 10 in glioblastomas promotes tumorigenic epidermal growth factor (EGF) signaling through loss of the annexin A7 (ANXA7) gene on 10q21.1-q21.2 and whether ANXA7 acts as a tumor suppressor gene by regulating EGFR in glioblastomas. Design, Setting, and Patients Multidimensional analysis of gene, coding sequence, promoter methylation, messenger RNA ( mRNA) transcript, protein data for ANXA7 ( and EGFR), and clinical patient data profiles of 543 high-grade gliomas from US medical centers and The Cancer Genome Atlas pilot project (made public 2006-2008; and unpublished, tumors collected 2001-2008). Functional analyses using LN229 and U87 glioblastoma cells. Main Outcome Measures Associations among ANXA7 gene dosage, coding sequence, promoter methylation, mRNA transcript, and protein expression. Effect of ANXA7 haploinsufficiency on EGFR signaling and patient survival. Joint effects of loss of ANXA7 and gain of EGFR expression on tumorigenesis. Results Heterozygous ANXA7 gene deletion is associated with significant loss of ANXA7 mRNA transcript expression (P=1 x 10(-15); linear regression) and a reduction (mean[SEM]) of 91.5% (2.3%) of ANXA7 protein expression compared with ANXA7 wild-type glioblastomas (P=.004; unpaired t test). ANXA7 loss of function stabilizes the EGFR protein (72%-744% increase in EGFR protein abundance) and augments EGFR transforming signaling in glioblastoma cells. ANXA7 haploinsufficiency doubles tumorigenic potential of glioblastoma cells, and combined ANXA7 knockdown and EGFR overexpression promotes tumorigenicity synergistically. The heterozygous loss of ANXA7 in approximate to 75% of glioblastomas in the The Cancer Genome Atlas plus infrequency of ANXA7 mutation (approximate to 6% of tumors) indicates its role as a haploinsufficiency gene. ANXA7 mRNA transcript expression, dichotomized at the median, associates with patient survival in 191 glioblastomas (log-rank P=.008; hazard ratio [HR], 0.667; 95% confidence interval [CI], 0.493-0.902; 46.9 vs 74.8 deaths/100 person-years for high vs low ANXA7 mRNA expression) and with a separate group of 180 high-grade gliomas (log-rank P=.00003; HR, 0.476; 95% CI, 0.333-0.680; 21.8 vs 50.0 deaths/100 person-years for high vs low ANXA7 mRNA expression). Deletion of the ANXA7 gene associates with poor patient survival in 189 glioblastomas (log-rank P=. 042; HR, 0.686; 95% CI, 0.476-0.989; 54.0 vs 80.1 deaths/100 person-years for wild-type ANXA7 vs ANXA7 deletion). Conclusion Haploinsufficiency of the tumor suppressor ANXA7 due to monosomy of chromosome 10 provides a clinically relevant mechanism to augment EGFR signaling in glioblastomas beyond that resulting from amplification of the EGFR gene. JAMA. 2009; 302(3):276-289 www.jama.com	[Bredel, Markus] Northwestern Univ, Feinberg Sch Med,Childrens Mem Res Ctr, Dept Neurol Surg,Robert H Lurie Comprehens Canc C, Lurie Ctr Canc Genet Res,NW Brain Tumor Inst, Chicago, IL 60611 USA; [Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Das, Sunit; Bredel, Markus] Northwestern Univ, Ctr Genet Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Dept Prevent Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Kessler, John A.] Northwestern Univ, Dept Neurol, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Feinberg Sch Med, Chicago, IL 60611 USA; [Xie, Hehuang; Soares, Marcelo B.] Northwestern Univ, Dept Pediat, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Harsh, Griffith R.; Bredel, Markus] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Bredel, Claudia; Sikic, Branimir I.; Bredel, Markus] Stanford Univ, Sch Med, Div Oncol, Dept Med, Palo Alto, CA 94304 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Bredel, Claudia; Bredel, Markus] Univ Freiburg, Dept Gen Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Claudia; Bredel, Markus] Univ Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Chakravarti, Arnab] Ohio State Univ, Sch Med, Dept Radiat Oncol, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Chakravarti, Arnab] Ohio State Univ, Sch Med, Richard L Solove Res Inst, Columbus, OH 43210 USA; [Robe, Pierre A.] Univ Liege, Dept Neurosurg, B-4000 Liege, Belgium; [Robe, Pierre A.] Univ Liege, Dept Human Genet, B-4000 Liege, Belgium; [Scheck, Adrienne C.] St Josephs Med Ctr, Barrow Neurol Inst, Ina Levine Brain Tumor Ctr, Phoenix, AZ USA	Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; University of Freiburg; University of Freiburg; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Liege; University of Liege; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Bredel, M (corresponding author), Northwestern Univ, Feinberg Sch Med,Childrens Mem Res Ctr, Dept Neurol Surg,Robert H Lurie Comprehens Canc C, Lurie Ctr Canc Genet Res,NW Brain Tumor Inst, 303 E Super St,Lurie Room 6-111, Chicago, IL 60611 USA.	m-bredel@northwestern.edu	Das, Sunit/J-3903-2015; Scheck, Adrienne/AAH-5040-2020	Das, Sunit/0000-0002-2146-4168; Vogel, Otto Hannes/0000-0002-0960-3508; Yadav, Ajay/0000-0003-3321-4198; Scheck, Adrienne/0000-0003-3497-1895	State of Illinois Excellence in Academic Medicine Program [211]; NIH/ NCI [RO1CA108633]; The Ohio State University-James Comprehensive Cancer Center; RTOG [U10CA21661]; CCOP [U10CA37422]; NATIONAL CANCER INSTITUTE [U10CA021661, U10CA037422, R01CA108633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020778, R01NS020013] Funding Source: NIH RePORTER	State of Illinois Excellence in Academic Medicine Program; NIH/ NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Ohio State University-James Comprehensive Cancer Center(Ohio State University); RTOG; CCOP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the State of Illinois Excellence in Academic Medicine Program (EAM Award 211 to Dr M. Bredel), by NIH/ NCI RO1CA108633 and funds from The Ohio State University-James Comprehensive Cancer Center ( both to Dr Chakravarti), by RTOG U10CA21661 and by CCOP U10CA37422. The results published here are in part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov.	Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; EARP HS, 1986, J BIOL CHEM, V261, P4777; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furge LL, 1999, J BIOL CHEM, V274, P33504, DOI 10.1074/jbc.274.47.33504; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Leighton X, 2004, CANCER LETT, V210, P239, DOI 10.1016/j.canlet.2004.01.018; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martin V, 2009, J CLIN PATHOL, V62, P314, DOI 10.1136/jcp.2008.059592; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pfisterer WK, 2004, NEURO-ONCOLOGY, V6, P290, DOI 10.1215/S1152851704000158; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SHIRVAN A, 1994, BIOCHEMISTRY-US, V33, P6888, DOI 10.1021/bi00188a019; Smilenov LB, 2006, CANCER LETT, V240, P17, DOI 10.1016/j.canlet.2005.08.015; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Srivastava M, 2004, CLIN CANCER RES, V10, P2344, DOI 10.1158/1078-0432.CCR-03-0278; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2002, MOL MED, V8, P781, DOI 10.1007/BF03402083; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Torosyan Y, 2006, CANCER RES, V66, P9609, DOI 10.1158/0008-5472.CAN-06-1574; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	40	46	51	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					276	289		10.1001/jama.2009.1022	http://dx.doi.org/10.1001/jama.2009.1022			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602687	Bronze, Green Accepted			2022-12-28	WOS:000267948100021
J	O'Flaherty, M; Bishop, J; Redpath, A; McLaughlin, T; Murphy, D; Chalmers, J; Capewell, S				O'Flaherty, Martin; Bishop, Jennifer; Redpath, Adam; McLaughlin, Terry; Murphy, David; Chalmers, James; Capewell, Simon			Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; CARDIOVASCULAR MORTALITY; US ADULTS; ENGLAND; DEATHS; RATES	Objective To examine recent trends and social inequalities in age specific coronary heart disease mortality. Design Time trend analysis using joinpoint regression. Setting Scotland, 1986-2006. Participants Men and women aged 35 years and over. Main outcome measures Age adjusted and age, sex, and deprivation specific coronary heart disease mortality. Results Persistent sixfold social differentials in coronary heart disease mortality were seen between the most deprived and the most affluent groups aged 35-44 years. These differentials diminished with increasing age but equalised only above 85 years. Between 1986 and 2006, overall, age adjusted coronary heart disease mortality decreased by 61% in men and by 56% in women. Among middle aged and older adults, mortality continued to decrease fairly steadily throughout the period. However, coronary heart disease mortality levelled from 1994 onwards among young men and women aged 35-44 years. Rates in men and women aged 45-54 showed similar flattening from about 2003. Rates in women aged 55-64 may also now be flattening. The flattening of coronary heart disease mortality in younger men and women was confined to the two most deprived fifths. Conclusions Premature death from coronary heart disease remains a major contributor to social inequalities. Furthermore, the flattening of the decline in mortality for coronary heart disease among younger adults may represent an early warning sign. The observed trends were confined to the most deprived groups. Marked deterioration in medical management of coronary heart disease seems implausible. Unfavourable trends in the major risk factors for coronary heart disease (smoking and poor diet) thus provide the most likely explanation for these inequalities.	[Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; [Redpath, Adam] ISD Scotland, CHD & Stroke Programme, Edinburgh EH12 9ED, Midlothian, Scotland	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131	UK Medical Research Council; MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MO'F is supported by the UK Medical Research Council.	Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Benjamin-Garner Ruby, 2002, Ethnicity and Disease, V12, P124; BOYCE J, 2008, SCOTTISH INDEX MULTI; Bromley C, 2008, SCOTTISH HLTH SURVEY; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Capewell S, 2001, LANCET, V358, P1213, DOI 10.1016/S0140-6736(01)06343-7; Critchley JA, 2003, J CLIN EPIDEMIOL, V56, P583, DOI 10.1016/S0895-4356(03)00059-3; Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Harald K, 2008, J EPIDEMIOL COMMUN H, V62, P251, DOI 10.1136/jech.2007.060707; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; *NHS NAT SERV SCOT, 2007, BETT DAT SCOTT HOSP; Norris RM, 1998, HEART, V80, P121; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; *OFF NAT STAT, 2008, NAT FOOD SURV 2006; *SCOTT EX, 2008, SCOTT IND MULT DEPR; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; SPROSTON K, 2003, HLTH SURVEY ENGLAND; Tobias Martin, 2006, N Z Med J, V119, pU1932; Waterhouse J, 1976, CANC INCIDENCE 5 CON; WILSON A, 1995, INT J EPIDEMIOL, V24, P678, DOI 10.1093/ije/24.4.678	27	78	79	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2009	339								b2613	10.1136/bmj.b2613	http://dx.doi.org/10.1136/bmj.b2613			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602713	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000268104900005
J	von Elm, E; Moher, D; Little, J				von Elm, Erik; Moher, David; Little, Julian		STREGA Collaboration	Reporting genetic association studies: the STREGA statement	LANCET			English	Editorial Material							IMPROVE		[von Elm, Erik] Univ Med Ctr Freiburg, Dept Med Biometry & Stat, German Cochrane Ctr, D-79104 Freiburg, Germany; [von Elm, Erik] Swiss Parapleg Res, Nottwil, Switzerland; [Moher, David] Ottawa Hosp, Res Inst, Methods Ctr, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David; Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Freiburg; Swiss Paraplegic Research; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	von Elm, E (corresponding author), Univ Med Ctr Freiburg, Dept Med Biometry & Stat, German Cochrane Ctr, D-79104 Freiburg, Germany.	vonelm@cochrane.de	Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Moher, David/0000-0003-2434-4206; von Elm, Erik/0000-0002-7412-0406				Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Ioannidis JPA, 2009, ANN INTERN MED, V150, P139, DOI 10.7326/0003-4819-150-2-200901200-00012; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	9	20	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					98	100		10.1016/S0140-6736(09)61265-4	http://dx.doi.org/10.1016/S0140-6736(09)61265-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472EG	19595330				2022-12-28	WOS:000268111600007
J	Drdla, R; Gassner, M; Gingl, E; Sandkuhler, J				Drdla, Ruth; Gassner, Matthias; Gingl, Ewald; Sandkuehler, Juergen			Induction of Synaptic Long-Term Potentiation After Opioid Withdrawal	SCIENCE			English	Article							PROTEIN-KINASE-C; INDUCED HYPERALGESIA; MORPHINE-WITHDRAWAL; CELLULAR MECHANISMS; TOLERANCE; NEURONS; ACTIVATION; PAIN; EXCITABILITY; DEPENDENCE	mu-Opioid receptor (MOR) agonists represent the gold standard for the treatment of severe pain but may paradoxically also enhance pain sensitivity, that is, lead to opioid-induced hyperalgesia (OIH). We show that abrupt withdrawal from MOR agonists induces long-term potentiation (LTP) at the first synapse in pain pathways. Induction of opioid withdrawal LTP requires postsynaptic activation of heterotrimeric guanine nucleotide-binding proteins and N-methyl-D-aspartate receptors and a rise of postsynaptic calcium concentrations. In contrast, the acute depression by opioids is induced presynaptically at these synapses. Withdrawal LTP can be prevented by tapered withdrawal and shares pharmacology and signal transduction pathways with OIH. These findings provide a previously unrecognized target to selectively combat pro-nociceptive effects of opioids without compromising opioid analgesia.	[Drdla, Ruth; Gassner, Matthias; Gingl, Ewald; Sandkuehler, Juergen] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, A-1090 Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Spitalgasse 4, A-1090 Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Austrian Science Fund [P18129-B02]	Austrian Science Fund(Austrian Science Fund (FWF))	Supported by grant no. P18129-B02 from the Austrian Science Fund (FWF).	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Brown CH, 2004, STRESS, V7, P97, DOI 10.1080/10253890410001727776; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; FRY JP, 1980, BRIT J PHARMACOL, V68, P585, DOI 10.1111/j.1476-5381.1980.tb14574.x; Gardell LR, 2002, J NEUROSCI, V22, P6747; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jhamandas KH, 1996, J NEUROSCI, V16, P2758; Kieffer BL, 2002, CELL, V108, P587, DOI 10.1016/S0092-8674(02)00666-9; MAO J, 1994, J NEUROSCI, V14, P2301; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Sweitzer SM, 2004, PAIN, V110, P281, DOI 10.1016/j.pain.2004.04.004; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Vera-Portocarrero LP, 2007, PAIN, V129, P35, DOI 10.1016/j.pain.2006.09.033; Wang HY, 2005, NEUROSCIENCE, V135, P247, DOI 10.1016/j.neuroscience.2005.06.003; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; WOOLF CJ, 1981, BRAIN RES, V209, P491, DOI 10.1016/0006-8993(81)90176-1; YAKSH TL, 1986, ANESTHESIOLOGY, V64, P590, DOI 10.1097/00000542-198605000-00008; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	27	149	157	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					207	210		10.1126/science.1171759	http://dx.doi.org/10.1126/science.1171759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590003				2022-12-28	WOS:000267802000049
J	Ramirez-Carrozzi, VR; Braas, D; Bhatt, DM; Cheng, CS; Hong, C; Doty, KR; Black, JC; Hoffmann, A; Carey, M; Smale, ST				Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Cheng, Christine S.; Hong, Christine; Doty, Kevin R.; Black, Joshua C.; Hoffmann, Alexander; Carey, Michael; Smale, Stephen T.			A Unifying Model for the Selective Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling	CELL			English	Article							HUMAN GENOME; DNA INTERACTIONS; BAF COMPLEX; CHROMATIN; PROMOTER; HISTONE; GENE; IDENTIFICATION; ACCESSIBILITY; POLY(DA-DT)	We describe a broad mechanistic framework for the transcriptional induction of mammalian primary response genes by Toll-like receptors and other stimuli. One major class of primary response genes is characterized by CpG-island promoters, which facilitate promiscuous induction from constitutively active chromatin without a requirement for SWI/SNF nucleosome remodeling complexes. The low nucleosome occupancy at promoters in this class can be attributed to the assembly of CpG islands into unstable nucleosomes, which may lead to SWI/SNF independence. Another major class consists of non-CpG-island promoters that assemble into stable nucleosomes, resulting in SWI/SNF dependence and a requirement for transcription factors that promote selective nucleosome remodeling. Some stimuli, including serum and tumor necrosis factor-alpha, exhibit a strong bias toward activation of SWI/SNF-independent CpG-island genes. In contrast, interferon-beta is strongly biased toward SWI/SNF-dependent non-CpG-island genes. By activating a diverse set of transcription factors, Toll-like receptors induce both classes and others for an optimal response to microbial pathogens.	[Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Hong, Christine; Doty, Kevin R.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Ramirez-Carrozzi, Vladimir R.; Braas, Daniel; Bhatt, Dev M.; Hong, Christine; Doty, Kevin R.; Black, Joshua C.; Carey, Michael; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Black, Joshua C.; Carey, Michael] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cheng, Christine S.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu	Black, Joshua/Q-2484-2015	Black, Joshua/0000-0002-2491-8815; Carey, Michael/0000-0003-3899-6280; Bhatt, Dev/0000-0003-3616-3701	Giannini Family Foundation Fellowship; German Academic Exchange Service; Jonsson Cancer Center Foundation Fellowship; NIH [T32AI007126, T32GM07185, R01GM086372, R01CA127279, P50CA092131]; NATIONAL CANCER INSTITUTE [R01CA127279, P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372, T32GM007185] Funding Source: NIH RePORTER	Giannini Family Foundation Fellowship; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Jonsson Cancer Center Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Genhong Cheng, Diana Hargreaves, Harvey Herschman, Siavash Kurdistani, Ruslan Medzhitov, Amy Weinmann, Jonathan Widom, and Michael Zhang for helpful discussions. V. R. R. C. was supported by a Giannini Family Foundation Fellowship, D. B. by the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD) and a Jonsson Cancer Center Foundation Fellowship, D. M. B. by NIH T32AI007126, K. R. D. by NIH T32GM07185, and S. T. S. by NIH R01GM086372, R01CA127279, and P50CA092131.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Williams LR, 2007, SIGHT SOUND, V17, P93; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	40	428	437	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					114	128		10.1016/j.cell.2009.04.020	http://dx.doi.org/10.1016/j.cell.2009.04.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596239	Bronze, Green Accepted			2022-12-28	WOS:000267848600019
J	Simon, JA				Simon, Jeffrey A.			Sweet Silencing	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; H2A UBIQUITYLATION; O-GLCNAC; GENE; UBIQUITINATION; MECHANISMS; COMPLEX; CELLS		Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Simon, JA (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	simon004@umn.edu						Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartweck LM, 2006, J EXP BOT, V57, P865, DOI 10.1093/jxb/erj071; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	16	5	5	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					45	46		10.1126/science.1177264	http://dx.doi.org/10.1126/science.1177264			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574378				2022-12-28	WOS:000267594000027
J	Jost, PJ; Grabow, S; Gray, D; McKenzie, MD; Nachbur, U; Huang, DCS; Bouillet, P; Thomas, HE; Borner, C; Silke, J; Strasser, A; Kaufmann, T				Jost, Philipp J.; Grabow, Stephanie; Gray, Daniel; McKenzie, Mark D.; Nachbur, Ueli; Huang, David C. S.; Bouillet, Philippe; Thomas, Helen E.; Borner, Christoph; Silke, John; Strasser, Andreas; Kaufmann, Thomas			XIAP discriminates between type I and type II FAS-induced apoptosis	NATURE			English	Article							ALPHA-DEPENDENT APOPTOSIS; DEFICIENT MICE; IMMUNE-SYSTEM; T-LYMPHOCYTES; CYTOCHROME-C; CELL-DEATH; PROTEIN; SMAC; ACTIVATION; RECEPTOR	FAS (also called APO-1 and CD95) and its physiological ligand, FASL, regulate apoptosis of unwanted or dangerous cells, functioning as a guardian against autoimmunity and cancer development(1-4). Distinct cell types differ in the mechanisms by which the 'death receptor' FAS triggers their apoptosis(1-4). In type I cells, such as lymphocytes, activation of 'effector caspases' by FAS-induced activation of caspase-8 suffices for cell killing, whereas in type II cells, including hepatocytes and pancreatic beta-cells, caspase cascade amplification through caspase-8-mediated activation of the proapoptotic BCL-2 family member BID (BH3 interacting domain death agonist) 5 is essential(6-8). Here we show that loss of XIAP (X-chromosome linked inhibitor of apoptosis protein) 9,10 function by gene targeting or treatment with a second mitochondria-derived activator of caspases (SMAC(11,) also called DIABLO(12); direct IAP-binding protein with low pI) mimetic drug in mice rendered hepatocytes and beta-cells independent of BID for FAS-induced apoptosis. These results show that XIAP is the critical discriminator between type I and type II apoptosis signalling and suggest that IAP inhibitors should be used with caution in cancer patients with underlying liver conditions.	[Jost, Philipp J.; Grabow, Stephanie; Gray, Daniel; Huang, David C. S.; Bouillet, Philippe; Strasser, Andreas; Kaufmann, Thomas] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Grabow, Stephanie; McKenzie, Mark D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [McKenzie, Mark D.; Thomas, Helen E.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Nachbur, Ueli; Silke, John] La Trobe Univ, Inst Biochem, Bundoora, Vic 3086, Australia; [Borner, Christoph] Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; St. Vincent's Institute of Medical Research; La Trobe University	Strasser, A (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	strasser@wehi.edu.au; thomas.kaufmann@pki.unibe.ch	Bouillet, Philippe/E-1241-2013; Jost, Philipp J./S-4962-2016; Silke, John/B-7622-2008; Huang, David C. S./C-7586-2013; Strasser, Andreas/C-7581-2013; Gray, Daniel HD/A-3293-2013	Bouillet, Philippe/0000-0002-9012-6058; Jost, Philipp J./0000-0003-2454-0362; Silke, John/0000-0002-7611-5774; Huang, David C. S./0000-0002-3101-4873; Strasser, Andreas/0000-0002-5020-4891; Gray, Daniel HD/0000-0002-8457-8242; Kaufmann, Thomas/0000-0001-9906-874X; Nachbur, Ueli/0000-0001-5968-2235	NHMRC ( Canberra); NCI [CA 80188, CA 43540]; Leukemia and Lymphoma Society of America [7015]; JDRF/ NHMRC; Cancer Council Victoria; Leukemia Foundation of Australia; Swiss National Science Foundation; Novartis Jubilaeumsstiftung; HepatoSys programme; German Jose Carreras Leukemia Foundation [06/09]; Spemann Graduate School of Biology and Medicine [GSC-4]; Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe;  [257502];  [251608];  [384404]; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	NHMRC ( Canberra)(National Health and Medical Research Council (NHMRC) of Australia); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); JDRF/ NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Jubilaeumsstiftung(Novartis); HepatoSys programme; German Jose Carreras Leukemia Foundation; Spemann Graduate School of Biology and Medicine; Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Vaux, J. Tschopp, S. Cory, J. Adams, S. Nagata and Y. Lazebnik for gifts of mice and reagents, K. Vella, D. Cooper and G. Siciliano for animal care, B. Helbert for genotyping, the Biochemistry Department of the Royal Melbourne Hospital for ALT/AST measurements, C. Young and D. Chau for technical assistance and D. Vaux, M. Van Delft and L. O'Reilly for advice. This work was supported by grants ( programmes 257502 and 251608; project 384404) and fellowships from the NHMRC ( Canberra), NCI ( NIH, CA 80188, CA 43540), Leukemia and Lymphoma Society of America ( SCOR grant 7015), JDRF/ NHMRC, Cancer Council Victoria, Leukemia Foundation of Australia, Swiss National Science Foundation ( T. K. and U. N.), Novartis Jubilaeumsstiftung ( U. N.), HepatoSys programme ( BMBF), German Jose Carreras Leukemia Foundation ( DJCLS R 06/09), Spemann Graduate School of Biology and Medicine ( GSC-4), DFG ( to C. B.) and Dr. Mildred-Scheel Stiftung/Deutsche Krebshilfe ( P. J. J.).	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Conte D, 2001, P NATL ACAD SCI USA, V98, P5049, DOI 10.1073/pnas.081547998; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; WAANDERS GA, 1990, INT IMMUNOL, V2, P461, DOI 10.1093/intimm/2.5.461; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	35	319	331	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1035	U128		10.1038/nature08229	http://dx.doi.org/10.1038/nature08229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19626005	Green Accepted			2022-12-28	WOS:000269085500039
J	Mills, EJ; Ford, N; Mugyenyi, P				Mills, Edward J.; Ford, Nathan; Mugyenyi, Peter			Expanding HIV care in Africa: making men matter	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; FOLLOW-UP; GENDER; SETTINGS; LOST		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON V5Z 4B4, Canada; [Ford, Nathan] Med Sans Frontieres, Cape Town, WA, South Africa; [Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda	University of Ottawa; Joint Clinic Research Center - United Arab Emirates	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON V5Z 4B4, Canada.	emills@cfenet.ubc.ca						Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; JOHNSON W, 2008, COMMUNICATION   0319; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Lewis S., 2006, 16 INT AIDS C TOR CA; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; NATTRASS N, 2006, AIDS GENDER ACCESS A; *UNAIDS, WOM HIV TRIALS; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; 2006, ACTION HIV AIDS HUMA	11	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 25	2009	374	9686					275	276		10.1016/S0140-6736(09)61348-9	http://dx.doi.org/10.1016/S0140-6736(09)61348-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477GW	19632481				2022-12-28	WOS:000268508200009
J	Jaiswal, S; Jamieson, CHM; Pang, WW; Park, CY; Chao, MP; Majeti, R; Traver, D; van Rooijen, N; Weissman, IL				Jaiswal, Siddhartha; Jamieson, Catriona H. M.; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Traver, David; van Rooijen, Nico; Weissman, Irving L.			CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis	CELL			English	Article							INTEGRIN-ASSOCIATED PROTEIN; COLONY-STIMULATING FACTOR; MYELOID PROGENITORS; EXPRESSION; MOBILIZATION; BLOOD; ENGRAFTMENT; RECEPTOR; MARKER; MICE	Macrophages clear pathogens and damaged or aged cells from the blood stream via phagocytosis. Cell-surface CD47 interacts with its receptor on macrophages, SIRP alpha, to inhibit phagocytosis of normal, healthy cells. We find that mobilizing cytokines and inflammatory stimuli cause CD47 to be transiently upregulated on mouse hematopoietic stem cells (HSCs) and progenitors just prior to and during their migratory phase, and that the level of CD47 on these cells determines the probability that they are engulfed in vivo. CD47 is also constitutively upregulated on mouse and human myeloid leukemias, and overexpression of CD47 on a myeloid leukemia line increases its pathogenicity by allowing it to evade phagocytosis. We conclude that CD47 upregulation is an important mechanism that provides protection to normal HSCs during inflammation-mediated mobilization, and that leukemic progenitors co-opt this ability in order to evade macrophage killing.	[Jaiswal, Siddhartha; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Stanford, Stanford Canc Ctr,Dept Pathol, Stanford, CA 94305 USA; [Jaiswal, Siddhartha; Pang, Wendy W.; Park, Christopher Y.; Chao, Mark P.; Majeti, Ravindra; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Jamieson, Catriona H. M.] Univ Calif San Diego, Moores UCSD Canc Ctr, Stem Cell Res Program, La Jolla, CA 92093 USA; [Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands	Stanford Cancer Institute; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Vrije Universiteit Amsterdam	Jaiswal, S (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Stanford, Stanford Canc Ctr,Dept Pathol, Stanford, CA 94305 USA.	sjaiswal@stanford.edu; irv@stanford.edu	Van Rooijen, Nico/Z-1578-2019	Majeti, Ravindra/0000-0002-5814-0984	National Institutes of Health [5R01CA086017-08, 5R01HL058770-08, 5P01DK053074-08]; Leukemia Society; Ludwig Institute; Smith Family Fund; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA086017] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Society; Ludwig Institute; Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in this study was supported in part by National Institutes of Health Grants 5R01CA086017-08, 5R01HL058770-08, and 5P01DK053074-08 awarded to I. L. W., the de Villier award of the Leukemia Society, the Ludwig Institute, and a gift from the Smith Family Fund. The authors would also like to thank Christina Muscat for antibody production, Libuse Jerabek for capable laboratory management, and Eric Brown and Mette Johanssen for providing valuable advice and reagents.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; CLINE MJ, 1977, EXP HEMATOL, V5, P186; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Olsson M, 2007, BIOCHEM BIOPH RES CO, V352, P193, DOI 10.1016/j.bbrc.2006.11.002; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Reinhold MI, 1997, J EXP MED, V185, P1, DOI 10.1084/jem.185.1.1; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uno S, 2007, ONCOL REP, V17, P1189; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	42	963	1043	9	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					271	285		10.1016/j.cell.2009.05.046	http://dx.doi.org/10.1016/j.cell.2009.05.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632178	Green Accepted, Bronze			2022-12-28	WOS:000268277000010
J	Bentz, CJ				Bentz, Charles J.			Review: Nicotine gum and varenicline, but not behavioral interventions, reduce relapse in persons who have stopped smoking	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Legacy Hlth Syst Tobacco Cessat Program, Portland, OR USA	Legacy Health	Bentz, CJ (corresponding author), Legacy Hlth Syst Tobacco Cessat Program, Portland, OR USA.							Fiore MC, 2008, TREATING TOBACCO USE; Tucker JA, 2006, ADDICTION, V101, P918, DOI 10.1111/j.1360-0443.2006.01396.x	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-11	10.7326/0003-4819-151-2-200907210-02011	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620155				2022-12-28	WOS:000268605300019
J	Siemionow, M; Papay, F; Alam, D; Bernard, S; Djohan, R; Gordon, C; Hendrickson, M; Lohman, R; Eghtesad, B; Coffman, K; Kodish, E; Paradis, C; Avery, R; Fung, J				Siemionow, Maria; Papay, Frank; Alam, Daniel; Bernard, Steven; Djohan, Risal; Gordon, Chad; Hendrickson, Mark; Lohman, Robert; Eghtesad, Bijan; Coffman, Kathy; Kodish, Eric; Paradis, Carmen; Avery, Robin; Fung, John			Near-total human face transplantation for a severely disfigured patient in the USA	LANCET			English	Article							FACIAL ALLOGRAFT TRANSPLANTATION; TOLERANCE; CADAVER; ALLOTRANSPLANTATION; INDUCTION; ISSUES; MODEL	Background Multiple reconstructive procedures are common for the reconstruction of complex facial deformities of skin, soft tissues, bony structures, and functional subunits, such as the nose, lips, and eyelids. However, the results have been unsatisfactory. An innovative approach entailing a single surgical procedure of face allograft transplantation is a viable alternative and gives improved results. Methods On Dec 9, 2008, a 45-year-old woman with a history of severe midface trauma underwent near-total face transplantation in which 80% of her face was replaced with a tailored composite tissue allograft. We addressed issues of immunosuppressive therapy, psychological and ethical outcomes, and re-integration of the patient into society. Findings After the operation, the patient did well physically and psychologically, and tolerated immunosuppression without any major complication. Routine biopsy on day 47 after transplantation showed rejection of graft mucosa; however, a single bolus of corticosteroids reversed rejection. During the first 3 weeks after transplantation, the patient accepted her new face; 6 months after surgery, the functional outcome has been excellent. In contrast to her status before transplantation, the patient can now breathe through her nose, smell, taste, speak intelligibly, eat solid foods, and drink from a cup. Interpretation We show the feasibility of reconstruction of severely disfigured patients in a single surgical procedure using composite face allotransplantation. Therefore, this should be taken in consideration as an early option for severely disfigured patients.	[Siemionow, Maria] Cleveland Clin, Cleveland, OH 44195 USA; [Papay, Frank; Bernard, Steven; Djohan, Risal; Gordon, Chad; Hendrickson, Mark; Lohman, Robert] Dermatol & Plast Surg Inst, Cleveland, OH USA; [Alam, Daniel] Head & Neck Inst, Cleveland, OH USA; [Eghtesad, Bijan; Fung, John] Inst Digest Dis, Cleveland, OH USA; [Coffman, Kathy] Neurol Inst, Cleveland, OH USA; [Kodish, Eric; Paradis, Carmen] Bioeth Dept, Cleveland, OH USA; [Avery, Robin] Inst Med, Cleveland, OH USA; [Fung, John] Surg Inst, Cleveland, OH USA	Cleveland Clinic Foundation	Siemionow, M (corresponding author), Cleveland Clin, 9500 Euclid Ave,Desk A-60, Cleveland, OH 44195 USA.	siemiom@ccf.org	FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441				Chenggang Y, 2008, AM J TRANSPLANT, V8, P2169, DOI 10.1111/j.1600-6143.2008.02352.x; Demir Y, 2004, PLAST RECONSTR SURG, V114, P1790, DOI 10.1097/01.PRS.0000142414.92308.AB; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Meningaud JP, 2008, PLAST RECONSTR SURG, V122, P1383, DOI 10.1097/PRS.0b013e3181882146; Morris P, 2007, TRANSPLANTATION, V83, P109, DOI 10.1097/01.tp.0000254201.89012.ae; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P876, DOI 10.1097/01.prs.0000204876.27481.fc; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P864, DOI 10.1097/01.prs.0000204875.10333.56; Siemionow M, 2005, TRANSPLANTATION, V79, P558, DOI 10.1097/01.TP.0000152799.16035.B7; Siemionow M, 2003, TRANSPLANTATION, V75, P1607, DOI 10.1097/01.TP.0000068870.71053.29; Siemionow M, 2002, TRANSPLANTATION, V74, P1211, DOI 10.1097/00007890-200211150-00002; Siemionow M, 2006, J RECONSTR MICROSURG, V22, P399, DOI 10.1055/s-2006-947693; Siemionow M, 2006, J RECONSTR MICROSURG, V22, P329, DOI 10.1055/s-2006-946709; Ulusal BG, 2003, PLAST RECONSTR SURG, V112, P1302, DOI 10.1097/01.PRS.0000079823.84984.BB; Unal S, 2005, ANN PLAS SURG, V55, P297, DOI 10.1097/01.sap.0000168693.25306.79; Yazici I, 2007, ANN PLAS SURG, V58, P338, DOI 10.1097/01.sap.0000237683.72676.12; Yazici I, 2006, PLAST RECONSTR SURG, V118, P1321, DOI 10.1097/01.prs.0000239452.31605.b3	19	236	244	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					203	209		10.1016/S0140-6736(09)61155-7	http://dx.doi.org/10.1016/S0140-6736(09)61155-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19608265				2022-12-28	WOS:000268263000028
J	Monastersky, R				Monastersky, Richard			Shooting for the Moon	NATURE			English	News Item																		ABELSON PH, 1964, SCIENCE, V145, P539, DOI 10.1126/science.145.3632.539; [Anonymous], 2003, ASSESSMENT DIRECTION; Hand E, 2009, NATURE, V459, P1038, DOI 10.1038/4591038a	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					314	315		10.1038/460314a	http://dx.doi.org/10.1038/460314a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606113				2022-12-28	WOS:000267979000008
J	Hawkey, CJ				Hawkey, C. J.			NSAIDs and aspirin: notorious or FAMOUS?	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HELICOBACTER-PYLORI INFECTION; LOW-DOSE ASPIRIN; NAPROXEN; ULCER; PREVENTION; ARTHRITIS; TRIAL; RISK		Univ Nottingham Hosp, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England	University of Nottingham	Hawkey, CJ (corresponding author), Univ Nottingham Hosp, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England.	Cj.hawkey@nottingham.ac.uk						Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; *BRIT NAT FOM, 2009, 10 1 1 NONST ANT DRU; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Hawkey CJ, 2008, RHEUMATOLOGY, V47, P1265, DOI 10.1093/rheumatology/ken229; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Hawkey CJ, 2003, GUT, V52, P600, DOI 10.1136/gut.52.4.600; *INF CTR HLTH SOC, PRESCR; Labenz J, 1997, GUT, V41, P33, DOI 10.1136/gut.41.1.33; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; Taha AS, 1996, NEW ENGL J MED, V334, P1435, DOI 10.1056/NEJM199605303342204; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI 10.1111/j.1572-0241.2008.01995.x	13	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 11	2009	374	9684					93	94		10.1016/S0140-6736(09)61245-9	http://dx.doi.org/10.1016/S0140-6736(09)61245-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19577799				2022-12-28	WOS:000268111600004
J	Andreae, DA; Andreae, MH				Andreae, D. A.; Andreae, M. H.			Uncertainties Page Should antihistamines be used to treat anaphylaxis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENT VISITS; EPINEPHRINE; MANAGEMENT; H-1-ANTIHISTAMINES; MULTICENTER; ANTAGONISTS; GUIDELINES; ALLERGIES; DRUG; FOOD		[Andreae, D. A.] St Josefs Hosp, Freiburg, Germany; [Andreae, M. H.] Vienna Med Univ, Vienna, Austria	Medical University of Vienna	Andreae, DA (corresponding author), St Josefs Hosp, Freiburg, Germany.	adriana@andreae.org	Andreae, Michael/AAE-5558-2022	Andreae, Michael/0000-0002-9052-0936				ALASTAIR JJ, 2004, NEW ENGL J MED, V350, P1013; Alrasbi M, 2007, ALLERGY, V62, P838, DOI 10.1111/j.1398-9995.2007.01434.x; *AM AC ALL ASTHM I, 2005, J ALLERGY CLIN IMMUN, V115, pS483; Bautista E, 2002, INT ARCH ALLERGY IMM, V128, P151, DOI 10.1159/000059406; Brown SGA, 2006, MED J AUSTRALIA, V185, P283, DOI 10.5694/j.1326-5377.2006.tb00563.x; Clark S, 2005, J ALLERGY CLIN IMMUN, V116, P643, DOI 10.1016/j.jaci.2005.06.026; Clark S, 2004, J ALLERGY CLIN IMMUN, V113, P347, DOI 10.1016/j.jaci.2003.10.053; Gonzalez SK, 2008, J TRAUMA, V64, P1665, DOI 10.1097/TA.0b013e31817156ce; Kemp SF, 2008, ALLERGY, V63, P1061, DOI 10.1111/j.1398-9995.2008.01733.x; Lin RY, 2000, ANN EMERG MED, V36, P462, DOI 10.1067/mem.2000.109445; RUNGE JW, 1992, ANN EMERG MED, V21, P237, DOI 10.1016/S0196-0644(05)80881-9; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sheikh A, 2007, ALLERGY, V62, P830, DOI 10.1111/j.1398-9995.2007.01435.x; Sheikh A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006312.pub2; Simons FER, 2007, ALLERGY, V62, P827, DOI 10.1111/j.1398-9995.2007.01433.x; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P837, DOI 10.1016/j.jaci.2004.01.079; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Soar J, 2008, RESUSCITATION, V77, P157, DOI 10.1016/j.resuscitation.2008.02.001; Soldovieri MV, 2008, CHEM RES TOXICOL, V21, P997, DOI 10.1021/tx800020c; WINBERY SL, 2002, HISTAMINE H1 ANTIHIS, P287	20	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2009	339								b2489	10.1136/bmj.b2489	http://dx.doi.org/10.1136/bmj.b2489			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LC	19592404				2022-12-28	WOS:000267898700001
J	Tzur, A; Kafri, R; LeBleu, VS; Lahav, G; Kirschner, MW				Tzur, Amit; Kafri, Ran; LeBleu, Valerie S.; Lahav, Galit; Kirschner, Marc W.			Cell Growth and Size Homeostasis in Proliferating Animal Cells	SCIENCE			English	Article							MOUSE FIBROBLASTS; INTERPHASE GROWTH; ESCHERICHIA-COLI; MAMMALIAN-CELLS; DNA RNA; CYCLE; DIVISION; YEAST; MASS; CONSTANCY	A long-standing question in biology is whether there is an intrinsic mechanism for coordinating growth and the cell cycle in metazoan cells. We examined cell size distributions in populations of lymphoblasts and applied a mathematical analysis to calculate how growth rates vary with both cell size and the cell cycle. Our results show that growth rate is size-dependent throughout the cell cycle. After initial growth suppression, there is a rapid increase in growth rate during the G(1) phase, followed by a period of constant exponential growth. The probability of cell division varies independently with cell size and cell age. We conclude that proliferating mammalian cells have an intrinsic mechanism that maintains cell size.	[Tzur, Amit; Kafri, Ran; Lahav, Galit; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [LeBleu, Valerie S.] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu	LeBleu, Valerie/E-2991-2015		NIH [GM083303, GM026875]; Human Frontier Science Program fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875, R01GM083303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM083303 (G.L.), a Human Frontier Science Program fellowship (R.K.), and NIH grant GM026875.	ANDERSON EC, 1970, BIOPHYS J, V10, P630, DOI 10.1016/S0006-3495(70)86325-1; ANDERSON EC, 1969, BIOPHYS J, V9, P246, DOI 10.1016/S0006-3495(69)86383-6; BELL GI, 1967, BIOPHYS J, V7, P329, DOI 10.1016/S0006-3495(67)86592-5; COLLINS JF, 1962, J GEN MICROBIOL, V28, P15, DOI 10.1099/00221287-28-1-15; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Echave P, 2007, CELL CYCLE, V6, P218, DOI 10.4161/cc.6.2.3744; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; KUBITSCH.HE, 1968, BIOPHYS J, V8, P1401, DOI 10.1016/S0006-3495(68)86562-2; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P613, DOI 10.1128/jb.168.2.613-618.1986; LeBleu VS, 2006, CYTOTECHNOLOGY, V51, P149, DOI 10.1007/s10616-006-9024-5; LOKEN MR, 1984, J CELL PHYSIOL, V118, P22, DOI 10.1002/jcp.1041180106; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; Sveiczer Akos, 2004, Theor Biol Med Model, V1, P12, DOI 10.1186/1742-4682-1-12; TRUCCO E, 1970, Bulletin of Mathematical Biophysics, V32, P459, DOI 10.1007/BF02476765; TRUCCO E, 1970, Bulletin of Mathematical Biophysics, V32, P475, DOI 10.1007/BF02476766; TYSON JJ, 1985, J MATH BIOL, V22, P61, DOI 10.1007/BF00276546; ZETTERBERG A, 1965, EXP CELL RES, V39, P22, DOI 10.1016/0014-4827(65)90003-0	26	280	288	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					167	171		10.1126/science.1174294	http://dx.doi.org/10.1126/science.1174294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589995	Green Accepted			2022-12-28	WOS:000267802000037
J	Gracey, M; King, M				Gracey, Michael; King, Malcolm			Indigenous health part 1: determinants and disease patterns	LANCET			English	Review							RISK-FACTORS; CARDIOVASCULAR-DISEASE; ABORIGINAL COMMUNITY; RENAL-DISEASE; 1ST NATIONS; HIV RISK; INFECTIONS; POPULATION; NUTRITION; MORTALITY	The world's almost 400 million Indigenous people have low standards of health. This poor health is associated with poverty, malnutrition, overcrowding, poor hygiene, environmental contamination, and prevalent infections. Inadequate clinical care and health promotion, and poor disease prevention services aggravate this situation. Some Indigenous groups, as they move from traditional to transitional and modern lifiestyles, are rapidly acquiring lifestyle diseases, such as obesity, cardiovascular disease, and type 2 diabetes, and physical, social, and mental disorders linked to misuse of alcohol and of other drugs. Correction of these inequities needs increased awareness, political commitment, and recognition rather than governmental denial and neglect of these serious and complex problems. Indigenous people should be encouraged, trained, and enabled to become increasingly involved in overcoming these challenges.	[Gracey, Michael] Unity First People Australia, Perth, WA 6005, Australia; [King, Malcolm] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Gracey, M (corresponding author), Unity First People Australia, Perth, WA 6005, Australia.	m.gracey@optusnet.com.au	lehmann, jennifer/AAB-8110-2019	King, Malcolm/0000-0002-1712-0303				Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; [Anonymous], 2005, PREV CHRON DIS VIT I; *AUSTR BUR STAT, 2004, 200403 AUSTR BUR STA; Basta PC, 2006, T ROY SOC TROP MED H, V100, P579, DOI 10.1016/j.trstmh.2005.07.014; Bastos WR, 2006, SCI TOTAL ENVIRON, V368, P344, DOI 10.1016/j.scitotenv.2005.09.048; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Blakely T, 2006, LANCET, V368, P44, DOI 10.1016/S0140-6736(06)68813-2; Bookallil M, 2005, Rural Remote Health, V5, P395; Bowd Alan D, 2005, Int J Circumpolar Health, V64, P5; Brennand EA, 2005, J OBSTET GYNAECOL CA, V27, P936, DOI 10.1016/S1701-2163(16)30739-3; Bunt JC, 2005, J CLIN ENDOCR METAB, V90, P3225, DOI 10.1210/jc.2005-0007; Burke V, 2007, DIABETES RES CLIN PR, V78, P360, DOI 10.1016/j.diabres.2007.04.007; Campbell Judy, 2002, INVISIBLE INVADERS S; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cargill VA, 2005, MED CLIN N AM, V89, P895, DOI 10.1016/j.mcna.2005.03.005; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Cook Victoria J, 2005, Can Respir J, V12, P134; Currie BJ, 2001, J PAEDIATR CHILD H, V37, P326, DOI 10.1046/j.1440-1754.2001.00661.x; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; de Quadros CA, 2003, J INFECT DIS, V187, pS102, DOI 10.1086/368032; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Dennehy PH, 2007, VACCINE, V25, P3137, DOI 10.1016/j.vaccine.2007.01.102; Department of Families Housing Community Services and Indigenous Affairs, 2009, CLOS GAP IND DIS CHA; Diaz E, 2007, INT J TUBERC LUNG D, V11, P1372; Dyck RF, 2005, KIDNEY INT, V68, pS53, DOI 10.1111/j.1523-1755.2005.09709.x; Elkin AP, 1973, AUSTR ABORIGINES; Fishbein DB, 2008, PEDIATRICS, V121, pS5, DOI 10.1542/peds.2007-1115B; Franco EL, 2005, VACCINE, V23, P2388, DOI 10.1016/j.vaccine.2005.01.016; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Freemantle CJ, 2006, LANCET, V367, P1758, DOI 10.1016/S0140-6736(06)68771-0; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Gracey M, 2006, ASIA PAC J CLIN NUTR, V15, P178; Gracey M, 1996, AUST NZ J MED, V26, P171, DOI 10.1111/j.1445-5994.1996.tb00881.x; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Gracey M, 1998, ANN TROP PAEDIATR, V18, pS53, DOI 10.1080/02724936.1998.11747981; Gracey MS, 2007, MED J AUSTRALIA, V186, P15, DOI 10.5694/j.1326-5377.2007.tb00779.x; GRACEY MS, 1981, BRIT MED BULL, V37, P71, DOI 10.1093/oxfordjournals.bmb.a071679; GUPTA G, 2005, BMJ-BRIT MED J, V324, P184; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; HERNANDEZ B, 2008, 12 INT AIDS C MEX CI; Hill K, 2007, INT J EPIDEMIOL, V36, P580, DOI 10.1093/ije/dym011; Hochman ME, 2007, KIDNEY INT, V71, P931, DOI 10.1038/sj.ki.5002100; Horton R, 2006, LANCET, V367, P1705, DOI 10.1016/S0140-6736(06)68745-X; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hoy WE, 2009, MED J AUSTRALIA, V190, P542, DOI 10.5694/j.1326-5377.2009.tb02555.x; Hunter E, 1993, ABORIGINAL HLTH HIST; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Kovesi T, 2007, CAN MED ASSOC J, V177, P155, DOI [10.1503/cmaj.061574, 10.1503/CMAJ.061574]; Larkin J, 2007, CAN J PUBLIC HEALTH, V98, P179, DOI 10.1007/BF03403708; Leggatt GR, 2007, CURR OPIN IMMUNOL, V19, P232, DOI 10.1016/j.coi.2007.01.004; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; LOCKHART M, 2001, 6 INT C AIDS AS PAC; LOPEZ V, 2008, 12 INT AIDS C MEX CI; MacMillan HL, 1996, CAN MED ASSOC J, V155, P1569; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; McDonald EL, 2008, MED J AUSTRALIA, V188, pS84; McMahon SK, 2004, MED J AUSTRALIA, V180, P459, DOI 10.5694/j.1326-5377.2004.tb06023.x; McNaghten AD, 2005, ETHNIC HEALTH, V10, P57, DOI 10.1080/1355785052000323038; Menzies R, 2006, EPIDEMIOL REV, V28, P71, DOI 10.1093/epirev/mxj005; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Nettleton C., 2007, OVERVIEW CURRENT KNO; ODEA K, 1993, DIABETES CARE, V16, P1004, DOI 10.2337/diacare.16.7.1004; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Pavkov ME, 2007, DIABETES CARE, V30, P1758, DOI 10.2337/dc06-2010; Pink B, 2008, HLTH WELFARE AUSTR A; Rhoades DA, 2005, CIRCULATION, V111, P1250, DOI 10.1161/01.CIR.0000157735.25005.3F; Rodriguez-Moran M, 2008, ARCH MED RES, V39, P352, DOI 10.1016/j.arcmed.2007.12.003; Salbe AD, 2002, PEDIATRICS, V110, P299, DOI 10.1542/peds.110.2.299; Scavini M, 2005, KIDNEY INT, V68, pS126, DOI 10.1111/j.1523-1755.2005.09721.x; Sharma Shobhona, 2008, Journal of Vector Borne Diseases, V45, P1; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Stang J, 2005, J AM DIET ASSOC, V105, P1916, DOI [10.1016/j.jada.2005.09.031, 10.1016/j.jada.2005.09.003]; Steer AC, 2008, EPIDEMIOL INFECT, V136, P621, DOI 10.1017/S095026880700917X; Steer AC, 2007, J PAEDIATR CHILD H, V43, P203, DOI 10.1111/j.1440-1754.2007.01051.x; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Strong K, 2006, INT J EPIDEMIOL, V35, P492, DOI 10.1093/ije/dyi315; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Trudgen R, 2000, WHY WARRIORS LIE DIE; *UN PERM FORM IND, WHO AR IND PEOPL; Vos T, 2007, BURDEN DIS INJURY AB; Waldram J, 2006, ABORIGINAL HLTH CANA; WALDRAM JB, 2008, ABORIGINAL HLTH CANA; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; Weil EJ, 2006, ETHNIC DIS, V16, P24; *WHO, 2008, GLOB BURD DIS 2004 4; Wilson C, 2005, AM J PUBLIC HEALTH, V95, P1518, DOI 10.2105/AJPH.2004.053710; Wright MR, 2005, MED J AUSTRALIA, V183, P124, DOI 10.5694/j.1326-5377.2005.tb06955.x; Young TK, 2000, CAN MED ASSOC J, V163, P561; Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419; Zavaleta C, 2007, AM J TROP MED HYG, V76, P703, DOI 10.4269/ajtmh.2007.76.703; ZHANEL GG, 1995, CLIN INFECT DIS, V21, P316, DOI 10.1093/clinids/21.2.316	97	752	765	8	206	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					65	75		10.1016/S0140-6736(09)60914-4	http://dx.doi.org/10.1016/S0140-6736(09)60914-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467UO	19577695				2022-12-28	WOS:000267768800035
J	Saksida, LM				Saksida, Lisa M.			Remembering Outside the Box	SCIENCE			English	Editorial Material							MEDIAL TEMPORAL-LOBE; OBJECT RECOGNITION; PERIRHINAL CORTEX; VISUAL-PERCEPTION; MEMORY-SYSTEMS; DISCRIMINATIONS		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Saksida, LM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	lms42@cam.ac.uk	Saksida, Lisa M/M-2753-2016	Saksida, Lisa M/0000-0002-8416-8171				Barense MD, 2005, J NEUROSCI, V25, P10239, DOI 10.1523/JNEUROSCI.2704-05.2005; Bartko SJ, 2007, J NEUROSCI, V27, P2548, DOI 10.1523/JNEUROSCI.5171-06.2007; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Bussey TJ, 2005, CURR OPIN NEUROBIOL, V15, P730, DOI 10.1016/j.conb.2005.10.014; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; Devlin JT, 2007, CURR BIOL, V17, P1484, DOI 10.1016/j.cub.2007.07.066; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; Lopez-Aranda MF, 2009, SCIENCE, V325, P87, DOI 10.1126/science.1170869; Manns JR, 2000, P NATL ACAD SCI USA, V97, P12375, DOI 10.1073/pnas.220398097; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	17	10	10	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					40	41		10.1126/science.1177156	http://dx.doi.org/10.1126/science.1177156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574374				2022-12-28	WOS:000267594000023
J	Tan, CSH; Pasculescu, A; Lim, WA; Pawson, T; Bader, GD; Linding, R				Tan, Chris Soon Heng; Pasculescu, Adrian; Lim, Wendell A.; Pawson, Tony; Bader, Gary D.; Linding, Rune			Positive Selection of Tyrosine Loss in Metazoan Evolution	SCIENCE			English	Article							PHOSPHORYLATION NETWORKS; BIOLOGICAL COMPLEXITY; MONOSIGA-BREVICOLLIS; GENOME	John Nash showed that within a complex system, individuals are best off if they make the best decision that they can, taking into account the decisions of the other individuals. Here, we investigate whether similar principles influence the evolution of signaling networks in multicellular animals. Specifically, by analyzing a set of metazoan species we observed a striking negative correlation of genomically encoded tyrosine content with biological complexity (as measured by the number of cell types in each organism). We discuss how this observed tyrosine loss correlates with the expansion of tyrosine kinases in the evolution of the metazoan lineage and how it may relate to the optimization of signaling systems in multicellular animals. We propose that this phenomenon illustrates genome-wide adaptive evolution to accommodate beneficial genetic perturbation.	[Tan, Chris Soon Heng; Pasculescu, Adrian; Pawson, Tony; Bader, Gary D.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tan, Chris Soon Heng; Pawson, Tony; Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tan, Chris Soon Heng; Bader, Gary D.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Linding, Rune] Inst Canc Res, Cellular & Mol Log Team, Sect Cell & Mol Biol, London SW3 6JB, England	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca; gary.bader@utoronto.ca; linding@icr.ac.uk	Pawson, Tony J/E-4578-2013; Bader, Gary/C-1176-2009; Tan, Soon Heng/C-1177-2009	Bader, Gary/0000-0003-0185-8861; Tan, Soon Heng/0000-0002-8172-5235; Linding, Rune/0000-0003-0420-4839	Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research [MOP-84324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Jorgensen, J. Zhang, K. Colwill, T. J. Gibson, J. Jin, and K. Lindorff-Larsen for suggestions and fruitful discussions. This project was in part supported by Genome Canada through the Ontario Genomics Institute and the Canadian Institutes of Health Research (MOP-84324). C. S. H. T. conceived the project. C. S. H. T., W. A. L., G. D. B., T. P., and R. L. designed the experiments. C. S. H. T., R. L., and A. P. performed the experiments. C. S. H. T., G. D. B., W. A. L., T. P., and R. L. wrote the paper. R. L. managed the project.	Bonner JT, 1998, INTEGR BIOL, V1, P28; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jorgensen Claus, 2008, Briefings in Functional Genomics & Proteomics, V7, P17, DOI 10.1093/bfgp/eln001; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; NASH JF, 1950, THESIS PRINCETON U P; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wright S, 1931, GENETICS, V16, P0097; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	17	78	79	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1686	1688		10.1126/science.1174301	http://dx.doi.org/10.1126/science.1174301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19589966	Green Accepted			2022-12-28	WOS:000270131800045
J	Gaspar-Maia, A; Alajem, A; Polesso, F; Sridharan, R; Mason, MJ; Heidersbach, A; Ramalho-Santos, J; McManus, MT; Plath, K; Meshorer, E; Ramalho-Santos, M				Gaspar-Maia, Alexandre; Alajem, Adi; Polesso, Fanny; Sridharan, Rupa; Mason, Mike J.; Heidersbach, Amy; Ramalho-Santos, Joao; McManus, Michael T.; Plath, Kathrin; Meshorer, Eran; Ramalho-Santos, Miguel			Chd1 regulates open chromatin and pluripotency of embryonic stem cells	NATURE			English	Article							SELF-RENEWAL; EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; FIBROBLASTS; GENERATION; LYSINE-4; PROTEIN	An open chromatin largely devoid of heterochromatin is a hallmark of stem cells. It remains unknown whether an open chromatin is necessary for the differentiation potential of stem cells, and which molecules are needed to maintain open chromatin. Here we show that the chromatin remodelling factor Chd1 is required to maintain the open chromatin of pluripotent mouse embryonic stem cells. Chd1 is a euchromatin protein that associates with the promoters of active genes, and downregulation of Chd1 leads to accumulation of heterochromatin. Chd1-deficient embryonic stem cells are no longer pluripotent, because they are incapable of giving rise to primitive endoderm and have a high propensity for neural differentiation. Furthermore, Chd1 is required for efficient reprogramming of fibroblasts to the pluripotent stem cell state. Our results indicate that Chd1 is essential for open chromatin and pluripotency of embryonic stem cells, and for somatic cell reprogramming to the pluripotent state.	[Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Ob Gyn, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Pathol, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre; Polesso, Fanny; Heidersbach, Amy; McManus, Michael T.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gaspar-Maia, Alexandre] Univ Coimbra, PhD Programme Biomed & Expt Biol, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Alajem, Adi; Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Sridharan, Rupa; Mason, Mike J.; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Mason, Mike J.; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Coimbra; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Dept Ob Gyn, 513 Parnassus Ave, San Francisco, CA 94143 USA.	mrsantos@diabetes.ucsf.edu	Gaspar-Maia, Alexandre/AAY-5416-2020; mcmanus, michael/AAB-1239-2020; Ramalho-Santos, Miguel/L-9092-2018; Santos, João/HHZ-5595-2022; Ramalho-Santos, João/F-8641-2012	Gaspar-Maia, Alexandre/0000-0001-8528-5575; mcmanus, michael/0000-0003-3013-6569; Ramalho-Santos, Miguel/0000-0003-0177-5556; Ramalho-Santos, João/0000-0002-1172-4018; Mason, Michael/0000-0002-5652-7739; Plath, Kathrin/0000-0001-7796-3372; Meshorer, Eran/0000-0003-4777-986X	Sandler Family; CIRM Young Investigator Award; NIH Director's New Innovator Award; Israel Science Foundation [ISF 215/07]; European Union [IRG-206872]; Alon Fellowship; California Institute for Regenerative Medicine; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	Sandler Family; CIRM Young Investigator Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Alon Fellowship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank A. Smith for Oct4-GiP ES cells, M. S. Parmacek for Gata6<SUP>-/-</SUP> ES cells, R. P. Perry and D. G. Stokes for the Chd1 antibody, M. Bigos and V. Stepps at the Flow Cytometry Core Facility and L. Ta and C. Barker at the Genomics Core Facility of the Gladstone Institutes for expert assistance, C. Chiu for technical assistance, members of the Santos laboratory, in particular M. Grskovic for advice, and A. Kriegstein, D. Melton, A. Alvarez-Buylla, D. Stainier, R. Blelloch, B. Panning, J. Reiter and M. Grskovic for discussions and critical reading of the manuscript. A. G.-M. was the recipient of a predoctoral fellowship from the Foundation for Science and Technology (POCI2010/FSE), Portugal. R. S. was the recipient of a CIRM postdoctoral training grant. This work was supported by grants from the Sandler Family to M. T. M., CIRM Young Investigator Award and NIH Director's New Innovator Award to K. P., Israel Science Foundation (ISF 215/07), European Union (IRG-206872) and Alon Fellowship to E. M., and NIH Director's New Innovator Award, California Institute for Regenerative Medicine and Juvenile Diabetes Research Foundation to M. R.-S.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	39	378	385	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					863	U97		10.1038/nature08212	http://dx.doi.org/10.1038/nature08212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19587682	Green Accepted			2022-12-28	WOS:000268938300031
J	Chiu, YH; MacMillan, JB; Chen, ZJJ				Chiu, Yu-Hsin; MacMillan, John B.; Chen, Zhijian J.			RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; EPSTEIN-BARR VIRUS; HEPATITIS-C VIRUS; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; KAPPA-B; RESPONSES; RECOGNITION; CELLS	Type I interferons (IFNs) are important for antiviral and autoimmune responses. Retinoic acid-induced gene I (RIG-I) and mitochondrial antiviral signaling (MAVS) proteins mediate IFN production in response to cytosolic double-stranded RNA or single-stranded RNA containing 5'-triphosphate (5'-ppp). Cytosolic B form double-stranded DNA, such as poly(dA-dT).poly(dA-dT)[poly(dA-dT)], can also induce IFN-beta, but the underlying mechanism is unknown. Here, we show that the cytosolic poly(dA-dT) DNA is converted into 5'-ppp RNA to induce IFN-beta through the RIG-I pathway. Biochemical purification led to the identification of DNA-dependent RNA polymerase III (Pol-III) as the enzyme responsible for synthesizing 5'-ppp RNA from the poly(dA-dT) template. Inhibition of RNA Pol-III prevents IFN-beta induction by transfection of DNA or infection with DNA viruses. Furthermore, Pol-III inhibition abrogates IFN-beta induction by the intracellular bacterium Legionella pneumophila and promotes the bacterial growth. These results suggest that RNA Pol-III is a cytosolic DNA sensor involved in innate immune responses.	[Chiu, Yu-Hsin; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [MacMillan, John B.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; MacMillan, John/0000-0003-1430-1077	National Institutes of Health; Welch Foundation; Chilton Foundation; Investigator of Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Chilton Foundation; Investigator of Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xiang Chen and Xiao-Dong Li for assistance in preparing BMDM, Hon-Ren Huang ( Harvard University) for technical advice, and Brian Skaug for critical reading of the manuscript. This work was supported by grants from the National Institutes of Health and the Welch Foundation (Z.J.C.) and by the Chilton Foundation (J.M.). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HOWE JG, 1993, MOL CELL BIOL, V13, P2655, DOI 10.1128/MCB.13.5.2655; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	29	847	907	2	110	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 7	2009	138	3					576	591		10.1016/j.cell.2009.06.015	http://dx.doi.org/10.1016/j.cell.2009.06.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19631370	Green Accepted, Bronze			2022-12-28	WOS:000268771900021
J	Stuckler, D; Basu, S; Suhrcke, M; Coutts, A; McKee, M				Stuckler, David; Basu, Sanjay; Suhrcke, Marc; Coutts, Adam; McKee, Martin			The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis	LANCET			English	Article							MORTALITY; JAPAN; RATES; ASIA	Background There is widespread concern that the present economic crisis, particularly its effect on unemployment, will adversely affect population health. We investigated how economic changes have affected mortality rates over the past three decades and identified how governments might reduce adverse effects. Methods We used multivariate regression, correcting for population ageing, past mortality and employment trends, and country-specific differences in health-care infrastructure, to examine associations between changes in employment and mortality, and how associations were modified by different types of government expenditure for 26 European Union (EU) countries between 1970 and 2007. Findings We noted that every 1% increase in unemployment was associated with a 0.79% rise in suicides at ages younger than 65 years (95% CI 0.16-1.42; 60-550 potential excess deaths [mean 310] EU-wide), although the effect size was non-significant at all ages (0.49%, -0.04 to 1.02), and with a 0.79% rise in homicides (95% CI 0.06-1.52; 3-80 potential excess deaths [mean 40] EU-wide). By contrast, road-traffic deaths decreased by 1.39% (0.64-2.14; 290-980 potential fewer deaths [mean 630] EU-wide). A more than 3% increase in unemployment had a greater effect on suicides at ages younger than 65 years (4.45%, 95% CI 0.65-8.24; 250-3220 potential excess deaths [mean 1740] EU-wide) and deaths from alcohol abuse (28.0%,12.30-43.70; 1550-5490 potential excess deaths [mean 3500] EU-wide). We noted no consistent evidence across the EU that all-cause mortality rates increased when unemployment rose, although populations varied substantially in how sensitive mortality was to economic crises, depending partly on differences in social protection. Every US$10 per person increased investment in active labour market programmes reduced the effect of unemployment on suicides by 0.038% (95% CI -0.004 to -0.071). Interpretation Rises in unemployment are associated with significant short-term increases in premature deaths from intentional violence, while reducing traffic fatalities. Active labour market programmes that keep and reintegrate workers in jobs could mitigate some adverse health effects of economic downturns.	[Stuckler, David] Univ Oxford Christ Church, Dept Sociol, Oxford OX1 1DP, England; [Stuckler, David; McKee, Martin] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [Suhrcke, Marc] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Suhrcke, Marc] Ctr Diet & Act Res CEDAR, Cambridge, England; [Coutts, Adam] Oxford Dept Polit & Int Relat, Oxford, England; [McKee, Martin] European Observ Hlth Syst & Policies, Brussels, Belgium	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of East Anglia; University of Cambridge; University of Oxford; European Observatory on Health Systems & Policies	Stuckler, D (corresponding author), Univ Oxford Christ Church, Dept Sociol, Meadow Flat, Oxford OX1 1DP, England.	David.stuckler@chch.ox.ac.uk	Suhrcke, Marc/AAE-9024-2019; Mckee, Martin/E-6673-2018; Stuckler, David/H-2261-2012; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Suhrcke, Marc/0000-0001-7263-8626; Boardman, Jed/0000-0002-6063-1504; Stuckler, David/0000-0002-1288-8401	Centre for Crime and justice Studies, King's College, London, UK; Wates Foundation; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI	Centre for Crime and justice Studies, King's College, London, UK; Wates Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Centre for Crime and justice Studies, King's College, London, UK, and the Wates Foundation provided financial support for the project.	American Society for Aesthetic Plastic Surgery, 2008, MED NEWS TODAY; Ashiagbor D., 2005, EUROPEAN EMPLOYMENT; BOUGEROL E, 2009, BC LOS ANGELES LOS A; Camacho M, 2006, J ECON DYN CONTROL, V30, P1687, DOI 10.1016/j.jedc.2005.08.012; Catalano R, 2005, INT J EPIDEMIOL, V34, P1212, DOI 10.1093/ije/dyi145; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Coutts AP, 2009, ACTIVE LABOUR MARKET; COWEN T, 2009, NY TIMES NEW YORK; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Durkheim E, 1897, SUICIDE ETUDE SOCIOL; Economou A, 2008, J ECON STUD, V35, P368, DOI 10.1108/01443580810903536; Edwards R, 2008, SOC SCI MED, V67, P2051, DOI 10.1016/j.socscimed.2008.09.032; Eriksson T., 2000, MORTALITY CRISIS TRA, P370; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Granados J, 2005, EUR J POPUL, V21, P393, DOI 10.1007/s10680-005-4767-9; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Granados JAT, 2008, DEMOGRAPHY, V45, P323, DOI 10.1353/dem.0.0008; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; Hopkins S, 2006, HEALTH POLICY, V75, P347, DOI 10.1016/j.healthpol.2005.04.002; JANTTI M, 2000, MORTALITY CRISIS TRA, P351; Jones A, 2000, HDB HLTH EC, P265; JOYCE T, 1993, J HUM RESOUR, V28, P185, DOI 10.2307/146093; KERWIN K, 2008, J HLTH EC, V27, P1532; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; LOCK K, BMJ IN PRESS; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; *OECD, 2008, ORG EC COOP DEV HLTH; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Valkonen T, 2000, EUR J PUBLIC HEALTH, V10, P274, DOI 10.1093/eurpub/10.4.274; VANDERWILK E, 2008, EUROPEAN STANDARD PO; Vuori J, 2005, J OCCUP ORGAN PSYCH, V78, P43, DOI 10.1348/096317904X23790; WATERS H, HLTH POLICY PLAN, V18, P172; Westerlund H, 2001, SOC SCI MED, V52, P405, DOI 10.1016/S0277-9536(00)00145-3; *WHO, 2008, WHOE UR HLTH ALL DAT; WHO, 2009, B WORLD HEALTH ORGAN, V87, P1; World Health Organization, 2009, FIN CRIS GLOB HLTH R; 2009, TELEGRAPH LONDON	44	892	909	0	232	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					315	323		10.1016/S0140-6736(09)61124-7	http://dx.doi.org/10.1016/S0140-6736(09)61124-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477GW	19589588				2022-12-28	WOS:000268508200029
J	Amabilino, DB				Amabilino, David B.			How Deformation Can Lend a Hand to Molecular Ordering	SCIENCE			English	Editorial Material							LIQUID-CRYSTALS; POLAR; PHASE		CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Amabilino, DB (corresponding author), CSIC, Inst Ciencia Mat Barcelona, Campus Univ,Esfera UAB, Bellaterra 08193, Catalonia, Spain.	amabilino@icmab.es	Amabilino, David B/D-4671-2012	Amabilino, David B/0000-0003-1674-8462				Dantlgraber G, 2007, J MATER CHEM, V17, P3419, DOI 10.1039/b705499h; DiDonna BA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215504; Gaikwad AV, 2009, SOFT MATTER, V5, P1994, DOI 10.1039/b814395a; Hough LE, 2009, SCIENCE, V325, P452, DOI 10.1126/science.1170028; Hough LE, 2009, SCIENCE, V325, P456, DOI 10.1126/science.1170027; Kamien RD, 2007, SCIENCE, V315, P1083, DOI 10.1126/science.1138506; Kostyanovsky RG, 2003, MENDELEEV COMMUN, P85, DOI 10.1070/MC2003v013n03ABEH001828; Pasteur L., 1848, ANN CHIM PHYS, V24, P442; Perez-Garcia L, 2002, CHEM SOC REV, V31, P342, DOI 10.1039/b201099m; Perez-Garcia L, 2007, CHEM SOC REV, V36, P941, DOI 10.1039/b610714a; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; Sekine T, 1997, J MATER CHEM, V7, P1307, DOI 10.1039/a702026k; Thisayukta J, 2000, J AM CHEM SOC, V122, P7441, DOI 10.1021/ja001370q; Walba DM, 2000, J PHYS ORG CHEM, V13, P830, DOI 10.1002/1099-1395(200012)13:12<830::AID-POC327>3.0.CO;2-J; Weissflog W, 2003, ADV MATER, V15, P630, DOI 10.1002/adma.200304570	15	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					402	403		10.1126/science.1177315	http://dx.doi.org/10.1126/science.1177315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628847				2022-12-28	WOS:000268255100031
J	Sarrazin, S; Mossadegh-Keller, N; Fukao, T; Aziz, A; Mourcin, F; Vanhille, L; Modis, LK; Kastner, P; Chan, S; Duprez, E; Otto, C; Sieweke, MH				Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Kastner, Philippe; Chan, Susan; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.			MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells	CELL			English	Article							COLONY-STIMULATING FACTOR; LINEAGE COMMITMENT; SELF-RENEWAL; PROGENITOR CELLS; GENE-EXPRESSION; BONE-MARROW; C-FMS; DIFFERENTIATION; MACROPHAGE; CYTOKINES	While hematopoietic stem cell (HSC) self-renewal is well studied, it remains unknown whether distinct control mechanisms enable HSC divisions that generate progeny cells with specific lineage bias. Here, we report that the monocytic transcription factor MafB specifically restricts the ability of M-CSF to instruct myeloid commitment divisions in HSCs. MafB deficiency specifically enhanced sensitivity to M-CSF and caused activation of the myeloid master-regulator PU.1 in HSCs in vivo. Single-cell analysis revealed that reduced MafB levels enabled M-CSF to instruct divisions producing asymmetric daughter pairs withone PU.1(+) cell. Asaconsequence, MafB(-/-) HSCs showed a PU.1 and M-CSF receptor-dependent competitive repopulation advantage specifically in the myelomonocytic, but not T lymphoid or erythroid, compartment. Lineage-biased repopulation advantage was progressive, maintained long term, and serially transplantable. Together, this indicates that an integrated transcription factor/cytokine circuit can control the rate of specific HSC commitment divisions without compromising other lineages or self-renewal.	[Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] Univ Aix Marseille, CIML, F-13288 Marseille 09, France; [Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] INSERM, U631, F-13258 Marseille, France; [Sarrazin, Sandrine; Mossadegh-Keller, Noushine; Fukao, Taro; Aziz, Athar; Mourcin, Frederic; Vanhille, Laurent; Modis, Louise Kelly; Duprez, Estelle; Otto, Claas; Sieweke, Michael H.] CNRS, UMR6102, Marseille, France; [Kastner, Philippe; Chan, Susan] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Fukao, Taro/I-3246-2014; Sieweke, Michael/AAR-7515-2020; Mourcin, Frederic/C-5511-2017; duprez, estelle a/R-2357-2016	Sieweke, Michael/0000-0002-3228-9537; Mourcin, Frederic/0000-0002-5344-9632; Duprez, Estelle/0000-0003-3810-5740; Mossadegh-Keller, Noushin/0000-0002-7088-3676	Association pour la Recherche sur le Cancer [3857, 3422]; Association for International Cancer Research [05-0079]; FdF [2004004150]; Agence Nationale de la Recherche [BLAN07-1_205752]; Fondation de France (FdF); Societe Francaise d'Hematologie; European Molecular Biology Organisation; INSERM	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association for International Cancer Research; FdF; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France (FdF)(Fondation de France); Societe Francaise d'Hematologie; European Molecular Biology Organisation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	S.S. received fellowships from the Fondation de France (FdF) and Societe Francaise d'Hematologie, T. F. from the European Molecular Biology Organisation and INSERM, and A. A. and L. V. from the French Ministere de l'Enseignement Superieur et de la Recherche. We gratefully acknowledge financial support by grants from the Association pour la Recherche sur le Cancer (3857 and 3422), Association for International Cancer Research (05-0079), FdF (2004004150), and Agence Nationale de la Recherche (BLAN07-1_205752). We thank L. Rohrschneider, R. P. Bourette, G. Mouchiroud, and R. Tsien for reagents, P. Grenot, M. Barad, N. Brun, and A. Zouine for expert flow cytometry, L. Chasson from RIO/Marseille-Nice Genopole platform for histology support, F. Diaz and the Maina group for mouse handling, E. Bertosio for blood counts, and F. Rossi, T. Graf, M. Djabali, U. Nehrbass, F. Morle, and M. H. S. group members for fruitful discussions.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bourette RP, 2007, ONCOGENE, V26, P234, DOI 10.1038/sj.onc.1209777; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Gemelli C, 2006, CELL DEATH DIFFER, V13, P1686, DOI 10.1038/sj.cdd.4401860; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KRIEGLER AB, 1994, EXP HEMATOL, V22, P432; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; MCARTHUR GA, 1994, BLOOD, V83, P972; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pawlak G, 2000, EXP HEMATOL, V28, P1164, DOI 10.1016/S0301-472X(00)00522-1; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Xie Y, 2001, CELL BIOCHEM BIOPHYS, V34, P1, DOI 10.1385/CBB:34:1:001; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	52	112	122	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					300	313		10.1016/j.cell.2009.04.057	http://dx.doi.org/10.1016/j.cell.2009.04.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632180	Bronze			2022-12-28	WOS:000268277000012
J	Corcoran, AJ; Barber, JR; Conner, WE				Corcoran, Aaron J.; Barber, Jesse R.; Conner, William E.			Tiger Moth Jams Bat Sonar	SCIENCE			English	Article							BIG BROWN BAT; ARCTIID MOTHS; EPTESICUS-FUSCUS; ECHOLOCATION; CLICKS; RESPONSES; PREY; APOSEMATISM; DEFENSES; BEHAVIOR	In response to sonar-guided attacking bats, some tiger moths make ultrasonic clicks of their own. The lepidopteran sounds have previously been shown to alert bats to some moths' toxic chemistry and also to startle bats unaccustomed to sonic prey. The moth sounds could also interfere with, or "jam," bat sonar, but evidence for such jamming has been inconclusive. Using ultrasonic recording and high-speed infrared videography of bat-moth interactions, we show that the palatable tiger moth Bertholdia trigona defends against attacking big brown bats (Eptesicus fuscus) using ultrasonic clicks that jam bat sonar. Sonar jamming extends the defensive repertoire available to prey in the long-standing evolutionary arms race between bats and insects.	[Corcoran, Aaron J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA; [Barber, Jesse R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Wake Forest University; Colorado State University	Conner, WE (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA.	corcaj8@wfu.edu; conner@wfu.edu			National Science Foundation [IOB-0615164]; WFU	National Science Foundation(National Science Foundation (NSF)); WFU	Funding for research was provided by National Science Foundation Grant IOB-0615164 to W.E.C. and a W.F.U. Dean's Fellowship to A.J.C.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; BATES DL, 1990, CAN J ZOOL, V68, P49, DOI 10.1139/z90-009; BLEST A. D., 1964, ZOOLOGICA [N Y], V49, P161; Davis M., 1984, P287; Dunning D. C., 1968, Zeitschrift fuer Tierpsychologie, V25, P129; DUNNING DC, 1965, SCIENCE, V147, P173, DOI 10.1126/science.147.3654.173; DUNNING DC, 1992, CAN J ZOOL, V70, P2218, DOI 10.1139/z92-298; FULLARD JH, 1979, CAN J ZOOL, V57, P647, DOI 10.1139/z79-076; FULLARD JH, 1994, J EXP BIOL, V194, P285; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; KICK SA, 1984, J NEUROSCI, V4, P2725; Marples NM, 1998, OIKOS, V83, P161, DOI 10.2307/3546557; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MILLER LA, 1991, J COMP PHYSIOL A, V168, P571, DOI 10.1007/BF00215079; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; ROEDER KD, 1964, J INSECT PHYSIOL, V10, P529, DOI 10.1016/0022-1910(64)90025-3; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SURLYKKE A, 1985, J COMP PHYSIOL A, V156, P831, DOI 10.1007/BF00610835; Tougaard J, 1998, J COMP PHYSIOL A, V182, P203, DOI 10.1007/s003590050171; Tougaard J., 2004, ECHOLOCATION BATS DO, P365; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; WILSON WW, 2004, ECHOLOCATION BATS DO, P365	26	91	94	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					325	327		10.1126/science.1174096	http://dx.doi.org/10.1126/science.1174096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608920				2022-12-28	WOS:000268036600047
J	Hornby, GS; Kurtoglu, T				Hornby, Gregory S.; Kurtoglu, Tolga			Toward a Smarter Web	SCIENCE			English	Editorial Material									[Hornby, Gregory S.] Univ Calif Santa Cruz, Univ Affiliated Res Ctr, Moffett Field, CA 94035 USA; [Kurtoglu, Tolga] NASA, Ames Res Ctr, Mission Crit Technol Inc, Moffett Field, CA 94035 USA	University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Hornby, GS (corresponding author), Univ Calif Santa Cruz, Univ Affiliated Res Ctr, Mail Stop 269-3, Moffett Field, CA 94035 USA.	gregory.s.hornby@nasa.gov; tolga.kurtoglu@nasa.gov						Biles J, 1994, P INT COMPUTER MUSIC, P131; Dawkins R., 1986, BLIND WATCHMAKER; De Jong Kenneth A., 2006, EVOLUTIONARY COMPUTA, DOI 10.1145/1274000.1274109; Frazer J., 1995, EVOLUTIONARY ARCHITE; Kurtoglu T, 2009, RES ENG DES, V20, P59, DOI 10.1007/s00163-008-0062-1; Lohn JD, 2008, AI EDAM, V22, P235, DOI 10.1017/S0890060408000164; SIMS K, 1991, COMP GRAPH, V25, P319, DOI 10.1145/127719.122752; Takagi H, 2001, P IEEE, V89, P1275, DOI 10.1109/5.949485; Todd S., 1992, EVOLUTIONARY ART COM; WAJIMA T, 2005, HITACHI REV, V54, P161; Wannarumon S, 2008, AI EDAM, V22, P19, DOI 10.1017/S0890060408000024; Witbrock M, 1999, EVOLUTIONARY DESIGN BY COMPUTERS, P251	12	4	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					277	278		10.1126/science.1174400	http://dx.doi.org/10.1126/science.1174400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608905				2022-12-28	WOS:000268036600032
J	Beasley, RP				Beasley, R. Palmer			Development of Hepatitis B Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTIONS; IMMUNE GLOBULIN; TAIWAN; EFFICACY; TRANSMISSION; PREVENTION; ANTIGEN; TRIAL; MEN		Univ Texas Houston, Sch Publ Hlth, Div Epidemiol & Dis Control, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Beasley, RP (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol & Dis Control, 1200 Herman Pressler, Houston, TX 77030 USA.	R.P.Beasley@uth.tmc.edu						BEASLEY RP, 1983, LANCET, V2, P1099; BEASLEY RP, 1983, J INFECT DIS, V147, P185, DOI 10.1093/infdis/147.2.185; BEASLEY RP, 1981, LANCET, V2, P388; BEASLEY RP, 1982, J INFECT DIS, V146, P198, DOI 10.1093/infdis/146.2.198; BEASLEY RP, 1981, LANCET, V2, P1129; BEASLEY RP, 1983, AM J EPIDEMIOL, V117, P213, DOI 10.1093/oxfordjournals.aje.a113532; BUYNAK EB, 1976, JAMA-J AM MED ASSOC, V235, P2832, DOI 10.1001/jama.235.26.2832; FRANCIS DP, 1982, ANN INTERN MED, V97, P362, DOI 10.7326/0003-4819-97-3-362; LEE GCY, 1983, J INFECT DIS, V148, P526, DOI 10.1093/infdis/148.3.526; SCHMECK HM, 1981, NY TIMES        1117; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; SZMUNESS W, 1980, NEW ENGL J MED, V303, P833, DOI 10.1056/NEJM198010093031501	12	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					322	324		10.1001/jama.2009.1024	http://dx.doi.org/10.1001/jama.2009.1024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602694	Bronze			2022-12-28	WOS:000267948100028
J	Edgar, BA; Kim, KJ				Edgar, Bruce A.; Kim, Kerry J.			Sizing Up the Cell	SCIENCE			English	Editorial Material									[Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Kim, Kerry J.] Univ Washington, Friday Harbor Labs, Ctr Cell Dynam, Friday Harbor, WA 98250 USA	Fred Hutchinson Cancer Center; University of Washington	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	bedgar@fhcrc.org; kjkim@u.washington.edu						COLLINS JF, 1962, J GEN MICROBIOL, V28, P15, DOI 10.1099/00221287-28-1-15; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Hall MN, 2004, CELL GROWTH CONTROL; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294	6	12	12	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					158	159		10.1126/science.1177203	http://dx.doi.org/10.1126/science.1177203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589991				2022-12-28	WOS:000267802000033
J	Nadeau, RM; Guilhem, A				Nadeau, Robert M.; Guilhem, Aurelie			Nonvolcanic Tremor Evolution and the San Simeon and Parkfield, California, Earthquakes	SCIENCE			English	Article							28 SEPTEMBER 2004; ANDREAS FAULT; EPISODIC TREMOR; SUBDUCTION; FORESHOCKS; ZONE	Nonvolcanic tremors occur adjacent to locked faults and may be closely related to the generation of earthquakes. Monitoring of the San Andreas Fault in the Parkfield, California, region revealed that after two strong earthquakes, tremor activity increased in a nearly dormant tremor zone, increased and became periodic in a previously active zone, and has remained elevated and periodic for over 4 years. Static shear- and Coulomb-stress increases of 6 to 14 kilopascals from these two earthquakes are coincident with sudden increases in tremor rates. The persistent changes in tremor suggest that stress is now accumulating more rapidly beneath this part of the San Andreas Fault, which ruptured in the moment magnitude 7.8 Ft. Tejon earthquake of 1857.	[Nadeau, Robert M.; Guilhem, Aurelie] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Nadeau, RM (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.		Nadeau, Robert/G-1884-2017	Nadeau, Robert/0000-0003-1255-0643	U.S. Geological Survey [06HQGR0167, 07HQAG0014, 08HQGR0100]; NSF [EAR-0537641, EAR-0544730]; Northern California Earthquake Data Center; University of California Berkeley Seismological Laboratory [09-09]	U.S. Geological Survey(United States Geological Survey); NSF(National Science Foundation (NSF)); Northern California Earthquake Data Center; University of California Berkeley Seismological Laboratory	Supported by the U.S. Geological Survey through awards 06HQGR0167, 07HQAG0014, and 08HQGR0100, and by NSF through awards EAR-0537641 and EAR-0544730. Seismic data are archived at the Northern California Earthquake Data Center. Data processing was done at the University of Californias Berkeley Seismological Laboratory. We thank R. Burgmann and D. S. Dreger for discussions. This is Berkeley Seismological Laboratory contribution 09-09.	Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; GRISCOM A, 1990, 1515 US GEOL SURV; Hiramatsu Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034342; Hirose H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026579; Johnston MJS, 2006, B SEISMOL SOC AM, V96, pS56, DOI 10.1785/0120050822; Kennedy BM, 2007, SCIENCE, V318, P1433, DOI 10.1126/science.1146511; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Langbein J, 2005, SEISMOL RES LETT, V76, P10, DOI 10.1785/gssrl.76.1.10; Liu YJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004930; Meltzner AJ, 1999, B SEISMOL SOC AM, V89, P1109; Miyazawa M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025087; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; NADEEAU R, 2008, EOS S, V89; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Payero JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032877; Peng ZG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036080; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2008, SCIENCE, V319, P186, DOI 10.1126/science.1150558; Rubinstein JL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005875; RYMER MJ, 1984, B SEISMOL SOC AM, V74, P925; Savage JC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005723; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; SHELLY DR, 2009, GEOPHYS RES LETT, V36; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1731; Toppozada TR, 2002, B SEISMOL SOC AM, V92, P2555, DOI 10.1785/0120000614; 2008, 20071437 US GEOL SUR	29	91	92	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					191	193		10.1126/science.1174155	http://dx.doi.org/10.1126/science.1174155			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589999				2022-12-28	WOS:000267802000044
J	Epstein, RM; Peters, E				Epstein, Ronald M.; Peters, Ellen			Beyond Information Exploring Patients' Preferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DECISION-MAKING; HEALTH-CARE; COMMUNICATION		[Epstein, Ronald M.] Univ Rochester, Med Ctr, Dept Family Med, Rochester Ctr Improve Commun Hlth Care, Rochester, NY 14610 USA; [Epstein, Ronald M.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester Ctr Improve Commun Hlth Care, Rochester, NY 14610 USA; [Epstein, Ronald M.] Univ Rochester, Med Ctr, Dept Oncol, Rochester Ctr Improve Commun Hlth Care, Rochester, NY 14610 USA; [Peters, Ellen] Univ Oregon, Eugene, OR 97403 USA	University of Rochester; University of Rochester; University of Rochester; University of Oregon	Epstein, RM (corresponding author), Univ Rochester, Med Ctr, Dept Family Med, Rochester Ctr Improve Commun Hlth Care, 1381 South Ave, Rochester, NY 14610 USA.	ronald_epstein@urmc.rochester.edu						[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Damasio A.R., 2000, FEELING WHAT HAPPENS; Duggan PS, 2006, PATIENT EDUC COUNS, V62, P271, DOI 10.1016/j.pec.2005.08.001; FISCHHOFF B, 2005, HDB ENV EC; Lichtenstein S, 2006, CONSTRUCTION OF PREFERENCE, P1, DOI 10.2277/ 0521542200; Little M, 2008, INTERN MED J, V38, P624, DOI 10.1111/j.1445-5994.2008.01700.x; McCaul KD, 2005, HEALTH PSYCHOL, V24, pS106, DOI 10.1037/0278-6133.24.4.S106; Meegan SP, 2002, INT J BEHAV DEV, V26, P6, DOI 10.1080/01650250143000283; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Rao JK, 2007, MED CARE, V45, P340, DOI 10.1097/01.mlr.0000254516.04961.d5; Silberman J, 2008, J GEN INTERN MED, V23, P1487, DOI 10.1007/s11606-008-0597-x; Thaler RH, 2003, AM ECON REV, V93, P175, DOI 10.1257/000282803321947001; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010	15	195	199	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					195	197		10.1001/jama.2009.984	http://dx.doi.org/10.1001/jama.2009.984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466WU	19584351				2022-12-28	WOS:000267696500031
J	Shintani, F; Izumi, M; Fujimura, N				Shintani, Futoshi; Izumi, Masaki; Fujimura, Naohiro			Neuroleptic malignant syndrome versus malignant disease: idiosyncratic or synchronous?	LANCET			English	Editorial Material									[Shintani, Futoshi; Fujimura, Naohiro] Tokyo Musashino Hosp, Dept Psychiat, Itabashi Ku, Tokyo 1730037, Japan; [Izumi, Masaki] Tokyo Musashino Hosp, Dept Internal Med, Tokyo 1730037, Japan		Shintani, F (corresponding author), Tokyo Musashino Hosp, Dept Psychiat, Itabashi Ku, Komone 4-11-11, Tokyo 1730037, Japan.	f-shintani@tmh.or.jp						Hall R, 2006, CLIN GERIATRICS, V14, P39; McLaren Kimberly D, 2004, Ann Gen Hosp Psychiatry, V3, P7, DOI 10.1186/1475-2832-3-7; Poston GJ, 2005, J CLIN ONCOL, V23, P7125, DOI 10.1200/JCO.2005.08.722; STEIN W, 1982, CLIN CHEM, V28, P19	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					90	90		10.1016/S0140-6736(09)60864-3	http://dx.doi.org/10.1016/S0140-6736(09)60864-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19577697				2022-12-28	WOS:000267768800038
J	Lee, SSJ; Bolnick, DA; Duster, T; Ossorio, P; TallBear, K				Lee, Sandra Soo-Jin; Bolnick, Deborah A.; Duster, Troy; Ossorio, Pilar; TallBear, Kimberly			The Illusive Gold Standard in Genetic Ancestry Testing	SCIENCE			English	Editorial Material									[Lee, Sandra Soo-Jin] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Duster, Troy] New York Univ, Dept Sociol, New York, NY 10012 USA; [Duster, Troy] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; [Ossorio, Pilar] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [TallBear, Kimberly] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Stanford University; University of Texas System; University of Texas Austin; New York University; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Lee, SSJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	sandra.lee@stanford.edu		Lee, Sandra Soo-Jin/0000-0002-2312-9814	NHGRI NIH HHS [P50 HG003389, R01 HG005086] Funding Source: Medline; NHLBI NIH HHS [K01 HL72465] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; *ASHG, 2008, ANC TEST STAT; Bolnick DA, 2007, SCIENCE, V318, P399, DOI 10.1126/science.1150098; Budowle B, 2008, BIOTECHNIQUES, V44, P603, DOI 10.2144/000112806; Burke W, 2008, AM J BIOETHICS, V8, P54, DOI 10.1080/15265160802109488; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Dalton R, 2002, NATURE, V420, P111, DOI 10.1038/420111a; Flack J M, 1999, J Hypertens Suppl, V17, pS19; Goering S, 2008, HASTINGS CENT REP, V38, P43, DOI 10.1353/hcr.2008.0027; Hart S., 2003, INVESTIGATIVE REPORT; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; TALLBEAR K, NATIVE AM D IN PRESS; WINICKOFF D, 2008, 68 CTR STUD LAW SOC; Wiwchar D., 2004, HA SHILTH SA NEWSL, V31, P1	16	49	49	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					38	39		10.1126/science.1173038	http://dx.doi.org/10.1126/science.1173038			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574373				2022-12-28	WOS:000267594000022
J	Webby, CJ; Wolf, A; Gromak, N; Dreger, M; Kramer, H; Kessler, B; Nielsen, ML; Schmitz, C; Butler, DS; Yates, JR; Delahunty, CM; Hahn, P; Lengeling, A; Mann, M; Proudfoot, NJ; Schofield, CJ; Bottger, A				Webby, Celia J.; Wolf, Alexander; Gromak, Natalia; Dreger, Mathias; Kramer, Holger; Kessler, Benedikt; Nielsen, Michael L.; Schmitz, Corinna; Butler, Danica S.; Yates, John R., III; Delahunty, Claire M.; Hahn, Phillip; Lengeling, Andreas; Mann, Matthias; Proudfoot, Nicholas J.; Schofield, Christopher J.; Boettger, Angelika			Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing	SCIENCE			English	Article							PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; NUCLEAR-PROTEIN; CLEARANCE	The finding that the metazoan hypoxic response is regulated by oxygen-dependent posttranslational hydroxylations, which regulate the activity and lifetime of hypoxia-inducible factor (HIF), has raised the question of whether other hydroxylases are involved in the regulation of gene expression. We reveal that the splicing factor U2 small nuclear ribonucleoprotein auxiliary factor 65-kilodalton subunit (U2AF65) undergoes posttranslational lysyl-5-hydroxylation catalyzed by the Fe(II) and 2-oxoglutarate-dependent dioxygenase Jumonji domain-6 protein (Jmjd6). Jmjd6 is a nuclear protein that has an important role in vertebrate development and is a human homolog of the HIF asparaginyl-hydroxylase. Jmjd6 is shown to change alternative RNA splicing of some, but not all, of the endogenous and reporter genes, supporting a specific role for Jmjd6 in the regulation of RNA splicing.	[Webby, Celia J.; Butler, Danica S.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Webby, Celia J.; Butler, Danica S.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Wolf, Alexander; Schmitz, Corinna; Boettger, Angelika] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Gromak, Natalia; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Dreger, Mathias] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Kramer, Holger; Kessler, Benedikt] Univ Oxford, Oxford OX3 7BN, England; [Nielsen, Michael L.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Yates, John R., III; Delahunty, Claire M.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Hahn, Phillip; Lengeling, Andreas] Helmholtz Ctr Infect Res, Res Grp Infect Genet, D-38124 Braunschweig, Germany; [Lengeling, Andreas] Univ Edinburgh, Roslin Inst, EBVC, Roslin EH25 9RG, Midlothian, Scotland; [Lengeling, Andreas] Univ Edinburgh, Royal Dick Sch Vet Studies, EBVC, Roslin EH25 9RG, Midlothian, Scotland	University of Oxford; University of Oxford; University of Munich; University of Oxford; University of Oxford; University of Oxford; Max Planck Society; Scripps Research Institute; Helmholtz Association; Helmholtz-Center for Infection Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; boettger@zi.biologie.uni-muenchen.de	Gromak, Natalia/F-6475-2014; Nielsen, Michael/C-4418-2008; Wolf, Alexander/K-2178-2013; Hahn, Phillip/A-4812-2012; Kramer, Holger/AAL-4433-2020; Hu, Ruogu/B-2203-2008; Kessler, Benedikt/AAY-8614-2021; Mann, Matthias/A-3454-2013	Hahn, Phillip/0000-0002-8741-3603; Kramer, Holger/0000-0002-6400-0945; Kessler, Benedikt/0000-0002-8160-2446; Mann, Matthias/0000-0003-1292-4799; Wolf, Alexander/0000-0003-0649-3363; Bottger, Angelika/0000-0003-3273-9558; Gromak, Natalia/0000-0002-4158-3586; Dreger, Mathias/0000-0002-0453-6414; Proudfoot, Nicholas/0000-0001-8646-3222; Nielsen, Michael/0000-0002-0067-9039; Schofield, Christopher/0000-0002-0290-6565	Glasstone Fellowship; Deutsche Forschungsgemeinschaft [BO1748-3, LE2130/2-1]; UK Biotechnology and Biological Sciences Research Council; European Union; Wellcome Trust; BBSRC [BB/D011523/1] Funding Source: UKRI; MRC [G9826944] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; Medical Research Council [G9826944] Funding Source: researchfish	Glasstone Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Glasstone Fellowship (to C.W.), Deutsche Forschungsgemeinschaft grants BO1748-3 awarded to A.B. and LE2130/2-1 awarded to A.L., the UK Biotechnology and Biological Sciences Research Council, the European Union, and the Wellcome Trust (to N.P.R.). C.J.S is a cofounder of ReOx.	Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gromak N, 2002, NUCLEIC ACIDS RES, V30, P3548, DOI 10.1093/nar/gkf480; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Nishii Y, 2000, FEBS LETT, V465, P153, DOI 10.1016/S0014-5793(99)01744-5; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, GENE DEV, V14, P1983; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolf A, 2007, EMBO REP, V8, P465, DOI 10.1038/sj.embor.7400956; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	18	301	312	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					90	93		10.1126/science.1175865	http://dx.doi.org/10.1126/science.1175865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574390	Green Submitted			2022-12-28	WOS:000267594000042
J	Ahlberg, P; Trinajstic, K; Johanson, Z; Long, J				Ahlberg, Per; Trinajstic, Kate; Johanson, Zerina; Long, John			Pelvic claspers confirm chondrichthyan-like internal fertilization in arthrodires	NATURE			English	Article								Recent finds(1,2) demonstrate that internal fertilization and viviparity (live birth) were more widespread in the Placodermi, an extinct group of armoured fishes, than was previously realized. Placoderms represent the sister group of the crown group jawed vertebrates (Gnathostomata)(3,4), making their mode(s) of reproduction potentially informative about primitive gnathostome conditions. An ossified pelvic fin basipterygium discovered in the arthrodire Incisoscutum ritchiei was hypothesized to be identical in males and females, with males presumed to have an additional cartilaginous element or series forming a clasper. Here we report the discovery of a completely ossified pelvic clasper in Incisoscutum ritchiei (WAM 03.3.28) which shows that this interpretation was incorrect: the basipterygium described previously(1) is in fact unique to females. The male clasper is a slender rod attached to a square basal plate that articulates directly with the pelvis. It carries a small cap of dermal bone covered in denticles and small hooks that may be homologous with the much larger dermal component of the ptyctodont clasper.	[Trinajstic, Kate] Curtin Univ, Dept Appl Chem, Western Australian Organ & Isotope Geochem Ctr, Perth, WA 6102, Australia; [Ahlberg, Per] Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; [Trinajstic, Kate] Western Australian Museum, Perth, WA 6000, Australia; [Trinajstic, Kate] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia; [Johanson, Zerina] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Long, John] Museum Victoria, Melbourne, Vic 3001, Australia; [Long, John] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2600, Australia; [Long, John] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	Curtin University; Uppsala University; Western Australian Museum; University of Western Australia; Natural History Museum London; Museum Victoria; Australian National University; Monash University	Trinajstic, K (corresponding author), Curtin Univ, Dept Appl Chem, Western Australian Organ & Isotope Geochem Ctr, Perth, WA 6102, Australia.	ktrinajs@bigpond.net.au	Ahlberg, Per/E-8086-2013; Trinajstic, Kate/B-2537-2009	Trinajstic, Kate/0000-0002-6519-6396; Long, John/0000-0001-8012-0114; Johanson, Zerina/0000-0002-8444-6776; Ahlberg, Per/0000-0001-9054-2900	Australian Research Council Discovery grants; Australian Geographic grant; Swedish Research Council	Australian Research Council Discovery grants(Australian Research Council); Australian Geographic grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank M. Siverson for access to specimens at the Western Australian Museum. J. L. and K. T. are supported by Australian Research Council Discovery grants, and field work at Gogo in 2001 was supported by an Australian Geographic grant. P. A. is supported by the Swedish Research Council. K. Bifield prepared the specimen.	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; MILES ROGER S., 1967, J LINN SOC ZOOL, V47, P99; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	7	32	34	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					888	889		10.1038/nature08176	http://dx.doi.org/10.1038/nature08176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19597477				2022-12-28	WOS:000268938300037
J	Shi, JX; Levinson, DF; Duan, JB; Sanders, AR; Zheng, YL; Pe'er, I; Dudbridge, F; Holmans, PA; Whittemore, AS; Mowry, BJ; Olincy, A; Amin, F; Cloninger, CR; Silverman, JM; Buccola, NG; Byerley, WF; Black, DW; Crowe, RR; Oksenberg, JR; Mirel, DB; Kendler, KS; Freedman, R; Gejman, PV				Shi, Jianxin; Levinson, Douglas F.; Duan, Jubao; Sanders, Alan R.; Zheng, Yonglan; Pe'er, Itsik; Dudbridge, Frank; Holmans, Peter A.; Whittemore, Alice S.; Mowry, Bryan J.; Olincy, Ann; Amin, Farooq; Cloninger, C. Robert; Silverman, Jeremy M.; Buccola, Nancy G.; Byerley, William F.; Black, Donald W.; Crowe, Raymond R.; Oksenberg, Jorge R.; Mirel, Daniel B.; Kendler, Kenneth S.; Freedman, Robert; Gejman, Pablo V.			Common variants on chromosome 6p22.1 are associated with schizophrenia	NATURE			English	Article							GENETICS	Schizophrenia, a devastating psychiatric disorder, has a prevalence of 0.5-1%, with high heritability (80-85%) and complex transmission(1). Recent studies implicate rare, large, high-penetrance copy number variants in some cases(2), but the genes or biological mechanisms that underlie susceptibility are not known. Here we show that schizophrenia is significantly associated with single nucleotide polymorphisms (SNPs) in the extended major histocompatibility complex region on chromosome 6. We carried out a genome-wide association study of common SNPs in the Molecular Genetics of Schizophrenia (MGS) case-control sample, and then a meta-analysis of data from the MGS, International Schizophrenia Consortium and SGENE data sets. No MGS finding achieved genome-wide statistical significance. In the meta-analysis of European-ancestry subjects (8,008 cases, 19,077 controls), significant association with schizophrenia was observed in a region of linkage disequilibrium on chromosome 6p22.1 (P = 9.54 x 10(-9)). This region includes a histone gene cluster and several immunity-related genes-possibly implicating aetiological mechanisms involving chromatin modification, transcriptional regulation, autoimmunity and/or infection. These results demonstrate that common schizophrenia susceptibility alleles can be detected. The characterization of these signals will suggest important directions for research on susceptibility mechanisms.	[Duan, Jubao; Sanders, Alan R.; Zheng, Yonglan; Gejman, Pablo V.] NorthShore Univ HealthSyst, Res Inst, Ctr Psychiat Genet, Evanston, IL 60201 USA; [Shi, Jianxin; Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Dudbridge, Frank] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2SR, England; [Holmans, Peter A.] MRC, Ctr Neuropsychiat Genet & Genom, Dept Psychol Med & Neurol, Sch Med, Cardiff CF23 6BQ, Wales; [Whittemore, Alice S.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94304 USA; [Mowry, Bryan J.] Queensland Ctr Mental Hlth Res, Brisbane, Qld 4072, Australia; [Mowry, Bryan J.] Queensland Inst Med Res, Brisbane, Qld 4072, Australia; [Olincy, Ann; Freedman, Robert] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Amin, Farooq] Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Amin, Farooq] Emory Univ, Atlanta, GA 30322 USA; [Cloninger, C. Robert] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Silverman, Jeremy M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Buccola, Nancy G.] Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA 70112 USA; [Byerley, William F.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Black, Donald W.; Crowe, Raymond R.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Black, Donald W.; Crowe, Raymond R.] Univ Iowa, Carver Coll Med, Mental Hlth Clin Res Ctr, Iowa City, IA 52242 USA; [Oksenberg, Jorge R.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Mirel, Daniel B.] MIT, Broad Inst, Ctr Genotyping & Anal, Cambridge, MA 02142 USA; [Mirel, Daniel B.] Harvard Univ, Cambridge, MA 02142 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23298 USA	NorthShore University Health System; Stanford University; Columbia University; MRC Biostatistics Unit; University of Cambridge; Stanford University; Queensland Centre for Mental Health Research; QIMR Berghofer Medical Research Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; University of Iowa; University of Iowa; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Virginia Commonwealth University; Virginia Commonwealth University	Gejman, PV (corresponding author), NorthShore Univ HealthSyst, Res Inst, Ctr Psychiat Genet, Evanston, IL 60201 USA.	pgejman@mac.com	Kendler, Kenneth/AAF-2876-2019; Holmans, Peter/F-4518-2015; Zheng, Yonglan/O-4112-2019; Silverman, Jeremy M./AAO-4268-2020; Cloninger, Claude/F-5357-2012; Zheng, Yonglan/C-4236-2011; Mowry, Bryan/G-5046-2010	Holmans, Peter/0000-0003-0870-9412; Zheng, Yonglan/0000-0001-6597-7072; Cloninger, Claude/0000-0003-3096-4807; Buccola, Nancy/0000-0003-1378-4636; Mowry, Bryan/0000-0002-4115-5645; Black, Donald/0000-0001-8038-1971; Freedman, Robert/0000-0002-2181-2898; Dudbridge, Frank/0000-0002-8817-8908	National Institute of Mental Health (USA); National Alliance for Research on Schizophrenia and Depression; Genetic Association Information Network (GAIN); Paul Michael Donovan Charitable Foundation; National Center for Research Resources (USA); NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067257, R01MH059587, U01MH046289, U01MH079470, R01MH061675, R01MH060870, R01MH060879, R01MH059588, U01MH046276, R01MH059565, U01MH079469, R01MH059566, R01MH081800, R01MH059586, R01MH059571, U01MH046318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037132] Funding Source: NIH RePORTER; Medical Research Council [G0801418, MC_U105292688] Funding Source: researchfish; MRC [MC_U105292688, G0801418] Funding Source: UKRI	National Institute of Mental Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Genetic Association Information Network (GAIN); Paul Michael Donovan Charitable Foundation; National Center for Research Resources (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the study participants, and the research staff at the study sites. This study was supported by funding from the National Institute of Mental Health (USA) and the National Alliance for Research on Schizophrenia and Depression. Genotyping of part of the sample was supported by the Genetic Association Information Network (GAIN), and by The Paul Michael Donovan Charitable Foundation. Genotyping was carried out by the Center for Genotyping and Analysis at the Broad Institute of Harvard and MIT with support from the National Center for Research Resources (USA). The GAIN quality control team (G. R. Abecasis and J. Paschall) made important contributions to the project. Wethank S. Purcell for assistance with PLINK.	Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Costa E, 2007, EPIGENETICS-US, V2, P29; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; Malcherek G, 2007, J IMMUNOL, V179, P3804, DOI 10.4049/jimmunol.179.6.3804; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Wassink TH, 2005, AM J MED GENET B, V136B, P36, DOI 10.1002/ajmg.b.30180	12	851	894	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					753	757		10.1038/nature08192	http://dx.doi.org/10.1038/nature08192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19571809	Green Accepted			2022-12-28	WOS:000268670300042
J	Tsang, V; Yacoub, M; Sridharan, S; Burch, M; Radley-Smith, R; Khaghani, A; Savoldo, B; Amrolia, PJ				Tsang, V.; Yacoub, M.; Sridharan, S.; Burch, M.; Radley-Smith, R.; Khaghani, A.; Savoldo, B.; Amrolia, P. J.			Late donor cardiectomy after paediatric heterotopic cardiac transplantation	LANCET			English	Article							POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; CYTOTOXIC T-CELLS; BARR-VIRUS EBV; HEART-TRANSPLANTATION; RECIPIENTS; DISORDER; CARDIOMYOPATHY; INFUSION; THERAPY; CHEMOTHERAPY	Background Cardiac transplantation is a life-saving procedure in infants and children with advanced cardiomyopathy. However, it is greatly limited by shortage of paediatric donors and the complications of long-term immunosuppression, including post-transplant lymphoproliferative disorder (PTLD). We report the management of an infant who had heterotopic cardiac transplantation for advanced cardiomyopathy with secondary pulmonary hypertension who developed seemingly incurable PTLD. Methods An 8-month-old girl presented in 1994 with signs of severe heart failure, secondary to dilated cardiomyopathy. At age 11 months, the patient underwent a heterotopic cardiac transplantation. Findings The patient developed many episodes of PTLD associated with Epstein-Barr virus infection that were resistant to several therapies, including reduction of immunosuppression. Native heart recovery enabled removal of the donor heart 10.5 years after the original operation to allow complete cessation of immunosuppression. Her postoperative course was uncomplicated and the outcome was excellent. 3.5 years after surgery, the patient remains well, in complete remission from her PTLD, and has normal cardiac function. Interpretation This case shows several issues relating to the use of heterotopic cardiac transplantation in infants and the capacity of the heart to recover. It also provides new insights into the interaction between the immune system with several aspects of modem management of post-transplantation PTLD.	[Yacoub, M.] Univ London Imperial Coll Sci Technol & Med, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Tsang, V.] Great Ormond St Hosp Sick Children, Dept Cardiothorac Surg, London, England; [Sridharan, S.; Burch, M.; Radley-Smith, R.] Great Ormond St Hosp Sick Children, Dept Cardiol, London, England; [Amrolia, P. J.] Great Ormond St Hosp Sick Children, Dept Haematol, London, England; [Amrolia, P. J.] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England; [Savoldo, B.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Baylor College of Medicine	Yacoub, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Heart Sci Ctr, Harefield UB9 6JH, Middx, England.	m.yacoub@imperial.ac.uk		Sridharan, Shankar/0000-0002-3159-8557				Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Buell JF, 2005, TRANSPL P, V37, P956, DOI 10.1016/j.transproceed.2004.12.124; Choquet S, 2006, BLOOD, V107, P3053, DOI 10.1182/blood-2005-01-0377; Comoli P, 2002, BLOOD, V99, P2592, DOI 10.1182/blood.V99.7.2592; Curfman GD, 2008, NEW ENGL J MED, V359, P749, DOI 10.1056/NEJMe0805480; Dandel M, 2005, CIRCULATION, V112, pI37, DOI 10.1161/CIRCULATIONAHA.104.525352; Dotti G, 2002, TRANSPLANTATION, V74, P1095, DOI 10.1097/00007890-200210270-00007; Frazier OH, 1999, ANN THORAC SURG, V68, P734, DOI 10.1016/S0003-4975(99)00801-2; Gao SZ, 2003, J HEART LUNG TRANSPL, V22, P505, DOI 10.1016/S1053-2498(02)01229-9; Gross TG, 2005, J CLIN ONCOL, V23, P6481, DOI 10.1200/JCO.2005.08.074; Gustafsson A, 2000, BLOOD, V95, P807, DOI 10.1182/blood.V95.3.807.003k24_807_814; Haddad E, 2001, BLOOD, V97, P1590, DOI 10.1182/blood.V97.6.1590; Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008; Hayashi RJ, 2001, J PEDIAT HEMATOL ONC, V23, P14, DOI 10.1097/00043426-200101000-00005; Khaghani A, 1997, J THORAC CARDIOV SUR, V113, P1042, DOI 10.1016/S0022-5223(97)70291-5; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Maloney DG, 2001, ANTI-CANCER DRUG, V12, pS1; Milpied N, 2000, ANN ONCOL, V11, P113, DOI 10.1023/A:1008372814223; MORRISTHURGOOD J, 1994, CIRCULATION, V90, P2342, DOI 10.1161/01.CIR.90.5.2342; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Pinkerton CR, 2002, BRIT J HAEMATOL, V118, P456, DOI 10.1046/j.1365-2141.2002.03681.x; Rickinson AB, 1996, CURR OPIN IMMUNOL, V8, P492, DOI 10.1016/S0952-7915(96)80036-7; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Savoldo B, 2001, TRANSPLANTATION, V72, P1078, DOI 10.1097/00007890-200109270-00017; Savoldo B, 2006, BLOOD, V108, P2942, DOI 10.1182/blood-2006-05-021782; SAWADA S, 1987, J IMMUNOL, V139, P1797; Smith RR, 2005, EUR J CARDIO-THORAC, V27, P790, DOI 10.1016/j.ejcts.2004.12.058; Strauss A, 2003, NEW ENGL J MED, V348, P1703, DOI 10.1056/NEJMe030027; Suryanarayan K, 2001, J PEDIAT HEMATOL ONC, V23, P452, DOI 10.1097/00043426-200110000-00012; SWINNEN LJ, 1995, BLOOD, V86, P3333, DOI 10.1182/blood.V86.9.3333.bloodjournal8693333; Webber SA, 2006, LANCET, V367, P233, DOI 10.1016/S0140-6736(06)67933-6; Yacoub M, 2008, AM J TRANSPLANT, V8, P1767, DOI 10.1111/j.1600-6143.2008.02366.x; Yacoub MH, 2001, EUR HEART J, V22, P534, DOI 10.1053/euhj.2001.2613	34	17	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					387	392		10.1016/S0140-6736(09)61201-0	http://dx.doi.org/10.1016/S0140-6736(09)61201-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19604574				2022-12-28	WOS:000268815200022
J	Cruickshank, M; Murray, G; Parkin, D; Smart, L; Walker, E; Waugh, N; Avis, M; Chilvers, C; Fielding, K; Hammond, R; Jenkins, D; Johnson, J; Neal, K; Russell, I; Seth, R; Whynes, D; Duncan, I; Robertson, A; Little, J; Sharp, L; Russell, I; Walker, L; Anthony, B; Bell, S; Bowie, A; Brown, K; Brown, J; Chew, K; Cochran, C; Cotton, S; Dean, J; Dunn, K; Edwards, J; Evans, D; Fenty, J; Finlayson, A; Gallagher, M; Gray, N; Heddle, M; Innes, A; Jobson, D; Keillor, M; MacGregor, J; Mackenzie, S; Mackie, A; McPherson, G; Okorocha, I; Reilly, M; Rodgers, J; Thornton, A; Yeats, R; Alexander, L; Buchanan, L; Henderson, S; Iterbeke, T; Lucas, S; Manderson, G; Nicol, S; Reid, G; Robinson, C; Sandilands, T; Adrian, M; Al-Sahab, A; Bentley, E; Brook, H; Bushby, C; Cannon, R; Cooper, B; Dowell, R; Dunderdale, M; Guo, L; Heideman, L; Jones, S; Lawson, S; Philips, Z; Platt, C; Prabhakaran, S; Rippin, J; Thompson, R; Williams, E; Woolley, C; Boroujerdi, M; Cotton, S; Harrild, K; Norrie, J; Day, N; Marteau, T; Parmar, M; Patnick, J; Woodman, C; Altman, D; Moss, S; Wells, M; Little, J; Sharp, L; Cotton, S; Cruickshank, M; Duncan, I; Harrild, K; Jenkins, D; Smart, L; Waugh, N; Cochran, C; Gray, N; Hammond, R; Neal, K; Thornton, A; Woolley, C				Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman; Avis, Mark; Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave; Duncan, Ian; Robertson, Alistair; Little, Julian; Sharp, Linda; Russell, Ian; Walker, Leslie; Anthony, Breda; Bell, Sarah; Bowie, Adrienne; Brown, Katrina; Brown, Joe; Chew, Kheng; Cochran, Claire; Cotton, Seonaidh; Dean, Jeannie; Dunn, Kate; Edwards, Jane; Evans, David; Fenty, Julie; Finlayson, Al; Gallagher, Marie; Gray, Nicola; Heddle, Maureen; Innes, Alison; Jobson, Debbie; Keillor, Mandy; MacGregor, Jayne; Mackenzie, Sheona; Mackie, Amanda; McPherson, Gladys; Okorocha, Ike; Reilly, Morag; Rodgers, Joan; Thornton, Alison; Yeats, Rachel; Alexander, Lindyanne; Buchanan, Lindsey; Henderson, Susan; Iterbeke, Tine; Lucas, Susanneke; Manderson, Gillian; Nicol, Sheila; Reid, Gael; Robinson, Carol; Sandilands, Trish; Adrian, Marg; Al-Sahab, Ahmed; Bentley, Elaine; Brook, Hazel; Bushby, Claire; Cannon, Rita; Cooper, Brenda; Dowell, Ruth; Dunderdale, Mark; Guo, Li; Heideman, Lisa; Jones, Steve; Lawson, Salli; Philips, Zoe; Platt, Christopher; Prabhakaran, Shakuntala; Rippin, John; Thompson, Rose; Williams, Elizabeth; Woolley, Claire; Boroujerdi, Massoud; Cotton, Seonaidh; Harrild, Kirsten; Norrie, John; Day, Nicholas; Marteau, Theresa; Parmar, Mahesh; Patnick, Julietta; Woodman, Ciaran; Altman, Doug; Moss, Sue; Wells, Michael; Little, Julian; Sharp, Linda; Cotton, Seonaidh; Cruickshank, Maggie; Duncan, Ian; Harrild, Kirsten; Jenkins, David; Smart, Louise; Waugh, Norman; Cochran, Claire; Gray, Nicola; Hammond, Rob; Neal, Keith; Thornton, Alison; Woolley, Claire		TOMBOLA Grp	Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-PAPILLOMAVIRUS; FOLLOW-UP; CANCER; MILD; PARTICIPATION; BORDERLINE; SMEAR; RISK; AGE; METAANALYSIS	Objectives To examine the effectiveness of cytological surveillance in primary care compared with immediate referral for colposcopic examination in women with low grade abnormal results on cervical cytology tests. Design Multicentre individually randomised controlled trial. Setting NHS cervical screening programmes in Grampian, Tayside, and Nottingham. Participants 4439 women, aged 20-59, with a cytology result showing borderline nuclear abnormalities or mild dyskaryosis, October 1999-October 2002. Interventions Cytological screening every six months in primary care (n=2223) or referral for colposcopy and related interventions (n=2216). All women were followed for three years, concluding with an exit appointment at which colposcopic examination was undertaken. Colposcopists assessing outcome at this appointment were blinded to randomisation. Main outcome measures Primary end point: cumulative incidence of cervical intraepithelial neoplasia grade II or more severe disease. Other end points: cervical intraepithelial neoplasia grade III or worse, clinically significant anxiety and depression, other self reported after effects, and rates of non-attendance. Analysis was by intention to treat; all those randomised were included. Results The cumulative incidence of cervical intraepithelial neoplasia grade II or worse was 79 per 1000 person years in the colposcopy arm and 58 per 1000 person years in the cytological surveillance arm (relative risk 1.37, 95% confidence interval 1.19 to 1.57). This difference was less marked for cervical intraepithelial neoplasia grade III or more severe disease, but the incidence was still higher in the colposcopy arm (relative risk 1.26, 1.04 to 1.53). Among women randomised to immediate colposcopy, 79% (74.9% to 82.5%) of cases of cervical intraepithelial neoplasia grade II or worse were diagnosed at the time of the immediate colposcopy, while among women randomised to cytological surveillance, 77% (72.1% to 81.2%) of cases were detected by surveillance cytology and related interventions. Similar proportions of women were anxious or depressed in the two arms. A higher proportion of women in the colposcopy arm reported after effects, and these were of longer duration and more severe. Non-attendance was low in both arms. Conclusion The more marked difference between the arms in the occurrence of cervical intraepithelial neoplasia grade II or worse than in the occurrence of grade III or worse can probably be accounted for by the spontaneous regression of some cases of grade II neoplasia. Compared with cytological surveillance, a policy of immediate colposcopy detects more cervical intraepithelial neoplasia grade II or worse, and some more grade III or worse, but might lead to overtreatment. Such a policy is associated with a higher rate of reported after effects, which are more severe and of longer duration than those associated with cytological surveillance.	[Cruickshank, Maggie; Murray, Graeme; Parkin, David; Smart, Louise; Walker, Eric; Waugh, Norman] Univ Aberdeen & NHS Grampian, Aberdeen, Scotland; [Avis, Mark; Chilvers, Claire; Fielding, Katherine; Hammond, Rob; Jenkins, David; Johnson, Jane; Neal, Keith; Russell, Ian; Seth, Rashmi; Whynes, Dave] Univ Nottingham & Nottingham NHS, Nottingham, England; [Duncan, Ian; Robertson, Alistair] Univ Dundee & NHS Tayside, Dundee, Tayside, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Sharp, Linda] Natl Canc Registry, Cork, Ireland; [Russell, Ian] Bangor Univ, Bangor, Gwynedd, Wales; [Walker, Leslie] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Aberdeen; University of Nottingham; University of Dundee; University of Ottawa; Bangor University; University of Hull	Little, J (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jlittle@uottawa.ca	Russell, Ian T/H-1181-2012; Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Cochran, Claire/0000-0001-7349-7685; Marteau, Theresa/0000-0003-3025-1129; Cruickshank, Margaret/0000-0002-8893-8620	Medical Research Council [G9700808]; NHS in England and Scotland; Chief Scientist Office [HSRU1] Funding Source: researchfish; MRC [G9700808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS in England and Scotland; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Council (grant No G9700808) and the NHS in England and Scotland. The MRC had no role in design, data collection, analysis, interpretation, or the writing of the report.	[Anonymous], 2001, LANCET, V358, P853; Bentley Elaine, 2006, J Low Genit Tract Dis, V10, P26, DOI 10.1097/01.lgt.0000192695.93172.75; BOSCH FX, 2005, 22 NHS CANC SCREEN; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P677, DOI 10.1158/1055-9965.EPI-04-0569; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Cotton SC, 2006, CONTEMP CLIN TRIALS, V27, P449, DOI 10.1016/j.cct.2006.04.001; Cruickshank M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2548; Cruickshank M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2549; DUNCAN ID, 1997, NHSCSP PUBLICATION, V8; Dunn TS, 2004, J REPROD MED, V49, P76; EGGINGTON S, 2006, NHSCSP PUBLICATION, V24; Etherington LJ, 1997, BRIT J OBSTET GYNAEC, V104, P1380, DOI 10.1111/j.1471-0528.1997.tb11007.x; Fayers P., 2007, QUALITY LIFE ASSESSM; Ferris DG, 1997, ARCH FAM MED, V6, P348, DOI 10.1001/archfami.6.4.348; FLANNELLY G, 1994, BRIT MED J, V308, P1399, DOI 10.1136/bmj.308.6941.1399; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; GAIL MH, 1985, CANCER TREAT REP, V69, P1107; Giannopoulos T, 2005, CYTOPATHOLOGY, V16, P277, DOI 10.1111/j.1365-2303.2005.00301.x; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; JOHNSON N, 1993, LANCET, V342, P91, DOI 10.1016/0140-6736(93)91290-3; JONES MH, 1992, LANCET, V339, P1440, DOI 10.1016/0140-6736(92)92031-A; Jones MH, 1996, J ROY SOC MED, V89, P257, DOI 10.1177/014107689608900506; Kitchener HC, 2004, BJOG-INT J OBSTET GY, V111, P63, DOI 10.1046/j.1471-0528.2003.00007.x; Kyrgiou M, 2007, CANCER TREAT REV, V33, P514, DOI 10.1016/j.ctrv.2007.05.002; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lester H, 1999, BRIT J GEN PRACT, V49, P223; Liu S, 2001, INT J GYNECOL CANCER, V11, P24, DOI 10.1046/j.1525-1438.2001.011001024.x; Lopes A., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P197, DOI 10.3109/01443619409004075; LUESLEY D, 2004, NHSCSP PUBLICATION, V20; MARTEAU TM, 1994, BRIT J CLIN PSYCHOL, V33, P1; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Melnikow J, 2002, J FAM PRACTICE, V51, P849; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Moss S, 2006, BRIT MED J, V332, P83, DOI 10.1136/bmj.38701.440961.7C; Olson SH, 2001, AM J EPIDEMIOL, V154, P574, DOI 10.1093/aje/154.6.574; Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Raffle AE, 2004, BRIT MED J, V328, P1272, DOI 10.1136/bmj.328.7451.1272; Raffle AE, 2003, BRIT MED J, V326, P901, DOI 10.1136/bmj.326.7395.901; Raffle AE, 2007, SCREENING EVIDENCE P; Rana DN, 2004, CYTOPATHOLOGY, V15, P263, DOI 10.1111/j.1365-2303.2004.00194.x; Scheungraber C, 2004, BRIT J CANCER, V90, P975, DOI 10.1038/sj.bjc.6601415; Shafi MI, 1997, BRIT J OBSTET GYNAEC, V104, P590, DOI 10.1111/j.1471-0528.1997.tb11538.x; Sharp L, 2006, CLIN TRIALS, V3, P431, DOI 10.1177/1740774506070812; Shiffman M, 2008, LANCET ONCOL, V9, P404, DOI 10.1016/S1470-2045(08)70110-4; Smith MCG, 2006, BJOG-INT J OBSTET GY, V113, P1321, DOI 10.1111/j.1471-0528.2006.01065.x; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Taylor RJ, 2001, J EPIDEMIOL COMMUN H, V55, P782, DOI 10.1136/jech.55.11.782; *TOMBOLA GROUP, BJOG IN PRESS; Vizcaino AP, 2000, INT J CANCER, V86, P429, DOI 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D; Winn CM, 2005, CYTOPATHOLOGY, V16, P281, DOI 10.1111/j.1365-2303.2005.00306.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	53	53	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2009	339								b2546	10.1136/bmj.b2546	http://dx.doi.org/10.1136/bmj.b2546			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PG	19638646	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000268672800001
J	Wenzel, V; Lindner, KH				Wenzel, Volker; Lindner, Karl H.			Best pharmacological practice in prehospital intubation	LANCET			English	Editorial Material							VASOPRESSIN; IMPACT		[Wenzel, Volker; Lindner, Karl H.] Innsbruck Med Univ, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Wenzel, V (corresponding author), Innsbruck Med Univ, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria.	volker.wenzel@uki.at						*ASS AN GREAT BRIT, 2009, AAGBI SAF GUID PREH; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Feneck RO, 2008, ANAESTHESIA, V63, P270, DOI 10.1111/j.1365-2044.2008.05475.x; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Mort TC, 2005, CRIT CARE MED, V33, P2672, DOI 10.1097/01.CCM.0000187131.67594.9E; Schwarz S, 2007, DEUT MED WOCHENSCHR, V132, P108, DOI 10.1055/s-2007-959298; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431	15	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					267	268		10.1016/S0140-6736(09)61071-0	http://dx.doi.org/10.1016/S0140-6736(09)61071-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19573905				2022-12-28	WOS:000268508200004
J	Jasny, BR; Zahn, LM; Marshall, E				Jasny, Barbara R.; Zahn, Laura M.; Marshall, Eliot			Connections INTRODUCTION	SCIENCE			English	Editorial Material																			0	27	30	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					405	405		10.1126/science.325_405	http://dx.doi.org/10.1126/science.325_405			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628849				2022-12-28	WOS:000268255100033
J	Vukusic, P				Vukusic, Pete			Evolutionary Photonics with a Twist	SCIENCE			English	Editorial Material									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	p.vukusic@ex.ac.uk			Biotechnology and Biological Sciences Research Council [JF16983, BB/E000177/1] Funding Source: Medline; BBSRC [BB/E000177/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bouligand Y., 1969, J PHYS C SOLID STATE, V30, pC4, DOI [10.1051/jphyscol:1969424, DOI 10.1051/JPHYSCOL:1969424]; CAVENEY S, 1971, PROC R SOC SER B-BIO, V178, P205, DOI 10.1098/rspb.1971.0062; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; DENTON E, 1971, SCI AM, V224, P64, DOI 10.1038/scientificamerican0171-64; GHIRADELLA H, 1989, J MORPHOL, V202, P69, DOI 10.1002/jmor.1052020106; Hill G. E., 2006, BIRD COLORATION, V1; Jewell SA, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/099; Meister R, 1996, PHYS REV E, V54, P3771, DOI 10.1103/PhysRevE.54.3771; Michelson AA, 1911, PHILOS MAG, V21, P554, DOI 10.1080/14786440408637061; NEVILLE A C, 1985, P99; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152; Pedrotti F. L., 1993, INTRO OPTICS; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941	15	35	35	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					398	399		10.1126/science.1177729	http://dx.doi.org/10.1126/science.1177729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628844				2022-12-28	WOS:000268255100028
J	Fuccio, L; Zagari, RM; Eusebi, LH; Laterza, L; Cennamo, V; Ceroni, L; Grilli, D; Bazzoli, F				Fuccio, Lorenzo; Zagari, Rocco Maurizio; Eusebi, Leonardo Henry; Laterza, Liboria; Cennamo, Vincenzo; Ceroni, Liza; Grilli, Diego; Bazzoli, Franco			Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?	ANNALS OF INTERNAL MEDICINE			English	Review							FOLLOW-UP; INTESTINAL METAPLASIA; PATHOLOGICAL-CHANGES; RANDOMIZED-TRIAL; STOMACH-CANCER; DOUBLE-BLIND; POPULATION; STATISTICS; PREVENTION; INFECTION	Background: Helicobacter pylori infection is associated with gastric cancer, but the effect of eradication treatment on gastric cancer risk is not well defined. Purpose: To determine whether H. pylori eradication treatment can reduce the risk for gastric cancer. Data Sources: PubMed, EMBASE, Cochrane Library, Google Scholar, and online clinical trial registers through 31 January 2009, without language restrictions. Study Selection: Randomized trials that compared eradication treatment with no treatment in H. pylori-positive patients and that assessed gastric cancer or progression of preneoplastic lesions during follow-up. Data Extraction: Two authors independently reviewed articles and extracted data. Data Synthesis: Seven studies met inclusion criteria, 1 of which was excluded from pooled analysis because of clinical and methodological heterogeneity. All studies were performed in areas with high incidence of gastric cancer, mostly in Asia. Overall, 37 of 3388 (1.1%) treated patients developed gastric cancer compared with 56 of 3307 (1.7%) untreated (control) participants. In a pooled analysis of 6 studies with a total of 6695 participants followed from 4 to 10 years, the relative risk for gastric cancer was 0.65 (95% CI, 0.43 to 0.98). Limitations: All studies but 1 were performed in Asia. Only 2 assessed gastric cancer incidence, and only 2 were double-blinded. Conclusion: Helicobacter pylori eradication treatment seems to reduce gastric cancer risk.	[Bazzoli, Franco] Univ Bologna, Policlin S Orsola, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy; Univ S Florida, Tampa, FL USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; State University System of Florida; University of South Florida	Bazzoli, F (corresponding author), Univ Bologna, Policlin S Orsola, Dipartimento Med Interna & Gastroenterol, Via Massarenti 9, I-40138 Bologna, Italy.	franco.bazzoli@unibo.it	Zagari, Rocco Maurizio/AAA-1836-2021; cennamo, Vincenzo/AAC-7601-2022; Fuccio, Lorenzo/A-2557-2010; Eusebi, Leonardo Henry/E-6687-2017	Fuccio, Lorenzo/0000-0001-8618-2447; Eusebi, Leonardo Henry/0000-0003-3323-7744				Chao A, 2002, INT J CANCER, V101, P380, DOI 10.1002/ijc.10614; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; *CHIN ASS GASTR CA, 1981, CLASS DIAGN CRIT HIS; *CHIN SOC GASTR CH, 2001, CHIN J DIG DIS, V2, P104; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1990, CANCER RES, V50, P4737; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Forman D, 1998, HELICOBACTER PYLORI, P354; Fuccio L, 2007, ALIMENT PHARM THER, V25, P133, DOI 10.1111/j.1365-2036.2006.03183.x; FUCCIO L, 2008, BMJ-BRIT MED J, V337, P1454; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P643; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; *INT AG RES CANC, 1994, SCH LIV FLUK HEL PYL; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Tian J, 2006, WORLD J GASTROENTERO, V12, P4569, DOI 10.3748/wjg.v12.i28.4569; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lambert R, 2002, INT J CANCER, V97, P811, DOI 10.1002/ijc.10150; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Ley C, 2004, CANCER EPIDEM BIOMAR, V13, P4, DOI 10.1158/1055-9965.EPI-03-0124; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Ogura K, 2008, J CLIN GASTROENTEROL, V42, P279, DOI 10.1097/01.mcg.0000248006.80699.7f; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Saito D, 2005, GASTROENTEROLOGY, V128, pA4; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Sung NY, 2007, BRIT J CANCER, V97, P700, DOI 10.1038/sj.bjc.6603893; Take S, 2005, AM J GASTROENTEROL, V100, P1037, DOI 10.1111/j.1572-0241.2005.41384.x; Takenaka R, 2007, ALIMENT PHARM THER, V25, P805, DOI 10.1111/j.1365-2036.2007.03268.x; TYTGAT GNJ, 1991, J GASTROEN HEPATOL, V6, P223, DOI 10.1111/j.1440-1746.1991.tb01469.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zhou Li Ya, 2005, Chin J Dig Dis, V6, P114, DOI 10.1111/j.1443-9573.2005.00204.x; Zhou LY, 2008, GASTROENTEROLOGY, V134, pA233; Zhou LY, 2003, CHINESE MED J-PEKING, V116, P11	49	278	298	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					121	W32		10.7326/0003-4819-151-2-200907210-00009	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620164				2022-12-28	WOS:000268605300006
J	Nava, S; Hill, N				Nava, Stefano; Hill, Nicholas			Non-invasive ventilation in acute respiratory failure	LANCET			English	Review							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; CONVENTIONAL MECHANICAL VENTILATION; COMMUNITY-ACQUIRED PNEUMONIA; NOT-INTUBATE ORDERS; AIRWAY PRESSURE; SUPPORT VENTILATION; ACUTE EXACERBATIONS; CONTROLLED-TRIAL; FIBEROPTIC BRONCHOSCOPY	Non-invasive mechanical ventilation has been increasingly used to avoid or serve as an alternative to intubation. Compared with medical therapy, and in some instances with invasive mechanical ventilation, it improves survival and reduces complications in selected patients with acute respiratory failure. The main indications are exacerbation of chronic obstructive pulmonary disease, cardiogenic pulmonary oedema, pulmonary infiltrates in immunocompromised patients, and weaning of previously intubated stable patients with chronic obstructive pulmonary disease. Furthermore, this technique can be used in postoperative patients or those with neurological diseases, to palliate symptoms in terminally ill patients, or to help with bronchoscopy; however further studies are needed in these situations before it can be regarded as first-line treatment. Non-invasive ventilation implemented as an alternative to intubation should be provided in an intensive care or high-dependency unit. When used to prevent intubation in otherwise stable patients it can be safely administered in an adequately staffed and monitored ward.	[Nava, Stefano] Fdn S Maugeri, Ist Sci Pavia, Resp Intens Care Unit, IRCCS, I-27100 Pavia, Italy; [Hill, Nicholas] Tufts Med Ctr, Boston, MA USA	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Tufts Medical Center	Nava, S (corresponding author), Fdn S Maugeri, Ist Sci Pavia, Resp Intens Care Unit, IRCCS, Via Maugeri, I-27100 Pavia, Italy.	stefano.nava@fsm.it						Aguilo R, 1997, CHEST, V112, P117, DOI 10.1378/chest.112.1.117; Amato M, 2006, PRINCIPLES PRACTICE, P251; Ambrosino N, 2008, EUR RESPIR J, V31, P874, DOI 10.1183/09031936.00143507; Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Antonelli M, 2003, INTENS CARE MED, V29, P126, DOI 10.1007/s00134-002-1554-5; Antonelli M, 2002, CHEST, V121, P1149, DOI 10.1378/chest.121.4.1149; Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3; APPENDINI L, 1994, AM J RESP CRIT CARE, V149, P1069, DOI 10.1164/ajrccm.149.5.8173743; Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; Battisti A, 2005, SWISS MED WKLY, V135, P339; Baudouin S, 2002, THORAX, V57, P192; Bellone A, 2005, INTENS CARE MED, V31, P807, DOI 10.1007/s00134-005-2649-6; Bellone A, 2004, CRIT CARE MED, V32, P1860, DOI 10.1097/01.CCM.0000139694.47326.B6; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Burns KEA, 2006, CAN J ANAESTH, V53, P305; Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Cheung TMT, 2004, CHEST, V126, P845, DOI 10.1378/chest.126.3.845; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Conti G, 2002, INTENS CARE MED, V28, P1701, DOI 10.1007/s00134-002-1478-0; Corrado A, 2004, EUR RESPIR J, V23, P419, DOI 10.1183/09031936.04.00029304; Crane SD, 2004, EMERG MED J, V21, P155, DOI 10.1136/emj.2003.005413; CRIMI C, 2008, EUR RESPIR J, V32, P1970; *CTR EV BAS MED, 2001, LEV EV; Cuomo A, 2004, PALLIATIVE MED, V18, P602, DOI 10.1191/0269216304pm933oa; Curtis JR, 2007, CRIT CARE MED, V35, P932, DOI 10.1097/01.CCM.0000256725.73993.74; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; Demoule A, 2006, INTENS CARE MED, V32, P1756, DOI 10.1007/s00134-006-0324-1; Demoule A, 2006, INTENS CARE MED, V32, P1747, DOI 10.1007/s00134-006-0229-z; Devlin JW, 2007, CRIT CARE MED, V35, P2298, DOI 10.1097/01.CCM.0000284512.21942.F8; Doherty MJ, 1998, THORAX, V53, P863, DOI 10.1136/thx.53.10.863; Domenighetti G, 2002, INTENS CARE MED, V28, P1226, DOI 10.1007/s00134-002-1373-8; Elliott MW, 2002, EUR RESPIR J, V19, P1159, DOI 10.1183/09031936.02.00297202; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; EWING S, 1988, EUR RESPIR J, V12, P116; Fernandez R, 2007, INTENS CARE MED, V33, P350, DOI 10.1007/s00134-006-0437-6; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P70, DOI 10.1164/rccm.200209-1074OC; Gay PC, 2001, AM J RESP CRIT CARE, V164, P1606, DOI 10.1164/ajrccm.164.9.2011119; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girault C, 1999, AM J RESP CRIT CARE, V160, P86, DOI 10.1164/ajrccm.160.1.9802120; Girault C, 2009, CRIT CARE MED, V37, P124, DOI 10.1097/CCM.0b013e3181928706; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Girou E, 2003, JAMA-J AM MED ASSOC, V290, P2985, DOI 10.1001/jama.290.22.2985; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Jolliet P, 2001, INTENS CARE MED, V27, P812, DOI 10.1007/s001340100869; Joris JL, 1997, CHEST, V111, P665, DOI 10.1378/chest.111.3.665; Keenan Sean P, 2005, Respir Care, V50, P610; Keenan SP, 2004, CRIT CARE MED, V32, P2516, DOI 10.1097/01.CCM.0000148011.51681.E2; Keenan SP, 2000, CRIT CARE MED, V28, P2094, DOI 10.1097/00003246-200006000-00072; Keenan SP, 2003, ANN INTERN MED, V138, P861, DOI 10.7326/0003-4819-138-11-200306030-00007; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; Kelly CA, 2002, EUR HEART J, V23, P1379, DOI 10.1053/euhj.2001.3156; Kindgen-Milles D, 2005, CHEST, V128, P821, DOI 10.1378/chest.128.2.821; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kuhnlein P, 2008, AMYOTROPH LATERAL SC, V9, P91, DOI 10.1080/17482960701830495; Kwok H, 2003, CRIT CARE MED, V31, P468, DOI 10.1097/01.CCM.0000045563.64187.20; Lellouche FO, 2002, INTENS CARE MED, V28, P1582, DOI 10.1007/s00134-002-1518-9; Levy M, 2004, CRIT CARE MED, V32, P2002, DOI 10.1097/01.CCM.0000142729.07050.C9; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Maheshwari V, 2006, CHEST, V129, P1226, DOI 10.1378/chest.129.5.1226; Maitre B, 2000, AM J RESP CRIT CARE, V162, P1063, DOI 10.1164/ajrccm.162.3.9910117; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Matte P, 2000, ACTA ANAESTH SCAND, V44, P75, DOI 10.1034/j.1399-6576.2000.440114.x; Nava S, 2007, EUR RESPIR J, V30, P156, DOI 10.1183/09031936.00128306; Nava S, 2006, INTENS CARE MED, V32, P361, DOI 10.1007/s00134-005-0050-0; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; NAVA S, 2008, AM J RESP CRIT CARE, V177, P767; Nava S, 2009, RESP CARE, V54, P71; Navalesi P, 2000, CRIT CARE MED, V28, P1785, DOI 10.1097/00003246-200006000-00015; Navalesi P, 2007, INTENS CARE MED, V33, P74, DOI 10.1007/s00134-006-0391-3; Nelson James A, 2011, J Emerg Med, V40, pe67, DOI 10.1016/j.jemermed.2007.12.022; Nieminen MS, 2005, EUR HEART J, V26, P384; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Perrin C, 2007, RESP MED, V101, P1572, DOI 10.1016/j.rmed.2006.12.002; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Peter JV, 2002, CRIT CARE MED, V30, P555, DOI 10.1097/00003246-200203000-00010; Plant PK, 2003, BRIT MED J, V326, P956, DOI 10.1136/bmj.326.7396.956; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Principi T, 2004, INTENS CARE MED, V30, P147, DOI 10.1007/s00134-003-2056-9; Rana S, 2006, CRIT CARE, V10, DOI 10.1186/cc4923; Saatci E, 2004, EUR RESPIR J, V23, P129, DOI 10.1183/09031936.03.00039503; Schettino G, 2005, CRIT CARE MED, V33, P1976, DOI 10.1097/01.CCM.0000178176.51024.82; Schettino GPP, 2001, INTENS CARE MED, V27, P1887, DOI 10.1007/s00134-001-1146-9; Sinuff T, 2000, CAN MED ASSOC J, V163, P969; Sinuff T, 2007, CRIT CARE MED, V35, P776, DOI 10.1097/01.CCM.0000256848.47911.77; Soma T, 2008, INTERNAL MED, V47, P493, DOI 10.2169/internalmedicine.47.0429; Soroksky A, 2003, CHEST, V123, P1018, DOI 10.1378/chest.123.4.1018; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Trevisan CE, 2008, CRIT CARE, V12, DOI 10.1186/cc6870; Vanpee D, 2002, Eur J Emerg Med, V9, P217, DOI 10.1097/00063110-200209000-00003; Vargas F, 2005, CRIT CARE, V9, pR382, DOI 10.1186/cc3724; Vignaux L, 2007, INTENS CARE MED, V33, P1444, DOI 10.1007/s00134-007-0713-0; Vitacca M, 2001, AM J RESP CRIT CARE, V164, P638, DOI 10.1164/ajrccm.164.4.2010046; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0	111	451	476	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					250	259		10.1016/S0140-6736(09)60496-7	http://dx.doi.org/10.1016/S0140-6736(09)60496-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19616722	Green Published, Bronze			2022-12-28	WOS:000268263000034
J	Gabrieli, JDE				Gabrieli, John D. E.			Dyslexia: A New Synergy Between Education and Cognitive Neuroscience	SCIENCE			English	Review							EVENT-RELATED POTENTIALS; DEVELOPMENTAL DYSLEXIA; WHITE-MATTER; INDIVIDUAL-DIFFERENCES; BRAIN ACTIVATION; FAMILIAL RISK; CHILDREN; ORGANIZATION; REMEDIATION; DEFICITS	Reading is essential in modern societies, but many children have dyslexia, a difficulty in learning to read. Dyslexia often arises from impaired phonological awareness, the auditory analysis of spoken language that relates the sounds of language to print. Behavioral remediation, especially at a young age, is effective for many, but not all, children. Neuroimaging in children with dyslexia has revealed reduced engagement of the left temporo-parietal cortex for phonological processing of print, altered white-matter connectivity, and functional plasticity associated with effective intervention. Behavioral and brain measures identify infants and young children at risk for dyslexia, and preventive intervention is often effective. A combination of evidence-based teaching practices and cognitive neuroscience measures could prevent dyslexia from occurring in the majority of children who would otherwise develop dyslexia.	[Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Gabrieli, JDE (corresponding author), MIT, Dept Brain & Cognit Sci, 43 Vassar St, Cambridge, MA 02139 USA.	gabrieli@mit.edu	Gabrieli, John/AAJ-2869-2020		Ellison Medical Foundation; MIT Class of 1976 Funds for Dyslexia Research; Martin Richmond Memorial Fund	Ellison Medical Foundation(Lawrence Ellison Foundation); MIT Class of 1976 Funds for Dyslexia Research; Martin Richmond Memorial Fund	This work was supported by the Ellison Medical Foundation, MIT Class of 1976 Funds for Dyslexia Research, and B. Richmond and J. Richmond through the Martin Richmond Memorial Fund. I thank J. Torgesen, P. Hook, D. Willingham, J. Christodoulou, I. Kovelman, T. Perrachione, S. Whitfield-Gabrieli, and C. Gabrieli for comments on the paper and P. O Loughlin and J. Gabrieli for help with the manuscript.	Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; [Anonymous], 2003, OVERCOMING DYSLEXIA; Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Cunningham A. E., 1998, J DIRECT INSTRUCTION, V1, P137; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; Demb JB, 1998, VISION RES, V38, P1555, DOI 10.1016/S0042-6989(98)00075-3; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Friend A, 2008, PSYCHOL SCI, V19, P1124, DOI 10.1111/j.1467-9280.2008.02213.x; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Guttorm TK, 2005, CORTEX, V41, P291, DOI 10.1016/S0010-9452(08)70267-3; Guttorm TK, 2001, J LEARN DISABIL-US, V34, P534, DOI 10.1177/002221940103400606; Hoeft F, 2007, BEHAV NEUROSCI, V121, P602, DOI 10.1037/0735-7044.121.3.602; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Maurer U, 2009, BIOL PSYCHIAT, V66, P341, DOI 10.1016/j.biopsych.2009.02.031; Meyler A, 2008, NEUROPSYCHOLOGIA, V46, P2580, DOI 10.1016/j.neuropsychologia.2008.03.012; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pennington B.F., 1996, DEV DYSLEXIA NEURAL, P41; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; RUMSEY JM, 1992, ARCH NEUROL-CHICAGO, V49, P527, DOI 10.1001/archneur.1992.00530290115020; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Stanovich KE, 2005, LEARN DISABILITY Q, V28, P103, DOI 10.2307/1593604; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Torgesen JK, 2001, DYSLEXIA, FLUENCY, AND THE BRAIN, P333; TORGESEN JK, 2006, SCI READING HDB, pCH27; TORGESEN JK, 2004, AM ED            FAL, P6; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Wolf M, 1999, J EDUC PSYCHOL, V91, P415, DOI 10.1037/0022-0663.91.3.415; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; ZIEGLER JC, DEV SCI IN PRESS, DOI DOI 10.1111/J.1467-7687.2009.00819.X; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004	48	318	324	7	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					280	283		10.1126/science.1171999	http://dx.doi.org/10.1126/science.1171999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DZ	19608907	Green Published			2022-12-28	WOS:000268036600034
J	Roth, A; Brune, C; Buhmann, H; Molenkamp, LW; Maciejko, J; Qi, XL; Zhang, SC				Roth, Andreas; Bruene, Christoph; Buhmann, Hartmut; Molenkamp, Laurens W.; Maciejko, Joseph; Qi, Xiao-Liang; Zhang, Shou-Cheng			Nonlocal Transport in the Quantum Spin Hall State	SCIENCE			English	Article								Nonlocal transport through edge channels holds great promise for low-power information processing. However, edge channels have so far only been demonstrated to occur in the quantum Hall regime, at high magnetic fields. We found that mercury telluride quantum wells in the quantum spin Hall regime exhibit nonlocal edge channel transport at zero external magnetic field. The data confirm that the quantum transport through the (helical) edge channels is dissipationless and that the contacts lead to equilibration between the counterpropagating spin states at the edge. The experimental data agree quantitatively with the theory of the quantum spin Hall effect. The edge channel transport paves the way for a new generation of spintronic devices for low-power information processing.	[Roth, Andreas; Bruene, Christoph; Buhmann, Hartmut; Molenkamp, Laurens W.] Univ Wurzburg, Phys Inst EP3, D-97074 Wurzburg, Germany; [Roth, Andreas; Bruene, Christoph; Buhmann, Hartmut; Molenkamp, Laurens W.] Univ Wurzburg, Rontgen Ctr Complex Mat Syst, D-97074 Wurzburg, Germany; [Maciejko, Joseph; Qi, Xiao-Liang; Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Maciejko, Joseph; Qi, Xiao-Liang; Zhang, Shou-Cheng] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	University of Wurzburg; University of Wurzburg; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Molenkamp, LW (corresponding author), Univ Wurzburg, Phys Inst EP3, D-97074 Wurzburg, Germany.	molenkmp@physik.uni-wuerzburg.de	Zhang, Shou-Cheng/B-2794-2010; Brüne, Christoph/AAO-2131-2020; Qi, Xiaoliang/F-9245-2010	Brüne, Christoph/0000-0002-2491-6414; Qi, Xiaoliang/0000-0003-0388-5003; Molenkamp, Laurens/0000-0003-4833-5179; Maciejko, Joseph/0000-0002-6946-1492	Deutsche Forschungsgemeinschaft [SFB 410]; German-Israeli Foundation [I-881-138.7/2005]; NSF [DMR-0342832]; Alexander von Humboldt Foundation; U.S. Department of Energy, Office of Basic Energy Sciences; Focus Center Research Program; National Science and Engineering Research Council of Canada; Stanford Graduate Fellowship Program;  [DE-AC03-76SF00515]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Focus Center Research Program; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stanford Graduate Fellowship Program; 	We thank T. Beringer, N. Eikenberg, M. Konig, and S. Wiedmann for assistance in some of the experiments. Supported by Deutsche Forschungsgemeinschaft grant SFB 410, German-Israeli Foundation grant I-881-138.7/2005, NSF grant DMR-0342832, the Alexander von Humboldt Foundation, the U.S. Department of Energy, Office of Basic Energy Sciences, under contract DE-AC03-76SF00515, the Focus Center Research Program (FCRP) Center on Functional Engineered Nanoarchitectonics, the National Science and Engineering Research Council of Canada, and the Stanford Graduate Fellowship Program. Computational work was made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (www.sharcnet.ca).	BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; Hankiewicz EM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241301; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Wu CJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106401; Xu CK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045322; Zhang S.C., 2008, PHYSICS, V1, P6, DOI DOI 10.1103/PHYSICS.1.6	11	688	703	2	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					294	297		10.1126/science.1174736	http://dx.doi.org/10.1126/science.1174736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608911	Green Submitted			2022-12-28	WOS:000268036600038
J	Timmermann, A; Menviel, L				Timmermann, Axel; Menviel, Laurie			What Drives Climate Flip-Flops?	SCIENCE			English	Editorial Material							GREENLAND ICE CORE; EVENTS		[Timmermann, Axel; Menviel, Laurie] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Int Pacific Res Ctr, Honolulu, HI 96822 USA	University of Hawaii System	Timmermann, A (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Int Pacific Res Ctr, Honolulu, HI 96822 USA.	axel@hawaii.edu; menviel@hawaii.edu	Timmermann, Axel/F-4977-2011; Menviel, Laurie/O-7833-2019; Timmermann, Axel/Y-2799-2019; Menviel, Laurie/D-6902-2013	Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; Menviel, Laurie/0000-0002-5068-1591				Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Schulz M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016144; Schulz M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000571; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Timm O, 2007, J CLIMATE, V20, P4377, DOI 10.1175/JCLI4237.1	14	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					273	274		10.1126/science.1177159	http://dx.doi.org/10.1126/science.1177159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608902	Green Submitted			2022-12-28	WOS:000268036600029
J	Kerac, M; Egan, R; Mayer, S; Walsh, A; Seal, A				Kerac, Marko; Egan, Rebecca; Mayer, Sam; Walsh, Anne; Seal, Andrew			New WHO growth standards: roll-out needs more resources	LANCET			English	Editorial Material							WORLD-HEALTH-ORGANIZATION; SEVERE ACUTE MALNUTRITION; SECONDARY DATA-ANALYSIS; PROGRAMS; CHILDREN		[Kerac, Marko; Seal, Andrew] UCL Ctr Int Hlth & Dev, London WC1N 1EH, England; [Egan, Rebecca; Mayer, Sam] Clinton Fdn HIV AIDS Initiat, Boston, NY USA; [Walsh, Anne] Valid Int, Oxford, England	University of London; University College London	Kerac, M (corresponding author), UCL Ctr Int Hlth & Dev, London WC1N 1EH, England.	marko.kerac@gmail.com	Kerac, Marko/GQR-1136-2022; Walsh, Anne/GXI-0454-2022; Seal, Andrew/C-8550-2014; Kerac, Marko/G-1777-2010	Seal, Andrew/0000-0003-3656-4054; Kerac, Marko/0000-0002-3745-7317	National Institute for Health Research [ACF-2008-18-010] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ACF IN MSF, 2009, BRIEF PAP ON CRIS MA; [Anonymous], 2009, WHO CHILD GROWTH STA; Colli E, 2006, EUR UROL, V49, P82, DOI 10.1016/j.eururo.2005.08.014; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; DEONIS M, 2007, BMJ             0315; *IASC GLOB NUTR CL, 2009, TASK FORC ASS MON EV; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; Waterlow J.C., 2006, PROTEIN ENERGY MALNU; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization World Food Programme UN Standing Committee on Nutrition et al, 2007, COMM BAS MAN SEV AC	14	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 11	2009	374	9684					100	102		10.1016/S0140-6736(09)61266-6	http://dx.doi.org/10.1016/S0140-6736(09)61266-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472EG	19595331				2022-12-28	WOS:000268111600008
J	Marcotte, EM; Tsechansky, M				Marcotte, Edward M.; Tsechansky, Mark			Disorder, Promiscuity, and Toxic Partnerships	CELL			English	Editorial Material							PROTEIN	Many genes are toxic when overexpressed, but general mechanisms for this toxicity have proven elusive. Vavouri et al. (2009) find that intrinsic protein disorder and promiscuous molecular interactions are strong determinants of dosage sensitivity, explaining in part the toxicity of dosage-sensitive oncogenes in mice and humans.	[Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Marcotte, Edward M.; Tsechansky, Mark] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 2500 Speedway, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu		Marcotte, Edward/0000-0001-8808-180X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067779, R01GM076536] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067779, R01 GM067779-04, R01 GM076536-04, R01 GM076536-04S1, R01 GM076536, R01 GM067779-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Wang HD, 2009, MOL CELL PROTEOMICS, V8, P1361, DOI 10.1074/mcp.M800490-MCP200	9	23	23	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					16	18		10.1016/j.cell.2009.06.024	http://dx.doi.org/10.1016/j.cell.2009.06.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596229	Green Accepted, Bronze			2022-12-28	WOS:000267848600008
J	Platt, R; Wilson, M; Chan, KA; Benner, JS; Marchibroda, J; McClellan, M				Platt, Richard; Wilson, Marcus; Chan, K. Arnold; Benner, Joshua S.; Marchibroda, Janet; McClellan, Mark			The New Sentinel Network - Improving the Evidence of Medical-Product Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE		[Platt, Richard] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Platt, Richard] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Wilson, Marcus] HealthCore, Wilmington, DE USA; [Chan, K. Arnold] I3 Drug Safety, Waltham, MA USA; [Benner, Joshua S.; McClellan, Mark] Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Marchibroda, Janet] IBM Corp, Fairfax, VA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Brookings Institution; International Business Machines (IBM)	Platt, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Chan, Kinwei/0000-0001-8161-1986				[Anonymous], SENTINEL INITIATIVE; Klein N. P., 2008, Morbidity and Mortality Weekly Report, V57, P258; Velentgas P, 2008, PHARMACOEPIDEM DR S, V17, P1226, DOI 10.1002/pds.1675	3	163	166	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					645	647		10.1056/NEJMp0905338	http://dx.doi.org/10.1056/NEJMp0905338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482JX	19635947	Bronze			2022-12-28	WOS:000268884100001
J	Vall-Mayans, M; Caballero, E; Sanz, B				Vall-Mayans, Marti; Caballero, Estrella; Sanz, Benicio			The emergence of lymphogranuloma venereum in Europe	LANCET			English	Editorial Material									[Vall-Mayans, Marti; Sanz, Benicio] Catalan Hlth Inst, STI Unit CAP Drassanes, Barcelona 08001, Catalonia, Spain; [Caballero, Estrella] Catalan Hlth Inst, Univ Hosp Vall Hebron, Microbiol Serv, Barcelona 08001, Catalonia, Spain	Hospital Universitari Vall d'Hebron	Vall-Mayans, M (corresponding author), Catalan Hlth Inst, STI Unit CAP Drassanes, Av Drassanes 17-21, Barcelona 08001, Catalonia, Spain.	mvall.bcn.ics@gencat.cat						Chen CY, 2007, SEX TRANSM DIS, V34, P451, DOI 10.1097/01.olq.0000245957.02939.ea; Hamdulay SS, 2006, POSTGRAD MED J, V82, P446, DOI 10.1136/pgmj.2005.044057; Kapoor S, 2008, J EUR ACAD DERMATOL, V22, P409, DOI 10.1111/j.1468-3083.2008.02573.x; RICE PA, 2008, SEXUALLY TRANSMITTED, P1258; VALLMAYANS M, 2008, EURO SURVEILL, V13	5	21	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					356	356		10.1016/S0140-6736(09)60993-4	http://dx.doi.org/10.1016/S0140-6736(09)60993-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19632496				2022-12-28	WOS:000268508200034
J	Begelman, M				Begelman, Mitchell			A Flare for Acceleration	SCIENCE			English	Editorial Material							JET; BLAZARS; ENERGY; RADIATION		Univ Colorado, JILA, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Begelman, M (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	mitch@jila.colorado.edu		BEGELMAN, MITCHELL/0000-0003-0936-8488				Acciari VA, 2009, SCIENCE, V325, P444, DOI 10.1126/science.1175406; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; DERMER CD, 1993, ASTROPHYS J, V416, P458, DOI 10.1086/173251; Giannios D, 2009, MON NOT R ASTRON SOC, V395, pL29, DOI 10.1111/j.1745-3933.2009.00635.x; HARTMAN RC, 1992, ASTROPHYS J, V385, pL1, DOI 10.1086/186263; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; SIKORA M, 1994, ASTROPHYS J, V421, P153, DOI 10.1086/173633	8	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					399	400		10.1126/science.1176908	http://dx.doi.org/10.1126/science.1176908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628845				2022-12-28	WOS:000268255100029
J	Kim, HD; Shay, T; O'Shea, EK; Regev, A				Kim, Harold D.; Shay, Tal; O'Shea, Erin K.; Regev, Aviv			Transcriptional Regulatory Circuits: Predicting Numbers from Alphabets	SCIENCE			English	Review							COMBINATORIAL CIS-REGULATION; GENE-EXPRESSION; NETWORKS; YEAST; SEQUENCE; EVOLUTION; LESSONS; MODULES; LOGIC; NOISE	Transcriptional regulatory circuits govern how cis and trans factors transform signals into messenger RNA (mRNA) expression levels. With advances in quantitative and high-throughput technologies that allow measurement of gene expression state in different conditions, data that can be used to build and test models of transcriptional regulation is being generated at a rapid pace. Here, we review experimental and computational methods used to derive detailed quantitative circuit models on a small scale and cruder, genome-wide models on a large scale. We discuss the potential of combining small- and large-scale approaches to understand the working and wiring of transcriptional regulatory circuits.	[Shay, Tal; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Shay, Tal; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Kim, Harold D.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Mol & Cellular Biol,Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Kim, Harold D.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Chem,Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Kim, Harold D.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Biol Chem,Howard Hughes Med Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute	Regev, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	aregev@broad.mit.edu	Shay, Tal/J-4028-2016	Shay, Tal/0000-0003-0755-1350	Burroughs Wellcome Fund; HHMI; NIH [GM51377, DP1-OD003958-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge the assistance of I. Amit. H.D.K. was supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface. E.K.O. was supported by HHMI and NIH GM51377. A.R. was supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface and by NIH DP1-OD003958-01.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Berger Michael F., 2006, V338, P245; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Corey DR, 2001, GENOME BIOL, V2; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P959, DOI 10.1038/nbt0806-959; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gertz J, 2009, MOL SYST BIOL, V5, DOI [10.1038/msb2009.1, 10.1038/msb.2009.1]; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Pe'er D, 2006, J MACH LEARN RES, V7, P167; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SEGAL E, 2002, RECOMB, P263; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wade JT, 2001, EMBO J, V20, P7160, DOI 10.1093/emboj/20.24.7160; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Ye C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000311; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	63	130	133	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					429	432		10.1126/science.1171347	http://dx.doi.org/10.1126/science.1171347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628860	Green Submitted, Green Accepted			2022-12-28	WOS:000268255100044
J	Polin, M; Tuval, I; Drescher, K; Gollub, JP; Goldstein, RE				Polin, Marco; Tuval, Idan; Drescher, Knut; Gollub, J. P.; Goldstein, Raymond E.			Chlamydomonas Swims with Two "Gears" in a Eukaryotic Version of Run-and-Tumble Locomotion	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; CILIA; MICROPIPETTES; COORDINATION; REINHARDTII; TRANSPORT; FLAGELLA; FLUID; FLOW	The coordination of eukaryotic flagella is essential for many of the most basic processes of life (motility, sensing, and development), yet its emergence and regulation and its connection to locomotion are poorly understood. Previous studies show that the unicellular alga Chlamydomonas, widely regarded as an ideal system in which to study flagellar biology, swims forward by the synchronous action of its two flagella. Using high-speed imaging over long intervals, we found a richer behavior: A cell swimming in the dark stochastically switches between synchronous and asynchronous flagellar beating. Three-dimensional tracking shows that these regimes lead, respectively, to nearly straight swimming and to abrupt large reorientations, which yield a eukaryotic version of the "run-and-tumble" motion of peritrichously flagellated bacteria.	[Polin, Marco; Tuval, Idan; Drescher, Knut; Gollub, J. P.; Goldstein, Raymond E.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Gollub, J. P.] Haverford Coll, Dept Phys, Haverford, PA 19041 USA	University of Cambridge; Haverford College	Goldstein, RE (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Wilberforce Rd, Cambridge CB3 0WA, England.	R.E.Goldstein@damtp.cam.ac.uk	Goldstein, Raymond/F-2932-2011; Polin, Marco/H-4202-2011; Tuval, Idan/G-9732-2011; Drescher, Knut/N-6730-2015	Goldstein, Raymond/0000-0003-2645-0598; Polin, Marco/0000-0002-0623-3046; Tuval, Idan/0000-0002-6629-0851; Drescher, Knut/0000-0002-7340-2444	Marie-Curie Program; Human Frontiers Science Program; Leverhulme Trust; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; U.S. Department of Energy; Schlumberger Chair Fund; BBSRC [BB/F021844/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021844/1] Funding Source: researchfish	Marie-Curie Program(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); U.S. Department of Energy(United States Department of Energy (DOE)); Schlumberger Chair Fund(Schlumberger); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Leptos, T. J. Pedley, C. A. Solari, K. Visscher, A. Nedelcu, D. Page-Croft, T. Parkin, and N. Price and acknowledge support from the Marie-Curie Program (M.P.), the Human Frontiers Science Program (I.T.), the Leverhulme Trust (J.P.G.), the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the U.S. Department of Energy, and the Schlumberger Chair Fund.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Berg H. C., 1983, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Drescher K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3053242; Gueron S, 1999, P NATL ACAD SCI USA, V96, P12240, DOI 10.1073/pnas.96.22.12240; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HEGEMANN P, 1989, CELL MOTIL CYTOSKEL, V14, P501, DOI 10.1002/cm.970140408; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Josef K, 2005, CELL MOTIL CYTOSKEL, V61, P83, DOI 10.1002/cm.20064; Mitchell DR, 2000, J PHYCOL, V36, P261, DOI 10.1046/j.1529-8817.2000.99218.x; Niedermayer T, 2008, CHAOS, V18, DOI 10.1063/1.2956984; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okita N, 2005, J CELL SCI, V118, P529, DOI 10.1242/jcs.01633; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Ruffer U, 1998, CELL MOTIL CYTOSKEL, V41, P297, DOI 10.1002/(SICI)1097-0169(1998)41:4<297::AID-CM3>3.0.CO;2-Y; RUFFER U, 1987, CELL MOTIL CYTOSKEL, V7, P87, DOI 10.1002/cm.970070111; Solari CA, 2006, P NATL ACAD SCI USA, V103, P1353, DOI 10.1073/pnas.0503810103; Vilfan A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058102; Vladimirov VA, 2004, J EXP BIOL, V207, P1203, DOI 10.1242/jeb.00881; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044	25	300	300	8	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					487	490		10.1126/science.1172667	http://dx.doi.org/10.1126/science.1172667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628868				2022-12-28	WOS:000268255100060
J	Sharma, V; Crne, M; Park, JO; Srinivasarao, M				Sharma, Vivek; Crne, Matija; Park, Jung Ok; Srinivasarao, Mohan			Structural Origin of Circularly Polarized Iridescence in Jeweled Beetles	SCIENCE			English	Article							CHOLESTERIC LIQUID-CRYSTALS; GRAIN-BOUNDARY SCARS; SPHERICAL CRYSTALLOGRAPHY; PATTERN-FORMATION; COLOR; BUTTERFLIES; REFLECTION; CUTICLE; LIGHT; MOTHS	The iridescent metallic green beetle, Chrysina gloriosa, which selectively reflects left circularly polarized light, possesses an exoskeleton decorated by hexagonal cells (similar to 10 mu m) that coexist with pentagons and heptagons. The fraction of hexagons decreases with an increase in curvature. In bright field microscopy, each cell contains a bright yellow core, placed in a greenish cell with yellowish border, but the core disappears in dark field. With use of confocal microscopy, we observe that these cells consist of nearly concentric nested arcs that lie on the surface of a shallow cone. We infer that the patterns are structurally and optically analogous to the focal conic domains formed spontaneously on the free surface of a cholesteric liquid crystal. These textures provide the basis for the morphogenesis as well as key insights for emulating the intricate optical response of the exoskeleton of scarab beetles.	[Sharma, Vivek; Park, Jung Ok; Srinivasarao, Mohan] Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA; [Sharma, Vivek; Crne, Matija; Park, Jung Ok; Srinivasarao, Mohan] Georgia Inst Technol, CAROM, Atlanta, GA 30332 USA; [Crne, Matija; Srinivasarao, Mohan] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sharma, V (corresponding author), Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA.		Sharma, Vivek/AAC-9903-2019; Sharma, Vivek/A-9772-2014; Srinivasarao, Mohan/M-9810-2013; Sharma, Vivek/B-3615-2009; Srinivasarao, Mohan/L-4041-2019	Sharma, Vivek/0000-0003-1152-1285; Sharma, Vivek/0000-0003-1152-1285; Sharma, Vivek/0000-0003-1152-1285; 	NSF [DMR-0706235]	NSF(National Science Foundation (NSF))	M.S. acknowledges support from NSF (DMR-0706235) and useful discussions with L. Tolbert, A. Rey, P. Collings, and H. Ghiradella.	Ball P., 1999, SELF MADE TAPESTRY P; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Belyakov V.A., 1989, OPTICS CHIRAL LIQUID; BERREMAN DW, 1986, PHYS REV LETT, V57, P1737, DOI 10.1103/PhysRevLett.57.1737; Bertheier S., 2007, IRIDESCENCES PHYS CO; BOULIGAND Y, 1983, BIFURCATION THEORY M; Bouligand Y, 2008, CR CHIM, V11, P281, DOI 10.1016/j.crci.2007.10.001; Brink DJ, 2007, J PHYS D APPL PHYS, V40, P2189, DOI 10.1088/0022-3727/40/7/050; BROER DJ, 1995, NATURE, V378, P467, DOI 10.1038/378467a0; CAVENEY S, 1971, PROC R SOC SER B-BIO, V178, P205, DOI 10.1098/rspb.1971.0062; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; De Silva L, 2005, ELECTROMAGNETICS, V25, P391, DOI 10.1080/02726340590957399; DEGENNES PG, 1995, INT SER MONOGR PHYS, V83, P263; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Goldstein DH, 2006, APPL OPTICS, V45, P7944, DOI 10.1364/AO.45.007944; Jewell SA, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/099; Kleman M., 2003, SOFT MATTER PHYS INT; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Lowrey S, 2007, J OPT SOC AM A, V24, P2418, DOI 10.1364/JOSAA.24.002418; Meister R, 1996, PHYS REV E, V54, P3771, DOI 10.1103/PhysRevE.54.3771; Michelson Albert A., 1927, STUDIES OPTICS; Nelson DR, 2004, P INT SCH PHYS, V155, P365; Neville A. C., 1993, BIOL FIBROUS COMPOSI; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; OSWALD P, 2005, NEMATIC CHOLESTERIC, P415; PACE A, 1972, SCIENCE, V176, P678, DOI 10.1126/science.176.4035.678; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; RIVERS VZ, 2003, INSECTES TRADITION O, P163; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; STEVENS PS, 1974, PATTERNS NATURE; STJOHN WD, 1995, PHYS REV E, V51, P1191, DOI 10.1103/PhysRevE.51.1191; Thompson D.W., 1961, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vitelli V, 2006, P NATL ACAD SCI USA, V103, P12323, DOI 10.1073/pnas.0602755103; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941	36	431	442	18	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					449	451		10.1126/science.1172051	http://dx.doi.org/10.1126/science.1172051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628862				2022-12-28	WOS:000268255100049
J	Suzuki, HI; Yamagata, K; Sugimoto, K; Iwamoto, T; Kato, S; Miyazono, K				Suzuki, Hiroshi I.; Yamagata, Kaoru; Sugimoto, Koichi; Iwamoto, Takashi; Kato, Shigeaki; Miyazono, Kohei			Modulation of microRNA processing by p53	NATURE			English	Article							PROLINE-RICH DOMAIN; TUMOR-SUPPRESSOR; EXPRESSION; CANCER; ACTIVATION; APOPTOSIS; COMPLEX; CELLS; MICROPROCESSOR; TUMORIGENESIS	MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, involved in diverse physiological and pathological processes. Although miRNAs can function as both tumour suppressors and oncogenes in tumour development(1), a widespread downregulation of miRNAs is commonly observed in human cancers and promotes cellular transformation and tumorigenesis(2-4). This indicates an inherent significance of small RNAs in tumour suppression. However, the connection between tumour suppressor networks and miRNA biogenesis machineries has not been investigated in depth. Here we show that a central tumour suppressor, p53, enhances the post-transcriptional maturation of several miRNAs with growth-suppressive function, including miR-16-1, miR-143 and miR-145, in response to DNA damage. In HCT116 cells and human diploid fibroblasts, p53 interacts with the Drosha processing complex through the association with DEAD-box RNA helicase p68 (also known as DDX5) and facilitates the processing of primary miRNAs to precursor miRNAs. We also found that transcriptionally inactive p53 mutants interfere with a functional assembly between Drosha complex and p68, leading to attenuation of miRNA processing activity. These findings suggest that transcription-independent modulation of miRNA biogenesis is intrinsically embedded in a tumour suppressive program governed by p53. Our study reveals a previously unrecognized function of p53 in miRNA processing, which may underlie key aspects of cancer biology.	[Suzuki, Hiroshi I.; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Yamagata, Kaoru; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Yamagata, Kaoru; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchisi, Saitama 3320012, Japan; [Sugimoto, Koichi] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol,Bunkyo Ku, Tokyo 1138421, Japan; [Iwamoto, Takashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi 4878501, Japan; [Iwamoto, Takashi] Chubu Univ, Ctr Educ Lab Anim Res, Aichi 4878501, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Juntendo University; Chubu University; Chubu University	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp		Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI [17016011]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Matsuyama, K. Kiyono, S. Ehata and R. A. Saito for discussion; M. Saitoh, K. Miyazawa, T. Watabe, K. Horiguchi, T. Shirakihara, K. Harada, M. Oka, A. Mizutani, T. Yamazaki and Y. Yoshimatsu for technical advice and reagents; T. Yokochi and Y. Morishita for encouragement; and all members of the Department of Molecular Pathology, University of Tokyo for assistance. This work was supported by KAKENHI (Grant-in-Aid for Scientific Research no. 17016011) on priority areas 'New strategies for cancer therapy based on advancement of basic research' and the Global Center of Excellence Program for 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H. I. S. is supported by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Roth J, 2000, ONCOGENE, V19, P1834, DOI 10.1038/sj.onc.1203500; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Song H, 2007, CELL CYCLE, V6, P1570, DOI 10.4161/cc.6.13.4456; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	37	898	933	2	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					529	U111		10.1038/nature08199	http://dx.doi.org/10.1038/nature08199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626115				2022-12-28	WOS:000268257000042
J	Ludwig, DS; Brownell, KD				Ludwig, David S.; Brownell, Kelly D.			Public Health Action Amid Scientific Uncertainty The Case of Restaurant Calorie Labeling Regulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOOD CHOICES		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Harvard University; Boston Children's Hospital; Yale University	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				Gerend MA, 2009, J ADOLESCENT HEALTH, V44, P84, DOI 10.1016/j.jadohealth.2008.06.014; Gifford KD, 2002, AM J MED, V113, P89, DOI 10.1016/S0002-9343(01)00996-2; Harnack LJ, 2008, INT J BEHAV NUTR PHY, V5, DOI [10.1186/1479-5868-5-51, 10.1186/1479-5868-5-63]; LIN BH, 1999, AM EATING HABITS CHA, VA; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5	8	31	31	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					434	435		10.1001/jama.2009.1045	http://dx.doi.org/10.1001/jama.2009.1045			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472NQ	19622824				2022-12-28	WOS:000268139200028
J	Borzak, S				Borzak, Steven			Fondaparinux led to less bleeding than enoxaparin in patients with non-ST-elevation acute coronary syndromes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Atlantis, FL USA		Borzak, S (corresponding author), Univ Miami, Miller Sch Med, Atlantis, FL USA.							Steinhubl SR, 2009, ANN INTERN MED, V150, P379, DOI 10.7326/0003-4819-150-6-200903170-00006; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-7	10.7326/0003-4819-151-2-200907210-02007	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620151				2022-12-28	WOS:000268605300015
J	Korula, J				Korula, Jacob			Immediate listing for liver transplantation did not differ from usual care for overall survival in stage B alcoholic cirrhosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Anantharaju A, 2003, ALCOHOL RES HEALTH, V27, P257; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-14	10.7326/0003-4819-151-2-200907210-02014	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620158				2022-12-28	WOS:000268605300022
J	Sosdian, S; Rosenthal, Y				Sosdian, Sindia; Rosenthal, Yair			Deep-Sea Temperature and Ice Volume Changes Across the Pliocene-Pleistocene Climate Transitions	SCIENCE			English	Article							BENTHIC FORAMINIFERAL MG/CA; OCEAN CIRCULATION; LEVEL; GLACIATION; ATLANTIC; RECORDS; ONSET; PACIFIC; HISTORY; CYCLES	Earth has undergone profound changes since the late Pliocene, which led to the development [similar to 2.7 million years ago (Ma)] and intensification (similar to 0.9 Ma) of large-scale Northern Hemisphere ice sheets, recorded as transitions in the benthic foraminiferal oxygen isotope (delta O-18(b)) record. Here we present an orbitally resolved record of deep ocean temperature derived from benthic foraminiferal magnesium/calcium ratios from the North Atlantic, which shows that temperature variations are a substantial portion of the global delta O-18(b) signal. The record shows two distinct cooling events associated with the late Pliocene (LPT, 2.5 to 3 Ma) and mid-Pleistocene (MPT, 1.2 to 0.85 Ma) climate transitions. Whereas the LPT increase in ice volume is attributed directly to global cooling, the shift to 100,000-year cycles at the MPT is more likely to be a response to an additional change in ice-sheet dynamics.	Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sosdian, S (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	sindia.sosdian@anu.edu.au			USSSP Schlanger ODP; NSF [OCE 02-20922]	USSSP Schlanger ODP; NSF(National Science Foundation (NSF))	We thank J. Wright for assistance with isotope measurements and suggestions, M. Raymo for numerous discussions, and W. Zhang and K. Lawrence for assistance with time series analysis. Two anonymous reviewers provided insightful suggestions that substantially improved the manuscript. We acknowledge the ODP and Woods Hole Oceanographic Institution Seafloor Samples Laboratory for supplying sediment samples. This work was supported by a USSSP Schlanger ODP Fellowship to S.S. and NSF award OCE 02-20922 to Y.R.	Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; CRONIN TM, 1994, PALAEOGEOGR PALAEOCL, V108, P437, DOI 10.1016/0031-0182(94)90245-3; Duplessy JC, 2002, QUATERNARY SCI REV, V21, P315, DOI 10.1016/S0277-3791(01)00107-X; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Hodell DA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001591; Kitamura A, 2006, QUATERNARY SCI REV, V25, P323, DOI 10.1016/j.quascirev.2005.02.009; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Lea DW, 2002, QUATERNARY SCI REV, V21, P283, DOI 10.1016/S0277-3791(01)00081-6; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; McClymont EL, 2005, GEOLOGY, V33, P389, DOI 10.1130/G21292.1; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1989, PALEOCEANOGRAPHY, V4, P413, DOI 10.1029/PA004i004p00413; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Ruddiman W. F., 1988, 3 MILLION YEARS EVOL, P227; Shackleton N.J., 1974, Colloques int Cent natn Res Scient, VNo. 219,1974, P203; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Yu JM, 2008, EARTH PLANET SC LETT, V276, P129, DOI 10.1016/j.epsl.2008.09.015	33	202	212	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					306	310		10.1126/science.1169938	http://dx.doi.org/10.1126/science.1169938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608915				2022-12-28	WOS:000268036600042
J	Latimer, N; Lord, J; Grant, RL; O'Mahony, R; Dickson, J; Conaghan, PG				Latimer, Nicholas; Lord, Joanne; Grant, Robert L.; O'Mahony, Rachel; Dickson, John; Conaghan, Philip G.		Natl Inst Hlth; Clinical Excellence Osteoarthrit G	Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; THERAPEUTIC ARTHRITIS RESEARCH; PLACEBO-CONTROLLED TRIAL; CYCLO-OXYGENASE-2 INHIBITORS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; ECONOMIC-EVALUATION; RISK; OUTCOMES	Objectives To investigate the cost effectiveness of cyclooxygenase-2 (COX 2) selective inhibitors and traditional non-steroidal anti-inflammatory drugs (NSAIDs), and the addition of proton pump inhibitors to these treatments, for people with osteoarthritis. Design An economic evaluation using a Markov model and data from a systematic review was conducted. Estimates of cardiovascular and gastrointestinal adverse events were based on data from three large randomised controlled trials, and observational data were used for sensitivity analyses. Efficacy benefits from treatment were estimated from a meta-analysis of trials reporting total Western Ontario and McMaster Universities (WOMAC) osteoarthritis index score. Other model inputs were obtained from the relevant literature. The model was run for a hypothetical population of people with osteoarthritis. Subgroup analyses were conducted for people at high risk of gastrointestinal or cardiovascular adverse events. Comparators Licensed COX 2 selective inhibitors (celecoxib and etoricoxib) and traditional NSAIDs (diclofenac, ibuprofen, and naproxen) for which suitable data were available were compared. Paracetamol was also included, as was the possibility of adding a proton pump inhibitor (omeprazole) to each treatment. Main outcome measures The main outcome measure was cost effectiveness, which was based on quality adjusted life years gained. Quality adjusted life year scores were calculated from pooled estimates of efficacy and major adverse events (that is, dyspepsia; symptomatic ulcer; complicated gastrointestinal perforation, ulcer, or bleed; myocardial infarction; stroke; and heart failure). Results Addition of a proton pump inhibitor to both COX 2 selective inhibitors and traditional NSAIDs was highly cost effective for all patient groups considered (incremental cost effectiveness ratio less than 1000 pound ((sic)1175, $1650)). This finding was robust across a wide range of effectiveness estimates if the cheapest proton pump inhibitor was used. In our base case analysis, adding a proton pump inhibitor to a COX 2 selective inhibitor (used at the lowest licensed dose) was a cost effective option, even for patients at low risk of gastrointestinal adverse events (incremental cost effectiveness ratio approximately 10 pound 000). Uncertainties around relative adverse event rates meant relative cost effectiveness for individual COX 2 selective inhibitors and traditional NSAIDs was difficult to determine. Conclusions Prescribing a proton pump inhibitor for people with osteoarthritis who are taking a traditional NSAID or COX 2 selective inhibitor is cost effective. The cost effectiveness analysis was sensitive to adverse event data and the specific choice of COX 2 selective inhibitor or NSAID agent should, therefore, take into account individual cardiovascular and gastrointestinal risks.	[Conaghan, Philip G.] Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Lord, Joanne] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Grant, Robert L.] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England; [Dickson, John] Guisborough Primary Care Hosp, Redcar & Cleveland Primary Care Trust, Guisborough TS14 6HZ, N Yorkshire, England	University of Leeds; Brunel University; Royal College of Physicians	Conaghan, PG (corresponding author), Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England.	p.conaghan@leeds.ac.uk	Lord, Joanne/H-1417-2011	Lord, Joanne/0000-0003-1086-1624; Latimer, Nicholas/0000-0001-5304-5585; Conaghan, Philip/0000-0002-3478-5665; Birrell, Fraser/0000-0002-6163-6155	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Institute for Health and Clinical Excellence commissioned and funded this analysis.	Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Barton GR, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-51; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bloor K, 1996, PHARMACOECONOMICS, V9, P484, DOI 10.2165/00019053-199609060-00003; Briggs A, 1999, BRIT MED J, V319, P120, DOI 10.1136/bmj.319.7202.120; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; *CTR EV VAL RISK H, PREF WEIGHTS 1998 20; CURTIS L, 2006, UNIT COSTS HLTH HLTH; *DEP HLTH, 2006, NIHS REF COSTS 2005; Department of health, 1998, HLTH SURV ENGL; DIEPPE P, 1993, BRIT J RHEUMATOL, V32, P595; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; HEMANDEZDIAZ S, 2006, BASIC CLIN PHARMACOL, V98, P266; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V331, P1310, DOI 10.1136/bmj.331.7528.1310; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; LAINE L, 2006, AM COLL REHUM 2006 A; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Laine L, 2006, J CARDIOVASC PHARM, V47, pS60, DOI 10.1097/00005344-200605001-00011; Maetzel A, 1998, ARTHRITIS RHEUM, V41, P16, DOI 10.1002/1529-0131(199801)41:1<16::AID-ART3>3.3.CO;2-W; Maetzel A, 2001, 23 CAN COORD OFF HLT; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Mayor S, 2007, BRIT MED J, V334, P441, DOI 10.1136/bmj.39139.644664.DB; *MED HEALTHC PROD, 2006, PHARM WORK PART PHVW; *MED HEALTHC PROD, 2008, CARD SAF COX 2 INH N; *MHRA, 2006, PHARM WORK PART PHVM; *NAT HLTH SERV BUS, NAT HLTH SERV ENGL W; *NAT HLTH SERV NAT, 2007, CARD GASTR SAF NSAID; National Collaborating Centre for Chronic Conditions (NCCCC), 2008, OST NAT CLIN GUID CA; National Institute for Health and Clinical Excellence, 2007, GUID MAN; *NIH CLIN EXC, 2006, HYP MAN HYP AD PRIM; *NIH CLIN EXC, 2001, GUID US CYCL COX 2 S; *NOV, 2006, DRUG REG AFF CLIN DE; *PRESCR PRIC AUTH, 2005, PRESCR PRIC AUTH NEW; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P570; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Scott DL, 2000, RHEUMATOLOGY, V39, P1095, DOI 10.1093/rheumatology/39.10.1095; SEGAL L, 2003, PRIORITY SETTING OST; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon Pickard A, 2005, QUAL LIFE RES, V14, P207, DOI 10.1007/s11136-004-3928-3; Spiegel BMR, 2003, ANN INTERN MED, V138, P795, DOI 10.7326/0003-4819-138-10-200305200-00007; *US FDA, 2000, 20998S009 NDA US FDA; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; 2007, BRIT NATL FORMULARY	50	68	71	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2009	339								b2538	10.1136/bmj.b2538	http://dx.doi.org/10.1136/bmj.b2538			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19602530	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000268104900003
J	Colman, RJ; Anderson, RM; Johnson, SC; Kastman, EK; Kosmatka, KJ; Beasley, TM; Allison, DB; Cruzen, C; Simmons, HA; Kemnitz, JW; Weindruch, R				Colman, Ricki J.; Anderson, Rozalyn M.; Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Beasley, T. Mark; Allison, David B.; Cruzen, Christina; Simmons, Heather A.; Kemnitz, Joseph W.; Weindruch, Richard			Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys	SCIENCE			English	Article							DIETARY RESTRICTION; ADULT MALE; LIFE-SPAN; MACAQUES	Caloric restriction (CR), without malnutrition, delays aging and extends life span in diverse species; however, its effect on resistance to illness and mortality in primates has not been clearly established. We report findings of a 20-year longitudinal adult-onset CR study in rhesus monkeys aimed at filling this critical gap in aging research. In a population of rhesus macaques maintained at the Wisconsin National Primate Research Center, moderate CR lowered the incidence of aging-related deaths. At the time point reported, 50% of control fed animals survived as compared with 80% of the CR animals. Furthermore, CR delayed the onset of age-associated pathologies. Specifically, CR reduced the incidence of diabetes, cancer, cardiovascular disease, and brain atrophy. These data demonstrate that CR slows aging in a primate species.	[Colman, Ricki J.; Anderson, Rozalyn M.; Johnson, Sterling C.; Cruzen, Christina; Simmons, Heather A.; Kemnitz, Joseph W.; Weindruch, Richard] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Kemnitz, Joseph W.; Weindruch, Richard] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Johnson, Sterling C.; Kastman, Erik K.; Kosmatka, Kristopher J.; Weindruch, Richard] William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Beasley, T. Mark; Allison, David B.] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA; [Kemnitz, Joseph W.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Colman, RJ (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	rcolman@primate.wisc.edu; rhweindr@wisc.edu	Kemnitz, Joseph/ABA-4668-2020; Simmons, Heather/U-6081-2019; Kemnitz, Joseph/HGC-4406-2022; Kastman, Erik/N-6645-2016	Kastman, Erik/0000-0001-7221-9042; Colman, Ricki/0000-0001-9706-0525; Kemnitz, Joseph W/0000-0001-6511-404X; Allison, David/0000-0003-3566-9399	NIH [P01 AG-11915, P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; William S. Middleton Memorial Veterans Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); William S. Middleton Memorial Veterans Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the excellent technical assistance provided by S. Baum, J. Christensen, J. A. Adriansjach, C. E. Armstrong, D. G. McLaren, C. Dizack, D. Shanmuganayagam, J. Root, and the Animal Care, Veterinary and Pathology Staff of the WNPRC. R.W. is a cofounder and member of the board of LifeGen Technologies, a company focused on nutritional genomics, including the impact of dietary interventions on the aging process. This work was supported by NIH grants P01 AG-11915 and P51 RR000167. This research was conducted in part at the WNPRC, which received support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This research was supported in part by facilities and resources at the William S. Middleton Memorial Veterans Hospital.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Anderson Rozalyn M., 2007, V35, P18; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 1998, AGING CLIN EXP RES, V10, P83, DOI 10.1007/BF03339642; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; MCCAY CM, 1989, NUTRITION, V5, P155; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rodriguez NA, 2002, J MED PRIMATOL, V31, P74, DOI 10.1034/j.1600-0684.2002.01001.x; Uno H, 1997, AGE, V20, P1, DOI 10.1007/s11357-997-0001-5; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Weindruch R., 1988, RETARDATION AGING DI; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	19	1542	1592	8	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					201	204		10.1126/science.1173635	http://dx.doi.org/10.1126/science.1173635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590001	Green Accepted			2022-12-28	WOS:000267802000047
J	Crabtree, GR; Schreiber, SL				Crabtree, Gerald R.; Schreiber, Stuart L.			SnapShot: Ca2+-Calcineurin-NFAT Signaling	CELL			English	Editorial Material							NF-ATC; CALCINEURIN		[Crabtree, Gerald R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Schreiber, Stuart L.] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA	Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060037-04, R01 AI060037-01, R01 AI060037-05, R01 AI060037-02, R01 AI060037-06, R01 AI060037-03, R01 AI060037-07, R01 AI060037] Funding Source: Medline; NICHD NIH HHS [R01 HD055391-03, R01 HD055391, R01 HD055391-04, R01 HD055391-02, R01 HD055391-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS046789, R01 NS046789-08, R01 NS046789-03, R01 NS046789-04, R01 NS046789-07, R01 NS046789-05, R01 NS046789-02, R01 NS046789-06, R01 NS046789-09, R01 NS046789-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015	10	83	91	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1							210.e1	10.1016/j.cell.2009.06.026	http://dx.doi.org/10.1016/j.cell.2009.06.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596245	Green Accepted, Bronze			2022-12-28	WOS:000267848600027
J	Molloy, AM; Quadros, EV; Sequeira, JM; Troendle, JF; Scott, JM; Kirke, PN; Mills, JL				Molloy, Anne M.; Quadros, Edward V.; Sequeira, Jeffrey M.; Troendle, James F.; Scott, John M.; Kirke, Peadar N.; Mills, James L.			Lack of Association between Folate-Receptor Autoantibodies and Neural-Tube Defects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIENCY SYNDROME; GENETIC RISK; AUTOIMMUNITY; PREGNANCY; CANCER; ALPHA; WOMEN	Background: A previous report described the presence of autoantibodies against folate receptors in 75% of serum samples from women with a history of pregnancy complicated by a neural-tube defect, as compared with 10% of controls. We sought to confirm this finding in an Irish population, which traditionally has had a high prevalence of neural-tube defects. Methods: We performed two studies. Study 1 consisted of analysis of stored frozen blood samples collected from 1993 through 1994 from 103 mothers with a history of pregnancy complicated by a neural-tube defect (case mothers), 103 mothers with a history of pregnancy but no complication by a neural-tube defect (matched with regard to number of pregnancies and sampling dates), 58 women who had never been pregnant, and 36 men. Study 2, conducted to confirm that the storage of samples did not influence the folate-receptor autoantibodies, included fresh samples from 37 case mothers, 22 control mothers, 10 women who had never been pregnant, and 9 men. All samples were assayed for blocking and binding autoantibodies against folate receptors. Results: In Study 1, blocking autoantibodies were found in 17% of case mothers, as compared with 13% of control mothers (odds ratio, 1.54; 95% confidence interval [CI], 0.70 to 3.39), and binding autoantibodies in 29%, as compared with 32%, respectively (odds ratio, 0.82; 95% CI, 0.44 to 1.50). Study 2 showed similar results, indicating that sample degradation was unlikely. Conclusions: The presence and titer of maternal folate-receptor autoantibodies were not significantly associated with a neural-tube defect-affected pregnancy in this Irish population. N Engl J Med 2009;361:152-60.	[Molloy, Anne M.; Scott, John M.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Molloy, Anne M.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Kirke, Peadar N.] Hlth Res Board, Child Hlth Epidemiol Unit, Dublin, Ireland; [Quadros, Edward V.; Sequeira, Jeffrey M.] SUNY Hlth Sci Ctr, Dept Med, Brooklyn, NY 11203 USA; [Quadros, Edward V.; Sequeira, Jeffrey M.] SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Troendle, James F.; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA	Trinity College Dublin; Trinity College Dublin; Health Research Board - Ireland; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Molloy, AM (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	amolloy@tcd.ie		Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049	Eunice Kennedy Shriver National Institute of Child Health and Human Development [N01-HD-3-3348]; Health Research Board, Ireland; National Institutes of Health [HD051880]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD051880] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Health Research Board, Ireland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the intramural research programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (N01-HD-3-3348) and the Health Research Board, Ireland, and a grant from the National Institutes of Health (HD051880, to Dr. Quadros).	Berrocal-Zaragoza MI, 2009, FERTIL STERIL, V91, P1518, DOI 10.1016/j.fertnstert.2008.08.104; Bliek JB, 2006, INT J GYNECOL OBSTET, V93, P142, DOI 10.1016/j.ijgo.2006.01.021; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; Cabrera RM, 2008, J REPROD IMMUNOL, V79, P85, DOI 10.1016/j.jri.2008.08.002; COSTA MD, 1974, J LAB CLIN MED, V83, P207; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Knutson KL, 2006, J CLIN ONCOL, V24, P4254, DOI 10.1200/JCO.2006.05.9311; LITTLE J, 1992, MONOGRAPHS EPIDEMIOL, V20, P96; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2008, DEV MED CHILD NEUROL, V50, P346, DOI 10.1111/j.1469-8749.2008.02053.x; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993	16	30	31	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					152	160		10.1056/NEJMoa0803783	http://dx.doi.org/10.1056/NEJMoa0803783			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587340	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000267748900008
J	Linzer, M; Manwell, LB; Williams, ES; Bobula, JA; Brown, RL; Varkey, AB; Man, B; McMurray, JE; Maguire, A; Horner-Ibler, B; Schwartz, MD				Linzer, Mark; Manwell, Linda Baier; Williams, Eric S.; Bobula, James A.; Brown, Roger L.; Varkey, Anita B.; Man, Bernice; McMurray, Julia E.; Maguire, Ann; Horner-Ibler, Barbara; Schwartz, Mark D.		MEMO Investigators	Working Conditions in Primary Care: Physician Reactions and Care Quality	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	31st Annual Meeting of the Society-of-General-Internal-Medicine	APR 09-12, 2008	Pittsburgh, PA	Soc Gen Internal Med			INTERNAL-MEDICINE; JOB-SATISFACTION; UNITED-STATES; OF-CARE; STRESS; WORKLIFE; BURNOUT	Background: Adverse primary care work conditions could lead to a reduction in the primary care workforce and lower-quality patient care. Objective: To assess the relationship among adverse primary care work conditions, adverse physician reactions (stress, burnout, and intent to leave), and patient care. Design: Cross-sectional analysis. Setting: 119 ambulatory clinics in New York, New York, and in the upper Midwest. Participants: 422 family practitioners and general internists and 1795 of their adult patients with diabetes, hypertension, or heart failure. Measurements: Physician perception of clinic workflow (time pressure and pace), work control, and organizational culture (assessed survey); physician satisfaction, stress, burnout, and intent to leave practice (assessed by survey); and health care quality and errors (assessed by chart audits). Results: More than one half of the physicians (53.1%) reported time pressure during office visits, 48.1% said their work pace was chaotic, 78.4% noted low control over their work, and 26.5% reported burnout. Adverse workflow (time pressure and chaotic environments), low work control, and unfavorable organizational culture were strongly associated with low physician satisfaction, high stress, burnout, and intent to leave. Some work conditions were associated with lower quality and more errors, but findings were inconsistent across work conditions and diagnoses. No association was found between adverse physician reactions, such as stress and burnout, and care quality or errors. Limitation: The analyses were cross-sectional, the measures were self-reported, and the sample contained an average of 4 patients per physician. Conclusion: Adverse work conditions are associated with adverse physician reactions, but no consistent associations were found between adverse work conditions and the quality of patient care, and no associations were seen between adverse physician reactions and the quality of patient care. Primary Funding Source: Agency for Healthcare Research and Quality.	[Linzer, Mark] Univ Wisconsin, Sch Med & Publ Hlth, Sect Gen Internal Med Scholars, Madison, WI 53705 USA; Med Coll Wisconsin, Madison, WI USA; Univ Alabama, Tuscaloosa, AL USA; Univ Wisconsin, Sch Nursing, Madison, WI 53705 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Rush Med Coll, Chicago, IL 60612 USA; NYU, Sch Med, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; University of Alabama System; University of Alabama Tuscaloosa; University of Wisconsin System; University of Wisconsin Madison; Loyola University Chicago; Rush University; New York University	Linzer, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Sect Gen Internal Med Scholars, 310 N Midvale Blvd,Suite 205, Madison, WI 53705 USA.	mxl@medicine.wisc.edu	Williams, Eric/G-9837-2017	Williams, Eric/0000-0001-6297-4837	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011955] Funding Source: NIH RePORTER; AHRQ HHS [5 R01 HS011955] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		American College of Physicians, 2006, IMP COLL PRIM CAR ME; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BROWN RL, 1992, EDUC PSYCHOL MEAS, V52, P325, DOI 10.1177/0013164492052002007; Chew LD, 2004, FAM MED, V36, P588; Compton MT, 2008, J GEN INTERN MED, V23, P1095, DOI 10.1007/s11606-008-0579-z; Devoe J, 2002, J FAM PRACTICE, V51, P223; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; DIXON WJ, 1968, TECHNOMETRICS, V10, P83, DOI 10.2307/1266226; DOWELL D, 2005, LONGWOOD REV, V3, P2; Eisenberg J M, 2001, Jt Comm J Qual Improv, V27, P444; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Hoff T, 2004, MED CARE RES REV, V61, P3, DOI 10.1177/1077558703257171; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; Kralewski JE, 1996, MED CARE, V34, P377, DOI 10.1097/00005650-199605000-00001; Landon BE, 2008, MED CARE RES REV, V65, P167, DOI 10.1177/1077558707310208; Lee TH, 2008, NEW ENGL J MED, V359, P2085, DOI 10.1056/NEJMp0805766; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; Linzer M, 2002, STRESS HEALTH, V18, P37, DOI 10.1002/smi.917; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; LINZER M, 2005, AHRQ PUBLICATION; MANWELL LB, 2009, WIS MED J, V108, P15; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; MOTOWIDLO SJ, 1986, J APPL PSYCHOL, V71, P618, DOI 10.1037/0021-9010.71.4.618; Ohman-Strickland PA, 2007, HEALTH SERV RES, V42, P1257, DOI 10.1111/j.1475-6773.2006.00644.x; Rohland BM, 2004, STRESS HEALTH, V20, P75, DOI 10.1002/smi.1002; Sainfort F, 2001, Jt Comm J Qual Improv, V27, P469; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Sox HC, 2006, ANN INTERN MED, V144, P57, DOI 10.7326/0003-4819-144-1-200601030-00010; Stone P. W., 2005, ADV PATIENT SAFETY R, V2, P467; WALLER NG, 1992, BEHAV GENET, V22, P265, DOI 10.1007/BF01066662; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; 1997, FED REG         1030	35	314	318	0	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					28	U48		10.7326/0003-4819-151-1-200907070-00006	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	470BF	19581644				2022-12-28	WOS:000267946100004
J	Wright, CF; Chitty, LS				Wright, Caroline F.; Chitty, Lyn S.			Science, Medicine, and the Future Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing	BRITISH MEDICAL JOURNAL			English	Review							NONINVASIVE PRENATAL-DIAGNOSIS; CHROMOSOMAL ANEUPLOIDY; SEX DETERMINATION; DIGITAL PCR; PLASMA; SELECTION; PREGNANCIES; DISORDERS; MUTATION; FETUS		[Wright, Caroline F.] PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England; [Chitty, Lyn S.] Inst Child Hlth, London WC1N 1EH, England; [Chitty, Lyn S.] Univ Coll London Hosp, Fetal Med Unit, London NW1 2BU, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Wright, CF (corresponding author), PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England.	caroline.wright@phgfoundation.org	Wright, Caroline/N-5355-2015	chitty, lyn/0000-0002-4857-7138; Wright, Caroline/0000-0003-2958-5076				Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Chan CLW, 2006, PRENATAL DIAG, V26, P610, DOI 10.1002/pd.1477; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; CHITTY L, 2007, NEWSLETTER BRIT SOC, V37, P8; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Finning K, 2007, TRANSFUSION, V47, P2126, DOI 10.1111/j.1537-2995.2007.01437.x; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; George SM, 2006, PRENATAL DIAG, V26, P604, DOI 10.1002/pd.1475; Gonzalez-Gonzalez MC, 2003, PRENATAL DIAG, V23, P232, DOI 10.1002/pd.570; Gonzalez-Gonzalez MC, 2002, PRENATAL DIAG, V22, P946, DOI 10.1002/pd.439; Illanes S, 2007, EARLY HUM DEV, V83, P563, DOI 10.1016/j.earlhumdev.2006.11.001; Li Y, 2007, PRENATAL DIAG, V27, P11, DOI 10.1002/pd.1608; Li Y, 2006, CLIN CHEM, V52, P2311, DOI 10.1373/clinchem.2006.076257; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Newson AJ, 2008, SEMIN FETAL NEONAT M, V13, P103, DOI 10.1016/j.siny.2007.12.004; Norbury G, 2008, SEMIN FETAL NEONAT M, V13, P76, DOI 10.1016/j.siny.2007.12.008; Poon LLM, 2000, CLIN CHEM, V46, P1832; Poon LLM, 2002, CLIN CHEM, V48, P35; Rijnders RJP, 2001, OBSTET GYNECOL, V98, P374, DOI 10.1016/S0029-7844(01)01480-6; van der Schoot CE, 2008, SEMIN FETAL NEONAT M, V13, P63, DOI 10.1016/j.siny.2007.12.012; VANDENHEUVEL A, PATIENT ED COUNS; Wilson J JG, 1968, PUBLIC HLTH PAPERS, V34; Wright C., 2009, CELL FREE FETAL NUCL; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047	33	21	24	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2009	339								b2451	10.1136/bmj.b2451	http://dx.doi.org/10.1136/bmj.b2451			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KW	19581324				2022-12-28	WOS:000267898000001
J	Smirnova, O; Mairesse, Y; Patchkovskii, S; Dudovich, N; Villeneuve, D; Corkum, P; Ivanov, MY				Smirnova, Olga; Mairesse, Yann; Patchkovskii, Serguei; Dudovich, Nirit; Villeneuve, David; Corkum, Paul; Ivanov, Misha Yu.			High harmonic interferometry of multi-electron dynamics in molecules	NATURE			English	Article							ATTOSECOND; INTERFERENCE; GENERATION	High harmonic emission occurs when an electron, liberated from a molecule by an incident intense laser field, gains energy from the field and recombines with the parent molecular ion. The emission provides a snapshot of the structure and dynamics of the recombining system, encoded in the amplitudes, phases and polarization of the harmonic light. Here we show with CO2 molecules that high harmonic interferometry can retrieve this structural and dynamic information: by measuring the phases and amplitudes of the harmonic emission, we reveal 'fingerprints' of multiple molecular orbitals participating in the process and decode the underlying attosecond multi-electron dynamics, including the dynamics of electron rearrangement upon ionization. These findings establish high harmonic interferometry as an effective approach to resolving multi-electron dynamics with sub-Angstrom spatial resolution arising from the de Broglie wavelength of the recombining electron, and attosecond temporal resolution arising from the timescale of the recombination event.	[Smirnova, Olga; Mairesse, Yann; Patchkovskii, Serguei; Dudovich, Nirit; Villeneuve, David; Corkum, Paul; Ivanov, Misha Yu.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Smirnova, Olga] Max Born Inst, D-12489 Berlin, Germany; [Mairesse, Yann] Univ Bordeaux 1, CELIA, CNRS, CEA,UMR 5107, F-33405 Talence, France; [Dudovich, Nirit] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Ivanov, Misha Yu.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England	National Research Council Canada; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Weizmann Institute of Science; Imperial College London	Smirnova, O (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	olga.smirnova@mbi-berlin.de	Ivanov, Mikhail/AAG-1727-2021; Villeneuve, David M/I-4140-2012; Mairesse, Yann/B-3049-2015	Villeneuve, David M/0000-0002-2810-3648; Mairesse, Yann/0000-0002-9098-7421; Corkum, Paul/0000-0003-3394-5572	NSERC SRO; AFOSR; Leibniz SAW award; Alexander von Humboldt foundation	NSERC SRO(Natural Sciences and Engineering Research Council of Canada (NSERC)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Leibniz SAW award; Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	We appreciate discussions with A. Stolow and M. Spanner. This research was partially supported by the NSERC SRO and an AFOSR grant. O.S. acknowledges the Leibniz SAW award, and M. I. acknowledges support from the Alexander von Humboldt foundation.	Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Baker S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.053901; Boutu W, 2008, NAT PHYS, V4, P545, DOI 10.1038/nphys964; COHEN HD, 1966, PHYS REV, V150, P30, DOI 10.1103/PhysRev.150.30; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Corsi C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.023901; Descamps D, 2000, OPT LETT, V25, P135, DOI 10.1364/OL.25.000135; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Le AT, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023814; Le AT, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041402; Le VH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.013414; Lein M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053004; Lein M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183903; Lein M, 2007, J PHYS B-AT MOL OPT, V40, pR135, DOI 10.1088/0953-4075/40/16/R01; Levesque J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.243001; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Lezius M, 2001, PHYS REV LETT, V86, P51, DOI 10.1103/PhysRevLett.86.51; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Litvinyuk IV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033003; Mairesse Y, 2003, SCIENCE, V302, P1540, DOI 10.1126/science.1090277; Markevitch AN, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.011402; McFarland BK, 2008, SCIENCE, V322, P1232, DOI 10.1126/science.1162780; Morishita T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013903; Muth-Bohm J, 2000, PHYS REV LETT, V85, P2280, DOI 10.1103/PhysRevLett.85.2280; Ortiz JV, 2003, INT J QUANTUM CHEM, V95, P593, DOI 10.1002/qua.10632; Pavicic D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243001; Remetter T, 2006, NAT PHYS, V2, P323, DOI 10.1038/nphys290; Rosca-Pruna F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.153902; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Tong XM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033402; Vozzi C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.153902; Wagner NL, 2006, P NATL ACAD SCI USA, V103, P13279, DOI 10.1073/pnas.0605178103; Zerne R, 1997, PHYS REV LETT, V79, P1006, DOI 10.1103/PhysRevLett.79.1006; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	37	868	878	4	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					972	977		10.1038/nature08253	http://dx.doi.org/10.1038/nature08253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19626004	Green Published			2022-12-28	WOS:000269085500026
J	Sanada, M; Suzuki, T; Shih, LY; Otsu, M; Kato, M; Yamazaki, S; Tamura, A; Honda, H; Sakata-Yanagimoto, M; Kumano, K; Oda, H; Yamagata, T; Takita, J; Gotoh, N; Nakazaki, K; Kawamata, N; Onodera, M; Nobuyoshi, M; Hayashi, Y; Harada, H; Kurokawa, M; Chiba, S; Mori, H; Ozawa, K; Omine, M; Hirai, H; Nakauchi, H; Koeffler, HP; Ogawa, S				Sanada, Masashi; Suzuki, Takahiro; Shih, Lee-Yung; Otsu, Makoto; Kato, Motohiro; Yamazaki, Satoshi; Tamura, Azusa; Honda, Hiroaki; Sakata-Yanagimoto, Mamiko; Kumano, Keiki; Oda, Hideaki; Yamagata, Tetsuya; Takita, Junko; Gotoh, Noriko; Nakazaki, Kumi; Kawamata, Norihiko; Onodera, Masafumi; Nobuyoshi, Masaharu; Hayashi, Yasuhide; Harada, Hiroshi; Kurokawa, Mineo; Chiba, Shigeru; Mori, Hiraku; Ozawa, Keiya; Omine, Mitsuhiro; Hirai, Hisamaru; Nakauchi, Hiromitsu; Koeffler, H. Phillip; Ogawa, Seishi			Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; RETROVIRAL VECTOR GCDNSAP; MYELODYSPLASTIC SYNDROMES; NEGATIVE REGULATION; UBIQUITIN LIGASES; V-CBL; MUTATIONS; PROTEIN; P53; TRANSFORMATION	Acquired uniparental disomy(aUPD) is a common feature of cancer genomes, leading to loss of heterozygosity. aUPD is associated not only with loss-of-function mutations of tumour suppressor genes(1), but also with gain-of-function mutations of proto-oncogenes(2). Here we show unique gain-of-function mutations of the C-CBL (also known as CBL) tumour suppressor that are tightly associated with aUPD of the 11q arm in myeloid neoplasms showing myeloproliferative features. The C-CBL proto-oncogene, a cellular homologue of v-Cbl, encodes an E3 ubiquitin ligase and negatively regulates signal transduction of tyrosine kinases(3-6). Homozygous C-CBL mutations were found in most 11q-aUPD-positive myeloid malignancies. Although the C-CBL mutations were oncogenic in NIH3T3 cells, c-Cbl was shown to functionally and genetically act as a tumour suppressor. C-CBL mutants did not have E3 ubiquitin ligase activity, but inhibited that of wild-type C-CBL and CBL-B (also known as CBLB), leading to prolonged activation of tyrosine kinases after cytokine stimulation. c-Cbl(-/-) haematopoietic stem/progenitor cells (HSPCs) showed enhanced sensitivity to a variety of cytokines compared to c-Cbl(+/+) HSPCs, and transduction of C-CBL mutants into c-Cbl(-/-) HSPCs further augmented their sensitivities to a broader spectrum of cytokines, including stem-cell factor (SCF, also known as KITLG), thrombopoietin (TPO, also known as THPO), IL3 and FLT3 ligand (FLT3LG), indicating the presence of a gain-of-function that could not be attributed to a simple loss-of-function. The gain-of-function effects of C-CBL mutants on cytokine sensitivity of HSPCs largely disappeared in a c-Cbl(-/-) background or by co-transduction of wild-type C-CBL, which suggests the pathogenic importance of loss of wild-type C-CBL alleles found in most cases of C-CBL-mutated myeloid neoplasms. Our findings provide a new insight into a role of gain-of-function mutations of a tumour suppressor associated with aUPD in the pathogenesis of some myeloid cancer subsets.	[Sanada, Masashi; Kato, Motohiro; Tamura, Azusa; Takita, Junko; Nakazaki, Kumi; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, Motohiro; Takita, Junko] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kumano, Keiki; Takita, Junko; Nakazaki, Kumi; Kurokawa, Mineo; Hirai, Hisamaru] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Sanada, Masashi; Yamazaki, Satoshi; Nakauchi, Hiromitsu; Ogawa, Seishi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Suzuki, Takahiro; Nobuyoshi, Masaharu; Ozawa, Keiya] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi 3290498, Japan; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taipei 105, Taiwan; [Otsu, Makoto; Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell & Regenerat Med, Minato Ku, Tokyo 1088639, Japan; [Gotoh, Noriko] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Honda, Hiroaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dev Biol, Minami Ku, Hiroshima 7348553, Japan; [Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Inst Clin Med, Dept Clin & Expt Hematol, Tsukuba, Ibaraki 3058571, Japan; [Oda, Hideaki] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; [Yamagata, Tetsuya] Dokkyo Univ, Sch Med, Dept Hematol, Mibu, Tochigi 3210293, Japan; [Kawamata, Norihiko; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Dept Genet, Setagaya Ku, Tokyo 1578535, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa, Gunma 3778577, Japan; [Harada, Hiroshi; Mori, Hiraku; Omine, Mitsuhiro] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Kanagawa 2278501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Jichi Medical University; Chang Gung Memorial Hospital; Chang Gung University; University of Tokyo; University of Tokyo; Hiroshima University; University of Tsukuba; Tokyo Women's Medical University; Dokkyo Medical University; Cedars Sinai Medical Center; National Center for Child Health & Development - Japan; Gunma Children's Medical Centre; Showa University	Ogawa, S (corresponding author), Univ Tokyo, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sly7012@adm.cgmh.org.tw; sogawa-tky@umin.ac.jp	GOTOH, Noriko/D-8430-2015; Furukawa, Yusuke/Y-1342-2018; Ogawa, Seishi/AAE-7088-2019; Mamiko, Sakata-yanagimoto/AAP-3298-2020	Furukawa, Yusuke/0000-0002-7249-6418; Kato, Motohiro/0000-0001-5145-1774; Otsu, Makoto/0000-0002-9769-0217; Gotoh, Noriko/0000-0003-3733-260X	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; National Health Research Institute, Taiwan [NHRI-EX96-9434SI, NIH-2R01CA026038-30]; Grants-in-Aid for Scientific Research [21390316] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology, and a grant from National Health Research Institute, Taiwan, NHRI-EX96-9434SI, and NIH-2R01CA026038-30. We thank W. Y. Langdon for providing a human C-CBL cDNA. A mast-cell cell line expressing c-KIT V3MC was a gift from M. F. Gurish. We also thank Y. Ogino and K. Fujita for their technical assistance.	Abbas S, 2008, HAEMATOL-HEMATOL J, V93, P1595, DOI 10.3324/haematol.13187; BLAKE TJ, 1991, ONCOGENE, V6, P653; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Haase D, 2008, ANN HEMATOL, V87, P515, DOI 10.1007/s00277-008-0483-y; Hamanaka S, 2007, MOL THER, V15, P560, DOI 10.1038/sj.mt.6300063; Honda H, 2000, BLOOD, V95, P1144, DOI 10.1182/blood.V95.4.1144.004k04_1144_1150; JAFFE E, 2002, WHO CLASSIFICATION T, P62; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sanuki S, 2008, J GENE MED, V10, P965, DOI 10.1002/jgm.1232; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	36	326	333	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					904	U145		10.1038/nature08240	http://dx.doi.org/10.1038/nature08240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19620960				2022-12-28	WOS:000268938300041
J	Samarasekera, U				Samarasekera, Udani			Countries race to contain resistance to key antimalarial	LANCET			English	News Item																			0	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 25	2009	374	9686					277	280		10.1016/S0140-6736(09)61349-0	http://dx.doi.org/10.1016/S0140-6736(09)61349-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19639670	Bronze			2022-12-28	WOS:000268508200010
J	Hough, LE; Jung, HT; Kruerke, D; Heberling, MS; Nakata, M; Jones, CD; Chen, D; Link, DR; Zasadzinski, J; Heppke, G; Rabe, JP; Stocker, W; Korblova, E; Walba, DM; Glaser, MA; Clark, NA				Hough, L. E.; Jung, H. T.; Krueerke, D.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Zasadzinski, J.; Heppke, G.; Rabe, J. P.; Stocker, W.; Koerblova, E.; Walba, D. M.; Glaser, M. A.; Clark, N. A.			Helical Nanofilament Phases	SCIENCE			English	Article							SMECTIC LIQUID-CRYSTALS; ACHIRAL MOLECULES; TRANSITION; CHIRALITY; SYSTEMS; MODEL	In the formation of chiral crystals, the tendency for twist in the orientation of neighboring molecules is incompatible with ordering into a lattice: Twist is expelled from planar layers at the expense of local strain. We report the ordered state of a neat material in which a local chiral structure is expressed as twisted layers, a state made possible by spatial limitation of layering to a periodic array of nanoscale filaments. Although made of achiral molecules, the layers in these filaments are twisted and rigorously homochiral-a broken symmetry. The precise structural definition achieved in filament self-assembly enables collective organization into arrays in which an additional broken symmetry-the appearance of macroscopic coherence of the filament twist-produces a liquid crystal phase of helically precessing layers.	[Hough, L. E.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Hough, L. E.; Heberling, M. S.; Nakata, M.; Jones, C. D.; Chen, D.; Link, D. R.; Koerblova, E.; Walba, D. M.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Jung, H. T.] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn BK 21, Taejon 305701, South Korea; [Krueerke, D.; Heppke, G.] Tech Univ Berlin, Inst Inorgan & Analyt Chem, D-10623 Berlin, Germany; [Zasadzinski, J.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Rabe, J. P.; Stocker, W.] Humboldt Univ, Dept Phys, D-10099 Berlin, Germany; [Koerblova, E.; Walba, D. M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Korea Advanced Institute of Science & Technology (KAIST); Technical University of Berlin; University of California System; University of California Santa Barbara; Humboldt University of Berlin; University of Colorado System; University of Colorado Boulder	Hough, LE (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	hough@colorado.edu; noel.clark@colorado.edu	Chen, Dong/D-3874-2014; Rabe, Jürgen P./D-1032-2010; Korblova, Eva/AAC-3502-2021; Glaser, Matthew/H-2345-2016; Walba, David/F-7284-2013; Clark, Noel A/AAP-9116-2020; Jung, Hee-Tae/C-1574-2011; Clark, Noel A./E-9011-2010	Chen, Dong/0000-0002-8904-9307; Rabe, Jürgen P./0000-0003-0847-6663; Korblova, Eva/0000-0002-3818-4373; Glaser, Matthew/0000-0002-8366-5598; Clark, Noel A./0000-0001-9301-5540; HOUGH, LOREN/0000-0002-1104-0126	NSF [DMR 0606528]; NSF Materials Research Science and Engineering Center [DMR 0820579]; Deutsche Forschungsgemeinschaft [Sfb 448]; NIH [HL-51177]; U.S. Department of Energy, Divisions of Materials and Chemical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051177] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Divisions of Materials and Chemical Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NSF grant DMR 0606528 (N.A.C.), NSF Materials Research Science and Engineering Center grant DMR 0820579 (N.A.C.), an NSF Graduate Research Fellowship (L.H.), Deutsche Forschungsgemeinschaft grant Sfb 448 (J.P.R.), and NIH grant HL-51177 (J.Z.). Use of the National Synchrotron Light Source was supported by the U.S. Department of Energy, Divisions of Materials and Chemical Sciences.	Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Araoka F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137801; BOULIGAND Y, 1984, J PHYS-PARIS, V45, P1899, DOI 10.1051/jphys:0198400450120189900; Choi SW, 2006, ANGEW CHEM INT EDIT, V45, P6503, DOI 10.1002/anie.200601129; Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956; COLLINGS P, 1997, 1 INT WORKSH BANN SH; de Vries AH, 2005, P NATL ACAD SCI USA, V102, P5392, DOI 10.1073/pnas.0408249102; DEGENNES PG, 1972, SOLID STATE COMMUN, V10, P753, DOI 10.1016/0038-1098(72)90186-X; Fernsler J, 2005, P NATL ACAD SCI USA, V102, P14191, DOI 10.1073/pnas.0500664102; Link DR, 1997, SCIENCE, V278, P1924, DOI 10.1126/science.278.5345.1924; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; Niwano H, 2004, J PHYS CHEM B, V108, P14889, DOI 10.1021/jp0311355; Noorduin WL, 2008, J AM CHEM SOC, V130, P1158, DOI 10.1021/ja7106349; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; RENN SR, 1988, PHYS REV A, V38, P2132, DOI 10.1103/PhysRevA.38.2132; Sekine T, 1997, JPN J APPL PHYS 1, V36, P6455, DOI 10.1143/JJAP.36.6455; Sekine T, 1997, J MATER CHEM, V7, P1307, DOI 10.1039/a702026k; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; SPECTOR MS, 2002, MAT CHIRALITY SPECIA, P281; Takezoe H, 2006, JPN J APPL PHYS 1, V45, P597, DOI 10.1143/JJAP.45.597; Thisayukta J, 2001, JPN J APPL PHYS 1, V40, P3277, DOI 10.1143/JJAP.40.3277; Thisayukta J, 2000, J AM CHEM SOC, V122, P7441, DOI 10.1021/ja001370q; Walba DM, 2005, CRYST GROWTH DES, V5, P2091, DOI 10.1021/cg050282k; WEISS RG, 2005, MOL GELS MAT SELF AS	25	249	250	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					456	460		10.1126/science.1170027	http://dx.doi.org/10.1126/science.1170027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628864				2022-12-28	WOS:000268255100051
J	Delvaeye, M; Noris, M; De Vriese, A; Esmon, CT; Esmon, NL; Ferrell, G; Del-Favero, J; Plaisance, S; Claes, B; Lambrechts, D; Zoja, C; Remuzzi, G; Conway, EM				Delvaeye, Mieke; Noris, Marina; De Vriese, Astrid; Esmon, Charles T.; Esmon, Naomi L.; Ferrell, Gary; Del-Favero, Jurgen; Plaisance, Stephane; Claes, Bart; Lambrechts, Diether; Zoja, Carla; Remuzzi, Giuseppe; Conway, Edward M.			Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEMBRANE COFACTOR PROTEIN; LECTIN-LIKE DOMAIN; ACTIVATABLE FIBRINOLYSIS INHIBITOR; FACTOR-H; THROMBOTIC MICROANGIOPATHIES; MYOCARDIAL-INFARCTION; COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; GENE MUTATION; INFLAMMATION	Background The hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. The common form of the syndrome is triggered by infection with Shiga toxin-producing bacteria and has a favorable outcome. The less common form of the syndrome, called atypical hemolytic-uremic syndrome, accounts for about 10% of cases, and patients with this form of the syndrome have a poor prognosis. Approximately half of the patients with atypical hemolytic-uremic syndrome have mutations in genes that regulate the complement system. Genetic factors in the remaining cases are unknown. We studied the role of thrombomodulin, an endothelial glycoprotein with anticoagulant, antiinflammatory, and cytoprotective properties, in atypical hemolytic-uremic syndrome. Methods We sequenced the entire thrombomodulin gene (THBD) in 152 patients with atypical hemolytic-uremic syndrome and in 380 controls. Using purified proteins and cell-expression systems, we investigated whether thrombomodulin regulates the complement system, and we characterized the mechanisms. We evaluated the effects of thrombomodulin missense mutations associated with atypical hemolytic uremic syndrome on complement activation by expressing thrombomodulin variants in cultured cells. Results Of 152 patients with atypical hemolytic-uremic syndrome, 7 unrelated patients had six different heterozygous missense THBD mutations. In vitro, thrombomodulin binds to C3b and factor H (CFH) and negatively regulates complement by accelerating factor I-mediated inactivation of C3b in the presence of cofactors, CFH or C4b binding protein. By promoting activation of the plasma procarboxypeptidase B, thrombomodulin also accelerates the inactivation of anaphylatoxins C3a and C5a. Cultured cells expressing thrombomodulin variants associated with atypical hemolytic-uremic syndrome had diminished capacity to inactivate C3b and to activate procarboxypeptidase B and were thus less protected from activated complement. Conclusions Mutations that impair the function of thrombomodulin occur in about 5% of patients with atypical hemolytic-uremic syndrome.	[Delvaeye, Mieke; De Vriese, Astrid; Claes, Bart; Lambrechts, Diether; Conway, Edward M.] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Leuven, Belgium; [Del-Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Grp, B-2610 Antwerp, Belgium; [Plaisance, Stephane] VIB BioInformat Training & Serv Facil, Ghent, Belgium; [Noris, Marina; Zoja, Carla; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis, I-24100 Bergamo, Italy; [Esmon, Charles T.; Esmon, Naomi L.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Esmon, Charles T.; Ferrell, Gary] Howard Hughes Med Inst, Oklahoma City, OK USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Conway, EM (corresponding author), Univ British Columbia, Life Sci Ctr, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	emconway@interchange.ubc.ca	zoja, carlamaria/ABF-5896-2020; Lambrechts, Diether/AAJ-3167-2020; NORIS, MARINA/ABG-2219-2020; Plaisance, Stephane/B-3488-2009; Verdrengh, Evelien/H-4571-2012; Plaisance, Stephane/ABI-6307-2020; Remuzzi, Giuseppe/V-9766-2017	zoja, carlamaria/0000-0003-2507-8894; Lambrechts, Diether/0000-0002-3429-302X; NORIS, MARINA/0000-0001-7651-5033; Plaisance, Stephane/0000-0002-1651-241X; Plaisance, Stephane/0000-0002-1651-241X; Conway, Edward/0000-0003-0081-0305; Del Favero, jurgen/0000-0002-7427-7489; Remuzzi, Giuseppe/0000-0002-6194-3446	National Institutes of Health [DK71221]; Istituto Superiore della Sanita [526D/9]; Fondazione ART Per La Ricerca Sui Trapianti (Milan); Fonds voor Wetenschappelijk Onderzoek [G.0675.08]; Fondation Leducq in Paris; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istituto Superiore della Sanita; Fondazione ART Per La Ricerca Sui Trapianti (Milan); Fonds voor Wetenschappelijk Onderzoek(FWO); Fondation Leducq in Paris(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the National Institutes of Health (DK71221), Istituto Superiore della Sanita (Project no. 526D/9), Fondazione ART Per La Ricerca Sui Trapianti (Milan) (all to Drs. Noris and Remuzzi), Fonds voor Wetenschappelijk Onderzoek (FWO #G.0675.08, to Dr. Conway), and Fondation Leducq in Paris (to Drs. C. T. Esmon and N. L. Esmon).	BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Buelens K, 2008, CIRC RES, V102, P295, DOI 10.1161/CIRCRESAHA.107.157099; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P743; Esmon C, 2005, NAT MED, V11, P475, DOI 10.1038/nm0505-475; Faioni EM, 2002, BRIT J HAEMATOL, V118, P595, DOI 10.1046/j.1365-2141.2002.03644.x; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Fremeaux-Bacchi V, 2005, J MED GENET, V42, P852, DOI 10.1136/jmg.2005.030783; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GERLITZ B, 1993, BIOCHEM J, V295, P131, DOI 10.1042/bj2950131; Geudens N, 2008, EUR RESPIR J, V32, P862, DOI 10.1183/09031936.00157107; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jokiranta TS, 2007, MOL IMMUNOL, V44, P3889, DOI 10.1016/j.molimm.2007.06.003; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kaare M, 2007, HUM REPROD, V22, P864, DOI 10.1093/humrep/del436; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Kunz G, 2000, BLOOD, V95, P569, DOI 10.1182/blood.V95.2.569; Liszewski MK, 2007, MOL IMMUNOL, V44, P1559, DOI 10.1016/j.molimm.2006.08.024; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Monteferrante G, 2007, MOL IMMUNOL, V44, P1704, DOI 10.1016/j.molimm.2006.08.004; Morigi M, 2001, BLOOD, V98, P1828, DOI 10.1182/blood.V98.6.1828; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Norlund L, 1997, THROMB HAEMOSTASIS, V78, P1164; Ohlin AK, 1999, THROMB HAEMOSTASIS, V81, P338; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Razzaq S, 2006, AM FAM PHYSICIAN, V74, P991; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Sucker C, 2007, NEPHROL DIAL TRANSPL, V22, P1347, DOI 10.1093/ndt/gfl753; Taylor F B Jr, 1994, Prog Clin Biol Res, V388, P175; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; van den Boom Dirk, 2007, Methods Mol Biol, V366, P287; Vercellotti GM, 1998, BLOOD COAGUL FIBRIN, V9, pS3; Villoutreix BO, 1998, J MOL MODEL, V4, P310, DOI 10.1007/s008940050088; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Wu KK, 2001, CIRCULATION, V103, P1386, DOI 10.1161/01.CIR.103.10.1386; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	57	368	394	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					345	357		10.1056/NEJMoa0810739	http://dx.doi.org/10.1056/NEJMoa0810739			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625716	Green Accepted			2022-12-28	WOS:000268184500005
J	Majeti, R; Chao, MP; Alizadeh, AA; Pang, WW; Jaiswal, S; Gibbs, KD; van Rooijen, N; Weissman, IL				Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Gibbs, Kenneth D., Jr.; van Rooijen, Nico; Weissman, Irving L.			CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells	CELL			English	Article							ACUTE MYELOGENOUS LEUKEMIA; SIGNAL-REGULATORY PROTEIN; RECEPTOR-ALPHA CHAIN; MONOCLONAL-ANTIBODY; DENDRITIC CELL; SIRP-ALPHA; NEGATIVE REGULATION; CANCER; PROGENITORS; MARKER	Acute myeloid leukemia (AML) is organized as a cellular hierarchy initiated and maintained by a subset of self-renewing leukemia stem cells (LSC). We hypothesized that increased CD47 expression on human AML LSC contributes to pathogenesis by inhibiting their phagocytosis through the interaction of CD47 with an inhibitory receptor on phagocytes. We found that CD47 was more highly expressed on AML LSC than their normal counterparts, and that increased CD47 expression predicted worse overall survival in three independent cohorts of adult AML patients. Furthermore, blocking monoclonal antibodies directed against CD47 preferentially enabled phagocytosis of AML LSC and inhibited their engraftment in vivo. Finally, treatment of human AML LSC-engrafted mice with anti-CD47 antibody depleted AML and targeted AML LSC. In summary, increased CD47 expression is an independent, poor prognostic factor that can be targeted on human AML stem cells with blocking monoclonal antibodies capable of enabling phagocytosis of LSC.	[Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Div Hematol, Dept Internal Med, Palo Alto, CA 94304 USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Weissman, Irving L.] Stanford Univ, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Majeti, Ravindra; Chao, Mark P.; Alizadeh, Ash A.; Pang, Wendy W.; Jaiswal, Siddhartha; Weissman, Irving L.] Stanford Univ, Ludwig Ctr Stanford, Palo Alto, CA 94304 USA; [Gibbs, Kenneth D., Jr.] Stanford Univ, Program Immunol, Palo Alto, CA 94304 USA; [Gibbs, Kenneth D., Jr.] Stanford Univ, Baxter Lab Genet Pharmacol, Palo Alto, CA 94304 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Vrije Universiteit Amsterdam	Majeti, R (corresponding author), Stanford Univ, Div Hematol, Dept Internal Med, Palo Alto, CA 94304 USA.	rmajeti@stanford.edu; irv@stanford.edu	Van Rooijen, Nico/Z-1578-2019; Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Gibbs, Kenneth/0000-0002-3532-5396; Majeti, Ravindra/0000-0002-5814-0984	Walter and Idun Y. Berry Foundation; Doctors Cancer Foundation; American Association for Cancer Research; Howard Hughes Medical Institute; American Medical Association Seed Research; Stanford Medical Scholars Research Program; Stanford Medical Scientist Training Program; NIH Interdisciplinary Regenerative Medicine Predoctoral; National Science Foundation Graduate Research; National Institutes of Health [R01CA86017]; Smith Family Fund; NATIONAL CANCER INSTITUTE [R01CA086017, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	Walter and Idun Y. Berry Foundation; Doctors Cancer Foundation; American Association for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Medical Association Seed Research; Stanford Medical Scholars Research Program; Stanford Medical Scientist Training Program; NIH Interdisciplinary Regenerative Medicine Predoctoral; National Science Foundation Graduate Research(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge Libuse Jerabek and Theresa Storm for excellent lab management, Adriane Mosely for animal husbandry, Chrissy Muscat for antibody preparation, Chris Park for histology assistance, and Garry Nolan for support. The authors are grateful to Drs. Jonathan Pollack, Lars Bullinger, Hartmut Dohner, Peter J. M. Valk, Ruud Delwel, and Bob Lowenberg for sharing microarray data as well as the corresponding clinical covariates for AML patients and to Rob Tibshirani for statistical advice. R. M. is supported by grants from the Walter and Idun Y. Berry Foundation, the Doctors Cancer Foundation, and the American Association for Cancer Research. R. M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. P. C. is supported by a Medical Student Training Fellowship from the Howard Hughes Medical Institute, an American Medical Association Seed Research Grant, and the Stanford Medical Scholars Research Program. W. W. P. is supported by the Stanford Medical Scientist Training Program and an NIH Interdisciplinary Regenerative Medicine Predoctoral Fellowship. S. J. is supported by the Stanford Medical Scientist Training Program. K. D. G. is supported by the National Science Foundation Graduate Research Fellowship and Stanford DARE Fellowship. I. L. W. is the Virginia and Daniel Ludwig Professor of Clinical Cancer at Stanford University. I. L. W. is a cofounder and Director of Stem Cells Inc. and cofounded Cellerant, Inc. but holds no stock in the company. I. L. W. is an inventor of U. S. Patent Application 11/528,890 entitled "Methods for Diagnosing and Evaluating Treatment of Blood Disorders.'' I. L. W., S. J., M. P. C., and R. M. have filed U. S. Patent Application Serial No. 12/321,215 entitled "Methods For Manipulating Phagocytosis Mediated by CD47.'' This research is supported by National Institutes of Health grant R01CA86017 to I. L. W. and funding from the Smith Family Fund.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ailles LE, 1997, BLOOD, V90, P2555, DOI 10.1182/blood.V90.7.2555.2555_2555_2564; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bullinger L, 2008, BLOOD, V111, P4490, DOI 10.1182/blood-2007-09-115055; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kikuchi Y, 2004, BIOCHEM BIOPH RES CO, V315, P912, DOI 10.1016/j.bbrc.2004.01.128; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Uno S, 2007, ONCOL REP, V17, P1189; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359	46	1012	1131	6	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					286	299		10.1016/j.cell.2009.05.045	http://dx.doi.org/10.1016/j.cell.2009.05.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632179	Bronze, Green Accepted			2022-12-28	WOS:000268277000011
J	Sowa, ME; Bennett, EJ; Gygi, SP; Harper, JW				Sowa, Mathew E.; Bennett, Eric J.; Gygi, Steven P.; Harper, J. Wade			Defining the Human Deubiquitinating Enzyme Interaction Landscape	CELL			English	Article							ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASE; PROTEIN; COMPLEX; BRCA1; TRANSCRIPTION; DEGRADATION; NUCLEAR	Deubiquitinating enzymes (Dubs) function to remove covalently attached ubiquitin from proteins, thereby controlling substrate activity and/or abundance. For most Dubs, their functions, targets, and regulation are poorly understood. To systematically investigate Dub function, we initiated a global proteomic analysis of Dubs and their associated protein complexes. This was accomplished through the development of a software platform called CompPASS, which uses unbiased metrics to assign confidence measurements to interactions from parallel nonreciprocal proteomic data sets. We identified 774 candidate interacting proteins associated with 75 Dubs. Using Gene Ontology, interactome topology classification, subcellular localization, and functional studies, we link Dubs to diverse processes, including protein turnover, transcription, RNA processing, DNA damage, and endoplasmic reticulum-associated degradation. This work provides the first glimpse into the Dub interaction landscape, places previously unstudied Dubs within putative biological pathways, and identifies previously unknown interactions and protein complexes involved in this increasingly important arm of the ubiquitin-proteasome pathway.	[Sowa, Mathew E.; Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [AG085011, GM054137, GM67945]; Paul Glenn Foundation; Stewart Trust; American Cancer Society; Damon Runyon Cancer Research Foundation [1974-08]; Herb Gordon Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn Foundation; Stewart Trust; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation; Herb Gordon Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marc Vidal (Dana Farber Cancer Institute) for the human ORFeome collection, Xue Li and Wilhem Haas from the Gygi laboratory for assistance with mass spectrometry, Frank Stegmeier and Steve Elledge (Harvard Medical School), Robin Voss and Peter Howley (Harvard Medical School), Vishva Dixit (Genetech), Paul Evans (Imperial College, London), Akio Sugiyama (TOYOBO), and Jennifer Svendsen (Harvard Medical School, Harper laboratory) for plasmids. We also thank John Koe Christianson, Steve Kaiser, and Ron Kopito (Stanford University) for the TCRaGFP cell line and antibodies against Hrd1, Ufd1L, and VAPA. This work was supported by grants from the National Institutes of Health (AG085011, GM054137), the Paul Glenn Foundation, and by the Stewart Trust to J. W. H. S. P. G was supported by GM67945 from the National Institutes of Health. M. E. S. was supported by a postdoctoral fellowship from the American Cancer Society. E. J. B. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG 1974-08) and Herb Gordon Postdoctoral Fellowship.	Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; COHN MA, 2008, J BIOL CHEM IN PRESS; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	44	1108	1155	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					389	403		10.1016/j.cell.2009.04.042	http://dx.doi.org/10.1016/j.cell.2009.04.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19615732	Bronze, Green Accepted			2022-12-28	WOS:000268277000019
J	Wawer, MJ; Makumbi, F; Kigozi, G; Serwadda, D; Watya, S; Nalugoda, F; Buwembo, D; Ssempijja, V; Kiwanuka, N; Moulton, LH; Sewankambo, NK; Reynolds, SJ; Quinn, TC; Opendi, P; Iga, B; Ridzon, R; Laeyendecker, O; Gray, RH				Wawer, Maria J.; Makumbi, Frederick; Kigozi, Godfrey; Serwadda, David; Watya, Stephen; Nalugoda, Fred; Buwembo, Dennis; Ssempijja, Victor; Kiwanuka, Noah; Moulton, Lawrence H.; Sewankambo, Nelson K.; Reynolds, Steven J.; Quinn, Thomas C.; Opendi, Pius; Iga, Boaz; Ridzon, Renee; Laeyendecker, Oliver; Gray, Ronald H.			Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial	LANCET			English	Article							DISCORDANT COUPLES; PREVENTION; COHORT; WOMEN	Background Observational studies have reported an association between male circumcision and reduced risk of HIV infection in female partners. We assessed whether circumcision in HIV-infected men would reduce transmission of the virus to female sexual partners. Methods 922 uncircumcised, HIV-infected, asymptomatic men aged 15-49 years with CD4-cell counts 350 cells per mu L or more were enrolled in this unblinded, randomised controlled trial in Rakai District, Uganda. Men were randomly assigned by computer-generated randomisation sequence to receive immediate circumcision (intervention; n=474) or circumcision delayed for 24 months (control; n=448). HIV-uninfected female partners of the randomised men were concurrently enrolled (intervention, n=93; control, n=70) and followed up at 6, 12, and 24 months, to assess HIV acquisition by male treatment assignment (primary outcome). A modified intention-to-treat (ITT) analysis, which included all concurrently enrolled couples in which the female partner had at least one follow-up visit over 24 months, assessed female HIV acquisition by use of survival analysis and Cox proportional hazards modelling. This trial is registered with ClinicalTrials.gov, number NCT00124878. Findings The trial was stopped early because of futility. 92 couples in the intervention group and 67 couples in the control group were included in the modified ITT analysis. 17 (18%) women in the intervention group and eight (12%) women in the control group acquired HIV during follow-up (p=0.36). Cumulative probabilities of female HIV infection at 24 months were 21.7% (95% Cl 12.7-33.4) in the intervention group and 13.4% (6.7-25.8) in the control group (adjusted hazard ratio 1.49, 95% CI 0.62-3.57; p=0.368). Interpretation Circumcision of HIV-infected men did not reduce HIV transmission to female partners over 24 months; longer-term effects could not be assessed. Condom use after male circumcision is essential for HIV prevention.	[Wawer, Maria J.; Gray, Ronald H.] Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Moulton, Lawrence H.] Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Makumbi, Frederick; Kigozi, Godfrey; Serwadda, David; Nalugoda, Fred; Buwembo, Dennis; Ssempijja, Victor; Kiwanuka, Noah; Sewankambo, Nelson K.; Opendi, Pius; Iga, Boaz] Rakai Hlth Sci Program, Kalisizo, Uganda; [Makumbi, Frederick; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Watya, Stephen] Makerere Univ, Mulago Hosp, Dept Surg, Urol Unit, Kampala, Uganda; [Sewankambo, Nelson K.] Makerere Univ, Fac Med, Coll Hlth Sci, Kampala, Uganda; [Reynolds, Steven J.; Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Reynolds, Steven J.; Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, NIH, Bethesda, MD 20892 USA; [Ridzon, Renee] Bill & Melinda Gates Fdn, Seattle, WA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Makerere University; Makerere University; Mulago National Referral Hospital; Makerere University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Bill & Melinda Gates Foundation	Wawer, MJ (corresponding author), Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, 615 N Wolfe St,Suite E4132, Baltimore, MD 21205 USA.	mwawer@jhsph.edu	Laeyendecker, Oliver B/B-9331-2009	Sewankambo, Nelson/0000-0001-9362-053X; Laeyendecker, Oliver/0000-0002-6429-4760; Moulton, Lawrence/0000-0001-7041-7387; Reynolds, Steven/0000-0002-5403-2759	Bill & Melinda Gates Foundation [22006]; FOGARTY INTERNATIONAL CENTER [T22TW000015, D43TW001508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The trial was funded by the Bill & Melinda Gates Foundation as an investigator-initiated grant (number 22006). Additional support for laboratory analyses an training were provided, respectively, by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, and the Fogarty International Center (grants SD43TW001508 and D43TW00015). The study was conducted by the Rakai Health Sciences Program, a research collaboration between the Uganda Virus Research Institute, and researchers at Makerere and Johns Hopkins Universities. We thank the members of the data and safety monitoring board, and the institutional review boards that provided oversight (the Committee for Human Research, Johns Hopkins Bloomberg School of Public Health, the Science and Ethics Committee of the Uganda Virus Research Institute, and the We:;tern Institutional Review Board). We are also grateful for the advice provided by the Rakai community advisory board. We thank Edward Mbidde (Uganda Virus Research Institute) for his support. Finally, we wish to express our gratitude to the study participants whose commitment and cooperation made the study possible.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; HUNTER DJ, 1994, AIDS, V8, P93, DOI 10.1097/00002030-199401000-00014; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; WAWER M, 2008, 15 C RETR OPP INF BO; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; World Health Organization, 2007, NEW DAT MAL CIRC HIV; Yang CF, 2001, AIDS RES HUM RETROV, V17, P361, DOI 10.1089/08892220150503726	18	222	229	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					229	237		10.1016/S0140-6736(09)60998-3	http://dx.doi.org/10.1016/S0140-6736(09)60998-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19616720	Green Accepted			2022-12-28	WOS:000268263000031
J	Bignami, G				Bignami, Giovanni			Why we need space travel	NATURE			English	Editorial Material									[Bignami, Giovanni] Inst Adv Study Pavia IUSS, I-27100 Pavia, Italy; [Bignami, Giovanni] Accademia Lincei, Rome, Italy; [Bignami, Giovanni] ESA, Space Sci Advisory Comm, F-75738 Paris 15, France	IUSS PAVIA	Bignami, G (corresponding author), Inst Adv Study Pavia IUSS, Lungo Ticino Sforza 56, I-27100 Pavia, Italy.	giovanni.bignami@gmail.com		Bignami, Giovanni/0000-0001-9582-2450					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					325	325		10.1038/460325a	http://dx.doi.org/10.1038/460325a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470MO	19606127				2022-12-28	WOS:000267979000016
J	Caselli, RJ; Dueck, AC; Osborne, D; Sabbagh, MN; Connor, DJ; Ahern, GL; Baxter, LC; Rapcsak, SZ; Shi, J; Woodruff, BK; Locke, DEC; Snyder, CH; Alexander, GE; Rademakers, R; Reiman, EM				Caselli, Richard J.; Dueck, Amylou C.; Osborne, David; Sabbagh, Marwan N.; Connor, Donald J.; Ahern, Geoffrey L.; Baxter, Leslie C.; Rapcsak, Steven Z.; Shi, Jiong; Woodruff, Bryan K.; Locke, Dona E. C.; Snyder, Charlene Hoffman; Alexander, Gene E.; Rademakers, Rosa; Reiman, Eric M.			Longitudinal Modeling of Age-Related Memory Decline and the APOE epsilon 4 Effect	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; E ALLELE EPSILON-4; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; RISK; INDIVIDUALS; POPULATION; DIAGNOSIS; DEMENTIA; CORTEX	Background The APOE epsilon 4 allele is associated with the risk of late-onset Alzheimer's disease. The age at which memory decline diverges among persons who are homozygous for the APOE epsilon 4 allele, those who are heterozygous for the allele, and noncarriers is unknown. Methods Using local advertisements, we recruited cognitively normal subjects between the ages of 21 and 97 years, who were grouped according to their APOE epsilon 4 status. We then followed the subjects with longitudinal neuropsychological testing. Anyone in whom mild cognitive impairment or dementia developed during follow-up was excluded. We compared the rates of decline in predetermined cognitive measures between carriers and noncarriers of the APOE epsilon 4 allele, using a mixed model for longitudinal change with age. Results We analyzed 815 subjects: 317 APOE epsilon 4 carriers (79 who were homozygous for the APOE epsilon 4 allele and 238 who were heterozygous) and 498 noncarriers. Carriers, as compared with noncarriers, were generally younger (mean age, 58.0 vs. 61.4 years; P<0.001) and were followed for a longer period (5.3 vs. 4.7 years, P = 0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in carriers began before the age of 60 years and showed greater acceleration than in noncarriers (P = 0.03), with a possible allele-dose effect (P = 0.008). We observed similar although weaker effects on measures of visuospatial awareness and general mental status. Conclusions Age-related memory decline in APOE epsilon 4 carriers diverges from that of noncarriers before the age of 60 years, despite ongoing normal clinical status.	[Caselli, Richard J.] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ 85259 USA; [Sabbagh, Marwan N.; Connor, Donald J.] Sun Hlth Res Inst, Sun City, AZ USA; [Ahern, Geoffrey L.; Rapcsak, Steven Z.; Alexander, Gene E.; Reiman, Eric M.] Univ Arizona, Tucson, AZ USA; [Baxter, Leslie C.; Shi, Jiong] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Reiman, Eric M.] Translat Genom Res Inst, Phoenix, AZ USA; [Rademakers, Rosa] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic Phoenix; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Arizona; Barrow Neurological Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; Translational Genomics Research Institute; Mayo Clinic	Caselli, RJ (corresponding author), Mayo Clin Arizona, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	caselli.richard@mayo.edu		Locke, Dona/0000-0002-1966-7716; Baxter, Leslie/0000-0002-3971-863X	National Institute on Aging [P30-AG19610, R01-AG031581]; National Institute of Mental Health [R01-MH057899]; Alzheimer's Association [IIRG-98-078]; Arizona Alzheimer's Consortium; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); Arizona Alzheimer's Consortium; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the National Institute on Aging (P30-AG19610 and R01-AG031581), the National Institute of Mental Health (R01-MH057899), the Alzheimer's Association (IIRG-98-078), the Arizona Alzheimer's Consortium, and the State of Arizona.	Alafuzoff I, 2000, ANN NY ACAD SCI, V903, P244, DOI 10.1111/j.1749-6632.2000.tb06374.x; Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Balding DJ, 2004, APPL LONGITUDINAL AN; Baxter LC, 2003, NEUROBIOL AGING, V24, P947, DOI 10.1016/S0197-4580(03)00006-X; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Brickell KL, 2006, ARCH NEUROL-CHICAGO, V63, P1307, DOI 10.1001/archneur.63.9.1307; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; Caselli RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1231, DOI 10.1001/archneurol.2008.1; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Caselli RJ, 2002, J AM GERIATR SOC, V50, P49, DOI 10.1046/j.1532-5415.2002.50007.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Crystal HA, 1996, ARCH NEUROL-CHICAGO, V53, P82, DOI 10.1001/archneur.1996.00550010102023; Ferris SH, 2006, ALZ DIS ASSOC DIS, V20, pS109, DOI 10.1097/01.wad.0000213870.40300.21; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; HIXSON JE, 1990, J LIPID RES, V31, P545; Howieson DB, 2008, J INT NEUROPSYCH SOC, V14, P192, DOI 10.1017/S1355617708080375; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morishima-Kawashima M, 2000, AM J PATHOL, V157, P2093, DOI 10.1016/S0002-9440(10)64847-X; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Petersen, 1999, ARCH NEUROL-CHICAGO, V56, P760; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; PETERSEN RC, 1992, NEUROLOGY, V42, P396, DOI 10.1212/WNL.42.2.396; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rey A, 1964, LEXAMEN CLINIQUE PSY; Salthouse TA, 2003, ALZ DIS ASSOC DIS, V17, P162, DOI 10.1097/00002093-200307000-00008; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P464, DOI 10.1080/13854040590945193; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	41	376	391	4	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					255	263		10.1056/NEJMoa0809437	http://dx.doi.org/10.1056/NEJMoa0809437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19605830	Green Accepted			2022-12-28	WOS:000267976100006
J	Taha, AS; McCloskey, C; Prasad, R; Bezlyak, V				Taha, Ali S.; McCloskey, Caroline; Prasad, Rakesh; Bezlyak, Vladimir			Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PROTON-PUMP INHIBITORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HIGH-RISK PATIENTS; HELICOBACTER-PYLORI; CLINICAL-TRIALS; CLOPIDOGREL; VALIDATION; ULCERATION	Background There are few therapeutic options for the prevention of gastrointestinal mucosal damage caused by low-dose aspirin. We therefore investigated the efficacy of famotidine, a well-tolerated histamine H(2)-receptor antagonist, in the prevention of peptic ulcers and erosive oesophagitis in patients receiving low-dose aspirin for vascular protection. Methods Adult patients (aged >= 18 years) from the cardiovascular, cerebrovascular, and diabetes clinics at Crosshouse Hospital, Kilmarnock, UK, were eligible for enrolment in this phase III, randomised, double-blind, placebo-controlled trial if they were taking aspirin 75-325 mg per day with or without other cardioprotective drugs. Patients without ulcers or erosive oesophagitis on endoscopy at baseline were randomly assigned by computer-generated randomisation sequence to receive famotidine 20 mg twice daily (n=204) or placebo twice daily (n=200). Patients had a final endoscopic examination at 12 weeks. The primary endpoint was the development of new ulcers in the stomach or duodenum or erosive oesophagitis at 12 weeks after randomisation. Analysis was by intention to treat, including all randomised patients who received at least one dose of study drug (famotidine or placebo). This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN96975557. Findings All randomised patients received at least one dose and were included in the ITT population. 82 patients (famotidine, n=33; placebo, n=49) did not have the final endoscopic examination and were assumed to have had normal findings; the main reason for participant withdrawal was refusal to continue. At 12 weeks, comparing patients assigned to famotidine with patients assigned to placebo, gastric ulcers had developed in seven (3.4%) of 204 patients compared with 30 (15.0%) of 200 patients (odds ratio [OR] 0.20, 95% Cl 0.09-0.47; p=0.0002); duodenal ulcers had developed in one (0.5%) patient compared with 17 (8.5%; OR 0.05, 0.01-0.40; p=0.0045); and erosive oesophagitis in nine (4.4%) compared with 38 (19.0%; OR 0.20, 0.09-0.42; p<0.0001), respectively. There were fewer adverse events in the famotidine group than in the placebo group (nine vs 15); four patients in the placebo group were admitted to hospital with upper gastrointestinal haemorrhage. The other most common adverse event was angina (famotidine, n=2; placebo, n=4). Interpretation Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients taking low-dose aspirin. These findings widen the therapeutic options for the prevention of gastrointestinal damage in patients needing vascular protection.	[Taha, Ali S.; McCloskey, Caroline; Prasad, Rakesh] Univ Glasgow, Crosshouse Hosp, Gastroenterol Unit, Kilmarnock KA2 0BE, Scotland; [Taha, Ali S.; McCloskey, Caroline; Prasad, Rakesh] Univ Glasgow, Dept Med, Kilmarnock KA2 0BE, Scotland; [Bezlyak, Vladimir] Univ Glasgow, Robertson Ctr Biostat, Kilmarnock KA2 0BE, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Taha, AS (corresponding author), Univ Glasgow, Crosshouse Hosp, Gastroenterol Unit, Kilmarnock KA2 0BE, Scotland.	ali.taha1@btinternet.com	Taha, Ali/AAF-4644-2020	Taha, Ali S/0000-0003-0873-1302	Astellas Pharma Inc, Japan	Astellas Pharma Inc, Japan(Astellas Pharmaceuticals)	The study drugs (famotidine and placebo) were donated by Merck Laboratories, UK. This study was sponsored by Astellas Pharma Inc, Japan. The data and safety monitoring committee included lan Ford (Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK), Peter R Mills (Gartnavel General Hospital, Glasgow, and University of Glasgow); and Toni Macdonald (University of Dundee, Dundee, UK).	Belch J., 2008, BMJ-BRIT MED J, V337, P1030, DOI DOI 10.1136/BMJ.A1840; Chan FKL, 2008, LANCET, V372, P1198, DOI 10.1016/S0140-6736(08)61497-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DANESHMEND TK, 1989, GASTROENTEROLOGY, V97, P944, DOI 10.1016/0016-5085(89)91502-3; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Rodriguez LAG, 2007, CLIN GASTROENTEROL H, V5, P1418, DOI 10.1016/j.cgh.2007.09.010; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hudson N, 1997, GASTROENTEROLOGY, V112, P1817, DOI 10.1053/gast.1997.v112.pm9178671; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lanas A, 2003, SCAND J GASTROENTERO, V38, P693, DOI 10.1080/00365520310003967; LANZA FL, 1990, DIGEST DIS SCI, V35, P1494, DOI 10.1007/BF01540567; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Niv Y, 2005, DIGEST DIS SCI, V50, P78, DOI 10.1007/s10620-005-1281-1; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Taha AS, 2008, ALIMENT PHARM THER, V28, P878, DOI 10.1111/j.1365-2036.2008.03808.x; Taha AS, 2007, ALIMENT PHARM THER, V26, P1171, DOI 10.1111/j.1365-2036.2007.03458.x; Taha AS, 2006, ALIMENT PHARM THER, V24, P633, DOI 10.1111/j.1365-2036.2006.03017.x; TAHA AS, 1995, GUT, V36, P334, DOI 10.1136/gut.36.3.334; Taha AS, 1999, GASTROENTEROLOGY, V116, P254, DOI 10.1016/S0016-5085(99)70120-4; Taha AS, 2006, ALIMENT PHARM THER, V23, P489, DOI 10.1111/j.1365-2036.2006.02784.x; Taha AS, 1996, NEW ENGL J MED, V334, P1435, DOI 10.1056/NEJM199605303342204; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; Yeomans ND, 2008, ALIMENT PHARM THERAP, V27, P465, DOI 10.1111/j.1365-2036.2008.03610.x; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI 10.1111/j.1572-0241.2008.01995.x	29	167	179	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 11	2009	374	9684					119	125		10.1016/S0140-6736(09)61246-0	http://dx.doi.org/10.1016/S0140-6736(09)61246-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19577798				2022-12-28	WOS:000268111600029
J	Scharmer, G				Scharmer, Goran			Sunspot Flows and Filaments	SCIENCE			English	Editorial Material							FINE-STRUCTURE; PENUMBRAL FILAMENTS; MAGNETOCONVECTION; ORIGIN		[Scharmer, Goran] Stockholm Univ, Inst Solar Phys, Royal Swedish Acad Sci, SE-10691 Stockholm, Sweden; [Scharmer, Goran] Stockholm Univ, Dept Astron, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden	Royal Swedish Academy of Sciences; Stockholm University; Stockholm University	Scharmer, G (corresponding author), Stockholm Univ, Inst Solar Phys, Royal Swedish Acad Sci, SE-10691 Stockholm, Sweden.	scharmer@astro.su.se						Carlsson M, 2004, ASTROPHYS J, V610, pL137, DOI 10.1086/423305; Heinemann T, 2007, ASTROPHYS J, V669, P1390, DOI 10.1086/520827; Ichimoto K, 2007, SCIENCE, V318, P1597, DOI 10.1126/science.1146046; Keller CU, 2004, ASTROPHYS J, V607, pL59, DOI 10.1086/421553; Montesinos B, 1997, NATURE, V390, P485, DOI 10.1038/37307; Nordlund A, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-2; Rempel M, 2009, SCIENCE, V325, P171, DOI 10.1126/science.1173798; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Scharmer GB, 2008, ASTROPHYS J LETT, V677, pL149, DOI 10.1086/587982; Scharmer GRB, 2002, NATURE, V420, P151, DOI 10.1038/nature01173; Schlichenmaier R, 1998, ASTROPHYS J, V493, pL121, DOI 10.1086/311137; Schlichenmaier R, 2003, ASTRON ASTROPHYS, V411, P257, DOI 10.1051/0004-6361:20031120; Schussler M, 2006, ASTROPHYS J, V641, pL73, DOI 10.1086/503772; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Zakharov V, 2008, ASTRON ASTROPHYS, V488, pL17, DOI 10.1051/0004-6361:200810266	15	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					155	156		10.1126/science.1175752	http://dx.doi.org/10.1126/science.1175752			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589989				2022-12-28	WOS:000267802000031
J	Fjerstad, M; Trussell, J; Sivin, I; Lichtenberg, ES; Cullins, V				Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa			Rates of Serious Infection after Changes in Regimens for Medical Abortion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLOSTRIDIUM-SORDELLII; UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TRIAL	Background: From 2001 through March 2006, Planned Parenthood health centers throughout the United States provided medical abortion (abortion by means of medication) principally by a regimen of oral mifepristone followed 24 to 48 hours later by vaginal misoprostol. In response to concern about serious infections, in early 2006 Planned Parenthood changed the route of misoprostol administration from vaginal to buccal and required either routine provision of antibiotics or universal screening and treatment for chlamydia; in July 2007, Planned Parenthood began requiring routine treatment with antibiotics for all medical abortions. Methods: We performed a retrospective analysis assessing the rates of serious infection after medical abortion during a time when misoprostol was administered vaginally (through March 2006), as compared with rates after a change to buccal administration of misoprostol and after initiation of additional infection-reduction measures. Results: Rates of serious infection dropped significantly after the joint change to buccal misoprostol from vaginal misoprostol and to either testing for sexually transmitted infection or routine provision of antibiotics as part of the medical abortion regimen. The rate declined 73%, from 0.93 per 1000 abortions to 0.25 per 1000 (absolute reduction, 0.67 per 1000; 95% confidence interval [CI], 0.44 to 0.94; P<0.001). The subsequent change to routine provision of antibiotics led to a further significant reduction in the rate of serious infection -- a 76% decline, from 0.25 per 1000 abortions to 0.06 per 1000 (absolute reduction, 0.19 per 1000; 95% CI, 0.02 to 0.34; P=0.03). Conclusions: The rate of serious infection after medical abortion declined by 93% after a change from vaginal to buccal administration of misoprostol combined with routine administration of antibiotics. N Engl J Med 2009;361:145-51.	[Fjerstad, Mary; Cullins, Vanessa] Planned Parenthood Federat Amer, New York, NY USA; [Sivin, Irving] Populat Council, Reprod Hlth Program, New York, NY 10021 USA; [Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Trussell, James] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Lichtenberg, E. Steve] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Population Council; Princeton University; University of Hull; University of York - UK; Northwestern University; Feinberg School of Medicine	Fjerstad, M (corresponding author), Ipas, POB 5027, Chapel Hill, NC 27514 USA.	fjerstadm@ipas.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NICHD NIH HHS [R24 HD047879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; [Anonymous], 2005, OBSTET GYNECOL, V106, P871; *CDCP, 2008, SEX TRANSM DIS SURV; Darney PD, 2005, CONTRACEPTION, V72, P319, DOI 10.1016/j.contraception.2005.07.009; Fischer M, 2005, NEW ENGL J MED, V353, P2352, DOI 10.1056/NEJMoa051620; FJERSTAD M, 1996, OBSTET GYNECOL, V87, P884; *FOOD DRUG ADM, 2007, MIF MIF INF; Hausknecht R, 2003, CONTRACEPTION, V67, P463, DOI 10.1016/S0010-7824(03)00049-0; Henderson JT, 2005, CONTRACEPTION, V72, P175, DOI 10.1016/j.contraception.2005.03.011; Middleton T, 2005, CONTRACEPTION, V72, P328, DOI 10.1016/j.contraception.2005.05.017; Sawaya GF, 1996, OBSTET GYNECOL, V87, P884; Shannon C, 2004, CONTRACEPTION, V70, P183, DOI 10.1016/j.contraception.2004.04.009; Spitz IM, 1998, NEW ENGL J MED, V338, P1241, DOI 10.1056/NEJM199804303381801; Winikoff B, 2008, OBSTET GYNECOL, V112, P1303, DOI 10.1097/AOG.0b013e31818d8eb4	14	60	61	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					145	151		10.1056/NEJMoa0809146	http://dx.doi.org/10.1056/NEJMoa0809146			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587339	Green Accepted			2022-12-28	WOS:000267748900007
J	Tu, XM; Manohar, S; Jagota, A; Zheng, M				Tu, Xiaomin; Manohar, Suresh; Jagota, Anand; Zheng, Ming			DNA sequence motifs for structure-specific recognition and separation of carbon nanotubes	NATURE			English	Article							SINGLE-STRANDED-DNA; MOLECULAR-DYNAMICS; HYBRIDS; DISPERSION; SIMULATION; POLYMERS; ENERGY	Single-walled carbon nanotubes (SWNTs) are a family of molecules that have the same cylindrical shape but different chiralities(1). Many fundamental studies and technological applications(2) of SWNTs require a population of tubes with identical chirality that current syntheses cannot provide. The SWNT sorting problem-that is, separation of a synthetic mixture of tubes into individual single-chirality components-has attracted considerable attention in recent years. Intense efforts so far have focused largely on, and resulted in solutions for, a weaker version of the sorting problem: metal/semiconductor separation(3,4). A systematic and general method to purify each and every single-chirality species of the same electronic type from the synthetic mixture of SWNTs is highly desirable, but the task has proven to be insurmountable to date. Here we report such a method, which allows purification of all 12 major single-chirality semiconducting species from a synthetic mixture, with sufficient yield for both fundamental studies and application development. We have designed an effective search of a DNA library of similar to 10(60) in size, and have identified more than 20 short DNA sequences, each of which recognizes and enables chromatographic purification of a particular nanotube species from the synthetic mixture. Recognition sequences exhibit a periodic purine-pyrimidines pattern, which can undergo hydrogen-bonding to form a two-dimensional sheet, and fold selectively on nanotubes into a well-ordered three-dimensional barrel. We propose that the ordered two-dimensional sheet and three-dimensional barrel provide the structural basis for the observed DNA recognition of SWNTs.	[Tu, Xiaomin; Zheng, Ming] DuPont Co Inc, Cent Res & Dev, Wilmington, DE 19880 USA; [Manohar, Suresh; Jagota, Anand] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA; [Jagota, Anand] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	DuPont; Lehigh University; Lehigh University	Zheng, M (corresponding author), DuPont Co Inc, Cent Res & Dev, Wilmington, DE 19880 USA.	ming.zheng@usa.dupont.com			US National Science Foundation [CMS-060950]	US National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the US National Science Foundation (grant CMS-060950). We thank T. Devine for technical assistance.	[Anonymous], 1999, PHYS PROPERTIES CARB; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Chen FM, 2007, NANO LETT, V7, P3013, DOI 10.1021/nl071349o; Frischknecht AL, 2008, J PHYS CHEM C, V112, P6271, DOI 10.1021/jp077522m; Gowtham S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125701; Haroz EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125405; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Johnson RR, 2008, NANO LETT, V8, P69, DOI 10.1021/nl071909j; Johnson RR, 2009, NANO LETT, V9, P537, DOI 10.1021/nl802645d; Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148; Kim WJ, 2009, J AM CHEM SOC, V131, P3128, DOI 10.1021/ja807989d; Lustig SR, 2005, J PHYS CHEM B, V109, P2559, DOI 10.1021/jp0452913; Manohar S, 2007, J PHYS CHEM C, V111, P17835, DOI 10.1021/jp071316x; Manohar S, 2008, NANO LETT, V8, P4365, DOI 10.1021/nl8022143; Marquis R, 2008, NANO LETT, V8, P1830, DOI 10.1021/nl0803141; Martin W, 2008, J PHYS CHEM B, V112, P16076, DOI 10.1021/jp8040567; Meng S, 2007, NANO LETT, V7, P45, DOI 10.1021/nl0619103; Ming Z, 2004, J AM CHEM SOC, V126, P15490, DOI 10.1021/ja0457967; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Tu XM, 2008, NANO RES, V1, P185, DOI 10.1007/s12274-008-8022-7; Yao YG, 2009, NANO LETT, V9, P1673, DOI 10.1021/nl900207v; Zhang L, 2009, J AM CHEM SOC, V131, P2454, DOI 10.1021/ja8096674; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Zheng M, 2007, J AM CHEM SOC, V129, P6084, DOI 10.1021/ja071577k	28	864	893	8	397	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					250	253		10.1038/nature08116	http://dx.doi.org/10.1038/nature08116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587767				2022-12-28	WOS:000267761000039
J	Brook, RH				Brook, Robert H.			Possible Outcomes of Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90407 USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Sch Publ Hlth, Los Angeles, CA 90095 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				Baucus M., 2008, CALL ACTION HLTH REF; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *WHIT HOUS, ISS HLTH CAR	3	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					194	195		10.1001/jama.2009.996	http://dx.doi.org/10.1001/jama.2009.996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584350				2022-12-28	WOS:000267696500030
J	Kragl, M; Knapp, D; Nacu, E; Khattak, S; Maden, M; Epperlein, HH; Tanaka, EM				Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Maden, Malcolm; Epperlein, Hans Henning; Tanaka, Elly M.			Cells keep a memory of their tissue origin during axolotl limb regeneration	NATURE			English	Article							CDNA LIBRARIES; BLASTEMA; DEDIFFERENTIATION; DIFFERENTIATION; THYMIDINE; NERVES; STUMP; SKIN	During limb regeneration adult tissue is converted into a zone of undifferentiated progenitors called the blastema that reforms the diverse tissues of the limb. Previous experiments have led to wide acceptance that limb tissues dedifferentiate to form pluripotent cells. Here we have reexamined this question using an integrated GFP transgene to track the major limb tissues during limb regeneration in the salamander Ambystoma mexicanum (the axolotl). Surprisingly, we find that each tissue produces progenitor cells with restricted potential. Therefore, the blastema is a heterogeneous collection of restricted progenitor cells. On the basis of these findings, we further demonstrate that positional identity is a cell-type-specific property of blastema cells, in which cartilage-derived blastema cells harbour positional identity but Schwann-derived cells do not. Our results show that the complex phenomenon of limb regeneration can be achieved without complete dedifferentiation to a pluripotent state, a conclusion with important implications for regenerative medicine.	[Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Tanaka, Elly M.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Epperlein, Hans Henning] Tech Univ Dresden, Fac Med, Inst Anat, D-01307 Dresden, Germany; [Kragl, Martin; Knapp, Dunja; Nacu, Eugen; Khattak, Shahryar; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Maden, Malcolm] Univ Florida, McKnight Brian Inst, Regenerat Project, Gainesville, FL 32611 USA	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; State University System of Florida; University of Florida	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010; Knapp, Dunja/N-2180-2017	Knapp, Dunja/0000-0002-7533-2208; Tanaka, Elly/0000-0003-4240-2158	Volkswagen Foundation [I/78 766]; DFG [SFB655, SPP1109, SPP 1356]; BMBF Biofutures program; Max Planck Institute; Center of Regenerative Therapies; Alexander von Humboldt Foundation	Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); BMBF Biofutures program(Federal Ministry of Education & Research (BMBF)); Max Planck Institute(Foundation CELLEX); Center of Regenerative Therapies; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by grants from the Volkswagen Foundation I/78 766; DFG SFB655, SPP1109, SPP 1356, the BMBF Biofutures program, funds from the Max Planck Institute, and the Center of Regenerative Therapies, Dresden. D. K. was a fellow of the Alexander von Humboldt Foundation. We are grateful to K. Agata, H. Tarui, T. Hayashi and M. Saitou for advice on the single-cell PCR technique. We thank I. Nusslein for assistance on FACS analysis and A. Merseburg for assistance on the nerve rescue experiments. We thank H. Andreas, T. Richter and M. Schuez for technical assistance. We are grateful to L. Rohde, C. Antos, G. Weidinger and A. To ' th for comments on the manuscript.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CARLSON BM, 1974, DEV BIOL, V39, P263, DOI 10.1016/S0012-1606(74)80029-1; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Epperlein HH, 2000, DEVELOPMENT, V127, P2751; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Horstadius S., 1946, Nova Acta Societatis Scientiarum Upsaliensis (4), V13, P1; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; Lheureux E, 1983, Prog Clin Biol Res, V110 Pt A, P455; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; MADEN M, 1982, DEV BIOL, V93, P257, DOI 10.1016/0012-1606(82)90257-3; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; NAMENWIRTH M, 1974, DEV BIOL, V41, P42, DOI 10.1016/0012-1606(74)90281-4; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; ROLLMANDINSMORE C, 1984, DEV BIOL, V106, P275, DOI 10.1016/0012-1606(84)90225-2; SLACK JMW, 1980, J EMBRYOL EXP MORPH, V58, P265; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Thornton CS, 1938, J MORPHOL, V62, P219, DOI 10.1002/jmor.1050620204; UMANSKI E, 1938, B BIOL MED EXP, V6, P141; Wada MR, 2002, DEVELOPMENT, V129, P2987; WALLACE BM, 1973, J EMBRYOL EXP MORPH, V29, P559; WALLACE H, 1972, J EMBRYOL EXP MORPH, V28, P419; Weiss P, 1925, ARCH MIKROSK ANAT EN, V104, P359, DOI 10.1007/BF02254265	41	582	599	14	244	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					60	65		10.1038/nature08152	http://dx.doi.org/10.1038/nature08152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571878				2022-12-28	WOS:000267545200029
J	Niwa, H; Ogawa, K; Shimosato, D; Adachi, K				Niwa, Hitoshi; Ogawa, Kazuya; Shimosato, Daisuke; Adachi, Kenjiro			A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR KLF4; SELF-RENEWAL; NANOG EXPRESSION; DIFFERENTIATION; ACTIVATION; SOX2; IDENTIFICATION; SUFFICIENT; PROMOTER	The cytokine leukaemia inhibitory factor (LIF) integrates signals into mouse embryonic stem (ES) cells to maintain pluripotency. Although the Jak-Stat3 pathway is essential and sufficient to mediate LIF signals(1,2), it is still unclear how these signals are linked to the core circuitry of pluripotency-associated transcription factors, consisting of Oct3/4 (also called Pou5f1), Sox2 and Nanog(3,4). Here we show that two LIF signalling pathways are each connected to the core circuitry via different transcription factors. In mouse ES cells, Klf4 is mainly activated by the Jak-Stat3 pathway and preferentially activates Sox2, whereas Tbx3 is preferentially regulated by the phosphatidylinositol-3-OH kinase-Akt and mitogen-activated protein kinase pathways and predominantly stimulates Nanog. In the absence of LIF, artificial expression of Klf4 or Tbx3 is sufficient to maintain pluripotency while maintaining the expression of Oct3/4. Notably, overexpression of Nanog supports LIF-independent self-renewal of mouse ES cells in the absence of Klf4 and Tbx3 activity. Therefore, Klf4 and Tbx3 are involved in mediating LIF signalling to the core circuitry but are not directly associated with the maintenance of pluripotency, because ES cells keep pluripotency without their expression in the particular context.	[Niwa, Hitoshi; Ogawa, Kazuya; Shimosato, Daisuke; Adachi, Kenjiro] RIKEN Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hitoshi; Shimosato, Daisuke] Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Niwa, Hitoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	RIKEN; Kobe University; Japan Science & Technology Agency (JST)	Niwa, H (corresponding author), RIKEN Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp						Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	640	661	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	2009	460	7251					118	122		10.1038/nature08113	http://dx.doi.org/10.1038/nature08113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571885				2022-12-28	WOS:000267545200041
J	Lassagne, B; Tarakanov, Y; Kinaret, J; Garcia-Sanchez, D; Bachtold, A				Lassagne, Benjamin; Tarakanov, Yury; Kinaret, Jari; Garcia-Sanchez, David; Bachtold, Adrian			Coupling Mechanics to Charge Transport in Carbon Nanotube Mechanical Resonators	SCIENCE			English	Article							SUSPENDED NANOTUBE; RESONANCE	Nanoelectromechanical resonators have potential applications in sensing, cooling, and mechanical signal processing. An important parameter in these systems is the strength of coupling the resonator motion to charge transport through the device. We investigated the mechanical oscillations of a suspended single-walled carbon nanotube that also acts as a single- electron transistor. The coupling of the mechanical and the charge degrees of freedom is strikingly strong as well as widely tunable (the associated damping rate is similar to 3 x 10(6) Hz). In particular, the coupling is strong enough to drive the oscillations in the nonlinear regime.	[Lassagne, Benjamin; Garcia-Sanchez, David; Bachtold, Adrian] CSIC, Inst Catala Nanotecnol, Ctr Invest Nanociencia & Nanotecnol, E-08193 Barcelona, Spain; [Tarakanov, Yury; Kinaret, Jari] Chalmers Univ Technol, Dept Appl Phys, SE-41296 Gothenburg, Sweden	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); CSIC-ICN - Centro de Investigacion en Nanociencia y Nanotecnologia (CIN2); Chalmers University of Technology	Bachtold, A (corresponding author), CSIC, Inst Catala Nanotecnol, Ctr Invest Nanociencia & Nanotecnol, Campus Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	adrian.bachtold@cin2.es	Kinaret, Jari/F-7877-2010; Bachtold, Adrian/C-1389-2014	Kinaret, Jari/0000-0002-1152-6089; Bachtold, Adrian/0000-0002-6145-2479	European Union [FP6-IST-021285-2, FP6-ICT-028158]; Swedish Foundation for Strategic Research	European Union(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	We thank G. Morigi and J. Moser for discussions. The research has been supported by the European Union funded projects FP6-IST-021285-2 and FP6-ICT-028158, and the Swedish Foundation for Strategic Research.	Aldridge JS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.156403; Almog R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.078103; Armour AD, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125313; Badzey RL, 2005, NATURE, V437, P995, DOI 10.1038/nature04124; BRINK M, 2007, THESIS CORNELL U; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Chiu HY, 2008, NANO LETT, V8, P4342, DOI 10.1021/nl802181c; Clerk AA, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/238; Conley WG, 2008, NANO LETT, V8, P1590, DOI 10.1021/nl073406j; Cottone F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.080601; Erbe A, 2000, APPL PHYS LETT, V77, P3102, DOI 10.1063/1.1324721; Eriksson A, 2008, NANO LETT, V8, P1224, DOI 10.1021/nl080345w; Gao B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085410; Garcia-Sanchez D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.085501; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; Landau L. D., 1960, MECHANICS; Lassagne B, 2008, NANO LETT, V8, P3735, DOI 10.1021/nl801982v; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Peano V, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.235401; Pistolesi F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165317; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Purcell ST, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.276103; Raab C, 2000, PHYS REV LETT, V85, P538, DOI 10.1103/PhysRevLett.85.538; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Shim SB, 2007, SCIENCE, V316, P95, DOI 10.1126/science.1137307; Witkamp B, 2006, NANO LETT, V6, P2904, DOI 10.1021/nl062206p; Woodside MT, 2002, SCIENCE, V296, P1098, DOI 10.1126/science.1069923; Zippilli S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096804	28	282	285	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1107	1110		10.1126/science.1174290	http://dx.doi.org/10.1126/science.1174290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19628818				2022-12-28	WOS:000269382300035
J	Ray, M; Hester, J				Ray, Mary; Hester, Joan			A Patient's Journey Persistent pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ray, Mary; Hester, Joan] Kings Coll Hosp London, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Hester, J (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	Joan.hester@kch.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2009	339								b2786	10.1136/bmj.b2786	http://dx.doi.org/10.1136/bmj.b2786			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633040				2022-12-28	WOS:000268352100006
J	Yi, CG; Guo, SZ				Yi, Chenggang; Guo, Shuzhong			Facial transplantation: lessons so far	LANCET			English	Editorial Material							COMPOSITE TISSUE ALLOTRANSPLANTATION; FACE TRANSPLANTATION; ALLOGRAFT; ISSUES		[Yi, Chenggang; Guo, Shuzhong] Fourth Mil Med Univ, Xijing Hosp, Inst Plast Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Guo, SZ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Plast Surg, Xian 710032, Shaanxi, Peoples R China.	yichg@163.com						Chenggang Y, 2008, AM J TRANSPLANT, V8, P2169, DOI 10.1111/j.1600-6143.2008.02352.x; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Gander B, 2006, TRANSPL INT, V19, P868, DOI 10.1111/j.1432-2277.2006.00371.x; Guntinas-Lichius O, 2008, NEW ENGL J MED, V358, P2179, DOI 10.1056/NEJMc080003; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Mathes DW, 2009, J AM COLL SURGEONS, V208, P1051, DOI 10.1016/j.jamcollsurg.2009.01.051; Morris P, 2007, TRANSPLANTATION, V83, P109, DOI 10.1097/01.tp.0000254201.89012.ae; Shirbacheh MV, 1998, TRANSPLANT P, V30, P2739, DOI 10.1016/S0041-1345(98)00800-8; Siemionow M, 2004, PLAST RECONSTR SURG, V113, P1421, DOI 10.1097/01.PRS.0000112792.44312.A5; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Vasilic D, 2007, PLAST RECONSTR SURG, V120, P657, DOI 10.1097/01.prs.0000270316.33293.ec	12	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					177	178		10.1016/S0140-6736(09)61292-7	http://dx.doi.org/10.1016/S0140-6736(09)61292-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474DP	19608266				2022-12-28	WOS:000268263000004
J	King, M; Smith, A; Gracey, M				King, Malcolm; Smith, Alexandra; Gracey, Michael			Indigenous health part 2: the underlying causes of the health gap	LANCET			English	Review							MENTAL-DISORDERS; NEW-ZEALAND; PREVALENCE; PEOPLE; EPIDEMIOLOGY; DISEASE	In this Review we delve into the underlying causes of health disparities between Indigenous and non-Indigenous people and provide an indigenous perspective to understanding these inequalities. We are able to present only a snapshot of the many research publications about indigenous health. Our aim is to provide clinicians with a framework to better understand such matters. Applying this lens, placed in context for each patient, will promote more culturally appropriate ways to interact with, to assess, and to treat Indigenous peoples. The topics covered include Indigenous notions of health and identity; mental health and addictions; urbanisation and environmental stresses; whole health and heating; and reconciliation.	[King, Malcolm] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Smith, Alexandra] Univ Toronto, Toronto, ON, Canada; [Gracey, Michael] Unity First People Australia, Perth, WA, Australia	University of Alberta; University of Toronto	King, M (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada.	malcolm.king@ualberta.ca		King, Malcolm/0000-0002-1712-0303				Aboriginal Healing Foundation, 2008, TRUTH REC TRANSF LEG; ADAMS M, 2002, ABORIG ISL HLTH WORK, V26, P11; Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anaya J, 2007, DECLARATION RIGHTS I; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; *ASS 1 NAT, 2009, GLOB IND STOP TB CON; *AUSTR BUR STAT, MAN PEOPL LIV AUSTR; BANTJES R, 2007, SOCIAL MOVEMENTS GLO, P311; BARTLETT JG, 2007, 3 INT NETW IND HLTH; Baxter J, 2006, AUST NZ J PSYCHIAT, V40, P914, DOI 10.1111/j.1440-1614.2006.01911.x; Beals J, 2005, AM J PSYCHIAT, V162, P1723, DOI 10.1176/appi.ajp.162.9.1723; Brant C., 1982, NATIVE ETHICS PRINCI; Chandler M.J., 1989, COPING SELF CONCEPT, P149; Chandler M. J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202; Chang D, 2008, EUR J RADIOL, V68, P72, DOI 10.1016/j.ejrad.2008.02.026; Cooke Martin, 2007, BMC Int Health Hum Rights, V7, P9, DOI 10.1186/1472-698X-7-9; CURRIE C, 2008, SUNSIH ANN W REG C E; DURAN E, 1995, NATIVE AM POSTCOLONI, P6; Durie M., 2005, NGA TAI MATATU TIDES; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M, 2009, HEALING TRADITIONS: THE MENTAL HEALTH OF ABORIGINAL PEOPLES IN CANADA, P36; *GOV NW TERR, 2008, OFF LANG NW TERR; Government of Nunavut, 2008, NUN NEW GOV NEW VIS; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Helin Calvin, 2006, DANCES DEPENDENCY IN; JAKUBEC D, 2008, SUNSIH ANN W REG C E; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; KING M, 2009, PIMATISIWIN J ABORIG, V2, P75; KINZIE JD, 1992, J NERV MENT DIS, V180, P33, DOI 10.1097/00005053-199201000-00008; Kirby M., 2002, STAND SEN COMM SOC A; Kirby Michael J., 2004, MENTAL HLTH MENTAL I; Kirmayer L., 2003, AUSTRALAS PSYCHIATRY, V11, pS15, DOI DOI 10.1046/J.1038-5282.2003.02010.X; Kirmayer LJ, 2009, HEALING TRADITIONS: THE MENTAL HEALTH OF ABORIGINAL PEOPLES IN CANADA, P3; Kirmayer LJ, 2009, HEALING TRADITIONS: THE MENTAL HEALTH OF ABORIGINAL PEOPLES IN CANADA, P289; Kirmayer LJ, 1996, ACTA PSYCHIAT SCAND, V94, P8, DOI 10.1111/j.1600-0447.1996.tb09818.x; LETENDRE A, 2008, THESIS U ALBERTA; Makokis L, 2007, 3 INT NETW IND HLTH; Manson SM, 2005, AM J PUBLIC HEALTH, V95, P851, DOI 10.2105/AJPH.2004.054171; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Marsden D., 2004, PIMATISIWIN J ABORIG, V2, P75; MCCORMICK R, 1995, INT J ADV COUNSEL, V18, P163, DOI DOI 10.1007/BF01407960; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Morrow V, 1999, SOCIOL REV, V47, P744, DOI 10.1111/1467-954X.00194; Mowbray M, 2007, INT S SOC DET IND HL; MUSSELL WJ, 1993, MAKING MEANING MENTA, P26; Nettleton C., 2007, OVERVIEW CURRENT KNO; Norris M.J., 2003, NOT STRANGERS THESE, P51; ODEA K, 1980, DIABETES CARE, V3, P31, DOI 10.2337/diacare.3.1.31; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; PHINNEY JS, 1992, J ADOLESCENCE, V15, P271, DOI 10.1016/0140-1971(92)90030-9; Powers W. K., 1982, YUWIPI VISION EXPERI; *PROV MAN, AB PEOPL MAN 2000, pCH5; *RHS NAT TEAM, 2007, 1 NAT REG LONG SURV; Settee, 2007, THESIS U SASKATCHEWA; Sioui's Georges E., 1992, AMERINDIAN AUTOHISTO; *STAT CAN, AB PEOPL CAN DEM PRO; *STAT NZ, MAOR LIV 1996 CENS; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Stewart SL, 2008, INT J HEALTH PROMOT, V46, P49, DOI 10.1080/14635240.2008.10708129; STOUT MD, 1996, CAN US WOM HLTH FOR; SUTTON P, 2005, 8 NAT RUR HLTH C AL; SZATHMARY EJE, 1987, SOC SCI MED, V24, P791, DOI 10.1016/0277-9536(87)90181-X; Tester FJ, 2004, SOC SCI MED, V58, P2625, DOI 10.1016/j.socscimed.2003.09.021; Waldram J, 2006, ABORIGINAL HLTH CANA; Warschauer M., 1997, COMPUT ASSIST LANG L, V10, P349, DOI [DOI 10.1080/0958822970100405, 10.1080/0958822970100405]; Wilson K, 2003, HEALTH PLACE, V9, P83, DOI 10.1016/S1353-8292(02)00016-3; World Health Organization, 1986, OTT CHART GES	67	793	802	2	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					76	85		10.1016/S0140-6736(09)60827-8	http://dx.doi.org/10.1016/S0140-6736(09)60827-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467UO	19577696				2022-12-28	WOS:000267768800036
J	Apps, JR; Beattie, RM				Apps, John R.; Beattie, R. Mark			Easily missed? Cow's milk allergy in children	BRITISH MEDICAL JOURNAL			English	Editorial Material							FOOD ALLERGY; CHILDHOOD; INFANTS; PREVENTION; FORMULAS; DISEASES		[Beattie, R. Mark] Southampton Gen Hosp, Paediat Med Unit, Southampton SO16 6YD, Hants, England; [Apps, John R.] N Cent Thames Fdn Sch Barnet & Chase Farm NHS Tru, Acad Fdn Programme, London EN2 8JL, England	University of Southampton; University of London; University College London	Beattie, RM (corresponding author), Southampton Gen Hosp, Paediat Med Unit, Southampton SO16 6YD, Hants, England.	Mark.beattie@suht.swest.nhs.uk		Beattie, Robert Mark/0000-0003-4721-0577				Eggesbo M, 2001, J PEDIATR-US, V139, P583, DOI 10.1067/mpd.2001.117067; Garrison MM, 2000, PEDIATRICS, V106, P184; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Heine RG, 2002, CURR OPIN ALLERGY CL, V2, P217, DOI 10.1097/00130832-200206000-00011; Host A, 1999, ARCH DIS CHILD, V81, P80, DOI 10.1136/adc.81.1.80; Host A, 2002, PEDIATR ALLERGY IMMU, V13, P23, DOI 10.1034/j.1399-3038.13.s.15.7.x; Host A, 2002, ANN ALLERG ASTHMA IM, V89, P33, DOI 10.1016/S1081-1206(10)62120-5; LUCCASSEN PLB, 1998, BRIT MED J, V316, P1563; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; McLean-Tooke APC, 2003, BMJ-BRIT MED J, V327, P1332, DOI 10.1136/bmj.327.7427.1332; Medeiros Lilian C. S., 2004, J. Pediatr. (Rio J.), V80, P363, DOI 10.1590/S0021-75572004000600006; Muraro A, 2004, PEDIAT ALLERG IMM-UK, V15, P291, DOI 10.1111/j.1399-3038.2004.00127.x; National Institute for Health and Clinical Excellence, 2007, AT ECZ CHILD MAN AT; Salvatore S, 2002, PEDIATRICS, V110, P972, DOI 10.1542/peds.110.5.972; Sampson HA, 2001, GASTROENTEROLOGY, V120, P1026, DOI 10.1053/gast.2001.23031; Sicherer SH, 2006, J ALLERGY CLIN IMMUN, V117, pS470, DOI 10.1016/j.jaci.2005.05.048; Sicherer SH, 2003, PEDIATRICS, V111, P1609; Vandenplas Y, 2007, ARCH DIS CHILD, V92, P902, DOI 10.1136/adc.2006.110999	18	13	13	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 3	2009	339								b2275	10.1136/bmj.b2275	http://dx.doi.org/10.1136/bmj.b2275			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466RB	19578085				2022-12-28	WOS:000267679000001
J	Baker, SJK; Wass, JAH				Baker, Sarah J. K.; Wass, John A. H.			A Patient's Journey Addison's disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wass, John A. H.] Univ Oxford, Churchill Hosp, Oxford OX2 7LJ, England	University of Oxford	Wass, JAH (corresponding author), Univ Oxford, Churchill Hosp, Oxford OX2 7LJ, England.	john.wass@noc.anglox.nhs.uk							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 2	2009	339								b2384	10.1136/bmj.b2384	http://dx.doi.org/10.1136/bmj.b2384			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QZ	19574314				2022-12-28	WOS:000267678700003
J	Canales, JP; Nedimovic, MR; Kent, GM; Carbotte, SM; Detrick, RS				Canales, J. Pablo; Nedimovic, Mladen R.; Kent, Graham M.; Carbotte, Suzanne M.; Detrick, Robert S.			Seismic reflection images of a near-axis melt sill within the lower crust at the Juan de Fuca ridge	NATURE			English	Article							EAST PACIFIC RISE; OMAN OPHIOLITE IMPLICATIONS; MOHO TRANSITION ZONE; MANTLE TRANSITION; GABBRO SILLS; MAGMA; BENEATH; GEOCHEMISTRY; CONSTRAINTS; GENERATION	The oceanic crust extends over two-thirds of the Earth's solid surface, and is generated along mid-ocean ridges from melts derived from the upwelling mantle(1). The upper and middle crust are constructed by dyking and sea-floor eruptions originating from magma accumulated in mid-crustal lenses at the spreading axis(2-6), but the style of accretion of the lower oceanic crust is actively debated(7). Models based on geological and petrological data from ophiolites propose that the lower oceanic crust is accreted from melt sills intruded at multiple levels between the Moho transition zone (MTZ) and the mid-crustal lens(8-11), consistent with geophysical studies that suggest the presence of melt within the lower crust(12-16). However, seismic images of molten sills within the lower crust have been elusive. Until now, only seismic reflections from mid-crustal melt lenses(2,17,18) and sills within the MTZ have been described(19), suggesting that melt is efficiently transported through the lower crust. Here we report deep crustal seismic reflections off the southern Juan de Fuca ridge that we interpret as originating from a molten sill at present accreting the lower oceanic crust. The sill sits 5-6 km beneath the sea floor and 850-900 m above the MTZ, and is located 1.4-3.2 km off the spreading axis. Our results provide evidence for the existence of low-permeability barriers to melt migration within the lower section of modern oceanic crust forming at intermediate-to-fast spreading rates, as inferred from ophiolite studies(9,10).	[Canales, J. Pablo; Detrick, Robert S.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Nedimovic, Mladen R.] Dalhousie Univ, Dept Earth Sci, Halifax, NS B3H 4J1, Canada; [Nedimovic, Mladen R.; Carbotte, Suzanne M.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Kent, Graham M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Woods Hole Oceanographic Institution; Dalhousie University; Columbia University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Canales, JP (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	jpcanales@whoi.edu	Nedimovic, Mladen/B-8459-2009; Nedimovic, Mladen/Q-6865-2019	Nedimovic, Mladen/0000-0003-0327-5192; Canales, Juan Pablo/0000-0003-3066-7888	US NSF	US NSF(National Science Foundation (NSF))	This research was supported by the US NSF. We thank the captain, crew and scientific party of RV Maurice Ewing Cruise 0207.	AHARONOV E, 1995, J GEOPHYS RES-SOL EA, V100, P20433, DOI 10.1029/95JB01307; Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; Boudier F, 1996, EARTH PLANET SC LETT, V144, P239, DOI 10.1016/0012-821X(96)00167-7; Canales JP, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003630; Carbotte SM, 2006, GEOLOGY, V34, P209, DOI 10.1130/G21969.1; CHRISTENSEN NI, 1979, J GEOPHYS RES, V84, P6849, DOI 10.1029/JB084iB12p06849; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Coogan LA, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000230; Crawford WC, 2002, EARTH PLANET SC LETT, V203, P117, DOI 10.1016/S0012-821X(02)00831-2; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; DILEK Y, 1998, GEOPHYS MONOGRAPH SE, V106, P153; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; GARMANY J, 1989, NATURE, V340, P628, DOI 10.1038/340628a0; HERRON TJ, 1978, J GEOPHYS RES, V83, P798, DOI 10.1029/JB083iB02p00798; HOOFT EE, 1993, GEOPHYS RES LETT, V20, P423, DOI 10.1029/93GL00295; Jousselin D, 2000, MAR GEOPHYS RES, V21, P229, DOI 10.1023/A:1026733019682; Karson FA, 2002, ANNU REV EARTH PL SC, V30, P347, DOI 10.1146/annurev.earth.30.091201.141132; KARSON JA, 1984, J GEOPHYS RES, V89, P6126, DOI 10.1029/JB089iB07p06126; Kelemen PB, 1997, EARTH PLANET SC LETT, V146, P475, DOI 10.1016/S0012-821X(96)00235-X; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Kelemen PB, 1998, GEOPH MONOG SERIES, V106, P267; Korenaga J, 1997, J GEOPHYS RES-SOL EA, V102, P27729, DOI 10.1029/97JB02604; Korenaga J, 1998, EARTH PLANET SC LETT, V156, P1, DOI 10.1016/S0012-821X(98)00004-1; Maclennan J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000605; Miller D.J., 1997, PROC OCEAN DRILL SCI, V153, P437; MUTTER JC, 1995, SCIENCE, V268, P391, DOI 10.1126/science.268.5209.391; Nedimovic MR, 2005, NATURE, V436, P1149, DOI 10.1038/nature03944; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; PHIPPSMORGAN J, 1993, J GEOPHYS RES, V98, P6283; Singh SC, 2006, NATURE, V442, P287, DOI 10.1038/nature04939; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; Stakes DS, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001038; Taylor MAJ, 2002, GEOPHYS J INT, V149, P15, DOI 10.1046/j.1365-246X.2002.01577.x; WILCOCK WSD, 1992, SCIENCE, V258, P1470, DOI 10.1126/science.258.5087.1470; WILSON DS, 1993, J GEOPHYS RES-SOL EA, V98, P16053, DOI 10.1029/93JB01227	37	56	56	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					89	U100		10.1038/nature08095	http://dx.doi.org/10.1038/nature08095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571883				2022-12-28	WOS:000267545200035
J	Pace, WD; Cifuentes, M; Valuck, RJ; Staton, EW; Brandt, EC; West, DR				Pace, Wilson D.; Cifuentes, Maribel; Valuck, Robert J.; Staton, Elizabeth W.; Brandt, Elias C.; West, David R.			An Electronic Practice-Based Network for Observational Comparative Effectiveness Research	ANNALS OF INTERNAL MEDICINE			English	Article								The Distributed Ambulatory Research in Therapeutics Network (DARTNet) is a federated network of electronic health data from 8 organizations representing more than 500 clinicians and more than 400 000 patients. DARTNet was designed to increase knowledge of the comparative effectiveness of prescription medications and medical devices. Traditional observational comparative effectiveness research is conducted using large data sets, such as claims databases. Such databases do not provide important clinical information that is critical to understanding comparative effectiveness. By linking electronic health records, laboratory and imaging data, and administrative data from diverse and geographically disparate patients, DARTNet provides important new insight into the comparative effectiveness of oral diabetes medications, and it is ready for expansion to further enable effectiveness research.	[Pace, Wilson D.] Univ Colorado Denver, Sch Med, Dept Family Med, Aurora, CO 80045 USA; Univ Colorado Denver, Sch Pharm, Aurora, CO 80045 USA; Amer Acad Family Phys Natl Res Network, Leawood, KS 66211 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Pace, WD (corresponding author), Univ Colorado Denver, Sch Med, Dept Family Med, Mailstop F496,Acad Off 1,12631 E 17th Ave, Aurora, CO 80045 USA.	wilson.pace@ucdenver.edu			Agency for Healthcare Research and Quality [HHSA 290200500371]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality ( contract HHSA 290200500371, task order 2).	*CLIN INT NETW AM, CINA PROT ENG; *HLTH IND FOR, ROAD TEST EL HLTH RE; Mold James W, 2005, Ann Fam Med, V3 Suppl 1, pS12, DOI 10.1370/afm.303; Rubin DB, 2006, MATCHED SAMPLING FOR CAUSAL EFFECTS, P1, DOI 10.2277/ 0521674360; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	7	60	60	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					338	U64		10.7326/0003-4819-151-5-200909010-00140	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00140			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19638402				2022-12-28	WOS:000269653100006
J	Burikhanov, R; Zhao, YM; Goswami, A; Qiu, S; Schwarze, SR; Rangnekar, VM				Burikhanov, Ravshan; Zhao, Yanming; Goswami, Anindya; Qiu, Shirley; Schwarze, Steven R.; Rangnekar, Vivek M.			The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis	CELL			English	Article							PROSTATE-CANCER; PROTEIN PAR-4; STRESS; EXPRESSION; CELLS; INDUCTION; KINASE; GRP78; PHOSPHORYLATION; BINDING	Prostate apoptosis response-4 (Par-4) is a proapoptotic protein with intracellular functions in the cytoplasm and nucleus. Unexpectedly, we noted Par-4 protein is spontaneously secreted by normal and cancer cells in culture, and by Par-4 transgenic mice that are resistant to spontaneous tumors. Short exposure to endoplasmic reticulum (ER) stress-inducing agents further increased cellular secretion of Par-4 by a brefeldin A-sensitive pathway. Secretion occurred independently of caspase activation and apoptosis. Interestingly, extracellular Par-4 induced apoptosis by binding to the stress response protein, glucose-regulated protein-78 (GRP78), expressed at the surface of cancer cells. The interaction of extracellular Par-4 and cell surface GRP78 led to apoptosis via ER stress and activation of the FADD/caspase-8/caspase-3 pathway. Moreover, apoptosis inducible by TRAIL, which also exerts cancer cell-specific effects, is dependent on extracellular Par-4 signaling via cell surface GRP78. Thus, Par-4 activates an extrinsic pathway involving cell surface GRP78 receptor for induction of apoptosis.	[Burikhanov, Ravshan; Zhao, Yanming; Goswami, Anindya; Qiu, Shirley; Rangnekar, Vivek M.] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA; [Schwarze, Steven R.] Univ Kentucky, Dept Biochem & Mol Biol, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Rangnekar, Vivek M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Rangnekar, VM (corresponding author), Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA.	vmrang01@email.uky.edu	Burikhanov, Ravshan/AAF-4895-2021		NIH/NCI [CA60872, CA105453, CA84511]; NATIONAL CANCER INSTITUTE [R01CA116658, R01CA060872, R01CA084511, R01CA105453] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grants CA60872, CA105453, and CA84511 (to V. M. R.). We thank Krishna Murthi Vasudevan (Dana-Farber Cancer Institute) for critical reading of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Chakraborty M, 2001, CANCER RES, V61, P7255; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Cook J, 1999, ONCOGENE, V18, P1205, DOI 10.1038/sj.onc.1202416; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; El-Guendy N, 2003, MOL CELL BIOL, V23, P5516, DOI 10.1128/MCB.23.16.5516-5525.2003; Garcia-Cao I, 2005, EMBO REP, V6, P577, DOI 10.1038/sj.embor.7400421; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; GOSWAMI A, 2008, CANCER RES, V68, P1; Gurumurthy S, 2005, MOL CELL BIOL, V25, P1146, DOI 10.1128/MCB.25.3.1146-1161.2005; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Moreno-Bueno G, 2007, CANCER RES, V67, P1927, DOI 10.1158/0008-5472.CAN-06-2687; Page G, 1999, ONCOGENE, V18, P7265, DOI 10.1038/sj.onc.1203170; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Zhao YM, 2007, CANCER RES, V67, P9276, DOI 10.1158/0008-5472.CAN-07-2124	24	178	187	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					377	388		10.1016/j.cell.2009.05.022	http://dx.doi.org/10.1016/j.cell.2009.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632185	Green Accepted, Bronze			2022-12-28	WOS:000268277000018
J	Levison, HF; Bottke, WF; Gounelle, M; Morbidelli, A; Nesvorny, D; Tsiganis, K				Levison, Harold F.; Bottke, William F.; Gounelle, Matthieu; Morbidelli, Alessandro; Nesvorny, David; Tsiganis, Kleomenis			Contamination of the asteroid belt by primordial trans-Neptunian objects	NATURE			English	Article							SIZE DISTRIBUTION; MAIN-BELT; NUMERICAL SIMULATIONS; TROJAN ASTEROIDS; CHAOTIC CAPTURE; ORIGIN; OXYGEN; METEORITES	The main asteroid belt, which inhabits a relatively narrow annulus similar to 2.1-3.3 AU from the Sun, contains a surprising diversity of objects ranging from primitive ice-rock mixtures to igneous rocks. The standard model used to explain this assumes that most asteroids formed in situ from a primordial disk that experienced radical chemical changes within this zone(1). Here we show that the violent dynamical evolution of the giant-planet orbits required by the so-called Nice model(2-4) leads to the insertion of primitive trans-Neptunian objects into the outer belt. This result implies that the observed diversity of the asteroid belt is not a direct reflection of the intrinsic compositional variation of the proto-planetary disk. The dark captured bodies, composed of organic-rich materials, would have been more susceptible to collisional evolution than typical main-belt asteroids. Their weak nature makes them a prodigious source of micrometeorites-sufficient to explain why most are primitive in composition and are isotopically different from most macroscopic meteorites(5,6).	[Levison, Harold F.; Bottke, William F.; Nesvorny, David] SW Res Inst, Boulder, CO 80302 USA; [Levison, Harold F.; Bottke, William F.; Nesvorny, David] NASA, Lunar Sci Inst, Ctr Lunar Origin & Evolut, Boulder, CO 80302 USA; [Gounelle, Matthieu] CNRS, Lab Mineral & Cosmochim Museum, F-75005 Paris, France; [Gounelle, Matthieu] Museum Natl Hist Nat, F-75005 Paris, France; [Morbidelli, Alessandro] Observ Cote Azur, F-06304 Nice, France; [Tsiganis, Kleomenis] Aristotle Univ Thessaloniki, Dept Phys, Thessaloniki 54006, Greece	National Aeronautics & Space Administration (NASA); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Aristotle University of Thessaloniki	Levison, HF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	hal@boulder.swri.edu	Tsiganis, Kleomenis/AAF-5316-2020; Levison, Harold F/C-6061-2013	Levison, Harold F/0000-0001-5847-8099; Tsiganis, Kleomenis/0000-0003-3334-6190	NASA's; S National Science Foundation's Astronomy Astrophysics; European Community	NASA's(National Aeronautics & Space Administration (NASA)); S National Science Foundation's Astronomy Astrophysics; European Community(European Commission)	H. F. L., W. F. B., A. M. and D. N. are grateful to NASA's Origins of Solar Systems and Outer Planet Research programmes. D. N. is also grateful to the US National Science Foundation's Astronomy & Astrophysics Grants programme for funding. M. G. wishes to thank Centre National de la Recherche Scientifique, Programme National de Planetologie and the European Community for funding. We thank S. Stewart and Z. Leinhardt for discussions and S. Weidenschilling and A. Harris, who acted as referees.	Bell J.F., 1989, ASTEROIDS, P921; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Bottke WF, 2000, ICARUS, V145, P301, DOI 10.1006/icar.2000.6361; Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; Burbine TH, 2008, REV MINERAL GEOCHEM, V68, P273, DOI 10.2138/rmg.2008.68.12; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Carvano JM, 2003, ICARUS, V161, P356, DOI 10.1016/S0019-1035(02)00035-0; Clark B. E., 2003, B AM ASTRON SOC, V35, P955; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Dermott S. F., 2002, ASTEROIDS, VIII, P423; GENGE MJ, 2006, P LUNAR PLANET SCI C, V37; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Jewitt DC, 2000, ASTRON J, V120, P1140, DOI 10.1086/301453; Leinhardt ZM, 2009, ICARUS, V199, P542, DOI 10.1016/j.icarus.2008.09.013; Levison HF, 2008, ICARUS, V196, P258, DOI 10.1016/j.icarus.2007.11.035; Licandro J, 2006, ADV SPACE RES, V38, P1991, DOI 10.1016/j.asr.2005.11.015; Matrajt G, 2006, GEOCHIM COSMOCHIM AC, V70, P4007, DOI 10.1016/j.gca.2006.05.010; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; MORBIDELLI A, ICARUS UNPUB; Mothe-Diniz T, 2003, ICARUS, V162, P10, DOI 10.1016/S0019-1035(02)00066-0; Nesvorny D, 2009, ASTRON J, V137, P5003, DOI 10.1088/0004-6256/137/6/5003; Szabo GM, 2007, MON NOT R ASTRON SOC, V377, P1393, DOI 10.1111/j.1365-2966.2007.11687.x; Tholen D.J., 1989, ASTEROIDS, VII, P298; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Yoshida F, 2005, ASTRON J, V130, P2900, DOI 10.1086/497571	30	209	212	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					364	366		10.1038/nature08094	http://dx.doi.org/10.1038/nature08094			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606143				2022-12-28	WOS:000267979000031
J	Nakanishi, H; Bishop, KJM; Kowalczyk, B; Nitzan, A; Weiss, EA; Tretiakov, KV; Apodaca, MM; Klajn, R; Stoddart, JF; Grzybowski, BA				Nakanishi, Hideyuki; Bishop, Kyle J. M.; Kowalczyk, Bartlomiej; Nitzan, Abraham; Weiss, Emily A.; Tretiakov, Konstantin V.; Apodaca, Mario M.; Klajn, Rafal; Stoddart, J. Fraser; Grzybowski, Bartosz A.			Photoconductance and inverse photoconductance in films of functionalized metal nanoparticles	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; CHARGE-LIMITED CURRENTS; MOLECULAR JUNCTIONS; HYDRATED ELECTRON; ALKANETHIOLS; RESISTANCE; TRANSPORT; CELLS	In traditional photoconductors(1-3), the impinging light generates mobile charge carriers in the valence and/or conduction bands, causing the material's conductivity to increase(4). Such positive photoconductance is observed in both bulk and nanostructured(5,6) photoconductors. Here we describe a class of nanoparticle-based materials whose conductivity can either increase or decrease on irradiation with visible light of wavelengths close to the particles' surface plasmon resonance. The remarkable feature of these plasmonic materials is that the sign of the conductivity change and the nature of the electron transport between the nanoparticles depend on the molecules comprising the self-assembled monolayers (SAMs)(7,8) stabilizing the nanoparticles. For SAMs made of electrically neutral (polar and non-polar) molecules, conductivity increases on irradiation. If, however, the SAMs contain electrically charged (either negatively or positively) groups, conductivity decreases. The optical and electrical characteristics of these previously undescribed inverse photoconductors can be engineered flexibly by adjusting the material properties of the nanoparticles and of the coating SAMs. In particular, in films comprising mixtures of different nanoparticles or nanoparticles coated with mixed SAMs, the overall photoconductance is a weighted average of the changes induced by the individual components. These and other observations can be rationalized in terms of light-induced creation of mobile charge carriers whose transport through the charged SAMs is inhibited by carrier trapping in transient polaron-like states(9,10). The nanoparticle-based photoconductors we describe could have uses in chemical sensors and/or in conjunction with flexible substrates.	[Nakanishi, Hideyuki; Kowalczyk, Bartlomiej; Nitzan, Abraham; Weiss, Emily A.; Apodaca, Mario M.; Stoddart, J. Fraser; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Nakanishi, Hideyuki; Bishop, Kyle J. M.; Kowalczyk, Bartlomiej; Tretiakov, Konstantin V.; Klajn, Rafal; Grzybowski, Bartosz A.] Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; [Nitzan, Abraham] Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Northwestern University; Northwestern University; Tel Aviv University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Kowalczyk, Bartlomiej/C-4919-2008; Grzybowski, Bartosz A/H-5741-2017; Bishop, Kyle J M/F-1742-2010; Stoddart, James Fraser/H-1518-2011; Weiss, Emily A/B-4718-2009; Tretiakov, Konstantin V./A-3594-2008	Stoddart, James Fraser/0000-0003-3161-3697; Tretiakov, Konstantin V./0000-0003-4620-2807; Grzybowski, Bartosz/0000-0001-6613-4261	Alfred P. Sloan Fellowship; Dreyfus Teacher-Scholar Award	Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Dreyfus Teacher-Scholar Award	We thank M. Ratner, G. C. Schatz and R. van Duyne for discussions and advice. This work was supported by the Alfred P. Sloan Fellowship and the Dreyfus Teacher-Scholar Award (to B. A. G.).	ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; Bozano LD, 2005, ADV FUNCT MATER, V15, P1933, DOI 10.1002/adfm.200500130; Engelkes VB, 2004, J AM CHEM SOC, V126, P14287, DOI 10.1021/ja046274u; Galperin M, 2005, NANO LETT, V5, P125, DOI 10.1021/nl048216c; Han S, 2004, CHEM PHYS LETT, V389, P176, DOI 10.1016/j.cplett.2004.03.083; Hayden O, 2006, NAT MATER, V5, P352, DOI 10.1038/nmat1635; JORTNER J, 1966, J PHYS CHEM-US, V70, P770, DOI 10.1021/j100875a026; Joshi N.V., 1990, PHOTOCONDUCTIVITY AR; Kalsin AM, 2007, J AM CHEM SOC, V129, P6664, DOI 10.1021/ja068329t; Kalsin AM, 2006, J AM CHEM SOC, V128, P15046, DOI 10.1021/ja0642966; Kalsin AM, 2006, NANO LETT, V6, P1896, DOI 10.1021/nl060967m; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kuznetsov AM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770725; LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648; Lee JS, 2007, NAT NANOTECHNOL, V2, P790, DOI 10.1038/nnano.2007.380; Lee T, 2004, J PHYS CHEM B, V108, P8742, DOI 10.1021/jp049541r; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; MANY A, 1962, PHYS REV, V126, P1980, DOI 10.1103/PhysRev.126.1980; Nguyen TD, 2005, P NATL ACAD SCI USA, V102, P10029, DOI 10.1073/pnas.0504109102; Nitzan A., 2006, CHEM DYNAMICS CONDEN; Novembre C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2896602; Pinchuk AO, 2007, J PHYS CHEM C, V111, P11816, DOI 10.1021/jp073403v; SCHNITKER J, 1987, J CHEM PHYS, V86, P3471, DOI 10.1063/1.452003; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Weiss EA, 2005, J AM CHEM SOC, V127, P11842, DOI 10.1021/ja052901j; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Witt D, 2004, CURR ORG CHEM, V8, P1763, DOI 10.2174/1385272043369421; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhan CG, 2003, J PHYS CHEM B, V107, P4403, DOI 10.1021/jp022326v; Zou SL, 2006, TOP APPL PHYS, V103, P67	30	212	214	6	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					371	375		10.1038/nature08131	http://dx.doi.org/10.1038/nature08131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606145				2022-12-28	WOS:000267979000033
J	Schiermeier, Q				Schiermeier, Quirin			G8 climate target questioned	NATURE			English	News Item																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					313	313		10.1038/460313a	http://dx.doi.org/10.1038/460313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606112	Bronze			2022-12-28	WOS:000267979000007
J	Kruzic, JJ				Kruzic, Jamie J.			Predicting Fatigue Failures	SCIENCE			English	Editorial Material							R-CURVES; WEIGHT FUNCTION; FRACTURE; CERAMICS; MECHANISMS; CRACKS		Oregon State Univ, Sch Mech Ind & Mfg Engn, Corvallis, OR 97331 USA	Oregon State University	Kruzic, JJ (corresponding author), Oregon State Univ, Sch Mech Ind & Mfg Engn, Corvallis, OR 97331 USA.	jamie.kruzic@oregonstate.edu	Kruzic, Jamie J./M-3558-2014; Durgad, Revanasiddappa/AAF-4110-2019	Kruzic, Jamie J./0000-0002-9695-1921; 				ANDREASEN JH, 1995, J AM CERAM SOC, V78, P406, DOI 10.1111/j.1151-2916.1995.tb08815.x; Fett T, 2000, INT J FRACTURE, V104, P375, DOI 10.1023/A:1007662309437; FETT T, 1995, J AM CERAM SOC, V78, P949, DOI 10.1111/j.1151-2916.1995.tb08420.x; FETT T, 1995, J AM CERAM SOC, V78, P945, DOI 10.1111/j.1151-2916.1995.tb08419.x; FETT T, 2009, J TEST EVAL, V37; Kruzic JJ, 2008, J AM CERAM SOC, V91, P1986, DOI 10.1111/j.1551-2916.2008.02380.x; Kruzic JJ, 2005, ACTA MATER, V53, P2595, DOI 10.1016/j.actamat.2005.02.018; Kruzic JJ, 2004, SCRIPTA MATER, V50, P459, DOI 10.1016/j.scriptamat.2003.11.002; Kruzic JJ, 1999, ACTA MATER, V47, P801, DOI 10.1016/S1359-6454(98)00409-1; Pezzotti G, 1999, J RAMAN SPECTROSC, V30, P867, DOI 10.1002/(SICI)1097-4555(199910)30:10<867::AID-JRS466>3.0.CO;2-0; Ritchie RO, 1999, INT J FRACTURE, V100, P55, DOI 10.1023/A:1018655917051; Wilson JR, 2008, AEROSPACE AM, V46, P32; 2005, ENGINE YB 2006, V2	13	32	36	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					156	158		10.1126/science.1173432	http://dx.doi.org/10.1126/science.1173432			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468FK	19589990				2022-12-28	WOS:000267802000032
J	Maynard, A; Rejeski, D				Maynard, Andrew; Rejeski, David			Too small to overlook	NATURE			English	Editorial Material									[Maynard, Andrew; Rejeski, David] Woodrow Wilson Int Ctr Scholars, Project Emerging Nanotechnol, Washington, DC 20004 USA		Maynard, A (corresponding author), Woodrow Wilson Int Ctr Scholars, Project Emerging Nanotechnol, 1300 Penn Ave, Washington, DC 20004 USA.	andrew.maynard@wilsoncenter.org	Maynard, Andrew/D-1076-2010	Maynard, Andrew/0000-0003-2117-5128				Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; *NAN MAT STEW PROG, 2009, INT REP; Scientific Committee on Emerging and Newly Identified Health Risks, 2009, RISK ASS PROD NAN	3	28	31	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 9	2009	460	7252					174	174		10.1038/460174a	http://dx.doi.org/10.1038/460174a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587746				2022-12-28	WOS:000267761000016
J	Boynton, WV; Ming, DW; Kounaves, SP; Young, SMM; Arvidson, RE; Hecht, MH; Hoffman, J; Niles, PB; Hamara, DK; Quinn, RC; Smith, PH; Sutter, B; Catling, DC; Morris, RV				Boynton, W. V.; Ming, D. W.; Kounaves, S. P.; Young, S. M. M.; Arvidson, R. E.; Hecht, M. H.; Hoffman, J.; Niles, P. B.; Hamara, D. K.; Quinn, R. C.; Smith, P. H.; Sutter, B.; Catling, D. C.; Morris, R. V.			Evidence for Calcium Carbonate at the Mars Phoenix Landing Site	SCIENCE			English	Article							EVOLVED GAS ANALYZER; MARTIAN METEORITES; CLIMATE; IDENTIFICATION; ASSEMBLAGES; EVAPORITES; MINERALS; ROCKS; ICE	Carbonates are generally products of aqueous processes and may hold important clues about the history of liquid water on the surface of Mars. Calcium carbonate (approximately 3 to 5 weight percent) has been identified in the soils around the Phoenix landing site by scanning calorimetry showing an endothermic transition beginning around 725 degrees C accompanied by evolution of carbon dioxide and by the ability of the soil to buffer pH against acid addition. Based on empirical kinetics, the amount of calcium carbonate is most consistent with formation in the past by the interaction of atmospheric carbon dioxide with liquid water films on particle surfaces.	[Boynton, W. V.; Hamara, D. K.; Smith, P. H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Ming, D. W.; Niles, P. B.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Kounaves, S. P.; Young, S. M. M.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Arvidson, R. E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Hecht, M. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hoffman, J.] Univ Texas Dallas, Dept Phys, Richardson, TX 75083 USA; [Quinn, R. C.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Catling, D. C.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Sutter, B.] NASA, Lyndon B Johnson Space Ctr, Jacobs Engn & Sci Contract Grp, Houston, TX 77058 USA	University of Arizona; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Tufts University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Texas System; University of Texas Dallas; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Bristol; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Boynton, WV (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	wboynton@LPL.Arizona.edu	Catling, David C/D-2082-2009	Hecht, Michael/0000-0002-4114-4583; Kounaves, Samuel/0000-0002-2629-4831; Catling, David/0000-0001-5646-120X	University of Arizona, Tucson; California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	University of Arizona, Tucson; California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	The Phoenix Mission was led by the University of Arizona, Tucson, on behalf of NASA and was managed by NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA. The spacecraft was developed by Lockheed Martin Space Systems, Denver.	ANDERSON DM, 1972, ANTARCT J, V30, P114; ARVIDSON RE, 2009, 40 LUN PLAN SCI C WO; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; BOOTH MC, 1978, J GEOPHYS RES, V83, P1809, DOI 10.1029/JB083iB04p01809; Boynton WV, 2001, J GEOPHYS RES-PLANET, V106, P17683, DOI 10.1029/1999JE001153; Bridges JC, 2000, EARTH PLANET SC LETT, V176, P267, DOI 10.1016/S0012-821X(00)00019-4; Bridges JC, 1999, METEORIT PLANET SCI, V34, P407, DOI 10.1111/j.1945-5100.1999.tb01349.x; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Doner Harvey E., 2002, P199; Ehlmann BL, 2008, SCIENCE, V322, P1828, DOI 10.1126/science.1164759; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Gooding J.L., 1986, INT WORKSH ANT MET, P48; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; HETT TL, 2009, 40 LUN PLAN SCI C WO; Hoffman JH, 2008, J AM SOC MASS SPECTR, V19, P1377, DOI 10.1016/j.jasms.2008.07.015; KELLER HU, 2009, 40 LUN PLAN SCI C WO; Kounaves SP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003084; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; MCCLELLA.AL, 1967, J COLLOID INTERF SCI, V23, P577, DOI 10.1016/0021-9797(67)90204-4; Papelis C, 2003, COLLOID SURFACE A, V215, P221, DOI 10.1016/S0927-7757(02)00448-X; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; STEPHENS SK, 1995, P LUNAR PLANET SCI C, V26, P1355; STEPHENS SK, 1995, THESIS CALTECH PASAD; Zent A, 2008, ICARUS, V196, P385, DOI 10.1016/j.icarus.2007.12.028	28	255	257	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					61	64		10.1126/science.1172768	http://dx.doi.org/10.1126/science.1172768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574384				2022-12-28	WOS:000267594000033
J	Hecht, MH; Kounaves, SP; Quinn, RC; West, SJ; Young, SMM; Ming, DW; Catling, DC; Clark, BC; Boynton, WV; Hoffman, J; DeFlores, LP; Gospodinova, K; Kapit, J; Smith, PH				Hecht, M. H.; Kounaves, S. P.; Quinn, R. C.; West, S. J.; Young, S. M. M.; Ming, D. W.; Catling, D. C.; Clark, B. C.; Boynton, W. V.; Hoffman, J.; DeFlores, L. P.; Gospodinova, K.; Kapit, J.; Smith, P. H.			Detection of Perchlorate and the Soluble Chemistry of Martian Soil at the Phoenix Lander Site	SCIENCE			English	Article							CHEMICAL-COMPOSITION; MARS; SURFACE; SPECTROMETER; ORIGIN; ROCKS	The Wet Chemistry Laboratory on the Phoenix Mars Lander performed aqueous chemical analyses of martian soil from the polygon-patterned northern plains of the Vastitas Borealis. The solutions contained similar to 10 mM of dissolved salts with 0.4 to 0.6% perchlorate (ClO4) by mass leached from each sample. The remaining anions included small concentrations of chloride, bicarbonate, and possibly sulfate. Cations were dominated by Mg2+ and Na+, with small contributions from K+ and Ca2+. A moderately alkaline pH of 7.7 +/- 0.5 was measured, consistent with a carbonate-buffered solution. Samples analyzed from the surface and the excavated boundary of the similar to 5-centimeter-deep ice table showed no significant difference in soluble chemistry.	[Hecht, M. H.; DeFlores, L. P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kounaves, S. P.; Young, S. M. M.; Gospodinova, K.; Kapit, J.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Quinn, R. C.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [West, S. J.] Invensys Proc Syst, Foxboro, MA 02035 USA; [Ming, D. W.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Catling, D. C.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Boynton, W. V.; Smith, P. H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hoffman, J.] Univ Texas Dallas, Dept Phys, Richardson, TX 75080 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Tufts University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Schneider Electric; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Bristol; University of Washington; University of Washington Seattle; University of Arizona; University of Texas System; University of Texas Dallas	Hecht, MH (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	michael.h.hecht@jpl.nasa.gov	Catling, David C/D-2082-2009	Hecht, Michael/0000-0002-4114-4583; Catling, David/0000-0001-5646-120X; Kounaves, Samuel/0000-0002-2629-4831	University of Arizona, Tucson; NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	University of Arizona, Tucson; NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA; Lockheed Martin Space Systems, Denver	The Phoenix Mission was led by the University of Arizona, Tucson, on behalf of NASA and was managed by NASAs Jet Propulsion Laboratory, California Institute of Technology, of Pasadena, CA. The spacecraft was developed by Lockheed Martin Space Systems, Denver.	Ader M, 2008, EARTH PLANET SC LETT, V269, P604, DOI 10.1016/j.epsl.2008.03.023; BANIN A., 2000, MARS, P594; Bao HM, 2004, ENVIRON SCI TECHNOL, V38, P5073, DOI 10.1021/es049516z; BARTH CA, 1973, SCIENCE, V179, P795, DOI 10.1126/science.179.4075.795; Besley L.M., 1969, J CHEM THERMODYN, V1, P13, DOI [10.1016/0021-9614(69)90032-9, DOI 10.1016/0021-9614(69)90032-9]; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Biemann K, 2007, P NATL ACAD SCI USA, V104, P10310, DOI 10.1073/pnas.0703732104; Bohlke JK, 2005, ANAL CHEM, V77, P7838, DOI 10.1021/ac051360d; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; DEVLIN DJ, 1986, THERMOCHIM ACTA, V104, P159, DOI 10.1016/0040-6031(86)85195-4; ERIKSEN GE, 1981, 1188 US GEOL SURV; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Hecht MH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003077; HUNTEN DM, 1979, J MOL EVOL, V14, P71, DOI 10.1007/BF01732369; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; Keller JM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002679; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Kounaves SP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003084; Kounaves SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001978; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; LAUER HV, 2009, LUNAR PLANET SCI C, V40; Lee MH, 2002, ANAL CHEM, V74, P2603, DOI 10.1021/ac011160b; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; MING DW, 2009, LUNAR PLANET SCI C, V40; Murphy DM, 2000, GEOPHYS RES LETT, V27, P3217, DOI 10.1029/1999GL011267; Orris G.J., 2003, 03314 US GEOL SURV; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; PERRIER S, 2006, J GEOPHYS RES, V111; Pestova ON, 2005, RUSS J APPL CHEM+, V78, P409, DOI 10.1007/s11167-005-0306-z; QUINN R, 1993, GEOCHIM COSMOCHIM AC, V57, P4611, DOI 10.1016/0016-7037(93)90186-Z; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SIMONAITIS R, 1975, PLANET SPACE SCI, V23, P1567, DOI 10.1016/0032-0633(75)90010-0; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; Zahnle K, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003160; Zent AP, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2007JE003052	44	733	744	6	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					64	67		10.1126/science.1172466	http://dx.doi.org/10.1126/science.1172466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574385				2022-12-28	WOS:000267594000034
J	Goldston, D				Goldston, David			Don't cry politicization	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environment, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					24	24		10.1038/460024a	http://dx.doi.org/10.1038/460024a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	464XW	19571860	Bronze			2022-12-28	WOS:000267545200012
J	Iglehart, JK				Iglehart, John K.			More Checks Than Balances in the Struggle for Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], NEW YORKER; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; FULLER A, 2009, NY TIMES        0712, pA18; Iglehart JK, 2004, NEW ENGL J MED, V350, P826, DOI 10.1056/NEJMhpr045002; MARTINEZ B, 2009, WALL STREET J   0710, pA4	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					E5	U12		10.1056/NEJMp0905045	http://dx.doi.org/10.1056/NEJMp0905045			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19605806				2022-12-28	WOS:000268443900004
J	Jabre, P; Combes, X; Lapostolle, F; Dhaouadi, M; Ricard-Hibon, A; Vivien, B; Bertrand, L; Beltramini, A; Gamand, P; Albizzati, S; Perdrizet, D; Lebail, G; Chollet-Xemard, C; Maxime, V; Brun-Buisson, C; Lefrant, JY; Bollaert, PE; Megarbane, B; Ricard, JD; Anquel, N; Vicaut, E; Adnet, F				Jabre, Patricia; Combes, Xavier; Lapostolle, Frederic; Dhaouadi, Mohamed; Ricard-Hibon, Agnes; Vivien, Benoit; Bertrand, Lionel; Beltramini, Alexandra; Gamand, Pascale; Albizzati, Stephane; Perdrizet, Deborah; Lebail, Gaelle; Chollet-Xemard, Charlotte; Maxime, Virginie; Brun-Buisson, Christian; Lefrant, Jean-Yves; Bollaert, Pierre-Edouard; Megarbane, Bruno; Ricard, Jean-Damien; Anquel, Nadia; Vicaut, Eric; Adnet, Frederic		KETASED Collaborative Study Grp	Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial	LANCET			English	Article							RELATIVE ADRENAL INSUFFICIENCY; FAILURE ASSESSMENT SCORE; SEPTIC SHOCK; CRITICALLY-ILL; SOFA SCORE; ORGAN DYSFUNCTION/FAILURE; INTENSIVE-CARE; CORTICOSTEROID INSUFFICIENCY; EMERGENCY-DEPARTMENT; CORTISOL RESPONSE	Background Critically ill patients often require emergency intubation. The use of etomidate as the sedative agent in this context has been challenged because it might cause a reversible adrenal insufficiency, potentially associated with increased in-hospital morbidity. We compared early and 28-day morbidity after a single dose of etomidate or ketamine used for emergency endotracheal intubation of critically ill patients. Methods In this randomised, controlled, single-blind trial, 655 patients who needed sedation for emergency intubation were prospectively enrolled from 12 emergency medical services or emergency departments and 65 intensive care units in France. Patients were randomly assigned by a computerised random-number generator list to receive 0.3 mg/kg of etomidate (n=328) or 2 mg/kg of ketamine (n=327) for intubation. Only the emergency physician enrolling patients was aware of group assignment. The primary endpoint was the maximum score of the sequential organ failure assessment during the first 3 days in the intensive care unit. We excluded from the analysis patients who died before reaching the hospital or those discharged from the intensive care unit before 3 days (modified intention to treat). This trial is registered with ClinicalTrials.gov, number NCT00440102. Findings 234 patients were analysed in the etomidate group and 235 in the ketamine group. The mean maximum SOFA score between the two groups did not differ significantly (10.3 [SD 3.7] for etomidate vs 9.6 [3.9] for ketamine; mean difference 0.7 [95% CI 0.0-1.4], p=0.056). Intubation conditions did not differ significantly between the two groups (median intubation difficulty score 1 [IQR 0-3] in both groups; p=0.70). The percentage of patients with adrenal insufficiency was significantly higher in the etomidate group than in the ketamine group (OR 6.7, 3.5-12.7). We recorded no serious adverse events with either study drug. Interpretation Our results show that ketamine is a safe and valuable alternative to etomidate for endotracheal intubation in critically ill patients, and should be considered in those with sepsis.	[Jabre, Patricia; Lapostolle, Frederic; Adnet, Frederic] Univ Paris 13, Avicenne Hosp, AP HP, SAMU 93,EA 3409, F-93000 Bobigny, France; [Jabre, Patricia; Combes, Xavier; Chollet-Xemard, Charlotte] Hop Henri Mondor, AP HP, Serv Anesthesie & Reanimat, Samu 94, F-94010 Creteil, France; [Jabre, Patricia] INSERM, U970, Paris, France; [Dhaouadi, Mohamed] CHU Nimes, Samu 30, Nimes, France; [Ricard-Hibon, Agnes] Hop Beaujon, Smur SAR Beaujon, Clichy, France; [Vivien, Benoit] Hop Necker Enfants Malad, AP HP, Samu Paris, Paris, France; [Bertrand, Lionel] Hop Montauban, Emergency Dept, Montauban, France; [Beltramini, Alexandra] Hop St Germain en Laye, Smur St Germain en Laye, St Germain En Laye, France; [Gamand, Pascale] Hop Meaux, Emergency Dept & Smur, Meaux, France; [Albizzati, Stephane; Bollaert, Pierre-Edouard] Hop Cent, Samu Reanimat 54, Nancy, France; [Perdrizet, Deborah] Hop La Roche sur Yon, Smur Roche sur Yon, La Roche Sur Yon, France; [Lebail, Gaelle] Hop Raymond Poincare, AP HP, Samu Hauts Seine, Garches, France; [Lefrant, Jean-Yves] Hop Nimes, Reanimat Chirurg, Nimes, France; [Megarbane, Bruno] Hop Lariboisiere, AP HP, F-75475 Paris, France; [Ricard, Jean-Damien] Hop Louis Mourier, AP HP, F-92701 Colombes, France; [Anquel, Nadia] Hop Kremlin Bicetre, Le Kremlin Bicetre, France; [Vicaut, Eric] Hop Fernand Widal, AP HP, Unite Rech Clin, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; CHD Vendee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Adnet, F (corresponding author), Univ Paris 13, Avicenne Hosp, AP HP, SAMU 93,EA 3409, 125 Route Stalingrad, F-93000 Bobigny, France.	frederic.adnet@avc.aphp.fr		Megarbane, Bruno/0000-0002-2522-2764	French Ministry of Health [PHRC 2006 AOM06103]	French Ministry of Health	The French Ministry of Health provided financial support (2006 Clinical Research Hospital Programme PHRC 2006 AOM06103). The study does not necessarily reflect the view of the Ministry and in no way anticipates the Ministry's future policy in this area. We thank B Rion (University Paris 6, Paris, France) and R M Walls (Harvard Medical School, Boston, MA, USA) for reviewing this report; and the Data Safety and Monitoring Board members of the KETASED study for their contribution: D Pateron (CHU Saint Antoine), P Casassus (Haute Autorite de Sante), P Queneau (Academie de Medecine), and A Cariou (CHU Cochin).	Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; Arts DGT, 2005, CRIT CARE MED, V33, P1988, DOI 10.1097/01.CCM.0000178178.02574.AB; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; de Jong MFC, 2007, CRIT CARE, V11, DOI 10.1186/cc5928; de Jong MFC, 2007, CRIT CARE MED, V35, P1896, DOI 10.1097/01.CCM.0000275387.51629.ED; DEJONG FH, 1984, J CLIN ENDOCR METAB, V59, P1143, DOI 10.1210/jcem-59-6-1143; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; LEDINGHAM IM, 1983, LANCET, V1, P1270; Liouber-Friedman D, 2007, CRIT CARE MED, V35, P1012, DOI 10.1097/01.CCM.0000259465.92018.6E; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; OLTMANNS KM, 2005, J INTERN MED; Patila T, 2006, ANN THORAC SURG, V82, P2072, DOI 10.1016/j.athoracsur.2006.06.025; Ray DC, 2007, CRIT CARE, V11, DOI 10.1186/cc5916; Riche FC, 2007, INTENS CARE MED, V33, P1761, DOI 10.1007/s00134-007-0770-4; Sivilotti MLA, 2003, ACAD EMERG MED, V10, P612, DOI 10.1197/aemj.10.6.612; Sivilotti MLA, 1998, ANN EMERG MED, V31, P313, DOI 10.1016/S0196-0644(98)70341-5; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Verborgh C, 1998, PHARMACOL BIOCHEM BE, V59, P663, DOI 10.1016/S0091-3057(97)00441-3; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Zed PJ, 2006, ACAD EMERG MED, V13, P378, DOI 10.1197/j.aem.2005.11.076	30	316	333	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					293	300		10.1016/S0140-6736(09)60949-1	http://dx.doi.org/10.1016/S0140-6736(09)60949-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19573904				2022-12-28	WOS:000268508200027
J	Paovonen, J; Naud, P; Salmeron, J; Wheeler, CM; Chow, SN; Apter, D; Kitchener, H; Castellsague, X; Teixeira, JC; Skinner, SR; Hedrick, J; Jaisamrarn, U; Limson, G; Garland, S; Szarewski, A; Romanowski, B; Aoki, FY; Schwarz, TF; Poppe, WAJ; Bosch, FX; Jenkins, D; Hardt, K; Zahaf, T; Descamps, D; Struyf, F; Lehtinen, M; Dubin, G				Paovonen, J.; Naud, P.; Salmeron, J.; Wheeler, C. M.; Chow, S-N; Apter, D.; Kitchener, H.; Castellsague, X.; Teixeira, J. C.; Skinner, S. R.; Hedrick, J.; Jaisamrarn, U.; Limson, G.; Garland, S.; Szarewski, A.; Romanowski, B.; Aoki, F. Y.; Schwarz, T. F.; Poppe, W. A. J.; Bosch, F. X.; Jenkins, D.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Lehtinen, M.; Dubin, G.		HPV PATRICIA Study Grp	Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women	LANCET			English	Article							PARTICLE VACCINE; CROSS-PROTECTION; UNITED-STATES; FOLLOW-UP; CANCER; LESIONS; ADENOCARCINOMA; PREVENTION; NEOPLASIA; CARCINOMA	Background The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine was immunogenic, generally well tolerated, and effective against HPV-16 or HPV-18 infections, and associated precancerous lesions in an event-triggered interim analysis of the phase III randomised, double-blind, controlled PApilloma TRIal against Cancer In young Adults (PATRICIA). We now assess the vaccine efficacy in the final event-driven analysis. Methods Women (15-25 years) were vaccinated at months 0, 1, and 6. Analyses were done in the according-to-protocol cohort for efficacy (ATP-E; vaccine, n=8093; control, n=8069), total vaccinated cohort (TVC, included all women receiving at least one vaccine dose, regardless of their baseline HPV status; represents the general population, including those who are sexually active; vaccine, n=9319; control, n=9325), and TVC-naive (no evidence of oncogenic HPV infection at baseline; represents women before sexual debut; vaccine, n=5822; control, n=5819). The primary endpoint was to assess vaccine efficacy against cervical intraepithelial neoplasia 2+ (CIN2+) that was associated with HPV-16 or HPV-18 in women who were seronegative at baseline, and DNA negative at baseline and month 6 for the corresponding type (ATP-E). This trial is registered with ClinicalTrials.gov, number NCT00122681. Findings Mean follow-up was 34.9 months (SD 6.4) after the third dose. Vaccine efficacy against CIN2+ associated with HPV-16/18 was 92.9% (96.1% CI 79.9-98.3) in the primary analysis and 98.1% (88.4-100) in an analysis in which probable causality to HPV type was assigned in lesions infected with multiple oncogenic types (ATP-E cohort). Vaccine efficacy against CIN2+ irrespective of HPV DNA in lesions was 30.4% (16.4-42.1) in the TVC and 70.2% (54.7-80.9) in the TVC-naive. Corresponding values against CIN3+ were 33.4% (9.1-51.5) in the TVC and 87.0% (54.9-97.7) in the TVC-naive. Vaccine efficacy against CIN2+ associated with 12 non-vaccine oncogenic types Was 54.0% (34.0-68.4; ATP-E). Individual cross-protection against CIN2+ associated with HPV-31, HPV-33, and HPV-45 was seen in the TVC. Interpretation The HPV-16/18 AS04-adjuvanted vaccine showed high efficacy against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types and substantial overall effect in cohorts that are relevant to universal mass vaccination and catch-up programmes.	[Paovonen, J.] Univ Helsinki, Dept Obstet & Gynaecol, FIN-00290 Helsinki, Finland; [Naud, P.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Wheeler, C. M.] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Wheeler, C. M.] Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; [Chow, S-N] Natl Taiwan Univ, Coll Med & Hosp, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Apter, D.] Sexual Hlth Clin, Family Federat Finland, Helsinki, Finland; [Kitchener, H.] St Marys Hosp, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 0JH, Lancs, England; [Castellsague, X.; Bosch, F. X.] CIBER ESP, IDIBELL, Hosp Llobregat, Inst Catala Oncol, Catalonia, Spain; [Teixeira, J. C.] Univ Estadual Campinas, Campinas, SP, Brazil; [Skinner, S. R.] Childrens Hosp Westmead, Vaccine Trials Grp, Telethon Inst Child Hlth Res, Sydney, NSW, Australia; [Skinner, S. R.] Univ Sydney, Discipline Paediat & Child Hlth, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Hedrick, J.] Kentucky Pediat & Adult Res, Bardstown, KY USA; [Jaisamrarn, U.] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynaecol, Bangkok 10330, Thailand; [Limson, G.] Univ Philippines, Coll Med, Philippine Gen Hosp, Makati Med Ctr, Makati, Philippines; [Garland, S.] Univ Melbourne, Dept Microbiol & Infect Dis, Royal Womens Hosp, Melbourne, Vic, Australia; [Garland, S.] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Szarewski, A.] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London, England; [Romanowski, B.] Univ Alberta, Edmonton, AB, Canada; [Aoki, F. Y.] Univ Manitoba, Winnipeg, MB, Canada; [Schwarz, T. F.] Univ Wurzburg, Acad Teaching Hosp, Cent Lab & Vaccinat Ctr, Stiftung Juliusspital, Wurzburg, Germany; [Poppe, W. A. J.] Univ Hosp KU Leuven Gasthuisberg, Dept Gynaecol, Louvain, Belgium; [Jenkins, D.] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Jenkins, D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.] GlaxoSmithKline Biol, Rixensart, Belgium; [Lehtinen, M.] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; [Dubin, G.] GlaxoSmithKline Biol, King Of Prussia, PA USA	University of Helsinki; Universidade Federal do Rio Grande do Sul; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; National Taiwan University; Family Federation of Finland; University of Manchester; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidade Estadual de Campinas; Telethon Kids Institute; University of Sydney; University of Sydney; Chulalongkorn University; Makati Medical Center; University of Melbourne; University of Melbourne; Cancer Research UK; University of London; Queen Mary University London; University of Alberta; University of Manitoba; University of Wurzburg; KU Leuven; University Hospital Leuven; University of Hull; University of York - UK; University of York - UK; GlaxoSmithKline; Tampere University; GlaxoSmithKline	Paovonen, J (corresponding author), Univ Helsinki, Dept Obstet & Gynaecol, Haartmaninkatu 2, FIN-00290 Helsinki, Finland.	Jorma.Paavonen@hus.fi	Skinner, Rachel S/J-8455-2017; Centeno-Mediavilla, Cristina/AAP-5566-2021; Teixeira, Julio Cesar/H-3151-2013; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Centeno-Mediavilla, Cristina/G-6063-2017; Pique, Xavier Castellsagué/N-5795-2014; Apter, Dan/D-6269-2017	Skinner, Rachel S/0000-0003-1970-9792; Centeno-Mediavilla, Cristina/0000-0002-7181-3063; Teixeira, Julio Cesar/0000-0002-0979-376X; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Centeno-Mediavilla, Cristina/0000-0002-7181-3063; Pique, Xavier Castellsagué/0000-0002-0802-3595; Chu, Tang-Yuan/0000-0003-2717-2681; Struyf, Frank/0000-0001-9988-0260; Salmeron, Jorge/0000-0002-5113-299X; Paavonen, Jorma/0000-0003-4775-606X; Apter, Dan/0000-0002-5175-8845	GlaxoSmithKline Biologicals [NCT00122681/580299/008]	GlaxoSmithKline Biologicals(GlaxoSmithKline)	This study (NCT00122681/580299/008) was funded by GlaxoSmithKline Biologicals. We thank study participants and their families. We wish to dedicate this report to Minnamaija Kekki, a subinvestigator for this study, who sadly passed away.	Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Jenkins D, 2008, GYNECOL ONCOL, V110, pS18, DOI 10.1016/j.ygyno.2008.06.027; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lehtinen M, 2006, INT J STD AIDS, V17, P517, DOI 10.1258/095646206778145550; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Pedersen C, 2007, J ADOLESCENT HEALTH, V40, P564, DOI 10.1016/j.jadohealth.2007.02.015; Reimers LL, 2009, CANCER EPIDEM BIOMAR, V18, P792, DOI 10.1158/1055-9965.EPI-08-0965; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Trottier H, 2009, CANCER EPIDEM BIOMAR, V18, P854, DOI 10.1158/1055-9965.EPI-08-1012; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; Verstraeten T, 2008, VACCINE, V26, P6630, DOI 10.1016/j.vaccine.2008.09.049; *VRBPAC, 2006, VACC REL BIOL PROD A; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2855, DOI 10.1002/cncr.23756; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Wright TC, 2008, GYNECOL ONCOL, V109, pS40, DOI 10.1016/j.ygyno.2008.02.002; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	30	1163	1206	6	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					301	314		10.1016/S0140-6736(09)61248-4	http://dx.doi.org/10.1016/S0140-6736(09)61248-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19586656				2022-12-28	WOS:000268508200028
J	Salman, RAS; Labovitz, DL; Stapf, C				Salman, Rustam Al-Shahi; Labovitz, Daniel L.; Stapf, Christian			Spontaneous intracerebral haemorrhage	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BRAIN; MANAGEMENT; STROKE; RISK; POPULATION; GUIDELINE; DIAGNOSIS		[Salman, Rustam Al-Shahi] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Labovitz, Daniel L.] NYU Med Ctr, Schwartz Hlth Care Ctr, New York, NY 10016 USA; [Stapf, Christian] Hop Lariboisiere, APHP, Stroke Unit, Serv Neurol, F-75475 Paris 10, France	University of Edinburgh; New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP	Salman, RAS (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	Rustam.Al-Shahi@ed.ac.uk	Labovitz, Daniel/AAT-4858-2021	Labovitz, Daniel/0000-0003-0754-4345; Stapf, Christian/0000-0002-3193-1006; Al-Shahi Salman, Rustam/0000-0002-2108-9222	Medical Research Council [G108/613] Funding Source: Medline; MRC [G108/613] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Shahi R, 2006, BMJ-BRIT MED J, V333, P235, DOI 10.1136/bmj.333.7561.235; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; CORDONNIER C, 2009, RADIOLOGICAL I UNPUB; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Dennis MS, 2003, CEREBROVASC DIS, V16, P9, DOI 10.1159/000069935; Einhaupl K, 2006, EUR J NEUROL, V13, P553, DOI 10.1111/j.1468-1331.2006.01398.x; Govan L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub2; HEISKANEN O, 1988, ACTA NEUROCHIR, V90, P81, DOI 10.1007/BF01560559; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jackson CA, 2006, J NEUROL NEUROSUR PS, V77, P1244, DOI 10.1136/jnnp.2006.089292; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Salman RAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005951.pub3; Salman RAS, 2008, STROKE, V39, P3222, DOI 10.1161/STROKEAHA.108.515544; STAM J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002005; Stapf C, 2007, CEREBROVASC DIS, V23, P318, DOI 10.1159/000098447; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318; Wardlaw JM, 2003, J NEUROL NEUROSUR PS, V74, P77, DOI 10.1136/jnnp.74.1.77	25	38	38	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2009	339								b2586	10.1136/bmj.b2586	http://dx.doi.org/10.1136/bmj.b2586			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633038				2022-12-28	WOS:000268352100007
J	Dickert, N; Wendler, D				Dickert, Neal; Wendler, David			Ancillary Care Obligations of Medical Researchers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SICKLE-CELL-DISEASE; CLINICAL CARE; RESPONSIBILITIES	An investigator planning a study in Africa of the prevalence of pulmonary hypertension in children with severe malaria anticipates that she and her team will encounter significant unmet health needs during the course of the study. She recognizes that study procedures, particularly echocardiography, may identify and diagnose conditions that are not treatable within the local health system due to resource constraints. Aware that some of these needs may be serious, as well as difficult and costly to treat, she asks the bioethics consultation service for assistance in determining the extent to which she as an investigator has a responsibility to provide clinical care for conditions that she finds while conducting the study. This article reviews the issue of investigators' responsibilities to meet participants' needs for ancillary care and argues that investigators can have a responsibility to provide care for a wide range of health needs, including at times care for conditions not connected to the research question or study procedures. That responsibility, however, is significantly limited by the depth of the investigator's relationship with participants and the resource demands of providing such care. JAMA. 2009;302(4):424-428	[Dickert, Neal] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wendler, David] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Dickert, N (corresponding author), Emory Univ, Sch Med, Div Cardiol, 1256 Briarcliff Rd,Bldg A,Ste 1 N,Mailstop 1256-0, Atlanta, GA 30322 USA.	njr@emory.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Dickert's participation in the initial Grand Rounds presentation was supported by the National Institutes of Health.	Aliyu ZY, 2008, AM J HEMATOL, V83, P63, DOI 10.1002/ajh.21057; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Dickert N, 2007, LANCET, V369, P874, DOI 10.1016/S0140-6736(07)60416-4; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; MCINTYRE A, 1994, PHILOS PUBLIC AFF, V23, P157, DOI 10.1111/j.1088-4963.1994.tb00009.x; Nuffield Council on Bioethics, ETH RES REL HEALTHC; Participants in 2006 Georgetown University Workshop on Ancillary-Care Obligations of Medical Researchers Working in Developing Countries, 2008, PLoS Med, V5, pe90, DOI 10.1371/journal.pmed.0050090; Richardson HS, 2007, AM J PUBLIC HEALTH, V97, P1956, DOI 10.2105/AJPH.2006.093658; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Scanlon T. M, 1998, WHAT WE OWE EACH OTH; World Medical Association, DECL HELS ETH PRINC	13	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					424	428		10.1001/jama.2009.1076	http://dx.doi.org/10.1001/jama.2009.1076			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472NQ	19622821				2022-12-28	WOS:000268139200025
J	Fonseca, V				Fonseca, Vivian			Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas A&M Hlth Sci Ctr, Scott & White Clin, Temple, TX USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Fonseca, V (corresponding author), Texas A&M Hlth Sci Ctr, Scott & White Clin, Temple, TX USA.							Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-12	10.7326/0003-4819-151-2-200907210-02012	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620156				2022-12-28	WOS:000268605300020
J	Siragusa, S				Siragusa, Sergio			Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DOUBLE-BLIND; PREVENTION		Univ Hosp Palermo, Palermo, Italy		Siragusa, S (corresponding author), Univ Hosp Palermo, Palermo, Italy.							Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Verso M, 2005, J CLIN ONCOL, V23, P4057, DOI 10.1200/JCO.2005.06.084	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-5	10.7326/0003-4819-151-2-200907210-02005	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620149				2022-12-28	WOS:000268605300013
J	Zhang, WQ; Kawamata, H; Liu, KP				Zhang, Weiqing; Kawamata, Hiroshi; Liu, Kopin			CH Stretching Excitation in the Early Barrier F + CHD3 Reaction Inhibits CH Bond Cleavage	SCIENCE			English	Article							PRODUCT ENERGY-DISTRIBUTION; REACTION DYNAMICS; MODE; SURFACE; ATOMS; PAIRS	Most studies of the impact of vibrational excitation on molecular reactivity have focused on reactions with a late barrier (that is, a transition state resembling the products). For an early barrier reaction, conventional wisdom predicts that a reactant's vibration should not couple efficiently to the reaction coordinate and thus should have little impact on the outcome. We report here an in-depth experimental study of the reactivity effects exerted by reactant C-H stretching excitation in a prototypical early-barrier reaction, F + CHD3. Rather counterintuitively, we find that the vibration hinders the overall reaction rate, inhibits scission of the excited bond itself (favoring the DF + CHD2 product channel), and influences the coproduct vibrational distribution despite being conserved in the CHD2 product. The results highlight substantial gaps in our predictive framework for state-selective polyatomic reactivity.	[Zhang, Weiqing; Kawamata, Hiroshi; Liu, Kopin] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Zhang, Weiqing] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China	Academia Sinica - Taiwan; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Liu, KP (corresponding author), Acad Sinica, Inst Atom & Mol Sci, POB 23-166, Taipei 10617, Taiwan.	kliu@po.iams.sinica.edu.tw	Liu, Kopin/F-7929-2012; /A-4824-2010	Liu, Kopin/0000-0001-7499-2397; Kawamata, Hiroshi/0000-0003-0893-1371	National Science Council of Taiwan; Academia Sinica; Air Force Office of Scientific Research [AOARD-09-4030]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the National Science Council of Taiwan, Academia Sinica, and the Air Force Office of Scientific Research (grant no. AOARD-09-4030).	ATKINS P, 2002, ATKINS PHYS CHEM, P968; Beck RD, 2003, SCIENCE, V302, P98, DOI 10.1126/science.1088996; Camden JP, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2155434; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Crim FF, 1999, ACCOUNTS CHEM RES, V32, P877, DOI 10.1021/ar950046a; Czako G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3068528; DING AMG, 1973, FARADAY DISCUSS, V55, P252, DOI 10.1039/dc9735500252; DUNCAN WT, 1995, J CHEM PHYS, V103, P9642, DOI 10.1063/1.470731; Espinosa-Garcia J, 2007, J PHYS CHEM A, V111, P2761, DOI 10.1021/jp0688759; Killelea DR, 2008, SCIENCE, V319, P790, DOI 10.1126/science.1152819; KIRSCH LJ, 1972, J CHEM PHYS, V57, P4498, DOI 10.1063/1.1678096; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Lin JJ, 2003, REV SCI INSTRUM, V74, P2495, DOI 10.1063/1.1561604; Liu ZH, 2006, SCIENCE, V312, P1024, DOI 10.1126/science.1124529; Palma J, 2002, CHEM PHYS LETT, V363, P529, DOI 10.1016/S0009-2614(02)01239-3; Persky A, 2006, CHEM PHYS LETT, V430, P251, DOI 10.1016/j.cplett.2006.09.013; POLANYI JC, 1977, FARADAY DISCUSS, V62, P267, DOI 10.1039/dc9776200267; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; Proctor DL, 2008, P NATL ACAD SCI USA, V105, P12673, DOI 10.1073/pnas.0801170105; Riedel J, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2894211; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Xie Z, 2006, CHEM PHYS LETT, V429, P355, DOI 10.1016/j.cplett.2006.08.039; Yan S, 2008, P NATL ACAD SCI USA, V105, P12667, DOI 10.1073/pnas.0800220105; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zhang BL, 2007, J PHYS CHEM A, V111, P9263, DOI 10.1021/jp072916z; Zhang BL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1859277; ZHANG W, J PHYS CH A IN PRESS; Zhou JG, 2004, J CHEM PHYS, V121, P813, DOI 10.1063/1.1761051; Zhou JG, 2003, J CHEM PHYS, V119, P8289, DOI 10.1063/1.1611877; Zhou JG, 2003, J CHEM PHYS, V119, P2538, DOI 10.1063/1.1587112	32	198	198	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					303	306		10.1126/science.1175018	http://dx.doi.org/10.1126/science.1175018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608914				2022-12-28	WOS:000268036600041
J	Brody, B				Brody, Benjamin			Who Has Capacity?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Brody, B (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					232	233		10.1056/NEJMp0902230	http://dx.doi.org/10.1056/NEJMp0902230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605827				2022-12-28	WOS:000267976100003
J	Muzzey, D; Gomez-Uribe, CA; Mettetal, JT; van Oudenaarden, A				Muzzey, Dale; Gomez-Uribe, Carlos A.; Mettetal, Jerome T.; van Oudenaarden, Alexander			A Systems-Level Analysis of Perfect Adaptation in Yeast Osmoregulation	CELL			English	Article							KINASE SIGNALING SPECIFICITY; GLYCEROL HOG PATHWAY; SACCHAROMYCES-CEREVISIAE; HIGH OSMOLARITY; HYPEROSMOTIC STRESS; OSMOTIC-STRESS; MODEL; ACCUMULATION; ROBUSTNESS; SHOCK	Negative feedback can serve many different cellular functions, including noise reduction in transcriptional networks and the creation of circadian oscillations. However, only one special type of negative feedback ("integral feedback'') ensures perfect adaptation, where steady-state output is independent of steady-state input. Here we quantitatively measure single-cell dynamics in the Saccharomyces cerevisiae hyperosmotic shock network, which regulates membrane turgor pressure. Importantly, we find that the nuclear enrichment of the MAP kinase Hog1 perfectly adapts to changes in external osmolarity, a feature robust to signaling fidelity and operating with very low noise. By monitoring multiple system quantities (e.g., cell volume, Hog1, glycerol) and using varied input waveforms (e.g., steps and ramps), we assess in a minimally invasive manner the network location of the mechanism responsible for perfect adaptation. We conclude that the system contains only one effective integrating mechanism, which requires Hog1 kinase activity and regulates glycerol synthesis but not leakage.	[Muzzey, Dale; Gomez-Uribe, Carlos A.; Mettetal, Jerome T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Gomez-Uribe, Carlos A.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Muzzey, Dale] Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; NIDDK NIH HHS [R90 DK071511-01, R90 DK071511, 5 R90 DK071511-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM068957-06, R01 GM068957-05, R01 GM068957, R01-GM068957, R01 GM068957-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gennemark Peter, 2006, In Silico Biology, V6, P193; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; Sontag ED, 2003, SYST CONTROL LETT, V50, P119, DOI 10.1016/S0167-6911(03)00136-1; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	31	243	245	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					160	171		10.1016/j.cell.2009.04.047	http://dx.doi.org/10.1016/j.cell.2009.04.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596242	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000267848600022
J	Nguyen, DX; Chiang, AC; Zhang, XHF; Kim, JY; Kris, MG; Ladanyi, M; Gerald, WL; Massague, J				Nguyen, Don X.; Chiang, Anne C.; Zhang, Xiang H. -F.; Kim, Juliet Y.; Kris, Mark G.; Ladanyi, Marc; Gerald, William L.; Massague, Joan			WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis	CELL			English	Article							GENE-EXPRESSION; BETA-CATENIN; BRAIN METASTASES; STEM-CELLS; CANCER; WNT; RECURRENCE; ACTIVATION; MUTATIONS; PATHWAY	Metastasis from lung adenocarcinoma can occur swiftly to multiple organs within months of diagnosis. The mechanisms that confer this rapid metastatic capacity to lung tumors are unknown. Activation of the canonical WNT/TCF pathway is identified here as a determinant of metastasis to brain and bone during lung adenocarcinoma progression. Gene expression signatures denoting WNT/TCF activation are associated with relapse to multiple organs in primary lung adenocarcinoma. Metastatic subpopulations isolated from independent lymphnode-derived lung adenocarcinoma cell lines harbor a hyperactive WNT/TCF pathway. Reduction of TCF activity in these cells attenuates their ability to form brain and bone metastases in mice, independently of effects on tumor growth in the lungs. The WNT/TCF target genes HOXB9 and LEF1 are identified as mediators of chemotactic invasion and colony outgrowth. Thus, a distinct WNT/TCF signaling program through LEF1 and HOXB9 enhances the competence of lung adenocarcinoma cells to colonize the bones and the brain. For a video summary of this article, see the Paper Flick file available with the online Supplemental Data.	[Nguyen, Don X.; Zhang, Xiang H. -F.; Kim, Juliet Y.; Massague, Joan] Cornell Univ, Canc Biol & Genet Program, Ithaca, NY 14853 USA; [Chiang, Anne C.; Kris, Mark G.] Cornell Univ, Dept Med, Ithaca, NY 14853 USA; [Ladanyi, Marc; Gerald, William L.] Cornell Univ, Dept Pathol, Ithaca, NY 14853 USA; [Ladanyi, Marc; Gerald, William L.] Cornell Univ, Human Oncol & Pathogenesis Program, Ithaca, NY 14853 USA; [Kris, Mark G.] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Cornell Univ, Canc Biol & Genet Program, Ithaca, NY 14853 USA.	j-massague@ski.mskcc.org	Ladanyi, Marc/AAG-8585-2019	Zhang, Xiang/0000-0002-5674-8670; Kris, Mark/0000-0002-7317-5341; Massague, Joan/0000-0001-9324-8408	Alan and Sandra Gerry Metastasis Research Initiative; National Institutes of Health [P01-129243]; Damon Runyon Cancer Research Foundation; American Society of Clinical Oncology Career Development Award; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA129243] Funding Source: NIH RePORTER	Alan and Sandra Gerry Metastasis Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; American Society of Clinical Oncology Career Development Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express deep gratitude to our late colleague William L. Gerald. We are indebted to H. Varmus, W. Pao, V. Rusch, and members of the Massague laboratory for insightful discussions. We thank A. Heguy for supervising sequencing and mutational analysis. H. Clevers, E. Batlle, R. Moon, W. Pao, and H. Varmus generously provided constructs and cell lines. This work was supported by the Alan and Sandra Gerry Metastasis Research Initiative and National Institutes of Health grant P01-129243 (M. G. K., M. L., W. L. G., and J. M.). D. X. N. was the Bayer postdoctoral fellow of the Damon Runyon Cancer Research Foundation. A. C. C. was supported by an American Society of Clinical Oncology Career Development Award. J. M. is an Investigator of the Howard Hughes Medical Institute.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BOS PD, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08021; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen AM, 2007, CANCER-AM CANCER SOC, V109, P1668, DOI 10.1002/cncr.22565; CHITALE D, 2009, ONCOGENE IN PRESS, DOI DOI 10.1038/ONC.2009.135; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Gaspar Laurie E, 2004, Expert Rev Anticancer Ther, V4, P259, DOI 10.1586/14737140.4.2.259; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Phelps RM, 1996, J CELL BIOCHEM, P32; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; RODENHUIS S, 1988, CANCER RES, V48, P5738; SASAKI Y, 1991, CANCER CHEMOTH PHARM, V27, P263, DOI 10.1007/BF00685110; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thomas AJ, 2000, J NEUROSURG, V93, P927, DOI 10.3171/jns.2000.93.6.0927; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	60	448	474	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					51	62		10.1016/j.cell.2009.04.030	http://dx.doi.org/10.1016/j.cell.2009.04.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19576624	Green Accepted, Bronze			2022-12-28	WOS:000267848600014
J	Sever, P				Sever, Peter			Is systolic blood pressure all that matters? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER		Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1NY, England	Imperial College London	Sever, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1NY, England.	p.sever@imperial.ac.uk			National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 1991, JAMA, V265, P3255; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mackenzie J, 1926, PRINCIPLES DIAGNOSIS; OROURKE M, 1995, HYPERTENSION, V26, P2, DOI 10.1161/01.HYP.26.1.2; Primatesta P, 2004, J HYPERTENS, V22, P1093, DOI 10.1097/00004872-200406000-00008; Sever P, 1999, BRIT MED J, V318, P1773, DOI 10.1136/bmj.318.7200.1773; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	11	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2009	339								b2665	10.1136/bmj.b2665	http://dx.doi.org/10.1136/bmj.b2665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LC	19592405				2022-12-28	WOS:000267898700002
J	van den Oord, RAHM; Sheikh, A				van den Oord, Rosanne A. H. M.; Sheikh, Aziz			Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-FUNCTION MUTATIONS; DERMATITIS; DISEASE	Objective To investigate whether filaggrin gene defects, present in up to one in 10 western Europeans and North Americans, increase the risk of developing allergic sensitisation and allergic disorders. Design Systematic review and meta-analysis. Data sources Medline, Embase, ISI Science Citation Index, BIOSIS, ISI Web of Knowledge, UK National Research Register, clinical trials. gov, the Index to Theses and Digital dissertations, and grey literature using OpenSIGLE. Study selection Genetic epidemiological studies (family, case-control) of the association between filaggrin gene defects and allergic sensitisation or allergic disorders. Data extraction Atopic eczema or dermatitis, food allergy, asthma, allergic rhinitis, and anaphylaxis, along with relevant immunological variables relating to the risk of allergic sensitisation as assessed by either positive skin prick testing or increased levels of allergen specific IgE. Data synthesis 24 studies were included. The odds of developing allergic sensitisation was 1.91 (95% confidence interval 1.44 to 2.54) in the family studies and 1.57 (1.20 to 2.07) in the case-control studies. The odds of developing atopic eczema was 1.99 (1.72 to 2.31) in the family studies and 4.78 (3.31 to 6.92) in the case-control studies. Three studies investigated the association between filaggrin gene mutations and allergic rhinitis in people without atopic eczema: overall odds ratio 1.78 (1.16 to 2.73). The four studies that investigated the association between filaggrin gene mutations and allergic rhinitis in people with atopic eczema reported a significant association: pooled odds ratio from case-control studies 2.84 (2.08 to 3.88). An overall odds ratio for the association between filaggrin gene mutations and asthma in people with atopic eczema was 2.79 (1.77 to 4.41) in case-control studies and 2.30 (1.66 to 3.18) in family studies. None of the studies that investigated filaggrin gene mutations and asthma in people without atopic eczema reported a significant association; overall odds ratio was 1.30 (0.7 to 2.30) in the case-control studies. The funnel plots suggested that publication bias was unlikely to be an explanation for these findings. No studies investigated the association between filaggrin gene mutations and food allergy or anaphylaxis. Conclusions Filaggrin gene defects increase the risk of developing allergic sensitisation, atopic eczema, and allergic rhinitis. Evidence of the relation between filaggrin gene mutations and atopic eczema was strong, with people manifesting increased severity and persistence of disease. Filaggrin gene mutations also increased the risk of asthma in people with atopic eczema. Restoring skin barrier function in filaggrin deficient people in early life may help prevent the development of sensitisation and halt the development and progression of allergic disease.	[van den Oord, Rosanne A. H. M.; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Greisenegger E, 2007, ALLERGY, V62, P31; Gupta R, 2007, THORAX, V62, P91, DOI 10.1136/thx.2004.038844; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Marenholz I, 2007, ALLERGY, V62, P92; Morar N, 2007, BRIT J DERMATOL, V157, P3; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; PARHAMP T, 2005, IMMUNE SYSTEM; Sheikh A, 2002, J ROY SOC MED, V95, P14, DOI 10.1258/jrsm.95.1.14; Simpson Colin R, 2007, Prim Care Respir J, V16, P322, DOI 10.3132/pcrj.2007.00065; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; STRACHAN DP, 2004, LIFE COURSE APPROACH; Trembath R, 2006, J MED GENET, V43, pS18	17	306	307	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2009	339								b2433	10.1136/bmj.b2433	http://dx.doi.org/10.1136/bmj.b2433			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LA	19589816	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267898500004
J	Wiggins, M; Bonell, C; Sawtell, M; Austerberry, H; Burchett, H; Allen, E; Strange, V				Wiggins, Meg; Bonell, Chris; Sawtell, Mary; Austerberry, Helen; Burchett, Helen; Allen, Elizabeth; Strange, Vicki			Health outcomes of youth development programme in England: prospective matched comparison study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERVENTION; PREVENTION; PREGNANCY; TRIAL	Objective To evaluate the effectiveness of youth development in reducing teenage pregnancy, substance use, and other outcomes. Design Prospective matched comparison study. Setting 54 youth service sites in England. Participants Young people (n = 2724) aged 13-15 years at baseline deemed by professionals as at risk of teenage pregnancy, substance misuse, or school exclusion or to be vulnerable. Intervention Intensive, multicomponent youth development programme including sex and drugs education (Young People's Development Programme) versus standard youth provision. Main outcome measures Various, including pregnancy, weekly cannabis use, and monthly drunkenness at 18 months. Results Young women in the intervention group more commonly reported pregnancy than did those in the comparison group (16% v 6%; adjusted odds ratio 3.55, 95% confidence interval 1.32 to 9.50). Young women in the intervention group also more commonly reported early heterosexual experience (58% v 33%; adjusted odds ratio 2.53, 1.09 to 5.92) and expectation of teenage parenthood (34% v 24%; 1.61, 1.07 to 2.43). Conclusions No evidence was found that the intervention was effective in delaying heterosexual experience or reducing pregnancies, drunkenness, or cannabis use. Some results suggested an adverse effect. Although methodological limitations may at least partly explain these findings, any further implementation of such interventions in the UK should be only within randomised trials.	[Bonell, Chris; Burchett, Helen; Allen, Elizabeth] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Wiggins, Meg; Sawtell, Mary; Austerberry, Helen; Strange, Vicki] Univ London, Inst Educ, Social Sci Res Unit, London WC1H 0NR, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education	Bonell, C (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	chris.bonell@lshtm.ac.uk	Chapman, Tony/F-6481-2011	Burchett, Helen/0000-0002-8380-2476	England's Department of Health	England's Department of Health	The research was funded by England's Department of Health. The funders required to see a draft of this paper 28 days before submission but in no way influenced the decision to publish or the contents of the paper. The funders were consulted about the design and methods used in the study and commented on drafts of the interim and final project reports. The research team was independent of the funders.	Bonell C, 2007, BMJ-BRIT MED J, V334, P614, DOI 10.1136/bmj.39139.414005.AD; Cho HS, 2005, J ABNORM CHILD PSYCH, V33, P363, DOI 10.1007/s10802-005-3574-4; FITZGIBBON C, 2000, EFFECTS PROVIDING SC; Grandjean P, 2004, ANNU REV PUBL HEALTH, V25, P199, DOI 10.1146/annurev.publhealth.25.050503.153941; HARDEN A, 2006, YOUNG PEOPLE PREGNAN; Imrie J, 2001, BRIT MED J, V322, P1451, DOI 10.1136/bmj.322.7300.1451; Kirby D., 2001, EMERGING ANSWERS 200; Kirby D, 2007, EMERGING ANSWERS 200; Kirby D. B., 2005, IMPLEMENTATION MULTI; McCord J, 2003, ANN AM ACAD POLIT SS, V587, P16, DOI 10.1177/0002716202250781; Palinkas LA, 1996, PREV MED, V25, P692, DOI 10.1006/pmed.1996.0108; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Philiber S., 2001, NATL EVALUATION CHIL; Philliber S, 2002, PERSPECT SEX REPRO H, V34, P244, DOI 10.2307/3097823; Stephenson JM, 2004, LANCET, V364, P338, DOI 10.1016/S0140-6736(04)16722-6; Wiggins M., 2008, YOUNG PEOPLES DEV PR	16	42	42	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2009	339								b2534	10.1136/bmj.b2534	http://dx.doi.org/10.1136/bmj.b2534			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469KX	19584408	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-28	WOS:000267898200001
J	Vasseur, DA; Fox, JW				Vasseur, David A.; Fox, Jeremy W.			Phase-locking and environmental fluctuations generate synchrony in a predator-prey community	NATURE			English	Article							POPULATION-DYNAMICS; SPATIAL SYNCHRONY; DISPERSAL; PATTERNS; SYSTEMS; NOISE	Spatially synchronized fluctuations in system state are common in physical and biological systems ranging from individual atoms(1) to species as diverse as viruses, insects and mammals(2-10). Although the causal factors are well known for many synchronized phenomena, several processes concurrently have an impact on spatial synchrony of species, making their separate effects and interactions difficult to quantify. Here we develop a general stochastic model of predator-prey spatial dynamics to predict the outcome of a laboratory microcosm experiment testing for interactions among all known synchronizing factors: ( 1) dispersal of individuals between populations; ( 2) spatially synchronous fluctuations in exogenous environmental factors ( the Moran effect); and ( 3) interactions with other species ( for example, predators) that are themselves spatially synchronized. The Moran effect synchronized populations of the ciliate protist Tetrahymena pyriformis; however, dispersal only synchronized prey populations in the presence of the predator Euplotes patella. Both model and data indicate that synchrony depends on cyclic dynamics generated by the predator. Dispersal, but not the Moran effect, 'phase-locks' cycles, which otherwise become 'decoherent' and drift out of phase. In the absence of cycles, phase-locking is not possible and the synchronizing effect of dispersal is negligible. Interspecific interactions determine population synchrony, not by providing an additional source of synchronized fluctuations, but by altering population dynamics and thereby enhancing the action of dispersal. Our results are robust to wide variation in model parameters representative of many natural predator-prey or host-pathogen systems. This explains why cyclic systems provide many of the most dramatic examples of spatial synchrony in nature.	[Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Fox, Jeremy W.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Yale University; University of Calgary	Vasseur, DA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	david.vasseur@yale.edu	Vasseur, David/A-2545-2013	Vasseur, David/0000-0003-1706-9613	Alberta Ingenuity; NSERC	Alberta Ingenuity; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	A. Gonzalez, E. McCauley and P. Morin provided comments on an earlier version of the manuscript. J. Scharein, T. Janes and J. MacNeil provided laboratory assistance. Funding was provided by Alberta Ingenuity and NSERC postdoctoral fellowships to D. A. V. and by an NSERC Discovery Grant and an Alberta Ingenuity New Faculty Award to J. W. F.	Abbott KC, 2007, OIKOS, V116, P903, DOI 10.1111/j.0030-1299.2007.15856.x; Bjornstad ON, 2000, J ANIM ECOL, V69, P869, DOI 10.1046/j.1365-2656.2000.00444.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cattadori IM, 2005, NATURE, V433, P737, DOI 10.1038/nature03276; Cazelles B, 2001, AM NAT, V157, P670, DOI 10.1086/320624; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Engen S, 2005, AM NAT, V166, P603, DOI 10.1086/491690; Fox JW, 2002, AM NAT, V159, P305, DOI 10.1086/338543; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Jansen VAA, 1999, TRENDS ECOL EVOL, V14, P278, DOI 10.1016/S0169-5347(99)01654-7; Jansen VAA, 2001, THEOR POPUL BIOL, V59, P119, DOI 10.1006/tpbi.2000.1506; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Ranta E, 2000, P ROY SOC B-BIOL SCI, V267, P1851, DOI 10.1098/rspb.2000.1220; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; Ripa J, 2007, OIKOS, V116, P783, DOI 10.1111/j.2007.0030-1299.15497.x; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Strogatz S., 2003, SYNC ORDER EMERGES C; Vasseur DA, 2007, OIKOS, V116, P1726, DOI 10.1111/j.2007.0030-1299.16101.x; Vasseur DA, 2007, ECOL LETT, V10, P1066, DOI 10.1111/j.1461-0248.2007.01099.x; Vasseur DA, 2007, ECOLOGY, V88, P2058, DOI 10.1890/06-1899.1	31	105	106	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					1007	U90		10.1038/nature08208	http://dx.doi.org/10.1038/nature08208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19626006				2022-12-28	WOS:000269085500033
J	Darzi, A				Darzi, Ara			A Time for Revolutions - The Role of Clinicians in Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Darzi, Ara] UK Dept Hlth, London, England; [Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Darzi, A (corresponding author), UK Dept Hlth, London, England.							Beveridge William, 1942, SOCIAL INSURANCE ALL	1	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6								10.1056/NEJMp0905707	http://dx.doi.org/10.1056/NEJMp0905707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19625710				2022-12-28	WOS:000268667300005
J	Kovacs, AM; Mehler, J				Kovacs, Agnes Melinda; Mehler, Jacques			Flexible Learning of Multiple Speech Structures in Bilingual Infants	SCIENCE			English	Article								Children acquire their native language according to a well-defined time frame. Surprisingly, although children raised in bilingual environments have to learn roughly twice as much about language as their monolingual peers, the speed of acquisition is comparable in monolinguals and bilinguals. Here, we show that preverbal 12-month-old bilingual infants have become more flexible at learning speech structures than monolinguals. When given the opportunity to simultaneously learn two different regularities, bilingual infants learned both, whereas monolinguals learned only one of them. Hence, bilinguals may acquire two languages in the time in which monolinguals acquire one because they quickly become more flexible learners.	[Kovacs, Agnes Melinda; Mehler, Jacques] Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Kovacs, AM (corresponding author), Scuola Int Super Studi Avanzati, Via Beirut 4, I-34014 Trieste, Italy.	agneskovacs@mtapi.hu		Kovacs, Agnes Melinda/0000-0003-3452-7727	NEST PATHFINDER; J.S. McDonnell Foundation; Maire Curie [035975]	NEST PATHFINDER; J.S. McDonnell Foundation; Maire Curie	This work was supported by the NEST PATHFINDER initiative "What it means to be human" (CALACEI), J.S. McDonnell Foundation, and Maire Curie 035975 DISCOS grants. A.M.K. is currently at the Hungarian Academy of Sciences and at the Central European University, Budapest, Hungary.	Bialystok E, 1999, CHILD DEV, V70, P636, DOI 10.1111/1467-8624.00046; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; PEARSON BZ, 1993, LANG LEARN, V43, P93, DOI 10.1111/j.1467-1770.1993.tb00174.x; Werker JF, 2008, TRENDS COGN SCI, V12, P144, DOI 10.1016/j.tics.2008.01.008	7	169	169	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					611	612		10.1126/science.1173947	http://dx.doi.org/10.1126/science.1173947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19589962				2022-12-28	WOS:000268493000050
J	Francis, NA; Butler, CC; Hood, K; Simpson, S; Wood, F; Nuttall, J				Francis, Nick A.; Butler, Christopher C.; Hood, Kerenza; Simpson, Sharon; Wood, Fiona; Nuttall, Jacqueline			Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMATION LEAFLET; PRESCHOOL-CHILDREN; MANAGEMENT; PARENTS; ILLNESS; EXPECTATIONS; PERCEPTIONS; STRATEGIES; VISITS	Objective To establish whether an interactive booklet on respiratory tract infections in children reduces reconsultation for the same illness episode, reduces antibiotic use, and affects future consulting intentions, while maintaining parental satisfaction with care. Design Pragmatic cluster randomised controlled trial. Setting 61 general practices in Wales and England. Participants 558 children (6 months to 14 years) presenting to primary care with an acute respiratory tract infection (7 days or less). Children with suspected pneumonia, asthma or a serious concomitant illness, or needing immediate hospital admission were excluded. Three withdrew and 27 were lost to follow-up, leaving 528 (94.6%) with main outcome data. Interventions Clinicians in the intervention group were trained in the use of an interactive booklet on respiratory tract infections and asked to use the booklet during consultations with recruited patients (and provide it as a take home resource). Clinicians in the control group conducted their consultations as usual. Main outcome measures The proportion of children who attended a face-to-face consultation about the same illness during the two week follow-up period. Secondary outcomes included antibiotic prescribing, antibiotic consumption, future consulting intentions, and parental satisfaction, reassurance, and enablement. Results Reconsultation occurred in 12.9% of children in the intervention group and 16.2% in the control group (absolute risk reduction 3.3%, 95% confidence interval-2.7% to 9.3%, P=0.29). Using multilevel modelling (at the practice and individual level) to account for clustering, no significant difference in reconsulting was noted (odds ratio 0.75; 0.41 to 1.38). Antibiotics were prescribed at the index consultation to 19.5% of children in the intervention group and 40.8% of children in the control group (absolute risk reduction 21.3%, 95% confidence interval 13.7 to 28.9), P<0.001). A significant difference was still present after adjusting for clustering (odds ratio 0.29; 0.14 to 0.60). There was also a significant difference in the proportion of parents who said they would consult in the future if their child developed a similar illness (odds ratio 0.34; 0.20 to 0.57). Satisfaction, reassurance, and parental enablement scores were not significantly different between the two groups. Conclusions Use of a booklet on respiratory tract infections in children within primary care consultations led to important reductions in antibiotic prescribing and reduced intention to consult without reducing satisfaction with care.	[Butler, Christopher C.; Hood, Kerenza; Wood, Fiona; Nuttall, Jacqueline] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales; [Hood, Kerenza; Nuttall, Jacqueline] Cardiff Univ, Sch Med, SE Wales Trials Unit, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University		francisna@cf.ac.uk	Francis, Nick/B-7413-2009; Hood, Kerenza/C-2528-2008	Francis, Nick/0000-0001-8939-7312; Hood, Kerenza/0000-0002-5268-8631; Wood, Fiona/0000-0001-7397-4074; Butler, Christopher/0000-0002-0102-3453; Simpson, Sharon Anne/0000-0002-6219-1768	Medical Research Council; Welsh Assembly Government; Pfizer UK; Welsh Office for Research and Development; Cardiff University; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G106/1225] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G106/1225] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly Government; Pfizer UK(Pfizer); Welsh Office for Research and Development; Cardiff University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge funding from the Medical Research Council and the Welsh Assembly Government in the form of a joint Health Services Fellowship for NF. Funding for the development of the training website was from an educational grant from Pfizer UK. The South-East Wales Trials Unit is funded by the Welsh Office for Research and Development. All authors declare that this work was conducted independently from the study funders.; Sponsorship: This study was sponsored by Cardiff University.	Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Arroll B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub2; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Braun BL, 2000, ARCH FAM MED, V9, P589, DOI 10.1001/archfami.9.7.589; Butler CC, 2003, BRIT MED J, V327, P1088, DOI 10.1136/bmj.327.7423.1088; Butler CC, 2002, LANCET, V359, P2153, DOI 10.1016/S0140-6736(02)09091-8; Butler CC, 1998, BRIT J GEN PRACT, V48, P1865; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Del Mar CB, 2006, COCHRANE DB SYST REV, V4, DOI 10.1002/14651858.cd000023; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Francis N, 2008, PATIENT EDUC COUNS, V73, P286, DOI 10.1016/j.pec.2008.07.020; Francis NA, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-23; HANSEN BWL, 1990, PATIENT EDUC COUNS, V16, P147, DOI 10.1016/0738-3991(90)90089-4; HEANEY D, 2001, BMJ-BRIT MED J, V322, P1; Hollinghurst S, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-10; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; Kai J, 1996, BRIT MED J, V313, P983; Kallestrup P, 2003, BRIT J GEN PRACT, V53, P43; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 2001, BRIT MED J, V322, P1214, DOI 10.1136/bmj.322.7296.1214; Macfarlane J, 2002, BRIT MED J, V324, P91, DOI 10.1136/bmj.324.7329.91; Macfarlane JT, 1997, BRIT J GEN PRACT, V47, P719; MCCORMICK A, 1995, MORBIDITY STAT GEN P; McWilliams DB, 2008, ARCH PEDIAT ADOL MED, V162, P151, DOI 10.1001/archpediatrics.2007.30; MORRELL DC, 1980, BRIT MED J, V280, P769, DOI 10.1136/bmj.280.6216.769; *NAT I HLTH CLIN E, CLIN GUID NAT I HLTH, V69; ROBERTS CR, 1983, JAMA-J AM MED ASSOC, V250, P1986, DOI 10.1001/jama.250.15.1986; Shapiro E, 2002, CLIN THER, V24, P197, DOI 10.1016/S0149-2918(02)85015-9; Smith SM, 2004, COCHRANE DB SYST REV, V4; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2; SPURLING GK, 2007, COCHRANE DB SYST REV, V3; STOTT NCH, 1979, BRIT MED J, V1, P29, DOI 10.1136/bmj.1.6155.29; Taylor JA, 2005, PEDIATR INFECT DIS J, V24, P489, DOI 10.1097/01.inf.0000164706.91337.5d; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; USHERWOOD TP, 1991, BRIT J GEN PRACT, V41, P58; Venekamp RP, 2015, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000219.PUB4, 10.1002/14651858.CD000219.pub4]	39	159	164	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2009	339								b2885	10.1136/bmj.b2885	http://dx.doi.org/10.1136/bmj.b2885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PH	19640941	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000268672900001
J	Elvy, J; Riordan, T; Sarsfield, P; Ahmad, T				Elvy, Juliet; Riordan, Terry; Sarsfield, Patrick; Ahmad, Tariq			Lesson of the Week A diarrhoeal illness with a difference?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; DIAGNOSIS; ANTIBODY; DISEASE; YOUNG		[Elvy, Juliet; Riordan, Terry] Royal Devon & Exeter Fdn NHS Trust, Dept Med Microbiol, Exeter EX2 5AD, Devon, England; [Sarsfield, Patrick] Royal Devon & Exeter Fdn NHS Trust, Dept Histopathol, Exeter EX2 5AD, Devon, England; [Ahmad, Tariq] Royal Devon & Exeter Fdn NHS Trust, Dept Gastroenterol, Exeter EX2 5AD, Devon, England		Elvy, J (corresponding author), Royal Devon & Exeter Fdn NHS Trust, Dept Med Microbiol, Exeter EX2 5AD, Devon, England.	juleselvy@doctors.org.uk						ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Boaz A, 2000, DIS COLON RECTUM, V43, P264, DOI 10.1007/BF02236993; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Delmee M, 2005, J MED MICROBIOL, V54, P187, DOI 10.1099/jmm.0.45844-0; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Kaplan N, 1996, J HOSP INFECT, V32, P322, DOI 10.1016/S0195-6701(96)90044-4; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; NAKAMURA S, 1981, MICROBIOL IMMUNOL, V25, P345, DOI 10.1111/j.1348-0421.1981.tb00036.x; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Staneck JL, 1996, J CLIN MICROBIOL, V34, P2718, DOI 10.1128/JCM.34.11.2718-2721.1996; STRIMLING MO, 1989, LANCET, V2, P866, DOI 10.1016/S0140-6736(89)93034-1; *UK HLTH PROT AG, DAT MAND HEALTHC ASS; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; WILSON KH, 1982, J CLIN MICROBIOL, V16, P464, DOI 10.1128/JCM.16.3.464-468.1982	18	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2009	339								b2648	10.1136/bmj.b2648	http://dx.doi.org/10.1136/bmj.b2648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IE	19620222				2022-12-28	WOS:000268351000001
J	Berriman, M; Haas, BJ; LoVerde, PT; Wilson, RA; Dillon, GP; Cerqueira, GC; Mashiyama, ST; Al-Lazikani, B; Andrade, LF; Ashton, PD; Aslett, MA; Bartholomeu, DC; Blandin, G; Caffrey, CR; Coghlan, A; Coulson, R; Day, TA; Delcher, A; DeMarco, R; Djikeng, A; Eyre, T; Gamble, JA; Ghedin, E; Gu, Y; Hertz-Fowler, C; Hirai, H; Hirai, Y; Houston, R; Ivens, A; Johnston, DA; Lacerda, D; Macedo, CD; McVeigh, P; Ning, ZM; Oliveira, G; Overington, JP; Parkhill, J; Pertea, M; Pierce, RJ; Protasio, AV; Quail, MA; Rajandream, MA; Rogers, J; Sajid, M; Salzberg, SL; Stanke, M; Tivey, AR; White, O; Williams, DL; Wortman, J; Wu, WJ; Zamanian, M; Zerlotini, A; Fraser-Liggett, CM; Barrell, BG; El-Sayed, NM				Berriman, Matthew; Haas, Brian J.; LoVerde, Philip T.; Wilson, R. Alan; Dillon, Gary P.; Cerqueira, Gustavo C.; Mashiyama, Susan T.; Al-Lazikani, Bissan; Andrade, Luiza F.; Ashton, Peter D.; Aslett, Martin A.; Bartholomeu, Daniella C.; Blandin, Gaelle; Caffrey, Conor R.; Coghlan, Avril; Coulson, Richard; Day, Tim A.; Delcher, Art; DeMarco, Ricardo; Djikeng, Appolinaire; Eyre, Tina; Gamble, John A.; Ghedin, Elodie; Gu, Yong; Hertz-Fowler, Christiane; Hirai, Hirohisha; Hirai, Yuriko; Houston, Robin; Ivens, Alasdair; Johnston, David A.; Lacerda, Daniela; Macedo, Camila D.; McVeigh, Paul; Ning, Zemin; Oliveira, Guilherme; Overington, John P.; Parkhill, Julian; Pertea, Mihaela; Pierce, Raymond J.; Protasio, Anna V.; Quail, Michael A.; Rajandream, Marie-Adele; Rogers, Jane; Sajid, Mohammed; Salzberg, Steven L.; Stanke, Mario; Tivey, Adrian R.; White, Owen; Williams, David L.; Wortman, Jennifer; Wu, Wenjie; Zamanian, Mostafa; Zerlotini, Adhemar; Fraser-Liggett, Claire M.; Barrell, Barclay G.; El-Sayed, Najib M.			The genome of the blood fluke Schistosoma mansoni	NATURE			English	Article							HIDDEN MARKOV MODEL; EMBRYONIC-DEVELOPMENT; TRYPANOSOMA-CRUZI; GENE; DATABASE; SEQUENCE; RETROTRANSPOSONS; DIVERSITY; DISCOVERY; ALIGNMENT	Schistosoma mansoni is responsible for the neglected tropical disease schistosomiasis that affects 210 million people in 76 countries. Here we present analysis of the 363 megabase nuclear genome of the blood fluke. It encodes at least 11,809 genes, with an unusual intron size distribution, and new families of micro-exon genes that undergo frequent alternative splicing. As the first sequenced flatworm, and a representative of the Lophotrochozoa, it offers insights into early events in the evolution of the animals, including the development of a body pattern with bilateral symmetry, and the development of tissues into organs. Our analysis has been informed by the need to find new drug targets. The deficits in lipid metabolism that make schistosomes dependent on the host are revealed, and the identification of membrane receptors, ion channels and more than 300 proteases provide new insights into the biology of the life cycle and new targets. Bioinformatics approaches have identified metabolic chokepoints, and a chemogenomic screen has pinpointed schistosome proteins for which existing drugs may be active. The information generated provides an invaluable resource for the research community to develop much needed new control tools for the treatment and eradication of this important and neglected disease.	[Berriman, Matthew; Aslett, Martin A.; Eyre, Tina; Gamble, John A.; Gu, Yong; Hertz-Fowler, Christiane; Houston, Robin; Ivens, Alasdair; Parkhill, Julian; Protasio, Anna V.; Quail, Michael A.; Rajandream, Marie-Adele; Rogers, Jane; Tivey, Adrian R.; Barrell, Barclay G.] Wellcome Trust Sanger Inst, Cambridge CB10 1SD, England; [Coulson, Richard; Overington, John P.] European Bioinformat Inst EMBL, Cambridge CB10 1SD, England; [Haas, Brian J.; Bartholomeu, Daniella C.; Blandin, Gaelle; Djikeng, Appolinaire; Ghedin, Elodie; Lacerda, Daniela; White, Owen; Wortman, Jennifer; Fraser-Liggett, Claire M.; El-Sayed, Najib M.] J Craig Venter Inst, Inst Genom Res, Rockville, MD 20850 USA; [LoVerde, Philip T.; Ashton, Peter D.; Wu, Wenjie] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [LoVerde, Philip T.; Ashton, Peter D.; Wu, Wenjie] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Wilson, R. Alan; Dillon, Gary P.; DeMarco, Ricardo] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Cerqueira, Gustavo C.; Macedo, Camila D.; El-Sayed, Najib M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Cerqueira, Gustavo C.; Delcher, Art; Pertea, Mihaela; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Cerqueira, Gustavo C.; Macedo, Camila D.; Salzberg, Steven L.; El-Sayed, Najib M.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mashiyama, Susan T.; Caffrey, Conor R.; Sajid, Mohammed] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Mashiyama, Susan T.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [Mashiyama, Susan T.] Univ Calif San Francisco, Dept Pharmaceut Chem, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [Al-Lazikani, Bissan; Zerlotini, Adhemar] Inst Canc Res, Haddow Labs, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; [Andrade, Luiza F.; Oliveira, Guilherme] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Coghlan, Avril] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Day, Tim A.; McVeigh, Paul; Zamanian, Mostafa] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [DeMarco, Ricardo] Univ Sao Paulo, Inst Quim, BR-05508 Sao Paulo, Brazil; [DeMarco, Ricardo] Univ Sao Paulo, Inst Fis Sao Carlos, BR-05508 Sao Paulo, Brazil; [Hirai, Hirohisha; Hirai, Yuriko] Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan; [Johnston, David A.] Nat Hist Museum, Biomed Parasitol Div, London SW7 5BD, England; [Pierce, Raymond J.] Univ Lille 2, INSERM, U547, Inst Pasteur Lille,IFR 142, Lille, France; [Stanke, Mario] Univ Gottingen, Inst Mikrobiol & Genet, Abt Bioinformat, D-37077 Gottingen, Germany; [Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); J. Craig Venter Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of York - UK; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research UK; University of London; Institute of Cancer Research - UK; Fundacao Oswaldo Cruz; University College Cork; Iowa State University; Universidade de Sao Paulo; Universidade de Sao Paulo; Kyoto University; Natural History Museum London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Gottingen; Illinois State University	Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	mb4@sanger.ac.uk; elsayed@umd.edu	Salzberg, Steven/Q-6514-2019; DeMarco, Ricardo/A-7773-2008; Cerqueira, Gustavo/AAV-7398-2020; Salzberg, Steven L/F-6162-2011; Al-Lazikani, Bissan/AAG-4723-2022; DoenÃas Tropicais, Inct/K-2308-2013; Protasio, Anna/F-7751-2016; Al-Lazikani, Bissan/AFK-6457-2022; 4, INCT/H-4499-2013; Ghedin, Elodie/Y-5654-2019; Zamanian, Mostafa/B-7993-2013; El-Sayed, Najib M.A./K-7266-2015; Pertea, Mihaela/AAT-2705-2021; Parkhill, Julian/G-4703-2011; Zerlotini, Adhemar/E-6533-2012; Ning, Zemin/D-2411-2013; Overington, John P./E-5764-2010; Wilson, Alan/AAD-5050-2020; Stanke, Mario/P-7876-2019; Inbeqmedi, Inct/I-1929-2013; Protasio, Anna V./AAJ-8991-2020; McVeigh, Paul/AAV-7138-2020; Overington, John P/G-8607-2015; Blandin, Gaelle/N-9745-2013; Quail, michael/ABE-6131-2020; Bartholomeu, Daniella C./J-4714-2015; Berriman, Matthew/A-7618-2011; Oliveira, Guilherme/E-2624-2014	Salzberg, Steven/0000-0002-8859-7432; DeMarco, Ricardo/0000-0001-8944-1301; Cerqueira, Gustavo/0000-0002-7692-3886; Salzberg, Steven L/0000-0002-8859-7432; Protasio, Anna/0000-0003-1723-800X; Ghedin, Elodie/0000-0002-1515-725X; El-Sayed, Najib M.A./0000-0001-7970-3312; Pertea, Mihaela/0000-0003-0762-8637; Parkhill, Julian/0000-0002-7069-5958; Zerlotini, Adhemar/0000-0002-7739-0284; Overington, John P./0000-0002-5859-1064; Stanke, Mario/0000-0001-8696-0384; Protasio, Anna V./0000-0003-1723-800X; McVeigh, Paul/0000-0003-1850-9692; Overington, John P/0000-0002-5859-1064; Blandin, Gaelle/0000-0003-2790-9524; Bartholomeu, Daniella C./0000-0003-0974-7357; Berriman, Matthew/0000-0002-9581-0377; Djikeng, Appolinaire/0000-0001-9271-3419; Ivens, Al/0000-0002-0112-3876; Johnston, David/0000-0001-6703-6014; Day, Tim/0000-0002-9037-6540; Fraser, Claire/0000-0003-1462-2428; Al-Lazikani, Bissan/0000-0003-3367-2519; Oliveira, Guilherme/0000-0003-0054-3438; Wilson, Alan/0000-0002-7210-0321; Pierce, Raymond/0000-0001-9820-8608; Ning, Zemin/0000-0003-4359-776X; Ashton, Peter/0000-0002-7446-5009; Zamanian, Mostafa/0000-0001-9233-1760; Dillon, Gary/0000-0002-7743-5040; Wortman, Jennifer/0000-0002-8713-1227; Hertz-Fowler, Christiane/0000-0002-0729-6479; Coghlan, Avril/0000-0002-2775-5951; Wu, Wenjie/0000-0002-0907-0561	Wellcome Trust [WT085775/Z/08/Z]; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI48828]; Oyama Health Foundation; Japan Society for the Promotion of Science [13557021]; Japan's Ministry of Education, Culture, Sports, Science and Technology; Sandler Foundation; NIH-Fogarty [5D43TW006580, 5D43TW007012-03]; NIH [AI054711-01A2]; PhRMA Foundation; Burroughs Wellcome Fund; United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO); CAPES; FAPESP;  [FAPEMIG REDE-281/05]; FOGARTY INTERNATIONAL CENTER [D43TW006580, D43TW007012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054711, U01AI048828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873, R01GM060595] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oyama Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sandler Foundation; NIH-Fogarty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO)(World Health Organization); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The genome sequencing and annotation work was funded by the Wellcome Trust (grant number WT085775/Z/08/Z) and the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant AI48828 to N. M. E.-S. We thank N. D. Rawlings of the MEROPS database team at the Wellcome Trust Sanger Institute for his help, J. C. Illes for discussions on polarity complexes, and F. Prosdocimi and M. R. D. Sananes for early discussions and analyses in the project. FISH chromosome mappings were partially supported by Oyama Health Foundation (H. H.), Japan Society for the Promotion of Science (13557021) (H. H.), 21st century Centers of Exellence and global Centers of Excellence of Japan's Ministry of Education, Culture, Sports, Science and Technology. Additional support was by The Sandler Foundation (C. R. C. and M. S.), NIH-Fogarty 5D43TW006580 (P. T. L.), NIH-Fogarty 5D43TW007012-03, NIH grant AI054711-01A2 (R. A. W. and G. P. D.), FAPEMIG REDE-281/05 (G. O.), the PhRMA Foundation (Postdoctoral Fellowship in Informatics to S. T. M.), The Burroughs Wellcome Fund (P. T. L.) and the United Nations Children's Fund (UNICEF)/United Nations Development Program (UNDP)/World bank/World Health Organization (WHO) Special program for research and training in tropical diseases (TDR) (P. T. L.). R. D. was a recipient of CAPES and FAPESP fellowships.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anamika K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-625; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barrett J., 1981, BIOCH PARASITIC HELM; Berriman M, 2004, METH MOL B, V270, P17; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biedler J, 2003, MOL BIOL EVOL, V20, P1811, DOI 10.1093/molbev/msg189; Boyle SN, 2007, DRUG DISCOV TODAY, V12, P717, DOI 10.1016/j.drudis.2007.07.019; Brouwers JFHM, 1997, MOL BIOCHEM PARASIT, V88, P175, DOI 10.1016/S0166-6851(97)00091-1; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Caffrey CR, 2008, EXPERT OPIN DRUG DIS, V3, P173, DOI 10.1517/17460441.3.2.173; CAO M, 1993, MOL BIOCHEM PARASIT, V57, P175, DOI 10.1016/0166-6851(93)90256-W; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DeMarco R, 2005, BIOCHEM BIOPH RES CO, V333, P230, DOI 10.1016/j.bbrc.2005.05.080; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Drew AC, 1999, MOL BIOL EVOL, V16, P1256, DOI 10.1093/oxfordjournals.molbev.a026216; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FLETCHER M, 1981, AM J TROP MED HYG, V30, P406, DOI 10.4269/ajtmh.1981.30.406; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hamdan FF, 2002, MOL BIOCHEM PARASIT, V119, P75, DOI 10.1016/S0166-6851(01)00400-5; Hirai H, 2004, METH MOL B, V270, P379; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Humphries JE, 2004, J BIOL CHEM, V279, P39880, DOI 10.1074/jbc.M405624200; Ieko M, 2006, FRONT BIOSCI-LANDMRK, V11, P232, DOI 10.2741/1794; Jeziorski MC, 2006, INT J PARASITOL, V36, P625, DOI 10.1016/j.ijpara.2006.02.002; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIM E, 1995, PARASITOLOGY, V110, P171, DOI 10.1017/S0031182000063939; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Paslier MC, 2000, GENOMICS, V65, P87, DOI 10.1006/geno.2000.6147; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning Gerard, 2005, WormBook, P1; Morales FC, 2004, MOL BIOCHEM PARASIT, V134, P65, DOI 10.1016/j.molbiopara.2003.10.016; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Nash T, 1998, ANTIMICROB AGENTS CH, V42, P1488, DOI 10.1128/AAC.42.6.1488; Okun I, 2008, ANTI-CANCER AGENT ME, V8, P322, DOI 10.2174/187152008783961914; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salkoff L, 2005, WormBook, P1; Sambon L. W., 1907, J TROP MED HYG, V10, P117; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; SIMPSON AJG, 1982, MOL BIOCHEM PARASIT, V6, P125, DOI 10.1016/0166-6851(82)90070-6; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Volfovsky N, 2003, GENOME RES, V13, P1216, DOI 10.1101/gr.677503; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu WJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-27; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	85	801	832	1	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					352	U65		10.1038/nature08160	http://dx.doi.org/10.1038/nature08160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606141	hybrid, Green Accepted			2022-12-28	WOS:000267979000029
J	Blow, N				Blow, Nathan			Untangling the protein web	NATURE			English	Editorial Material																		Feret J, 2009, P NATL ACAD SCI USA, V106, P6453, DOI 10.1073/pnas.0809908106; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; VIDAL M, 2009, NATURE METHODS, V6, P91; VIDAL M, 2009, NATURE METHODS, V6, P39; VIDAL M, 2009, NATURE METHODS, V6, P83; VIDAL M, 2009, NATURE METHODS, V6, P47	9	26	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					415	418		10.1038/460415a	http://dx.doi.org/10.1038/460415a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606149	Bronze			2022-12-28	WOS:000267979000043
J	Fisher, RS; Doma, SP				Fisher, Robert S.; Doma, Siva P.			Segmental Diverticulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fisher, Robert S.; Doma, Siva P.] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fisher, RS (corresponding author), Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.	siva.doma@tuhs.temple.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					286	286		10.1056/NEJMicm0801643	http://dx.doi.org/10.1056/NEJMicm0801643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605833				2022-12-28	WOS:000267976100010
J	Wells, K; Jones, L				Wells, Kenneth; Jones, Loretta			"Research" in Community-Partnered, Participatory Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRATEGIES; ENGAGEMENT		[Wells, Kenneth] Univ Calif Los Angeles, Hlth Serv Res Ctr, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Wells, Kenneth] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Wells, Kenneth] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA; [Jones, Loretta] Healthy African Amer Families II, Los Angeles, CA USA; [Jones, Loretta] Charles R Drew Univ Med & Sci, Los Angeles, CA 90059 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Charles R. Drew University of Medicine & Science	Wells, K (corresponding author), Univ Calif Los Angeles, Hlth Serv Res Ctr, Jane & Terry Semel Inst Neurosci & Human Behav, 10920 Wilshire Blvd,Ste 300, Los Angeles, CA 90024 USA.	kwells@mednet.ucla.edu			NIA NIH HHS [P30 AG021684, 2P30AG021684-07] Funding Source: Medline; NICHD NIH HHS [U01 HD044245, 2U01HD044245] Funding Source: Medline; NIMHD NIH HHS [P20 MD000182, MD00148/MD00182, P20 MD000148] Funding Source: Medline; NIMH NIH HHS [P30 MH082760, R01 MH078853-01A1, P30 MH082760-01, R01MH78853, 1P30MH082760-01, R01 MH078853] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD044245] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH082760, R01MH078853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000182] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chung BW, 2009, AM J PUBLIC HEALTH, V99, P237, DOI 10.2105/AJPH.2008.141408; DeGruy-Leary, 2005, POST TRAUMATIC SLAVE; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Israel B A, 2001, J Public Health Manag Pract, V7, P1; Jones L., 2008, COMMUNITY BASED PART, P67; Jones L, 2007, JAMA-J AM MED ASSOC, V297, P407, DOI 10.1001/jama.297.4.407; *MERR WEBST, 2009, DICT THES; RANDALL V, 2006, DYING BLACK; Wells Kenneth B, 2006, Ethn Dis, V16, pS3; Zambrana R E, 1996, J Med Syst, V20, P317, DOI 10.1007/BF02257043	10	88	89	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					320	321		10.1001/jama.2009.1033	http://dx.doi.org/10.1001/jama.2009.1033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470BR	19602693	Green Accepted			2022-12-28	WOS:000267948100027
J	Fraser, WD				Fraser, William D.			Hyperparathyroidism	LANCET			English	Review							BONE-MINERAL DENSITY; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; CALCIUM-SENSING RECEPTOR; VITAMIN-D STATUS; LEFT-VENTRICULAR HYPERTROPHY; GLOMERULAR-FILTRATION-RATE; HIGH PHOSPHATE THERAPY; QUALITY-OF-LIFE; PARATHYROID-HORMONE	Hyperparathyroidism is due to increased activity of the parathyroid glands, either from an intrinsic abnormal change altering excretion of parathyroid hormone (primary or tertiary hyperparathyroidism) or from an extrinsic abnormal change affecting calcium homoeostasis stimulating production of parathyroid hormone (secondary hyperparathyroidism). Primary hyperparathyroidism is the third most common endocrine disorder, with the highest incidence in postmenopausal women. Asymptomatic disease is common, and severe disease with renal stones and metabolic bone disease arises less frequently now than it did 20-30 years ago. Primary hyperparathyroidism can be cured by surgical removal of an adenoma, increasingly by minimally invasive parathyroidectomy. Medical management of mild disease is possible with bisphosphonates, hormone replacement therapy, and calcimimetics. Vitamin D deficiency is a common cause of secondary hyperparathyroidism, particularly in elderly people. However, the biochemical definition of vitamin D deficiency and its treatment are subject to much debate. Secondary hyperparathyroidism as the result of chronic kidney disease is important in the genesis of renal bone disease, and several new treatments could help achieve the guidelines set out by the kidney disease outcomes quality initiative.	Univ Liverpool, Sch Clin Sci, Unit Clin Chem, Liverpool L69 3GA, Merseyside, England	University of Liverpool	Fraser, WD (corresponding author), Univ Liverpool, Sch Clin Sci, Unit Clin Chem, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.	w.d.fraser@liverpool.ac.uk						ABUGASSA S, 1992, EUR J SURG, V158, P397; Adami S, 2002, J BONE MINER RES, V17, pN18; Ammann P, 2003, AGING CLIN EXP RES, V15, P500, DOI 10.1007/BF03327373; [Anonymous], 1997, Am J Kidney Dis, V30, pS15; [Anonymous], 1997, Am J Kidney Dis, V30, pS67; Avenell A, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000227.PUB3; Barkun J, 2006, CAN J SURG, V49, P59; Bates CJ, 2003, OSTEOPOROSIS INT, V14, P152, DOI 10.1007/s00198-002-1338-3; BEARD CM, 1989, ARCH INTERN MED, V149, P1887, DOI 10.1001/archinte.149.8.1887; Bilezikian JP, 2002, J BONE MINER RES, V17, pN57; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Brossard JH, 1996, J CLIN ENDOCR METAB, V81, P3923, DOI 10.1210/jc.81.11.3923; Brossard JH, 2000, CLIN CHEM, V46, P697; Brown SA, 2003, OSTEOPOROSIS INT, V14, P442, DOI 10.1007/s00198-002-1331-x; Caillard C, 2007, SURGERY, V141, P153, DOI 10.1016/j.surg.2006.12.004; Cantor T, 2003, NEFROLOGIA, V23, P69; Carnevale V, 2004, CLIN CHEM, V50, P626, DOI 10.1373/clinchem.2003.026328; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Charytan C, 2005, AM J KIDNEY DIS, V46, P58, DOI 10.1053/j.ajkd.2005.04.013; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1489, DOI 10.1093/ndt/gfh125; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Chiang CY, 2005, CLIN ENDOCRINOL, V62, P99, DOI 10.1111/j.1365-2265.2004.02180.x; Chow CC, 2003, J CLIN ENDOCR METAB, V88, P581, DOI 10.1210/jc.2002-020890; Christiansen P, 1999, BONE, V25, P589, DOI 10.1016/S8756-3282(99)00207-0; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; DAUPHINE RT, 1975, ANN INTERN MED, V83, P365, DOI 10.7326/0003-4819-83-3-365; DAVIES M, 1984, ACTA ENDOCRINOL-COP, V106, P499, DOI 10.1530/acta.0.1060499; DAVIES M, 1981, BRIT MED J, V282, P1023, DOI 10.1136/bmj.282.6269.1023; Davies M, 2002, CLIN ENDOCRINOL, V57, P145, DOI 10.1046/j.1365-2265.2002.01581.x; De Prisco C, 2005, AM J MED SCI, V329, P57, DOI 10.1097/00000441-200502000-00001; Divieti P, 2002, ENDOCRINOLOGY, V143, P171, DOI 10.1210/en.143.1.171; Dotzenrath CME, 2006, WORLD J SURG, V30, P680, DOI 10.1007/s00268-005-0444-8; EGSMOSE C, 1987, AGE AGEING, V16, P35, DOI 10.1093/ageing/16.1.35; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; El-Hajj Fuleihan G, 2002, J BONE MINER RES, V17, pN51; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; FUJIWARA S, 1992, RADIAT RES, V130, P372, DOI 10.2307/3578384; Gao P, 2001, J BONE MINER RES, V16, P605, DOI 10.1359/jbmr.2001.16.4.605; Gayed IW, 2005, J NUCL MED, V46, P248; Glendenning P, 2006, ANN CLIN BIOCHEM, V43, P23, DOI 10.1258/000456306775141650; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Grant CS, 2005, ARCH SURG-CHICAGO, V140, P472, DOI 10.1001/archsurg.140.5.472; Grzela T, 2006, INT J MOL MED, V17, P779; Gunn IR, 2004, ANN CLIN BIOCHEM, V41, P441, DOI 10.1258/0004563042466802; Guo CY, 1996, J CLIN ENDOCR METAB, V81, P3487, DOI 10.1210/jc.81.10.3487; HAMDY NAT, 1995, BRIT MED J, V310, P358, DOI 10.1136/bmj.310.6976.358; HAMDY NAT, 1987, BONE, V8, pS69; Hershman JM, 2003, J BONE MINER RES, V18, P1889, DOI 10.1359/jbmr.2003.18.10.1889; Huang QL, 2000, J ENDOCRINOL INVEST, V23, P263, DOI 10.1007/BF03343720; ISHIMURA E, 1993, HORM METAB RES, V25, P493, DOI 10.1055/s-2007-1002158; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jesudason D, 2002, BONE, V31, P626, DOI 10.1016/S8756-3282(02)00866-9; Johnson LR, 2001, CLIN CHEM, V47, P919; JONES DB, 1983, POSTGRAD MED J, V59, P350, DOI 10.1136/pgmj.59.692.350; KANIS JA, 1979, Q J MED, V48, P289; KAPLAN RA, 1977, J CLIN PHARMACOL, V17, P410, DOI 10.1002/j.1552-4604.1977.tb04624.x; Katz SC, 2003, AM SURGEON, V69, P170; Kazama Junichiro James, 2003, Clin Exp Nephrol, V7, P144, DOI 10.1007/s10157-003-0226-2; Kebebew E, 2004, ARCH SURG-CHICAGO, V139, P974, DOI 10.1001/archsurg.139.9.974; Khan AA, 2004, J CLIN ENDOCR METAB, V89, P3319, DOI 10.1210/jc.2003-030908; Khosla S, 1999, J BONE MINER RES, V14, P1700, DOI 10.1359/jbmr.1999.14.10.1700; KHOSLA S, 1993, J CLIN ENDOCR METAB, V76, P715, DOI 10.1210/jc.76.3.715; Khosla S, 2002, J BONE MINER RES, V17, pN103; KNUDTZON J, 1995, CLIN ENDOCRINOL, V42, P199, DOI 10.1111/j.1365-2265.1995.tb01863.x; KRALL EA, 1989, NEW ENGL J MED, V321, P1777, DOI 10.1056/NEJM198912283212602; Langub MC, 2003, ENDOCRINOLOGY, V144, P1135, DOI 10.1210/en.2002-221026; LARSSON K, 1989, ACTA ORTHOP SCAND, V60, P268, DOI 10.3109/17453678909149275; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; Lindberg JS, 2005, J AM SOC NEPHROL, V16, P800, DOI 10.1681/ASN.2004060512; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Makitie O, 2003, CLIN ENDOCRINOL, V58, P163, DOI 10.1046/j.1365-2265.2003.01685.x; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; MARCUS R, 1984, ANN INTERN MED, V100, P633, DOI 10.7326/0003-4819-100-5-633; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MARX SJ, 1980, ANN INTERN MED, V92, P351, DOI 10.7326/0003-4819-92-3-351; Mazzaglia PJ, 2008, ARCH SURG-CHICAGO, V143, P260, DOI 10.1001/archsurg.143.3.260; Melton LJ, 2002, J BONE MINER RES, V17, pN12; Moe SM, 2005, NEPHROL DIAL TRANSPL, V20, P2186, DOI 10.1093/ndt/gfh966; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; Mollerup CL, 1999, WORLD J SURG, V23, P173, DOI 10.1007/PL00013175; Monier-Faugere MC, 2001, KIDNEY INT, V60, P1460, DOI 10.1046/j.1523-1755.2001.00949.x; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x; MUNDY GR, 1980, LANCET, V1, P1317, DOI 10.1016/S0140-6736(80)91783-3; Murray RML, 2001, J CLIN ENDOCR METAB, V86, P4133, DOI 10.1210/jcem.86.9.7864; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; NUSSBAUM SR, 1988, SURGERY, V104, P1121; OOMS ME, 1995, J BONE MINER RES, V10, P1177; Orr-Walker BJ, 2000, ARCH INTERN MED, V160, P2161, DOI 10.1001/archinte.160.14.2161; PARFITT A M, 1991, Journal of Bone and Mineral Research, V6, pS97; Parker CR, 2002, J CLIN ENDOCR METAB, V87, P4482, DOI 10.1210/jc.2001-010385; Pasieka JL, 2002, WORLD J SURG, V26, P942, DOI 10.1007/s00268-002-6623-y; Patel S, 2007, CALCIFIED TISSUE INT, V80, P221, DOI 10.1007/s00223-007-9001-9; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P135, DOI 10.1210/jc.2004-0842; PETTIFOR JM, 2003, NUTR ASPECTS BONE HL, P76; Phitayakorn R, 2006, AM J SURG, V191, P418, DOI 10.1016/j.amjsurg.2005.10.049; Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; QUARLES LD, 1992, J CLIN ENDOCR METAB, V75, P145, DOI 10.1210/jc.75.1.145; Qunibi WY, 2004, KIDNEY INT, V65, P1914, DOI 10.1111/j.1523-1755.2004.00590.x; Raggi P, 2004, J HEART VALVE DIS, V13, P134; Rasmuson T, 2006, ACTA ONCOL, V45, P1059, DOI 10.1080/02841860500516618; RIVKEES SA, 1992, J CLIN ENDOCR METAB, V75, P1514, DOI 10.1210/jc.75.6.1514; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Roman SA, 2005, SURGERY, V138, P1121, DOI 10.1016/j.surg.2005.08.033; Roman S, 2007, CURR OPIN ONCOL, V19, P1, DOI 10.1097/CCO.0b013e32801173fb; Rossini M, 2001, J BONE MINER RES, V16, P113, DOI 10.1359/jbmr.2001.16.1.113; Rubin MR, 2003, J CLIN ENDOCR METAB, V88, P1174, DOI 10.1210/jc.2002-020667; SALAHUDEEN AK, 1989, CLIN SCI, V76, P289, DOI 10.1042/cs0760289; Saleh F, 2006, J BONE MINER METAB, V24, P58, DOI 10.1007/s00774-005-0647-y; Salusky IB, 2003, KIDNEY INT, V63, P1801, DOI 10.1046/j.1523-1755.2003.00915.x; SALUSKY IB, 1994, KIDNEY INT, V45, P253, DOI 10.1038/ki.1994.31; Sambrook PN, 2004, J CLIN ENDOCR METAB, V89, P1572, DOI 10.1210/jc.2003-031782; Santini SA, 2004, CLIN CHEM, V50, P1247, DOI 10.1373/clinchem.2003.030759; Sato K, 2001, J CLIN ENDOCR METAB, V86, P5564, DOI 10.1210/jc.86.11.5564; SCHNEIDER AB, 1995, J CLIN ENDOCR METAB, V80, P254, DOI 10.1210/jc.80.1.254; SEIBEL MJ, 1992, J CLIN ENDOCR METAB, V74, P481, DOI 10.1210/jc.74.3.481; SELBY PL, 1986, NEW ENGL J MED, V314, P1481, DOI 10.1056/NEJM198606053142304; Selby PL, 1999, J BONE MINER RES, V14, P652, DOI 10.1359/jbmr.1999.14.4.652; Sheldon DG, 2002, ARCH SURG-CHICAGO, V137, P1022, DOI 10.1001/archsurg.137.9.1022; SHERRARD DJ, 1993, KIDNEY INT, V43, P436, DOI 10.1038/ki.1993.64; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Silverberg SJ, 2003, J CLIN ENDOCR METAB, V88, P4725, DOI 10.1210/jc.2002-021266; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Simonelli C, 2005, CURR MED RES OPIN, V21, P1069, DOI 10.1185/030079905X50598; Siperstein A, 2004, SURGERY, V136, P872, DOI 10.1016/j.surg.2004.06.024; Slatopolsky E, 2000, KIDNEY INT, V58, P753, DOI 10.1046/j.1523-1755.2000.00222.x; SLATOPOLSKY E, 1994, AM J KIDNEY DIS, V23, P229, DOI 10.1016/S0272-6386(12)80977-2; SOLOMON BL, 1994, AM J MED, V96, P101, DOI 10.1016/0002-9343(94)90128-7; Sosa JA, 1998, J CLIN ENDOCR METAB, V83, P2658, DOI 10.1210/jc.83.8.2658; Stefenelli T, 1997, SURGERY, V121, P157, DOI 10.1016/S0039-6060(97)90285-3; Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106; Stein MS, 1999, J AM GERIATR SOC, V47, P1195, DOI 10.1111/j.1532-5415.1999.tb05199.x; STENSTROM G, 1974, ACTA MED SCAND, V195, P473; Talpos GB, 2000, SURGERY, V128, P1013, DOI 10.1067/msy.2000.110844; Taylor J, 1996, J ROY COLL SURG EDIN, V41, P174; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Triponez F, 2006, SURGERY, V140, P990, DOI 10.1016/j.surg.2006.06.039; Tsuchida T, 2006, NEPHRON CLIN PRACT, V102, pC108, DOI 10.1159/000089668; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; VanderWalde LH, 2006, ARCH SURG-CHICAGO, V141, P885, DOI 10.1001/archsurg.141.9.885; Vestergaard P, 2004, J INTERN MED, V255, P108, DOI 10.1046/j.0954-6820.2003.01237.x; Vieth R, 2003, J CLIN ENDOCR METAB, V88, P185, DOI 10.1210/jc.2002-021064; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; WILSON RJ, 1988, ANN INTERN MED, V109, P959, DOI 10.7326/0003-4819-109-12-959; Wolf M, 2005, SEMIN DIALYSIS, V18, P302, DOI 10.1111/j.1525-139X.2005.18406.x; Zanchetta JR, 2001, J BONE MINER RES, V16, P189, DOI 10.1359/jbmr.2001.16.1.189	151	575	614	3	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					145	158		10.1016/S0140-6736(09)60507-9	http://dx.doi.org/10.1016/S0140-6736(09)60507-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19595349				2022-12-28	WOS:000268111600032
J	Jorgensen, KJ; Gotzsche, PC				Jorgensen, Karsten Juhl; Gotzsche, Peter C.			Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER INCIDENCE; BENEFITS; WOMEN; TIME	Objective To estimate the extent of overdiagnosis (the detection of cancers that will not cause death or symptoms) in publicly organised screening programmes. Design Systematic review of published trends in incidence of breast cancer before and after the introduction of mammography screening. Data sources PubMed (April 2007), reference lists, and authors. Review methods One author extracted data on incidence of breast cancer (including carcinoma in situ), population size, screening uptake, time periods, and age groups, which were checked independently by the other author. Linear regression was used to estimate trends in incidence before and after the introduction of screening and in older, previously screened women. Meta-analysis was used to estimate the extent of overdiagnosis. Results Incidence data covering at least seven years before screening and seven years after screening had been fully implemented, and including both screened and non-screened age groups, were available from the United Kingdom; Manitoba, Canada; New South Wales, Australia; Sweden; and parts of Norway. The implementation phase with its prevalence peak was excluded and adjustment made for changing background incidence and compensatory drops in incidence among older, previously screened women. Overdiagnosis was estimated at 52% (95% confidence interval 46% to 58%). Data from three countries showed a drop in incidence as the women exceeded the age limit for screening, but the reduction was small and the estimate of overdiagnosis was compensated for in this review. Conclusions The increase in incidence of breast cancer was closely related to the introduction of screening and little of this increase was compensated for by a drop in incidence of breast cancer in previously screened women. One in three breast cancers detected in a population offered organised screening is overdiagnosed.	[Jorgensen, Karsten Juhl; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Jorgensen, KJ (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	kj@cochrane.dk		Boyages, John/0000-0003-3208-3966; Jorgensen, Karsten/0000-0001-8554-0388				ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; Chiu C, 2006, CANCER CAUSE CONTROL, V17, P153, DOI 10.1007/s10552-005-2368-x; Demers Alain A, 2005, Chronic Dis Can, V26, P13; Douek M, 2003, BRIT J SURG, V90, P44; Giles GG, 2003, ANN ONCOL, V14, P1209, DOI 10.1093/annonc/mdg326; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Hemminki K, 2004, J CLIN ONCOL, V22, P4652, DOI 10.1200/JCO.2004.04.156; Johnson A, 2005, J EVAL CLIN PRACT, V11, P27, DOI 10.1111/j.1365-2753.2004.00491.x; Jonsson H, 2005, INT J CANCER, V117, P842, DOI 10.1002/ijc.21228; Jorgensen KJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-12; Lindgren A, 1997, APMIS, V105, P62, DOI 10.1111/j.1699-0463.1997.tb00541.x; Luke Colin, 2006, Asian Pac J Cancer Prev, V7, P69; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; *NHS, NHS PUBL, V61; *NHS HLTH SOC CAR, 2004, BREAST SCREEN PROGR; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; *OFVIND S, 2006, TIDSSKR NOR LAEGEFOR, V126, P2935; Olsen AH, 2003, BRIT J CANCER, V88, P362, DOI 10.1038/sj.bjc.6600712; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2004, J MED SCREEN, V11, P23, DOI 10.1258/096914104772950718; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sjonell G, 1999, Lakartidningen, V96, P904; Svendsen AL, 2006, CANCER-AM CANCER SOC, V106, P1883, DOI 10.1002/cncr.21823; Thorat MA, 2008, NAT CLIN PRACT ONCOL, V5, P314, DOI 10.1038/ncponc1113; Vainio H, 2002, IARC HDB CANC PREVEN, V7; WELCH GH, 2004, SHOULD I BE TESTED C; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Zahl PH, 2008, LANCET ONCOL, V9, P199, DOI 10.1016/S1470-2045(08)70049-4; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	33	307	311	1	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2009	339								b2587	10.1136/bmj.b2587	http://dx.doi.org/10.1136/bmj.b2587			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LA	19589821	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267898500005
J	Vasan, RS; Glazer, NL; Felix, JF; Lieb, W; Wild, PS; Felix, SB; Watzinger, N; Larson, MG; Smith, NL; Dehghan, A; Grosshennig, A; Schillert, A; Teumer, A; Schmidt, R; Kathiresan, S; Lumley, T; Aulchenko, YS; Konig, IR; Zeller, T; Homuth, G; Struchalin, M; Aragam, J; Bis, JC; Rivadeneira, F; Erdmann, J; Schnabel, RB; Dorr, M; Zweiker, R; Lind, L; Rodeheffer, RJ; Greiser, KH; Levy, D; Haritunians, T; Deckers, JW; Stritzke, J; Lackner, KJ; Volker, U; Ingelsson, E; O'Donnell, CJ; Heckbert, SR; Stricker, BH; Kullo, I; Ziegler, A; Reffelmann, T; Redfield, MM; Werdan, K; Mitchell, GF; Rice, K; Arnett, DK; Hofman, A; Gottdiener, JS; Uitterlinden, AG; Meitinger, T; Blettner, M; Friedrich, N; Wang, TJ; Psaty, BM; van Duijn, CM; Wichmann, HE; Munzel, T; Kroemer, HK; Benjamin, E; Rotter, JI; Witteman, JC; Schunkert, H; Schmidt, H; Volzke, H; Blankenberg, S				Vasan, Ramachandran S.; Glazer, Nicole L.; Felix, Janine F.; Lieb, Wolfgang; Wild, Philipp S.; Felix, Stephan B.; Watzinger, Norbert; Larson, Martin G.; Smith, Nicholas L.; Dehghan, Abbas; Grosshennig, Anika; Schillert, Arne; Teumer, Alexander; Schmidt, Reinhold; Kathiresan, Sekar; Lumley, Thomas; Aulchenko, Yurii S.; Koenig, Inke R.; Zeller, Tanja; Homuth, Georg; Struchalin, Maksim; Aragam, Jayashri; Bis, Joshua C.; Rivadeneira, Fernando; Erdmann, Jeanette; Schnabel, Renate B.; Doerr, Marcus; Zweiker, Robert; Lind, Lars; Rodeheffer, Richard J.; Greiser, Karin Halina; Levy, Daniel; Haritunians, Talin; Deckers, Jaap W.; Stritzke, Jan; Lackner, Karl J.; Voelker, Uwe; Ingelsson, Erik; O'Donnell, Christopher J.; Heckbert, Susan R.; Stricker, Bruno H.; Kullo, Iftikhar; Ziegler, Andreas; Reffelmann, Thorsten; Redfield, Margaret M.; Werdan, Karl; Mitchell, Gary F.; Rice, Kenneth; Arnett, Donna K.; Hofman, Albert; Gottdiener, John S.; Uitterlinden, Andre G.; Meitinger, Thomas; Blettner, Maria; Friedrich, Nele; Wang, Thomas J.; Psaty, Bruce M.; van Duijn, Cornelia M.; Wichmann, H. -Erich; Munzel, Thomas; Kroemer, Heyo K.; J. Benjamin, Emelia; Rotter, Jerome I.; Witteman, Jacqueline C.; Schunkert, Heribert; Schmidt, Helena; Voelzke, Henry; Blankenberg, Stefan			Genetic Variants Associated With Cardiac Structure and Function A Meta-analysis and Replication of Genome-wide Association Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR MASS; CONVERTING-ENZYME GENE; CORONARY HEART-DISEASE; LEFT ATRIAL SIZE; ELDERLY COHORT; ECHOCARDIOGRAPHIC MEASUREMENTS; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; CARDIOVASCULAR HEALTH; SYSTOLIC DYSFUNCTION	Context Echocardiographic measures of left ventricular (LV) structure and function are heritable phenotypes of cardiovascular disease. Objective To identify common genetic variants associated with cardiac structure and function by conducting a meta-analysis of genome-wide association data in 5 population-based cohort studies (stage 1) with replication (stage 2) in 2 other community-based samples. Design, Setting, and Participants Within each of 5 community-based cohorts comprising the EchoGen consortium (stage 1; n = 12 612 individuals of European ancestry; 55% women, aged 26-95 years; examinations between 1978-2008), we estimated the association between approximately 2.5 million single-nucleotide polymorphisms ( SNPs; imputed to the HapMap CEU panel) and echocardiographic traits. In stage 2, SNPs significantly associated with traits in stage 1 were tested for association in 2 other cohorts (n = 4094 people of European ancestry). Using a prespecified P value threshold of 5 x 10(-7) to indicate genome-wide significance, we performed an inverse variance-weighted fixed-effects meta-analysis of genome-wide association data from each cohort. Main Outcome Measures Echocardiographic traits: LV mass, internal dimensions, wall thickness, systolic dysfunction, aortic root, and left atrial size. Results In stage 1, 16 genetic loci were associated with 5 echocardiographic traits: 1 each with LV internal dimensions and systolic dysfunction, 3 each with LV mass and wall thickness, and 8 with aortic root size. In stage 2, 5 loci replicated (6q22 locus associated with LV diastolic dimensions, explaining < 1% of trait variance; 5q23, 12p12, 12q14, and 17p13 associated with aortic root size, explaining 1%-3% of trait variance). Conclusions We identified 5 genetic loci harboring common variants that were associated with variation in LV diastolic dimensions and aortic root size, but such findings explained a very small proportion of variance. Further studies are required to replicate these findings, identify the causal variants at or near these loci, characterize their functional significance, and determine whether they are related to overt cardiovascular disease. JAMA. 2009;302(2):168-178 www.jama.com	[Vasan, Ramachandran S.; Smith, Nicholas L.; Lumley, Thomas; Bis, Joshua C.; Haritunians, Talin; Kullo, Iftikhar; Arnett, Donna K.; van Duijn, Cornelia M.; Witteman, Jacqueline C.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Vasan, Ramachandran S.; Witteman, Jacqueline C.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Witteman, Jacqueline C.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Smith, Nicholas L.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Haritunians, Talin; Kullo, Iftikhar] NHLBI, Bethesda, MD 20892 USA; [Felix, Janine F.; Rivadeneira, Fernando; Wichmann, H. -Erich] Univ Washington, Cardiovasc Hlth Study, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Felix, Janine F.; Rivadeneira, Fernando; Wichmann, H. -Erich] Univ Washington, Dept Med, Seattle, WA USA; [Aulchenko, Yurii S.; Hofman, Albert] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dehghan, Abbas; Ziegler, Andreas; Wichmann, H. -Erich] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wichmann, H. -Erich] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Dehghan, Abbas] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA USA; [Wichmann, H. -Erich] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Grp Hlth, Seattle, WA 98101 USA; [Gottdiener, John S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Meitinger, Thomas] Univ Maryland Hosp, Div Cardiol, Baltimore, MD 21201 USA; [Deckers, Jaap W.; Schunkert, Heribert] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA USA; [Lieb, Wolfgang; Grosshennig, Anika; Koenig, Inke R.; Aragam, Jayashri; Reffelmann, Thorsten; Uitterlinden, Andre G.; Munzel, Thomas; Schmidt, Helena] Erasmus MC, Rotterdam Study, Dept Epidemiol, Rotterdam, Netherlands; [Erdmann, Jeanette; Blettner, Maria] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stritzke, Jan] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Wild, Philipp S.; Schillert, Arne; Schnabel, Renate B.; Lackner, Karl J.; Voelzke, Henry] Med Univ Lubeck, MONICA KORA Med Clin 2, D-23538 Lubeck, Germany; [Schillert, Arne; Teumer, Alexander; Zeller, Tanja; Redfield, Margaret M.] Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; [Kroemer, Heyo K.] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany; [Friedrich, Nele] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Kroemer, Heyo K.] German Res Ctr Environm Hlth, Neuherberg, Germany; [Kroemer, Heyo K.] Univ Munich, Neuherberg, Germany; [Friedrich, Nele] Tech Univ Munich, Munich, Germany; [Felix, Stephan B.; Homuth, Georg; Doerr, Marcus; J. Benjamin, Emelia] Johannes Gutenberg Univ Mainz, Gutenberg Heart Study, Dept Med 2, Mainz, Germany; [Voelker, Uwe] Johannes Gutenberg Univ Mainz, Dept Clin Chem & Lab Med, Mainz, Germany; [Wang, Thomas J.] Johannes Gutenberg Univ Mainz, Inst Med Biometry Epidemiol & Informat, Mainz, Germany; [Schmidt, Reinhold; Struchalin, Maksim; Ingelsson, Erik] Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Rotter, Jerome I.] Inst Pharmacol, Greifswald, Germany; [Psaty, Bruce M.] Inst Community Med, Greifswald, Germany; [Watzinger, Norbert; Schmidt, Reinhold; Struchalin, Maksim; Zweiker, Robert; Ingelsson, Erik; Werdan, Karl; Psaty, Bruce M.; Rotter, Jerome I.] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Larson, Martin G.; Lind, Lars] Med Univ Graz, Austrian Stroke Prevent Study, Dept Internal Med, Div Cardiol, Graz, Austria; [Kathiresan, Sekar] Med Univ Graz, Dept Neurol, Graz, Austria; [Blankenberg, Stefan] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Rodeheffer, Richard J.] Uppsala Univ, Dept Med Sci, PIVUS Study, Uppsala, Sweden; [O'Donnell, Christopher J.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Greiser, Karin Halina; Heckbert, Susan R.; Mitchell, Gary F.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Levy, Daniel; Stricker, Bruno H.] Inst Med Epidemiol Biostat & Informat, CARLA Study, Halle, Germany; Univ Halle Wittenberg, Halle, Salle, Germany; [Haritunians, Talin] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Lubeck; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ernst Moritz Arndt Universitat Greifswald; Medical University of Graz; Medical University of Graz; Medical University of Graz; Uppsala University; Karolinska Institutet; Mayo Clinic; Martin Luther University Halle Wittenberg; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Ste 2, Framingham, MA 01702 USA.	vasan@bu.edu	Rivadeneira, Fernando/O-5385-2015; Teumer, Alexander/S-7438-2019; König, Inke R/A-4544-2009; Wild, Philipp S./M-2106-2019; Schnabel, Renate B/F-6527-2014; Dehghan, Abbas/ABE-7377-2020; Erdmann, Jeanette/A-4417-2009; Lieb, Wolfgang/AAC-7650-2022; Schnabel, Renate B/ABE-6668-2021; Aulchenko, Yurii/M-8270-2013; Meitinger, Thomas/O-1318-2015; Dörr, Marcus/F-1919-2010; Erdmann, Jeanette/P-7513-2014; Rice, Kenneth M/A-4150-2013; Munzel, Thomas/A-2912-2014; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Rotter, Jerome/AAY-6598-2021; Wichmann, Heinz Erich/AAA-5695-2022; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011; Ziegler, Andreas/G-4246-2012; Dehghan, Abbas/B-9896-2008	Rivadeneira, Fernando/0000-0001-9435-9441; Teumer, Alexander/0000-0002-8309-094X; König, Inke R/0000-0003-0504-6465; Schnabel, Renate B/0000-0001-7170-9509; Aulchenko, Yurii/0000-0002-7899-1575; Dörr, Marcus/0000-0001-7471-475X; Erdmann, Jeanette/0000-0002-4486-6231; Rice, Kenneth M/0000-0001-5779-4495; Munzel, Thomas/0000-0001-5503-4150; Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Benjamin, Emelia/0000-0003-4076-2336; Ziegler, Andreas/0000-0002-8386-5397; Glazer, Nicole/0000-0002-6397-609X; Blankenberg, Stefan/0000-0001-6488-2362; Felix, Janine/0000-0002-9801-5774; Wild, Philipp/0000-0003-4413-9752; Dehghan, Abbas/0000-0001-6403-016X; Stritzke, Jan/0000-0003-3143-7005; Wang, Thomas/0000-0003-4063-6508; Meitinger, Thomas/0000-0002-8838-8403; Zeller, Tanja/0000-0003-3379-2641; Van Duijn, Cornelia/0000-0002-2374-9204; Volker, Uwe/0000-0002-5689-3448; Larson, Martin/0000-0002-9631-1254	National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC35129, N01HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL087652]; National Center for Research Resources [M01RR00069]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Netherlands Organization of Scientific Research NWO [175.010.2005.011, 911.03.012]; Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI)/NWO [050 60 810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands organization for scientific research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Netherlands Heart Foundation; Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports, the European Commission; Municipality of Rotterdam; European Union [LSHM-CT2006-037593]; National Genome Network [01GS0418, 01GR0466]; German Federal Ministry of Education and Research (BMBF); Helmholtz Zentrum Munchen; National Research Center for Environmental Health, Neuherberg, Germany; BMBF; Munich Center of Health Sciences; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC25195, 2K24HL04334, RO1HL080124, RO1HL077477, R01HL093328]; Affymetrix, Inc [N02-HL-6-4278]; government of RheinlandPfalz [961-386261/733]; Boehringer Ingelheim; PHILIPS Medical Systems; Gutenberg Heart Study; Federal Ministry of Education and Research, Germany [A3 01GS0833]; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Competence Network Heart Failure of the Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Austrian Science Fund [P20545_P05];  [RO1 HL55502]; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085083, N01HC085086, N01HC025195, N01HC075150, N01HC045133, N01HC085081, N01HC085079, N01HC055222, N01HC085080, N01HC085082, N01HC085085, N01HC085084, N01HC015103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080124, K24HL004334, R01HL055502, R01HL087652, R01HL064278, R01HL093328, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK033651] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI)/NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports, the European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; European Union(European Commission); National Genome Network; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen(Helmholtz Association); National Research Center for Environmental Health, Neuherberg, Germany; BMBF(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; government of RheinlandPfalz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Gutenberg Heart Study; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Competence Network Heart Failure of the Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Austrian Science Fund(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Cardiovascular Health Study: Contract numbers N01-HC-85079 through N01-HC-85086, N01-HC35129, N01HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center.; Rotterdam Study: The genome-wide associations database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011, 911.03.012) and the Research Institute for Diseases in the Elderly ( RIDE). This study was supported by the Netherlands Genomics Initiative (NGI)/NWO project number 050 60 810. The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands organization for scientific research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Heart Foundation, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. We thank Michael Moorhouse, PhD, Department of Bioinformatics, and Pascal Arp, BSc, Mila Jhamai, BSc, Marijn Verkerk, BSc, and Sander Bervoets, BSc, Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands, for their help in creating the database.; MONICA-KORA: The study was funded by the European Union sponsored project Cardiogenics (LSHM-CT2006-037593), by the National Genome Network (01GS0418 to Drs Schunkert and Erdmann; 01GR0466 to Dr Ziegler) and by the National Genome Network Plus sponsored by the German Federal Ministry of Education and Research (BMBF). The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen (former GSF) National Research Center for Environmental Health, Neuherberg, Germany, and supported by grants from the BMBF and Munich Center of Health Sciences ( MC Health) as part of LMU innovativ.; Framingham Heart Study: This work was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278), and by grants from the National Heart, Lung, and Blood Institute 2K24HL04334, RO1HL080124, RO1HL077477, and R01HL093328 (all to Dr Vasan).; Gutenberg Heart Study: The Gutenberg Heart Study is funded through the government of RheinlandPfalz ("Stiftung Rheinland Pfalz for Innovation," contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskul re Prevention" of the Johannes Gutenberg University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Heart Study. Specifically, the research reported in this article was supported by the National Genome Network " NGFNplus" ( contract number project A3 01GS0833) by the Federal Ministry of Education and Research, Germany.; Study of Health in Pomerania ( SHIP): SHIP is funded by the Federal Ministry of Education and Research ( grants No. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Echocardiography in the 5-year follow-up was funded by the Competence Network Heart Failure of the Federal Ministry of Education and Research, and statistical analyses were supported by Deutsche Forschungsgemeinschaft ( by grant SFB TR 19). Genome-wide data have been supported by the Federal Ministry of Education and Research (grant No. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and by the Federal State of Mecklenburg-West Pomerania.; Austrian Stroke Prevention Study: Current analyses of the Austrian Stroke Prevention Study are funded by the Austrian Science Fund Project P20545_P05 Genetics of cerebral small vessel disease (Dr H. Schmidt).; Mayo Clinic, Olmsted County: Dr Rodheffer was supported in part by RO1 HL55502.	Arnett DK, 2001, AM J HYPERTENS, V14, P1226, DOI 10.1016/S0895-7061(01)02200-2; Arnett DK, 2004, CURR HYPERTENS REP, V6, P36, DOI 10.1007/s11906-004-0009-5; Arnett DK, 2001, HYPERTENSION, V38, P767, DOI 10.1161/hy1001.092650; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Bella JN, 2004, J HYPERTENS, V22, P281, DOI 10.1097/00004872-200402000-00011; Bella JN, 2002, ARTERIOSCL THROM VAS, V22, P1008, DOI 10.1161/01.ATV.0000017473.78775.F6; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; BIELEN E, 1991, AM HEART J, V121, P1743, DOI 10.1016/0002-8703(91)90021-9; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Celentano A, 1999, AM J CARDIOL, V83, P1196, DOI 10.1016/S0002-9149(99)00058-2; Chien Kuo-Liong, 2006, BMC Cardiovasc Disord, V6, P37; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gardin JM, 2006, AM J CARDIOL, V97, P270, DOI 10.1016/j.amjcard.2005.08.039; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gomez-Angelats E, 2000, J HUM HYPERTENS, V14, P47, DOI 10.1038/sj.jhh.1000941; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; HARSHFIELD GA, 1990, AM J HYPERTENS, V3, P538, DOI 10.1093/ajh/3.7.538; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Jamshidi Y, 2002, CIRCULATION, V105, P950, DOI 10.1161/hc0802.104535; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kazmierczak B, 1998, AM J PATHOL, V152, P431; Kupari M, 1998, CIRCULATION, V97, P569; Kuznetsova T, 2004, CIRCULATION, V110, P2644, DOI 10.1161/01.CIR.0000145541.63406.BA; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LI Y, 2008, AM J HUM GENET S, V79, P2290; Lindpaintner K, 1996, NEW ENGL J MED, V334, P1023, DOI 10.1056/NEJM199604183341604; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Muller HH, 2007, GENET EPIDEMIOL, V31, P844, DOI 10.1002/gepi.20245; Netherton SJ, 2002, DIABETES, V51, P1194, DOI 10.2337/diabetes.51.4.1194; Palatini P, 2002, EUR J CLIN INVEST, V32, P467, DOI 10.1046/j.1365-2362.2002.01009.x; Palatini P, 2001, J HYPERTENS, V19, P1217, DOI 10.1097/00004872-200107000-00006; Poch E, 2000, HYPERTENSION, V35, P214, DOI 10.1161/01.HYP.35.1.214; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Prior RL, 2002, FASEB J, V16, pA1009; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rankinen T, 2001, HYPERTENSION, V38, P30, DOI 10.1161/01.HYP.38.1.30; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SCHMIDT R, 1994, NEUROEPIDEMIOLOGY, V13, P308, DOI 10.1159/000110396; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; Schunkert H, 2005, GESUNDHEITSWESEN, V67, pS74, DOI 10.1055/s-2005-858247; Schunkert H, 1999, CIRCULATION, V99, P2255, DOI 10.1161/01.CIR.99.17.2255; Sedlacek K, 2002, HYPERTENSION, V40, P162, DOI 10.1161/01.HYP.0000025145.12159.70; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Swan L, 2003, EUR HEART J, V24, P579, DOI 10.1016/S0195-668X(02)00524-9; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 1997, CIRCULATION, V96, P1863, DOI 10.1161/01.CIR.96.6.1863; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	59	170	171	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					168	178		10.1001/jama.2009.978-a	http://dx.doi.org/10.1001/jama.2009.978-a			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584346	Bronze, Green Accepted			2022-12-28	WOS:000267696500026
J	Collins, GS; Altman, DG				Collins, Gary S.; Altman, Douglas G.			An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCOTTISH HEART HEALTH; SECONDARY PREVENTION; LIPID MODIFICATION; DISEASE; SCORE; DEPRIVATION; PROGNOSIS; ACCURACY; MEN	Objective To independently evaluate the performance of the QRISK score for predicting 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and compare the performance with Framingham equations. Design Prospective open cohort study. Setting 274 practices from England and Wales contributing to the THIN database. Participants 1.07 million patients, registered between 1 January 1995 and 1 April 2006, aged 35-74 years (5.4 million person years) with 43 990 cardiovascular events. Main outcome measures First diagnosis of cardiovascular disease (myocardial infarction, coronary heart disease, stroke, and transient ischaemic attack) recorded in general practice records. Results This independent validation indicated that QRISK offers an improved performance in predicting the 10 year risk of cardiovascular disease in a large cohort of UK patients over the Anderson Framingham equation. Discrimination and calibration statistics were better with QRISK. QRISK explained 32% of the variation in men and 37% in women, compared with 27% and 31% respectively for Anderson Framingham. QRISK underpredicted risk by 13% for men and 10% for women, whereas Anderson Framingham overpredicted risk by 32% for men and 10% for women. In total, 85 010 (8%) of patients would be reclassified from high risk (>= 20%) with Anderson Framingham to low risk with QRISK, with an observed 10 year cardiovascular disease risk of 17.5% (95% confidence interval 16.9% to 18.1%) for men and 16.8% (15.7% to 18.0%) for women. The incidence rate of cardiovascular disease events among men was 30.5 per 1000 person years (95% confidence interval 29.9 to 31.2) in high risk patients identified with QRISK and 23.7 per 1000 person years (23.2 to 24.1) in high risk patients identified with Anderson Framingham. Similarly, the incidence rate of cardiovascular disease events among women was 26.7 per 1000 person years (25.8 to 27.7) in high risk patients identified with QRISK compared with 22.2 per 1000 person years (21.4 to 23.0) in high risk patients identified with Anderson Framingham. Conclusions The QRISK cardiovascular disease risk equation offers an improvement over the long established Anderson Framingham equation in terms of identifying a high risk population for cardiovascular disease in the United Kingdom. QRISK underestimates 10 year cardiovascular disease risk, but the magnitude of underprediction is smaller than the overprediction with Anderson Framingham.	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England	University of Oxford	Collins, GS (corresponding author), Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England.	gary.collins@csm.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Altman, Douglas G/A-9714-2012	Collins, Gary Stephen/0000-0002-2772-2316; 	Department of Health	Department of Health	This study was commissioned by the Department of Health. The funder had no role in the study design, analysis, or interpretation or writing of the manuscript.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Box G.E., 1987, EMPIRICAL MODEL BUIL; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; COLLINS GS, 2008, REPORT DEP HLTH INDE; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; HIPPISLEYCOX J, DERIVATION VALIDATIO; *JBS2, 2005, HEART S5, V91, P5; LLOYDJONES DM, 2004, JAMA-J AM MED ASSOC, V291, P2202; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Neil HAW, 2008, INT J CLIN PRACT, V62, P1322, DOI 10.1111/j.1742-1241.2008.01828.x; *NIH CLIN EXC, 2006, STAT PREV CARD EV PA; *NIH CLIN EXC, 2008, LIP MOD CARD RISK AS; R Development Core Team, R LANG ENV STAT COMP; ROBINS M, 2008, REPSONSE SECTION 4 3; Robson J, 2008, HEART, V94, P1331, DOI 10.1136/hrt.2008.150979; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Toth PP, 2007, J CLIN LIPIDOL, V1, P234, DOI 10.1016/j.jacl.2007.07.002; Tunstall-Pedoe H, 2006, HEART, V92, P307, DOI 10.1136/hrt.2005.077289; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	32	121	127	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2009	339								b2584	10.1136/bmj.b2584	http://dx.doi.org/10.1136/bmj.b2584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KX	19584409	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267898200002
J	Black, N; Jenkinson, C				Black, Nick; Jenkinson, Crispin			Measuring patients' experiences and outcomes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Black, Nick] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Jenkinson, Crispin] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	nick.black@lshtm.ac.uk						[Anonymous], PATIENT REPORTED OUT; Black N, 2009, BRIT J OPHTHALMOL, V93, P13, DOI 10.1136/bjo.2007.136150; Bream E, 2009, J HEALTH SERV RES PO, V14, P174, DOI 10.1258/jhsrp.2009.008115; BROWNE J, PATIENT REPORTED OUT; CALLAHAN LF, 2008, ARTHRITIS RHEUM, V58, pS1162; Care Quality Commission, NHS PAT SURV; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; *DEP HLTH, 2008, HLTH QUAL CAR ALL NH; Department of Health, NHS ENGL OP FRAM 200; FITZPATRICK R, 1997, HEALTH TECHNOL ASSES, V2, P1; Gwaltney CJ, 2008, VALUE HEALTH, V11, P322, DOI 10.1111/j.1524-4733.2007.00231.x; Jenkinson C., 1998, HLTH STATUS MEASUREM; Jenkinson Crispin, 2003, J Health Serv Res Policy, V8, P83, DOI 10.1258/135581903321466049; Marshall S, 2006, J EVAL CLIN PRACT, V12, P559, DOI 10.1111/j.1365-2753.2006.00650.x; McDowell I, 2006, MEASURING HLTH; Nelson EC, 1987, J CHRON DIS, V40, P55; Urological Sciences Research Foundation, INT PROST SYMPT SCOR	18	116	119	2	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 2	2009	339								b2495	10.1136/bmj.b2495	http://dx.doi.org/10.1136/bmj.b2495			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QZ	19574317	Green Accepted			2022-12-28	WOS:000267678700007
J	Hakansson, K; Rovio, S; Helkala, EL; Vilska, AR; Winblad, B; Soininen, H; Nissinen, A; Mohammed, AH; Kivipelto, M				Hakansson, Krister; Rovio, Suvi; Helkala, Eeva-Liisa; Vilska, Anna-Riitta; Winblad, Bengt; Soininen, Hilkka; Nissinen, Aulikki; Mohammed, Abdul H.; Kivipelto, Miia			Association between mid-life marital status and cognitive function in later life: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; SOCIAL RELATIONSHIPS; JAPANESE POPULATION; LEISURE ACTIVITIES; BRAIN RESERVE; DEMENTIA; HEALTH; EDUCATION; IMPAIRMENT	Objectives To evaluate whether mid-life marital status is related to cognitive function in later life. Design Prospective population based study with an average follow-up of 21 years. Setting Kuopio and Joensuu regions in eastern Finland. Participants Participants were derived from random, population based samples previously investigated in 1972, 1977, 1982, or 1987; 1449 individuals (73%), aged 65-79, underwent re-examination in 1998. Main outcome measures Alzheimer's disease and mild cognitive impairment. Results People cohabiting with a partner in mid-life (mean age 50.4) were less likely than all other categories (single, separated, or widowed) to show cognitive impairment later in life at ages 65-79. Those widowed or divorced in mid-life and still so at follow-up had three times the risk compared with married or cohabiting people. Those widowed both at mid-life and later life had an odds ratio of 7.67 (1.6 to 40.0) for Alzheimer's disease compared with married or cohabiting people. The highest increased risk for Alzheimer's disease was in carriers of the apolipoprotein E e4 allele who lost their partner before mid-life and were still widowed or divorced at follow-up. The progressive entering of several adjustment variables from mid-life did not alter these associations. Conclusions Living in a relationship with a partner might imply cognitive and social challenges that have a protective effect against cognitive impairment later in life, consistent with the brain reserve hypothesis. The specific increased risk for widowed and divorced people compared with single people indicates that other factors are needed to explain parts of the results. A sociogenetic disease model might explain the dramatic increase in risk of Alzheimer's disease for widowed apolipoprotein E e4 carriers.	[Mohammed, Abdul H.] Vaxjo Univ, Dept Psychol, Sch Social Sci, Vaxjo, Sweden; [Winblad, Bengt; Mohammed, Abdul H.; Kivipelto, Miia] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Helkala, Eeva-Liisa] Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; [Vilska, Anna-Riitta] Savonia Univ Appl Sci, Kuopio, Finland; [Soininen, Hilkka; Kivipelto, Miia] Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland	Linnaeus University; Vaxjo University; Karolinska Institutet; University of Eastern Finland; Savonia University of Applied Sciences; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Karolinska Inst, KI Alzheimers Dis Res Ctr, Dept NVS, S-14186 Huddinge, Sweden.	Miia.Kivipelto@ki.se	Hakansson, Krister/B-4621-2010; Kivipelto, Miia/AAS-3557-2021; Rovio, Suvi P/L-4149-2015	Hakansson, Krister/0000-0002-0057-0308; Rovio, Suvi P/0000-0003-0911-7478; Kivipelto, Miia/0000-0003-0992-3875	EVO-grant of Kuopio University Hospital [5772720]; Academy of Finland [103334, 206951]; EU [QLK-2002-172]; Swedish Council for Working Life and Social Research; Finnish Cultural Foundation; Foundation of Juho Vainio; Gamla Tjanarinnor Foundation; Helsingin Sanomain 100-vuotissaatio; Gun and Bertil Stohne Foundation	EVO-grant of Kuopio University Hospital; Academy of Finland(Academy of Finland); EU(European Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation of Juho Vainio; Gamla Tjanarinnor Foundation; Helsingin Sanomain 100-vuotissaatio; Gun and Bertil Stohne Foundation	This study was funded by EVO-grant of Kuopio University Hospital (5772720), Academy of Finland (grants 103334 and 206951), EU grant QLK-2002-172, the Swedish Council for Working Life and Social Research, the Finnish Cultural Foundation, the Foundation of Juho Vainio, the Gamla Tjanarinnor Foundation, the Helsingin Sanomain 100-vuotissaatio and the Gun and Bertil Stohne Foundation.; The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Amieva H, 2005, BRAIN, V128, P1093, DOI 10.1093/brain/awh451; BAMES L, 2004, GERONTOLOGIST, V44, P330; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; BICKEL H, 1994, PSYCHOL MED, V24, P179, DOI 10.1017/S0033291700026945; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Comas-Herrera A, 2007, INT J GERIATR PSYCH, V22, P1037, DOI 10.1002/gps.1830; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Coyle JT, 2003, NEW ENGL J MED, V348, P2489, DOI 10.1056/NEJMp030051; Del Ser T, 1999, BRAIN, V122, P2309, DOI 10.1093/brain/122.12.2309; Diamond MC, 2001, AN ACAD BRAS CIENC, V73, P211, DOI 10.1590/S0001-37652001000200006; Eriksson UK, 2008, DEMENT GERIATR COGN, V25, P148, DOI 10.1159/000112729; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Gallacher I, 2005, INT J EPIDEMIOL, V34, P872, DOI 10.1093/ije/dyi107; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Helmer C, 1999, NEUROLOGY, V53, P1953, DOI 10.1212/WNL.53.9.1953; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; IRWIN M, 1987, PSYCHIAT CLIN N AM, V10, P449; Jorm AF, 2000, GERONTOLOGY, V46, P219, DOI 10.1159/000022163; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kiecolt-Glaser JK, 2002, PSYCHOSOM MED, V64, P15, DOI 10.1097/00006842-200201000-00004; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Marx J, 2005, SCIENCE, V309, P864, DOI 10.1126/science.309.5736.864; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mohammed AH, 2002, PROG BRAIN RES, V138, P109, DOI 10.1016/S0079-6123(02)38074-9; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Qiu CX, 2001, ARCH NEUROL-CHICAGO, V58, P2034, DOI 10.1001/archneur.58.12.2034; Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Solomon A, 2007, NEUROLOGY, V68, P751, DOI 10.1212/01.wnl.0000256368.57375.b7; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	51	163	168	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2009	339								b2462	10.1136/bmj.b2462	http://dx.doi.org/10.1136/bmj.b2462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QZ	19574312	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267678700006
J	Shaffer, PL; Goehring, A; Shankaranarayanan, A; Gouaux, E				Shaffer, Paul L.; Goehring, April; Shankaranarayanan, Aruna; Gouaux, Eric			Structure and Mechanism of a Na+-Independent Amino Acid Transporter	SCIENCE			English	Article							LYSINURIC PROTEIN INTOLERANCE; CRYSTAL-STRUCTURE; FAMILY; IDENTIFICATION; SUPERFAMILY; ANTIPORTER; EXPRESSION; GALACTOSE; CYSTINE; SLC7A7	Amino acid, polyamine, and organocation (APC) transporters are secondary transporters that play essential roles in nutrient uptake, neurotransmitter recycling, ionic homeostasis, and regulation of cell volume. Here, we present the crystal structure of apo-ApcT, a proton-coupled broad-specificity amino acid transporter, at 2.35 angstrom resolution. The structure contains 12 transmembrane helices, with the first 10 consisting of an inverted structural repeat of 5 transmembrane helices like the leucine transporter LeuT. The ApcT structure reveals an inward-facing, apo state and an amine moiety of lysine-158 located in a position equivalent to the sodium ion site Na2 of LeuT. We propose that lysine-158 is central to proton-coupled transport and that the amine group serves the same functional role as the Na2 ion in LeuT, thus demonstrating common principles among proton-and sodium-coupled transporters.	[Shaffer, Paul L.; Goehring, April; Shankaranarayanan, Aruna; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	New York Consortium for Membrane Protein Structure, NIH-supported Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, T32GM008281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070039] Funding Source: NIH RePORTER	New York Consortium for Membrane Protein Structure, NIH-supported Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the New York Consortium for Membrane Protein Structure, a NIH-supported Protein Structure Initiative (E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. Coordinates and structure factors of the apo ApcT, ApcT-7F11 Fab complex, and ApcT K158A-7F11 Fab complex have been deposited in the Protein DataBank with accession codes 3GIA, 3GI9, and 3GI8, respectively.	BANNAI S, 1980, J BIOL CHEM, V255, P2372; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Cosgriff AJ, 2000, J BACTERIOL, V182, P2207, DOI 10.1128/JB.182.8.2207-2217.2000; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	30	242	243	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					1010	1014		10.1126/science.1176088	http://dx.doi.org/10.1126/science.1176088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608859	Green Accepted			2022-12-28	WOS:000269242800050
J	Abdo, AA; Ackermann, M; Ajello, M; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Bignami, GF; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Caliandro, GA; Cameron, RA; Camilo, F; Caraveo, PA; Carlson, P; Casandjian, JM; Cecchi, C; Celik, O; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cognard, I; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; Corbet, R; Cutini, S; Dermer, CD; Desvignes, G; de Angelis, A; de Luca, A; de Palma, F; Digel, SW; Dormody, M; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Edmonds, Y; Farnier, C; Favuzzi, C; Fegan, SJ; Focke, WB; Frailis, M; Freire, PCC; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hobbs, G; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, TJ; Johnson, WN; Johnston, S; Kamae, T; Katagiri, H; Kataoka, J; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Kramer, M; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Manchester, RN; Marelli, M; Mazziotta, MN; McConville, W; McEnery, JE; McLaughlin, MA; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Porter, TA; Raino, S; Rando, R; Ransom, SM; Ray, PS; Razzano, M; Rea, N; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, LS; Rodriguez, AY; Romani, RW; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Schalk, TL; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Stappers, BW; Starck, JL; Striani, E; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Tanaka, T; Thayer, JB; Thayer, JG; Theureau, G; Thompson, DJ; Thorsett, SE; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Van Etten, A; Vasileiou, V; Venter, C; Vilchez, N; Vitale, V; Waite, AP; Wallace, E; Wang, P; Watters, K; Webb, N; Weltevrede, P; Winer, BL; Wood, KS; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Bignami, G. F.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Caliandro, G. A.; Cameron, R. A.; Camilo, F.; Caraveo, P. A.; Carlson, P.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cognard, I.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; Corbet, R.; Cutini, S.; Dermer, C. D.; Desvignes, G.; de Angelis, A.; de Luca, A.; de Palma, F.; Digel, S. W.; Dormody, M.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Edmonds, Y.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Frailis, M.; Freire, P. C. C.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hobbs, G.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Johnston, S.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Kramer, M.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Manchester, R. N.; Marelli, M.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; McLaughlin, M. A.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Ransom, S. M.; Ray, P. S.; Razzano, M.; Rea, N.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Romani, R. W.; Roth, M.; Ryde, F.; Sadrozinski, H. F. W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Schalk, T. L.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Stappers, B. W.; Starck, J. L.; Striani, E.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Theureau, G.; Thompson, D. J.; Thorsett, S. E.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Vasileiou, V.; Venter, C.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wallace, E.; Wang, P.; Watters, K.; Webb, N.; Weltevrede, P.; Winer, B. L.; Wood, K. S.; Ylinen, T.; Ziegler, M.			A Population of Gamma-Ray Millisecond Pulsars Seen with the Fermi Large Area Telescope	SCIENCE			English	Article							EMISSION; RADIO; DISCOVERY	Pulsars are born with subsecond spin periods and slow by electromagnetic braking for several tens of millions of years, when detectable radiation ceases. A second life can occur for neutron stars in binary systems. They can acquire mass and angular momentum from their companions, to be spun up to millisecond periods and begin radiating again. We searched Fermi Large Area Telescope data for pulsations from all known millisecond pulsars (MSPs) outside of globular clusters, using rotation parameters from radio telescopes. Strong gamma-ray pulsations were detected for eight MSPs. The gamma-ray pulse profiles and spectral properties resemble those of young gamma-ray pulsars. The basic emission mechanism seems to be the same for MSPs and young pulsars, with the emission originating in regions far from the neutron star surface.	[Dumora, D.; Grondin, M. H.; Guillemot, L.; Lemoine-Goumard, M.; Lovellette, M. N.; Parent, D.; Smith, D. A.] Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France; [Abdo, A. A.; Chekhtman, A.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Makeev, A.; Ray, P. S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Waite, A. P.; Wang, P.; Watters, K.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. W.; Schalk, T. L.; Thorsett, S. E.; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Axelsson, M.; Carlson, P.; Conrad, J.; Meurer, C.; Ryde, F.; Ylinen, T.] Oskar Klein Ctr Cosmo Particle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Starck, J. L.] Univ Paris Diderot, Lab AIM, CEA Saclay, CEA IRFU CNRS,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Makeev, A.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Makeev, A.] Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bignami, G. F.; de Luca, A.] Ist Univ Studi Super, I-27100 Pavia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.; Wallace, E.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Camilo, F.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Caraveo, P. A.; Marelli, M.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Carlson, P.; Conrad, J.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Celik, Oe; Cheung, C. C.; Corbet, R.; Gehrels, N.; Harding, A. K.; Hays, E.; McEnery, J. E.; Ritz, S.; Thompson, D. J.; Venter, C.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cognard, I.; Desvignes, G.; Theureau, G.] CNRS, UMR 6115, Lab Phys & Chim Environm, F-45071 Orleans, France; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Corbet, R.; Vasileiou, V.] Univ Baltimore, Baltimore, MD 21250 USA; [Cutini, S.; Gasparrini, D.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [de Angelis, A.; Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.; Dumora, D.; Reposeur, T.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dumora, D.; Grondin, M. H.; Johnson, T. J.; Lemoine-Goumard, M.; Lott, B.; McConville, W.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, Ctr Etud Nucl Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Freire, P. C. C.] Arecibo Observ, Arecibo, PR 00612 USA; [Fukazawa, Y.; Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.; McConville, W.; Mizuno, T.; Moiseev, A. A.] Univ Maryland, College Pk, MD 20742 USA; [Guiriec, S.] Univ Alabama, Huntsville, AL 35899 USA; [Hobbs, G.; Johnston, S.; Manchester, R. N.; Weltevrede, P.] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Kataoka, J.; Latronico, L.] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Knoedlseder, J.; Vilchez, N.; Webb, N.] UPS, Ctr Etud Spatiale Rayonnements, CNRS, F-31028 Toulouse 4, France; [Kramer, M.; Stappers, B. W.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [McLaughlin, M. A.] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [Moiseev, A. A.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Morselli, A.; Striani, E.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Ransom, S. M.] NRAO, Charlottesville, VA 22903 USA; [Rea, N.] Sterrenkundig Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Rea, N.; Rodriguez, A. Y.; Torres, D. F.] Inst Ciencies Espai IEECCSIC, Barcelona 08193, Spain; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB RealTime Comp Inc, Lattingtown, NY 11560 USA; [Striani, E.; Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Venter, C.] NorthWest Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Brez, A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Van Etten, A.; Waite, A. P.; Wang, P.; Watters, K.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. W.; Parkinson, P. M. Saz; Schalk, T. L.; Thorsett, S. E.; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; University of California System; University of California Santa Cruz; Oskar Klein Centre; Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Columbia University; Istituto Nazionale Astrofisica (INAF); Royal Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; George Mason University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; University System of Maryland; University of Baltimore; Agenzia Spaziale Italiana (ASI); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; National Aeronautics & Space Administration (NASA); Hiroshima University; University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Huntsville; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Waseda University; RIKEN; Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Manchester; Jodrell Bank Centre for Astrophysics; West Virginia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Max Planck Society; National Radio Astronomy Observatory (NRAO); University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); University of Innsbruck; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Rome Tor Vergata; Purdue University System; Purdue University; ICREA; North West University - South Africa; Linnaeus University; University of Kalmar; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Santa Cruz; Politecnico di Bari	Guillemot, L (corresponding author), Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France.	guillemo@cenbg.in2p3.fr; tyrel.j.johnson@nasa.gov; kerrm@u.washington.edu; smith@cenbg.in2p3.fr	Torres, Diego F./O-9422-2016; Johnson, Neil/G-3309-2014; Bastieri, Denis/AAC-5917-2020; Gasparrini, Dario/X-6699-2019; Gargano, Fabio/AAD-5121-2021; Gargano, Fabio/O-8934-2015; Kuss, Michael W/H-8959-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; Jóhannesson, Guðlaugur/O-8741-2015; Takahashi, Hiromitsu H/T-2713-2017; Giglietto, Nicola/Y-2425-2019; Freire, Paulo/ABE-8926-2021; Baldini, Luca/E-5396-2012; Nolan, Patrick L/A-5582-2009; McEnery, Julie E/D-6612-2012; Hays, Elizabeth/D-3257-2012; Fukazawa, Yasushi/G-2081-2017; Venter, Christo/E-6884-2011; giglietto, nicola/I-8951-2012; Starck, Jean-Luc/D-9467-2011; Funk, Stefan/AAI-1568-2021; Tosti, Gino/E-9976-2013; tramacere, andrea/B-9424-2012; Reimer, Olaf/A-3117-2013; Torres, Diego F./AAF-7931-2019; Loparco, Francesco/O-8847-2015; Torres, Diego F/ABD-7940-2020; Sgrò, Carmelo/K-3395-2016; Parkinson, Pablo Miguel Saz/I-7980-2013; Mazziotta, Mario N/O-8867-2015; Gehrels, Neil/D-2971-2012; lubrano, pasquale/F-7269-2012; Johnston, Simon/AAW-8490-2020; Caraveo, Patrizia/AAL-5708-2020; Thompson, David J/D-2939-2012; Harding, Alice K/D-3160-2012; Rando, Riccardo/M-7179-2013; Rea, Nanda/I-2853-2015; Reimer, Anita/K-5822-2015; Tajima, Hiroyasu/I-6228-2014; Moskalenko, Igor V/A-1301-2007; Morselli, Aldo/G-6769-2011; cohen-tanugi, Johann/ABB-1481-2021; Funk, Stefan/B-7629-2015; Hobbs, George/AAS-5025-2020; Cutini, Sara/ABB-1787-2020; Rando, Riccardo/O-1302-2019; Orlando, Elena/R-5594-2016	Torres, Diego F./0000-0002-1522-9065; Bastieri, Denis/0000-0002-6954-8862; Gasparrini, Dario/0000-0002-5064-9495; Gargano, Fabio/0000-0002-5055-6395; Gargano, Fabio/0000-0002-5055-6395; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Takahashi, Hiromitsu H/0000-0001-6314-5897; Giglietto, Nicola/0000-0002-9021-2888; Freire, Paulo/0000-0003-1307-9435; Fukazawa, Yasushi/0000-0002-0921-8837; Venter, Christo/0000-0002-2666-4812; giglietto, nicola/0000-0002-9021-2888; Starck, Jean-Luc/0000-0003-2177-7794; Funk, Stefan/0000-0002-2012-0080; tramacere, andrea/0000-0002-8186-3793; Reimer, Olaf/0000-0001-6953-1385; Torres, Diego F./0000-0002-1522-9065; Loparco, Francesco/0000-0002-1173-5673; Mazziotta, Mario N/0000-0001-9325-4672; lubrano, pasquale/0000-0003-0221-4806; Johnston, Simon/0000-0002-7122-4963; Caraveo, Patrizia/0000-0003-2478-8018; Thompson, David J/0000-0001-5217-9135; Rea, Nanda/0000-0003-2177-6388; Reimer, Anita/0000-0001-8604-7077; Tajima, Hiroyasu/0000-0002-1721-7252; Moskalenko, Igor V/0000-0001-6141-458X; Morselli, Aldo/0000-0002-7704-9553; cohen-tanugi, Johann/0000-0001-9022-4232; Funk, Stefan/0000-0002-2012-0080; Cutini, Sara/0000-0002-1271-2924; Rando, Riccardo/0000-0001-6992-818X; Cameron, Robert/0000-0003-0942-2747; de Palma, Francesco/0000-0001-5898-2834; Ackermann, Markus/0000-0001-8952-588X; Pesce-Rollins, Melissa/0000-0003-1790-8018; Cecchi, Claudia/0000-0002-2192-8233; Bignami, Giovanni/0000-0001-9582-2450; Ransom, Scott/0000-0001-5799-9714; Casandjian, Jean-Marc/0000-0003-1404-0524; Spandre, Gloria/0000-0003-0802-3453; Tibaldo, Luigi/0000-0001-7523-570X; De Luca, Andrea/0000-0001-6739-687X; Baldini, Luca/0000-0002-9785-7726; Sgro', Carmelo/0000-0001-5676-6214; Fusco, Piergiorgio/0000-0002-9383-2425; Tosti, Gino/0000-0002-0839-4126; Katagiri, Hideaki/0000-0003-2347-8819; Kerr, Matthew/0000-0002-0893-4073; Berenji, Bijan/0000-0002-4551-772X; Monzani, Maria Elena/0000-0002-8254-5308; Johnson, Tyrel/0000-0002-2771-472X; Charles, Eric/0000-0002-3925-7802; Ciprini, Stefano/0000-0002-0712-2479; Sadrozinski, Hartmut/0000-0003-0019-5410; Thorsett, Stephen/0000-0002-2025-9613; McLaughlin, Maura/0000-0001-7697-7422; Murgia, Simona/0000-0003-0516-9422; De Angelis, Alessandro/0000-0002-3288-2517; Grenier, Isabelle/0000-0003-3274-674X; Pepe, Monica/0000-0001-5624-4010; SPINELLI, Paolo/0000-0001-6688-8864; Ray, Paul/0000-0002-5297-5278; Omodei, Nicola/0000-0002-5448-7577; Giordano, Francesco/0000-0002-8651-2394; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Porter, Troy/0000-0002-2621-4440; Tanaka, Takaaki/0000-0002-4383-0368; SANCHEZ, David/0000-0002-7210-4496; Kramer, Michael/0000-0002-4175-2271; Cheung, Chi (Teddy)/0000-0002-4377-0174; Cognard, Ismael/0000-0002-1775-9692; Orlando, Elena/0000-0001-6406-9910; Frailis, Marco/0000-0002-7400-2135	NASA; U.S. Department of Energy; Commissariat a l Energie Atomique/IRFU; CNRS/Institut National de Physique Nuclaire et de Physique des Particules (France); Agenzia Spaziale Italiana; Istituto Nazionale di Fisica Nucleare (Italy); Ministry of Education, Culture, Sports, Science and Technology; High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency (Japan); K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); Istituto Nazionale di Astrofisica (Italy); Commonwealth Government; CSIRO; Science and Technology Facilities Council [ST/G002487/1] Funding Source: researchfish; STFC [ST/G002487/1] Funding Source: UKRI; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy(United States Department of Energy (DOE)); Commissariat a l Energie Atomique/IRFU(French Atomic Energy Commission); CNRS/Institut National de Physique Nuclaire et de Physique des Particules (France)(Centre National de la Recherche Scientifique (CNRS)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Istituto Nazionale di Fisica Nucleare (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); Japan Aerospace Exploration Agency (Japan); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board (Sweden); Istituto Nazionale di Astrofisica (Italy)(Istituto Nazionale Astrofisica (INAF)); Commonwealth Government; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA)	The Fermi LAT Collaboration is supported by NASA and the U.S. Department of Energy; the Commissariat a l Energie Atomique/IRFU and CNRS/Institut National de Physique Nuclaire et de Physique des Particules (France); the Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare (Italy); the Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (Japan); and the K. A. Wallenberg Foundation, Swedish Research Council, and National Space Board (Sweden). Additional analysis during the operations phase was provided by the Istituto Nazionale di Astrofisica (Italy). The Parkes telescope is funded by the Commonwealth Government and is managed by CSIRO. The GBT is operated by the NRAO, a facility of NSF operated under cooperative agreement by Associated Universities Inc. The Arecibo Observatory is part of the National Astronomy and Ionosphere Center, operated by Cornell University under a cooperative agreement with NSF. The Nancay Radio Telescope is operated by the Paris Observatory, associated with the CNRS. The Lovell Telescope is owned and operated by the University of Manchester with support from the UK Science and Technology Facilities Council. The Westerbork Synthesis Radio Telescope is operated by ASTRON in the Netherlands	Abdo AA, 2009, ASTROPHYS J, V699, P1171, DOI 10.1088/0004-637X/699/2/1171; Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Abdo AA, 2009, ASTROPHYS J SUPPL S, V183, P46, DOI 10.1088/0067-0049/183/1/46; Abdo AA, 2009, ASTROPHYS J LETT, V699, pL102, DOI 10.1088/0004-637X/699/2/L102; Abdo AA, 2009, ASTROPHYS J, V700, P1059, DOI 10.1088/0004-637X/700/2/1059; Abdo AA, 2009, ASTROPHYS J, V696, P1084, DOI 10.1088/0004-637X/696/2/1084; Abdo AA, 2009, ASTROPHYS J LETT, V695, pL72, DOI 10.1088/0004-637X/695/1/L72; ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Bulik T, 2000, MON NOT R ASTRON SOC, V317, P97, DOI 10.1046/j.1365-8711.2000.03662.x; CAMILO F, 2005, ASP C SER, V328, P147; Crawford F, 2006, ASTROPHYS J, V652, P1499, DOI 10.1086/508403; DEJAGER OC, 1989, ASTRON ASTROPHYS, V221, P180; Deller AT, 2008, ASTROPHYS J LETT, V685, pL67, DOI 10.1086/592401; Dowd A, 2000, ASTR SOC P, V202, P275; Harding AK, 2005, ASTROPHYS J, V622, P531, DOI 10.1086/427840; Hobbs G, 2004, MON NOT R ASTRON SOC, V353, P1311, DOI 10.1111/j.1365-2966.2004.08157.x; Hotan AW, 2006, MON NOT R ASTRON SOC, V369, P1502, DOI 10.1111/j.1365-2966.2006.10394.x; Kaplan DL, 2005, PUBL ASTRON SOC PAC, V117, P643, DOI 10.1086/430368; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Kuiper L, 2000, ASTRON ASTROPHYS, V359, P615; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Lommen AN, 2000, ASTROPHYS J, V545, P1007, DOI 10.1086/317841; Lorimer D.R., 2004, HDB PULSAR ASTRONOMY, V4; Manchester RN, 2007, AIP CONF PROC, V983, P584; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Muslimov AG, 2004, ASTROPHYS J, V617, P471, DOI 10.1086/425227; Pellizzoni A, 2009, ASTROPHYS J LETT, V695, pL115, DOI 10.1088/0004-637X/695/1/L115; SHKLOVSKII IS, 1970, SOV ASTRON, V13, P734; Smith DA, 2008, ASTRON ASTROPHYS, V492, P923, DOI 10.1051/0004-6361:200810285; Story SA, 2007, ASTROPHYS J, V671, P713, DOI 10.1086/521016; Theureau G, 2005, ASTRON ASTROPHYS, V430, P373, DOI 10.1051/0004-6361:20047152; Thompson DJ, 1999, ASTROPHYS J, V516, P297, DOI 10.1086/307083; Verbiest JPW, 2008, ASTROPHYS J, V679, P675, DOI 10.1086/529576; Voute JLL, 2002, ASTRON ASTROPHYS, V385, P733, DOI 10.1051/0004-6361:20020123; Watters KP, 2009, ASTROPHYS J, V695, P1289, DOI 10.1088/0004-637X/695/2/1289; Zhang L, 2007, ASTROPHYS J, V666, P1165, DOI 10.1086/520490; Zhang L, 2003, ASTRON ASTROPHYS, V398, P639, DOI 10.1051/0004-6361:20021570	39	180	181	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					848	852		10.1126/science.1176113	http://dx.doi.org/10.1126/science.1176113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19574349				2022-12-28	WOS:000269242400039
J	Gutierrez-Valencia, A; Viciana, P; Palacios, R; Ruiz-Valderas, R; Lozano, F; Terron, A; Rivero, A; Lopez-Cortes, LF				Gutierrez-Valencia, Alicia; Viciana, Pompeyo; Palacios, Rosario; Ruiz-Valderas, Rosa; Lozano, Fernando; Terron, Alberto; Rivero, Antonio; Lopez-Cortes, Luis F.		Soc Andaluza Enfermedades Infeccio	Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PLASMA-CONCENTRATIONS; PHARMACOKINETICS; NEVIRAPINE; THERAPY; ADULTS; EMTRICITABINE; COMBINATION; DIDANOSINE; INITIATION	Background: More than 50% of patients who start efavirenz treatment develop limiting neuropsychiatric adverse events (NPAEs). Objective: To assess whether stepwise dosing of efavirenz decreases the incidence and severity of NPAEs while maintaining virologic efficacy. Design: Randomized, double-blind, controlled trial. Setting: 7 HIV clinics in Spain. Patients: 114 HIV-infected patients eligible for efavirenz treatment plus 2 nucleoside or nucleotide reverse transcriptase inhibitors. Intervention: Random assignment (by computer-generated sequence) to receive efavirenz, 200 mg/d on days 1 through 6, 400 mg/d on days 7 through 13, and 600 mg/d on day 14 and after, or efavirenz, 600 mg/d, from day 1. Both groups received 2 nucleoside or nucleotide reverse transcriptase inhibitors chosen by the patient's physician. Measurements: Neuropsychiatric symptoms and sleep quality were assessed by questionnaires at 0, 7, 14, and 30 days. The primary outcome was efavirenz-related NPAEs during the first 2 weeks, and the secondary outcome was plasma HIV RNA level at 24 weeks. Results: Compared with the stepped-dose group, the full-dose group had higher incidence and severity of dizziness (66.0% vs. 32.8%; P = 0.001), hangover (45.8% vs. 20.7%; P = 0.008), impaired concentration (22.9% vs. 8.9%; P = 0.038), and hallucinations (6.1% vs. 0%; P = 0.056) during the first week. From week 2, the incidence of efavirenz-related NPAEs was similar in both groups, although the severity was greater in the full-dose group. Virologic and immunologic efficacy seemed similar in both groups. Limitations: The sample size was calculated on the basis of a high absolute difference in rates of efavirenz-related NPAEs between the groups. A lower absolute difference and a larger sample size could have made the differences between groups reach statistical significance beyond the first week. In addition, the sample size does not allow confirmation of similar efficacy between treatment groups. Conclusion: Stepwise dose escalation of efavirenz over 2 weeks reduces the incidence and intensity of efavirenz-related NPAEs while maintaining efficacy. Primary Funding Source: Consejeria de Salud, Junta de Andalucia, Spain.	Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Seville, Spain; Hosp Univ Valme, Seville, Spain; Hosp Univ Virgen Victoria, Malaga, Spain; Hosp Jerez, Cadiz, Spain; Hosp Univ Reina Sofia, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Valme; Hospital Virgen de la Victoria; Hospital de Jerez; Hospital Universitario Reina Sofia - Cordoba	Lopez-Cortes, LF (corresponding author), Hosp Univ Virgen Rocio, Serv Enfermedades Infecciosas, Ave Manuel Siurot S-N, Seville 41013, Spain.	lflopez@telefonica.net	Rivero, Antonio/ABE-5294-2020; Lopez.Cortes, Luis Fernando/W-8323-2019; Gutiérrez-Valencia, Alicia/AAJ-5391-2020; IBIS, VIH/O-8856-2015	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Gutiérrez-Valencia, Alicia/0000-0003-3445-1574; Rivero, Antonio/0000-0001-5005-8268	Consejeria de Salud [224/05]; Junta de Andaluci	Consejeria de Salud; Junta de Andaluci	Grant Support: By grant 224/05 from the Consejeria de Salud, Junta de Andaluci	Blanch J, 2001, J ACQ IMMUN DEF SYND, V27, P336, DOI 10.1097/00126334-200108010-00003; BOBES J, 2004, BANCO INSTRUMENTOS B, P118; CAHN P, 2000, 13 INT AIDS C DURB S; Clarke SM, 2001, BRIT J CLIN PHARMACO, V51, P213, DOI 10.1046/j.1365-2125.2001.00342.x; Clifford DB, 2005, ANN INTERN MED, V143, P714, DOI 10.7326/0003-4819-143-10-200511150-00008; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Colombo S, 2005, PHARMACOGENET GENOM, V15, P599, DOI 10.1097/01.fpc.0000172241.42546.d3; Csajka C, 2003, CLIN PHARMACOL THER, V73, P20, DOI 10.1067/mcp.2003.22; *CTR DRUG EV RES, 1998, EF MED REV; European Medicines Agency, SUST SUMM PROD CHAR; FISKE WD, 2001, 41 INT C ANT AG CHEM; Fumaz CR, 2005, JAIDS-J ACQ IMM DEF, V38, P560, DOI 10.1097/01.qai.0000147523.41993.47; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Haas DW, 2004, AIDS, V18, P2391; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Lopez-Cortes LF, 2005, JAIDS-J ACQ IMM DEF, V39, P551; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Lopez-Cortes LF, 2001, AIDS, V15, P1192, DOI 10.1097/00002030-200106150-00022; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Molina JM, 2005, J INFECT DIS, V191, P830, DOI 10.1086/428091; Molina JM, 2000, J INFECT DIS, V182, P599, DOI 10.1086/315711; Moyle G, 2006, HIV MED, V7, P243, DOI 10.1111/j.1468-1293.2006.00363.x; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1, P1; Ramirez-Duque N, 2006, ENFERM INFEC MICR CL, V24, P64, DOI 10.1157/13083380; Stahle L, 2004, THER DRUG MONIT, V26, P267, DOI 10.1097/00007691-200406000-00008; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Takahashi M, 2007, AIDS RES HUM RETROV, V23, P983, DOI 10.1089/aid.2006.0193; Veldkamp AI, 2001, J INFECT DIS, V184, P37, DOI 10.1086/320998	29	31	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					149	W34		10.7326/0003-4819-151-3-200908040-00127	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00127			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19581631				2022-12-28	WOS:000268947800001
J	Cassidy, J				Cassidy, Jane			Whistleblowing: Name and Shame	BRITISH MEDICAL JOURNAL			English	Editorial Material							STUDENTS; BRISTOL					janecassi@yahoo.co.uk						Aylin P, 2004, BRIT MED J, V329, P825, DOI 10.1136/bmj.329.7470.825; *BMA, 2009, WHISTLEBLOW ADVICE; *BMA SURV, 2009, SPEAK UP PATIENTS; Bolsin S, 2000, INT J QUAL HEALTH C, V12, P433, DOI 10.1093/intqhc/12.5.433; Bolsin SN, 1998, MED J AUSTRALIA, V169, P369, DOI 10.5694/j.1326-5377.1998.tb126806.x; *BRISTOL ROY INFIR, 2001, LEARN BRISTOL REP; COLLIER J, 1986, MED EDUC, V20, P86, DOI 10.1111/j.1365-2923.1986.tb01052.x; *COMM RACIAL EQUAL, 1988, MED SCH ADMISS; DYER C, 2008, BRIT MED J, V337, P2822; Freestone L, 2006, INT J QUAL HEALTH C, V18, P452, DOI 10.1093/intqhc/mzl054; Goldie J, 2003, MED EDUC, V37, P368, DOI 10.1046/j.1365-2923.2003.01471.x; GOODERHAM P, 2009, BRIT MED J, V338, P2090; *HLTHCARE COMM, 2009, INVEST MIDSTAFFORDS; *HLTHWATCH, 2003, OBSTACLES HONESTY; *MED BALLS, 2009, PRIVATE EYE; NURS MIDWIF COUN, REASON SUBSTAN HEAR; *OFF PRES OBAMA, ETHICS AGENDA; SMITH R, 2009, MAY HAVE LED 1200; *TRUST REV CANC, 2009, BBC NEWS	19	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 30	2009	339								b2693	10.1136/bmj.b2693	http://dx.doi.org/10.1136/bmj.b2693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PI	19633039				2022-12-28	WOS:000268673000005
J	Hardwick, JM; Youle, RJ				Hardwick, J. Marie; Youle, Richard J.			SnapShot: BCL-2 Proteins	CELL			English	Editorial Material									[Hardwick, J. Marie] Johns Hopkins, Baltimore, MD 21205 USA; NINDS, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hardwick, JM (corresponding author), Johns Hopkins, Baltimore, MD 21205 USA.				NIGMS NIH HHS [R01 GM077875, R01 GM077875-04] Funding Source: Medline; NINDS NIH HHS [R01 NS037402] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037402, ZIANS002859] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	54	59	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					404	404						1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632186	Green Accepted, Bronze			2022-12-28	WOS:000268277000020
J	Tilman, D; Socolow, R; Foley, JA; Hill, J; Larson, E; Lynd, L; Pacala, S; Reilly, J; Searchinger, T; Somerville, C; Williams, R				Tilman, David; Socolow, Robert; Foley, Jonathan A.; Hill, Jason; Larson, Eric; Lynd, Lee; Pacala, Stephen; Reilly, John; Searchinger, Tim; Somerville, Chris; Williams, Robert			Beneficial Biofuels-The Food, Energy, and Environment Trilemma	SCIENCE			English	Editorial Material							CROPPING SYSTEMS; LAND-USE; BIOENERGY; BIOMASS; EMISSIONS; CLIMATE; CARBON; CORN; OPPORTUNITIES; AGRICULTURE		[Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Larson, Eric; Williams, Robert] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Foley, Jonathan A.; Hill, Jason] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Lynd, Lee] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Pacala, Stephen] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reilly, John] MIT, Ctr Energy & Environm Policy Res, Cambridge, MA 02142 USA; [Searchinger, Tim] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; Princeton University; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Princeton University; Massachusetts Institute of Technology (MIT); Princeton University; University of California System; University of California Berkeley	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Hill, Jason/A-8919-2008; Foley, Jonathan A/GRS-5522-2022; Tilman, David/ABD-5309-2021; Molina, Carolina/E-3898-2015; Noojipady, Praveen/B-2511-2010; Somerville, Christopher R/A-4048-2009; Lynd, Lee R/N-1260-2013	Hill, Jason/0000-0001-7609-6713; Molina, Carolina/0000-0001-6659-994X; Somerville, Christopher R/0000-0003-4647-0094; Lynd, Lee R/0000-0002-5642-668X				Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; Antizar-Ladislao B, 2008, BIOFUEL BIOPROD BIOR, V2, P455, DOI 10.1002/bbb.97; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Cantrell KB, 2008, BIORESOURCE TECHNOL, V99, P7941, DOI 10.1016/j.biortech.2008.02.061; Dale BE, 2009, BIOFUEL BIOPROD BIOR, V3, P219, DOI 10.1002/bbb.132; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Firbank LG, 2008, BIOENERG RES, V1, P12, DOI 10.1007/s12155-007-9000-8; Gibbs HK, 2008, ENVIRON RES LETT, V3; Heggenstaller AH, 2008, AGRON J, V100, P1740, DOI 10.2134/agronj2008.0087; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; National Academy of Sciences National Academy of Engineering National Research Council, 2009, LIQ TRANSP FUELS COA; O'Hare M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024001; Pineiro G, 2009, ECOL APPL, V19, P277, DOI 10.1890/08-0645.1; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Solomon B, 2009, ROUTL EXPLOR ENVIRON, P1; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	26	1134	1171	11	610	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					270	271		10.1126/science.1177970	http://dx.doi.org/10.1126/science.1177970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608900				2022-12-28	WOS:000268036600027
J	Ishizaki, K; Noda, S				Ishizaki, Kenji; Noda, Susumu			Manipulation of photons at the surface of three-dimensional photonic crystals	NATURE			English	Article							SPONTANEOUS-EMISSION CONTROL; LIGHT-EMISSION; WAVES; EQUATIONS; LAYER	In three-dimensional (3D) photonic crystals(1-12), refractive-index variations with a periodicity comparable to the wavelength of the light passing through the crystal give rise to so-called photonic bandgaps, which are analogous to electronic bandgaps for electrons moving in the periodic electrostatic potential of a material's crystal structure. Such 3D photonic bandgap crystals are envisioned to become fundamental building blocks for the control and manipulation of photons in optical circuits. So far, such schemes have been pursued by embedding artificial defects(3-5,8-12) and light emitters(4-9) inside the crystals, making use of 3D bandgap directional effects. Here we show experimentally that photons can be controlled and manipulated even at the 'surface' of 3D photonic crystals, where 3D periodicity is terminated, establishing a new and versatile route for photon manipulation. By making use of an evanescent-mode coupling technique, we demonstrate that 3D photonic crystals possess two-dimensional surface states, and we map their band structure. We show that photons can be confined and propagate through these two-dimensional surface states, and we realize their localization at arbitrary surface points by designing artificial surface-defect structures through the formation of a surface-mode gap. Surprisingly, the quality factors of the surface-defect mode are the largest reported for 3D photonic crystal nanocavities (Q up to similar to 9,000). In addition to providing a new approach for photon manipulation by photonic crystals, our findings are relevant for the generation and control of plasmon-polaritons in metals and the related surface photon physics. The absorption-free nature of the 3D photonic crystal surface may enable new sensing applications and provide routes for the realization of efficient light-matter interactions.	[Ishizaki, Kenji; Noda, Susumu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Ishizaki, Kenji; Noda, Susumu] Japan Sci & Technol Agcy, Kyoto 6158510, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	snoda@kuee.kyoto-u.ac.jp			Global Centre of Excellence for Education and Research on Photonics and Electronics Science and Engineering of Kyoto University, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); JSPS	Global Centre of Excellence for Education and Research on Photonics and Electronics Science and Engineering of Kyoto University, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Q. Sun for assistance with the experiment and numerical analysis, and S. Kawashima, S. Takahashi, Y. Tanaka, T. Asano and M. Fujita for discussions and advice. This work was supported in part by the Global Centre of Excellence for Education and Research on Photonics and Electronics Science and Engineering of Kyoto University, Japan, and by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science (JSPS). K. I. acknowledges support from a Research Fellowship of the JSPS.	Aoki K, 2008, NAT PHOTONICS, V2, P688, DOI 10.1038/nphoton.2008.202; Astratov VN, 1999, PHYS REV B, V60, P16255, DOI 10.1103/PhysRevB.60.R16255; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Coquillat D, 2004, OPT EXPRESS, V12, P1097, DOI 10.1364/OPEX.12.001097; Galli M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.081307; HO KM, 1994, SOLID STATE COMMUN, V89, P413, DOI 10.1016/0038-1098(94)90202-X; Imada M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197942; JI J, 2007, APPL PHYS LETT, V91; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kawashima S, 2007, J MICROELECTROMECH S, V16, P1140, DOI 10.1109/JMEMS.2007.904950; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; Lodahl P, 2004, NATURE, V430, P654, DOI 10.1038/nature02772; MEADE RD, 1991, PHYS REV B, V44, P10961, DOI 10.1103/PhysRevB.44.10961; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Noda S, 2000, SCIENCE, V289, P604, DOI 10.1126/science.289.5479.604; Noda S, 2007, NAT PHOTONICS, V1, P449, DOI 10.1038/nphoton.2007.141; Ogawa S, 2008, ELECTRON LETT, V44, P377, DOI 10.1049/el:20083634; Ogawa SP, 2004, SCIENCE, V305, P227, DOI 10.1126/science.1097968; OTTO A, 1968, Z PHYS, V216, P398, DOI 10.1007/BF01391532; Paraire N, 2007, APPL PHYS B-LASERS O, V89, P245, DOI 10.1007/s00340-007-2805-5; Qi MH, 2004, NATURE, V429, P538, DOI 10.1038/nature02575; Rinne SA, 2008, NAT PHOTONICS, V2, P52, DOI 10.1038/nphoton.2007.252; SOZUER HS, 1994, J MOD OPTIC, V41, P231, DOI 10.1080/09500349414550291; TIEN PK, 1969, APPL PHYS LETT, V14, P291, DOI 10.1063/1.1652820; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yamamoto N, 1998, JPN J APPL PHYS 2, V37, pL1052, DOI 10.1143/JJAP.37.L1052; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	27	148	153	4	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					367	U78		10.1038/nature08190	http://dx.doi.org/10.1038/nature08190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606144				2022-12-28	WOS:000267979000032
J	Nayar, A				Nayar, Anjali			A lakeful of trouble	NATURE			English	Editorial Material							KIVU											HABERYAN KA, 1987, PALAEOGEOGR PALAEOCL, V61, P169, DOI 10.1016/0031-0182(87)90048-4; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2002, ACTA VULCANOL, V14, P115, DOI DOI 10.1400/19084; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tedesco D, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004762	7	16	16	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					321	323		10.1038/460321a	http://dx.doi.org/10.1038/460321a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606123	Bronze			2022-12-28	WOS:000267979000012
J	Patterson, TF; Mackool, BT; Gilman, MD; Piris, A				Patterson, Thomas F.; Mackool, Bonnie T.; Gilman, Matthew D.; Piris, Adriano			A Man with Skin and Pulmonary Lesions after Bone Marrow Transplantation Disseminated fusarium infection involving the lungs and skin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Conference on Infectious Diseases of Adults	APR 16, 2008	Boston, MA				CANCER CENTER; HEMATOLOGIC MALIGNANCIES; INVASIVE ASPERGILLOSIS; NEUTROPENIC PATIENTS; RISK-FACTORS; EPIDEMIOLOGY; ZYGOMYCOSIS; EXPERIENCE; PNEUMONIA; MORTALITY		[Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, Div Infect Dis, San Antonio, TX 78229 USA; [Patterson, Thomas F.] S Texas Vet Hlth Care Syst, San Antonio, TX USA; [Mackool, Bonnie T.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Gilman, Matthew D.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Piris, Adriano] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Patterson, TF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Infect Dis, San Antonio, TX 78229 USA.							[Anonymous], 1979, BRIT J DIS CHEST, V73, P349; Boutati EI, 1997, BLOOD, V90, P999, DOI 10.1182/blood.V90.3.999.999_999_1008; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gorschluter M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-35; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; HARON E, 1993, MEDICINE, V72, P137, DOI 10.1097/00005792-199372030-00001; Kauffman Carol A, 2002, Semin Respir Infect, V17, P106, DOI 10.1053/srin.2002.33442; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Marr KA, 2000, CURR OPIN INFECT DIS, V13, P615, DOI 10.1097/00001432-200012000-00006; Mennink-Kersten MASH, 2006, INFECT DIS CLIN N AM, V20, P711, DOI 10.1016/j.idc.2006.06.009; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; Nucci M, 2003, CANCER, V98, P315, DOI 10.1002/cncr.11510; Nucci M, 1997, CLIN INFECT DIS, V24, P575, DOI 10.1093/clind/24.4.575; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Pagano L, 2006, J CHEMOTHERAPY, V18, P339, DOI 10.1179/joc.2006.18.4.339; Pagano L, 2001, HAEMATOLOGICA, V86, P862; Pagano L, 2006, HAEMATOLOGICA, V91, P1068; Pappas PG, 2006, INFECT DIS CLIN N AM, V20, P485, DOI 10.1016/j.idc.2006.07.004; Patterson TF, 2005, LANCET, V366, P1013, DOI 10.1016/S0140-6736(05)67381-3; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480	26	10	10	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					287	296		10.1056/NEJMcpc0809065	http://dx.doi.org/10.1056/NEJMcpc0809065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	470LL	19605834				2022-12-28	WOS:000267976100012
J	Hupperets, MDW; Verhagen, EALM; van Mechelen, W				Hupperets, Maarten D. W.; Verhagen, Evert A. L. M.; van Mechelen, Willem			Effect of unsupervised home based proprioceptive training on recurrences of ankle sprain: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROSPECTIVE COHORT; PROGRAM; STRENGTH; INJURIES; PREVENTION; RISK; EVERSION; PLAYERS	Objective To evaluate the effectiveness of an unsupervised proprioceptive training programme on recurrences of ankle sprain after usual care in athletes who had sustained an acute sports related injury to the lateral ankle ligament. Design Randomised controlled trial, with one year follow-up. Setting Primary care. Participants 522 athletes, aged 12-70, who had sustained a lateral ankle sprain up to two months before inclusion; 256 (120 female and 136 male) in the intervention group; 266 (128 female and 138 male) in the control group. Intervention Both groups received treatment according to usual care. Athletes allocated to the intervention group additionally received an eight week home based proprioceptive training programme. Main outcome measure Self reported recurrence of ankle sprain. Results During the one year follow-up, 145 athletes reported a recurrent ankle sprain: 56 (22%) in the intervention group and 89 (33%) in the control group. Nine athletes needed to be treated to prevent one recurrence (number needed to treat). The intervention programme was associated with a 35% reduction in risk of recurrence. Cox regression analysis showed significantly fewer recurrent ankle sprains in the intervention than in the control group. This effect was found for self reported recurrent ankle sprains (relative risk 0.63, 95% confidence interval 0.45 to 0.88), recurrent ankle sprains leading to loss of sports time (0.53, 0.32 to 0.88), and recurrent ankle sprains resulting in healthcare costs or lost productivity costs (0.25, 0.12 to 0.50). No significant differences were found between medically treated athletes in the intervention group and medically treated controls. Athletes in the intervention group who were not medically treated had a significantly lower risk of recurrence than controls who were not medically treated. Conclusions The use of a proprioceptive training programme after usual care of an ankle sprain is effective for the prevention of self reported recurrences. This proprioceptive training was specifically beneficial in athletes whose original sprain was not medically treated.	[Hupperets, Maarten D. W.; Verhagen, Evert A. L. M.; van Mechelen, Willem] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, NL-1081 BT Amsterdam, Netherlands; [Verhagen, Evert A. L. M.; van Mechelen, Willem] TNO VUmc, Body Work Res Ctr Phys Act Work & Hlth, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	van Mechelen, W (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	w.vanmechelen@vumc.nl	Verhagen, Evert/A-1502-2013; van Mechelen, Willem/C-8463-2013	Verhagen, Evert/0000-0001-9227-8234; van Mechelen, Willem/0000-0001-7136-6382	Netherlands Organization for Health Research and Development (ZonMw) [750-20-002]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw), grant number 750-20-002. No author or related institution has received any financial benefit from research in this study.	Bahr R, 1997, SCAND J MED SCI SPOR, V7, P166, DOI 10.1111/j.1600-0838.1997.tb00134.x; Bernier JN, 1998, J ORTHOP SPORT PHYS, V27, P264, DOI 10.2519/jospt.1998.27.4.264; Eils E, 2001, MED SCI SPORT EXER, V33, P1991, DOI 10.1097/00005768-200112000-00003; EKSTRAND J, 1990, FOOT ANKLE, V11, P41, DOI 10.1177/107110079001100108; Emery CA, 2005, CAN MED ASSOC J, V172, P749, DOI 10.1503/cmaj.1040805; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Freeman M A, 1965, J Bone Joint Surg Br, V47, P669; HANDOLL HH, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000018; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoiness P, 2003, SCAND J MED SCI SPOR, V13, P266, DOI 10.1034/j.1600-0838.2003.10140.x; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hupperets MDW, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-71; Kaminski TW, 1999, J ATHL TRAINING, V34, P239; Kaminski TW, 2003, BRIT J SPORT MED, V37, P410, DOI 10.1136/bjsm.37.5.410; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P305, DOI 10.2106/00004623-199173020-00021; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; MILGROM C, 1991, FOOT ANKLE, V12, P26, DOI 10.1177/107110079101200105; Parkkari J, 2001, SPORTS MED, V31, P985, DOI 10.2165/00007256-200131140-00003; SAUNDERS EA, 1980, AM FAM PHYSICIAN, V22, P132; Sekir U, 2007, KNEE SURG SPORT TR A, V15, P654, DOI 10.1007/s00167-006-0108-8; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; SURVE I, 1994, AM J SPORT MED, V22, P601, DOI 10.1177/036354659402200506; TROPP H, 1985, AM J SPORT MED, V13, P259, DOI 10.1177/036354658501300408; vanMechelen W, 1997, SPORTS MED, V24, P176, DOI 10.2165/00007256-199724030-00006; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; VERHAGEN EAL, 2004, ANKLE SPRAINS VOLLEY; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031; Verhagen EALM, 2004, BRIT J SPORT MED, V38, P477, DOI 10.1136/bjsm.2003.005785; Vriend I, 2005, ONGEVALSLETSELS SPOR; Wedderkopp N, 2003, SCAND J MED SCI SPOR, V13, P371, DOI 10.1046/j.1600-0838.2003.00336.x; Willems T, 2002, J ATHL TRAINING, V37, P487	31	127	133	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2009	339								b2684	10.1136/bmj.b2684	http://dx.doi.org/10.1136/bmj.b2684			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LA	19589822	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000267898500006
J	van Gils, EJM; Veenhoven, RH; Hak, E; Rodenburg, GD; Bogaert, D; IJzerman, EPF; Bruin, JP; van Alphen, L; Sanders, EAM				van Gils, Elske J. M.; Veenhoven, Reinier H.; Hak, Eelko; Rodenburg, Gerwin D.; Bogaert, Debby; IJzerman, Ed P. F.; Bruin, Jacob P.; van Alphen, Loek; Sanders, Elisabeth A. M.			Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; LONGITUDINAL DATA; UNITED-STATES; DISEASE; COLONIZATION; IMMUNOGENICITY; SEROTYPES; ADULTS; ERA	Context The effects of reduced-dose schedules of 7-valent pneumococcal conjugate vaccine (PCV-7) on pneumococcal carriage in children are largely unknown, although highly relevant in the context of subsequent herd effects. Objective To examine the effects of a 2-dose and 2 + 1-dose PCV-7 schedule on nasopharyngeal pneumococcal carriage in young children compared with controls. Design, Setting, and Patients A randomized controlled trial of nasopharyngeal carriage of Streptococcus pneumoniae enrolling 1003 healthy newborns and 1 of their parents in a general community in the Netherlands, with follow-up to age 24 months and conducted between July 7, 2005, and February 14, 2008. Intervention Infants were randomly assigned to receive 2 doses of PCV-7 at 2 and 4 months; 2 + 1 doses of PCV-7 at 2, 4, and 11 months; or no dosage (control group). Main Outcome Measure Vaccine serotype pneumococcal carriage rates in infants in the second year of life. Results At 12 months, vaccine serotype pneumococcal carriage was significantly decreased after both PCV-7 schedules, with vaccine serotype pneumococcal carriage rates of 25% (95% confidence interval [CI], 20%-30%) and 20% (95% CI, 16%-25%) in the 2-dose and 2 + 1-dose schedule groups, respectively, vs 38% (95% CI, 33%-44%) in the control group (both P < .001). At 18 months, in the 2 + 1-dose schedule group, vaccine serotype pneumococcal carriage had further decreased to 16% (95% CI, 12%-20%) and, at 24 months, to 14% (95% CI, 11%-18%; both P < .001); whereas in the 2-dose schedule group, vaccine serotype pneumococcal carriage had remained stable at 18 months (24%; 95% CI, 20%-29%), but at 24 months had further decreased to 15% (95% CI, 11%-19%; both P < .001). In the control group, vaccine serotype pneumococcal carriage remained around 36% to 38% until 24 months. Conclusion Compared with no pneumococcal vaccination, a 2 + 1-dose and 2-dose schedule of PCV-7 resulted in significant reductions of vaccine serotype pneumococcal carriage in the second year of life. Trial Registration clinicaltrials.gov Identifier: NCT00189020 JAMA. 2009;302(2):159-167	[van Gils, Elske J. M.; Hak, Eelko; Rodenburg, Gerwin D.; Bogaert, Debby; Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, NL-3508 AB Utrecht, Netherlands; [Hak, Eelko] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; [van Gils, Elske J. M.; Veenhoven, Reinier H.; Rodenburg, Gerwin D.] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands; [Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [IJzerman, Ed P. F.; Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands; [van Alphen, Loek] Netherlands Vaccine Inst, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Spaarne Hospital; University of Groningen	Sanders, EAM (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, POB 85090, NL-3508 AB Utrecht, Netherlands.	l.sanders@umcutrecht.nl		Bogaert, Debby/0000-0003-2651-7000	Dutch Ministry of Health	Dutch Ministry of Health	This work was supported by the Dutch Ministry of Health.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; HARRELL FE, 1986, BIOMETRICS, V42, P121; Heath PT, 2002, ARCH DIS CHILD, V86, P396, DOI 10.1136/adc.86.6.396; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsu K. K., 2007, Morbidity and Mortality Weekly Report, V56, P1077; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Jokinen JT, 2004, J INFECT DIS, V190, P545, DOI 10.1086/422531; Jones VF, 2005, PEDIATR INFECT DIS J, V24, P969, DOI 10.1097/01.inf.0000187030.83080.8a; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Veenhoven RH, 2004, CLIN INFECT DIS, V39, P911, DOI 10.1086/422651; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2005, PEDIATR INFECT DIS J, V24, P729, DOI 10.1097/01.inf.0000174138.25465.ec; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	115	116	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					159	167		10.1001/jama.2009.975	http://dx.doi.org/10.1001/jama.2009.975			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584345				2022-12-28	WOS:000267696500025
J	McHutchison, JG; Lawitz, EJ; Shiffman, ML; Muir, AJ; Galler, GW; McCone, J; Nyberg, LM; Lee, WM; Ghalib, RH; Schiff, ER; Galati, JS; Bacon, BR; Davis, MN; Mukhopadhyay, P; Koury, K; Noviello, S; Pedicone, LD; Brass, CA; Albrecht, JK; Sulkowski, MS				McHutchison, John G.; Lawitz, Eric J.; Shiffman, Mitchell L.; Muir, Andrew J.; Galler, Greg W.; McCone, Jonathan; Nyberg, Lisa M.; Lee, William M.; Ghalib, Reem H.; Schiff, Eugene R.; Galati, Joseph S.; Bacon, Bruce R.; Davis, Mitchell N.; Mukhopadhyay, Pabak; Koury, Kenneth; Noviello, Stephanie; Pedicone, Lisa D.; Brass, Clifford A.; Albrecht, Janice K.; Sulkowski, Mark S.		IDEAL Study Team	Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOTYPE-1 PATIENTS; TREATMENT DURATION; INITIAL TREATMENT; PLUS RIBAVIRIN; THERAPY; VIRUS; INTERFERON-ALPHA-2B; STEATOSIS; TRIAL	BACKGROUND Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C virus (HCV) infection. However, these regimens have not been adequately compared. METHODS At 118 sites, patients who had HCV genotype 1 infection and who had not previously been treated were randomly assigned to undergo 48 weeks of treatment with one of three regimens: peginterferon alfa-2b at a standard dose of 1.5 mu g per kilogram of body weight per week or a low dose of 1.0 mu g per kilogram per week, plus ribavirin at a dose of 800 to 1400 mg per day, or peginterferon alfa-2a at a dose of 180 mu g per week plus ribavirin at a dose of 1000 to 1200 mg per day. We compared the rate of sustained virologic response and the safety and adverse-event profiles between the peginterferon alfa-2b regimens and between the standard-dose peginterferon alfa-2b regimen and the peginterferon alfa-2a regimen. RESULTS Among 3070 patients, rates of sustained virologic response were similar among the regimens: 39.8% with standard-dose peginterferon alfa-2b, 38.0% with low-dose peginterferon alfa-2b, and 40.9% with peginterferon alfa-2a (P = 0.20 for standard-dose vs. low-dose peginterferon alfa-2b; P = 0.57 for standard-dose peginterferon alfa-2b vs. peginterferon alfa-2a). Estimated differences in response rates were 1.8% (95% confidence interval [CI], -2.3 to 6.0) between standard-dose and low-dose peginterferon alfa-2b and -1.1% (95% CI, -5.3 to 3.0) between standard-dose peginterferon alfa-2b and peginterferon alfa-2a. Relapse rates were 23.5% (95% CI, 19.9 to 27.2) for standard-dose peginterferon alfa-2b, 20.0% (95% CI, 16.4 to 23.6) for low-dose peginterferon alfa-2b, and 31.5% (95% CI, 27.9 to 35.2) for peginterferon alfa-2a. The safety profile was similar among the three groups; serious adverse events were observed in 8.6 to 11.7% of patients. Among the patients with undetectable HCV RNA levels at treatment weeks 4 and 12, a sustained virologic response was achieved in 86.2% and 78.7%, respectively. CONCLUSIONS In patients infected with HCV genotype 1, the rates of sustained virologic response and tolerability did not differ significantly between the two available peginterferon ribavirin regimens or between the two doses of peginterferon alfa-2b. (ClinicalTrials.gov number, NCT00081770.)	[McHutchison, John G.; Muir, Andrew J.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Lawitz, Eric J.] Alamo Med Res, San Antonio, TX USA; [Galler, Greg W.] Kelsey Res Fdn, Houston, TX USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Ghalib, Reem H.] Methodist Dallas Med Ctr, Liver Inst, Dallas, TX USA; [Shiffman, Mitchell L.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [McCone, Jonathan] Mt Vernon Endoscopy Ctr, Alexandria, VA USA; [Nyberg, Lisa M.] Kaiser Permanente, San Diego Med Ctr, San Diego, CA USA; [Schiff, Eugene R.] Univ Miami, Ctr Liver Dis, Miami, FL USA; [Davis, Mitchell N.] S Florida Ctr Gastroenterol, Wellington, New Zealand; [Bacon, Bruce R.] St Louis Univ, Sch Med, St Louis, MO 63103 USA; [Mukhopadhyay, Pabak; Koury, Kenneth; Noviello, Stephanie; Pedicone, Lisa D.; Brass, Clifford A.; Albrecht, Janice K.] Schering Plough Res Inst, Kenilworth, NJ USA; [Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University; Kaiser Permanente; University of Miami; Saint Louis University; Merck & Company; Schering-Plough Research Institute; Johns Hopkins University	McHutchison, JG (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	mchut001@mc.duke.edu		Davis, Mitchell/0000-0002-0526-5564; Afdhal, Nezam/0000-0002-7342-6593	Schering-Plough	Schering-Plough(Merck & CompanySchering Plough Corporation)	Supported by grants from Schering-Plough.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; *EUR MED AG, SUMM PROD CHAR REB; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison J, 2008, J VIRAL HEPATITIS, V15, P475, DOI 10.1111/j.1365-2893.2008.00973.x; Moucari R, 2007, J HEPATOL, V46, P596, DOI 10.1016/j.jhep.2006.10.016; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Muir AJ, 2004, NEW ENGL J MED, V351, P1268; Myers RP, 2003, J VIRAL HEPATITIS, V10, P16, DOI 10.1046/j.1365-2893.2003.00387.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Reddy KR, 2008, J VIRAL HEPATITIS, V15, P129, DOI 10.1111/j.1365-2893.2007.00901.x; Rustgi VK, 2008, ALIMENT PHARM THER, V27, P433, DOI 10.1111/j.1365-2036.2007.03587.x; Soresi M, 2006, LIVER INT, V26, P1119, DOI 10.1111/j.1478-3231.2006.01347.x; World Health Organization (WHO), HEP C FACT SHEET; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319	21	958	1022	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					580	593		10.1056/NEJMoa0808010	http://dx.doi.org/10.1056/NEJMoa0808010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19625712	Green Published			2022-12-28	WOS:000268667300008
J	Albain, KS; Swann, RS; Rusch, VW; Turrisi, AT; Shepherd, FA; Smith, C; Chen, Y; Livingston, RB; Feins, RH; Gandara, DR; Fry, WA; Darling, G; Johnson, DH; Green, MR; Miller, RC; Ley, J; Sause, WT; Cox, JD				Albain, Kathy S.; Swann, R. Suzanne; Rusch, Valerie W.; Turrisi, Andrew T., III; Shepherd, Frances A.; Smith, Colum; Chen, Yuhchyau; Livingston, Robert B.; Feins, Richard H.; Gandara, David R.; Fry, Willard A.; Darling, Gail; Johnson, David H.; Green, Mark R.; Miller, Robert C.; Ley, Joanne; Sause, Willliam T.; Cox, James D.			Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial	LANCET			English	Article							THERAPY-ONCOLOGY-GROUP; INDUCTION CHEMOTHERAPY; THORACIC RADIOTHERAPY; CHEST RADIOTHERAPY; CLINICAL-TRIALS; SURGERY; CONCURRENT; RADIATION; CISPLATIN	Background Results from phase 11 studies in patients with stage IIIA non-small-cell lung cancer with ipsilateral mediastinal nodal metastases (N2) have shown the feasibility of resection after concurrent chemotherapy and radiotherapy with promising rates of survival. We therefore did this phase III trial to compare concurrent chemotherapy and radiotherapy followed by resection with standard concurrent chemotherapy and definitive radiotherapy without resection. Methods Patients with stage T1-3pN2M0 non-small-cell lung cancer were randomly assigned in a 1:1 ratio to concurrent induction chemotherapy (two cycles of cisplatin [50 mg/m(2) on days 1, 8, 29, and 361 and etoposide [50 mg/m(2) on days 1-5 and 29-33]) plus radiotherapy (45 Gy) in multiple academic and community hospitals. if no progression, patients in group 1 underwent resection and those in group 2 continued radiotherapy uninterrupted up to 61 Gy. Two additional cycles of cisplatin and etoposide were given in both groups. The primary endpoint was overall survival (OS). Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00002550. Findings 202 patients (median age 59 years, range 31-77) were assigned to group 1 and 194 (61 years, 32-78) to group 2. Median OS was 23.6 months (IQR 9.0-not reached) in group 1 versus 22.2 months (9.4-52.7) in group 2 (hazard ratio [HR] 0.87 [0.70-1.10]; p=0.24). Number of patients alive at 5 years was 37 (point estimate 27%) in group 1 and 24 (point estimate 20%) in group 2 (odds ratio 0.63 [0.36-1.10]; p=0.10). With NO status at thoracotomy, the median OS was 34.4 months (IQR 15.7-not reached; 19 [point estimate 41%] patients alive at 5 years). Progression-free survival (PFS) was better in group 1 than in group 2, median 12.8 months (5.3-42.2) vs 10.5 months (4.8-20.6), HR 0.77 [0.62-0.96]; p=0.017); the number of patients without disease progression at 5 years was 32 (point estimate 22%) versus 13 (point estimate 11%), respectively. Neutropenia and oesophagitis were the main grade 3 or 4 toxicities associated with chemotherapy plus radiotherapy in group 1 (77 [38%] and 20 [10%], respectively) and group 2 (80 [41%] and 44 [23%], respectively). In group 1, 16 (8%) deaths were treatment related versus four (2%) in group 2. in an exploratory analysis, OS was improved for patients who underwent lobectomy, but not pneumonectomy, versus chemotherapy plus radiotherapy. Interpretation Chemotherapy plus radiotherapy with or without resection (preferably lobectomy) are options for patients with stage IIIA(N2) non-small-cell lung cancer.	[Albain, Kathy S.] Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA; [Swann, R. Suzanne; Ley, Joanne] Radiat Therapy Oncol Grp, Philadelphia, PA USA; [Rusch, Valerie W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Turrisi, Andrew T., III] Wayne State Univ, Detroit, MI USA; [Shepherd, Frances A.] Univ Hlth Network, Princess Margaret Hosp Site, Toronto, ON, Canada; [Smith, Colum] Tom Baker Canc Clin, Calgary, AB, Canada; [Chen, Yuhchyau] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Livingston, Robert B.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Feins, Richard H.] Univ N Carolina, Chapel Hill, NC USA; [Gandara, David R.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Fry, Willard A.] NorthShore Univ Hlth Syst, Evanston Hosp, Evanston, IL USA; [Darling, Gail] Univ Hlth Network, Toronto Gen Hosp Site, Toronto, ON, Canada; [Johnson, David H.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Green, Mark R.] Med Univ S Carolina, Charleston, SC 29425 USA; [Miller, Robert C.] Mayo Clin, Rochester, MN USA; [Sause, Willliam T.] Intermt Med Ctr, Salt Lake City, UT USA; [Cox, James D.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Loyola University Chicago; Radiation Therapy Oncology Group (RTOG); Memorial Sloan Kettering Cancer Center; Wayne State University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Tom Baker Cancer Clinic; University of Calgary; University of Rochester; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; NorthShore University Health System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Vanderbilt University; Medical University of South Carolina; Mayo Clinic; Intermountain Healthcare; Intermountain Medical Center; University of Texas System; UTMD Anderson Cancer Center	Albain, KS (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	kalbain@lumc.edu	Johnson, David/AHI-8369-2022	Miller, Robert/0000-0001-8932-2732; Rusch, Valerie/0000-0003-2345-6900	National Cancer Institute [CA21661, CA37422, CA32115, CA46441, CA77202, CA49957, CA03927, CA25224]; Canadian Cancer Society [NCIC10362]; NATIONAL CANCER INSTITUTE [U10CA037422, U10CA049957, U10CA003927, U10CA077202, U10CA025224, U10CA180846, U10CA046441, R44CA121661, U10CA032115, U10CA021661] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This trial was funded by the National Cancer Institute (pHs Cooperative Agreement grant numbers CA21661, CA37422, CA32115, CA46441, CA77202, CA49957, CA03927, CA25224) with high priority designation, and Canadian Cancer Society (NCIC10362), and administered by the Radiation Therapy Oncology Group (RTOG, R9309), with participation by Southwest Oncology Group, National Cancer Institute of Canada Clinical Trials Group, Eastern Cooperative Oncology Group, Cancer and Leukemia Group B, and North Central Cancer Treatment Group. We thank the many North American Intergroup discipline chairs and others who provided advice or assistance during the design of this study or while the study was in progress; the members of the Lung Cancer Committees of the Southwest Oncology Group, National Cancer Institute of Canada Clinical Trials Group, Eastern Cooperative Oncology Group, Cancer and Leukemia Group B, and the North Central Cancer Treatment Group for their support of this study over the long accrual period; and especially the lung cancer survivors who were treated and followed up on this protocol, and the lay advocates who supported this trial design.	ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880, DOI 10.1200/JCO.1995.13.8.1880; Albain KS, 2005, J CLIN ONCOL, V23, p624S; Albain KS, 2002, J CLIN ONCOL, V20, P3454, DOI 10.1200/JCO.2002.03.055; ALBAIN KS, 2003, P AN M AM SOC CLIN, V22, P621; COX DR, 1972, J R STAT SOC B, V187, P220; Curran WJ, 2003, P AN M AM SOC CLIN, V22, P621; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; DILLMAN RO, 1990, NEW ENGL J MED, V323, P940, DOI 10.1056/NEJM199010043231403; Eberhardt WE, 2003, LUNG CANCER-J IASLC, V42, pS9, DOI 10.1016/S0169-5002(03)00300-3; Farray D, 2005, J CLIN ONCOL, V23, P3257, DOI 10.1200/JCO.2005.03.008; Furuse K, 1999, J CLIN ONCOL, V17, P2692, DOI 10.1200/JCO.1999.17.9.2692; JOHNSON DH, 1990, ANN INTERN MED, V113, P33, DOI 10.7326/0003-4819-113-1-33; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; LECHEVALIER T, 1991, JNCI-J NATL CANCER I, V83, P417, DOI 10.1093/jnci/83.6.417; MARTINI N, 1987, SURG CLIN N AM, V67, P1037; MOUNTAIN CF, 1988, SEMIN ONCOL, V15, P236; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; PISTERS K, 2005, LUNG CANC PRINCIPLES, P626; Pritchard RS, 1996, ANN INTERN MED, V125, P723, DOI 10.7326/0003-4819-125-9-199611010-00003; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; ROTH JA, 1994, J NATL CANCER I, V86, P673, DOI 10.1093/jnci/86.9.673; SAUSE WT, 1995, J NATL CANCER I, V87, P198, DOI 10.1093/jnci/87.3.198; van Meerbeeck JP, 2007, JNCI-J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	25	1012	1039	0	69	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					379	386		10.1016/S0140-6736(09)60737-6	http://dx.doi.org/10.1016/S0140-6736(09)60737-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19632716	Green Published, Green Accepted			2022-12-28	WOS:000268815200021
J	Michels, KB; zur Hausen, H				Michels, Karin B.; zur Hausen, Harald			HPV vaccine for all	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; PARTICLE VACCINE; UNITED-STATES; PREVALENCE; INFECTION; CANCER; WOMEN; DNA		[Michels, Karin B.] Harvard Univ, Sch Med,Obstet & Gynecol Epidemiol Ctr, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [zur Hausen, Harald] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; German Cancer Research Center (DKFZ)	Michels, KB (corresponding author), Harvard Univ, Sch Med,Obstet & Gynecol Epidemiol Ctr, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu						Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; EINSTEIN MH, 2009, 25 INT PAP C MALM SW; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Schwarz TF, 2008, GYNECOL ONCOL, V110, pS1, DOI 10.1016/j.ygyno.2008.05.036; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	12	43	46	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					268	270		10.1016/S0140-6736(09)61247-2	http://dx.doi.org/10.1016/S0140-6736(09)61247-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19586657				2022-12-28	WOS:000268508200005
J	Munster, VJ; de Wit, E; van den Brand, JMA; Herfst, S; Schrauwen, EJA; Bestebroer, TM; van de Vijver, D; Boucher, CA; Koopmans, M; Rimmelzwaan, GF; Kuiken, T; Osterhaus, ADME; Fouchier, RAM				Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets	SCIENCE			English	Article							H5N1 VIRUSES; A VIRUS; HUMANS; VIRULENCE; MAMMALS	The swine-origin A(H1N1) influenza virus that has emerged in humans in early 2009 has raised concerns about pandemic developments. In a ferret pathogenesis and transmission model, the 2009 A(H1N1) influenza virus was found to be more pathogenic than a seasonal A(H1N1) virus, with more extensive virus replication occurring in the respiratory tract. Replication of seasonal A(H1N1) virus was confined to the nasal cavity of ferrets, but the 2009 A(H1N1) influenza virus also replicated in the trachea, bronchi, and bronchioles. Virus shedding was more abundant from the upper respiratory tract for 2009 A(H1N1) influenza virus as compared with seasonal virus, and transmission via aerosol or respiratory droplets was equally efficient. These data suggest that the 2009 A(H1N1) influenza virus has the ability to persist in the human population, potentially with more severe clinical consequences.	[Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; [Munster, Vincent J.; de Wit, Emmie; van den Brand, Judith M. A.; Herfst, Sander; Schrauwen, Eefje J. A.; Bestebroer, Theo M.; van de Vijver, David; Boucher, Charles A.; Koopmans, Marion; Rimmelzwaan, Guus F.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; [Koopmans, Marion] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment	Fouchier, RAM (corresponding author), Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Munster, Vincent/I-7607-2018; Fouchier, Ron A/A-1911-2014; de Wit, Emmie/A-1549-2019	Munster, Vincent/0000-0002-2288-3196; Fouchier, Ron A/0000-0001-8095-2869; de Wit, Emmie/0000-0002-9763-7758; van de Vijver, David/0000-0001-5877-8526; Kuiken, Thijs/0000-0001-5501-9049; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172	National Institute of Allergy and Infectious Diseases-NIH [HHSN266200700010C]	National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.M., E.d.W, and R.F. were financed through National Institute of Allergy and Infectious Diseases-NIH contract HHSN266200700010C.	Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Lackenby A, 2008, EUROSURVEILLANCE, V13, P113; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mizuta K, 2004, EPIDEMIOL INFECT, V132, P721, DOI 10.1017/S0950268804002237; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; NOVEL AVI, 2009, NEW ENGL J MED, V360, P2605; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; *WHO, 2009, WKLY EPIDEMIOL REC, V21, P185; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	18	486	519	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					481	483		10.1126/science.1177127	http://dx.doi.org/10.1126/science.1177127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19574348	Green Accepted			2022-12-28	WOS:000268255100058
J	Kalaszczynska, I; Geng, Y; Iino, T; Mizuno, SI; Choi, Y; Kondratiuk, I; Silver, DP; Wolgemuth, DJ; Akashi, K; Sicinski, P				Kalaszczynska, Ilona; Geng, Yan; Iino, Tadafumi; Mizuno, Shin-ichi; Choi, Yoon; Kondratiuk, Ilona; Silver, Daniel P.; Wolgemuth, Debra J.; Akashi, Koichi; Sicinski, Piotr			Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells	CELL			English	Article							DEPENDENT KINASES; C-MYC; EXPRESSION; PROGRESSION; GENE; MICE; MOUSE; PROLIFERATION; ACCUMULATION; PROGENITOR	Cyclins are regulatory subunits of cyclin-dependent kinases. Cyclin A, the first cyclin ever cloned, is thought to be an essential component of the cell-cycle engine. Mammalian cells encode two A-type cyclins, testis-specific cyclin A1 and ubiquitously expressed cyclin A2. Here, we tested the requirement for cyclin A function using conditional knockout mice lacking both A-type cyclins. We found that acute ablation of cyclin A in fibroblasts did not affect cell proliferation, but led to prolonged expression of another cyclin, cyclin E, across the cell cycle. However, combined ablation of all A- and E-type cyclins extinguished cell division. In contrast, cyclin A function was essential for cell-cycle progression of hematopoietic and embryonic stem cells. Expression of cyclin A is particularly high in these compartments, which might render stem cells dependent on cyclin A, whereas in fibroblasts cyclins A and E play redundant roles in cell proliferation.	[Kalaszczynska, Ilona; Geng, Yan; Choi, Yoon; Kondratiuk, Ilona; Sicinski, Piotr] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Iino, Tadafumi; Mizuno, Shin-ichi; Akashi, Koichi] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Silver, Daniel P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kalaszczynska, Ilona; Geng, Yan; Iino, Tadafumi; Mizuno, Shin-ichi; Choi, Yoon; Kondratiuk, Ilona; Akashi, Koichi; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Silver, Daniel P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wolgemuth, Debra J.] Columbia Univ, Ctr Med, Dept Genet & Dev, New York, NY 10032 USA; [Wolgemuth, Debra J.] Columbia Univ, Ctr Med, Dept Obstet & Gynecol, New York, NY 10032 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	peter_sicinski@dfci.harvard.edu	Silver, Daniel/P-3443-2019; Kalaszczynska, Ilona/AAG-4832-2021; Kondratiuk, Ilona/M-7078-2018	Kalaszczynska, Ilona/0000-0001-6698-1372; Kondratiuk, Ilona/0000-0002-7740-8923	National Institutes of Health [R01CA132740, R01CA108950, R01 HD34915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034915] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA132740, R01CA108950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Sicinski lab, R. Bronson, E. Sicinska, M. A. Ciemerych-Litwinienko, A. Minamishima, S. Kobayashi, and B. Will for help and advice, B. Clurman for anti-cyclin E1 antibody, and F. Liu for anti-phospho Smad3 antibodies. This work was supported by R01CA132740 and R01CA108950 grants from the National Institutes of Health (to P. S.) and R01 HD34915 (to D. J. W.). P. S. is a Scholar of The Leukemia and Lymphoma Society.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BARRETT JF, 1995, J BIOL CHEM, V270, P15923, DOI 10.1074/jbc.270.27.15923; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LI W, 2009, TRANSGENIC IN PRESS, DOI DOI 10.1007/S11248-009-9276-X; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nieduszynski CA, 2002, GENOME BIOL, V3; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Sweeney C, 1996, DEVELOPMENT, V122, P53; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; van der Meer T, 2004, REPRODUCTION, V127, P503, DOI 10.1530/rep.1.00131; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang JJ, 1997, J BIOL CHEM, V272, P3103, DOI 10.1074/jbc.272.5.3103; Yang R, 1997, CANCER RES, V57, P913; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G	48	156	159	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2009	138	2					352	365		10.1016/j.cell.2009.04.062	http://dx.doi.org/10.1016/j.cell.2009.04.062			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19592082	Green Accepted, Bronze			2022-12-28	WOS:000268277000016
J	Neuman, P; Cubanski, J				Neuman, Patricia; Cubanski, Juliette			Medicare Part D Update - Lessons Learned and Unfinished Business	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRESCRIPTION-DRUG BENEFIT; NATIONAL-SURVEY; COVERAGE; BENEFICIARIES; NONADHERENCE; SENIORS		[Neuman, Patricia; Cubanski, Juliette] Henry J Kaiser Family Fdn, Medicare Policy Project, Washington, DC USA		Neuman, P (corresponding author), Henry J Kaiser Family Fdn, Medicare Policy Project, Washington, DC USA.							Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; Altman DE, 2004, NEW ENGL J MED, V350, P9, DOI 10.1056/NEJMp038224; [Anonymous], 2007, 2007 ANN REP BOARDS; *AV HLTH, 2008, AV BEN TOP 10 PDPS F; BERNDT ER, 2007, SURV CURR BUS, V87, P59; *CTR MED MED SERV, 2009, 2009 ENR INF; *CTR MED MED SERV, 2008, THINGS THINK YOU COM; Cubanski J, 2007, HEALTH AFFAIR, V26, pW1, DOI 10.1377/hlthaff.26.1.w1; DANZON P, 2004, HLTH AFF MILLWOOD S; *DAT CTR MED MED S, 2004, PRESCR MED MOD MED D; DUGGAN M, 2008, 13917 NBER; Dulio A., 2007, VOICES BENEFICIARIES; *FAM US, 2007, NO BARG MED DRUG PLA; Frank RG, 2008, HEALTH AFFAIR, V27, P33, DOI 10.1377/hlthaff.27.1.33; GRUBER J, 2009, MEDICARE BENEFICIARI; HARGRAVE E, 2009, 091 MED PAYM ADV COM; HARGRAVE E, 2009, MEDICARE PRESCRIPTIO; HEATON E, 2006, ASSESSING MEDICARE P; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; HOADLEY J, 2008, MED PAY ADV COMM DEC; Hoadley J, 2008, MEDICARE D; Iglehart JK, 2004, NEW ENGL J MED, V350, P826, DOI 10.1056/NEJMhpr045002; Ketcham J. D., 2008, 14326 NBER; LEVY H, 2009, 14692 NBER; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Neuman P, 2007, HEALTH AFFAIR, V26, pW630, DOI 10.1377/hlthaff.26.5.w630; *OFF INSP GEN, 2009, PUBL OFF INSP GEN; PEAR R, 2003, NY TIMES        0607; Raebel MA, 2008, MED CARE, V46, P1116, DOI 10.1097/MLR.0b013e318185cddd; Regan JF, 2007, HEALTH CARE FINANC R, V29, P119; RICE T, 2008, ACADEMYHEALTH ANN RE; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Schneeweiss S, 2009, HEALTH AFFAIR, V28, pW305, DOI 10.1377/hlthaff.28.2.w305; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Summer L, 2008, MEDICARE D; The Boards of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2004, 2004 ANN REP BOARDS; The Boards of Trustees Federal Hospital Insurance and Federal Supplemetary Medical Insurance Trust Funds, 2008, 2008 ANN REP BOARDS; US House of Representatives. Committee on Oversight and Government Reform, 2008, MED D; WILL GF, 2008, WASHINGTON POST 0921, pB7; Yin W, 2008, ANN INTERN MED, V148, P169, DOI 10.7326/0003-4819-148-3-200802050-00200; Zhang Y, 2009, HEALTH AFFAIR, V28, pW317, DOI 10.1377/hlthaff.28.2.w317; 2008, NY TIMES        0902	44	37	37	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					406	414		10.1056/NEJMhpr0809949	http://dx.doi.org/10.1056/NEJMhpr0809949			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DC	19625722				2022-12-28	WOS:000268184500014
J	Buttiker, M				Buettiker, Markus			Edge-State Physics Without Magnetic Fields	SCIENCE			English	Editorial Material							HGTE QUANTUM-WELLS; BACKSCATTERING; CONTACTS; REGIME		Univ Geneva, Dept Theoret Phys, CH-1211 Geneva, Switzerland	University of Geneva	Buttiker, M (corresponding author), Univ Geneva, Dept Theoret Phys, 24 Quai E Ansermet, CH-1211 Geneva, Switzerland.	markus.buttiker@unige.ch						Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; ALPHENAAR BW, 1990, PHYS REV LETT, V64, P677, DOI 10.1103/PhysRevLett.64.677; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; KOMIYAMA S, 1989, PHYS REV B, V40, P12566, DOI 10.1103/PhysRevB.40.12566; Li J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136806; Martin I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036804; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; VANWEES BJ, 1989, PHYS REV LETT, V62, P1181, DOI 10.1093/annhyg/meq079	14	86	90	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					278	279		10.1126/science.1177157	http://dx.doi.org/10.1126/science.1177157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608906				2022-12-28	WOS:000268036600033
J	Ciotti, L				Ciotti, Luca			GALAXY FORMATION Anatomy of elliptical galaxies	NATURE			English	Editorial Material							BLACK-HOLES		Univ Bologna, Dept Astron, I-40127 Bologna, Italy	University of Bologna	Ciotti, L (corresponding author), Univ Bologna, Dept Astron, I-40127 Bologna, Italy.	luca.ciotti@unibo.it						Ciotti L, 2007, ASTROPHYS J, V665, P1038, DOI 10.1086/519833; Graham AW, 2003, ASTRON J, V125, P2951, DOI 10.1086/375320; Hopkins PF, 2009, ASTROPHYS J SUPPL S, V181, P486, DOI 10.1088/0067-0049/181/2/486; Kormendy J, 2009, ASTROPHYS J SUPPL S, V182, P216, DOI 10.1088/0067-0049/182/1/216; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Merritt D, 2006, REP PROG PHYS, V69, P2513, DOI 10.1088/0034-4885/69/9/R01; Naab T, 2007, ASTROPHYS J, V658, P710, DOI 10.1086/510841; Pellegrini S, 2005, MON NOT R ASTRON SOC, V364, P169, DOI 10.1111/j.1365-2966.2005.09549.x; TOOMRE A, 1977, EVOLUTION GALAXIES S, P401	10	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					333	334		10.1038/460333a	http://dx.doi.org/10.1038/460333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606134				2022-12-28	WOS:000267979000022
J	Li, JWH; Vederas, JC				Li, Jesse W. -H.; Vederas, John C.			Drug Discovery and Natural Products: End of an Era or an Endless Frontier?	SCIENCE			English	Review							LEADS; MICROBIOLOGY; METAGENOMICS; DIVERSITY; CHEMISTRY; BIOLOGY	Historically, the majority of new drugs have been generated from natural products (secondary metabolites) and from compounds derived from natural products. During the past 15 years, pharmaceutical industry research into natural products has declined, in part because of an emphasis on high-throughput screening of synthetic libraries. Currently there is substantial decline in new drug approvals and impending loss of patent protection for important medicines. However, untapped biological resources, "smart screening" methods, robotic separation with structural analysis, metabolic engineering, and synthetic biology offer exciting technologies for new natural product drug discovery. Advances in rapid genetic sequencing, coupled with manipulation of biosynthetic pathways, may provide a vast resource for the future discovery of pharmaceutical agents.	[Li, Jesse W. -H.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca		Vederas, John/0000-0002-2996-0326	Natural Sciences and Engineering Research Council of Canada; Canadian Research Chairs program; University of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Research Chairs program(Canada Research Chairs); University of Alberta(University of Alberta)	Supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Research Chairs program, and the University of Alberta.	Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Blow N, 2008, NATURE, V453, P687, DOI 10.1038/453687a; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Brautaset T, 2008, CHEM BIOL, V15, P1198, DOI 10.1016/j.chembiol.2008.08.009; *BRIST S COMP, 2004 GREEN SYNTH PAT; Brower V, 2008, J NATL CANCER I, V100, P838, DOI 10.1093/jnci/djn199; Bugni TS, 2008, J NAT PROD, V71, P1095, DOI 10.1021/np800184g; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Cooper LE, 2008, CHEM BIOL, V15, P1035, DOI 10.1016/j.chembiol.2008.07.020; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fischbach MA, 2007, P NATL ACAD SCI USA, V104, P11951, DOI 10.1073/pnas.0705348104; Garber K, 2005, NAT BIOTECHNOL, V23, P399, DOI 10.1038/nbt0405-399; Garneau S, 2002, BIOCHIMIE, V84, P577, DOI 10.1016/S0300-9084(02)01414-1; Hamilton GR, 2000, CAN J ANAESTH, V47, P367, DOI 10.1007/BF03020955; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Houlton S, 2009, CHEM WORLD-UK, V6, P12; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; JARVIS LM, 2009, CHEM ENG NEWS, V87, P5; Jayasuriya H, 2007, ANGEW CHEM INT EDIT, V46, P4684, DOI 10.1002/anie.200701058; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kennedy J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-27; Kirsop BE, 1996, J IND MICROBIOL BIOT, V17, P505, DOI 10.1007/BF01574782; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Lang G, 2008, J NAT PROD, V71, P1595, DOI 10.1021/np8002222; Lee SSJ, 2009, SCIENCE, V323, P342, DOI 10.1126/science.1165768; Lewinsohn E, 2009, PLANT SCI, V176, P161, DOI 10.1016/j.plantsci.2008.09.018; Malik NN, 2008, DRUG DISCOV TODAY, V13, P909, DOI 10.1016/j.drudis.2008.09.007; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Mulzer J, 2008, CR CHIM, V11, P1336, DOI 10.1016/j.crci.2008.02.005; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Olano C, 2008, METAB ENG, V10, P281, DOI 10.1016/j.ymben.2008.07.001; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P33, DOI 10.1073/pnas.0710424105; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Skropeta D, 2008, NAT PROD REP, V25, P1131, DOI 10.1039/b808743a; Stutzman-Engwall K, 2005, METAB ENG, V7, P27, DOI 10.1016/j.ymben.2004.07.003; Wase NV, 2008, EXPERT OPIN DRUG DIS, V3, P903, DOI 10.1517/17460441.3.8.903; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; WOLSING JM, 2008, DEFENSE COUNSEL  JUL, P209; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012	45	1389	1447	15	794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					161	165		10.1126/science.1168243	http://dx.doi.org/10.1126/science.1168243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589993				2022-12-28	WOS:000267802000035
J	Ernst, E				Ernst, Edzard			Chiropractic for paediatric conditions: substantial evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOPATHIC MANIPULATIVE TREATMENT; SPINAL MANIPULATION; ASTHMA; TRIAL		[Ernst, Edzard] Univ Exeter, Peninsula Med Sch, Exeter, Devon, England; [Ernst, Edzard] Univ Plymouth, Exeter, Devon, England	University of Exeter; University of Plymouth	Ernst, E (corresponding author), Univ Exeter, Peninsula Med Sch, Exeter, Devon, England.	Edzard.Ernst@pms.ac.uk						Balon J, 1998, NEW ENGL J MED, V339, P1013, DOI 10.1056/NEJM199810083391501; BLOMERTH PR, 1994, J MANIP PHYSIOL THER, V17, P335; Bockenhauer Susan E., 2002, Journal of the American Osteopathic Association, V102, P371; *BRIT CHIR ASS, 3 UPD BCA V SIM SING; Bronfort G, 2001, J MANIP PHYSIOL THER, V24, P369, DOI 10.1067/mmt.2001.116417; Brown R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2782; Browning M, 2008, CLIN CHIROPR, V11, P122, DOI DOI 10.1016/j.clch.2008.10.003; Ernst E, 2006, J ROY SOC MED, V99, P192, DOI 10.1258/jrsm.99.4.192; FALLON JM, 1997, CHIROPRACT PAEDIAT, V2, P167; Froehle R M, 1996, J Manipulative Physiol Ther, V19, P169; Glazener CMA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005230; Guiney PA, 2005, J AM OSTEOPATH ASSOC, V105, P7; Harris E, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2254; Hawk C, 2007, J ALTERN COMPLEM MED, V13, P491, DOI 10.1089/acm.2007.7088; Hayden Clive, 2006, Complement Ther Clin Pract, V12, P83, DOI 10.1016/j.ctcp.2005.12.005; HIPPERSON AJ, 2004, CLIN CHIROPR, V7, P180; Hondras MA, 2002, COCHRANE DB SYST REV, V4; HUSEREAU D, 2003, SPINAL MANIPULATION; KLOUGART N, 1989, J MANIP PHYSIOL THER, V12, P281; Leach RA, 2002, J MANIP PHYSIOL THER, V25, P58, DOI 10.1067/mmt.2002.120416; Lewis BJ, 2006, J ROY SOC MED, V99, P278, DOI 10.1258/jrsm.99.6.278; Mercer C, 1999, 5 BIENNIAL C WORLD F, P170; MILLER J, 2007, CLIN CHIROPR, V10, P139; Mills MV, 2003, ARCH PEDIAT ADOL MED, V157, P861, DOI 10.1001/archpedi.157.9.861; NIELSEN NH, 1995, CLIN EXP ALLERGY, V25, P80, DOI 10.1111/j.1365-2222.1995.tb01006.x; NILSSON N, 1985, EUR J CHIROPRACTIC, V33, P264; Olafsdottir E, 2001, ARCH DIS CHILD, V84, P138, DOI 10.1136/adc.84.2.138; REED WR, 1994, J MANIP PHYSIOL THER, V17, P596; SINGH S, 2008, GUARDIAN        0419; Wiberg JMM, 1999, J MANIP PHYSIOL THER, V22, P517, DOI 10.1016/S0161-4754(99)70003-5	30	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2009	339								b2766	10.1136/bmj.b2766	http://dx.doi.org/10.1136/bmj.b2766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469LA	19589818				2022-12-28	WOS:000267898500009
J	Laine, C				Laine, Christine			Annals: A Gathering Place for Internal Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AGE		Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Laine, C (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	claine@acponline.org		Wilson, Jennifer/0000-0003-4025-3136				Conway PH, 2009, NEW ENGL J MED, V361, P328, DOI 10.1056/NEJMp0905631; Huth EJ, 2002, ANN INTERN MED, V137, P34, DOI 10.7326/0003-4819-137-1-200207020-00010; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; Smith R, 2006, TROUBLE MED J, P33	5	11	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					509	510		10.7326/0003-4819-151-7-200910060-00012	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19581642				2022-12-28	WOS:000270470500008
J	Frank, RG; Zeckhauser, RJ				Frank, Richard G.; Zeckhauser, Richard J.			Health Care 2009: Health Insurance Exchanges -- Making the Markets Work.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHOICE		[Frank, Richard G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Zeckhauser, Richard J.] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Frank, Richard G.; Zeckhauser, Richard J.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; National Bureau of Economic Research	Frank, RG (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.							ABALUCK J., 2009, 14759 NBER; Frank RG, 2009, J ECON BEHAV ORGAN, V71, P550, DOI 10.1016/j.jebo.2009.04.005; Kunreuther H, 2002, MARKET LETT, V13, P259, DOI 10.1023/A:1020287225409; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Strombom BA, 2002, J HEALTH ECON, V21, P89, DOI 10.1016/S0167-6296(01)00124-2	5	15	15	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1135	1137		10.1056/NEJMp0906246	http://dx.doi.org/10.1056/NEJMp0906246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19625711				2022-12-28	WOS:000269828000004
J	Geurts, AM; Cost, GJ; Freyvert, Y; Zeitler, B; Miller, JC; Choi, VM; Jenkins, SS; Wood, A; Cui, XX; Meng, XD; Vincent, A; Lam, S; Michalkiewicz, M; Schilling, R; Foeckler, J; Kalloway, S; Weiler, H; Menoret, S; Anegon, I; Davis, GD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Jacob, HJ; Buelow, R				Geurts, Aron M.; Cost, Gregory J.; Freyvert, Yevgeniy; Zeitler, Bryan; Miller, Jeffrey C.; Choi, Vivian M.; Jenkins, Shirin S.; Wood, Adam; Cui, Xiaoxia; Meng, Xiangdong; Vincent, Anna; Lam, Stephen; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Foeckler, Jamie; Kalloway, Shawn; Weiler, Hartmut; Menoret, Severine; Anegon, Ignacio; Davis, Gregory D.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Jacob, Howard J.; Buelow, Roland			Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases	SCIENCE			English	Article							PROSPECTS; PROGRESS		[Geurts, Aron M.; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Weiler, Hartmut; Jacob, Howard J.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Geurts, Aron M.; Michalkiewicz, Mieczyslaw; Schilling, Rebecca; Weiler, Hartmut; Jacob, Howard J.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Cost, Gregory J.; Freyvert, Yevgeniy; Zeitler, Bryan; Miller, Jeffrey C.; Choi, Vivian M.; Jenkins, Shirin S.; Meng, Xiangdong; Vincent, Anna; Lam, Stephen; Foeckler, Jamie; Kalloway, Shawn; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [Wood, Adam; Cui, Xiaoxia; Davis, Gregory D.] Sigma Aldrich Biotechnol, St Louis, MO 63103 USA; [Menoret, Severine; Anegon, Ignacio] Univ Nantes, CHU Nantes, INSERM, UMR 643, F-44322 Nantes, France; [Jacob, Howard J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Buelow, Roland] Open Monoclonal Technol Inc, Palo Alto, CA 94303 USA	Medical College of Wisconsin; Medical College of Wisconsin; Sangamo Therapeutics, Inc.; Merck KGaA; MilliporeSigma; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Medical College of Wisconsin	Jacob, HJ (corresponding author), Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA.	jacob@mcw.edu; rbuelow@omtinc.net	Anegon, Ignacio/I-7498-2018; Anegon, Ignacio/I-7760-2018	Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653	NIH [5U01HL066579-08, 5P01HL082798-03]; Medical College of Wisconsin; Sigma-Aldrich; American Physiological Society Fellowship in Physiological Genomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066579, P01HL082798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin(General Electric); Sigma-Aldrich; American Physiological Society Fellowship in Physiological Genomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants 5U01HL066579-08 and 5P01HL082798-03, a sponsored research agreement between the Medical College of Wisconsin and Sigma-Aldrich, and the American Physiological Society Fellowship in Physiological Genomics to A.M.G. The authors are filing patents based on the results reported in this paper.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Klug A, 2005, P JPN ACAD B-PHYS, V81, P87, DOI 10.2183/pjab.81.87; Michalkiewicz M, 2007, AM J PHYSIOL-HEART C, V293, pH881, DOI 10.1152/ajpheart.00060.2007; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313	6	695	850	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					433	433		10.1126/science.1172447	http://dx.doi.org/10.1126/science.1172447			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628861	Green Accepted			2022-12-28	WOS:000268255100045
J	Erqou, S; Kaptoge, S; Perry, PL; Di Angelantonio, E; Thompson, A; White, IR; Marcovina, SM; Collins, R; Thompson, SG; Danesh, J				Erqou, Sebhat; Kaptoge, Stephen; Perry, Philip L.; Di Angelantonio, Emanuele; Thompson, Alexander; White, Ian R.; Marcovina, Santica M.; Collins, Rory; Thompson, Simon G.; Danesh, John		Emerging Risk Factors Collaboratio	Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NESTED CASE-CONTROL; ACUTE MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; ELEVATED LIPOPROTEIN(A); OXIDIZED PHOSPHOLIPIDS; PLASMA LIPOPROTEIN(A); REGRESSION DILUTION; LP(A) LIPOPROTEIN; RELATIVE RISK	Context Circulating concentration of lipoprotein(a) (Lp[a]), a large glycoprotein attached to a low-density lipoprotein-like particle, may be associated with risk of coronary heart disease (CHD) and stroke. Objective To assess the relationship of Lp(a) concentration with risk of major vascular and nonvascular outcomes. Study Selection Long-term prospective studies that recorded Lp(a) concentration and subsequent major vascular morbidity and/or cause-specific mortality published between January 1970 and March 2009 were identified through electronic searches of MEDLINE and other databases, manual searches of reference lists, and discussion with collaborators. Data Extraction Individual records were provided for each of 126 634 participants in 36 prospective studies. During 1.3 million person-years of follow-up, 22 076 first-ever fatal or nonfatal vascular disease outcomes or nonvascular deaths were recorded, including 9336 CHD outcomes, 1903 ischemic strokes, 338 hemorrhagic strokes, 751 unclassified strokes, 1091 other vascular deaths, 8114 nonvascular deaths, and 242 deaths of unknown cause. Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. Analyses excluded participants with known preexisting CHD or stroke at baseline. Data Synthesis Lipoprotein(a) concentration was weakly correlated with several conventional vascular risk factors and it was highly consistent within individuals over several years. Associations of Lp(a) with CHD risk were broadly continuous in shape. In the 24 cohort studies, the rates of CHD in the top and bottom thirds of baseline Lp(a) distributions, respectively, were 5.6 (95% confidence interval [CI], 5.4-5.9) per 1000 person-years and 4.4 (95% CI, 4.2-4.6) per 1000 person-years. The risk ratio for CHD, adjusted for age and sex only, was 1.16 (95% CI, 1.11-1.22) per 3.5-fold higher usual Lp(a) concentration (ie, per 1 SD), and it was 1.13 (95% CI, 1.09-1.18) following further adjustment for lipids and other conventional risk factors. The corresponding adjusted risk ratios were 1.10 (95% CI, 1.02-1.18) for ischemic stroke, 1.01 (95% CI, 0.981.05) for the aggregate of nonvascular mortality, 1.00 (95% CI, 0.97-1.04) for cancer deaths, and 1.00 (95% CI, 0.95-1.06) for nonvascular deaths other than cancer. Conclusion Under a wide range of circumstances, there are continuous, independent, and modest associations of Lp(a) concentration with risk of CHD and stroke that appear exclusive to vascular outcomes. JAMA. 2009;302(4):412-423	[Danesh, John] Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [White, Ian R.; Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Marcovina, Santica M.] Univ Washington, Seattle, WA 98195 USA; [Collins, Rory] Univ Oxford, Oxford, England	University of Cambridge; MRC Biostatistics Unit; University of Washington; University of Washington Seattle; University of Oxford	Danesh, J (corresponding author), Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Ulmer, Hanno/S-6615-2019; Davey Smith, George/A-7407-2013; vhmpp, aks/F-9756-2012; Gudnason, Vilmundur/K-6885-2015; Breteler, Monique M.B./J-5058-2014; Tikhonoff, Valerie/AAC-3728-2019; Lamarche, Benoit/ABA-4785-2021; de la Camara, Agustin Gomez/S-7123-2018; Meisinger, Christine/B-5358-2014; Tosetto, Alberto/AAM-3200-2020; Thompson, Alexander/A-6109-2010; Brunner, Eric/H-2114-2011; Sundström, Johan/A-6286-2009; Stefanadis, Christodoulos/ABH-2232-2020; PALMIERI, LUIGI/O-1845-2017; Dankner, Rachel/Q-5245-2019; DiAngelantonio, Emanuele/ABE-6852-2020; Marmot, Michael/Y-3920-2019; Ferrieres, Jean/S-7993-2016; donfrancesco, chiara/K-1460-2016	Ulmer, Hanno/0000-0001-5911-1002; Davey Smith, George/0000-0002-1407-8314; Gudnason, Vilmundur/0000-0001-5696-0084; Breteler, Monique M.B./0000-0002-0626-9305; Tikhonoff, Valerie/0000-0001-7846-0101; Lamarche, Benoit/0000-0002-4443-5378; Tosetto, Alberto/0000-0002-0119-5204; Brunner, Eric/0000-0002-0595-4474; Sundström, Johan/0000-0003-2247-8454; Stefanadis, Christodoulos/0000-0001-5974-6454; PALMIERI, LUIGI/0000-0002-4298-2642; Dankner, Rachel/0000-0001-6454-6000; Daniels, Lori/0000-0002-4841-9922; Sutherland, Susan/0000-0001-7184-8920; Di Angelantonio, Emanuele/0000-0001-8776-6719; s, hema/0000-0002-3440-9475; Koenig, Wolfgang/0000-0002-2064-9603; Chen, Zhengming/0000-0001-6423-105X; Wood, Angela/0000-0002-7937-304X; Marmot, Michael/0000-0002-2431-6419; Ferrieres, Jean/0000-0001-6144-1297; Nietert, Paul/0000-0002-3933-4986; Jespersen, Jorgen/0000-0002-3059-2356; Lawlor, Debbie A/0000-0002-6793-2262; Whincup, Peter/0000-0002-5589-4107; Woodward, Mark/0000-0001-9800-5296; Bladbjerg, Else Marie/0000-0003-0912-2437; Lochen, Maja-Lisa/0000-0002-8532-6573; Pennells, Lisa Anne/0000-0002-8594-3061; Jorgensen, Torben/0000-0001-9453-2830; Ramachandran, Vasan/0000-0001-7357-5970; He, Yao/0000-0001-6205-7895; Engstrom, Gunnar/0000-0002-8618-9152; donfrancesco, chiara/0000-0002-8040-5571; Rothenbacher, Dietrich/0000-0002-3563-2791; Wensley, Frances/0000-0003-4371-5340; Lewington, Sarah/0000-0002-4496-4771; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Morris, Richard/0000-0001-7240-4563; Amouyel, Philippe/0000-0001-9088-234X; Tverdal, Aage/0000-0002-2909-5678	British Heart Foundation [RG/08/014]; UK Medical Research Council; BUPA Foundation; GlaxoSmithKline; Merck Sharp and Dohme; Gates Cambridge Trust; Overseas Studentship Award; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U105260792, MC_U137686857, MC_U105260558, G0600705] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R03AG021162] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674, RG/08/014/24067] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U137686857, G0100222, G8802774, G0600705, G19/35, MC_U105260558, MC_U105260792] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp and Dohme(Merck & Company); Gates Cambridge Trust; Overseas Studentship Award; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ERFC Coordinating Centre is supported by a program grant from the British Heart Foundation (RG/08/014) and supported by grants from the UK Medical Research Council and the BUPA Foundation. Aspects of this work have been supported by unrestricted educational grants from GlaxoSmithKline and a grant from Merck Sharp and Dohme in relation to Lp(a). A variety of sources have supported recruitment, follow-up, and laboratory measurements in the 116 cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list naming some of these funding sources, available at http://www.phpc.cam.ac.uk/MEU/.Dr Erqou is supported by a Gates Cambridge Trust and Overseas Studentship Award. Drs Di Angelantonio and Thompson have been supported by UK Medical Research Council PhD studentships.	ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; [Anonymous], TREATMENT HDL REDUCE; Anuurad E, 2006, CLIN LAB MED, V26, P751, DOI 10.1016/j.cll.2006.07.002; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Barlera S, 2007, EUR J HUM GENET, V15, P221, DOI 10.1038/sj.ejhg.5201732; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berg K, 1997, CLIN GENET, V52, P254; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Boomsma D I, 2000, Twin Res, V3, P152, DOI 10.1375/136905200320565436; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; Braeckman L, 1996, EUR HEART J, V17, P1808; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; Craig WY, 1998, CLIN CHEM, V44, P2301; Cremer P, 1997, ATHEROSCLEROSIS, V129, P221, DOI 10.1016/S0021-9150(96)06030-3; D'Angelo A, 2006, HAEMATOLOGICA, V91, P1613; Dahlen G, 1988, Arctic Med Res, V47 Suppl 1, P458; DAHLEN G, 1972, ACTA MED SCAND, P1; Dahlen GH, 1998, J INTERN MED, V244, P425; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Dati F, 2004, CLIN CHEM LAB MED, V42, P670, DOI 10.1515/CCLM.2004.114; Downs JR, 1997, AM J CARDIOL, V80, P287, DOI 10.1016/S0002-9149(97)00347-0; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Evans RW, 2001, J CLIN EPIDEMIOL, V54, P51, DOI 10.1016/S0895-4356(00)00260-2; Gardner CD, 2000, AM J CARDIOL, V86, P299, DOI 10.1016/S0002-9149(00)00918-8; Gaw A, 2005, ATHEROSCLEROSIS, V180, P381, DOI 10.1016/j.atherosclerosis.2004.12.015; Gaw A, 2000, ATHEROSCLEROSIS, V148, P95, DOI 10.1016/S0021-9150(99)00259-2; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Ingelsson E, 2005, J AM COLL CARDIOL, V46, P2054, DOI 10.1016/j.jacc.2005.07.059; Insull W, 2004, ARCH INTERN MED, V164, P1121, DOI 10.1001/archinte.164.10.1121; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; KEIL JE, 1984, AM HEART J, V108, P779, DOI 10.1016/0002-8703(84)90671-9; Kiechl S, 2007, ARTERIOSCL THROM VAS, V27, P1788, DOI 10.1161/ATVBAHA.107.145805; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; KOSTNER GM, 1989, CIRCULATION, V80, P1313, DOI 10.1161/01.CIR.80.5.1313; Kostner Karam M, 2004, Semin Vasc Med, V4, P211, DOI 10.1055/s-2004-835380; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Lakka HM, 2000, ARCH INTERN MED, V160, P1160, DOI 10.1001/archinte.160.8.1160; Lubin F, 1998, NUTR CANCER, V30, P78, DOI 10.1080/01635589809514645; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; MAHER VMG, 1995, JAMA-J AM MED ASSOC, V274, P1771, DOI 10.1001/jama.274.22.1771; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Marcovina SM, 2000, CLIN CHEM, V46, P1956; Marcovina SM, 1998, AM J CARDIOL, V82, p57U, DOI 10.1016/S0002-9149(98)00954-0; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Merki E, 2008, CIRCULATION, V118, P743, DOI 10.1161/CIRCULATIONAHA.108.786822; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Nielsen LB, 1998, ARTERIOSCL THROM VAS, V18, P641, DOI 10.1161/01.ATV.18.4.641; Onat A, 2001, ATHEROSCLEROSIS, V156, P1, DOI 10.1016/S0021-9150(01)00500-7; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619, DOI 10.1161/01.ATV.20.12.2619; Pitsavos C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-32; Poon M, 1997, CIRCULATION, V96, P2514, DOI 10.1161/01.CIR.96.8.2514; Price JF, 2001, ATHEROSCLEROSIS, V157, P241, DOI 10.1016/S0021-9150(00)00719-X; Rajecki M, 2005, BLOOD COAGUL FIBRIN, V16, P119, DOI 10.1097/01.mbc.0000161565.74387.5b; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Shai I, 2005, EUR HEART J, V26, P1633, DOI 10.1093/eurheartj/ehi222; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Simons LA, 2002, AM J CARDIOL, V89, P69, DOI 10.1016/S0002-9149(01)02168-3; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; Tate JR, 1998, CLIN CHEM, V44, P1629; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Tsimikas S, 2007, ARTERIOSCL THROM VAS, V27, P2094, DOI 10.1161/01.atv.0000280571.28102.d4; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Wang WY, 2002, ANN EPIDEMIOL, V12, P107, DOI 10.1016/S1047-2797(01)00273-3; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x	101	1032	1085	5	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					412	423						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622820	Green Published, Green Accepted			2022-12-28	WOS:000268139200024
J	Assmann, M; Veit, F; Bayer, M; van der Poel, M; Hvam, JM				Assmann, M.; Veit, F.; Bayer, M.; van der Poel, M.; Hvam, J. M.			Higher-Order Photon Bunching in a Semiconductor Microcavity	SCIENCE			English	Article							COHERENT; LIGHT; INTERFEROMETRY	Quantum mechanically indistinguishable particles such as photons may show collective behavior. Therefore, an appropriate description of a light field must consider the properties of an assembly of photons instead of independent particles. We have studied multiphoton correlations up to fourth order in the single-mode emission of a semiconductor microcavity in the weak and strong coupling regimes. The counting statistics of single photons were recorded with picosecond time resolution, allowing quantitative measurement of the few-photon bunching inside light pulses. Our results show bunching behavior in the strong coupling case, which vanishes in the weak coupling regime as the cavity starts lasing. In particular, we verify the n factorial prediction for the zero-delay correlation function of n thermal light photons.	[Assmann, M.; Veit, F.; Bayer, M.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [van der Poel, M.; Hvam, J. M.] Tech Univ Denmark, DTU Foton, DK-2800 Kongens Lyngby, Denmark	Dortmund University of Technology; Technical University of Denmark	Bayer, M (corresponding author), Tech Univ Dortmund, D-44221 Dortmund, Germany.	manfred.bayer@tu-dortmund.de	Assmann, Marc/I-9754-2019; Bayer, Manfred/I-7947-2013; Hvam, Jørn M/I-2987-2016	Assmann, Marc/0000-0003-4953-1286; Hvam, Jørn M/0000-0002-2429-1012; Bayer, Manfred/0000-0002-0893-5949	Deutsche Forschungsgemeinschaft research group	Deutsche Forschungsgemeinschaft research group(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft research group "Quantum optics in semiconductor nanostructures." A patent application for the optical setup presented here is currently being filed.	AGARWAL GS, 1970, PHYS REV A-GEN PHYS, V1, P1445, DOI 10.1103/PhysRevA.1.1445; ARECCHI FT, 1966, PHYS LETT, V20, P27, DOI 10.1016/0031-9163(66)91034-1; Baym G, 1998, ACTA PHYS POL B, V29, P1839; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; FANO U, 1961, AM J PHYS, V29, P539, DOI 10.1119/1.1937827; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Jensen JR, 2000, APPL PHYS LETT, V76, P3262, DOI 10.1063/1.126601; Kasprzak J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067402; McAlister DF, 1997, PHYS REV A, V55, pR1609, DOI 10.1103/PhysRevA.55.R1609; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; MORGAN BL, 1966, PHYS REV LETT, V16, P1012, DOI 10.1103/PhysRevLett.16.1012; Savona V, 1996, PHYS REV B, V53, P13051, DOI 10.1103/PhysRevB.53.13051; Scarcelli G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063602; Schwendimann P, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085317; TITULAER UM, 1965, PHYS REV, V140, pB676, DOI 10.1103/PhysRev.140.B676; Ulrich SM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043906	16	88	88	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					297	300		10.1126/science.1174488	http://dx.doi.org/10.1126/science.1174488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608912				2022-12-28	WOS:000268036600039
J	Fordham, S; Lloyd, G				Fordham, Steve; Lloyd, Gavin			Practice Lesson of the Week Clinical management of injured patients with ankylosing spondylitis	BRITISH MEDICAL JOURNAL			English	Article							SPINE; COMPLICATIONS; PREVALENCE; FRACTURES		[Fordham, Steve; Lloyd, Gavin] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Lloyd, G (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	gavin.lloyd@rdeft.nhs.uk						American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Feldtkeller E, 2006, RHEUMATOL INT, V26, P234, DOI 10.1007/s00296-004-0556-8; FOX MW, 1993, J NEUROSURG, V78, P871, DOI 10.3171/jns.1993.78.6.0871; GRAHAM B, 1989, SPINE, V14, P803, DOI 10.1097/00007632-198908000-00005; Harrop JS, 2005, SPINE, V30, pE417, DOI 10.1097/01.brs.0000170594.45021.67; Maskery NSS, 2002, EMERG MED J, V19, P592, DOI 10.1136/emj.19.6.592; Papadopoulos MC, 1999, BRIT MED J, V319, P171, DOI 10.1136/bmj.319.7203.171; Thumbikat P, 2007, SPINE, V32, P2989, DOI 10.1097/BRS.0b013e31815cddfc	9	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 17	2009	339								b2568	10.1136/bmj.b2568	http://dx.doi.org/10.1136/bmj.b2568			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BY	19617263				2022-12-28	WOS:000268105300001
J	Bard, E; Rickaby, REM				Bard, Edouard; Rickaby, Rosalind E. M.			Migration of the subtropical front as a modulator of glacial climate	NATURE			English	Article							ATLANTIC OVERTURNING CIRCULATION; INDIAN-OCEAN; ORGANIC-MATTER; SOUTH ATLANTIC; RECORD; SEDIMENTS; MODEL; FLUCTUATIONS; TEMPERATURE; VARIABILITY	Ice cores extracted from the Antarctic ice sheet suggest that glacial conditions, and the relationship between isotopically derived temperatures and atmospheric p(CO2) have been constant over the last 800,000 years of the Late Pleistocene epoch(1). But independent lines of evidence, such as the extent of Northern Hemisphere ice sheets(2), sea level(3) and other temperature records(4), point towards a fluctuating severity of glacial periods, particularly during the more extreme glacial stadials centred around 340,000 and 420,000 years ago (marine isotope stages 10 and 12). Previously unidentified mechanisms therefore appear to have mediated the relationship between insolation, CO2 and climate. Here we test whether northward migration of the subtropical front (STF) off the southeastern coast of South Africa acts as a gatekeeper for the Agulhas current(5,6), which controls the transport of heat and salt from the Indo-Pacific Ocean to the Atlantic Ocean. Using a new 800,000-year record of sea surface temperature and ocean productivity from ocean sediment core MD962077, we demonstrate that during cold stadials (particularly marine isotope stages 10 and 12), productivity peaked and sea surface temperature was up to 6 degrees C cooler than modern temperatures. This suggests that during these cooler stadials, the STF moved northward by up to 76 latitude, nearly shutting off the Agulhas current. Our results, combined with faunal assemblages from the south Atlantic(7,8) show that variable northwards migration of the Southern Hemisphere STF can modulate the severity of each glacial period by altering the strength of the Agulhas current carrying heat and salt to the Atlantic meridional overturning circulation. We show hence that the degree of northwards migration of the STF can partially decouple global climate from atmospheric partial pressure of carbon dioxide, p(CO2), and help to resolve the long-standing puzzle of differing glacial amplitudes within a consistent range of atmospheric p(CO2).	[Bard, Edouard] Univ Paul Cezanne Aix Marseille, CNRS, IRD, Coll France,CEREGE,UMR 6635, F-13545 Aix En Provence 4, France; [Rickaby, Rosalind E. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Oxford	Bard, E (corresponding author), Univ Paul Cezanne Aix Marseille, CNRS, IRD, Coll France,CEREGE,UMR 6635, Europole Arbois BP 80, F-13545 Aix En Provence 4, France.	bard@cerege.fr; rosr@earth.ox.ac.uk	Bard, Edouard/G-7717-2014	Rickaby, Rosalind/0000-0002-6095-8419	Gary Comer Foundation; CNRS; College de France	Gary Comer Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); College de France	We thank D. P. Schrag and E. Goddard for their help with analyses in the early stages of this work. We thank C. Sonzogni, F. Rostek, N. Thouveny and J. Carignan for help with analyses and age model, and D. Sansom for help with the figures. We also thank H. Gildor, Y. Ashkenazy, R. Toggweiler, M. Meredith, M.-F. Loutre, P. Huybers and N. Edwards for comments and discussion on an earlier version of this manuscript. R. E. M. R. is grateful to the Royal Society for the International Outgoing Visit award for the exchange visits to CEREGE, which facilitated the development of the ideas and the manuscript. Palaeoclimate work at CEREGE is supported by grants from the Gary Comer Foundation, the CNRS and the College de France. Core MD962077 was collected by the RV Marion Dufresne supported by the Institut Polaire Francais (IPEV).	Ashkenazy Y, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001436; Bard E, 2001, PALEOCEANOGRAPHY, V16, P235, DOI 10.1029/2000PA000537; BE AWH, 1976, SCIENCE, V194, P419, DOI 10.1126/science.194.4263.419; Berger A, 2006, CLIM PAST, V2, P131, DOI 10.5194/cp-2-131-2006; Berger WH, 1996, SOUTH ATLANTIC, P363; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Conte MH, 1998, GEOCHIM COSMOCHIM AC, V62, P51, DOI 10.1016/S0016-7037(97)00327-X; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Howard WR, 1992, PALEOCEANOGRAPHY, V7, P79, DOI 10.1029/91PA02994; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; KUHLBRODT K, 2004, REV GEOPHYS, V45, pG2001; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125; MASSONDELMOTTE V, QUAT SCI RE IN PRESS; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001604; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Pailler D, 2002, GEOCHIM COSMOCHIM AC, V66, P849, DOI 10.1016/S0016-7037(01)00817-1; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rau A, 2006, QUATERN INT, V148, P65, DOI 10.1016/j.quaint.2005.11.007; Raymo ME, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000921; Rickaby REM, 2007, EARTH PLANET SC LETT, V253, P83, DOI 10.1016/j.epsl.2006.10.016; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rojas M, 2009, CLIM DYNAM, V32, P525, DOI 10.1007/s00382-008-0421-7; Rosell-Mele A, 2001, GEOCHEM GEOPHY GEOSY, V2; ROSENTHAL Y, 1995, PALEOCEANOGRAPHY, V10, P395, DOI 10.1029/95PA00310; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; Schmittner A, 2002, SCIENCE, V295, P1489, DOI 10.1126/science.1066174; Schulte S, 2003, QUATERNARY SCI REV, V22, P1757, DOI 10.1016/S0277-3791(03)00172-0; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; SIJP WP, J CLIM IN PRESS; Sonzogni C, 1997, DEEP-SEA RES PT II, V44, P1445, DOI 10.1016/S0967-0645(97)00010-6; Stoll HM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000015; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taylor S.R., 1985, CONTINENTAL CRUST IT; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Williams GP, 2006, J CLIMATE, V19, P1706, DOI 10.1175/JCLI3766.1; Zheng Y, 2002, GEOCHIM COSMOCHIM AC, V66, P1759, DOI 10.1016/S0016-7037(01)00886-9; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8	47	158	164	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					380	U93		10.1038/nature08189	http://dx.doi.org/10.1038/nature08189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606147				2022-12-28	WOS:000267979000035
J	Brumfiel, G				Brumfiel, Geoff			Arms pact could boost US-Russian science	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					316	316		10.1038/460316a	http://dx.doi.org/10.1038/460316a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606114	Bronze			2022-12-28	WOS:000267979000009
J	Li, F; Tsien, JZ				Li, Fei; Tsien, Joe Z.			Memory and the NMDA Receptors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Li, Fei] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China	University System of Georgia; Augusta University; Shanghai Jiao Tong University	Li, F (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.				NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034663-01, R01 AG034663] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Jiang HQ, 2009, NEUROSCI LETT, V450, P356, DOI 10.1016/j.neulet.2008.10.075; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Tsien JZ, 2000, SCI AM, V282, P62, DOI 10.1038/scientificamerican0400-62	5	213	224	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					302	303		10.1056/NEJMcibr0902052	http://dx.doi.org/10.1056/NEJMcibr0902052			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605837	Green Accepted			2022-12-28	WOS:000267976100015
J	Clarke-Pearson, DL				Clarke-Pearson, Daniel L.			Screening for Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSVAGINAL SONOGRAPHY; ASYMPTOMATIC WOMEN; PELVIC MASSES; TUMOR-MARKERS; COLOR DOPPLER; GRAY-SCALE; HIGH-RISK; ULTRASOUND; EFFICACY; ALGORITHM	A 56-year-old woman presents to her physician, requesting screening for ovarian cancer. She reports the recent death of a friend from ovarian cancer at the age of 65 years. The patient has no family history of ovarian or breast cancer. The physical examination, including pelvic and rectal examination, is normal. Should the physician recommend screening for ovarian cancer?	Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Clarke-Pearson, DL (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Old Clin Rm 3009,CB 7570, Chapel Hill, NC 27599 USA.	danielcp@med.unc.edu						American Cancer Society, DET GUID OV CANC CAN; [Anonymous], 2002, GYNECOL ONCOL, V87, P237, DOI 10.1006/gyno.2002.6865; Bast RC, 2005, INT J GYNECOL CANCER, V15, P274, DOI 10.1111/j.1525-1438.2005.00441.x; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BOURNE TH, 1993, BRIT MED J, V306, P1025, DOI 10.1136/bmj.306.6884.1025; CAMPBELL S, 1989, BMJ-BRIT MED J, V299, P1363, DOI 10.1136/bmj.299.6712.1363; CARTER JR, 1995, AM J OBSTET GYNECOL, V172, P901, DOI 10.1016/0002-9378(95)90019-5; DEPRIEST PD, 1994, GYNECOL ONCOL, V55, P174, DOI 10.1006/gyno.1994.1273; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Fishman DA, 2005, AM J OBSTET GYNECOL, V192, P1214, DOI 10.1016/j.ajog.2005.01.041; FLEISCHER AC, 1993, J ULTRAS MED, V12, P705, DOI 10.7863/jum.1993.12.12.705; Gaarenstroom KN, 2006, INT J GYNECOL CANCER, V16, P54, DOI 10.1111/j.1525-1438.2006.00480.x; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; Hayashi H, 1999, GYNECOL OBSTET INVES, V47, P58, DOI 10.1159/000010063; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hogg R, 2004, J CLIN ONCOL, V22, P1315, DOI 10.1200/JCO.2004.07.179; JACOBS I, 1989, HUM REPROD, V4, P1; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Mol BWJ, 2001, GYNECOL ONCOL, V80, P162, DOI 10.1006/gyno.2000.6052; National Comprehensive Cancer Network, NAT COMPR CANC NETW; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Olivier RI, 2006, GYNECOL ONCOL, V100, P20, DOI 10.1016/j.ygyno.2005.08.038; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; SASSONE AM, 1991, OBSTET GYNECOL, V78, P70; Sato S, 2000, CANCER, V89, P582, DOI 10.1002/1097-0142(20000801)89:3<582::AID-CNCR13>3.0.CO;2-#; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; SKATES SJ, 1995, CANCER, V76, P2004, DOI 10.1002/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; STEIN SM, 1995, AM J ROENTGENOL, V164, P381, DOI 10.2214/ajr.164.2.7839975; Tabor A, 1994, J Med Screen, V1, P215; U.S. Preventive Services Task Force, 2005, Am Fam Physician, V71, P759; Valentin L, 1999, ULTRASOUND OBST GYN, V14, P338, DOI 10.1046/j.1469-0705.1999.14050338.x; van der Velde NM, 2009, INT J CANCER, V124, P919, DOI 10.1002/ijc.24038; van Nagell JR, 2007, CANCER-AM CANCER SOC, V109, P1887, DOI 10.1002/cncr.22594; van Nagell JR, 2000, GYNECOL ONCOL, V77, P350, DOI 10.1006/gyno.2000.5816; Visintin I, 2008, CLIN CANCER RES, V14, P7158, DOI 10.1158/1078-0432.CCR-14-21-COR; VISINTIN I, 2008, CLIN CANC RES, V14, P5308; WHITTEMORE AS, 1994, GYNECOL ONCOL, V55, pS15, DOI 10.1006/gyno.1994.1334; Wilson JMG, 1968, PRINCIPLES PRACTICE; WOOLAS RP, 1993, JNCI-J NATL CANCER I, V85, P1748, DOI 10.1093/jnci/85.21.1748; Zhang Z, 2007, GYNECOL ONCOL, V107, P526, DOI 10.1016/j.ygyno.2007.08.009	47	249	270	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					170	177		10.1056/NEJMcp0901926	http://dx.doi.org/10.1056/NEJMcp0901926			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587342				2022-12-28	WOS:000267748900010
J	Hartung, T				Hartung, Thomas			Toxicology for the twenty-first century	NATURE			English	Article							SKIN IRRITATION; FOOD; TOXICITY; THOUGHT; FUTURE; SAFETY; RISK; PREVALENCE; REVOLUTION; EVOLUTION		[Hartung, Thomas] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Hartung, Thomas] Johns Hopkins Ctr Alternat Anim Testing, Baltimore, MD USA; [Hartung, Thomas] Univ Konstanz, D-7750 Constance, Germany	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Konstanz	Hartung, T (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	thartung@jhsph.edu						Austin PC, 2006, J CLIN EPIDEMIOL, V59, P964, DOI 10.1016/j.jclinepi.2006.01.012; Basketter DA, 2004, CONTACT DERMATITIS, V51, P1, DOI 10.1111/j.0105-1873.2004.00385.x; BOTTINI AA, 2008, ALTEX, V26, P3; Bremer S, 2007, CURR PHARM DESIGN, V13, P3047, DOI 10.2174/138161207782110462; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Committee on Toxicity Testing and Assessment of Environmental Agents N. R. C., 2007, TOX TEST 21 CENT VIS; Davila JC, 2004, TOXICOL SCI, V79, P214, DOI 10.1093/toxsci/kfh100; Gottmann E, 2001, ENVIRON HEALTH PERSP, V109, P509, DOI 10.2307/3454710; Hansson SO, 2006, TOXICOLOGY, V218, P100, DOI 10.1016/j.tox.2005.10.003; Hareng L, 2005, REPROD TOXICOL, V20, P441, DOI 10.1016/j.reprotox.2005.04.003; Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P147; Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P91; Hartung T, 2008, ALTEX-ALTERN TIEREXP, V25, P3; Hartung T, 2007, ALTEX-ALTERN TIEREXP, V24, P143; Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059; Hartung T, 2008, ATLA-ALTERN LAB ANIM, V36, P635, DOI 10.1177/026119290803600607; Hofer T, 2004, ARCH TOXICOL, V78, P549, DOI 10.1007/s00204-004-0577-9; Hoffmann S, 2006, HUM EXP TOXICOL, V25, P497, DOI 10.1191/0960327106het648oa; Hoffmann S, 2005, TOXICOL SCI, V85, P422, DOI 10.1093/toxsci/kfi099; Hoffmann S, 2005, REGUL TOXICOL PHARM, V41, P159, DOI 10.1016/j.yrtph.2004.11.003; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P103; Lotti M, 2002, NATURE, V416, P481, DOI 10.1038/416481a; MacGregor JT, 2003, TOXICOL SCI, V75, P236, DOI 10.1093/toxsci/kfg197; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Orrenius S, 2006, CHEM RES TOXICOL, V19, P729, DOI 10.1021/tx0600651; Pognan F, 2004, PHARMACOGENOMICS, V5, P879, DOI 10.1517/14622416.5.7.879; Purchase IFH, 2004, TOXICOLOGY, V202, P1, DOI 10.1016/j.tox.2004.06.029; Rietjens IMCM, 2006, CHEM RES TOXICOL, V19, P977, DOI 10.1021/tx0601051; SCHARDEIN JL, 1985, ENVIRON HEALTH PERSP, V61, P55, DOI 10.2307/3430062; Service RF, 2008, SCIENCE, V321, P1036, DOI 10.1126/science.321.5892.1036; Stevens JL, 2006, CHEM RES TOXICOL, V19, P1393, DOI 10.1021/tx060213n; Stummann TC, 2008, CURR STEM CELL RES T, V3, P117, DOI 10.2174/157488808784223104; Taylor K, 2008, ATLA-ALTERN LAB ANIM, V36, P327, DOI 10.1177/026119290803600310; Wandall B, 2007, ARCH TOXICOL, V81, P605, DOI 10.1007/s00204-007-0194-5; Wood M, 2006, J HAZARD MATER, V133, P8, DOI 10.1016/j.jhazmat.2005.07.089	38	398	421	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					208	212		10.1038/460208a	http://dx.doi.org/10.1038/460208a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587762				2022-12-28	WOS:000267761000031
J	Hauser, MD				Hauser, Marc D.			The possibility of impossible cultures	NATURE			English	Article							GRAMMAR; EVOLUTION; LINGUISTICS; LANGUAGE		[Hauser, Marc D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Hauser, Marc D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hauser, Marc D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh102559@gmail.com			US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	I dedicate this paper to Noam Chomsky and Peter Marler for their insights into the many problems discussed here, as well as their friendship and advice over several years. For support during the writing of this article, and for research funds, I thank Harvard University's Mind/Brain/Behavior Interfaculty Initiative, J. Epstein, S. Shuman and the US National Science Foundation (Human & Social Dynamics priority area). For comments and discussion on drafts, I thank A. Abzhanov, A. Bejan, C. Boeckx, N. Chomsky, D. Dennett, B. Huebner, R. Jackendoff, N. Kanwisher, M. Kinsbourne, M. Kirschner, J. Junge, F. Lerdahl, G. McGhee, D. Roy, G. Striedter and F. Tsao.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Barner D, 2008, COGNITION, V107, P603, DOI 10.1016/j.cognition.2007.11.010; BARYOSEF O, 2005, J ISRAEL PREHIST SOC, V35, P467; Boeckx C, 2005, LINGUIST REV, V22, P447, DOI 10.1515/tlir.2005.22.2-4.447; CALL J, 2004, GESTURAL COMMUNICATI; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cases I, 2002, ENVIRON MICROBIOL, V4, P623, DOI 10.1046/j.1462-2920.2002.00346.x; Changeux JP, 1985, NEURONAL MAN; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Cheney DL., 2008, BABOON METAPHYSICS; Chomsky N., 2000, NATURE LANGUAGE; Chomsky N, 1980, RULES REPRESENTATION; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deacon T., 1997, SYMBOLIC SPECIES; Dehaene S., 2005, MONKEY BRAIN HUMAN B, P133; Dwyer S., 1999, PHILOS LINGUISTICS, P169; EDELMAN G, 1990, NEURAL DARWINISM; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Gallistel C. R., 1990, ORG LEARNING; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Grant P.R., 2007, WHY SPECIES MULTIPLY; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Harman G, 1999, PROCEEDINGS OF THE TWENTIETH WORLD CONGRESS OF PHILOSOPHY, VOL 1, P107; Hauser M., 2006, MORAL MINDS; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2000, WILD MINDS; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; JACKENDOFF R, 2000, FDN LANGUAGE; JACKENDOFF R, 2008, LANGUAGE CONSCIOUSNE; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Jacob Francois, 1976, LOGIC LIFE; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; Kelemen D, 1999, TRENDS COGN SCI, V3, P461, DOI 10.1016/S1364-6613(99)01402-3; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Klein R., 2002, DAWN HUMAN CULTURE; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; LAHIRI A, 2008, UNIVERSALS LANG, P31; Lerdahl F., 1992, CONTEMP MUSIC REV, V6, P97, DOI [10.1080/07494469200640161, DOI 10.1080/07494469200640161]; Lerdahl F., 2001, TONAL PITCH SPACE; Lerdahl Fred, 1983, GENERATIVE THEORY TO; Lightfoot DW, 2002, LANGUAGE ORGAN; Marler Peter, 1992, Seminars in the Neurosciences, V4, P415, DOI 10.1016/1044-5765(92)90050-C; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McGhee GR, 1999, PERS PALEOB; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mithen S., 1996, PREHISTORY MIND; Monod J., 1974, CHANCE NECESSITY; Moro A., 2008, BOUNDARIES BABEL; Nettl Bruno, 2005, STUDY ETHNOMUSICOLOG; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nisbett Richard E., 2004, GEOGRAPHY THOUGHT; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Pinker S., 1997, MIND WORKS; Pinker Steven, 1994, LANGUAGE INSTINCT; Premack D, 2007, P NATL ACAD SCI USA, V104, P13861, DOI 10.1073/pnas.0706147104; Raup D. M., 1967, Journal of Paleontology, V41, P43; Rawls J., 2001, UTILITARISM; Ristau C.A., 1991, P91; Rozin P, 2000, AM BEHAV SCI, V43, P970, DOI 10.1177/0002764200043006006; Savage-Rumbaugh E S, 1993, Monogr Soc Res Child Dev, V58, P1; Shettleworth, 2010, COGNITION EVOLUTION; Shweder R. A., 2003, WHY DO MEN BARBECUE; Striedter G. F., 2005, PRINCIPLES BRAIN EVO; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Thomas RDK, 2000, SCIENCE, V288, P1239, DOI 10.1126/science.288.5469.1239; Thompson SP, 2007, LANG LEARN DEV, V3, P1, DOI 10.1080/15475440709336999; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Tomasello M, 1997, PRIMATE COGNITION; Tomasello M., 2003, CONSTRUCTING LANGUAG; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	80	47	50	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					190	196		10.1038/460190a	http://dx.doi.org/10.1038/460190a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587759				2022-12-28	WOS:000267761000028
J	Gordon, JRS; Wahls, T; Carlos, RC; Pipinos, II; Rosenthal, GE; Cram, P				Gordon, Jennifer R. S.; Wahls, Terry; Carlos, Ruth C.; Pipinos, Iraklis I.; Rosenthal, Gary E.; Cram, Peter			Failure to Recognize Newly Identified Aortic Dilations in a Health Care System With an Advanced Electronic Medical Record	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT SAFETY; ANEURYSMS; DOCUMENTATION; NOTIFICATION; REPAIR	Background: Concern is growing about missed test results, but data assessing their effect on patient safety are limited. Objective: To examine the frequency with which computed tomography (CT)-documented dilations of the abdominal aorta are accompanied by evidence in the electronic medical record (EMR) that a clinician recognized the abnormality. Design: Retrospective cohort study. Setting: 2 hospitals in the Veterans Affairs Health Care System. Patients: Patients with new dilations of the abdominal aorta detected on CT performed in 2003. Measurements: Radiology report and EMR evidence that the radiologist notified the clinical service, aneurysm size, and interval between CT and EMR recognition. Results: Computed tomography scans of 4112 patients were reviewed and 440 (11%) aortic dilations were identified, of which 91 were new findings. Radiologists directly notified clinical teams about 5 (5%) new dilations. Clinical teams did not record in the EMR recognition of 53 of 91 (58%) dilations within 3 months of the CT, and 9% of these dilations were 5.5 cm or larger. The median time to recognition of aneurysm in the EMR was 237 days, and no EMR documentation existed for 16 abnormalities (29% of surviving patients) during a mean follow-up of 3.2 years. No evidence indicated that any of the aneurysms ruptured or that patient deaths resulted from the delayed follow-up. Limitation: Clinicians may have recognized some aneurysms but did not document them in the EMR. Conclusion: Clinicians neglect to note a substantial proportion of new aortic dilations in the EMR. The findings highlight the need for better strategies to ensure documentation of follow-up of tests. Primary Funding Source: National Institutes of Health.	[Cram, Peter] Univ Iowa, Carver Coll Med, Div Gen Med, Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Michigan, Coll Med, Ann Arbor, MI 48109 USA; Univ Nebraska Med Ctr, Omaha, NE USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center	Cram, P (corresponding author), Univ Iowa, Carver Coll Med, Div Gen Med, Iowa City Vet Affairs Med Ctr, Mail Stop 152, Iowa City, IA 52242 USA.	peter-cram@uiowa.edu	Cram, Peter/K-4472-2014	Cram, Peter/0000-0002-1910-346X; Pipinos, Iraklis/0000-0001-6873-6346; Wahls, Terry/0000-0001-6059-7994	NATIONAL CANCER INSTITUTE [K07CA108664] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033035] Funding Source: NIH RePORTER; NCI NIH HHS [CA108664] Funding Source: Medline; NCRR NIH HHS [RR01997201] Funding Source: Medline; NHLBI NIH HHS [1 K08 HL079967-01] Funding Source: Medline; NIA NIH HHS [R01 AG033035] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baig N, 2003, AM J GASTROENTEROL, V98, P2078, DOI 10.1016/S0002-9270(03)00424-6; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Carroll AE, 2003, PEDIATRICS, V111, P976, DOI 10.1542/peds.111.5.976; Choksi VR, 2006, AM J ROENTGENOL, V186, P933, DOI 10.2214/AJR.04.1913; Cram P, 2005, JT COMM J QUAL PATIE, V31, P90, DOI 10.1016/S1553-7250(05)31013-0; Fernando KJ, 2001, BRIT J SURG, V88, P309, DOI 10.1046/j.1365-2168.2001.01666.x; Holohan TV, 2005, SOUTH MED J, V98, P1083, DOI 10.1097/01.smj.0000170729.51651.f7; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Katz HP, 2008, J GEN INTERN MED, V23, P517, DOI 10.1007/s11606-007-0491-y; Kohn LT., 2000, ERR IS HUMAN BUILDIN, P245; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Nepple KG, 2008, MAYO CLIN PROC, V83, P439, DOI 10.4065/83.4.439; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Schiff GD, 2000, AM J MED, V109, P494, DOI 10.1016/S0002-9343(00)00546-5; Schiff GD, 2005, ARCH INTERN MED, V165, P574, DOI 10.1001/archinte.165.5.574; Singh H, 2007, J AM MED INFORM ASSN, V14, P459, DOI 10.1197/jamia.M2280; Szalados JE, 2007, CRIT CARE MED, V35, pS44, DOI 10.1097/01.CCM.0000252921.55611.36; WACHTER RM, 2008, WACHTERS WORLD; Wanhainen A, 2008, SCAND J SURG, V97, P105, DOI 10.1177/145749690809700204	22	34	34	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					21	U35		10.7326/0003-4819-151-1-200907070-00005	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19581643				2022-12-28	WOS:000267946100003
J	Ringstad, N; Abe, N; Horvitz, HR				Ringstad, Niels; Abe, Namiko; Horvitz, H. Robert			Ligand-Gated Chloride Channels Are Receptors for Biogenic Amines in C-elegans	SCIENCE			English	Article							ION CHANNELS; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; IDENTIFICATION; SUPERFAMILY; MEMBRANE; SYNAPSE	Biogenic amines such as serotonin and dopamine are intercellular signaling molecules that function widely as neurotransmitters and neuromodulators. We have identified in the nematode Caenorhabditis elegans three ligand-gated chloride channels that are receptors for biogenic amines: LGC-53 is a high-affinity dopamine receptor, LGC-55 is a high-affinity tyramine receptor, and LGC-40 is a low-affinity serotonin receptor that is also gated by choline and acetylcholine. lgc-55 mutants are defective in a behavior that requires endogenous tyramine, which indicates that this ionotropic tyramine receptor functions in tyramine signaling in vivo. Our studies suggest that direct activation of membrane chloride conductances is a general mechanism of action for biogenic amines in the modulation of C. elegans behavior.	[Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NIH [GM24663]; Howard Hughes Medical Institute; Life Sciences Research Foundation; The Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Life Sciences Research Foundation; The Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM24663. N.R. received support from the Howard Hughes Medical Institute, the Life Sciences Research Foundation and The Medical Foundation. H.R.H. is an Investigator of the Howard Hughes Medical Institute.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529; Cooper J., 2003, BIOCH BASIS NEUROPHA; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Green KA, 1997, PFLUG ARCH EUR J PHY, V434, P313, DOI 10.1007/s004240050402; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Magoski NS, 1999, J NEUROPHYSIOL, V81, P1330, DOI 10.1152/jn.1999.81.3.1330; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; TECOTT LH, 2003, COMPREHENSIVE TXB PS, P49; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	21	75	79	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					96	100		10.1126/science.1169243	http://dx.doi.org/10.1126/science.1169243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574391	Green Submitted, Green Accepted			2022-12-28	WOS:000267594000044
J	Smith, PH; Tamppari, LK; Arvidson, RE; Bass, D; Blaney, D; Boynton, WV; Carswell, A; Catling, DC; Clark, BC; Duck, T; DeJong, E; Fisher, D; Goetz, W; Gunnlaugsson, HP; Hecht, MH; Hipkin, V; Hoffman, J; Hviid, SF; Keller, HU; Kounaves, SP; Lange, CF; Lemmon, MT; Madsen, MB; Markiewicz, WJ; Marshall, J; Mckay, CP; Mellon, MT; Ming, DW; Morris, RV; Pike, WT; Renno, N; Staufer, U; Stoker, C; Taylor, P; Whiteway, JA; Zent, AP				Smith, P. H.; Tamppari, L. K.; Arvidson, R. E.; Bass, D.; Blaney, D.; Boynton, W. V.; Carswell, A.; Catling, D. C.; Clark, B. C.; Duck, T.; DeJong, E.; Fisher, D.; Goetz, W.; Gunnlaugsson, H. P.; Hecht, M. H.; Hipkin, V.; Hoffman, J.; Hviid, S. F.; Keller, H. U.; Kounaves, S. P.; Lange, C. F.; Lemmon, M. T.; Madsen, M. B.; Markiewicz, W. J.; Marshall, J.; Mckay, C. P.; Mellon, M. T.; Ming, D. W.; Morris, R. V.; Pike, W. T.; Renno, N.; Staufer, U.; Stoker, C.; Taylor, P.; Whiteway, J. A.; Zent, A. P.			H2O at the Phoenix Landing Site	SCIENCE			English	Article							MARS; ICE; DIFFUSION; BEHAVIOR	The Phoenix mission investigated patterned ground and weather in the northern arctic region of Mars for 5 months starting 25 May 2008 (solar longitude between 76.5 degrees and 148 degrees). A shallow ice table was uncovered by the robotic arm in the center and edge of a nearby polygon at depths of 5 to 18 centimeters. In late summer, snowfall and frost blanketed the surface at night; H2O ice and vapor constantly interacted with the soil. The soil was alkaline (pH = 7.7) and contained CaCO3, aqueous minerals, and salts up to several weight percent in the indurated surface soil. Their formation likely required the presence of water.	[Smith, P. H.; Boynton, W. V.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Tamppari, L. K.; Bass, D.; Blaney, D.; DeJong, E.; Hecht, M. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Arvidson, R. E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Carswell, A.] Optech Inc, Vaughan, ON L4K 5Z8, Canada; [Catling, D. C.] Univ Bristol, Bristol BS8 1RJ, Avon, England; [Catling, D. C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Duck, T.] Dalhousie Univ, Halifax, NS B3H 1Z9, Canada; [Fisher, D.] Geol Survey Canada, Ottawa, ON K1A 0E8, Canada; [Fisher, D.] Univ Ottawa, Ottawa, ON K1A 0E8, Canada; [Goetz, W.; Hviid, S. F.; Keller, H. U.; Markiewicz, W. J.] Max Planck Inst Solar Syst Res, D-31791 Katlenburg Lindau, Germany; [Gunnlaugsson, H. P.] Univ Aarhus, Inst Phys & Astron, DK-8000 Aarhus C, Denmark; [Hipkin, V.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Hoffman, J.] Univ Texas Dallas, Richardson, TX 75080 USA; [Kounaves, S. P.] Tufts Univ, Medford, MA 02155 USA; [Lange, C. F.] Univ Alberta, Edmonton, AB T6G 2H1, Canada; [Lemmon, M. T.] Texas A&M Univ, College Stn, TX 77843 USA; [Madsen, M. B.] Univ Copenhagen, DK-2100 Copenhagen, Denmark; [Marshall, J.] SETI Inst, Mountain View, CA 94043 USA; [Mckay, C. P.; Stoker, C.; Zent, A. P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Mellon, M. T.] Univ Colorado, Boulder, CO 80309 USA; [Ming, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Pike, W. T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Renno, N.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Staufer, U.] Univ Neuchatel, Inst Microtechnol, CH-2002 Neuchatel, Switzerland; [Staufer, U.] Delft Univ Technol, Micro & Nano Engn Lab, NL-2628 CD Delft, Netherlands; [Taylor, P.; Whiteway, J. A.] York Univ, Toronto, ON M3J 1P3, Canada	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Washington University (WUSTL); University of Bristol; University of Washington; University of Washington Seattle; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Ottawa; Max Planck Society; Aarhus University; Canadian Space Agency; University of Texas System; University of Texas Dallas; Tufts University; University of Alberta; Texas A&M University System; Texas A&M University College Station; University of Copenhagen; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Michigan System; University of Michigan; Imperial College London; University of Neuchatel; Delft University of Technology; York University - Canada	Smith, PH (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	psmith@lpl.arizona.edu	Catling, David C/D-2082-2009; Mellon, Michael/C-3456-2016; Blaney, Diana/M-1756-2019; Lemmon, Mark/X-2333-2019; Stoker, Carol/ABE-1381-2021; Madsen, Morten Bo/D-2082-2011; Staufer, Urs/J-6866-2016; Lemmon, Mark T/E-9983-2010; Gunnlaugsson, Haraldur/L-6535-2016	Blaney, Diana/0000-0002-4267-7939; Lemmon, Mark/0000-0002-4504-5136; Stoker, Carol/0000-0001-7265-292X; Madsen, Morten Bo/0000-0001-8909-5111; Staufer, Urs/0000-0002-3519-6467; Lemmon, Mark T/0000-0002-4504-5136; Catling, David/0000-0001-5646-120X; Hecht, Michael/0000-0002-4114-4583; Gunnlaugsson, Haraldur/0000-0002-8958-0245; Kounaves, Samuel/0000-0002-2629-4831	NASA; Canadian Space Agency; Science and Technology Facilities Council [PP/D002192/1, PP/D002354/1, ST/G008485/1] Funding Source: researchfish; STFC [PP/D002192/1, PP/D002354/1, ST/G008485/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); Canadian Space Agency(Canadian Space Agency); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Funding for Research came from NASA and the Canadian Space Agency.	Arvidson R, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003021; Bonitz RG, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003030; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Feldman WC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028936; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Mellon MT, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003039; Mellon MT, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003067; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mitrofanov IG, 2003, SCIENCE, V300, P2081, DOI 10.1126/science.1084350; RENNO N, 2009, LUNAR PLANET SCI C, V40; Seelos KD, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003088; Smith PH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003083; Tanaka K.L., 2005, 2888 US GEOL SURV SC; Whiteway JA, 2009, SCIENCE, V325, P68, DOI 10.1126/science.1172344; Whiteway J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003002; Zent A, 2008, ICARUS, V196, P385, DOI 10.1016/j.icarus.2007.12.028; [No title captured]	23	380	389	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					58	61		10.1126/science.1172339	http://dx.doi.org/10.1126/science.1172339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574383				2022-12-28	WOS:000267594000032
J	Pereira, JP; Kelly, LM; Xu, Y; Cyster, JG				Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.			EBI2 mediates B cell segregation between the outer and centre follicle	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; GERMINAL-CENTERS; LYMPHOID FOLLICLES; RECEPTOR; EXPRESSION; CHEMOKINE; RESPONSIVENESS; VISUALIZATION; ARCHITECTURE	B cell follicles are specialized microenvironments that support events necessary for humoral immunity(1-3). After antigen encounter, activated B cells initially seek T-cell help at the follicle-T-zone boundary and then move to interfollicular and T-zone distal ( outer) regions of the follicle(4-10). Subsequently, some cells move to the follicle centre, become germinal centre B cells and undergo antibody affinity maturation(1,2,11). Although germinal centres within follicles were described in 1885 (ref. 12), the molecular cues mediating segregation of B cells between the outer and centre follicle have remained undefined. Here we present a role for the orphan G-protein-coupled receptor, Epstein-Barr virus induced molecule-2 (EBI2, also known as GPR183)(13), in this process. EBI2 is expressed in mature B cells and increases in expression early after activation, before being downregulated in germinal centre B cells. EBI2 deficiency in mice led to a reduction in the early antibody response to a T-dependent antigen. EBI2-deficient B cells failed to move to the outer follicle at day 2 of activation, and instead were found in the follicle centre, whereas EBI2 overexpression was sufficient to promote B cell localization to the outer follicle. In mixed bone marrow chimaeras, EBI2-deficient B cells phenocopied germinal centre B cells in preferentially localizing to the follicle centre. When downregulation of EBI2 in wild-type B cells was antagonized, participation in the germinal centre reaction was impaired. These studies identify an important role for EBI2 in promoting B cell localization in the outer follicle, and show that differential expression of this receptor helps position B cells appropriately for mounting T-dependent antibody responses.	[Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Pereira, Joao P.; Kelly, Lisa M.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu	kelly, Lisa/GWU-9804-2022	Pereira, Joao/0000-0002-5694-4938	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI045073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Allen for help with microscopy and discussions, J. Green, E. Gray and K. Suzuki for helpful advice and J. An for expert assistance with the mouse colony. We also thank N. Killen and J. Dietrich for help with gene targeting. J. P. P. is an Associate and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by grants from the National Institutes of Health.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; ISHII K, 1993, J BIOL CHEM, V268, P9780; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Lossos IS, 2003, SEMIN CANCER BIOL, V13, P191, DOI 10.1016/S1044-579X(03)00015-4; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x	31	250	253	4	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1122	U85		10.1038/nature08226	http://dx.doi.org/10.1038/nature08226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19597478	Green Accepted			2022-12-28	WOS:000269314000037
J	Tyrer, P				Tyrer, Peter			Are general practitioners really unable to diagnose depression?	LANCET			English	Editorial Material							PRIMARY-CARE; CONTROLLED-TRIAL; MIXED ANXIETY; CLASSIFICATION; DISORDER; HEALTH		Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London W6 8RP, England	Imperial College London	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London W6 8RP, England.	p.tyrer@imperial.ac.uk						Casey P, 2006, J AFFECT DISORDERS, V92, P291, DOI 10.1016/j.jad.2006.01.021; Clark LA, 2006, BRIT J PSYCHIAT, V189, P481, DOI 10.1192/bjp.bp.106.03825; Cole J, 2008, BRIT J PSYCHIAT, V192, P83, DOI 10.1192/bjp.bp.107.039826; COOPER B, 1965, BRIT J PSYCHIAT, V111, P595, DOI 10.1192/bjp.111.476.595; Das-Munshi J, 2008, BRIT J PSYCHIAT, V192, P171, DOI 10.1192/bjp.bp.107.036707; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Goldberg DP, 1972, DETECTION PSYCHIAT I; JOHNSTONE A, 1976, LANCET, V1, P605, DOI 10.1016/S0140-6736(76)90415-3; KARTERNDAHL DA, 2005, PRIM CARE COMPANION, V7, P91; Khan N, 2007, BRIT J PSYCHIAT, V191, P206, DOI 10.1192/bjp.bp.106.032011; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Seivewright H, 1998, PSYCHOL MED, V28, P1149, DOI 10.1017/S0033291798007119; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Tyrer P, 2001, BRIT J PSYCHIAT, V179, P191, DOI 10.1192/bjp.179.3.191; Weich S, 2007, BRIT J PSYCHIAT, V191, P164, DOI 10.1192/bjp.bp.106.032219	16	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					589	590		10.1016/S0140-6736(09)61156-9	http://dx.doi.org/10.1016/S0140-6736(09)61156-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19640580				2022-12-28	WOS:000269222600004
J	Lundin, A; Hemmingsson, T				Lundin, Andreas; Hemmingsson, Tomas			Unemployment and suicide	LANCET			English	Editorial Material							MORTALITY; MEN		[Lundin, Andreas; Hemmingsson, Tomas] Karolinska Inst, Dept Publ Hlth Sci, SE-17176 Stockholm, Sweden	Karolinska Institutet	Lundin, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, SE-17176 Stockholm, Sweden.	andreas.lundin@ki.se		Hemmingsson, Tomas/0000-0001-6156-3964				Ahs AMH, 2006, SCAND J PUBLIC HEALT, V34, P159, DOI 10.1080/14034940510032374; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Eliason M, 2009, J HUM RESOUR, V44, P277, DOI 10.1353/jhr.2009.0020; Johansson SE, 1997, PUBLIC HEALTH, V111, P41, DOI 10.1038/sj.ph.1900317; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; MARTIKAINEN PT, 1990, BMJ-BRIT MED J, V301, P407, DOI 10.1136/bmj.301.6749.407; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6; PLATT S, 1984, SOC SCI MED, V19, P93, DOI 10.1016/0277-9536(84)90276-4; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Voss M, 2004, AM J PUBLIC HEALTH, V94, P2155, DOI 10.2105/AJPH.94.12.2155	10	30	30	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					270	271		10.1016/S0140-6736(09)61202-2	http://dx.doi.org/10.1016/S0140-6736(09)61202-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477GW	19589589				2022-12-28	WOS:000268508200006
J	Schweitzer, F; Fagiolo, G; Sornette, D; Vega-Redondo, F; Vespignani, A; White, DR				Schweitzer, Frank; Fagiolo, Giorgio; Sornette, Didier; Vega-Redondo, Fernando; Vespignani, Alessandro; White, Douglas R.			Economic Networks: The New Challenges	SCIENCE			English	Editorial Material							COMPLEX NETWORKS; EVOLUTION; MODEL; SCIENCES; DYNAMICS; MARKET	The current economic crisis illustrates a critical need for new and fundamental understanding of the structure and dynamics of economic networks. Economic systems are increasingly built on interdependencies, implemented through trans-national credit and investment networks, trade relations, or supply chains that have proven difficult to predict and control. We need, therefore, an approach that stresses the systemic complexity of economic networks and that can be used to revise and extend established paradigms in economic theory. This will facilitate the design of policies that reduce conflicts between individual interests and global efficiency, as well as reduce the risk of global failure by making economic networks more robust.	[Schweitzer, Frank; Sornette, Didier] ETH, D MTEC, CH-8032 Zurich, Switzerland; [Fagiolo, Giorgio] Scuola Super Sant Anna, LEM, I-56127 Pisa, Italy; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, CH-1211 Geneva, Switzerland; [Vega-Redondo, Fernando] European Univ Inst, Dept Econ, I-50133 Florence, Italy; [Vega-Redondo, Fernando] Inst Valenciano Invest Econ, Valencia 46020, Spain; [Vespignani, Alessandro] Indiana Univ, Sch Informat & Pervas Technol, Bloomington, IN 47408 USA; [Vespignani, Alessandro] Inst Sci Interchange, I-10133 Turin, Italy; [White, Douglas R.] Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA 92697 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Scuola Superiore Sant'Anna; University of Geneva; European University Institute; Indiana University System; Indiana University Bloomington; University of California System; University of California Irvine	Schweitzer, F (corresponding author), ETH, D MTEC, Kreuzpl 5, CH-8032 Zurich, Switzerland.	fschweitzer@ethz.ch	Fagiolo, Giorgio/HGB-6892-2022; Fagiolo, Giorgio/A-6084-2010; Schweitzer, Frank/B-2127-2012; Fagiolo, Giorgio/AAI-6807-2021	Fagiolo, Giorgio/0000-0001-5355-3352; Schweitzer, Frank/0000-0003-1551-6491; Fagiolo, Giorgio/0000-0001-5355-3352; Vespignani, Alessandro/0000-0003-3419-4205; White, Douglas/0000-0002-0148-9392				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Bala V, 2000, ECONOMETRICA, V68, P1181, DOI 10.1111/1468-0262.00155; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Battiston S, 2007, ADV COMPLEX SYST, V10, P29, DOI 10.1142/S0219525907000933; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Callander S, 2005, J PUBLIC ECON, V89, P1469, DOI 10.1016/j.jpubeco.2004.03.009; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Granovetter Mark., 1995, GETTING JOB STUDY CO, V2nd; Hagedoorn J, 2002, RES POLICY, V31, P477, DOI 10.1016/S0048-7333(01)00120-2; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Kirman A, 1997, J EVOL ECON, V7, P339, DOI 10.1007/s001910050047; Konig MD, 2008, NETW HETEROG MEDIA, V3, P201; Kogut B, 2001, AM SOCIOL REV, V66, P317, DOI 10.2307/3088882; Kosfeld M., 2004, REV NETW ECON, V3, P20; Marsili M, 2004, P NATL ACAD SCI USA, V101, P1439, DOI 10.1073/pnas.0305684101; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Powell WW, 2005, AM J SOCIOL, V110, P1132, DOI 10.1086/421508; Reichardt J, 2007, EUR PHYS J B, V60, P217, DOI 10.1140/epjb/e2007-00340-y; Reyes J, 2008, ADV COMPLEX SYST, V11, P685, DOI 10.1142/S0219525908001945; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO, P268	27	526	559	33	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					422	425		10.1126/science.1173644	http://dx.doi.org/10.1126/science.1173644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474AR	19628858				2022-12-28	WOS:000268255100042
J	Nielsen, AF; Gloggnitzer, J; Martinez, J				Nielsen, Anne F.; Gloggnitzer, Jiradet; Martinez, Javier			Ars2 and the Cap-Binding Complex Team up for Silencing	CELL			English	Editorial Material							SMALL RNAS; ARABIDOPSIS; SERRATE	In this issue, Sabin et al. (2009) and Gruber et al. (2009) reveal the protein Ars2 as a versatile regulator of RNA silencing. They show that Ars2 stimulates microRNA processing, contributes to antiviral resistance in flies, and is important for cell proliferation in mammals.	[Nielsen, Anne F.; Gloggnitzer, Jiradet; Martinez, Javier] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Nielsen, Anne Faerch/0000-0003-2653-4863; Martinez, Javier/0000-0001-9152-7323				Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07	8	10	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					224	226		10.1016/j.cell.2009.07.009	http://dx.doi.org/10.1016/j.cell.2009.07.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632172	Bronze			2022-12-28	WOS:000268277000004
J	Harnett, J				Harnett, John			Review: Blood pressure-lowering treatments reduce CV morbidity and mortality in patients receiving dialysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; CONTROLLED-TRIAL; HEMODIALYSIS		Mem Univ Newfoundland, St John, NF, Canada	Memorial University Newfoundland	Harnett, J (corresponding author), Mem Univ Newfoundland, St John, NF, Canada.							Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; Li PKT, 2003, ANN INTERN MED, V139, P105, DOI 10.7326/0003-4819-139-2-200307150-00010; Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Tepel M, 2008, NEPHROL DIAL TRANSPL, V23, P3605, DOI 10.1093/ndt/gfn304; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657	6	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-6	10.7326/0003-4819-151-2-200907210-02006	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620150				2022-12-28	WOS:000268605300014
J	Pitzer, VE; Viboud, C; Simonsen, L; Steiner, C; Panozzo, CA; Alonso, WJ; Miller, MA; Glass, RI; Glasser, JW; Parashar, UD; Grenfell, BT				Pitzer, Virginia E.; Viboud, Cecile; Simonsen, Lone; Steiner, Claudia; Panozzo, Catherine A.; Alonso, Wladimir J.; Miller, Mark A.; Glass, Roger I.; Glasser, John W.; Parashar, Umesh D.; Grenfell, Bryan T.			Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus Epidemics	SCIENCE			English	Article							UNITED-STATES; SPATIAL HIERARCHIES; TRAVELING-WAVES; SEASONALITY; EFFICACY; DIARRHEA; SAFETY; PROTECTION; DISEASE; DEATHS	Historically, annual rotavirus activity in the United States has started in the southwest in late fall and ended in the northeast 3 months later; this trend has diminished in recent years. Traveling waves of infection or local environmental drivers cannot account for these patterns. A transmission model calibrated against epidemiological data shows that spatiotemporal variation in birth rate can explain the timing of rotavirus epidemics. The recent large-scale introduction of rotavirus vaccination provides a natural experiment to further test the impact of susceptible recruitment on disease dynamics. The model predicts a pattern of reduced and lagged epidemics postvaccination, closely matching the observed dynamics. Armed with this validated model, we explore the relative importance of direct and indirect protection, a key issue in determining the worldwide benefits of vaccination.	[Pitzer, Virginia E.; Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA; [Pitzer, Virginia E.; Viboud, Cecile; Alonso, Wladimir J.; Miller, Mark A.; Glass, Roger I.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Steiner, Claudia] US Dept HHS, Healthcare Cost & Utilizat Project, Ctr Delivery Org & Markets, Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; [Panozzo, Catherine A.; Glasser, John W.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Epidemiol Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University; Agency for Healthcare Research & Quality; Centers for Disease Control & Prevention - USA; Princeton University; Princeton University	Pitzer, VE (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA.	vep2@psu.edu	Simonsen, Lone/K-4531-2014; Alonso, Wladimir J./N-9223-2017	Simonsen, Lone/0000-0003-1535-8526; Alonso, Wladimir J./0000-0001-7038-0801; Pitzer, Virginia/0000-0003-1015-2289	NIH [R01 GM083983-01]; Bill and Melinda Gates Foundation; RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.E.P and B.G. were supported by NIH (grant R01 GM083983-01) and the Bill and Melinda Gates Foundation. V.E.P, B.G., and L.S. were also supported by the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC).	ANDERSON R M, 1991; Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06; BERNSTEIN DI, 1991, J INFECT DIS, V164, P277, DOI 10.1093/infdis/164.2.277; Cilla G, 2000, EPIDEMIOL INFECT, V125, P677, DOI 10.1017/S0950268800004842; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cox MJ, 2003, EPIDEMIOL INFECT, V131, P719, DOI 10.1017/S0950268803008720; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Fischer TK, 2007, J INFECT DIS, V195, P1117, DOI 10.1086/512863; Glass RI, 2006, NEW ENGL J MED, V354, P75, DOI 10.1056/NEJMe058285; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAMILTON BE, 2003, REVISED BIRTH FERTIL; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; KAPIKIAN AZ, 2001, FIELDS VIROLOGY, V2, P1657; LEBARON CW, 1990, JAMA-J AM MED ASSOC, V264, P983, DOI 10.1001/jama.264.8.983; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Nakajima H, 2001, LANCET, V357, P1950, DOI 10.1016/S0140-6736(00)05086-8; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Purohit SG, 1998, J DIARRHOEAL DIS RES, V16, P74; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Torok TJ, 1997, PEDIATR INFECT DIS J, V16, P941, DOI 10.1097/00006454-199710000-00007; Turcios RM, 2006, PEDIATR INFECT DIS J, V25, P451, DOI 10.1097/01.inf.0000214987.67522.78; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	30	169	169	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					290	294		10.1126/science.1172330	http://dx.doi.org/10.1126/science.1172330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608910	Green Accepted			2022-12-28	WOS:000268036600037
J	Stickley, CE; St John, K; Koc, N; Jordan, RW; Passchier, S; Pearce, RB; Kearns, LE				Stickley, Catherine E.; St John, Kristen; Koc, Nalan; Jordan, Richard W.; Passchier, Sandra; Pearce, Richard B.; Kearns, Lance E.			Evidence for middle Eocene Arctic sea ice from diatoms and ice-rafted debris	NATURE			English	Article							GLACIATION; TRANSPORT; MA	Oceanic sediments from long cores drilled on the Lomonosov ridge, in the central Arctic(1), contain ice-rafted debris (IRD) back to the middle Eocene epoch, prompting recent suggestions that ice appeared in the Arctic about 46 million years (Myr) ago(2,3). However, because IRD can be transported by icebergs (derived from land-based ice) and also by sea ice(4), IRD records(2,3) are restricted to providing a history of general ice-rafting only. It is critical to differentiate sea ice from glacial (land-based) ice as climate feedback mechanisms vary and global impacts differ between these systems: sea ice directly affects ocean-atmosphere exchanges(5), whereas land-based ice affects sea level and consequently ocean acidity(6). An earlier report(3) assumed that sea ice was prevalent in the middle Eocene Arctic on the basis of IRD, and although somewhat preliminary supportive evidence exists(2), these data are neither comprehensive nor quantified. Here we show the presence of middle Eocene Arctic sea ice from an extraordinary abundance of a group of sea-ice-dependent fossil diatoms (Synedropsis spp.). Analysis of quartz grain textural characteristics further supports sea ice as the dominant transporter of IRD at this time. Together with new information on cosmopolitan diatoms and existing IRD records(2), our data strongly suggest a two-phase establishment of sea ice: initial episodic formation in marginal shelf areas similar to 47.5 Myr ago, followed similar to 0.5 Myr later by the onset of seasonally paced sea-ice formation in offshore areas of the central Arctic. Our data establish a 2-Myr record of sea ice, documenting the transition from a warm, ice-free(3) environment to one dominated by winter sea ice at the start of the middle Eocene climatic cooling phase(7).	[Stickley, Catherine E.; Koc, Nalan] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [St John, Kristen; Kearns, Lance E.] James Madison Univ, Dept Geog & Environm Sci, Harrisonburg, VA 22807 USA; [Stickley, Catherine E.; Koc, Nalan] Polar Environm Ctr, Norwegian Polar Inst, N-9296 Tromso, Norway; [Jordan, Richard W.] Yamagata Univ, Dept Earth & Environm Sci, Yamagata 9908560, Japan; [Passchier, Sandra] Montclair State Univ, Dept Earth & Environm Studies, Montclair, NJ 07043 USA; [Pearce, Richard B.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Pearce, Richard B.] Natl Oceanog Ctr, Southampton, Hants, England	UiT The Arctic University of Tromso; James Madison University; Norwegian Polar Institute; Yamagata University; Montclair State University; University of Southampton; NERC National Oceanography Centre	Stickley, CE (corresponding author), Univ Tromso, Dept Geol, N-9037 Tromso, Norway.	catherine.stickley@npolar.no	Passchier, Sandra/B-1993-2008; Passchier, Sandra/AAQ-2243-2021	Passchier, Sandra/0000-0001-7204-7025; Passchier, Sandra/0000-0001-7204-7025; Jordan, Richard/0000-0002-8997-7349	VISTA ( Norwegian Academy of Science and Letters and StatoilHydro); Research Council of Norway	VISTA ( Norwegian Academy of Science and Letters and StatoilHydro); Research Council of Norway(Research Council of Norway)	This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). C. E. S. and N. K. acknowledge funding by VISTA ( Norwegian Academy of Science and Letters and StatoilHydro) and the Research Council of Norway. We thank R. M. DeConto, M. P. Olney, S. M. Bohaty, A. Davies, M. A. Pearce, F. Sangiorgi, H. Brinkhuis, P. K. Bijl, J. Backman, J. Pike and A. E. S. Kemp for discussions. C. E. S. thanks StatoilHydro, Bergen for access to facilities, J. A. Barron, E. Fourtanier, I. Suto and J. Onodera for preliminary talks, and W. Hale for facilitating sample collection.	Abbot DS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036703; ARMAND LK, 2003, SEA ICE INTRO ITS PH, P333, DOI DOI 10.1002/9780470757161.CH11; Backman J., 2006, P IODP, V302, DOI [10.2204/iodp.proc.302.104.2006, DOI 10.2204/IODP.PROC.302.2006]; Backman J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001476; Barron J.A., 1995, SILICEOUS MICROFOSSI, V8, P107, DOI DOI 10.1017/S2475263000001446; Bohaty SM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001676; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; Darby DA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001479; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; DUNHILL G, 1998, OF980367 US GEOL SUR, P1; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Gleason JD, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001685; HASLE GR, 1994, PHYCOLOGIA, V33, P248, DOI 10.2216/i0031-8884-33-4-248.1; HELLAND PE, 1993, AM J SCI, V293, P744, DOI 10.2475/ajs.293.8.744; Krylov AA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001497; Lowenstein TK, 2006, SCIENCE, V313, P1928, DOI 10.1126/science.1129555; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; NURNBERG D, 1994, MAR GEOL, V119, P185, DOI 10.1016/0025-3227(94)90181-3; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RIEBESELL U, 1991, POLAR BIOL, V11, P239; St John K, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001483; Stein R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026776; Stickley CE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001485; Suto I, 2009, MICROPALEONTOLOGY, V55, P259; Tripati AK, 2008, EARTH PLANET SC LETT, V265, P112, DOI 10.1016/j.epsl.2007.09.045; Waddell LM, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001451; WILLIAMS AT, 1993, SEDIMENTOLOGY, V40, P63, DOI 10.1111/j.1365-3091.1993.tb01091.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	31	125	129	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					376	U88		10.1038/nature08163	http://dx.doi.org/10.1038/nature08163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19606146				2022-12-28	WOS:000267979000034
J	[Anonymous]				[Anonymous]			Net gains	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					307	307		10.1038/460307a	http://dx.doi.org/10.1038/460307a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470MO	19606097	Bronze			2022-12-28	WOS:000267979000001
J	Dechassa, ML; D'Arcy, S; Luger, K				Dechassa, Mekonnen Lemma; D'Arcy, Sheena; Luger, Karolin			A Positive Spin on the Centromere	CELL			English	Editorial Material							HISTONE H3; CENP-A; SCM3; CHROMATIN; PARTICLE; PROTEIN; CORE	The properties of centromeric nucleosomes have been the subject of considerable debate and controversy. Furuyama and Henikoff (2009) now provide surprising evidence that centromeric nucleosomes wrap DNA in an orientation that is opposite to that of canonical nucleosomes.	[Dechassa, Mekonnen Lemma; D'Arcy, Sheena; Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; [Dechassa, Mekonnen Lemma; D'Arcy, Sheena; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute; Colorado State University	Luger, K (corresponding author), Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA.	karolin.luger@colostate.edu	D'Arcy, Sheena/C-8592-2018	D'Arcy, Sheena/0000-0001-5055-988X; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alilat M, 1999, J MOL BIOL, V291, P815, DOI 10.1006/jmbi.1999.2988; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	9	9	9	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					22	24		10.1016/j.cell.2009.06.037	http://dx.doi.org/10.1016/j.cell.2009.06.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596232	Bronze			2022-12-28	WOS:000267848600011
J	Fekairi, S; Scaglione, S; Chahwan, C; Taylor, ER; Tissier, A; Coulon, S; Dong, MQ; Ruse, C; Yates, JR; Russell, P; Fuchs, RP; McGowan, CH; Gaillard, PHL				Fekairi, Samira; Scaglione, Sarah; Chahwan, Charly; Taylor, Ewan R.; Tissier, Agnes; Coulon, Stephane; Dong, Meng-Qiu; Ruse, Cristian; Yates, John R., III; Russell, Paul; Fuchs, Robert P.; McGowan, Clare H.; Gaillard, Pierre-Henri L.			Human SLX4 Is a Holliday Junction Resolvase Subunit that Binds Multiple DNA Repair/Recombination Endonucleases	CELL			English	Article							REPLICATION FORK PROGRESSION; PROMOTES REPLICATION; UBIQUITIN LIGASE; RIBOSOMAL DNA; REPAIR GENE; PROTEIN; RECOMBINATION; RESOLUTION; DAMAGE; MUS81-EME1	Structure-specific endonucleases resolve DNA secondary structures generated during DNA repair and recombination. The yeast 50 flap endonuclease Slx1-Slx4 has received particular attention with the finding that Slx4 has Slx1-independent key functions in genome maintenance. Although Slx1 is a highly conserved protein in eukaryotes, no orthologs of Slx4 were reported other than in fungi. Here we report the identification of Slx4 orthologs in metazoa, including fly MUS312, essential for meiotic recombination, and human BTBD12, an ATM/ATR checkpoint kinase substrate. Human SLX1-SLX4 displays robust Holliday junction resolvase activity in addition to 50 flap endonuclease activity. Depletion of SLX1 and SLX4 results in 53BP1 foci accumulation and H2AX phosphorylation as well as cellular hypersensitivity to MMS. Furthermore, we show that SLX4 binds the XPF ERCC4 and MUS81 subunits of the XPF-ERCC1 and MUS81-EME1 endonucleases and is required for DNA interstrand crosslink repair. We propose that SLX4 acts as a docking platform for multiple structure-specific endonucleases.	[Fekairi, Samira; Scaglione, Sarah; Tissier, Agnes; Coulon, Stephane; Fuchs, Robert P.; Gaillard, Pierre-Henri L.] Conventionne Univ Aix Marseille 2, Genome Instabil & Carcinogenesis UPR3081, CNRS, IGC, F-13402 Marseille, France; [Chahwan, Charly; Taylor, Ewan R.; Russell, Paul; McGowan, Clare H.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dong, Meng-Qiu; Ruse, Cristian; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Russell, Paul; McGowan, Clare H.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Gaillard, PHL (corresponding author), Conventionne Univ Aix Marseille 2, Genome Instabil & Carcinogenesis UPR3081, CNRS, IGC, IMM 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	gaillard@ifr88.cnrs-mrs.fr	Ruse, Cristian/A-4609-2011; gaillard, pierre-henri/AAC-6004-2020; Coulon, Stéphane/T-8451-2017; Tissier, Agnes/I-4850-2018	Ruse, Cristian/0000-0001-8237-6308; gaillard, pierre-henri/0000-0003-0781-0826; Coulon, Stéphane/0000-0001-8090-914X; TISSIER, Agnes/0000-0002-5676-8719	ATIP-CNRS; Marie Curie [IRG MIRG-CT-2006-046581]; Association pour la Recherche sur le Cancer [ARC-SF1052]; NIH [GM59447, CA77325, P41 RR011823]; NATIONAL CANCER INSTITUTE [R01CA077325] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059447] Funding Source: NIH RePORTER	ATIP-CNRS(Centre National de la Recherche Scientifique (CNRS)); Marie Curie(European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all members of the IGC department as well as Angelos Constantinou for encouragement and stimulating discussions. We thank Mauro Modesti, Genevieve Almouzni, and Michael N. Boddy for critical reading of the manuscript, Benoit Di Martino for technical help, Denise Aragnol and Laurence Roder for MUS312 cDNA, and Rick Wood for providing rXPF-ERCC1. This work was primarily funded by an ATIP-CNRS grant, Marie Curie IRG MIRG-CT-2006-046581, and Association pour la Recherche sur le Cancer grant ARC-SF1052 that were awarded to P.-H. L. G. as well as by NIH grants GM59447 and CA77325 awarded to P. R., and NIH P41 RR011823 awarded to J.R.Y. III. We thank Wade Harper, Jeff Sekelsky, John Rouse, and Monica Colaiacovo for communicating their results prior to publication.	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Brookman KW, 1996, MOL CELL BIOL, V16, P6553; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Coulon S, 2006, MOL BIOL CELL, V17, P2081, DOI 10.1091/mbc.E05-11-1006; Coulon S, 2004, MOL BIOL CELL, V15, P71, DOI 10.1091/mbc.E03-08-0586; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kaliraman V, 2002, CURR GENET, V41, P389, DOI 10.1007/s00294-002-0319-6; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lewis SM, 2006, DNA REPAIR, V5, P1146, DOI 10.1016/j.dnarep.2006.05.014; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Lyndaker AM, 2008, GENETICS, V179, P1807, DOI 10.1534/genetics.108.090654; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Mullen JR, 2001, GENETICS, V157, P103; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Symington LS, 2008, MOL CELL, V32, P603, DOI 10.1016/j.molcel.2008.11.011; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Vazquez MV, 2008, DNA REPAIR, V7, P1693, DOI 10.1016/j.dnarep.2008.06.014; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	62	314	326	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					78	89		10.1016/j.cell.2009.06.029	http://dx.doi.org/10.1016/j.cell.2009.06.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596236	Bronze, Green Accepted			2022-12-28	WOS:000267848600016
J	Ladurner, AG				Ladurner, Andreas G.			Chromatin Places Metabolism Center Stage	CELL			English	Editorial Material							HISTONE ACETYLATION; SYNTHETASE	Dynamic changes in histone and transcription factor acetylation modulate gene expression. A study in Science (Wellen et al., 2009) reports that changes in glucose metabolism alter the availability of acetyl-CoA, the essential cofactor for protein acetylation. These findings reveal a direct connection between central metabolism and mammalian gene expression.	[Ladurner, Andreas G.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Ladurner, Andreas G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ladurner, AG (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	ladurner@embl.de		Ladurner, Andreas/0000-0003-3835-232X				Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	10	14	15	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					18	20		10.1016/j.cell.2009.06.025	http://dx.doi.org/10.1016/j.cell.2009.06.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596230	Bronze			2022-12-28	WOS:000267848600009
J	Cattaneo, A; Faber, SM; Binney, J; Dekel, A; Kormendy, J; Mushotzky, R; Babul, A; Best, PN; Bruggen, M; Fabian, AC; Frenk, CS; Khalatyan, A; Netzer, H; Mahdavi, A; Silk, J; Steinmetz, M; Wisotzki, L				Cattaneo, A.; Faber, S. M.; Binney, J.; Dekel, A.; Kormendy, J.; Mushotzky, R.; Babul, A.; Best, P. N.; Brueggen, M.; Fabian, A. C.; Frenk, C. S.; Khalatyan, A.; Netzer, H.; Mahdavi, A.; Silk, J.; Steinmetz, M.; Wisotzki, L.			The role of black holes in galaxy formation and evolution	NATURE			English	Review							ACTIVE GALACTIC NUCLEI; HOST GALAXIES; COOLING FLOWS; ELLIPTIC GALAXIES; PERSEUS CLUSTER; RADIO GALAXIES; AGN FEEDBACK; GAS CLOUDS; STARBURSTS; ENTROPY	Virtually all massive galaxies, including our own, host central black holes ranging in mass from millions to billions of solar masses. The growth of these black holes releases vast amounts of energy that powers quasars and other weaker active galactic nuclei. A tiny fraction of this energy, if absorbed by the host galaxy, could halt star formation by heating and ejecting ambient gas. A central question in galaxy evolution is the degree to which this process has caused the decline of star formation in large elliptical galaxies, which typically have little cold gas and few young stars, unlike spiral galaxies.	[Cattaneo, A.; Steinmetz, M.; Wisotzki, L.] Astrophys Inst Potsdam, D-14482 Potsdam, Germany; [Cattaneo, A.] Univ Lyon 1, Observ Lyon, F-69561 St Genis Laval, France; [Faber, S. M.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Binney, J.; Silk, J.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Dekel, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Mushotzky, R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kormendy, J.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Babul, A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 1A1, Canada; [Best, P. N.] Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Brueggen, M.] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Fabian, A. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Frenk, C. S.] Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; [Khalatyan, A.] Observ Astron Marseille Provence, F-13388 Marseille 13, France; [Netzer, H.] Tel Aviv Univ, Wise Observ, IL-69978 Tel Aviv, Israel; [Mahdavi, A.] San Francisco State Univ, Dept Phys & Astron, San Francisco, CA 94132 USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of California System; University of California Santa Cruz; University of Oxford; Hebrew University of Jerusalem; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Texas System; University of Texas Austin; University of Victoria; University of Edinburgh; Jacobs University; University of Cambridge; Durham University; UDICE-French Research Universities; Aix-Marseille Universite; Tel Aviv University; California State University System; San Francisco State University	Cattaneo, A (corresponding author), Astrophys Inst Potsdam, Sternwarte 16, D-14482 Potsdam, Germany.	acattaneo@aip.de	Netzer, Hagai/AAA-1835-2019; Dekel, Avishai/ABF-9516-2021; Babul, Arif/E-2730-2010; Steinmetz, Matthias/Q-7785-2019; Frenk, Carlos/Z-3084-2019; Mushotzky, Richard/AAW-9465-2021	Dekel, Avishai/0000-0003-4174-0374; Babul, Arif/0000-0003-1746-9529; Steinmetz, Matthias/0000-0001-6516-7459; silk, joe/0000-0002-1566-8148; Mushotzky, Richard/0000-0002-7962-5446; Kormendy, John/0000-0001-9854-5217; Binney, James/0000-0002-1926-2436; netzer, Hagai/0000-0002-6766-0260; Frenk, Carlos/0000-0002-2338-716X	STFC [ST/F002289/1, ST/G001979/1, ST/F002300/1, ST/H008519/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G001979/1, ST/F002300/1, ST/H008519/1, ST/F002289/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Allen SW, 2006, MON NOT R ASTRON SOC, V372, P21, DOI 10.1111/j.1365-2966.2006.10778.x; Arav N, 2001, ASTROPHYS J, V561, P118, DOI 10.1086/323369; Baldry IK, 2004, ASTROPHYS J, V600, P681, DOI 10.1086/380092; BARDEEN JM, 1970, NATURE, V226, P64, DOI 10.1038/226064a0; Bennert N, 2008, ASTROPHYS J, V677, P846, DOI 10.1086/529068; Best PN, 2007, MON NOT R ASTRON SOC, V379, P894, DOI [10.1111/j.1365-2966.2007.11937.x, 10.1111/J.1365-2966.2007.11937.x]; Best PN, 2006, MON NOT R ASTRON SOC, V368, pL67, DOI 10.1111/j.1745-3933.2006.00159.x; Best PN, 2005, MON NOT R ASTRON SOC, V362, P25, DOI 10.1111/j.1365-2966.2005.09192.x; Bildfell C, 2008, MON NOT R ASTRON SOC, V389, P1637, DOI 10.1111/j.1365-2966.2008.13699.x; BINNEY J, 1995, MON NOT R ASTRON SOC, V276, P663, DOI 10.1093/mnras/276.2.663; Binney J, 2007, MON NOT R ASTRON SOC, V377, P142, DOI 10.1111/j.1365-2966.2007.11575.x; BINNEY J, 1977, ASTROPHYS J, V215, P483, DOI 10.1086/155378; Blandford RD, 1999, MON NOT R ASTRON SOC, V303, pL1, DOI 10.1046/j.1365-8711.1999.02358.x; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; BOHRINGER H, 1993, MON NOT R ASTRON SOC, V264, pL25; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195, DOI 10.1093/mnras/112.2.195; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; BURNS JO, 1990, ASTRON J, V99, P14, DOI 10.1086/115307; Cattaneo A, 2007, MON NOT R ASTRON SOC, V376, P1547, DOI 10.1111/j.1365-2966.2007.11512.x; Cattaneo A, 2006, MON NOT R ASTRON SOC, V370, P1651, DOI 10.1111/j.1365-2966.2006.10608.x; Cattaneo A, 2003, MON NOT R ASTRON SOC, V344, P45, DOI 10.1046/j.1365-8711.2003.06778.x; Cattaneo A, 2009, MON NOT R ASTRON SOC, V395, P518, DOI 10.1111/j.1365-2966.2009.14557.x; Chartas G, 2007, ASTRON J, V133, P1849, DOI 10.1086/512364; Chen Y, 2007, ASTRON ASTROPHYS, V466, P805, DOI 10.1051/0004-6361:20066471; Churazov E, 2002, MON NOT R ASTRON SOC, V332, P729, DOI 10.1046/j.1365-8711.2002.05332.x; Ciotti L, 2007, ASTROPHYS J, V665, P1038, DOI 10.1086/519833; Cox TJ, 2006, ASTROPHYS J, V650, P791, DOI 10.1086/507474; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; de Kool M, 2001, ASTROPHYS J, V548, P609, DOI 10.1086/318996; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dekel A, 2008, MON NOT R ASTRON SOC, V383, P119, DOI 10.1111/j.1365-2966.2007.12569.x; Donahue M, 2006, ASTROPHYS J, V643, P730, DOI 10.1086/503270; Dunlop JS, 2003, MON NOT R ASTRON SOC, V340, P1095, DOI 10.1046/j.1365-8711.2003.06333.x; Dunn RJH, 2006, MON NOT R ASTRON SOC, V373, P959, DOI 10.1111/j.1365-2966.2006.11080.x; EDGE AC, 1991, MON NOT R ASTRON SOC, V252, P414, DOI 10.1093/mnras/252.3.414; EVRARD AE, 1991, ASTROPHYS J, V383, P95, DOI 10.1086/170767; Faber SM, 2007, ASTROPHYS J, V665, P265, DOI 10.1086/519294; Faber SM, 1997, ASTRON J, V114, P1771, DOI 10.1086/118606; Fabian AC, 2006, MON NOT R ASTRON SOC, V373, pL16, DOI 10.1111/j.1745-3933.2006.00234.x; Fabian AC, 2006, MON NOT R ASTRON SOC, V366, P417, DOI 10.1111/j.1365-2966.2005.09896.x; FALL SM, 1980, MON NOT R ASTRON SOC, V193, P189, DOI 10.1093/mnras/193.2.189; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Forman W, 2005, ASTROPHYS J, V635, P894, DOI 10.1086/429746; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Heckman TM, 2006, NEW ASTRON REV, V50, P677, DOI 10.1016/j.newar.2006.06.022; Helmboldt JF, 2008, ASTROPHYS J, V681, P897, DOI 10.1086/588514; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P50, DOI 10.1086/499493; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; HUTCHINGS JB, 1983, NATURE, V303, P584, DOI 10.1038/303584a0; KAISER N, 1991, ASTROPHYS J, V383, P104, DOI 10.1086/170768; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Khalatyan A, 2008, MON NOT R ASTRON SOC, V387, P13, DOI 10.1111/j.1365-2966.2008.13093.x; Khochfar S, 2008, ASTROPHYS J, V680, P54, DOI 10.1086/587470; King A, 2003, ASTROPHYS J, V596, pL27, DOI 10.1086/379143; KORMENDY J, 2008, ASTROPHYS J IN PRESS; Kormendy J., 1993, NEAREST ACTIVE GALAX, P197; Krolik J. H., 1999, ACTIVE GALACTIC NUCL; Lloyd-Davies EJ, 2000, MON NOT R ASTRON SOC, V315, P689, DOI 10.1046/j.1365-8711.2000.03380.x; Lutz D, 2008, ASTROPHYS J, V684, P853, DOI 10.1086/590367; Magliocchetti M, 2007, MON NOT R ASTRON SOC, V379, P260, DOI 10.1111/j.1365-2966.2007.11939.x; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; MARCONI A, 2003, APJ, V589, P21; Mathews WG, 2007, ASTROPHYS J, V660, P1137, DOI 10.1086/513691; McCarthy IG, 2008, MON NOT R ASTRON SOC, V386, P1309, DOI 10.1111/j.1365-2966.2008.13141.x; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067; Naab T., 2006, APJ, V636, P81; Naab T, 2007, ASTROPHYS J, V658, P710, DOI 10.1086/510841; Nardini E, 2008, MON NOT R ASTRON SOC, V385, pL130, DOI 10.1111/j.1745-3933.2008.00450.x; Nesvadba NPH, 2008, ASTRON ASTROPHYS, V491, P407, DOI 10.1051/0004-6361:200810346; Nusser A, 2006, MON NOT R ASTRON SOC, V373, P739, DOI 10.1111/j.1365-2966.2006.11061.x; Oh SP, 2003, MON NOT R ASTRON SOC, V342, P664, DOI 10.1046/j.1365-8711.2003.06594.x; Peterson JR, 2006, PHYS REP, V427, P1, DOI 10.1016/j.physrep.2005.12.007; Ponman TJ, 1996, MON NOT R ASTRON SOC, V283, P690, DOI 10.1093/mnras/283.2.690; Proga D, 2007, ASTR SOC P, V373, P267; Quintero AD, 2004, ASTROPHYS J, V602, P190, DOI 10.1086/380601; Rafferty DA, 2006, ASTROPHYS J, V652, P216, DOI 10.1086/507672; REES MJ, 1977, MON NOT R ASTRON SOC, V179, P541, DOI 10.1093/mnras/179.4.541; Robertson B, 2006, ASTROPHYS J, V641, P90, DOI 10.1086/500348; Ruszkowski M, 2004, ASTROPHYS J, V611, P158, DOI 10.1086/422158; Salome P, 2006, ASTRON ASTROPHYS, V454, P437, DOI 10.1051/0004-6361:20054745; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Schawinski K, 2007, MON NOT R ASTRON SOC, V382, P1415, DOI 10.1111/j.1365-2966.2007.12487.x; SILK J, 1977, ASTROPHYS J, V211, P638, DOI 10.1086/154972; Silk J, 2005, MON NOT R ASTRON SOC, V364, P1337, DOI 10.1111/j.1365-2966.2005.09672.x; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Springel V, 2005, ASTROPHYS J, V620, pL79, DOI 10.1086/428772; Steinmetz M, 1999, ASTROPHYS SPACE SCI, V269, P513, DOI 10.1023/A:1017006732013; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; Tremonti CA, 2007, ASTROPHYS J, V663, pL77, DOI 10.1086/520083; Turner TJ, 2004, ASTROPHYS J, V603, P62, DOI 10.1086/381312; Valageas P, 1999, ASTRON ASTROPHYS, V350, P725; Voit GM, 2005, ASTROPHYS J, V634, P955, DOI 10.1086/497063	98	267	267	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					213	219		10.1038/nature08135	http://dx.doi.org/10.1038/nature08135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587763	Green Submitted			2022-12-28	WOS:000267761000032
J	Frank, KM; Hogarth, DK; Miller, JL; Mandal, S; Mease, PJ; Samulski, RJ; Weisgerber, GA; Hart, J				Frank, Karen M.; Hogarth, D. Kyle; Miller, Jonathan L.; Mandal, Saptarshi; Mease, Philip J.; Samulski, R. Jude; Weisgerber, Glen A.; Hart, John			Brief Report: Investigation of the Cause of Death in a Gene-Therapy Trial.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENOASSOCIATED VIRUS AAV; DISSEMINATED INTRAVASCULAR COAGULATION; NECROSIS-FACTOR ANTAGONISTS; CLINICAL-TRIALS; HISTOPLASMOSIS; UPDATE; DISEASES; VECTORS; INFECTIONS; INFLIXIMAB	We present a case of disseminated histoplasmosis, complicated by retroperitoneal bleeding and leading to death, in a patient who was receiving systemic immunosuppressive therapy for rheumatoid arthritis and who was enrolled in a gene-therapy trial. This trial was designed to evaluate intraarticular delivery of a tumor necrosis factor (alpha) (TNF-(alpha)) antagonist, through an adeno-associated virus (AAV) type 2 delivery system, for inflammatory arthritis. The patient's receipt of concurrent anti-TNF-(alpha) therapy and other immunosuppressive therapy while she was living in an area where histoplasmosis was endemic was thought to be the most likely explanation for the infection; the evidence presented suggests that this fatal infection was unlikely to have been related to exposure to the agent administered in the gene-therapy trial. This case reinforces the importance of considering infectious complications, such as those from endemic mycoses, in patients receiving treatment with a TNF-(alpha) antagonist and the importance of having a well-designed monitoring plan when subjects in a research study become ill. (ClinicalTrials.gov number, NCT00126724.).	[Frank, Karen M.; Miller, Jonathan L.; Mandal, Saptarshi; Hart, John] Univ Chicago, Med Ctr, Dept Pathol, Chicago, IL 60637 USA; [Hogarth, D. Kyle] Univ Chicago, Med Ctr, Div Pulm & Crit Care, Dept Med, Chicago, IL 60637 USA; [Mease, Philip J.] Univ Washington, Sch Med, Swedish Med Ctr, Seattle Rheumatol Associates,Div Rheumatol Res, Seattle, WA USA; [Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Weisgerber, Glen A.] St Johns Hosp, Springfield, IL USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Seattle Rheumatology Associates; Swedish Medical Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Frank, KM (corresponding author), Univ Chicago, Med Ctr, Dept Pathol, 5841 S Maryland Ave,MC 0001, Chicago, IL 60637 USA.	kfrank@uchicago.edu						Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Boissier MC, 2007, HUM GENE THER, V18, P525, DOI 10.1089/hum.2006.174; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Cavassini M, 2002, INTENS CARE MED, V28, P1501, DOI 10.1007/s00134-002-1430-3; Connolly PA, 2007, CLIN VACCINE IMMUNOL, V14, P1587, DOI 10.1128/CVI.00071-07; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;406::AID-JMV22&gt;3.0.CO;2-N; Food and Drug Administration, 2008, INF HEALTHC PROF CIM; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; Gardiner C, 2000, BRIT J HAEMATOL, V111, P1230, DOI 10.1046/j.1365-2141.2000.02466.x; Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Mingozzi F, 2007, CURR GENE THER, V7, P316, DOI 10.2174/156652307782151425; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Murphy SL, 2008, MOL THER, V16, P138, DOI 10.1038/sj.mt.6300334; *OFF BIOT ACT, 2007, M NIH REC DNA ADV CO; Svenson M, 2007, RHEUMATOLOGY, V46, P1828, DOI 10.1093/rheumatology/kem261; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Tsiodras S, 2008, MAYO CLIN PROC, V83, P181; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wallis RS, 2005, CLIN INFECT DIS, V41, pS194, DOI 10.1086/429996; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Weisman MH, 2002, J RHEUMATOL, V29, P33; Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259; Wheat LJ, 2006, EXPERT OPIN BIOL TH, V6, P1207, DOI 10.1517/14712598.6.11.1207; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	30	45	51	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					161	169		10.1056/NEJMoa0801066	http://dx.doi.org/10.1056/NEJMoa0801066			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587341	Bronze			2022-12-28	WOS:000267748900009
J	Buckley, MJ; Mansouri, FA; Hoda, H; Mahboubi, M; Browning, PGF; Kwok, SC; Phillips, A; Tanaka, K				Buckley, Mark J.; Mansouri, Farshad A.; Hoda, Hassan; Mahboubi, Majid; Browning, Philip G. F.; Kwok, Sze C.; Phillips, Adam; Tanaka, Keiji			Dissociable Components of Rule-Guided Behavior Depend on Distinct Medial and Prefrontal Regions	SCIENCE			English	Article							FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE; NEURONAL-ACTIVITY; RHESUS-MONKEYS; COGNITIVE CONTROL; MACACA-MULATTA; REWARD CONTINGENCY; DECISION-MAKING; MACAQUE MONKEYS	Much of our behavior is guided by rules. Although human prefrontal cortex (PFC) and anterior cingulate cortex (ACC) are implicated in implementing rule-guided behavior, the crucial contributions made by different regions within these areas are not yet specified. In an attempt to bridge human neuropsychology and nonhuman primate neurophysiology, we report the effects of circumscribed lesions to macaque orbitofrontal cortex (OFC), principal sulcus ( PS), superior dorsolateral PFC, ventrolateral PFC, or ACC sulcus, on separable cognitive components of a Wisconsin Card Sorting Test (WCST) analog. Only the PS lesions impaired maintenance of abstract rules in working memory; only the OFC lesions impaired rapid reward-based updating of representations of rule value; the ACC sulcus lesions impaired active reference to the value of recent choice-outcomes during rule-based decision-making.	[Buckley, Mark J.; Browning, Philip G. F.; Kwok, Sze C.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Mansouri, Farshad A.; Hoda, Hassan; Mahboubi, Majid; Phillips, Adam; Tanaka, Keiji] RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama, Japan	University of Oxford; RIKEN	Buckley, MJ (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	buckley@psy.ox.ac.uk; farshad@postman.riken.go.jp	Tanaka, Keiji/N-5917-2015; Browning, Philip/M-8917-2015; Hoda, Hassan/S-3656-2016	Tanaka, Keiji/0000-0002-1910-3427; Browning, Philip/0000-0002-8327-2946; Hoda, Hassan/0000-0003-1292-0464; Kwok, Sze Chai/0000-0002-7439-1193	Royal Society University; U.K. Medical Research Council; Ministry of Education, Culture, Sports, Science, and Technology of Japan; MRC; Medical Research Council [G0300817] Funding Source: researchfish; MRC [G0300817] Funding Source: UKRI	Royal Society University(Royal Society of London); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was jointly supported by a Royal Society University Research Fellowship (M.J.B.), a U.K. Medical Research Council (MRC) project grant (M.J.B.), a grant-inaid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (K.T.), and an MRC program grant held by D. Gaffan, whom we thank for encouragement and support. We also wish to thank M. G. Baxter for assistance with anesthesia, and G. J. Daubney, K. Rockland, N. Ichinohe, H. Mashiko, and Y. Abe for assistance in preparing tissues for histology.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; BENGTSSON SL, 2009, CEREB CORTEX; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckley MJ, 2006, TRENDS COGN SCI, V10, P100, DOI 10.1016/j.tics.2006.01.008; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; BUTTER CM, 1963, EXP NEUROL, V7, P65, DOI 10.1016/0014-4886(63)90094-3; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chudasama Y, 2007, CEREB CORTEX, V17, P1154, DOI 10.1093/cercor/bhl025; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; GAFFAN D, 1989, BEHAV BRAIN RES, V31, P207, DOI 10.1016/0166-4328(89)90003-X; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Heaton, 1981, WISCONSIN CARD SORTI; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KOWALSKA DM, 1991, NEUROPSYCHOLOGIA, V29, P583, DOI 10.1016/0028-3932(91)90012-W; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MILLER EK, 2008, NEUROSCIENCE RULE GU, P419; MISHKIN M, 1978, BRAIN RES, V143, P313, DOI 10.1016/0006-8993(78)90571-1; Moore TL, 2009, BEHAV NEUROSCI, V123, P231, DOI 10.1037/a0014723; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; PASSINGHAM R, 1975, BRAIN RES, V92, P89, DOI 10.1016/0006-8993(75)90529-6; PETRIDES M, 1982, BEHAV BRAIN RES, V5, P407, DOI 10.1016/0166-4328(82)90044-4; PETRIDES M, 1995, J NEUROSCI, V15, P359; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2008, J NEUROSCI, V28, P8338, DOI 10.1523/JNEUROSCI.2272-08.2008; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Walton ME, 2003, J NEUROSCI, V23, P6475; WATANABE M, 1990, EXP BRAIN RES, V80, P296; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	64	212	213	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					52	58		10.1126/science.1172377	http://dx.doi.org/10.1126/science.1172377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574382				2022-12-28	WOS:000267594000031
J	Lopez-Aranda, MF; Lopez-Tellez, JF; Navarro-Lobato, I; Masmudi-Martin, M; Gutierrez, A; Khan, ZU				Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Navarro-Lobato, Irene; Masmudi-Martin, Mariam; Gutierrez, Antonia; Khan, Zafar U.			Role of Layer 6 of V2 Visual Cortex in Object-Recognition Memory	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; AREA V2; MACAQUE MONKEYS; PERCEPTION; RGS14; PROTEINS; DYNAMICS; COMPLEX; SYSTEM; BRAIN	Cellular responses in the V2 secondary visual cortex to simple as well as complex visual stimuli have been well studied. However, the role of area V2 in visual memory remains unexplored. We found that layer 6 neurons of V2 are crucial for the processing of object-recognition memory (ORM). Using the protein regulator of G protein signaling-14 (RGS-14) as a tool, we found that the expression of this protein into layer 6 neurons of rat-brain area V2 promoted the conversion of a normal short-term ORM that normally lasts for 45 minutes into long-term memory detectable even after many months. Furthermore, elimination of the same-layer neurons by means of injection of a selective cytotoxin resulted in the complete loss of normal as well as protein-mediated enhanced ORM.	[Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Navarro-Lobato, Irene; Masmudi-Martin, Mariam; Khan, Zafar U.] Univ Malaga, Neurobiol Lab, Ctr Invest Med Sanitarias, E-29071 Malaga, Spain; [Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Khan, Zafar U.] Univ Malaga, Dept Med, Fac Med, E-29071 Malaga, Spain; [Gutierrez, Antonia] Univ Malaga, Fac Sci, Dept Cell Biol, E-29071 Malaga, Spain; [Lopez-Aranda, Manuel F.; Lopez-Tellez, Juan F.; Gutierrez, Antonia; Khan, Zafar U.] Inst Hlth Carlos III, CIBERNED, Madrid, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; CIBERNED	Khan, ZU (corresponding author), Univ Malaga, Neurobiol Lab, Ctr Invest Med Sanitarias, Campus Teatinos S-N, E-29071 Malaga, Spain.	zkhan@uma.es	Al-Masmudi Martín, Mariam/B-1119-2016; KHAN, Zafaruddin/J-6217-2012; López-Aranda, Manuel F./GNM-7102-2022; Navarro Lobato, Irene/A-9105-2016	Al-Masmudi Martín, Mariam/0000-0001-5005-9199; KHAN, Zafaruddin/0000-0003-0742-399X; López-Aranda, Manuel F./0000-0001-9063-0740; Navarro Lobato, Irene/0000-0002-7866-3192; Gutierrez Perez, Antonia/0000-0002-6264-6152; Lopez-Tellez, Juan Felix/0000-0003-4115-3380	Ministerio de Ciencia e Innovacion [BFU 06-0306]; Junta de Andalucia [CTS 586/07, FIS PI060556]; CIBERNED	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); CIBERNED(Instituto de Salud Carlos III)	This work was supported financially by Ministerio de Ciencia e Innovacion grant BFU 06-0306 and Junta de Andalucia grant CTS 586/07 to Z.U.K. and FIS PI060556 grant to A.G. M.F.L. is the recipient of a CIBERNED contract. Application for the patent on RGS-14 protein has already been filed, and issue of patent is pending.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 2005, CURR OPIN NEUROBIOL, V15, P730, DOI 10.1016/j.conb.2005.10.014; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Gattass R, 1997, CEREB CORTEX, V7, P110, DOI 10.1093/cercor/7.2.110; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; LEBIHAN D, 1993, P NATL ACAD SCI USA, V90, P11802, DOI 10.1073/pnas.90.24.11802; Lopez-Aranda MF, 2006, EUR J NEUROSCI, V23, P2971, DOI 10.1111/j.1460-9568.2006.04838.x; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nolan BC, 2005, BEHAV NEUROSCI, V119, P190, DOI 10.1037/0735-7044.119.1.190; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stepniewska I, 1996, J COMP NEUROL, V371, P129; Traissard N, 2007, NEUROPSYCHOPHARMACOL, V32, P851, DOI 10.1038/sj.npp.1301116; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200	28	54	60	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					87	89		10.1126/science.1170869	http://dx.doi.org/10.1126/science.1170869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574389				2022-12-28	WOS:000267594000041
J	Mitchell, AJ; Vaze, A; Rao, S				Mitchell, Alex J.; Vaze, Amol; Rao, Sanjay			Clinical diagnosis of depression in primary care: a meta-analysis	LANCET			English	Article							GENERAL-PRACTICE CONSULTATIONS; CASE-FINDING INSTRUMENTS; PRIMARY-HEALTH-CARE; MAJOR DEPRESSION; PSYCHOLOGICAL-PROBLEMS; AFFECTIVE-DISORDERS; EMOTIONAL-PROBLEMS; ELDERLY PATIENTS; RISK-FACTORS; UNMET NEED	Background Depression is a major burden for the health-care system worldwide. Most care for depression is delivered by general practitioners (GPs). We assessed the rate of true positives and negatives, and false positives and negatives in primary care when GPs make routine diagnoses of depression. Methods We undertook a meta-analysis of 118 studies that assessed the accuracy of unassisted diagnoses of depression by GPs. 41 of these studies were included because they had a robust outcome standard of a structured or semi-structured interview. Findings 50 371 patients were pooled across 41 studies and examined. GPs correctly identified depression in 47.3% (95% CI 41.7% to 53.0%) of cases and recorded depression in their notes in 33.6% (22.4% to 45.7%). 19 studies assessed both rule-in and rule-out accuracy; from these studies, the weighted sensitivity was 50.1% (41.3% to 59.0%) and specificity was 81.3% (74.5% to 87.3%). At a rate of 21.9%, the positive predictive value was 42.0% (39.6% to 44.3%) and the negative predictive value was 85.8% (84.8% to 86.7%). This finding suggests that for every 100 unselected cases seen in primary care, there are more false positives (n=15) than either missed (n=10) or identified cases (n=10). Accuracy was improved with prospective examination over an extended period (3-12 months) rather than relying on a one-off assessment or case-note records. Interpretation GPs can rule out depression in most people who are not depressed; however, the modest prevalence of depression in primary care means that misidentifications outnumber missed cases. Diagnosis could be improved by re-assessment of individuals who might have depression.	[Mitchell, Alex J.; Vaze, Amol; Rao, Sanjay] Leicester Gen Hosp, Leicestershire Partnership Trust, Leicester LE5 4PW, Leics, England; [Mitchell, Alex J.] Leicester Royal Infirm, Dept Canc & Mol Med, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Mitchell, AJ (corresponding author), Leicester Gen Hosp, Leicestershire Partnership Trust, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	Alex.Mitchell@leitspart.nhs.uk	Mitchell, Alex J/P-5671-2015; Mitchell, Alex/Z-1920-2019; Mitchell, Alex J/A-3090-2009	Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex/0000-0001-6014-598X; Mitchell, Alex J/0000-0001-6014-598X				ABEN I, 2003, HUISARTS WETENSCHAP, V46, P487; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Aragones E, 2004, INT J PSYCHIAT MED, V34, P331, DOI 10.2190/N835-FDYX-2E2E-V8XM; Balestrieri M, 2004, SOC PSYCH PSYCH EPID, V39, P171, DOI 10.1007/s00127-004-0722-z; Balestrieri M, 2007, EPIDEMIOL PSICHIAT S, V16, P144, DOI 10.1017/S1121189X00004772; Barkow K, 2002, PSYCHOL MED, V32, P595, DOI 10.1017/S0033291702005263; Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x; BOWERS J, 1990, MED J AUSTRALIA, V153, P192, DOI 10.5694/j.1326-5377.1990.tb136858.x; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; Bushnell J, 2004, BRIT J GEN PRACT, V54, P838; Cape J, 1999, BRIT J GEN PRACT, V49, P875; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Christensen KS, 2003, BRIT J GEN PRACT, V53, P758; Crawford MJ, 1998, INT J GERIATR PSYCH, V13, P172, DOI 10.1002/(SICI)1099-1166(199803)13:3<172::AID-GPS754>3.3.CO;2-3; Druss BG, 2007, ARCH GEN PSYCHIAT, V64, P1196, DOI 10.1001/archpsyc.64.10.1196; Aragones E, 2006, FAM PRACT, V23, P363, DOI 10.1093/fampra/cmi120; Friedman B, 2007, AM J GERIAT PSYCHIAT, V15, P28, DOI 10.1097/01.JGP.0000224732.74767.ad; Furedi J, 2003, PSYCHOSOMATICS, V44, P402, DOI 10.1176/appi.psy.44.5.402; GERBER P D, 1989, Journal of General Internal Medicine, V4, P7, DOI 10.1007/BF02596483; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Gilchrist G, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-28; Gledhill J, 2003, J ADOLESCENCE, V26, P245, DOI 10.1016/S0140-1971(02)00128-8; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P419; Harman JS, 2006, J GEN INTERN MED, V21, P926, DOI 10.1007/BF02743139; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; Herrman H, 2002, PSYCHOL MED, V32, P889, DOI 10.1017/S003329170200586X; Hickie IB, 2001, MED J AUSTRALIA, V175, pS18; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Hutton C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-71; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; JONES LR, 1987, GEN HOSP PSYCHIAT, V9, P287, DOI 10.1016/0163-8343(87)90085-5; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; Klinkman MS, 1997, ARCH FAM MED, V6, P567, DOI 10.1001/archfami.6.6.567; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; Licht-Strunk E, 2009, J AFFECT DISORDERS, V114, P310, DOI 10.1016/j.jad.2008.06.006; MACASKILL P, 2005, ENCY BIOSTATISTICS; Maginn S, 2004, SOC PSYCH PSYCH EPID, V39, P464, DOI 10.1007/s00127-004-0751-7; Menchetti M, 2009, J PSYCHOSOM RES, V66, P335, DOI 10.1016/j.jpsychores.2008.10.008; Miller MJ, 2005, MIL MED, V170, P158; MITCHELL AJ, 2009, ENCY MED DECISION MA; Munitz H, 2000, EUR J PSYCHIAT, V14, P85; Nuyen J, 2005, PSYCHOL MED, V35, P1185, DOI 10.1017/S0033291705004812; O'Connor DW, 2001, INT PSYCHOGERIATR, V13, P367, DOI 10.1017/S104161020100775X; ORMEL J, 1990, PSYCHOL MED, V20, P909, DOI 10.1017/S0033291700036606; Pai MMM, 2004, EVID BASED MED, V141, pA11, DOI DOI 10.1136/EBM.9.4.101; Pini S, 1997, GEN HOSP PSYCHIAT, V19, P411, DOI 10.1016/S0163-8343(97)00053-4; Pollock K, 2002, BRIT MED J, V325, P687, DOI 10.1136/bmj.325.7366.687; POND CD, 1994, FAM PRACT, V11, P141, DOI 10.1093/fampra/11.2.141; Prior L, 2003, SOC SCI MED, V56, P2191, DOI 10.1016/S0277-9536(02)00235-6; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rhodes AE, 2004, INT J METH PSYCH RES, V13, P165, DOI 10.1002/mpr.172; Ronalds G, 1997, BRIT J PSYCHIAT, V171, P427, DOI 10.1192/bjp.171.5.427; Rost K, 1994, Arch Fam Med, V3, P333, DOI 10.1001/archfami.3.4.333; Rost K, 1998, GEN HOSP PSYCHIAT, V20, P12, DOI 10.1016/S0163-8343(97)00095-9; Saltini A, 2004, PSYCHOL MED, V34, P729, DOI 10.1017/S0033291703001260; Schmaling KB, 2005, J HEALTH CARE POOR U, V16, P780; SCHULBERG HC, 1985, ARCH GEN PSYCHIAT, V42, P1164; Schwenk TL, 1996, GEN HOSP PSYCHIAT, V18, P407, DOI 10.1016/S0163-8343(96)00062-X; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; STRAUSS PR, 1995, S AFR MED J, V85, P755; Stromberg R, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-34; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Tiemens BG, 1999, PSYCHOL MED, V29, P833, DOI 10.1017/S0033291799008545; Tiemens BG, 1999, GEN HOSP PSYCHIAT, V21, P87, DOI 10.1016/S0163-8343(98)00077-2; TURRINA C, 1994, BRIT J PSYCHIAT, V165, P533, DOI 10.1192/bjp.165.4.533; TYLEE AT, 1993, BRIT J GEN PRACT, V43, P327; *US DEP HHS, 1993, DEPR GUID PAN DEPR P; USTUN TB, 1995, MENTAL ILLNESS GEN H, P347; van Marwijk HWJ, 1996, SCAND J PRIM HEALTH, V14, P142; Van Weel-Baumgarten EM, 2000, BRIT J GEN PRACT, V50, P284; Volkers AC, 2004, J AFFECT DISORDERS, V82, P259, DOI 10.1016/j.jad.2003.11.003; VONKORFF M, 1987, ARCH GEN PSYCHIAT, V44, P152; Vuorilehto M, 2005, PSYCHOL MED, V35, P673, DOI 10.1017/S0033291704003770; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Wittchen HU, 2002, HUM PSYCHOPHARM CLIN, V17, pS1, DOI 10.1002/hup.398; Wittchen HU, 2001, INT CLIN PSYCHOPHARM, V16, P121, DOI 10.1097/00004850-200105000-00001; Zastrow A, 2008, J PSYCHOSOM RES, V64, P543, DOI 10.1016/j.jpsychores.2007.11.010	80	691	712	4	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					609	619		10.1016/S0140-6736(09)60879-5	http://dx.doi.org/10.1016/S0140-6736(09)60879-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19640579				2022-12-28	WOS:000269222600021
J	Raman, S; Pipavath, S				Raman, Siva; Pipavath, Sudhakar			Asymmetric Edema of the Upper Lung Due to Mitral Valvular Dysfunction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raman, Siva; Pipavath, Sudhakar] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raman, S (corresponding author), Univ Washington, Seattle, WA 98195 USA.								0	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					E6	E6		10.1056/NEJMicm0801147	http://dx.doi.org/10.1056/NEJMicm0801147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641197				2022-12-28	WOS:000268443900012
J	Hyder, AA; Merritt, MW				Hyder, Adnan A.; Merritt, Maria W.			Ancillary Care for Public Health Research in Developing Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL RESEARCHERS; CLINICAL CARE; RESPONSIBILITIES		[Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Ste E-8132, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Hyder, Adnan/AAT-9503-2021	Hyder, Adnan/0000-0002-7292-577X	FIC NIH HHS [D43 TW007292, R25 TW001604, R25-TW01604] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007292, R25TW001604] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2008, PLOS MED, V5, pe90; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Dickert N, 2007, LANCET, V369, P874, DOI 10.1016/S0140-6736(07)60416-4; Richardson HS, 2007, AM J PUBLIC HEALTH, V97, P1956, DOI 10.2105/AJPH.2006.093658; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Watkins Kevin., 2007, HUMAN DEV REPORT 200	6	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					429	431		10.1001/jama.2009.1072	http://dx.doi.org/10.1001/jama.2009.1072			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472NQ	19622822	Green Accepted			2022-12-28	WOS:000268139200026
J	Mattsson, N; Zetterberg, H; Hansson, O; Andreasen, N; Parnetti, L; Jonsson, M; Herukka, SK; van der Flier, WM; Blankenstein, MA; Ewers, M; Rich, K; Kaiser, E; Verbeek, M; Tsolaki, M; Mulugeta, E; Rosen, E; Aarsland, D; Visser, PJ; Schroder, J; Marcusson, J; de Leon, M; Hampel, H; Scheltens, P; Pirttila, T; Wallin, A; Jonhagen, ME; Minthon, L; Winblad, B; Blennow, K				Mattsson, Niklas; Zetterberg, Henrik; Hansson, Oskar; Andreasen, Niels; Parnetti, Lucilla; Jonsson, Michael; Herukka, Sanna-Kaisa; van der Flier, Wiesje M.; Blankenstein, Marinus A.; Ewers, Michael; Rich, Kenneth; Kaiser, Elmar; Verbeek, Marcel; Tsolaki, Magda; Mulugeta, Ezra; Rosen, Erik; Aarsland, Dag; Visser, Pieter Jelle; Schroeder, Johannes; Marcusson, Jan; de Leon, Mony; Hampel, Harald; Scheltens, Philip; Pirttilae, Tuula; Wallin, Anders; Jonhagen, Maria Eriksdotter; Minthon, Lennart; Winblad, Bengt; Blennow, Kaj			CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBROSPINAL-FLUID TAU; PHOSPHORYLATED-TAU; INTERNATIONAL WORKSHOP; DIAGNOSTIC-ACCURACY; VASCULAR DEMENTIA; RESEARCH CRITERIA; A-BETA-42; MARKERS; PROTEIN; BETA-AMYLOID((1-42))	Context Small single-center studies have shown that cerebrospinal fluid (CSF) biomarkers may be useful to identify incipient Alzheimer disease (AD) in patients with mild cognitive impairment (MCI), but large-scale multicenter studies have not been conducted. Objective To determine the diagnostic accuracy of CSF beta-amyloid(1-42) (A beta 42), total tau protein (T-tau), and tau phosphorylated at position threonine 181 (P-tau) for predicting incipient AD in patients with MCI. Design, Setting, and Participants The study had 2 parts: a cross-sectional study involving patients with AD and controls to identify cut points, followed by a prospective cohort study involving patients with MCI, conducted 1990-2007. A total of 750 individuals with MCI, 529 with AD, and 304 controls were recruited by 12 centers in Europe and the United States. Individuals with MCI were followed up for at least 2 years or until symptoms had progressed to clinical dementia. Main Outcome Measures Sensitivity, specificity, positive and negative likelihood ratios (LRs) of CSF A beta 42, T-tau, and P-tau for identifying incipient AD. Results During follow-up, 271 participants with MCI were diagnosed with AD and 59 with other dementias. The A beta 42 assay in particular had considerable intersite variability. Patients who developed AD had lower median A beta 42 (356; range, 96-1075 ng/L) and higher P-tau (81; range, 15-183 ng/L) and T-tau (582; range, 83-2174 ng/L) levels than MCI patients who did not develop AD during follow-up (579; range, 1211420 ng/L for A beta 42; 53; range, 15-163 ng/L for P-tau; and 294; range, 31-2483 ng/L for T-tau, P < .001). The area under the receiver operating characteristic curve was 0.78 (95% confidence interval [CI], 0.75-0.82) for A beta 42, 0.76 (95% CI, 0.72-0.80) for P-tau, and 0.79 (95% CI, 0.76-0.83) for T-tau. Cut-offs with sensitivity set to 85% were defined in the AD and control groups and tested in the MCI group, where the combination of A beta 42/P-tau ratio and T-tau identified incipient AD with a sensitivity of 83% (95% CI, 78%-88%), specificity 72% (95% CI, 68%-76%), positive LR, 3.0 (95% CI, 2.5-3.4), and negative LR, 0.24 (95% CI, 0.21-0.28). The positive predictive value was 62% and the negative predictive value was 88%. Conclusions This multicenter study found that CSF A beta 42, T-tau, and P-tau identify incipient AD with good accuracy, but less accurately than reported from single-center studies. Intersite assay variability highlights a need for standardization of analytical techniques and clinical procedures. JAMA. 2009;302(4):385-393	[Mattsson, Niklas; Zetterberg, Henrik; Jonsson, Michael; Rosen, Erik; Wallin, Anders; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Neurochem & Psychiat, Inst Neurosci & Physiol, Molndal, Sweden; [Hansson, Oskar; Minthon, Lennart] Lund Univ, Clin Memory Res Unit, Lund, Sweden; [Andreasen, Niels; Jonhagen, Maria Eriksdotter; Winblad, Bengt] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Parnetti, Lucilla] Univ Perugia, I-06100 Perugia, Italy; [Herukka, Sanna-Kaisa; Pirttilae, Tuula] Univ Kuopio, Dept Neurol, Kuopio, Finland; [Herukka, Sanna-Kaisa; Pirttilae, Tuula] Univ Kuopio, Brain Res Unit, Clin Res Ctr Mediteknia, FIN-70211 Kuopio, Finland; [Herukka, Sanna-Kaisa; Pirttilae, Tuula] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [van der Flier, Wiesje M.; Blankenstein, Marinus A.; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [van der Flier, Wiesje M.; Blankenstein, Marinus A.; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Ewers, Michael; Hampel, Harald] Univ Dublin, Adelaide & Meath Hosp Incorporating Natl Children, Trinity Coll, Lab Neuroimaging & Biomarker Res,TCIN, Dublin, Ireland; [Ewers, Michael; Hampel, Harald] Univ Dublin, Adelaide & Meath Hosp Incorporating Natl Children, Dept Psychiat, Sch Med, Dublin, Ireland; [Ewers, Michael; Hampel, Harald] Univ Munich, Dept Psychiat, Alzheimer Mem Ctr, D-8000 Munich, Germany; [Rich, Kenneth; de Leon, Mony] NYU, Sch Med, Ctr Brain Hlth, New York, NY USA; [Kaiser, Elmar; Schroeder, Johannes] Heidelberg Univ, Sekt Gerontopsychiat, D-6900 Heidelberg, Germany; [Verbeek, Marcel] Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, NL-6525 ED Nijmegen, Netherlands; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Mem & Dementia Ctr, Dept Neurol 3, G Papanicolaore Gen Hosp, Thessaloniki, Greece; [Mulugeta, Ezra; Aarsland, Dag] Stavanger Univ Hosp, Ctr Clin Neurosci Res, Stavanger, Norway; [Visser, Pieter Jelle] Univ Maastricht, Dept Psychiat & Neuropsychol, Inst Brain & Behav, Maastricht, Netherlands; [Marcusson, Jan] Linkoping Univ, Dept Neurosci & Locomot, Div Geriatr Med, Linkoping, Sweden	University of Gothenburg; Lund University; Karolinska Institutet; University of Perugia; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Trinity College Dublin; Trinity College Dublin; University of Munich; New York University; Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Aristotle University of Thessaloniki; Stavanger University Hospital; Maastricht University; Linkoping University	Mattsson, N (corresponding author), Sahlgrenska Univ Hosp Molndal, Clin Neurochem Lab, S-43180 Molndal, Sweden.	niklas.mattsson@neuro.gu.se	Eriksdotter, Maria/I-5427-2015; Scheltens, Philip/E-1205-2012; Visser, Pieter J/C-8541-2015; Scheltens, Philip/AAL-9631-2020; de Leon, Mony/AAP-7890-2021; Hansson, Oskar/A-7134-2013; Verbeek, Marcel M/D-1971-2010; Parnetti, Lucilla/K-8258-2016; Mattsson-Carlgren, Niklas/H-7597-2019; Visser, Pieter Jelle/S-5242-2019	Eriksdotter, Maria/0000-0003-2498-4000; Visser, Pieter J/0000-0001-8008-9727; Scheltens, Philip/0000-0002-1046-6408; Hansson, Oskar/0000-0001-8467-7286; Verbeek, Marcel M/0000-0003-4635-7876; Parnetti, Lucilla/0000-0001-5722-3967; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Visser, Pieter Jelle/0000-0001-8008-9727; Blankenstein, Marinus/0000-0003-1186-0770; Tsolaki, Magda/0000-0002-2072-8010; Aarsland, Dag/0000-0001-6314-216X; van der Flier, Wiesje/0000-0001-8766-6224; de Leon, Mony/0000-0003-2245-4380; Hampel, Harald/0000-0003-0894-8982	Swedish Brain Power consortium [2006-2740, 2006-6227]; Swedish Research Council (Clinical Neuroproteomics of Neurodegenerative Diseases (cNEUPRO) [QLK-6-CT-2002-02455]; European Union; European Commission Fifth framework programme; Sahlgrenska University Hospital; Goteborg Medical Society; Stiftelsen for Gamla Tjanarinnor; Alzheimer Foundation, Sweden	Swedish Brain Power consortium; Swedish Research Council (Clinical Neuroproteomics of Neurodegenerative Diseases (cNEUPRO)(Swedish Research Council); European Union(European Commission); European Commission Fifth framework programme(European Commission); Sahlgrenska University Hospital; Goteborg Medical Society; Stiftelsen for Gamla Tjanarinnor; Alzheimer Foundation, Sweden	This study was supported by grants 2006-2740 (Dr Blennow) and 2006-6227 (Dr Zetterberg), from the Swedish Brain Power consortium, the Swedish Research Council (Clinical Neuroproteomics of Neurodegenerative Diseases (cNEUPRO); grant QLK-6-CT-2002-02455 from the European Union, the European Commission Fifth framework programme; the Sahlgrenska University Hospital; the Goteborg Medical Society; Stiftelsen for Gamla Tjanarinnor; the Alzheimer Foundation, Sweden; and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andersson C, 2007, DEMENT GERIATR COGN, V23, P87, DOI 10.1159/000097354; Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; Andreasen N, 2003, ACTA NEUROL SCAND, V107, P47, DOI 10.1034/j.1600-0404.107.s179.9.x; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Herukka SK, 2007, NEUROBIOL AGING, V28, P507, DOI 10.1016/j.neurobiolaging.2006.02.001; Herukka SK, 2005, NEUROLOGY, V64, P1294, DOI 10.1212/01.WNL.0000156914.16988.56; Kutner M., 2004, APPL LINEAR STAT MOD; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Maruyama M, 2004, ARCH NEUROL-CHICAGO, V61, P716, DOI 10.1001/archneur.61.5.716; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Riemenschneider M, 2000, NEUROSCI LETT, V284, P85, DOI 10.1016/S0304-3940(00)00976-9; Riemenschneider M, 2002, ARCH NEUROL-CHICAGO, V59, P1729, DOI 10.1001/archneur.59.11.1729; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sjogren M, 2001, CLIN CHEM, V47, P1776; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, pS97, DOI 10.1097/00002093-200607001-00015; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Visser PJ, 2008, PSYCHOL MED, V38, P113, DOI 10.1017/S0033291707000554; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zetterberg H, 2003, NEUROSCI LETT, V352, P67, DOI 10.1016/j.neulet.2003.08.011; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307	46	786	819	0	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					385	393		10.1001/jama.2009.1064	http://dx.doi.org/10.1001/jama.2009.1064			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622817	Bronze, Green Submitted			2022-12-28	WOS:000268139200021
J	Lopes, RD; Hafley, GE; Allen, KB; Ferguson, TB; Peterson, ED; Harrington, RA; Mehta, RH; Gibson, CM; Mack, MJ; Kouchoukos, NT; Califf, RM; Alexander, JH				Lopes, Renato D.; Hafley, Gail E.; Allen, Keith B.; Ferguson, T. Bruce; Peterson, Eric D.; Harrington, Robert A.; Mehta, Rajendra H.; Gibson, C. Michael; Mack, Michael J.; Kouchoukos, Nicholas T.; Califf, Robert M.; Alexander, John H.			Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEG WOUND COMPLICATIONS; SAPHENOUS-VEIN; RANDOMIZED-TRIAL; VASCULAR HARVEST; PREVENT-IV; SAPHENECTOMY; METAANALYSIS	Background Vein-graft harvesting with the use of endoscopy (endoscopic harvesting) is a technique that is widely used to reduce postoperative wound complications after coronary-artery bypass grafting (CABG), but the long-term effects on the rate of vein-graft failure and on clinical outcomes are unknown. Methods We studied the outcomes in patients who underwent endoscopic harvesting (1753 patients) as compared with those who underwent graft harvesting under direct vision, termed open harvesting (1247 patients), in a secondary analysis of 3000 patients undergoing CABG. The method of graft harvesting was determined by the surgeon. Vein-graft failure was defined as stenosis of at least 75% of the diameter of the graft on angiography 12 to 18 months after surgery (data were available in an angiographic subgroup of 1817 patients and 4290 grafts). Clinical outcomes included death, myocardial infarction, and repeat revascularization. Generalized estimating equations were used to adjust for baseline covariates associated with vein-graft failure and to account for the potential correlation between grafts within a patient. Cox proportional-hazards modeling was used to assess long-term clinical outcomes. Results The baseline characteristics were similar between patients who underwent endoscopic harvesting and those who underwent open harvesting. Patients who underwent endoscopic harvesting had higher rates of vein-graft failure at 12 to 18 months than patients who underwent open harvesting (46.7% vs. 38.0%, P<0.001). At 3 years, endoscopic harvesting was also associated with higher rates of death, myocardial infarction, or repeat revascularization (20.2% vs. 17.4%; adjusted hazard ratio, 1.22; 95% confidence interval [CI], 1.01 to 1.47; P = 0.04), death or myocardial infarction (9.3% vs. 7.6%; adjusted hazard ratio, 1.38; 95% CI, 1.07 to 1.77; P = 0.01), and death (7.4% vs. 5.8%; adjusted hazard ratio, 1.52; 95% CI, 1.13 to 2.04; P = 0.005). Conclusions Endoscopic vein-graft harvesting is independently associated with vein-graft failure and adverse clinical outcomes. Randomized clinical trials are needed to further evaluate the safety and effectiveness of this harvesting technique.	[Lopes, Renato D.; Hafley, Gail E.; Peterson, Eric D.; Harrington, Robert A.; Mehta, Rajendra H.; Alexander, John H.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27715 USA; [Allen, Keith B.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Ferguson, T. Bruce] E Carolina Univ, Greenville, NC USA; [Gibson, C. Michael] PERFUSE Angiog Lab, Boston, MA USA; [Mack, Michael J.] Cardiopulm Res Sci & Technol Inst, Dallas, TX USA; [Kouchoukos, Nicholas T.] Missouri Baptist Med Ctr, St Louis, MO USA	Duke University; Duke University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of North Carolina; East Carolina University	Alexander, JH (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, DUMC Box 3850, Durham, NC 27715 USA.	john.h.alexander@duke.edu	Gibson, C. Michael/AAE-8212-2019; Peterson, Eric David/ABF-5033-2021; Alexander, John/GVS-7271-2022	Alexander, John/0000-0002-1444-2462	Corgentech (now Anesiva)	Corgentech (now Anesiva)	The PREVENT IV trial, on which this study was based, was funded by a grant from Corgentech (now Anesiva).	Alexander JH, 2005, AM HEART J, V150, P643, DOI 10.1016/j.ahj.2005.05.021; Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Allen KB, 2003, HEART SURG FORUM, V6, pE143; Allen KB, 1998, ANN THORAC SURG, V66, P26, DOI 10.1016/S0003-4975(98)00392-0; Allen KB, 1997, ANN THORAC SURG, V64, P265, DOI 10.1016/S0003-4975(97)00277-4; Allen KB, 2000, HEART SURG FORUM, V3, P325; Allen K, 2005, INNOVATIONS, V1, P51, DOI 10.1097/01.gim.0000196315.32179.82; Alrawi SJ, 2001, HEART SURG FORUM, V4, P120; Athanasiou T, 2004, EUR J CARDIO-THORAC, V26, P1015, DOI 10.1016/j.ejcts.2004.07.013; Athanasiou T, 2003, ANN THORAC SURG, V76, P2141, DOI 10.1016/S0003-4975(03)01435-8; Aziz O, 2006, EUR J CARDIO-THORAC, V29, P324, DOI 10.1016/j.ejcts.2005.11.032; Black EA, 2002, EUR J CARDIO-THORAC, V22, P381, DOI 10.1016/S1010-7940(02)00296-8; Black EA, 2001, ANN THORAC SURG, V71, P1503, DOI 10.1016/S0003-4975(01)02463-8; Bonde P, 2004, ANN THORAC SURG, V77, P2076, DOI 10.1016/j.athoracsur.2003.11.001; Bonde P, 2002, HEART SURG FORUM, V5, P378; Cheng D, 2005, INNOVATIONS, V1, P61, DOI 10.1097/01.gim.0000196316.48694.41; Dahmen G, 2004, BIOMETRICAL J, V46, P214, DOI 10.1002/bimj.200310018; EAGLE KA, 2005, CIRCULATION, V111, P2014; Eagle Kim A, 2004, Circulation, V110, pe340; Fabricius AM, 2000, ANN THORAC SURG, V70, P473, DOI 10.1016/S0003-4975(00)01370-9; Fabricius AM, 2000, HEART SURG FORUM, V3, P32; GIBSON M, 1992, AM J CARDIOL, V69, P1286, DOI 10.1016/0002-9149(92)91222-P; Kiaii, 2002, J THORAC CARDIOV SUR, V123, P1224; Kiaii B, 2002, J THORAC CARDIOV SUR, V123, P204, DOI 10.1067/mtc.2002.118682; Lai TJ, 2006, TEX HEART I J, V33, P316; Lamm P, 2002, HEART SURG FORUM, V5, P355; Lancey RA, 2001, J CARDIOVASC SURG, V42, P297; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lumsden A B, 1996, Cardiovasc Surg, V4, P771, DOI 10.1016/S0967-2109(96)00055-5; Nickum C, 2005, JAAPA-J AM ACAD PHYS, V18, P42; Nickum C, 2005, JAAPA-J AM ACAD PHYS, V18, P44; Nickum C, 2005, JAAPA-J AM ACAD PHYS, V18, P51; Nickum Christopher W, 2005, JAAPA, V18, P51; ORegan DJ, 1997, EUR J CARDIO-THORAC, V12, P428; Paletta CE, 2000, ANN THORAC SURG, V70, P492, DOI 10.1016/S0003-4975(00)01414-4; Rousou LJ, 2009, ANN THORAC SURG, V87, P62, DOI 10.1016/j.athoracsur.2008.08.049; Seabolt PB, 2003, CURR OPIN CARDIOL, V18, P444, DOI 10.1097/00001573-200311000-00004; *SOC THOR SURG, 2008, STS AD CARD SURG DAT; Stokes ME, 2000, CATEGORICAL DATA ANA; Wilson A P, 1987, Eur J Cardiothorac Surg, V1, P158, DOI 10.1016/1010-7940(87)90033-9; WipkeTevis DD, 1996, HEART LUNG, V25, P108, DOI 10.1016/S0147-9563(96)80112-9; Yun KL, 2005, J THORAC CARDIOV SUR, V129, P496, DOI 10.1016/j.jtcvs.2004.08.054	42	248	270	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					235	244		10.1056/NEJMoa0900708	http://dx.doi.org/10.1056/NEJMoa0900708			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19605828				2022-12-28	WOS:000267976100004
J	Krasuski, RA; Hart, SA; Allen, D; Qureshi, A; Pettersson, G; Houghtaling, PL; Batizy, LH; Blackstone, E				Krasuski, Richard A.; Hart, Stephen A.; Allen, Drew; Qureshi, Athar; Pettersson, Gosta; Houghtaling, Penny L.; Batizy, Lillian H.; Blackstone, Eugene			Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL SEPTAL ANEURYSM; CRYPTOGENIC STROKE; PARADOXICAL EMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CEREBROVASCULAR EVENTS; UNEXPLAINED STROKE; ISCHEMIC-STROKE; RISK; FIBRILLATION; HYPOXEMIA	Context A recent survey suggested that cardiothoracic surgeons may alter planned procedures to repair incidentally discovered patent foramen ovale (PFO). How frequently this occurs and the impact on outcomes remain unknown. Objective To measure the frequency of incidentally discovered PFO closure during cardiothoracic surgery and determine its perioperative and long-term impact. Design, Setting, and Patients We reviewed the intraoperative transesophageal echocardiograms of 13 092 patients without prior diagnosis of PFO or atrial septal defect undergoing surgery at the Cleveland Clinic, Cleveland, Ohio, from 1995 through 2006. Postoperative outcomes were prospectively collected until discharge. Main Outcome Measures All- cause hospital mortality and stroke were predetermined primary outcomes; length of hospital stay, length of intensive care unit stay, and time on cardiopulmonary bypass were secondary outcomes. Results Intraoperative PFO was diagnosed in 2277 patients in the study population (17%), and risk factors for stroke were similar in patients with and without PFO. After propensity matching was performed with the comparator groups, patients with PFO demonstrated similar rates of in-hospital death (3.4% vs 2.6%, P=.11) and postoperative stroke (2.3% vs 2.3%, P=.84). Surgical closure was performed in 639 PFO patients (28%), and surgeons were more likely to close defects in patients who were younger (mean [SD] age, 61.1 [ 14] vs 64.4 [ 13] years; P<.001), were undergoing mitral or tricuspid valve surgery (51% vs 32%, P<.001), or had history of transient ischemic attack or stroke (16% vs 10%, P<.001). Patients with repaired PFO demonstrated a 2.47-times greater odds (95% confidence interval, 1.02-6.00) of having a postoperative stroke compared with those with unrepaired PFO (2.8% vs 1.2%, P=.04). Long-term analysis demonstrated that PFO repair was associated with no survival difference (P=.12). Conclusions Incidental PFO is common in patients undergoing cardiothoracic surgery but is not associated with increased perioperative morbidity or mortality. Surgical closure appears unrelated to long-term survival and may increase postoperative stroke risk. JAMA. 2009; 302(3):290-297 www.jama.com	[Krasuski, Richard A.] Cleveland Clin, Dept Cardiovasc Med, Sect Clin Cardiol, Cleveland, OH 44195 USA; [Hart, Stephen A.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Allen, Drew] Cleveland Clin, Dept Internal Med, Cleveland, OH 44195 USA; [Qureshi, Athar] Cleveland Clin, Dept Pediat Cardiol, Cleveland, OH 44195 USA; [Houghtaling, Penny L.; Batizy, Lillian H.; Blackstone, Eugene] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Pettersson, Gosta; Blackstone, Eugene] Cleveland Clin, Dept Cardiothorac Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Krasuski, RA (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Sect Clin Cardiol, J2-4,9500 Euclid Ave, Cleveland, OH 44195 USA.	krasusr@ccf.org	Krasuski, Richard/AAI-8177-2020	Hart, Stephen/0000-0002-1651-4511; Krasuski, Richard/0000-0003-3150-5215				Aggarwal K, 2002, J AM SOC ECHOCARDIOG, V15, P1021, DOI 10.1067/mje.2002.121279; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; BALDWIN RT, 1991, ANN THORAC SURG, V52, P865, DOI 10.1016/0003-4975(91)91230-S; Banks TA, 2002, ANN THORAC SURG, V73, P296, DOI 10.1016/S0003-4975(01)02855-7; BERGSTRALH EJ, 56 MAYO FDN; Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; Cohnheim J, 1877, THROMBOSE EMBOLIE VO; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Efron B, 1998, INTRO BOOTSTRAP; FEDULLO AJ, 1985, AM J MED SCI, V289, P164, DOI 10.1097/00000441-198504000-00007; Ferrari E, 1999, J AM COLL CARDIOL, V33, P1317, DOI 10.1016/S0735-1097(99)00003-0; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hansen A, 2008, EUR J ECHOCARDIOGR, V9, P692, DOI 10.1093/ejechocard/jen013; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hart RG, 2007, NEUROLOGY, V69, P546; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; JONES EF, 1995, STROKE, V26, P218; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; Koullias GJ, 2004, CIRCULATION, V109, P3056, DOI 10.1161/01.CIR.0000132371.91318.6D; Krasuski RA, 2007, CLEV CLIN J MED, V74, P137, DOI 10.3949/ccjm.74.2.137; Lakshminarayan K, 2008, NEUROLOGIST, V14, P143, DOI 10.1097/NRL.0b013e31815cffae; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0; Matsumura Y, 2002, Eur J Echocardiogr, V3, P8, DOI 10.1053/euje.2001.0113; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Molina Carlos A, 2007, Cerebrovasc Dis, V24 Suppl 1, P84, DOI 10.1159/000107382; Morewood GH, 2001, ANESTHESIOLOGY, V95, P1507, DOI 10.1097/00000542-200112000-00033; Opotowsky AR, 2008, JAMA-J AM MED ASSOC, V299, P521, DOI 10.1001/jama.299.5.521; Ouseph R, 1997, J AM SOC ECHOCARDIOG, V10, P973, DOI 10.1016/S0894-7317(97)80014-4; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Rigatelli G, 2008, CATHETER CARDIO INTE, V71, P573, DOI 10.1002/ccd.21390; Srivastava TN, 1997, NEW ENGL J MED, V337, P681, DOI 10.1056/NEJM199709043371005; Sukernik MR, 2007, ANESTH ANALG, V105, P602, DOI 10.1213/01.ane.0000278735.06194.0c; Sukernik MR, 2005, J CARDIOTHOR VASC AN, V19, P150, DOI 10.1053/j.jvca.2005.01.022; Thanigaraj S, 2006, EUR J ECHOCARDIOGR, V7, P179, DOI 10.1016/j.euje.2005.05.004; VANCAMP G, 1993, AM J CARDIOL, V71, P596, DOI 10.1016/0002-9149(93)90518-H; Weiss SJ, 1996, ANESTHESIOLOGY, V84, P721, DOI 10.1097/00000542-199603000-00028	41	47	47	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					290	297		10.1001/jama.2009.1012	http://dx.doi.org/10.1001/jama.2009.1012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602688	Bronze			2022-12-28	WOS:000267948100022
J	Vavouri, T; Semple, JI; Garcia-Verdugo, R; Lehner, B				Vavouri, Tanya; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben			Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage Sensitivity	CELL			English	Article							CAENORHABDITIS-ELEGANS; INTERACTION NETWORK; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RECOGNITION MODULES; YEAST PROTEOME; LINEAR MOTIFS; GENOME; PHENOTYPES; SEQUENCE	Why are genes harmful when they are overexpressed? By testing possible causes of overexpression phenotypes in yeast, we identify intrinsic protein disorder as an important determinant of dosage sensitivity. Disordered regions are prone to make promiscuous molecular interactions when their concentration is increased, and we demonstrate that this is the likely cause of pathology when genes are overexpressed. We validate our findings in two animals, Drosophila melanogaster and Caenorhabditis elegans. In mice and humans the same properties are strongly associated with dosage-sensitive oncogenes, such that mass-action-driven molecular interactions may be a frequent cause of cancer. Dosage-sensitive genes are tightly regulated at the transcriptional, RNA, and protein levels, which may serve to prevent harmful increases in protein concentration under physiological conditions. Mass-action-driven interaction promiscuity is a single theoretical framework that can be used to understand, predict, and possibly treat the effects of increased gene expression in evolution and disease.	[Vavouri, Tanya; Semple, Jennifer I.; Garcia-Verdugo, Rosa; Lehner, Ben] UPF, EMBL CRG Syst Biol Unit, Ctr Genom Regulat, Barcelona 08003, Spain; [Lehner, Ben] UPF, ICREA, Ctr Genom Regulat, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), UPF, EMBL CRG Syst Biol Unit, Ctr Genom Regulat, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.es	Lehner, Ben/L-3413-2014; Vavouri, Tanya/I-6124-2019; Semple, Jennifer/K-4782-2014; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Vavouri, Tanya/0000-0003-2352-9049; Semple, Jennifer/0000-0001-7221-9560; Lehner, Ben/0000-0002-8817-1124; Garcia-Verdugo, Rosa/0000-0002-6039-8861	European Research Council (ERC); ICREA; Spanish Ministry of Science and Innovation (MICINN); CRGEMBL Systems Biology Program; Marie Currie Intra-European Training Fellowship; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); ICREA(ICREA); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CRGEMBL Systems Biology Program; Marie Currie Intra-European Training Fellowship; ICREA(ICREA)	We thank Mark Isalan and Madan Babu for helpful discussions, Pedro Beltrao for providing DisEMBL scores, and Mike Boxem for C. elegans vectors. This work was funded by a European Research Council (ERC) Starting Grant, ICREA, the Spanish Ministry of Science and Innovation (MICINN), the CRGEMBL Systems Biology Program, and a Marie Currie Intra-European Training Fellowship to T. V.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beltrao P, 2005, PLOS COMPUT BIOL, V1, P202, DOI 10.1371/journal.pcbi.0010026; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chin CS, 2005, GENOME RES, V15, P205, DOI 10.1101/gr.3243305; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Semple JI, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-1; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Toba G, 1999, GENETICS, V151, P725; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	46	258	266	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					198	208		10.1016/j.cell.2009.04.029	http://dx.doi.org/10.1016/j.cell.2009.04.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596244	Bronze			2022-12-28	WOS:000267848600025
J	Virgin, HW; Wherry, EJ; Ahmed, R				Virgin, Herbert W.; Wherry, E. John; Ahmed, Rafi			Redefining Chronic Viral Infection	CELL			English	Review							CD8 T-CELLS; C VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; I INTERFERON-PRODUCTION; HEPATITIS-B-VIRUS; PLASMA-CELLS; DISEASE PROGRESSION; PROTECTIVE IMMUNITY; PERSISTENT VIRUS; HUMAN TISSUES	Viruses that cause chronic infection constitute a stable but little-recognized part of our meta-genome: our virome. Ongoing immune responses hold these chronic viruses at bay while avoiding immunopathologic damage to persistently infected tissues. The immunologic imprint generated by these responses to our virome defines the normal immune system. The resulting dynamic but metastable equilibrium between the virome and the host can be dangerous, benign, or even symbiotic. These concepts require that we reformulate how we assign etiologies for diseases, especially those with a chronic inflammatory component, as well as how we design and interpret genome-wide association studies, and how we vaccinate to limit or control our virome.	[Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Midwest Reg Ctr Excellence Biodef & Emerging Infe, St Louis, MO 63110 USA; [Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); The Wistar Institute; Emory University; Emory University	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA.	virgin@wustl.edu; jwherry@wistar.org; ra@microbio.emory.edu	Wherry, John/ABI-1280-2020	Virgin, Herbert/0000-0001-8580-7628	Commonwealth of Pennsylvania; Ellison Medical Foundation; Bill and Melinda Gates Foundation	Commonwealth of Pennsylvania; Ellison Medical Foundation(Lawrence Ellison Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	H. W. V., E. J. W., and R. A. are supported by the NIH. H. W. V. is supported by the Broad Medical Foundation. E. J. W. is supported by the Commonwealth of Pennsylvania and the Ellison Medical Foundation, and R. A. is supported by the Bill and Melinda Gates Foundation. We thank A. Arvin, E. Barto, B. Beutler, J.- L. Casanova., F. Chisari, L. Corey, I. Davidson, E. Dubberke, V. Fraser, D. Ganem, L. Gooding, J. Gordon, A. Grakoui, E. Kieff, D. Knipe, L. Lenaerts, K. Murphy, C. Parish, L. Ratner, C. Rice, B. Roizman, A. Shaw, D. ThorleyLawson, E. Unanue, B. Walker, C. Walker, D. Wang, D. White, J. Wilson, and L. Zerboni for sharing comments and manuscripts with us.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bailey J, 2004, CURR OPIN IMMUNOL, V16, P470, DOI 10.1016/j.coi.2004.05.005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Barton ES, 2005, J VIROL, V79, P14149, DOI 10.1128/JVI.79.22.14149-14160.2005; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BERNS K, 2008, FIELDS VIROLOGY, P2437; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; BLACKLOW NR, 1968, J NATL CANCER I, V40, P319; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; CASALI P, 1983, CURR TOP MICROBIOL, V104, P7; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Chen CL, 2005, J VIROL, V79, P14781, DOI 10.1128/JVI.79.23.14781-14792.2005; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Dal Canto AJ, 2001, J CLIN INVEST, V107, pR15, DOI 10.1172/JCI11540; Davidson I, 2008, VIRUS RES, V137, P1, DOI 10.1016/j.virusres.2008.06.014; DE LA, 2002, ARCH INTERN MED, V162, P2125; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;406::AID-JMV22&gt;3.0.CO;2-N; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fernandez MA, 2008, J IMMUNOL, V180, P1556, DOI 10.4049/jimmunol.180.3.1556; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; Hobman T., 2007, FIELDS VIROLOGY, P1069; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; HOWLEY P, 2007, FIELDS VIROLOGY, P2297; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; KIEFF E, 2007, FIELDS VIROLOGY, P2605; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; KURITZKES DR, 2007, FIELDS VIROLOGY, P2187; Kurz SK, 1999, J VIROL, V73, P8612, DOI 10.1128/JVI.73.10.8612-8622.1999; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lairmore M. D., 2007, FIELDS VIROLOGY, P2071; Leggatt GR, 2007, CURR OPIN IMMUNOL, V19, P232, DOI 10.1016/j.coi.2007.01.004; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levisetti MG, 2003, INT IMMUNOL, V15, P1473, DOI 10.1093/intimm/dxg143; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Loh J, 2005, PLOS PATHOG, V1, P80, DOI 10.1371/journal.ppat.0010010; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McGovern BH, 2007, ANTIVIR THER, V12, pH3; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Meylan F, 2005, BLOOD, V105, P4377, DOI 10.1182/blood-2004-07-2596; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MIYAZAWA M, 1987, J EXP MED, V166, P890, DOI 10.1084/jem.166.4.890; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Norja P, 2008, J VIROL, V82, P6427, DOI 10.1128/JVI.00471-08; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stapleton JT, 2004, J CLIN MICROBIOL, V42, P3915, DOI 10.1128/JCM.42.9.3915-3919.2004; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; STRAUS SE, 2000, MANDELL DOUGLAS BENN, P1557; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Swanson PA, 2008, J EXP MED, V205, P1647, DOI 10.1084/jem.20080570; Taylor J. M., 2007, FIELDS VIROLOGY, P3031; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Upton JW, 2005, VIROLOGY, V341, P271, DOI 10.1016/j.virol.2005.07.014; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Dyk LF, 2003, J VIROL, V77, P5118, DOI 10.1128/JVI.77.9.5118-5126.2003; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; VIRGIN HW, 2007, FIELDS VIROLOGY, P327; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Whitton JL, 2004, AUTOIMMUNITY, V37, P375, DOI 10.1080/08916930410001713089; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; WOLD WS, 2008, FIELDS VIROLOGY, P2395; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; YAMANISHI K, 2007, FIELDS VIROLOGY, P2819; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zelinskyy G, 2006, EUR J IMMUNOL, V36, P2658, DOI 10.1002/eji.200636059; Zellweger RM, 2006, EUR J IMMUNOL, V36, P3175, DOI 10.1002/eji.200636087; Zerboni L, 2008, NEUROTROPIC VIRAL INFECTIONS, P225, DOI 10.1017/CBO9780511541728.016; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016; ZUR HH, 2008, INT J CANCER, V123, P247	160	696	728	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					30	50		10.1016/j.cell.2009.06.036	http://dx.doi.org/10.1016/j.cell.2009.06.036			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596234	Bronze			2022-12-28	WOS:000267848600013
J	Annas, GJ				Annas, George J.			Protecting Privacy and the Public -- Limits on Police Use of Bioidentifiers in Europe.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DNA		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; Cole Simon A., 2004, DNA CRIMINAL JUSTICE, V63, P63; Duster T., 2004, DNA CRIMINAL JUSTICE, P315; GLANTZ LH, 1989, AM J PUBLIC HEALTH, V79, P1427, DOI 10.2105/AJPH.79.10.1427; Home Office, 2009, KEEP RIGHT PEOPL DNA; HSU SS, 2008, WASHINGTON POST 1212, pA2; Kaye DH, 2004, DNA CRIMINAL JUSTICE, P247; McCartney C, 2006, BRIT J CRIMINOL, V46, P175, DOI 10.1093/bjc/azi094; National Research Council, 1997, BITS POW ISS GLOB AC; Nature, 2008, NATURE, V456, P675; *PRIV OFF, 2007, PRIV IMP ASS OFF GUI; Rothstein MA, 2006, J LAW MED ETHICS, V34, P153, DOI 10.1111/j.1748-720X.2006.00024.x; Simoncelli T, 2006, J LAW MED ETHICS, V34, P199, DOI 10.1111/j.1748-720X.2006.00027.x; Solzhenitsyn Alexander, 1969, CANC WARD; STURCKE J, 2009, GUARDIAN        0415, P1; SWIRE P, 2008, CHERTOFF SAYS FINGER; Wambaugh J., 1989, BLOODING; Williams Robin, 2004, Surveill Soc, V2, P1; 2008, ECONOMIST, V12, P73	19	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					196	201		10.1056/NEJMhle0811035	http://dx.doi.org/10.1056/NEJMhle0811035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19587347				2022-12-28	WOS:000267748900017
J	Gupta, A; Urquhart, DS; Devaraj, A; Balfour-Lynn, IM				Gupta, A.; Urquhart, D. S.; Devaraj, A.; Balfour-Lynn, I. M.			Endgames Picture quiz A 2 year old with fever and cough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMPYEMA; MANAGEMENT; CHILDREN; PNEUMONIA		[Gupta, A.; Urquhart, D. S.; Balfour-Lynn, I. M.] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England; [Devaraj, A.] Royal Brompton Hosp, Dept Radiol, London SW3 6NP, England	Royal Brompton Hospital; Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk						Bai K J, 1998, Respirology, V3, P261, DOI 10.1111/j.1440-1843.1998.tb00132.x; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Chang AB, 1996, PEDIATR PULM, V22, P207, DOI 10.1002/(SICI)1099-0496(199609)22:3<207::AID-PPUL11>3.3.CO;2-D; Clark J, 2009, ADV EXP MED BIOL, V634, P61, DOI 10.1007/978-0-387-79838-7_6; Eastham KM, 2004, THORAX, V59, P522, DOI 10.1136/thx.2003.016105; Fitzpatrick M, 2002, THORAX, V57, P1, DOI 10.1136/thorax.57.1.1; FREIJ BJ, 1984, PEDIATR INFECT DIS J, V3, P578, DOI 10.1097/00006454-198411000-00021; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Hardie W, 1996, CLIN INFECT DIS, V22, P1057, DOI 10.1093/clinids/22.6.1057; Jaffe A, 2008, THORAX, V63, P897, DOI 10.1136/thx.2007.094250; Jaffe A, 2005, PEDIATR PULM, V40, P148, DOI 10.1002/ppul.20251; King S, 2002, BRIT MED BULL, V61, P203, DOI 10.1093/bmb/61.1.203; Saglani S, 2005, ARCH DIS CHILD, V90, P70, DOI 10.1136/adc.2003.042176; Sonnappa S, 2007, PAEDIATR RESPIR REV, V8, P164, DOI 10.1016/j.prrv.2007.05.002; Spencer DA, 2006, BRIT MED J, V332, P1333, DOI 10.1136/bmj.332.7553.1333; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Thomson AH, 2002, THORAX, V57, P343, DOI 10.1136/thorax.57.4.343	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2009	339								b2150	10.1136/bmj.b2150	http://dx.doi.org/10.1136/bmj.b2150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469KY	19586972				2022-12-28	WOS:000267898300001
J	Brunner, D; Gerardot, BD; Dalgarno, PA; Wust, G; Karrai, K; Stoltz, NG; Petroff, PM; Warburton, RJ				Brunner, Daniel; Gerardot, Brian D.; Dalgarno, Paul A.; Wuest, Gunter; Karrai, Khaled; Stoltz, Nick G.; Petroff, Pierre M.; Warburton, Richard J.			A Coherent Single-Hole Spin in a Semiconductor	SCIENCE			English	Article							CHARGED QUANTUM-DOT; ELECTRON-SPIN; STATES; MEDIA	Semiconductors have uniquely attractive properties for electronics and photonics. However, it has been difficult to find a highly coherent quantum state in a semiconductor for applications in quantum sensing and quantum information processing. We report coherent population trapping, an optical quantum interference effect, on a single hole. The results demonstrate that a hole spin in a quantum dot is highly coherent.	[Brunner, Daniel; Gerardot, Brian D.; Dalgarno, Paul A.; Wuest, Gunter; Warburton, Richard J.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Karrai, Khaled] Univ Munich, Dept Phys, D-80539 Munich, Germany; [Stoltz, Nick G.; Petroff, Pierre M.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Warburton, Richard J.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	Heriot Watt University; University of Munich; University of California System; University of California Santa Barbara; University of Basel	Warburton, RJ (corresponding author), Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	r.j.warburton@hw.ac.uk	Brunner, Daniel/J-3460-2012; Warburton, Richard/ABC-3609-2021; Petroff, Pierre/M-9840-2019; Gerardot, Brian D./AHB-1102-2022; Dalgarno, Paul/A-4065-2010; Gerardot, Brian D/D-2418-2009	Brunner, Daniel/0000-0002-4003-3056; Gerardot, Brian D/0000-0002-0279-898X; Warburton, Richard/0000-0002-3095-3596; Dalgarno, Paul/0000-0001-7701-373X	UK Engineering and Physical Sciences Research Council; Royal Society of Edinburgh; EPSRC [EP/G02216X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G02216X/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Edinburgh; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the UK Engineering and Physical Sciences Research Council and the Royal Society of Edinburgh.	Amasha S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046803; Bergmann K, 1998, REV MOD PHYS, V70, P1003, DOI 10.1103/RevModPhys.70.1003; Bulaev DV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076805; Dreiser J, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075317; Eble B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146601; Fischer J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155329; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Frogley MD, 2006, NAT MATER, V5, P175, DOI 10.1038/nmat1586; Fu KMC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.187405; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Greilich A, 2006, SCIENCE, V313, P341, DOI 10.1126/science.1128215; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Heiss D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241306; Imamoglu A, 2006, PHYS STATUS SOLIDI B, V243, P3725, DOI 10.1002/pssb.200642282; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Laurent S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147401; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Mikkelsen MH, 2007, NAT PHYS, V3, P770, DOI 10.1038/nphys736; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Phillips MC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183602; Ramsay AJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.197401; SCULLY MO, 1992, PHYS REV LETT, V69, P1360, DOI 10.1103/PhysRevLett.69.1360; Stinaff EA, 2006, SCIENCE, V311, P636, DOI 10.1126/science.1121189; Syperek M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.187401; Wynands R, 1999, APPL PHYS B-LASERS O, V68, P1, DOI 10.1007/s003400050581; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401	27	288	291	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					70	72		10.1126/science.1173684	http://dx.doi.org/10.1126/science.1173684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574387				2022-12-28	WOS:000267594000036
J	Kim, HM; Webster, PJ; Curry, JA				Kim, Hye-Mi; Webster, Peter J.; Curry, Judith A.			Impact of Shifting Patterns of Pacific Ocean Warming on North Atlantic Tropical Cyclones	SCIENCE			English	Article							SEASONAL HURRICANE FREQUENCY; EL-NINO; ANNUAL CYCLE; ENSO	Two distinctly different forms of tropical Pacific Ocean warming are shown to have substantially different impacts on the frequency and tracks of North Atlantic tropical cyclones. The eastern Pacific warming (EPW) is identical to that of the conventional El Nino, whereas the central Pacific warming (CPW) has maximum temperature anomalies located near the dateline. In contrast to EPW events, CPW episodes are associated with a greater-than-average frequency and increasing landfall potential along the Gulf of Mexico coast and Central America. Differences are shown to be associated with the modulation of vertical wind shear in the main development region forced by differential teleconnection patterns emanating from the Pacific. The CPW is more predictable than the EPW, potentially increasing the predictability of cyclones on seasonal time scales.	[Kim, Hye-Mi; Webster, Peter J.; Curry, Judith A.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Webster, PJ (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, 311 Ferst Dr, Atlanta, GA 30332 USA.	pjw@eas.gatech.edu		Kim, Hye-Mi/0000-0003-4713-4658	Climate Dynamics Division of the National Sciences Foundation; Georgia Institute of Technology Foundation; European Centre for Medium Range Weather Forecasts;  [NSF-ATM 0531771];  [0826909]; Directorate For Geosciences [0826909] Funding Source: National Science Foundation	Climate Dynamics Division of the National Sciences Foundation; Georgia Institute of Technology Foundation; European Centre for Medium Range Weather Forecasts; ; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research has been supported in part by Climate Dynamics Division of the National Sciences Foundation under Award NSF-ATM 0531771 and 0826909 and the Georgia Institute of Technology Foundation. We are indebted to the European Centre for Medium Range Weather Forecasts for access to the System 3 seasonal forecast archives.	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Elsner JB, 2001, GEOPHYS RES LETT, V28, P4123, DOI 10.1029/2001GL013669; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GRAY WM, 1993, WEATHER FORECAST, V8, P73, DOI 10.1175/1520-0434(1993)008<0073:PABSTC>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1669, DOI 10.1175/1520-0493(1984)112<1669:ASHFPI>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Ho CH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005766; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Kug JS, 2009, J CLIMATE, V22, P1499, DOI 10.1175/2008JCLI2624.1; Landsea CW, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P177; Larkin NK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022860; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Saunders MA, 2000, GEOPHYS RES LETT, V27, P1147, DOI 10.1029/1999GL010948; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Tang BH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021072; Torrence C, 1998, Q J ROY METEOR SOC, V124, P1985, DOI 10.1256/smsqj.55009; Vitart F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030740; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; WEBSTER PJ, 1995, METEOROL ATMOS PHYS, V56, P33, DOI 10.1007/BF01022520; Weng HY, 2007, CLIM DYNAM, V29, P113, DOI 10.1007/s00382-007-0234-0	25	268	292	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					77	80		10.1126/science.1174062	http://dx.doi.org/10.1126/science.1174062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574388				2022-12-28	WOS:000267594000038
J	Kolodrubetz, MH; Petta, JR				Kolodrubetz, Michael H.; Petta, Jason R.			Coherent Holes in a Semiconductor Quantum Dot	SCIENCE			English	Editorial Material							SPIN		[Kolodrubetz, Michael H.; Petta, Jason R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University	Kolodrubetz, MH (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	mkolodru@princeton.edu; petta@princeton.edu	Petta, Jason R/J-6663-2013; Kolodrubetz, Michael/B-2438-2018	Petta, Jason R/0000-0002-6416-0789; Kolodrubetz, Michael/0000-0001-5628-3300				Amasha S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046803; Bergmann K, 1998, REV MOD PHYS, V70, P1003, DOI 10.1103/RevModPhys.70.1003; Brunner D, 2009, SCIENCE, V325, P70, DOI 10.1126/science.1173684; Fischer J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155329; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fu KMC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.187405; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Imamoglu A, 2006, PHYS STATUS SOLIDI B, V243, P3725, DOI 10.1002/pssb.200642282; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054	14	12	13	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					42	43		10.1126/science.1176296	http://dx.doi.org/10.1126/science.1176296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574376				2022-12-28	WOS:000267594000025
J	Settele, J; Kuhn, E				Settele, Josef; Kuehn, Elisabeth			Insect Conservation	SCIENCE			English	Editorial Material							MACULINEA BUTTERFLIES; ANTS		[Settele, Josef; Kuehn, Elisabeth] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Settele, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Theodor Lieser Str 4, D-06120 Halle, Germany.	Josef.Settele@ufz.de; Elisabeth.Kuehn@ufz.de	Kuehn, Elisabeth/AEW-0162-2022; Settele, Josef/A-6371-2009	Kuehn, Elisabeth/0000-0001-8894-2462; Settele, Josef/0000-0002-8624-4983				Als TD, 2004, NATURE, V432, P386, DOI 10.1038/nature03020; Anton C, 2007, MOL ECOL, V16, P3828, DOI 10.1111/j.1365-294X.2007.03441.x; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Settele J, 2005, STUDIES ECOLOGY CONS, V2; Settele Josef, 2008, BioRisk, V1, P1; Spangenberg JH, 2007, SUSTAIN DEV, V15, P343, DOI 10.1002/sd.320; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Thomas J. A., 2005, STUDIES ECOLOGY CONS, V2, P28; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Thomas JA, 2002, NATURE, V417, P505, DOI 10.1038/417505a; Watzold F, 2008, ECOL ECON, V68, P295, DOI 10.1016/j.ecolecon.2008.03.007; Witek M, 2006, OECOLOGIA, V148, P729, DOI 10.1007/s00442-006-0404-5	17	66	68	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					41	42		10.1126/science.1176892	http://dx.doi.org/10.1126/science.1176892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19574375				2022-12-28	WOS:000267594000024
J	Maro, JC; Platt, R; Holmes, JH; Strom, BL; Hennessy, S; Lazarus, R; Brown, JS				Maro, Judith C.; Platt, Richard; Holmes, John H.; Strom, Brian L.; Hennessy, Sean; Lazarus, Ross; Brown, Jeffrey S.			Design of a National Distributed Health Data Network	ANNALS OF INTERNAL MEDICINE			English	Article							AMBULATORY PATIENTS; PUBLIC-HEALTH; CARE; CREATININE; DRUGS; THERAPEUTICS; MEDICATIONS; POTASSIUM; THERAPY	A distributed health data network is a system that allows secure remote analysis of separate data sets, each comprising a different medical organization's or health plan's records. Distributed health data networks are currently being planned that could cover millions of people, permitting studies of comparative clinical effectiveness, best practices, diffusion of medical technologies, and quality of care. These networks could also support assessment of medical product safety and other public health needs. Distributed network technologies allow data holders to control all uses of their data, which overcomes many practical obstacles related to confidentiality, regulation, and proprietary interests. Some of the challenges and potential methods of operation of a multipurpose, multi-institutional distributed health data network are described.	[Brown, Jeffrey S.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; MIT, Cambridge, MA 02139 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Univ Penn, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard Pilgrim Health Care; University of Pennsylvania	Brown, JS (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jeff_brown@harvardpilgrim.org		Brown, Jeffrey/0000-0002-9340-7189; lazarus, ross/0000-0003-3939-1961; Maro, Judith/0000-0001-9900-2142	Agency for Healthcare Research and Quality; U. S. Department of Health and Human Services [290-05-0033]; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE)	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U. S. Department of Health and Human Services; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE)	By the Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services ( contract no. 290-05-0033), as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program.	*AG HEALTHC RES QU, 2008, DISTR NETW AMB RES T; *AG HEALTHC RES QU, 2008, DEV DISTR RES NETW C; Andrade SE, 2008, PHARMACOEPIDEM DR S, V17, P240, DOI 10.1002/pds.1550; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P546, DOI 10.1002/pds.1235; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; CHAN KA, 2005, AHRQ PUBLICATION, P225; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; Halamka J, 2005, J AM MED INFORM ASSN, V12, P596, DOI 10.1197/jamia.M1866; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; Inst. Med, 2008, LEARN HEALTHC SYST C; JONAS J, 2006, AN P 2006 ACM SIGMOD; Lazarus R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-235; McMurry AJ, 2007, J AM MED INFORM ASSN, V14, P527, DOI 10.1197/jamia.M2371; Moore KM, 2008, PHARMACOEPIDEM DR S, V17, P1137, DOI 10.1002/pds.1642; *NAT CANC I, 2006, CANC BIOM INF GRID F; *NAT CANC I, 2009, NAT INV CANC RES CON; *OBS MED OUTC PART, 2009, OBS MED OUTC PARTN P; Platt R, 2001, PHARMACOEPIDEM DR S, V10, P373, DOI 10.1002/pds.607; Raebel MA, 2006, ANN PHARMACOTHER, V40, P386, DOI 10.1345/aph.1G589; Raebel MA, 2005, J GEN INTERN MED, V20, P1120, DOI 10.1111/j.1525-1497.2005.0257.x; Raebel MA, 2007, PHARMACOEPIDEM DR S, V16, P55, DOI 10.1002/pds.1217; Raebel MA, 2007, ANN PHARMACOTHER, V41, P193, DOI 10.1345/aph.1H520; Raebel MA, 2006, J MANAGE CARE PHARM, V12, P656, DOI 10.18553/jmcp.2006.12.8.656; Raebel MA, 2006, AM J MANAG CARE, V12, P268; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Simon SR, 2005, J AM GERIATR SOC, V53, P2165, DOI 10.1111/j.1532-5415.2005.00498.x; *US FDA, SENT IN STRUCT FUNCT; US Food and Drug Administration, 2008, SENT IN NAT STRAT MO; Wagner AK, 2006, PHARMACOEPIDEM DR S, V15, P369, DOI 10.1002/pds.1193; Yih W Katherine, 2004, MMWR Suppl, V53, P43	31	99	99	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					341	U69		10.7326/0003-4819-151-5-200909010-00139	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492KB	19638403				2022-12-28	WOS:000269653100007
J	Hartgrink, HH; Jansen, EPM; van Grieken, NCT; van de Velde, CJH				Hartgrink, Henk H.; Jansen, Edwin P. M.; van Grieken, Nicole C. T.; van de Velde, Cornelis J. H.			Gastric cancer	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR MICROSATELLITE-INSTABILITY; POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED CLINICAL-TRIAL; MARUYAMA INDEX SURGERY; LYMPH-NODE METASTASIS; TOTAL GASTRECTOMY; ADJUVANT CHEMOTHERAPY; PHASE-II	Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists. Prevention and personalised treatment are regarded as the best options to reduce gastric cancer mortality rates. Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype, host gene polymorphisms, presence of precursor lesions, and environmental factors. Although adequate surgery remains the cornerstone of gastric cancer treatment, this single modality treatment seems to have reached its maximum achievable effect for local control and survival. Minimally invasive techniques can be used for treatment of early gastric cancers. Achievement of locoregional control for advanced disease remains very difficult. Extended resections that are standard practice in some Asian countries have not been shown to be as effective in other developed countries. We present an update of the incidence, causes, pathology, and treatment of gastric cancer, consisting of surgery, new strategies with neoadjuvant and adjuvant chemotherapy or radiotherapy, or both, novel treatment strategies using gene signatures, and the effect of caseload on patient outcomes.	[Hartgrink, Henk H.; van de Velde, Cornelis J. H.] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [Jansen, Edwin P. M.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [van Grieken, Nicole C. T.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg, K6-50,POB 9600, NL-2300 RC Leiden, Netherlands.	c.j.h.van_de_velde@lumc.nl	van de Velde, Cornelis/AAY-8360-2020	van Grieken, Nicole/0000-0001-9992-0760	NHLBI NIH HHS [T32 HL007185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Ajani JA, 2004, J CLIN ONCOL, V22, P2774, DOI 10.1200/JCO.2004.01.015; AJANI JA, 1991, CANCER-AM CANCER SOC, V68, P1501, DOI 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO;2-L; Ajani JA, 2006, J CLIN ONCOL, V24, P3953, DOI 10.1200/JCO.2006.06.4840; Allal AS, 2005, INT J RADIAT ONCOL, V63, P1286, DOI 10.1016/j.ijrobp.2005.05.033; Allum WH, 2008, BRIT J SURG, V95, P406, DOI 10.1002/bjs.6197; An CH, 2005, CLIN CANCER RES, V11, P656; [Anonymous], 1990, CANCER-AM CANCER SOC, V66, P2324; Bacani J, 2005, J MOL DIAGN, V7, P465, DOI 10.1016/S1525-1578(10)60577-6; Bachmann MO, 2002, BRIT J SURG, V89, P914, DOI 10.1046/j.1365-2168.2002.02135.x; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Barber M, 2008, J PATHOL, V216, P295, DOI 10.1002/path.2426; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beghelli S, 2006, SURGERY, V139, P347, DOI 10.1016/j.surg.2005.08.021; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Blackshaw Guy R J C, 2003, Gastric Cancer, V6, P225, DOI 10.1007/s10120-003-0257-0; BLEIBERG H, 1989, EUR J SURG ONCOL, V15, P535; Boige V, 2007, J CLIN ONCOL, V25; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Buffart TE, 2007, J PATHOL, V211, P45, DOI 10.1002/path.2085; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Carvalho B, 2003, EUR J CANCER, V39, P1222, DOI 10.1016/S0959-8049(03)00177-1; Coburn NG, 2008, INT J RADIAT ONCOL, V70, P1073, DOI 10.1016/j.ijrobp.2007.07.2378; CORREA P, 1992, CANCER RES, V52, P6735; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2007, NEW ENGL J MED, V357, P1863, DOI 10.1056/NEJMe078182; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Damhuis RAM, 2002, EUR J SURG ONCOL, V28, P401, DOI 10.1053/ejso.2001.1246; de Graaf GW, 2007, EJSO-EUR J SURG ONC, V33, P988, DOI 10.1016/j.ejso.2007.01.007; De Vries AC, 2007, ALIMENT PHARM THER, V26, P25, DOI 10.1111/j.1365-2036.2007.03475.x; DENT DM, 1988, BRIT J SURG, V75, P110, DOI 10.1002/bjs.1800750206; Drognitz O, 2008, INT J RADIAT ONCOL, V70, P715, DOI 10.1016/j.ijrobp.2007.07.2331; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Elsaleh H, 2001, Clin Colorectal Cancer, V1, P104; Fiorica F, 2007, CANCER TREAT REV, V33, P729, DOI 10.1016/j.ctrv.2007.08.005; Fleisher AS, 1999, CANCER RES, V59, P1090; FORMAN D, BMJ, V302, P1302; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Fuccio L, 2007, ALIMENT PHARM THER, V25, P133, DOI 10.1111/j.1365-2036.2006.03183.x; FUCHS C, 2008, 2006 GASTR CANC S SA, P115; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gianni L, 2001, Ann Oncol, V12, P1178; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; GOUZI JL, 1989, ANN SURG, V209, P162, DOI 10.1097/00000658-198902000-00005; Grau JJ, 2008, J SURG ONCOL, V98, P130, DOI 10.1002/jso.21096; Grundei T, 2000, CLIN CANCER RES, V6, P4782; Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9; GUNDERSON LL, 1982, INT J RADIAT ONCOL, V8, P1, DOI 10.1016/0360-3016(82)90377-7; Gylling A, 2007, GUT, V56, P926, DOI 10.1136/gut.2006.114876; HALLISSEY MT, 1994, LANCET, V343, P1309, DOI 10.1016/S0140-6736(94)92464-3; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANLEY AJG, 1995, INT J EPIDEMIOL, V24, P255, DOI 10.1093/ije/24.2.255; Hartgrink HH, 2004, EJSO-EUR J SURG ONC, V30, P643, DOI 10.1016/j.ejso.2004.04.013; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Henning GT, 2000, INT J RADIAT ONCOL, V46, P109, DOI 10.1016/S0360-3016(99)00379-X; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1007/BF02573066; Hundahl SA, 2007, GASTRIC CANCER, V10, P84, DOI 10.1007/s10120-007-0426-7; Jansen EPM, 2007, BRIT J CANCER, V97, P712, DOI 10.1038/sj.bjc.6603965; Jansen EPM, 2007, INT J RADIAT ONCOL, V69, P1424, DOI 10.1016/j.ijrobp.2007.05.004; Jansen EPM, 2007, INT J RADIAT ONCOL, V67, P781, DOI 10.1016/j.ijrobp.2006.09.012; Jansen EPM, 2005, J CLIN ONCOL, V23, P4509, DOI 10.1200/JCO.2005.21.196; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KAMPSCHOER GHM, 1989, BRIT J SURG, V76, P905, DOI 10.1002/bjs.1800760910; Kayaalp C, 2002, EUR J SURG ONCOL, V28, P540, DOI 10.1053/ejso.2002.1296; Keam B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-148; Kim HJ, 2005, RADIOLOGY, V236, P879, DOI 10.1148/radiol.2363041101; Kim JJ, 2007, GASTROINTEST ENDOSC, V66, P693, DOI 10.1016/j.gie.2007.04.013; Kim MM, 2008, INT J RADIAT ONCOL, V71, P167, DOI 10.1016/j.ijrobp.2007.09.019; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Kim SH, 1999, J GASTROINTEST SURG, V3, P24, DOI 10.1016/S1091-255X(99)80004-3; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kitamura K, 1999, BRIT J SURG, V86, P119, DOI 10.1046/j.1365-2168.1999.00967.x; KLAASSEN DJ, 1985, J CLIN ONCOL, V3, P373, DOI 10.1200/JCO.1985.3.3.373; Kodera Y, 1997, WORLD J SURG, V21, P622, DOI 10.1007/s002689900283; Kokkola A, 1998, CANCER GENET CYTOGEN, V107, P32, DOI 10.1016/S0165-4608(98)00092-2; Kollmannsberger C, 2005, ANN ONCOL, V16, P1326, DOI 10.1093/annonc/mdi252; Koo SH, 2000, CANCER GENET CYTOGEN, V117, P97, DOI 10.1016/S0165-4608(99)00152-1; Kozak KR, 2008, INT J RADIAT ONCOL, V72, P517, DOI 10.1016/j.ijrobp.2007.12.029; Kwee RM, 2007, J CLIN ONCOL, V25, P2107, DOI 10.1200/JCO.2006.09.5224; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lenz HJ, 1996, J CLIN ONCOL, V14, P176, DOI 10.1200/JCO.1996.14.1.176; Liu C, 2008, NUTR REV, V66, P237, DOI 10.1111/j.1753-4887.2008.00029.x; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; McCulloch P, 2004, COCHRANE DB SYST REV, V4; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Meyer HJ, 2005, EJSO-EUR J SURG ONC, V31, P595, DOI 10.1016/j.ejso.2005.03.002; Meyers M, 2001, CANCER RES, V61, P5193; Mochiki E, 2004, WORLD J SURG, V28, P247, DOI 10.1007/s00268-003-7191-5; MOERTEL CG, 1984, J CLIN ONCOL, V2, P1249, DOI 10.1200/JCO.1984.2.11.1249; Moutinho C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-10; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Napieralski R, 2005, CLIN CANCER RES, V11, P3025, DOI 10.1158/1078-0432.CCR-04-1605; Noda N, 1998, BRIT J SURG, V85, P831; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Oda I., 2006, GASTRIC CANCER, V9, P262, DOI DOI 10.1007/S10120-006-0389-0]; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Orsenigo E, 2008, SURG ENDOSC, V22, P118, DOI 10.1007/s00464-007-9385-7; Ott K, 2003, CLIN CANCER RES, V9, P2307; Ott K, 2008, CLIN CANCER RES, V14, P2012, DOI 10.1158/1078-0432.CCR-07-0934; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Ottini L, 2006, ANN ONCOL, V17, pVII97, DOI 10.1093/annonc/mdl960; Ottini L, 2004, CARCINOGENESIS, V25, P2337, DOI 10.1093/carcin/bgh257; Palli D, 2007, INT J CANCER, V120, P859, DOI 10.1002/ijc.22435; Park DJ, 2006, EJSO-EUR J SURG ONC, V32, P48, DOI 10.1016/j.ejso.2005.09.006; Park SG, 2000, COMMUN STAT-SIMUL C, V29, P533, DOI 10.1080/03610910008813626; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peeters KCMJ, 2005, WORLD J SURG, V29, P1576, DOI 10.1007/s00268-005-7907-9; Petrelli NJ, 2004, J CLIN ONCOL, V22, P2041, DOI 10.1200/JCO.2004.03.956; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ringash J, 2005, INT J RADIAT ONCOL, V63, P732, DOI 10.1016/j.ijrobp.2005.03.013; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; ROBERTSON CS, 1994, ANN SURG, V220, P176, DOI 10.1097/00000658-199408000-00009; Saikawa Y, 2008, INT J RADIAT ONCOL, V71, P173, DOI 10.1016/j.ijrobp.2007.09.010; Saikawa Y, 2006, WORLD J SURG, V30, P1962, DOI 10.1007/s00268-006-0142-1; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sano T, 2002, JPN J CLIN ONCOL, V32, P363, DOI 10.1093/jjco/hyf085; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; SCHEIN PS, 1982, CANCER, V49, P1771, DOI 10.1002/1097-0142(19820501)49:9<1771::AID-CNCR2820490907>3.0.CO;2-M; Shehzad K, 2007, SURG ONCOL, V16, P85, DOI 10.1016/j.suronc.2007.04.012; Shinmura K, 2005, CLIN GENET, V67, P81, DOI 10.1111/j.1399-0004.2005.00380.x; Shinohara T, 2005, EJSO-EUR J SURG ONC, V31, P743, DOI 10.1016/j.ejso.2005.03.005; Shiraishi Norio, 2006, Gastric Cancer, V9, P167, DOI 10.1007/s10120-006-0380-9; SINDELAR WF, 1993, AM J SURG, V165, P178, DOI 10.1016/S0002-9610(05)80423-4; Skoropad V, 2002, J SURG ONCOL, V80, P72, DOI 10.1002/jso.10102; Smalley SR, 2002, INT J RADIAT ONCOL, V52, P283, DOI 10.1016/S0360-3016(01)02646-3; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Songun I, 1996, EUR J CANCER, V32A, P433, DOI 10.1016/0959-8049(95)00591-9; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sultan J, 2008, BRIT J SURG, V95, P1127, DOI 10.1002/bjs.6299; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Tajima Y, 2009, ANN SURG, V249, P58, DOI 10.1097/SLA.0b013e3181927267; Thompson AM, 2007, BRIT J SURG, V94, P578, DOI 10.1002/bjs.5729; Tsugane S, 2007, GASTRIC CANCER, V10, P75, DOI 10.1007/s10120-007-0420-0; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; UICC, 2002, TNM CLASS MAL TUM; van Grieken NCT, 2000, J PATHOL, V192, P301, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH697&gt;3.0.CO;2-F; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang JY, 2004, HEPATO-GASTROENTEROL, V51, P1229; WANG YP, 2006, COCHRANE DB SYST REV, V1; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350; Weiss MM, 2003, J PATHOL, V199, P157, DOI 10.1002/path.1260; Wenner J, 2005, ANTICANCER RES, V25, P419; Wieland P, 2004, INT J RADIAT ONCOL, V59, P1236, DOI 10.1016/j.ijrobp.2004.02.051; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Wu MS, 2000, GENE CHROMOSOME CANC, V27, P403, DOI 10.1002/(SICI)1098-2264(200004)27:4<403::AID-GCC10>3.3.CO;2-T; Wydmanski J, 2007, RADIOTHER ONCOL, V82, P132, DOI 10.1016/j.radonc.2007.01.009; Xirasagar S, 2008, EJSO-EUR J SURG ONC, V34, P23, DOI 10.1016/j.ejso.2007.08.002; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Yan TD, 2007, ANN SURG ONCOL, V14, P2702, DOI 10.1245/s10434-007-9487-4; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Yu WS, 1998, AM SURGEON, V64, P1104; Zhang ZX, 1998, INT J RADIAT ONCOL, V42, P929, DOI 10.1016/S0360-3016(98)00280-6	176	810	855	1	179	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					477	490		10.1016/S0140-6736(09)60617-6	http://dx.doi.org/10.1016/S0140-6736(09)60617-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19625077	Green Accepted			2022-12-28	WOS:000268898400030
J	Ostrom, E				Ostrom, Elinor			A General Framework for Analyzing Sustainability of Social-Ecological Systems	SCIENCE			English	Editorial Material							LOCAL ENFORCEMENT; COMMONS; PANACEAS; FORESTS; INSTITUTIONS; RESOURCES; TRAGEDY; SCALE	A major problem worldwide is the potential loss of fisheries, forests, and water resources. Understanding of the processes that lead to improvements in or deterioration of natural resources is limited, because scientific disciplines use different concepts and languages to describe and explain complex social-ecological systems (SESs). Without a common framework to organize findings, isolated knowledge does not cumulate. Until recently, accepted theory has assumed that resource users will never self-organize to maintain their resources and that governments must impose solutions. Research in multiple disciplines, however, has found that some government policies accelerate resource destruction, whereas some resource users have invested their time and energy to achieve sustainability. A general framework is used to identify 10 subsystem variables that affect the likelihood of self-organization in efforts to achieve a sustainable SES.	[Ostrom, Elinor] Indiana Univ, Bloomington, IN 47408 USA; [Ostrom, Elinor] Arizona State Univ, Ctr Study Inst Div, Tempe, AZ 85287 USA	Indiana University System; Indiana University Bloomington; Arizona State University; Arizona State University-Tempe	Ostrom, E (corresponding author), Indiana Univ, Bloomington, IN 47408 USA.	ostrom@indiana.edu	Lobo, Diele/I-9106-2012	Newman, Gregory/0000-0003-0503-5782				Acheson James M., 1998, LINKING SOCIAL ECOLO, P390; Agrawal A, 2000, PEOPLE FORESTS COMMU, P57; Axelrod R, 2001, HARNESSING COMPLEXIT; Baland J.-M, 2000, HALTING DEGRADATION; Basurto X, 2005, SOC NATUR RESOUR, V18, P643, DOI 10.1080/08941920590959631; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Brander JA, 1998, AM ECON REV, V88, P119; Brock WA, 2007, P NATL ACAD SCI USA, V104, P15206, DOI 10.1073/pnas.0702096104; Chhatre A, 2008, P NATL ACAD SCI USA, V105, P13286, DOI 10.1073/pnas.0803399105; CLARK CW, 2006, WORLDWIDE CRISIS FIS; Coleman EA, 2009, ECOL ECON, V68, P2106, DOI 10.1016/j.ecolecon.2009.02.006; Cumming GS., 2008, COMPLEXITY THEORY SU, P15; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Janssen M., 2002, COMPLEXITY ECOSYSTEM; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Meinzen-Dick R, 2007, P NATL ACAD SCI USA, V104, P15200, DOI 10.1073/pnas.0702296104; Mwangi E., 2007, SOCIOECONOMIC CHANGE; Nagendra H, 2007, P NATL ACAD SCI USA, V104, P15218, DOI 10.1073/pnas.0702319104; Ostrom Elinor, 2002, DRAM COMM; Norgaard RB, 2008, CONSERV BIOL, V22, P862, DOI 10.1111/j.1523-1739.2008.00922.x; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E., 1994, RULES GAMES COMMON P; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Pennisi E, 2003, SCIENCE, V302, P1646, DOI 10.1126/science.302.5651.1646; Pritchett L, 2004, WORLD DEV, V32, P191, DOI 10.1016/j.worlddev.2003.08.009; SCHLAGER E, 1994, LAND ECON, V70, P294, DOI 10.2307/3146531; Trawick PB, 2001, HUM ECOL, V29, P1, DOI 10.1023/A:1007199304395; Wade R., 1994, VILLAGE REPUBLICS EC; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104; WILSON PN, 1993, ECON DEV CULT CHANGE, V41, P299, DOI 10.1086/452012	34	3802	3979	112	2100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					419	422		10.1126/science.1172133	http://dx.doi.org/10.1126/science.1172133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474AR	19628857				2022-12-28	WOS:000268255100041
J	Campbell, SM; Reeves, D; Kontopantelis, E; Sibbald, B; Roland, M				Campbell, Stephen M.; Reeves, David; Kontopantelis, Evangelos; Sibbald, Bonnie; Roland, Martin			Effects of Pay for Performance on the Quality of Primary Care in England	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENGLISH GENERAL-PRACTICE; OUTCOMES FRAMEWORK; CLINICAL CARE; CRITERIA; ANGINA; ASTHMA	Background A pay-for-performance scheme based on meeting targets for the quality of clinical care was introduced to family practice in England in 2004. Methods We conducted an interrupted time-series analysis of the quality of care in 42 representative family practices, with data collected at two time points before implementation of the scheme (1998 and 2003) and at two time points after implementation (2005 and 2007). At each time point, data on the care of patients with asthma, diabetes, or coronary heart disease were extracted from medical records; data on patients' perceptions of access to care, continuity of care, and interpersonal aspects of care were collected from questionnaires. The analysis included aspects of care that were and those that were not associated with incentives. Results Between 2003 and 2005, the rate of improvement in the quality of care increased for asthma and diabetes (P<0.001) but not for heart disease. By 2007, the rate of improvement had slowed for all three conditions (P<0.001), and the quality of those aspects of care that were not associated with an incentive had declined for patients with asthma or heart disease. As compared with the period before the pay-for-performance scheme was introduced, the improvement rate after 2005 was unchanged for asthma or diabetes and was reduced for heart disease (P = 0.02). No significant changes were seen in patients' reports on access to care or on interpersonal aspects of care. The level of the continuity of care, which had been constant, showed a reduction immediately after the introduction of the pay-for-performance scheme (P<0.001) and then continued at that reduced level. Conclusions Against a background of increases in the quality of care before the pay-for-performance scheme was introduced, the scheme accelerated improvements in quality for two of three chronic conditions in the short term. However, once targets were reached, the improvement in the quality of care for patients with these conditions slowed, and the quality of care declined for two conditions that had not been linked to incentives. Continuity of care was reduced after the introduction of the scheme.	[Campbell, Stephen M.; Reeves, David; Kontopantelis, Evangelos; Sibbald, Bonnie; Roland, Martin] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Roland, Martin] Univ Cambridge, Gen Practice & Primary Care Res Unit, Inst Publ Hlth, Cambridge, England	University of Manchester; University of Cambridge	Campbell, SM (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Oxford Rd, Manchester M13 9PL, Lancs, England.	stephen.campbell@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Reeves, David/H-6203-2014	Kontopantelis, Evangelos/0000-0001-6450-5815; Reeves, David/0000-0001-6377-6859; Campbell, Stephen/0000-0002-2328-4136; Roland, Martin/0000-0002-8533-3060	Department of Health for England	Department of Health for England	Supported by the Department of Health for England.	BMA & NHS Employers, 2009, QUALITY OUTCOMES FRA; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P125, DOI 10.1136/qhc.11.2.125; Campbell SM, 1999, QUAL HEALTH CARE, V8, P6, DOI 10.1136/qshc.8.1.6; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Goodall S, 2006, BRIT J GEN PRACT, V56, P918; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mangin D, 2007, BRIT J GEN PRACT, V57, P435; McDonald R, 2009, ANN FAM MED, V7, P121, DOI 10.1370/afm.946; Mead N, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-13; *NAT HLTH SERV INF, 2008, GP EARN EXP ENQ 2005; National Health Service Information Centre, 2008, NAT QUAL OUTC FRAM S; National Health Service Information Centre, 2006, NAT QUAL OUTC FRAM S; *QRESEARCH INF CTR, 2007, TIM SER AN SEL CLIN; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	21	460	464	2	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					368	378		10.1056/NEJMsa0807651	http://dx.doi.org/10.1056/NEJMsa0807651			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625717	Green Published			2022-12-28	WOS:000268184500007
J	Keele, BF; Jones, JH; Terio, KA; Estes, JD; Rudicell, RS; Wilson, ML; Li, YY; Learn, GH; Beasley, TM; Schumacher-Stankey, J; Wroblewski, E; Mosser, A; Raphael, J; Kamenya, S; Lonsdorf, EV; Travis, DA; Mlengeya, T; Kinsel, MJ; Else, JG; Silvestri, G; Goodall, J; Sharp, PM; Shaw, GM; Pusey, AE; Hahn, BH				Keele, Brandon F.; Jones, James Holland; Terio, Karen A.; Estes, Jacob D.; Rudicell, Rebecca S.; Wilson, Michael L.; Li, Yingying; Learn, Gerald H.; Beasley, T. Mark; Schumacher-Stankey, Joann; Wroblewski, Emily; Mosser, Anna; Raphael, Jane; Kamenya, Shadrack; Lonsdorf, Elizabeth V.; Travis, Dominic A.; Mlengeya, Titus; Kinsel, Michael J.; Else, James G.; Silvestri, Guido; Goodall, Jane; Sharp, Paul M.; Shaw, George M.; Pusey, Anne E.; Hahn, Beatrice H.			Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz	NATURE			English	Article							GOMBE NATIONAL-PARK; IMMUNODEFICIENCY VIRUS-INFECTION; IMMUNE ACTIVATION; HIV-INFECTION; T-CELLS; TRANSMISSION; RESISTANCE; COMMUNITY; ABSENCE; TISSUE	African primates are naturally infected with over 40 different simian immunodeficiency viruses (SIVs), two of which have crossed the species barrier and generated human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2)(1,2). Unlike the human viruses, however, SIVs do not generally cause acquired immunodeficiency syndrome (AIDS) in their natural hosts(3). Here we show that SIVcpz, the immediate precursor of HIV-1, is pathogenic in free-ranging chimpanzees. By following 94 members of two habituated chimpanzee communities in Gombe National Park, Tanzania, for over 9 years, we found a 10- to 16-fold higher age-corrected death hazard for SIVcpz-infected (n = 17) compared to uninfected (n = 77) chimpanzees. We also found that SIVcpz-infected females were less likely to give birth and had a higher infant mortality rate than uninfected females. Immunohistochemistry and in situ hybridization of post-mortem spleen and lymph node samples from three infected and two uninfected chimpanzees revealed significant CD4(+) T-cell depletion in all infected individuals, with evidence of high viral replication and extensive follicular dendritic cell virus trapping in one of them. One female, who died within 3 years of acquiring SIVcpz, had histopathological findings consistent with end-stage AIDS. These results indicate that SIVcpz, like HIV-1, is associated with progressive CD4(+) T-cell loss, lymphatic tissue destruction and premature death. These findings challenge the prevailing view that all natural SIV infections are non-pathogenic and suggest that SIVcpz has a substantial negative impact on the health, reproduction and lifespan of chimpanzees in the wild.	[Keele, Brandon F.; Li, Yingying; Learn, Gerald H.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rudicell, Rebecca S.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Jones, James Holland] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Terio, Karen A.; Kinsel, Michael J.] Univ Illinois, Zool Pathol Program, Maywood, IL 60153 USA; [Estes, Jacob D.] NCI, Sci Applicat Int Corp Frederick Inc, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; [Wilson, Michael L.; Schumacher-Stankey, Joann; Wroblewski, Emily; Pusey, Anne E.] Univ Minnesota, Dept Ecol Evolut & Behav, Jane Goodall Inst Ctr Primate Studies, St Paul, MN 55108 USA; [Mosser, Anna; Raphael, Jane; Kamenya, Shadrack] Jane Goodall Inst, Gombe Stream Res Ctr, Kigoma, Tanzania; [Lonsdorf, Elizabeth V.] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Travis, Dominic A.] Lincoln Pk Zoo, Dept Conservat & Sci, Chicago, IL 60614 USA; [Mlengeya, Titus] Tanzania Natl Pk, Arusha, Tanzania; [Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Div Anim Resources, Atlanta, GA 30322 USA; [Silvestri, Guido] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19107 USA; [Goodall, Jane] Jane Goodall Inst, Arlington, VA 22203 USA; [Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; University of Pennsylvania; University of Edinburgh	Hahn, BH (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul/Y-3787-2019; Sharp, Paul M/F-5783-2010; Wilson, Michael Lawrence/AAC-9154-2020; Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011; Terio, Karen/AAC-5376-2019; Sharp, Paul M/GPX-1497-2022	Sharp, Paul M/0000-0001-9771-543X; Wilson, Michael Lawrence/0000-0003-3073-4518; Learn, Gerald H/0000-0003-0434-7733; Sharp, Paul M/0000-0001-9771-543X; Pusey, Anne/0000-0002-2280-8954; Jones, James/0000-0003-1680-6757; Hahn, Beatrice/0000-0002-9400-9887	National Institutes of Health [R01 AI50529, R01 AI58715, U19 AI067854, T32 GM008111]; National Cancer Institute [HHSN266200400088C]; UAB Center for AIDS Research [P30 AI 27767]; Yerkes National Primate Research Center [RR-00165]; National Science Foundation [DBS-9021946, SBR-9319909, BSC-0452315, IIS-0431141, BSC-0648481]; Jane Goodall Institute; Harris Steel Group; University of Minnesota; University of Illinois; US Fish and Wildlife Service Great Ape Conservation Fund; Windibrow, Arcus, Guthman and Davee Foundations; Lincoln Park Zoo; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R01AI050529, R01AI058715, P30AI027767, R37AI050529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Center for AIDS Research; Yerkes National Primate Research Center; National Science Foundation(National Science Foundation (NSF)); Jane Goodall Institute; Harris Steel Group; University of Minnesota(University of Minnesota System); University of Illinois; US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Windibrow, Arcus, Guthman and Davee Foundations; Lincoln Park Zoo; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the field staff at the Gombe Stream Research Centre for collecting behavioural data as well as urine and faecal samples from wild chimpanzees; E. Kaaya for help with necropsies; A. Collins for logistical support; the Tanzania Commission for Science and Technology, the Tanzania Wildlife Research Institute, and the Tanzania National Parks for permission to conduct research in Gombe; I. White for discussions; L. Lowenstine for histological consultation; M. Salazar and Y. Chen for technical assistance; and J. C. White for artwork and manuscript preparation. This work was supported by grants from the National Institutes of Health (R01 AI50529, R01 AI58715, U19 AI067854, T32 GM008111), the National Cancer Institute (contract HHSN266200400088C), the UAB Center for AIDS Research (P30 AI 27767), the Yerkes National Primate Research Center (RR-00165), the National Science Foundation (DBS-9021946, SBR-9319909, BSC-0452315, IIS-0431141, BSC-0648481), the Jane Goodall Institute, the Harris Steel Group, the University of Minnesota, the University of Illinois, the US Fish and Wildlife Service Great Ape Conservation Fund, the Windibrow, Arcus, Guthman and Davee Foundations, and the Lincoln Park Zoo. R. S. R. was funded by a Howard Hughes Medical Institute Med-into-Grad Fellowship. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gougeon ML, 1997, J IMMUNOL, V158, P2964; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KING NW, 1993, NONHUMAN PRIMATES, V1, P5; Koopman G, 1999, AIDS RES HUM RETROV, V15, P365, DOI 10.1089/088922299311330; MULDER DW, 1994, LANCET, V343, P1021, DOI 10.1016/S0140-6736(94)90133-3; Pandrea I, 2009, CURR HIV RES, V7, P57, DOI 10.2174/157016209787048456; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schindler M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000107; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Silvestri G, 2009, J INTERN MED, V265, P97, DOI 10.1111/j.1365-2796.2008.02049.x; Singer J.D., 2003, APPL LONGITUDINAL DA; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573	29	245	248	0	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					515	519		10.1038/nature08200	http://dx.doi.org/10.1038/nature08200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19626114	Green Accepted			2022-12-28	WOS:000268257000039
J	Navario, P				Navario, Peter			PEPFAR's biggest success is also its largest liability	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; RAPID SCALE-UP; SOUTH-AFRICA; OUTCOMES; PROGRAM		Council Foreign Relat, New York, NY 10065 USA		Navario, P (corresponding author), Council Foreign Relat, New York, NY 10065 USA.	ckennedy@cfr.org						Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; GERSON M, 2009, WASHINGTON POST 0128; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; MCNEIL DG, 2009, NY TIMES        0130; *OFF GLOB AIDS COO, 2009, CEL LIF US PRES EM P; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/00002030-200309050-00023; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3	12	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					184	185		10.1016/S0140-6736(09)61312-X	http://dx.doi.org/10.1016/S0140-6736(09)61312-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474DP	19616705				2022-12-28	WOS:000268263000008
J	Briggs, AW; Good, JM; Green, RE; Krause, J; Maricic, T; Stenzel, U; Lalueza-Fox, C; Rudan, P; Brajkovic, D; Kucan, Z; Gusic, I; Schmitz, R; Doronichev, VB; Golovanova, LV; de la Rasilla, M; Fortea, J; Rosas, A; Paabo, S				Briggs, Adrian W.; Good, Jeffrey M.; Green, Richard E.; Krause, Johannes; Maricic, Tomislav; Stenzel, Udo; Lalueza-Fox, Carles; Rudan, Pavao; Brajkovic, Dejana; Kucan, Zeljko; Gusic, Ivan; Schmitz, Ralf; Doronichev, Vladimir B.; Golovanova, Liubov V.; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Paeaebo, Svante			Targeted Retrieval and Analysis of Five Neandertal mtDNA Genomes	SCIENCE			English	Article							ANCIENT DNA; MITOCHONDRIAL-DNA; REVEALS; POPULATIONS; SEQUENCES; SELECTION; GENETICS; REMAINS; SIMCOAL; HUMANS	Analysis of Neandertal DNA holds great potential for investigating the population history of this group of hominins, but progress has been limited due to the rarity of samples and damaged state of the DNA. We present a method of targeted ancient DNA sequence retrieval that greatly reduces sample destruction and sequencing demands and use this method to reconstruct the complete mitochondrial DNA (mtDNA) genomes of five Neandertals from across their geographic range. We find that mtDNA genetic diversity in Neandertals that lived 38,000 to 70,000 years ago was approximately one-third of that in contemporary modern humans. Together with analyses of mtDNA protein evolution, these data suggest that the long-term effective population size of Neandertals was smaller than that of modern humans and extant great apes.	[Briggs, Adrian W.; Good, Jeffrey M.; Green, Richard E.; Krause, Johannes; Maricic, Tomislav; Stenzel, Udo; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona 08003, Spain; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternay Paleontol & Geol, HR-10000 Zagreb, Croatia; [Schmitz, Ralf] Landschaftsverband Rheinland Landesmuseum, D-53115 Bonn, Germany; [Schmitz, Ralf] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72074 Tubingen, Germany; [Doronichev, Vladimir B.; Golovanova, Liubov V.] Lab Prehist, St Petersburg, Russia; [de la Rasilla, Marco; Fortea, Javier] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Croatian Academy of Sciences & Arts; Eberhard Karls University of Tubingen; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Briggs, AW (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	briggs@eva.mpg.de	Krause, Johannes/AFP-2642-2022; LALUEZA-FOX, CARLES/AAG-5341-2020; Liubov, Golovanova V./Q-2995-2016; Krause, Johannes/E-6640-2015; Rosas, Antonio/D-9742-2016	Krause, Johannes/0000-0001-9144-3920; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Krause, Johannes/0000-0001-5475-4690; Rosas, Antonio/0000-0002-5829-9952; Doronichev, Vladimir/0000-0003-0198-0250; de la RASILLA, Marco/0000-0002-5505-0625; Golovanova, Liubov/0000-0002-6099-4081; Green, Richard/0000-0003-0516-5827	Max Planck Society; Principado de Asturias; Spanish Ministry of Education and Science; NSF [OISE-0754461]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Principado de Asturias(Principality of Asturias); Spanish Ministry of Education and Science(Spanish Government); NSF(National Science Foundation (NSF))	We thank P. Johnson, M. Knapp, A.-S. Malaspinas, M. Meyer, J. Sullivan, M. Slatkin, and anonymous reviewers for comments; the Croatian Academy of Sciences and Arts and the Berlin-Brandenburg Academy of Sciences for logistic and scientific support; and the Presidential Innovation Fund of the Max Planck Society for financial support. The government of the Principado de Asturias funded excavations at the El Sidron site. C.L.-F. was supported by the Spanish Ministry of Education and Science and J.M.G. by an NSF international postdoctoral fellowship (OISE-0754461). Sequences are deposited at the EBI (European Bioinformatics Institute) nucleotide database with the following accession numbers: Neandertal 1 (Feldhofer 1), FM865407; Neandertal 2 (Feldhofer 2), FM865408; Sidron 1253, FM865409; Vindija 33.25, FM865410; Mezmaiskaya 1, FM865411.	Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Anderung C, 2008, FORENSIC SCI INT-GEN, V2, P104, DOI 10.1016/j.fsigen.2007.09.004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2006, CURR BIOL, V16, pR650, DOI 10.1016/j.cub.2006.07.035; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jesus FF, 2006, GENET MOL RES, V5, P466; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Mackelprang R, 2008, SCIENCE, V321, P211, DOI 10.1126/science.1161890; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Skinner AR, 2005, APPL RADIAT ISOTOPES, V62, P219, DOI 10.1016/j.apradiso.2004.08.008	30	349	375	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					318	321		10.1126/science.1174462	http://dx.doi.org/10.1126/science.1174462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608918				2022-12-28	WOS:000268036600045
J	Emery, B; Agalliu, D; Cahoy, JD; Watkins, TA; Dugas, JC; Mulinyawe, SB; Ibrahim, A; Ligon, KL; Rowitch, DH; Barres, BA				Emery, Ben; Agalliu, Dritan; Cahoy, John D.; Watkins, Trent A.; Dugas, Jason C.; Mulinyawe, Sara B.; Ibrahim, Adilijan; Ligon, Keith L.; Rowitch, David H.; Barres, Ben A.			Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination	CELL			English	Article							OLIGODENDROCYTE DIFFERENTIATION; NERVOUS-SYSTEM; NKX2.2; BRAIN; SOX10; OLIG1; EXPRESSION; LINEAGE; BINDING; PROTEIN	The transcriptional control of CNS myelin gene expression is poorly understood. Here we identify gene model 98, which we have named myelin gene regulatory factor (MRF), as a transcriptional regulator required for CNS myelination. Within the CNS, MRF is specifically expressed by postmitotic oligodendrocytes. MRF is a nuclear protein containing an evolutionarily conserved DNA binding domain homologous to a yeast transcription factor. Knockdown of MRF in oligodendrocytes by RNA interference prevents expression of most CNS myelin genes; conversely, overexpression of MRF within cultured oligodendrocyte progenitors or the chick spinal cord promotes expression of myelin genes. In mice lacking MRF within the oligodendrocyte lineage, premyelinating oligodendrocytes are generated but display severe deficits in myelin gene expression and fail to myelinate. These mice display severe neurological abnormalities and die because of seizures during the third postnatal week. These findings establish MRF as a critical transcriptional regulator essential for oligodendrocyte maturation and CNS myelination.	[Emery, Ben; Agalliu, Dritan; Cahoy, John D.; Watkins, Trent A.; Dugas, Jason C.; Mulinyawe, Sara B.; Ibrahim, Adilijan; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Emery, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	bemery@stanford.edu	Emery, Ben/I-6223-2013	Rowitch, David/0000-0002-0079-0060; Emery, Ben/0000-0002-9132-3045	National Eye Institute [RO1 EY10257]; Australian NHMRC CJ Martin; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Australian NHMRC CJ Martin; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Professor Klaus-Armin Nave for kindly providing the CNP-Cre mouse line. We are indebted to Lydia-Marie Joubert for processing samples for TEM and Elizabeth Zou for processing samples for Affymetrix analysis. This work was funded by the National Eye Institute (RO1 EY10257, B. A. B.) and the Myelin Repair Foundation. B. E. is supported by an Australian NHMRC CJ Martin award.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fu H, 2002, DEVELOPMENT, V129, P681; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Pakkasjarvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185; Qi YC, 2001, DEVELOPMENT, V128, P2723; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Stohr H, 2000, CYTOGENET CELL GENET, V88, P211, DOI 10.1159/000015552; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	27	332	338	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					172	185		10.1016/j.cell.2009.04.031	http://dx.doi.org/10.1016/j.cell.2009.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596243	Green Accepted, Bronze			2022-12-28	WOS:000267848600023
J	Moore, SW; Biais, N; Sheetz, MP				Moore, Simon W.; Biais, Nicolas; Sheetz, Michael P.			Traction on Immobilized Netrin-1 Is Sufficient to Reorient Axons	SCIENCE			English	Article							COMMISSURAL AXONS; RECEPTOR; DCC; GUIDANCE; GROWTH		[Moore, Simon W.; Biais, Nicolas; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ms2001@columbia.edu		Moore, Simon/0000-0003-1330-8381	NIH [PN2 EY016586-02, AI079030]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. E. Kennedy for critical reading, N. Gauthier for discussion, and support from NIH grants PN2 EY016586-02 (S.W.M. and M.P.S.) and AI079030 (N.B.).	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0	9	69	70	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					166	166		10.1126/science.1173851	http://dx.doi.org/10.1126/science.1173851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589994	Green Accepted			2022-12-28	WOS:000267802000036
J	Stebe, KJ; Lewandowski, E; Ghosh, M				Stebe, Kathleen J.; Lewandowski, Eric; Ghosh, Moniraj			Oriented Assembly of Metamaterials	SCIENCE			English	Editorial Material							INDEX		[Stebe, Kathleen J.; Lewandowski, Eric] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Ghosh, Moniraj] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	University of Pennsylvania; Johns Hopkins University	Stebe, KJ (corresponding author), Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	kstebe@seas.upenn.edu						Aizenberg J, 2000, PHYS REV LETT, V84, P2997, DOI 10.1103/PhysRevLett.84.2997; DENKOV ND, 1992, LANGMUIR, V8, P3183, DOI 10.1021/la00048a054; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Harris DJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.148301; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; John BS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819091; Lee JH, 2009, OPT LETT, V34, P443, DOI 10.1364/OL.34.000443; Loudet JC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018301; Ming T, 2008, ANGEW CHEM INT EDIT, V47, P9685, DOI 10.1002/anie.200803642; Rycenga M, 2008, ADV MATER, V20, P2416, DOI 10.1002/adma.200800360; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Zhao K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.268301	16	161	162	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					159	160		10.1126/science.1174401	http://dx.doi.org/10.1126/science.1174401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589992				2022-12-28	WOS:000267802000034
J	Davies, A; Kemp, AES; Pike, J				Davies, Andrew; Kemp, Alan E. S.; Pike, Jennifer			Late Cretaceous seasonal ocean variability from the Arctic	NATURE			English	Article							SEA; TEMPERATURES; ENTRAINMENT; PERSPECTIVE; SEDIMENT; DIATOMS; CYCLE; GYRE	The modern Arctic Ocean is regarded as a barometer of global change and amplifier of global warming(1) and therefore records of past Arctic change are critical for palaeoclimate reconstruction. Little is known of the state of the Arctic Ocean in the greenhouse period of the Late Cretaceous epoch (65-99 million years ago), yet records from such times may yield important clues to Arctic Ocean behaviour in near-future warmer climates. Here we present a seasonally resolved Cretaceous sedimentary record from the Alpha ridge of the Arctic Ocean. This palaeo-sediment trap provides new insight into the workings of the Cretaceous marine biological carbon pump. Seasonal primary production was dominated by diatom algae but was not related to upwelling as was previously hypothesized(2). Rather, production occurred within a stratified water column, involving specially adapted species in blooms resembling those of the modern North Pacific subtropical gyre(3), or those indicated for the Mediterranean sapropels(4). With increased CO2 levels and warming currently driving increased stratification in the global ocean(5), this style of production that is adapted to stratification may become more widespread. Our evidence for seasonal diatom production and flux testify to an ice-free summer, but thin accumulations of terrigenous sediment within the diatom ooze are consistent with the presence of intermittent sea ice in the winter, supporting a wide body of evidence for low temperatures in the Late Cretaceous Arctic Ocean(6-8), rather than recent suggestions of a 15 degrees C mean annual temperature at this time(9).	[Davies, Andrew; Kemp, Alan E. S.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Pike, Jennifer] Cardiff Univ, Sch Ocean & Earth Sci, Cardiff CF10 3YE, S Glam, Wales	NERC National Oceanography Centre; University of Southampton; Cardiff University	Kemp, AES (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England.	aesk@noc.soton.ac.uk	Davies, Andrew/GXA-2513-2022; Pike, Jennifer/D-2589-2009; Kemp, Alan/AAU-9882-2021	Davies, Andrew/0000-0002-7048-2709; Pike, Jennifer/0000-0001-9415-6003; 	NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by the award of a NERC Research Studentship (A. D.) and a NERC Research Grant (A. E. S. K. and J. P.). We are grateful to P. Mudie for facilitating sampling of the CESAR-6 core and to D. Clark for providing samples from core FL-437. We thank R. Pearce for assistance with electron microscopy and K. Davis for expertise in drafting. We also thank P. Wilson and H. Palike for comments on the manuscript.	Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; BODEN P, 1991, MICROPALEONTOLOGY, V37, P313, DOI 10.2307/1485893; Chin K, 2008, P ROY SOC B-BIOL SCI, V275, P2675, DOI 10.1098/rspb.2008.0801; DELLAGNESE DJ, 1994, J PALEONTOL, V68, P31, DOI 10.1017/S0022336000025580; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Falcon-Lang HJ, 2004, PALAEOGEOGR PALAEOCL, V212, P45, DOI 10.1016/j.palaeo.2004.05.016; Francus P, 2002, J PALEOLIMNOL, V28, P283, DOI 10.1023/A:1021624415920; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Harwood D.M., 1995, SILICEOUS MICROFOSSI, V8, P81, DOI DOI 10.1017/S2475263000001434; HARWOOD D. M., 2007, PALEONTOL SOC PAP, V13, P33, DOI DOI 10.1017/S1089332600001455; Hay WW, 1999, GEOL S AM S, P1; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Kemp AES, 2000, DEEP-SEA RES PT II, V47, P2129, DOI 10.1016/S0967-0645(00)00019-9; Kemp AES, 2002, DEV PALEOENVIRON RES, V2, P7; Kemp AES, 1999, NATURE, V398, P57, DOI 10.1038/18001; KEMPEMA EW, 1989, J SEDIMENT PETROL, V59, P308; KITCHELL JA, 1982, PALAEOGEOGR PALAEOCL, V40, P135, DOI 10.1016/0031-0182(82)90087-6; Kuypers MMM, 2004, GEOLOGY, V32, P853, DOI 10.1130/G20458.1; MCQUOID MR, 1995, J PHYCOL, V31, P44, DOI 10.1111/j.0022-3646.1995.00044.x; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; MUDIE PJ, 1986, J GEODYN, V6, P215, DOI 10.1016/0264-3707(86)90040-2; Otto-Bliesner BL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000821; Sachs JP, 1999, SCIENCE, V286, P2485, DOI 10.1126/science.286.5449.2485; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; Scherer Reed P., 1994, Journal of Paleolimnology, V12, P171, DOI 10.1007/BF00678093; Singler HR, 2005, J PLANKTON RES, V27, P545, DOI 10.1093/plankt/fbi030; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Smedsrud LH, 2001, J GLACIOL, V47, P461, DOI 10.3189/172756501781832142; STOFFYNEGLI P, 1987, GEO-MAR LETT, V7, P223, DOI 10.1007/BF02242775; Tapia PM, 2002, MICROPALEONTOLOGY, V48, P303, DOI 10.1661/0026-2803(2002)048[0303:UCDBOT]2.0.CO;2; Wagner T, 2004, PALEOCEANOGRAPHY, V19, DOI [10.1029/2004PA001087, 10.1029/2003PA000898]	33	70	74	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					254	U118		10.1038/nature08141	http://dx.doi.org/10.1038/nature08141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587768	Green Accepted			2022-12-28	WOS:000267761000040
J	de Waal, FBM				de Waal, Frans B. M.			Darwin's last laugh	NATURE			English	Editorial Material							EVOLUTION		Emory Univ, Yerkes Natl Primate Res Ctr, Living Links Ctr, Atlanta, GA 30322 USA	Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Living Links Ctr, 954 N Gatewood Rd, Atlanta, GA 30322 USA.	dewaal@emory.edu						Bolhuis JJ, 2009, NATURE, V458, P832, DOI 10.1038/458832a; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048	5	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					175	175		10.1038/460175a	http://dx.doi.org/10.1038/460175a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587747				2022-12-28	WOS:000267761000017
J	Yamanaka, S				Yamanaka, Shinya			Elite and stochastic models for induced pluripotent stem cell generation	NATURE			English	Article							HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE; DIFFERENTIATION; INDUCTION; EXPRESSION; SYSTEM; GENES; MYC	Induced pluripotent stem cells offer unprecedented potential for disease research, drug screening, toxicology and regenerative medicine. However, the process of reprogramming is inefficient and often incomplete. Here I consider reasons for bottlenecks in induced pluripotent stem cell generation, and propose a model in which most or all cells have the potential to become pluripotent.	[Yamanaka, Shinya] Kyoto Univ, CiRA, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, CiRA, Kyoto 6068507, Japan.	yamanaka@cira.kyoto-u.ac.jp						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Varas F, 2009, STEM CELLS, V27, P300, DOI 10.1634/stemcells.2008-0696; Waddington C H, 1957, STRATEGY GENES DISCU; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	365	398	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					49	52		10.1038/nature08180	http://dx.doi.org/10.1038/nature08180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571877				2022-12-28	WOS:000267545200027
J	Zhang, Y; Donohue, JM; Lave, JR; O'Donnell, G; Newhouse, JP				Zhang, Yuting; Donohue, Julie M.; Lave, Judith R.; O'Donnell, Gerald; Newhouse, Joseph P.			The Effect of Medicare Part D on Drug and Medical Spending.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BENEFICIARIES; ADJUSTMENT; COVERAGE; EVENTS; COSTS	Background: It is not known what effect the increased use of prescription drugs by enrollees in Medicare Part D has had on spending for other medical care. Methods: We compared spending for prescription drugs and other medical care 2 years before the implementation of Part D in January 2006 with such expenditures 2 years after the program's implementation in four groups of elderly beneficiaries: Medicare Advantage enrollees with stable, uncapped, employer-based drug coverage throughout the study period (no-cap group), those who had no previous drug coverage, and those who had previous limited benefits (with either a $150 or a $350 quarterly cap) before they were covered by Part D in 2006. Results: Between December 2005 and December 2007, as compared with the increase in the no-cap group, the increase in total monthly drug spending was $41 higher (95% confidence interval [CI], $33 to $50) (74%) among enrollees with no previous drug coverage, $27 higher (95% CI, $20 to $34) (27%) among those with a previous $150 quarterly cap, and $13 higher (95% CI, $8 to $18) (11%) among those with a previous $350 cap. The use of both lipid-lowering and antidiabetic medications rose in the groups with no or minimal previous drug coverage. As compared with expenditures in the no-cap group, monthly medical expenditures (excluding drugs) were $33 lower (95% CI, $29 to $37) in the group with no previous coverage and $46 lower (95% CI, $29 to $63) in the group with a previous $150 quarterly cap, whereas medical spending was $30 higher (95% CI, $25 to $36) in the group with a previous $350 cap. Conclusions: Enrollment in Medicare Part D was associated with increased spending on prescription drugs. Groups that had no or minimal drug coverage before the implementation of Part D had reductions in other medical spending that approximately offset the increased spending on drugs, but medical spending increased in the group that had more generous previous coverage. N Engl J Med 2009;361:52-61.	[Zhang, Yuting; Donohue, Julie M.; Lave, Judith R.] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [O'Donnell, Gerald] Highmark, Pittsburgh, PA USA; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Donohue, JM (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, 130 De Soto St,Crabtree Hall 613, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019	Donohue, Julie/0000-0003-2418-6017; Zhang, Yuting/0000-0002-6460-6779	National Center for Research Resources; NIH [KL2-RR024154-03]; Alfred P. Sloan Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Center for Research Resources, a component of the National Institutes of Health (NIH); the NIH Roadmap for Medical Research (KL2-RR024154-03, to Dr. Donohue); and the Alfred P. Sloan Foundation (to Dr. Newhouse).	*BUR LAB STAT, 2008, PROD PRIC IND IND DA; *C BUDG OFF, 2002, ISS DES PRESCR DRUG; *C BUDG OFF, 2008, MARCH 2008 BAS MED; Choudhry NK, 2007, HEALTH AFFAIR, V26, P186, DOI 10.1377/hlthaff.26.1.186; Cook T.C., 1979, QUASIEXPERIMENTATION; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; Field TS, 2005, MED CARE, V43, P1171, DOI 10.1097/01.mlr.0000185690.10336.70; Fortess EE, 2001, J AM GERIATR SOC, V49, P793, DOI 10.1046/j.1532-5415.2001.49158.x; Gaynor M, 2007, FORUM HLTH EC POLICY, V10, P1; Gold M, 2001, HEALTH AFFAIR, V20, P120, DOI 10.1377/hlthaff.20.4.120; Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; *HJ KAIS FAM FDN, 2005, MED CHARTB; *HJ KAIS FAM FDN, 2007, FACT SHEET MED PRESC; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; LI F, 2007, P AM STAT ASS JOINT; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Shetty Sharashchandra, 2005, J Manag Care Pharm, V11, P559; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Stuart B, 2004, CLIN THER, V26, P1688, DOI 10.1016/j.clinthera.2004.10.012; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	27	109	109	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					52	61		10.1056/NEJMsa0807998	http://dx.doi.org/10.1056/NEJMsa0807998			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19571283	Bronze, Green Accepted			2022-12-28	WOS:000267533100009
J	Bhatt, DL				Bhatt, Deepak L.			Prasugrel in Clinical Practice.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STENTS		[Bhatt, Deepak L.] VA Boston Healthcare Syst, Dept Cardiol, Boston, MA USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Integrated Intervent Cardiovasc Program, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, Dept Cardiol, Boston, MA USA.							Bavry AA, 2008, LANCET, V372, P536; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Curfman GD, 2007, NEW ENGL J MED, V356, P1059, DOI 10.1056/NEJMe068306; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	6	66	68	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					940	942		10.1056/NEJMp0806848	http://dx.doi.org/10.1056/NEJMp0806848			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19605807				2022-12-28	WOS:000269480400002
J	Parker, HG; VonHoldt, BM; Quignon, P; Margulies, EH; Shao, S; Mosher, DS; Spady, TC; Elkahloun, A; Cargill, M; Jones, PG; Maslen, CL; Acland, GM; Sutter, NB; Kuroki, K; Bustamante, CD; Wayne, RK; Ostrander, EA				Parker, Heidi G.; VonHoldt, Bridgett M.; Quignon, Pascale; Margulies, Elliott H.; Shao, Stephanie; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Cargill, Michele; Jones, Paul G.; Maslen, Cheryl L.; Acland, Gregory M.; Sutter, Nathan B.; Kuroki, Keiichi; Bustamante, Carlos D.; Wayne, Robert K.; Ostrander, Elaine A.			An Expressed Fgf4 Retrogene Is Associated with Breed-Defining Chondrodysplasia in Domestic Dogs	SCIENCE			English	Article							GENE DUPLICATION; GENOME; EVOLUTION; ACHONDROPLASIA; MUTATIONS; ELEMENTS; DNA	Retrotransposition of processed mRNAs is a common source of novel sequence acquired during the evolution of genomes. Although the vast majority of retroposed gene copies, or retrogenes, rapidly accumulate debilitating mutations that disrupt the reading frame, a small percentage become new genes that encode functional proteins. By using a multibreed association analysis in the domestic dog, we demonstrate that expression of a recently acquired retrogene encoding fibroblast growth factor 4 (fgf4) is strongly associated with chondrodysplasia, a short-legged phenotype that defines at least 19 dog breeds including dachshund, corgi, and basset hound. These results illustrate the important role of a single evolutionary event in constraining and directing phenotypic diversity in the domestic dog.	[Parker, Heidi G.; Quignon, Pascale; Shao, Stephanie; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [VonHoldt, Bridgett M.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Margulies, Elliott H.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cargill, Michele] Affymetrix Corp, Santa Clara, CA 95051 USA; [Jones, Paul G.] WALTHAM Ctr Pet Nutr, Melton Mowbray LE14 4RT, Leics, England; [Maslen, Cheryl L.] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA; [Acland, Gregory M.] Cornell Univ, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Acland, Gregory M.; Sutter, Nathan B.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Kuroki, Keiichi] Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA; [Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Mars; WALTHAM Petcare Science Institute; Oregon Health & Science University; Cornell University; Cornell University; University of Missouri System; University of Missouri Columbia; Cornell University	Ostrander, EA (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Ostrander, Elaine/0000-0001-6075-9738; Bustamante, Carlos D./0000-0002-4187-7920; Parker, Heidi G./0000-0002-9707-6380	NSF [0733033, 516310]; NIH [5R01EY006855, 1R24GM082910, 1R01GM83606]; NATIONAL EYE INSTITUTE [R01EY006855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536, ZICHG200365, ZIAHG200325, ZIAHG200341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM082910, R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NSF grants 0733033 (R.K.W.) and 516310 (C.D.B.) and NIH grants 5R01EY006855 and 1R24GM082910 (G.M.A.) and 1R01GM83606 (C.D.B.).	*AM KENN CLUB, 1998, COMPL DOG BOOK OFF P; Betran E, 2006, MOL BIOL EVOL, V23, P2191, DOI 10.1093/molbev/msl090; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; COLBY C, 1995, GENETICS, V140, P1129; Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Fraidenraich D, 1998, DEV BIOL, V204, P197, DOI 10.1006/dbio.1998.9053; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Heuertz S, 2006, EUR J HUM GENET, V14, P1240, DOI 10.1038/sj.ejhg.5201700; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Horton William A, 2002, Rev Endocr Metab Disord, V3, P381, DOI 10.1023/A:1020914026829; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; PALMER N, 1993, PATHOLOGY DOMESTIC A, V1; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; SIMONSEN KL, 1995, GENETICS, V141, P413; Stockard CR., 1941, AM ANAT MEM; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	220	224	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					995	998		10.1126/science.1173275	http://dx.doi.org/10.1126/science.1173275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19608863	Green Accepted			2022-12-28	WOS:000269242800046
J	Cheng, N; Tsunenari, T; Yau, KW				Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai			Intrinsic light response of retinal horizontal cells of teleosts	NATURE			English	Article							SUSTAINED CALCIUM CURRENT; GAMMA-AMINOBUTYRIC-ACID; GANGLION-CELLS; MELANOPSIN; OPSIN; MODULATION; RECEPTORS; ZEBRAFISH; GOLDFISH; TISSUE	The discovery of intrinsically photosensitive retinal ganglion cells has overthrown the long-held belief that rods and cones are the exclusive retinal photoreceptors(1,2). Intrinsically photosensitive retinal ganglion cells use melanopsin(3) as the photopigment, and mediate non-image-forming visual functions such as circadian photoentrainment. In fish, in situ hybridization studies indicated that melanopsin is present in retinal horizontal cells(4-6)-lateral association neurons critical for creating the centre-surround receptive fields of visual neurons. This raises the question of whether fish horizontal cells are intrinsically photosensitive. This notion was examined previously in flat-mount roach retina, but all horizontal-cell light response disappeared after synaptic transmission was blocked(6), making any conclusion difficult to reach. To examine this question directly, we have now recorded from single, acutely dissociated horizontal cells from catfish and goldfish. We found that light induced a response in catfish cone horizontal cells, but not rod horizontal cells, consisting of a modulation of the nifedipine-sensitive, voltage-gated calcium current. The light response was extremely slow, lasting for many minutes. Similar light responses were observed in a high percentage of goldfish horizontal cells. We have cloned two melanopsin genes and one vertebrate ancient (VA) opsin gene from catfish. In situ hybridization indicated that melanopsin, but less likely VA opsin, was expressed in the horizontal-cell layer of catfish retina. This intrinsic light response may serve to modulate, over a long time-scale, lateral inhibition mediated by these cells. Thus, at least in some vertebrates, there are retinal non-rod/non-cone photoreceptors involved primarily in image-forming vision.	[Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Cheng, Ning; Tsunenari, Takashi; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheng, N (corresponding author), NINDS, Unit Dev Neural Plast, NIH, Bethesda, MD 20892 USA.	chengn2@mail.nih.gov; kwyau@mail.jhmi.edu			NIH; Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837, R01EY014596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant and the Antonio Champalimaud Vision Award (Portugal) to K.-W. Y. We thank R. Johnson, C. Liu and D. Liu for advice on molecular cloning and in situ hybridization staining, Y. Shen, C. Linn and G. Matthews for suggestions on retinal dissociation. D. Bergles, P. Fuchs and J. Nathans offered comments throughout the work. L. Belluscio let N. C. take a brief leave of absence from her postdoctoral work to return to Hopkins in order to complete some experiments. Members of the Yau laboratory, especially M. Do and D.-G. Luo, as well as K. Murari, have provided comments on the manuscript.	AYOUB GS, 1984, J PHYSIOL-LONDON, V355, P191, DOI 10.1113/jphysiol.1984.sp015414; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BEAN BP, 1992, METHOD ENZYMOL, V207, P181; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davis SF, 2003, AM J PHYSIOL-CELL PH, V284, pC757, DOI 10.1152/ajpcell.00252.2002; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DONG CJ, 1994, J NEUROSCI, V14, P2648; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Kojima D, 2000, J NEUROSCI, V20, P2845; Linn CL, 1999, J NEUROPHYSIOL, V81, P425, DOI 10.1152/jn.1999.81.2.425; McMahon DG, 1996, BRAIN RES, V718, P89, DOI 10.1016/0006-8993(96)00043-1; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; NAKA KI, 1975, J NEUROPHYSIOL, V38, P53, DOI 10.1152/jn.1975.38.1.53; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P1097, DOI 10.1152/jn.1989.61.6.1097; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SHINGAI R, 1986, J NEUROPHYSIOL, V56, P32, DOI 10.1152/jn.1986.56.1.32; Soni BG, 1998, NATURE, V394, P27, DOI 10.1038/27794; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; TACHIBANA M, 1981, J PHYSIOL-LONDON, V321, P141, DOI 10.1113/jphysiol.1981.sp013976; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	30	37	38	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 13	2009	460	7257					899	U139		10.1038/nature08175	http://dx.doi.org/10.1038/nature08175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633653	Green Accepted			2022-12-28	WOS:000268938300040
J	Stefansson, H; Ophoff, RA; Steinberg, S; Andreassen, OA; Cichon, S; Rujescu, D; Werge, T; Pietilainen, OPH; Mors, O; Mortensen, PB; Sigurdsson, E; Gustafsson, O; Nyegaard, M; Tuulio-Henriksson, A; Ingason, A; Hansen, T; Suvisaari, J; Lonnqvist, J; Paunio, T; Borglum, AD; Hartmann, A; Fink-Jensen, A; Nordentoft, M; Hougaard, D; Norgaard-Pedersen, B; Bottcher, Y; Olesen, J; Breuer, R; Moller, HJ; Giegling, I; Rasmussen, HB; Timm, S; Mattheisen, M; Bitter, I; Rethelyi, JM; Magnusdottir, BB; Sigmundsson, T; Olason, P; Mason, G; Gulcher, JR; Haraldsson, M; Fossdal, R; Thorgeirsson, TE; Thorsteinsdottir, U; Ruggeri, M; Tosato, S; Franke, B; Strengman, E; Kiemeney, LA; Melle, I; Djurovic, S; Abramova, L; Kaleda, V; Sanjuan, J; de Frutos, R; Bramon, E; Vassos, E; Fraser, G; Ettinger, U; Picchioni, M; Walker, N; Toulopoulou, T; Need, AC; Ge, D; Yoon, JL; Shianna, KV; Freimer, NB; Cantor, RM; Murray, R; Kong, A; Golimbet, V; Carracedo, A; Arango, C; Costas, J; Jonsson, EG; Terenius, L; Agartz, I; Petursson, H; Nothen, MM; Rietschel, M; Matthews, PM; Muglia, P; Peltonen, L; St Clair, D; Goldstein, DB; Stefansson, K; Collier, DA				Stefansson, Hreinn; Ophoff, Roel A.; Steinberg, Stacy; Andreassen, Ole A.; Cichon, Sven; Rujescu, Dan; Werge, Thomas; Pietilainen, Olli P. H.; Mors, Ole; Mortensen, Preben B.; Sigurdsson, Engilbert; Gustafsson, Omar; Nyegaard, Mette; Tuulio-Henriksson, Annamari; Ingason, Andres; Hansen, Thomas; Suvisaari, Jaana; Lonnqvist, Jouko; Paunio, Tiina; Borglum, Anders D.; Hartmann, Annette; Fink-Jensen, Anders; Nordentoft, Merete; Hougaard, David; Norgaard-Pedersen, Bent; Bottcher, Yvonne; Olesen, Jes; Breuer, Rene; Moeller, Hans-Jurgen; Giegling, Ina; Rasmussen, Henrik B.; Timm, Sally; Mattheisen, Manuel; Bitter, Istvan; Rethelyi, Janos M.; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Olason, Pall; Mason, Gisli; Gulcher, Jeffrey R.; Haraldsson, Magnus; Fossdal, Ragnheidur; Thorgeirsson, Thorgeir E.; Thorsteinsdottir, Unnur; Ruggeri, Mirella; Tosato, Sarah; Franke, Barbara; Strengman, Eric; Kiemeney, Lambertus A.; Melle, Ingrid; Djurovic, Srdjan; Abramova, Lilia; Kaleda, Vasily; Sanjuan, Julio; de Frutos, Rosa; Bramon, Elvira; Vassos, Evangelos; Fraser, Gillian; Ettinger, Ulrich; Picchioni, Marco; Walker, Nicholas; Toulopoulou, Timi; Need, Anna C.; Ge, Dongliang; Yoon, Joeng Lim; Shianna, Kevin V.; Freimer, Nelson B.; Cantor, Rita M.; Murray, Robin; Kong, Augustine; Golimbet, Vera; Carracedo, Angel; Arango, Celso; Costas, Javier; Joensson, Erik G.; Terenius, Lars; Agartz, Ingrid; Petursson, Hannes; Nothen, Markus M.; Rietschel, Marcella; Matthews, Paul M.; Muglia, Pierandrea; Peltonen, Leena; St Clair, David; Goldstein, David B.; Stefansson, Kari; Collier, David A.		GROUP	Common variants conferring risk of schizophrenia	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MENTAL-RETARDATION; GENE; NEUROGRANIN; POPULATION; DELETIONS; DISEASES; 1Q21.1; MEMORY; SCAN	Schizophrenia is a complex disorder, caused by both genetic and environmental factors and their interactions. Research on pathogenesis has traditionally focused on neurotransmitter systems in the brain, particularly those involving dopamine. Schizophrenia has been considered a separate disease for over a century, but in the absence of clear biological markers, diagnosis has historically been based on signs and symptoms. A fundamental message emerging from genome-wide association studies of copy number variations (CNVs) associated with the disease is that its genetic basis does not necessarily conform to classical nosological disease boundaries. Certain CNVs confer not only high relative risk of schizophrenia but also of other psychiatric disorders(1-3). The structural variations associated with schizophrenia can involve several genes and the phenotypic syndromes, or the 'genomic disorders', have not yet been characterized(4). Single nucleotide polymorphism (SNP)-based genome-wide association studies with the potential to implicate individual genes in complex diseases may reveal underlying biological pathways. Here we combined SNP data from several large genome-wide scans and followed up the most significant association signals. We found significant association with several markers spanning the major histocompatibility complex (MHC) region on chromosome 6p21.3-22.1, a marker located upstream of the neurogranin gene (NRGN) on 11q24.2 and a marker in intron four of transcription factor 4 (TCF4) on 18q21.2. Our findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition.	[Stefansson, Hreinn; Steinberg, Stacy; Gustafsson, Omar; Ingason, Andres; Bottcher, Yvonne; Olason, Pall; Mason, Gisli; Gulcher, Jeffrey R.; Fossdal, Ragnheidur; Thorgeirsson, Thorgeir E.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Ophoff, Roel A.; Strengman, Eric] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Ophoff, Roel A.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Andreassen, Ole A.; Melle, Ingrid] Ullevaal Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole A.; Melle, Ingrid] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Cichon, Sven; Mattheisen, Manuel] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Rujescu, Dan; Hartmann, Annette; Giegling, Ina] Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-80336 Munich, Germany; [Werge, Thomas; Hansen, Thomas; Rasmussen, Henrik B.] Univ Copenhagen, Mental Hlth Ctr Sct Hans, Res Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Pietilainen, Olli P. H.; Peltonen, Leena] Biomedicum Helsinki, Inst Mol Med, Helsinki 00290, Finland; [Pietilainen, Olli P. H.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mors, Ole; Borglum, Anders D.] Aarhus Univ Hosp, Ctr Psychiat Res, DK-8240 Risskov, Denmark; [Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus, Denmark; [Sigurdsson, Engilbert; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Haraldsson, Magnus; Petursson, Hannes] Natl Univ Hosp Reykjavik, Dept Psychiat, IS-101 Reykjavik, Iceland; [Sigurdsson, Engilbert; Magnusdottir, Brynja B.; Sigmundsson, Thordur; Haraldsson, Magnus; Petursson, Hannes; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland; [Nyegaard, Mette; Borglum, Anders D.] Aarhus Univ, Dept Human Genet, DK-8000 Aarhus C, Denmark; [Suvisaari, Jaana; Lonnqvist, Jouko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland; [Paunio, Tiina] Biomedicum, Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Fink-Jensen, Anders] Copenhagen Univ Hosp, Mental Hlth Ctr, Rigshosp, DK-2100 Copenhagen O, Denmark; [Nordentoft, Merete] Bispebjerg Hosp, Psychiat Ctr Bisbebjerg, DK-2400 Copenhagen NV, Denmark; [Hougaard, David; Norgaard-Pedersen, Bent] State Serum Inst, Sect Neonatal Screening & Hormones, Dept Clin Chem & Immunol, DK-2300 Copenhagen S, Denmark; [Olesen, Jes] Glostrup Cty Hosp, Dept Neurol, DK-2600 Glostrup, Denmark; [Breuer, Rene; Rietschel, Marcella] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Moeller, Hans-Jurgen] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Timm, Sally] Copenhagen Univ Hosp, Mental Hlth Ctr Frederiksberg, DK-2000 Copenhagen, Denmark; [Bitter, Istvan; Rethelyi, Janos M.] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1083 Budapest, Hungary; [Ruggeri, Mirella; Tosato, Sarah] Univ Verona, Sect Psychiat & Clin Psychol, I-37134 Verona, Italy; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Djurovic, Srdjan] Ullevaal Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Djurovic, Srdjan] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Abramova, Lilia; Kaleda, Vasily; Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 117152, Russia; [Sanjuan, Julio] Univ Valencia, Unidad Psiquiatria, Fac Biol, CIBERSAM, Valencia 46010, Spain; [de Frutos, Rosa] Univ Valencia, Dept Genet, Fac Biol, CIBERSAM, Valencia 46010, Spain; [Bramon, Elvira; Vassos, Evangelos; Ettinger, Ulrich; Picchioni, Marco; Murray, Robin] Kings Coll London, Inst Psychiat, Div Psychol Med, London SE5 8AF, England; [Vassos, Evangelos; Ettinger, Ulrich; Toulopoulou, Timi; Murray, Robin] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Fraser, Gillian; St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Walker, Nicholas] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Need, Anna C.; Ge, Dongliang; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, Durham, NC 27708 USA; [Yoon, Joeng Lim; Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Carracedo, Angel] Univ Santiago de Compostela, Fdn Publ Galega Med, Xenom Complexo Univ Hosp Santiago, IML, Santiago De Compostela 15782, Spain; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, IML, Santiago De Compostela 15782, Spain; [Arango, Celso] Hosp Gen Univ Gregorio Maran, CIBERSAM, Madrid, Spain; [Costas, Javier] Fdn Publ Galega Med Xen, Valencia 46010, Spain; [Costas, Javier] CIBERER, Valencia 46010, Spain; [Joensson, Erik G.; Terenius, Lars; Agartz, Ingrid] Karolinska Hosp & Inst, Dept Clin Neurosci, HUBIN Project, SE-17176 Stockholm, Sweden; [Nothen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Matthews, Paul M.] GlaxoSmithKline, Hammersmith Hosp, Clin Imaging Ctr, Clin Pharmacol & Discovery Med, London W12 ONN, England; [Muglia, Pierandrea] GlaxoSmithKline R&D, Med Genet, I-37135 Verona, Italy; [Collier, David A.] Sichuan Univ, W China Hosp, Dept Psychiat, Sichuan 610065, Peoples R China	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of Oslo; University of Oslo; University of Bonn; University of Munich; University of Copenhagen; University of Helsinki; Wellcome Trust Sanger Institute; Aarhus University; Aarhus University; Landspitali National University Hospital; University of Iceland; Aarhus University; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Statens Serum Institut; University of Copenhagen; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munich; University of Copenhagen; Semmelweis University; University of Verona; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Oslo; University of Oslo; Russian Academy of Medical Sciences; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; University of London; King's College London; University of London; King's College London; University of Aberdeen; Duke University; University of California System; University of California Los Angeles; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Karolinska Institutet; Karolinska University Hospital; University of Bonn; GlaxoSmithKline; Imperial College London; GlaxoSmithKline; Sichuan University	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kari.stefansson@decode.is	Myin-Germeys, Inez/L-5106-2014; Toulopoulou, Timothea/F-4458-2011; Bramon, Elvira/HHC-3809-2022; Tosato, Sarah/E-6045-2010; Ettinger, Ulrich/D-3731-2014; Arango, Celso/AAZ-8314-2021; VG, Kaleda/K-5466-2013; Rujescu, Dan/GRS-3875-2022; Vassos, Evangelos/F-9825-2013; Bitter, Istvan/J-8196-2017; Krabbendam, Lydia/F-9163-2010; Costas, Javier/B-5016-2008; Franke, Barbara/D-4836-2009; Kiemeney, Lambertus A./D-3357-2009; Ingason, Andres/G-6817-2012; Hansen, Thomas/GWZ-2858-2022; Mattheisen, Manuel/B-4949-2012; Giegling, Ina/ABA-3677-2021; van Os, Jim/C-2113-2014; Magnusdottir, Brynja/AAH-3482-2019; Nordentoft, Merete/AAH-3253-2019; Mattheisen, Manuel/S-3725-2019; Golimbet, V/E-2328-2016; Andreassen, Ole A./AAY-7531-2020; Muglia, Pierandrea/ABD-9235-2020; Collier, David A/D-1649-2011; Abramova, Liliya/K-4665-2013; Stefansson, Kari/AAE-7187-2019; Ruggeri, Mirella/E-6091-2010; Nöthen, Markus/B-2027-2009; Melle, Ingrid S/B-4858-2011; Werge, Thomas/G-7263-2012; Bramon, Elvira/A-9463-2011; Ge, Dongliang/A-2073-2010; St Clair, David/AAN-2412-2021; Cichon, Sven/H-8803-2013; Mortensen, Preben B/D-2358-2015; Hansen, Thomas Folkmann/O-5965-2014; van Os, Jim/I-9496-2012; Arango Lopez, Celso/H-6433-2015; Goldstein, David/AAY-8125-2020; Hougaard, David/AAD-6368-2019; Cichon, Sven/B-9618-2014; Sigurdsson, Engilbert/D-2486-2014; Picchioni, Marco M/E-3300-2010; Nyegaard, Mette/M-3379-2019; Nyegaard, Mette/G-4443-2012; Carracedo, Angel/D-4257-2012; Hartmann, Annette/AAS-6331-2021; murray, robin/F-8658-2012	Bramon, Elvira/0000-0003-1369-5983; Tosato, Sarah/0000-0002-9665-7538; Ettinger, Ulrich/0000-0002-0160-0281; Arango, Celso/0000-0003-3382-4754; VG, Kaleda/0000-0002-1209-1443; Vassos, Evangelos/0000-0001-6363-0438; Bitter, Istvan/0000-0002-9464-4709; Krabbendam, Lydia/0000-0003-4074-5149; Costas, Javier/0000-0003-0306-3990; Franke, Barbara/0000-0003-4375-6572; Kiemeney, Lambertus A./0000-0002-2368-1326; Mattheisen, Manuel/0000-0002-8442-493X; Magnusdottir, Brynja/0000-0002-6131-7269; Mattheisen, Manuel/0000-0002-8442-493X; Golimbet, V/0000-0002-9960-7114; Muglia, Pierandrea/0000-0002-3973-8606; Collier, David A/0000-0003-4087-1559; Abramova, Liliya/0000-0003-4397-924X; Nöthen, Markus/0000-0002-8770-2464; Melle, Ingrid S/0000-0002-9783-548X; Cichon, Sven/0000-0002-9475-086X; Mortensen, Preben B/0000-0002-5230-9865; Hansen, Thomas Folkmann/0000-0001-6703-7762; van Os, Jim/0000-0002-7245-1586; Arango Lopez, Celso/0000-0003-3382-4754; Cichon, Sven/0000-0002-9475-086X; Sigurdsson, Engilbert/0000-0001-9404-7982; Picchioni, Marco M/0000-0001-6681-147X; Nyegaard, Mette/0000-0003-4973-8543; Nyegaard, Mette/0000-0003-4973-8543; Carracedo, Angel/0000-0003-1085-8986; Need, Anna/0000-0003-3955-8207; Rethelyi, Janos/0000-0002-3641-012X; Bruggeman, Richard/0000-0002-3238-8471; Andreassen, Ole A./0000-0002-4461-3568; murray, robin/0000-0003-0829-0519; Mors, Ole/0000-0002-5660-0393; Stefansson, Hreinn/0000-0002-9331-6666; Djurovic, Srdjan/0000-0002-8140-8061; Myin-Germeys, Inez/0000-0002-3731-4930; Kong, Augustine/0000-0001-8193-5438; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Fink-Jensen, Anders/0000-0001-7143-1236; Agartz, Ingrid/0000-0002-9839-5391; Jonsson, Erik/0000-0001-8368-6332; Matthews, Paul M/0000-0002-1619-8328; Olesen, Jes/0000-0002-6712-2702; Borglum, Anders/0000-0001-8627-7219; Suvisaari, Jaana/0000-0001-7167-0990; Ge, David/0000-0002-9732-8170	EU [LSHM-CT-2006-037761, PIAP-GA-2008-218251, HEALTH-F2-2009-223423]; NIMH [R01 MH078075]; German Federal Ministry of Education and Research [NGFN-2]; Marie Curie [PIAP-GA-2008-218251]; GlaxoSmithKline; National Institutes of Health [1R01HL087679-01]; STAMPEED; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER	EU(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Marie Curie(European Commission); GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STAMPEED; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the subjects and their relatives and staff at the recruitment centres. This work was sponsored by EU grants LSHM-CT-2006-037761 (Project SGENE), PIAP-GA-2008-218251 (Project PsychGene) and HEALTH-F2-2009-223423 (Project PsychCNVs). Genotyping of the Dutch samples was sponsored by NIMH funding, R01 MH078075. This work was also supported by the National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF) and Marie Curie grant PIAP-GA-2008-218251 (PsychGene). M. M. N. received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. We are grateful to S. Schreiber and M. Krawczak for providing genotype data for PopGen controls, and to K.-H. Jockel and R. Erbel for providing control individuals from the Heinz Nixdorf Recall Study. Recruitment of the patients from Munich was partially supported by GlaxoSmithKline. We are grateful to the Genetics Research Centre GmbH, an initiative by GlaxoSmithKline and LMU. The Northern Finland Birth Cohort 1966 (NFBC66) is thanked for providing population controls for the study. The genotyping of NFBC66 was financially supported by National Institutes of Health grant 1R01HL087679-01, STAMPEED.	BERNAL J, 1992, ACTA MED AUST, V19, P32; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Huang FL, 2007, LEARN MEMORY, V14, P512, DOI 10.1101/lm.636107; Juvonen H, 2007, ARCH GEN PSYCHIAT, V64, P894, DOI 10.1001/archpsyc.64.8.894; Kalscheuer VM, 2008, AM J MED GENET A, V146A, P2053, DOI 10.1002/ajmg.a.32419; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Li T, 2001, SCHIZOPHR RES, V49, P73, DOI 10.1016/S0920-9964(00)00111-0; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; PITT D, 1978, AUST PAEDIATR J, V14, P182; Pritchard JK, 2000, GENETICS, V155, P945; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064	27	1235	1281	5	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					744	U99		10.1038/nature08186	http://dx.doi.org/10.1038/nature08186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19571808	Green Accepted			2022-12-28	WOS:000268670300040
J	Imai, T; Yamazaki, T; Kobayakawa, R; Kobayakawa, K; Abe, T; Suzuki, M; Sakano, H				Imai, Takeshi; Yamazaki, Takahiro; Kobayakawa, Reiko; Kobayakawa, Ko; Abe, Takaya; Suzuki, Misao; Sakano, Hitoshi			Pre-Target Axon Sorting Establishes the Neural Map Topography	SCIENCE			English	Article							MOUSE OLFACTORY SYSTEM; GANGLION-CELL AXONS; ODORANT RECEPTORS; BULB; EXPRESSION; PROJECTIONS; GUIDANCE; NEURONS; GENE; MICE	Sensory information detected by the peripheral nervous system is represented as a topographic map in the brain. It has long been thought that the topography of the map is determined by graded positional cues that are expressed by the target. Here, we analyzed the pre-target axon sorting for olfactory map formation in mice. In olfactory sensory neurons, an axon guidance receptor, Neuropilin-1, and its repulsive ligand, Semaphorin-3A, are expressed in a complementary manner. We found that expression levels of Neuropilin-1 determined both pre-target sorting and projection sites of axons. Olfactory sensory neuron-specific knockout of Semaphorin-3A perturbed axon sorting and altered the olfactory map topography. Thus, pre-target axon sorting plays an important role in establishing the topographic order based on the relative levels of guidance molecules expressed by axons.	[Imai, Takeshi; Yamazaki, Takahiro; Kobayakawa, Reiko; Kobayakawa, Ko; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Suzuki, Misao] Kumamoto Univ, Ctr Anim Resources & Dev, Div Transgen Technol, Kumamoto 8600081, Japan	University of Tokyo; RIKEN; Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080; Kobayakawa, Reiko/0000-0001-6613-5969; Kobayakawa, Ko/0000-0001-6406-5610	Japan Science and Technology Agency; Global COE program; Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the PREST program of the Japan Science and Technology Agency (R.K.), the Global COE program (K.K.), the Mitsubishi Foundation, and a Specially Promoted Research Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; NARUSE I, 1990, DEV BRAIN RES, V51, P253, DOI 10.1016/0165-3806(90)90283-5; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SATODA M, 1995, J NEUROSCI, V15, P942; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; YOON MG, 1977, J PHYSIOL-LONDON, V264, P379, DOI 10.1113/jphysiol.1977.sp011674; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	38	160	160	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					585	590		10.1126/science.1173596	http://dx.doi.org/10.1126/science.1173596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19589963				2022-12-28	WOS:000268493000043
J	Boettiger, AN; Levine, M				Boettiger, Alistair N.; Levine, Michael			Synchronous and Stochastic Patterns of Gene Activation in the Drosophila Embryo	SCIENCE			English	Article							EXPRESSION; DORSAL; MESODERM; GRADIENT; RNA; TRANSCRIPTION; CONSEQUENCES; MELANOGASTER; PROTEIN; NOISE	Drosophila embryogenesis is characterized by rapid transitions in gene activity, whereby crudely distributed gradients of regulatory proteins give way to precise on/off patterns of gene expression. To explore the underlying mechanisms, a partially automated, quantitative in situ hybridization method was used to visualize expression profiles of 14 developmental control genes in hundreds of embryos. These studies revealed two distinct patterns of gene activation: synchronous and stochastic. Synchronous genes display essentially uniform expression of nascent transcripts in all cells of an embryonic tissue, whereas stochastic genes display erratic patterns of de novo activation. RNA polymerase II is "pre-loaded" (stalled) in the promoter regions of synchronous genes, but not stochastic genes. Transcriptional synchrony might ensure the orderly deployment of the complex gene regulatory networks that control embryogenesis.	[Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Boettiger, Alistair N.] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Boettiger, Alistair/G-1988-2011	Boettiger, Alistair/0000-0002-3554-5196; Levine, Michael/0000-0001-7629-0081	NSF; NIH [GM34431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.N.B. is supported by NSF Graduate Research Fellowship Program. This study was funded by a grant from NIH (GM34431).	Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bialek W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258101; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Frank LH, 1996, DEVELOPMENT, V122, P1343; GONZALEZCRESPO S, 1993, GENE DEV, V7, P1703, DOI 10.1101/gad.7.9.1703; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Imam F, 1999, GENETICS, V152, P307; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; SKEATH JB, 1994, DEVELOPMENT, V120, P1517; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	35	193	197	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					471	473		10.1126/science.1173976	http://dx.doi.org/10.1126/science.1173976			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628867	Green Accepted			2022-12-28	WOS:000268255100055
J	Grove, CA; De Masi, F; Barrasa, MI; Newburger, DE; Alkema, MJ; Bulyk, ML; Walhout, AJM				Grove, Christian A.; De Masi, Federico; Barrasa, M. Inmaculada; Newburger, Daniel E.; Alkema, Mark J.; Bulyk, Martha L.; Walhout, Albertha J. M.			A Multiparameter Network Reveals Extensive Divergence between C. elegans bHLH Transcription Factors	CELL			English	Article							GENOME-WIDE RNAI; PROTEIN-DNA; MICROARRAY DATA; BINDING; FAMILY; SPECIFICITY; DATABASE; SYSTEM; TWIST; YAP	Differences in expression, protein interactions, and DNA binding of paralogous transcription factors ("TF parameters'') are thought to be important determinants of regulatory and biological specificity. However, both the extent of TF divergence and the relative contribution of individual TF parameters remain undetermined. We comprehensively identify dimerization partners, spatiotemporal expression patterns, and DNA-binding specificities for the C. elegans bHLH family of TFs, and model these data into an integrated network. This network displays both specificity and promiscuity, as some bHLH proteins, DNA sequences, and tissues are highly connected, whereas others are not. By comparing all bHLH TFs, we find extensive divergence and that all three parameters contribute equally to bHLH divergence. Our approach provides a framework for examining divergence for other protein families in C. elegans and in other complex multicellular organisms, including humans. Cross-species comparisons of integrated networks may provide further insights into molecular features underlying protein family evolution. For a video summary of this article, see the PaperFlick file available with the online Supplemental Data.	[Grove, Christian A.; Barrasa, M. Inmaculada; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Grove, Christian A.; Barrasa, M. Inmaculada; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [De Masi, Federico; Newburger, Daniel E.; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Alkema, Mark J.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	mlbulyk@receptor.med.harvard.edu; marian.walhout@umassmed.edu	De Masi, Federico/A-4499-2010	De Masi, Federico/0000-0003-4859-4170; Grove, Christian/0000-0001-9076-6015; Walhout, Marian/0000-0001-5587-3608	NIH [DK068429, GM084491, R01 HG002966, R01 HG003985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002966, R01HG003985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Berger for technical assistance and advice with PBMs and data analysis; S. Jaeger and R. P. McCord for statistical advice, assistance, and help with Matlab; T. Siggers for genome scanning assistance; and members of the Walhout and Bulyk laboratories and J. Dekker for advice and critical reading of the manuscript. Special thanks to Shohei Mitani for the hlh- 30 (tm1978) mutant C. elegans strain and Maria Ow for outcrossing this strain. This work was supported by NIH grants DK068429 to A. J. M. W., GM084491 to M. J. A., and R01 HG002966 and R01 HG003985 to M. L. B.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Grove CA, 2008, MOL BIOSYST, V4, P309, DOI 10.1039/b715909a; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hallam S, 2000, DEVELOPMENT, V127, P4239; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Krause M, 1997, DEVELOPMENT, V124, P2179; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ooe N, 2007, GENE, V400, P122, DOI 10.1016/j.gene.2007.06.005; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Pickett CL, 2007, DEV BIOL, V310, P226, DOI 10.1016/j.ydbio.2007.07.034; Portman DS, 2000, DEVELOPMENT, V127, P5415; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tamai KK, 2007, DEV BIOL, V308, P562, DOI 10.1016/j.ydbio.2007.05.024; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Vermeirssen V, 2007, GENOME RES, V17, P1061, DOI 10.1101/gr.6148107; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 1998, BBA-GENE STRUCT EXPR, V1397, P189, DOI 10.1016/S0167-4781(97)00227-3; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Yuan J, 1998, ONCOGENE, V17, P1109, DOI 10.1038/sj.onc.1202036; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	48	177	232	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					314	327		10.1016/j.cell.2009.04.058	http://dx.doi.org/10.1016/j.cell.2009.04.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632181	Green Accepted, Bronze			2022-12-28	WOS:000268277000013
J	Ernst, AA				Ernst, Amy A.			Review: Little evidence exists for type of dressing or support surface or for nutritional supplements for pressure ulcers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HYPERBARIC-OXYGEN		Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Ernst, AA (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.							Kaide CG, 2008, EMERG MED CLIN N AM, V26, P571, DOI 10.1016/j.emc.2008.01.005; Kessler L, 2003, DIABETES CARE, V26, P2378, DOI 10.2337/diacare.26.8.2378; Landi F, 2003, ANN INTERN MED, V139, P635, DOI 10.7326/0003-4819-139-8-200310210-00006; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-13	10.7326/0003-4819-151-2-200907210-02013	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620157				2022-12-28	WOS:000268605300021
J	Hatton, R; Patel, M; Devendra, D				Hatton, Rebecca; Patel, Madhukar; Devendra, Devasenan			Practice 10-Minute Consultation Thyroid swellings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Devendra, Devasenan] Brent Teaching Primary Care Trust, London W12 0NN, England; [Devendra, Devasenan] Cent Middlesex Hosp, London W12 0NN, England; [Devendra, Devasenan] Univ London Imperial Coll Sci Technol & Med, Div Invest Sci, London W12 0NN, England; [Hatton, Rebecca] Cent Middlesex Hosp, London NW10 7NS, England; [Patel, Madhukar] Brent Teaching Primary Care Trust, London HA0 4UZ, England	Imperial College London; Imperial College London; Imperial College London	Devendra, D (corresponding author), Brent Teaching Primary Care Trust, London W12 0NN, England.	d.devendra@imperial.ac.uk						Gharib Hossein, 2006, Endocr Pract, V12, P63; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; National Institute for Health and Clinical Excellence, 2011, NAT I HLTH CLIN EXC; Polyzos Stergios A, 2007, Hormones (Athens), V6, P101	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2009	339								b2563	10.1136/bmj.b2563	http://dx.doi.org/10.1136/bmj.b2563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BS	19596720				2022-12-28	WOS:000268104700003
J	Carbone, F; Kwon, OH; Zewail, AH				Carbone, Fabrizio; Kwon, Oh-Hoon; Zewail, Ahmed H.			Dynamics of Chemical Bonding Mapped by Energy-Resolved 4D Electron Microscopy	SCIENCE			English	Article							LOSS SPECTROSCOPY; TIME; REAL; XANES; SPACE; EELS	Chemical bonding dynamics are fundamental to the understanding of properties and behavior of materials and molecules. Here, we demonstrate the potential of time-resolved, femtosecond electron energy loss spectroscopy (EELS) for mapping electronic structural changes in the course of nuclear motions. For graphite, it is found that changes of milli-electron volts in the energy range of up to 50 electron volts reveal the compression and expansion of layers on the subpicometer scale (for surface and bulk atoms). These nonequilibrium structural features are correlated with the direction of change from sp(2) [two-dimensional (2D) graphene] to sp(3) (3D-diamond) electronic hybridization, and the results are compared with theoretical charge-density calculations. The reported femtosecond time resolution of four-dimensional (4D) electron microscopy represents an advance of 10 orders of magnitude over that of conventional EELS methods.	[Carbone, Fabrizio; Kwon, Oh-Hoon; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Kwon, Oh-Hoon/B-3324-2015; Carbone, Fabrizio/A-2969-2012	Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	National Science Foundation; Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the National Science Foundation and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. We thank B. Barwick for helpful and stimulating discussion.	Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Bressler C, 2008, Z KRISTALLOGR, V223, P307, DOI 10.1524/zkri.2008.0030; Calliari L, 2008, SURF INTERFACE ANAL, V40, P814, DOI 10.1002/sia.2652; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Carbone F, 2009, CHEM PHYS LETT, V468, P107, DOI 10.1016/j.cplett.2008.12.027; Eberlein T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.233406; Egerton R.F., 2011, ELECT ENERGY LOSS SP; ELLIS TH, 1985, SCIENCE, V230, P256, DOI 10.1126/science.230.4723.256; FAHY S, 1986, PHYS REV B, V34, P1191, DOI 10.1103/PhysRevB.34.1191; Flannigan DJ, 2009, NANO LETT, V9, P875, DOI 10.1021/nl803770e; Hitchcock AP, 2008, MICRON, V39, P311, DOI 10.1016/j.micron.2007.09.008; Ishioka K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121402; Jeschke HO, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015003; Kampfrath T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.187403; Kaplan A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073401; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Lenner M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721392; Marinopoulos AG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245419; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; Petek H, 2000, SCIENCE, V288, P1402, DOI 10.1126/science.288.5470.1402; Raman RK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077401; Savrasov SY, 2005, Z KRISTALLOGR, V220, P555, DOI 10.1524/zkri.220.5.555.65067; SEIBERT K, 1990, PHYS REV B, V42, P2842, DOI 10.1103/PhysRevB.42.2842; THOMAS JM, 1985, ACCOUNTS CHEM RES, V18, P324, DOI 10.1021/ar00119a001; Yurtsever A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.217402; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587; ZEWAIL AH, 2000, PRIX NOBEL NOBEL PRI; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403	32	141	146	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					181	184		10.1126/science.1175005	http://dx.doi.org/10.1126/science.1175005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589997				2022-12-28	WOS:000267802000041
J	Rieger, MA; Hoppe, PS; Smejkal, BM; Eitelhuber, AC; Schroeder, T				Rieger, Michael A.; Hoppe, Philipp S.; Smejkal, Benjamin M.; Eitelhuber, Andrea C.; Schroeder, Timm			Hematopoietic Cytokines Can Instruct Lineage Choice	SCIENCE			English	Article							STIMULATING FACTOR-RECEPTOR; CELLS; COMMITMENT; MACROPHAGE; DIFFERENTIATION; GRANULOCYTE; PROGENITORS; EXPRESSION	The constant regeneration of the blood system during hematopoiesis requires tightly controlled lineage decisions of hematopoietic progenitor cells (HPCs). Because of technical limitations, differentiation of individual HPCs could not previously be analyzed continuously. It was therefore disputed whether cell-extrinsic cytokines can instruct HPC lineage choice or only allow survival of cells that are already lineage-restricted. Here, we used bioimaging approaches that allow the continuous long-term observation of individual differentiating mouse HPCs. We demonstrate that the physiological cytokines, macrophage colony-stimulating factor and granulocyte colony-stimulating factor, can instruct hematopoietic lineage choice.	[Rieger, Michael A.; Hoppe, Philipp S.; Smejkal, Benjamin M.; Eitelhuber, Andrea C.; Schroeder, Timm] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Rieger, Michael A/L-8324-2017; Schroeder, Timm/F-8448-2010	Rieger, Michael A/0000-0002-4158-5872; Schroeder, Timm/0000-0001-9320-0252	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Graf for the LysM::GFP mice; A. Roth, C. Raithel, and K. Azadov for technical assistance; and B. Schauberger for programming contributions. This study was supported by the Deutsche Forschungsgemeinschaft. Authors contributions: M.A.R. designed and performed experiments, discussed results, and wrote the paper with T.S.; P.S.H., B.M.S., and A.C.E. performed experiments and commented on the manuscript; and T.S. developed the time-lapse imaging and cell-tracking technology, advanced it with all the authors, and designed the study.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Faust N, 2000, BLOOD, V96, P719; Goldsmith MA, 1998, P NATL ACAD SCI USA, V95, P7006, DOI 10.1073/pnas.95.12.7006; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; KINASHI T, 1991, J EXP MED, V173, P1267, DOI 10.1084/jem.173.5.1267; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; MCARTHUR GA, 1994, BLOOD, V83, P972; METCALF D, 1982, J CELL PHYSIOL, V111, P275, DOI 10.1002/jcp.1041110308; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Robb L, 2007, ONCOGENE, V26, P6715, DOI 10.1038/sj.onc.1210756; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Stadtfeld M, 2004, METH MOLEC MED, V105, P395; Stoffel R, 1999, P NATL ACAD SCI USA, V96, P698, DOI 10.1073/pnas.96.2.698; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	28	299	310	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					217	218		10.1126/science.1171461	http://dx.doi.org/10.1126/science.1171461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19590005				2022-12-28	WOS:000267802000052
J	Vavvas, D; Brodowska, K				Vavvas, Demetrios; Brodowska, Katarzyna			Traumatic Bleb.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vavvas, Demetrios; Brodowska, Katarzyna] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Harvard University; Massachusetts Eye & Ear Infirmary	Vavvas, D (corresponding author), Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.	dvavvas@partners.org		Vavvas, Demetrios/0000-0002-8622-6478					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					E2	E2		10.1056/NEJMicm0802306	http://dx.doi.org/10.1056/NEJMicm0802306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587336				2022-12-28	WOS:000267748900012
J	Li, SS; Shin, HJ; Ding, EL; van Dam, RM				Li, Shanshan; Shin, Hyun Joon; Ding, Eric L.; van Dam, Rob M.			Adiponectin Levels and Risk of Type 2 Diabetes A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MOLECULAR-WEIGHT ADIPONECTIN; DOSE-RESPONSE DATA; INSULIN-RESISTANCE; PLASMA ADIPONECTIN; CONCENTRATIONS PREDICT; METABOLIC SYNDROME; TREND ESTIMATION; OLDER MEN; FOLLOW-UP; PROGRESSION	Context The association of obesity with development of type 2 diabetes may be partly mediated by altered secretion of adipokines by adipose tissue. Greater adiposity down-regulates secretion of adiponectin, an adipokine with anti-inflammatory and insulin-sensitizing properties. The strength and consistency of the relation between plasma adiponectin and risk of type 2 diabetes is unclear. Objective To systematically review prospective studies of the association of plasma adiponectin levels and risk of type 2 diabetes. Data Sources A systematic search of the MEDLINE, EMBASE, and Science Citation Index Expanded databases using adiponectin and diabetes and various synonyms and reference lists of retrieved articles up to April 10, 2009. Study Selection We included prospective studies with plasma adiponectin levels as the exposure and incidence of type 2 diabetes as the outcome variable. Data Extraction Two reviewers independently extracted data and assessed study quality. Generalized least-squares trend estimation was used to assess dose-response relationships. Pooled relative risks and 95% confidence intervals were calculated using random-effects models to incorporate between-study variation. Results Thirteen prospective studies with a total of 14 598 participants and 2623 incident cases of type 2 diabetes were included in the meta-analysis. Higher adiponectin levels were monotonically associated with a lower risk of type 2 diabetes. The relative risk of type 2 diabetes was 0.72 (95% confidence interval, 0.67-0.78) per 1-log mu g/mL increment in adiponectin levels. This inverse association was consistently observed in whites, East Asians, Asian Indians, African Americans, and Native Americans and did not differ by adiponectin assay, method of diabetes ascertainment, duration of follow-up, or proportion of women. The estimated absolute risk difference (cases per 1000 person-years) per 1-log mu g/mL increment in adiponectin levels was 3.9 for elderly Americans and 30.8 for Americans with impaired glucose tolerance. Conclusion Higher adiponectin levels are associated with a lower risk of type 2 diabetes across diverse populations, consistent with a dose-response relationship. JAMA. 2009;302(2):179-188 www.jama.com	[Li, Shanshan; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Shin, Hyun Joon; Ding, Eric L.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Shin, Hyun Joon] Framingham Union Hosp, Metro W Med Ctr, Framingham, MA USA; [van Dam, Rob M.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [van Dam, Rob M.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	van Dam, RM (corresponding author), 655 Huntington Ave, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	Ding, Eric L./K-1118-2019; van Dam, Rob M/F-9674-2010; Li, Shanshan/N-2593-2019	Ding, Eric L./0000-0002-5881-8097; van Dam, Rob M/0000-0002-7354-8734; Li, Shanshan/0000-0001-6268-125X; Shin, Hyun Joon/0000-0001-5781-0643	American Diabetes Association; Paul and Daisy Soros Fellowships for New Americans; Boston Obesity Nutrition Research Center [P30 DK4600]	American Diabetes Association(American Diabetes Association); Paul and Daisy Soros Fellowships for New Americans; Boston Obesity Nutrition Research Center	Dr Ding is supported in part by a postdoctoral fellowship grant from the American Diabetes Association and by a grant from the Paul and Daisy Soros Fellowships for New Americans. Dr van Dam is supported in part by a grant from the Boston Obesity Nutrition Research Center (P30 DK4600).	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fargnoli JL, 2008, AM J CLIN NUTR, V88, P1213, DOI 10.3945/ajcn.2008.26480; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Jalovaara K, 2008, METABOLISM, V57, P1130, DOI 10.1016/j.metabol.2008.03.019; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kanaya AM, 2006, ARCH INTERN MED, V166, P350, DOI 10.1001/archinte.166.3.350; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schwarz PEH, 2006, DIABETES CARE, V29, P1645, DOI 10.2337/dc05-2123; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Snijder MB, 2006, DIABETES CARE, V29, P2498, DOI 10.2337/dc06-0952; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; Tabak AG, 2009, HORM METAB RES, V41, P626, DOI 10.1055/s-0029-1216359; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Vendramini MF, 2006, DIABETES RES CLIN PR, V73, P304, DOI 10.1016/j.diabres.2006.02.002; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	730	764	2	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					179	188		10.1001/jama.2009.976	http://dx.doi.org/10.1001/jama.2009.976			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584347	Bronze			2022-12-28	WOS:000267696500027
J	Horton, R				Horton, Richard			Venice statement: global health initiatives and health systems	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; *WHO, 2009, VEN DRAFT CONCL STAT	2	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					10	12		10.1016/S0140-6736(09)61195-8	http://dx.doi.org/10.1016/S0140-6736(09)61195-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467UO	19577680	Green Submitted			2022-12-28	WOS:000267768800009
J	Bu, L; Jiang, X; Martin-Puig, S; Caron, L; Zhu, SJ; Shao, Y; Roberts, DJ; Huang, PL; Domian, IJ; Chien, KR				Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Zhu, Shenjun; Shao, Ying; Roberts, Drucilla J.; Huang, Paul L.; Domian, Ibrahim J.; Chien, Kenneth R.			Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages	NATURE			English	Article							EMBRYONIC STEM-CELLS; CARDIAC PROGENITORS; SMOOTH-MUSCLE; CARDIOMYOCYTE; DIFFERENTIATION; CARDIOGENESIS; POPULATION; PRECURSORS; CONTRIBUTE; ORIGINS	The generation and expansion of diverse cardiovascular cell lineages is a critical step during human cardiogenesis, with major implications for congenital heart disease. Unravelling the mechanisms for the diversification of human heart cell lineages has been hampered by the lack of genetic tools to purify early cardiac progenitors and define their developmental potential(1-4). Recent studies in the mouse embryo have identified a multipotent cardiac progenitor that contributes to all of the major cell types in the murine heart(5-8). In contrast to murine development, human cardiogenesis has a much longer onset of heart cell lineage diversification and expansion, suggesting divergent pathways. Here we identify a diverse set of human fetal ISL1(+) cardiovascular progenitors that give rise to the cardiomyocyte, smooth muscle and endothelial cell lineages. Using two independent transgenic and gene-targeting approaches in human embryonic stem cell lines, we show that purified ISL1(+) primordial progenitors are capable of self-renewal and expansion before differentiation into the three major cell types in the heart. These results lay the foundation for the generation of human model systems for cardiovascular disease and novel approaches for human regenerative cardiovascular medicine.	[Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Zhu, Shenjun; Shao, Ying; Huang, Paul L.; Domian, Ibrahim J.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Bu, Lei; Jiang, Xin; Martin-Puig, Silvia; Caron, Leslie; Domian, Ibrahim J.; Chien, Kenneth R.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Roberts, Drucilla J.] Harvard Univ, Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs,Med Sch, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Plaza,CPZN 3208,185 Cambridge St, Boston, MA 02114 USA.	krchien@partners.org	Caron, Leslie/AAE-3511-2022; Roberts, Drucilla/AAB-6379-2022	Caron, Leslie/0000-0003-4118-2974; Martin-Puig, Silvia/0000-0003-3048-6729; BU, LEI/0000-0003-4476-2157; Huang, Paul/0000-0002-5436-8658	Foundation Alfonso Martin Escudero, Spain; Harvard Stem Cell Institute; Leducq Foundation	Foundation Alfonso Martin Escudero, Spain; Harvard Stem Cell Institute; Leducq Foundation(Leducq Foundation)	We thank C. Cowan for advice on human ES cell culture and electroporation; A. Nagy for providing the DsRed-MST plasmid; Y. Qyang for discussion and comments; E. Hansson for a critical reading of this manuscript; M. Lindsay and M. Ortega-Molina for help on human fetal heart anatomy; L. B. Prickett-Rice and K. Folz-Donahue for flow cytometry support; and Advanced Bioscience Resources for providing the human fetal tissues. S. M. P. is funded by Foundation Alfonso Martin Escudero, Spain. This study is supported by Harvard Stem Cell Institute and the Leducq Foundation.	Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	25	413	449	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					113	U130		10.1038/nature08191	http://dx.doi.org/10.1038/nature08191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19571884				2022-12-28	WOS:000267545200040
J	Chwastiak, LA; Tek, C				Chwastiak, Lydia A.; Tek, Cenk			The unchanging mortality gap for people with schizophrenia	LANCET			English	Editorial Material							HEART-DISEASE RISK; CATIE SCHIZOPHRENIA; ANTIPSYCHOTIC TREATMENT; CLOZAPINE; TRIAL; PHASE-1		[Chwastiak, Lydia A.; Tek, Cenk] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Yale University	Chwastiak, LA (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA.	lydia.chwastiak@yale.edu	Tek, Cenk/M-1552-2019					Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Barnett AH, 2009, EUR ARCH PSY CLIN N, V259, P239, DOI 10.1007/s00406-008-0863-2; Daumit GL, 2008, SCHIZOPHR RES, V105, P175, DOI 10.1016/j.schres.2008.07.006; Gianfrancesco FD, 2002, J CLIN PSYCHIAT, V63, P920, DOI 10.4088/JCP.v63n1010; Kelly DL, 2006, J CLIN PSYCHIAT, V67, P1404, DOI 10.4088/JCP.v67n0911; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Meyer JM, 2008, SCHIZOPHR RES, V103, P104, DOI 10.1016/j.schres.2008.04.023; Meyer JM, 2008, SCHIZOPHR RES, V101, P273, DOI 10.1016/j.schres.2007.12.487; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X	11	27	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					590	592		10.1016/S0140-6736(09)61072-2	http://dx.doi.org/10.1016/S0140-6736(09)61072-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19595448				2022-12-28	WOS:000269222600005
J	Choudhary, C; Kumar, C; Gnad, F; Nielsen, ML; Rehman, M; Walther, TC; Olsen, JV; Mann, M				Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias			Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions	SCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; MASS-SPECTROMETRY; ACTIVATION; SITE; ACETYLTRANSFERASE; DOMAIN; SIGNAL	Lysine acetylation is a reversible posttranslational modification of proteins and plays a key role in regulating gene expression. Technological limitations have so far prevented a global analysis of lysine acetylation's cellular roles. We used high-resolution mass spectrometry to identify 3600 lysine acetylation sites on 1750 proteins and quantified acetylation changes in response to the deacetylase inhibitors suberoylanilide hydroxamic acid and MS-275. Lysine acetylation preferentially targets large macromolecular complexes involved in diverse cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear transport, and actin nucleation. Acetylation impaired phosphorylation-dependent interactions of 14-3-3 and regulated the yeast cyclin-dependent kinase Cdc28. Our data demonstrate that the regulatory scope of lysine acetylation is broad and comparable with that of other major posttranslational modifications.	[Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Choudhary, Chunaram; Nielsen, Michael L.; Olsen, Jesper V.; Mann, Matthias] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Max Planck Society; University of Copenhagen	Mann, M (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Kumar, Chanchal/C-2901-2008; Rehman, Michael/W-2855-2019; Olsen, Jesper/ABH-4638-2020; Mann, Matthias/A-3454-2013; Choudhary, Chunaram/E-9819-2011; choudhary, chunaram/ABE-6634-2020; Nielsen, Michael/C-4418-2008	Olsen, Jesper/0000-0002-4747-4938; Mann, Matthias/0000-0003-1292-4799; Choudhary, Chunaram/0000-0002-9863-433X; choudhary, chunaram/0000-0002-9863-433X; Gnad, Florian/0000-0002-2287-2251; Walther, Tobias/0000-0003-1442-1327; Nielsen, Michael/0000-0002-0067-9039	Deutsche Krebshilfe [108401]; Max Planck Society; European Molecular Biology Organization	Deutsche Krebshilfe(Deutsche Krebshilfe); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work is supported by the Deutsche Krebshilfe (108401) and the Max Planck Society. M.L.N. is supported by the European Molecular Biology Organization	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahn NG, 2008, CURR OPIN CHEM BIOL, V12, P1, DOI 10.1016/j.cbpa.2008.02.016; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tedford Nathan C., 2008, Briefings in Functional Genomics & Proteomics, V7, P383, DOI 10.1093/bfgp/eln037; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	46	2993	4266	12	721	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					834	840		10.1126/science.1175371	http://dx.doi.org/10.1126/science.1175371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19608861				2022-12-28	WOS:000269242400036
J	Deng, YB; Guo, XL; Ferguson, DO; Chang, S				Deng, Yibin; Guo, Xiaolan; Ferguson, David O.; Chang, Sandy			Multiple roles for MRE11 at uncapped telomeres	NATURE			English	Article							DOUBLE-STRAND BREAK; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; ATM ACTIVATION; COMPLEX; REPAIR; TRF2; POT1	Progressive telomere attrition or uncapping of the shelterin complex elicits a DNA damage response as a result of a cell's inability to distinguish dysfunctional telomeric ends from DNA double-strand breaks(1). Telomere deprotection activates both ataxia telangiectasia mutated (ATM) and telangiectasia and Rad3-related (ATR) kinase-dependent DNA damage response pathways, and promotes efficient non-homologous end-joining (NHEJ) of dysfunctional telomeres(2-5). The mammalian MRE11-RAD50-NBS1 (MRN; NBS1 is also known as NBN) complex interacts with ATM to sense chromosomal double-strand breaks and coordinate global DNA damage responses(6,7). Although the MRN complex accumulates at dysfunctional telomeres, it is not known whether mammalian MRN promotes repair at these sites. Here we address this question by using mouse alleles that either inactivate the entire MRN complex or eliminate only the nuclease activities of MRE11 (ref. 8). We show that cells lacking MRN do not activate ATM when telomeric repeat binding factor 2 (TRF2) is removed from telomeres, and ligase 4 (LIG4)-dependent chromosome end-to-end fusions are markedly reduced. Residual chromatid fusions involve only telomeres generated by leading strand synthesis. Notably, although cells deficient for MRE11 nuclease activity efficiently activate ATM and recruit 53BP1 (also known as TP53BP1) to deprotected telomeres, the 3' telomeric overhang persists to prevent NHEJ-mediated chromosomal fusions. Removal of shelterin proteins that protect the 3' overhang in the setting of MRE11 nuclease deficiency restores LIG4-dependent chromosome fusions. Our data indicate a critical role for the MRN complex in sensing dysfunctional telomeres, and show that in the absence of TRF2, MRE11 nuclease activity removes the 3' telomeric overhang to promote chromosome fusions. MRE11 can also protect newly replicated leading strand telomeres from NHEJ by promoting 5' strand resection to generate POT1a-TPP1-bound 3' overhangs.	[Deng, Yibin; Guo, Xiaolan; Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Guo, Xiaolan] N Sichuan Med Coll, Inst Rheumatol & Immunol, Nanchong 637000, Sichuan, Peoples R China; [Ferguson, David O.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; North Sichuan Medical University; University of Michigan System; University of Michigan	Chang, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Box 1010,1515 Holcombe Blvd, Houston, TX 77030 USA.	schang@mdanderson.org		Deng, Yibin/0000-0001-5711-3565	National Institute on Aging (NIA) [RO1 AG028888]; National Cancer Institute (NCI) [RO1 CA129037]; Welch Foundation; Susan G. Koman Race for the Cure Foundation; Abraham and Phyllis Katz Foundation; Michael Kadoorie Cancer Genetic Research Program; NCI Howard Temin Award [K01CA124461]; NATIONAL CANCER INSTITUTE [R01CA129037, P30CA046592, K01CA124461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028888] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Susan G. Koman Race for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Abraham and Phyllis Katz Foundation; Michael Kadoorie Cancer Genetic Research Program; NCI Howard Temin Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to M. Zhao, Z. Lu, P. Iyengar and J. Buis for technical help. Both J. Karlseder and P. Carpenter are thanked for providing antibodies. S. C. acknowledges financial support from the National Institute on Aging (NIA) (RO1 AG028888), the National Cancer Institute (NCI) (RO1 CA129037), the Welch Foundation, the Susan G. Koman Race for the Cure Foundation, the Abraham and Phyllis Katz Foundation and the Michael Kadoorie Cancer Genetic Research Program. Y. D. was supported by an NCI Howard Temin Award (K01CA124461).	Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DINKELMANN M, NATURE STRU IN PRESS; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	153	160	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					914	U157		10.1038/nature08196	http://dx.doi.org/10.1038/nature08196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633651	Green Accepted			2022-12-28	WOS:000268938300043
J	Terasawa, T; Balk, EM; Chung, M; Garlitski, AC; Alsheikh-Ali, AA; Lau, J; Ip, S				Terasawa, Teruhiko; Balk, Ethan M.; Chung, Mei; Garlitski, Ann C.; Alsheikh-Ali, Alawi A.; Lau, Joseph; Ip, Stanley			Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation	ANNALS OF INTERNAL MEDICINE			English	Review							PULMONARY VEIN ISOLATION; ANTIARRHYTHMIC-DRUG THERAPY; CAVOTRICUSPID ISTHMUS ABLATION; SUPERIOR VENA-CAVA; LONG-TERM CONTROL; ANTRUM ISOLATION; ELECTRICAL ISOLATION; IMAGE INTEGRATION; LINEAR ABLATION; TIP CATHETER	Background: Atrial fibrillation is the most common sustained arrhythmia. Medical treatment often fails to control symptoms. Purpose: To compare the benefits and harms of radiofrequency catheter ablation and medical therapy in adults with atrial fibrillation. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials (2000 to December 2008) were searched for English-language reports of studies in adults. Study Selection: 6 independent reviewers screened abstracts to identify longitudinal studies of adults with atrial fibrillation who underwent radiofrequency catheter ablation. Studies reported arrhythmia or other cardiovascular outcomes at least 6 months after ablation or any adverse events. Data Extraction: Data were extracted by 1 of 4 reviewers and were verified by a cardiac electrophysiologist. Study quality and overall strength of evidence for each question were rated by 2 independent reviewers; disagreements were resolved by consensus. Data Synthesis: 108 studies met eligibility criteria. Moderate strength of evidence (3 trials; n = 30 to 198) showed that radiofrequency ablation after a failed drug course was more likely than continuation of drug therapy alone to lead to maintained sinus rhythm. Low strength of evidence (4 trials [n = 30 to 137] and 1 retrospective study [n = 1171]) suggested that radiofrequency ablation improved quality of life, promoted avoidance of anticoagulation, and decreased readmission rates compared with medical treatment. Major adverse events occurred in fewer than 5% of patients in most of 84 studies. Limitations: Study follow-up was generally 12 months or less. Large heterogeneity of applied techniques and reporting of outcomes precluded many definitive conclusions. Reporting of adverse events was poor. Publication and selective reporting biases could not be ruled out. Studies with small samples and studies reported in a language other than English were excluded. Conclusion: Radiofrequency catheter ablation is effective for up to 12 months of rhythm control when used as a second-line therapy for atrial fibrillation in relatively young patients with near-intact cardiac function. Longer studies that use primary end points of stroke and mortality are needed.	[Ip, Stanley] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Boston, MA 02111 USA	Tufts Medical Center	Ip, S (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Box 63,800 Washington St, Boston, MA 02111 USA.	sip@tuftsmedicalcenter.org	Balk, Ethan/AAJ-2547-2020		Agency for Healthcare Research and Quality; U. S. Department of Health and Human Services [290-02-0022]; Tufts Medical Center/Pfizer	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U. S. Department of Health and Human Services; Tufts Medical Center/Pfizer(Pfizer)	Grant Support: By the Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services (contract 290-02-0022). Dr. Alsheikh-Ali received an unrestricted faculty development award from Tufts Medical Center/Pfizer.	Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Arruda M, 2007, J CARDIOVASC ELECTR, V18, P1261, DOI 10.1111/j.1540-8167.2007.00953.x; Berkowitsch A, 2005, PACE, V28, pS83, DOI 10.1111/j.1540-8159.2005.00018.x; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Bertaglia E, 2005, PACE, V28, P366, DOI 10.1111/j.1540-8159.2005.09516.x; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Beukema WP, 2005, CIRCULATION, V112, P2089, DOI 10.1161/CIRCULATIONAHA.104.484766; Bhargava M, 2004, J CARDIOVASC ELECTR, V15, P8, DOI 10.1046/j.1540-8167.2004.03266.x; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Calo L, 2006, J AM COLL CARDIOL, V47, P2504, DOI 10.1016/j.jacc.2006.02.047; Cha YM, 2008, CIRCULATION, V117, P2583, DOI 10.1161/CIRCULATIONAHA.107.716712; Cheema A, 2006, J INTERV CARD ELECTR, V15, P145, DOI 10.1007/s10840-006-9005-9; Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056; Chugh A, 2005, HEART RHYTHM, V2, P464, DOI 10.1016/j.hrthm.2005.01.027; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Corrado A, 2008, J CARDIOVASC ELECTR, V19, P807, DOI 10.1111/j.1540-8167.2008.01124.x; Della Bella P, 2005, EUROPACE, V7, P95, DOI 10.1016/j.eupc.2004.12.008; Dixit S, 2008, HEART RHYTHM, V5, P174, DOI 10.1016/j.hrthm.2007.09.024; Dixit S, 2006, J CARDIOVASC ELECTR, V17, P1074, DOI 10.1111/j.1540-8167.2006.00558.x; Dong JZ, 2005, CHINESE MED J-PEKING, V118, P1150; Essebag V, 2005, EUR HEART J, V26, P2550, DOI 10.1093/eurheartj/ehi507; Estner HL, 2006, EUROPACE, V8, P583, DOI 10.1093/europace/eul079; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Forleo GB, 2007, EUROPACE, V9, P613, DOI 10.1093/europace/eum144; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gerstenfeld EP, 2007, J CARDIOVASC ELECTR, V18, P23, DOI 10.1111/j.1540-8167.2006.00662.x; Gerstenfeld EP, 2006, HEART RHYTHM, V3, P165, DOI 10.1016/j.hrthm.2005.10.016; Gjesdal K, 2008, SCAND CARDIOVASC J, V42, P3, DOI 10.1080/14017430701798838; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P392, DOI 10.1111/j.1540-8167.2006.00753.x; Haissaguerre M, 2004, CIRCULATION, V109, P3007, DOI 10.1161/01.CIR.0000130645.95357.97; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052; Hsu LF, 2005, PACE, V28, pS106, DOI 10.1111/j.1540-8159.2005.00062.x; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ip S, 2009, COMP EFFECTIVENESS R; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Kanj MH, 2007, J AM COLL CARDIOL, V49, P1634, DOI 10.1016/j.jacc.2006.12.041; Karch MR, 2005, CIRCULATION, V111, P2875, DOI 10.1161/CIRCULATIONAHA.104.491530; Katritsis D, 2008, J INTERV CARD ELECTR, V22, P31, DOI 10.1007/s10840-008-9247-9; Kettering K, 2008, PACE, V31, P652, DOI 10.1111/j.1540-8159.2008.01067.x; Khaykin Y, 2004, HEART RHYTHM, V1, P33, DOI 10.1016/j.hrthm.2004.02.007; Kilicaslan F, 2006, J CARDIOVASC ELECTR, V17, P495, DOI 10.1111/j.1540-8167.2006.00451.x; Kilicaslan F, 2005, J AM COLL CARDIOL, V45, P690, DOI 10.1016/j.jacc.2004.11.047; Kistler PM, 2007, J CARDIOVASC ELECTR, V18, P1282, DOI 10.1111/j.1540-8167.2007.00981.x; Kistler PM, 2006, J CARDIOVASC ELECTR, V17, P1093, DOI 10.1111/j.1540-8167.2006.00594.x; Kistler PM, 2008, EUR HEART J, V29, P3029, DOI 10.1093/eurheartj/ehn453; Kottkamp H, 2004, J AM COLL CARDIOL, V44, P869, DOI 10.1016/j.jacc.2004.047.049; KRITTAYAPHONG R, 2003, J MED ASS THAI S1, V86, pS8; Lakkireddy D, 2005, HEART RHYTHM, V2, P1309, DOI 10.1016/j.hrthm.2005.09.010; Lemola K, 2006, J AM COLL CARDIOL, V48, P340, DOI 10.1016/j.jacc.2006.04.053; Li XP, 2008, CIRC J, V72, P1125; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Liu XP, 2006, CIRC J, V70, P1392, DOI 10.1253/circj.70.1392; Liu XP, 2005, CHINESE MED J-PEKING, V118, P1773; Ma J, 2006, CHINESE MED J-PEKING, V119, P2042, DOI 10.1097/00029330-200612020-00004; Macle L, 2002, J CARDIOVASC ELECTR, V13, P1067, DOI 10.1046/j.1540-8167.2002.01067.x; Mansour M, 2004, J CARDIOVASC ELECTR, V15, P532, DOI 10.1046/j.1540-8167.2004.03503.x; Mantovan R, 2005, J CARDIOVASC ELECTR, V16, P1293, DOI 10.1111/j.1540-8167.2005.00217.x; Marrouche NF, 2007, J CARDIOVASC ELECTR, V18, P583, DOI 10.1111/j.1540-8167.2007.00879.x; Marrouche NF, 2003, CIRCULATION, V107, P2710, DOI 10.1161/01.CIR.0000070541.83326.15; Martinek M, 2007, PACE, V30, P1215, DOI 10.1111/j.1540-8159.2007.00843.x; Matiello M, 2008, EUROPACE, V10, P955, DOI 10.1093/europace/eun144; Matsuo S, 2007, J CARDIOVASC ELECTR, V18, P704, DOI 10.1111/j.1540-8167.2007.00842.x; Nair GM, 2009, J CARDIOVASC ELECTR, V20, P138, DOI 10.1111/j.1540-8167.2008.01285.x; Nilsson B, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.029; Nilsson B, 2006, EUROPACE, V8, P962, DOI 10.1093/europace/eul100; Noheria A, 2008, ARCH INTERN MED, V168, P581, DOI 10.1001/archinte.168.6.581; Okada T, 2007, J AM COLL CARDIOL, V49, P1436, DOI 10.1016/j.jacc.2006.10.076; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Oral H, 2006, CIRCULATION, V113, P1824, DOI 10.1161/CIRCULATIONAHA.105.601898; Oral H, 2005, HEART RHYTHM, V2, P1165, DOI 10.1016/j.hrthm.2005.08.003; Oral H, 2004, CIRCULATION, V110, P2797, DOI 10.1161/01.CIR.0000146786.87037.26; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Oral H, 2006, CIRCULATION, V114, P759, DOI 10.1161/CIRCULATIONAHA.106.641225; Pak HN, 2008, J CARDIOVASC ELECTR, V19, P473, DOI 10.1111/j.1540-8167.2007.01074.x; Pappone C, 2004, CIRCULATION, V110, P3036, DOI 10.1161/01.CIR.0000147186.83715.95; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Piorkowski C, 2008, PACE, V31, P863, DOI 10.1111/j.1540-8159.2008.01101.x; Proclemer A, 2008, EUROPACE, V10, P1085, DOI 10.1093/europace/eun197; Richter B, 2006, EUR HEART J, V27, P2553, DOI 10.1093/eurheartj/ehl307; Rodgers M, 2008, Health Technol Assess, V12, piii; RODGERS M, 2008, HEALTH TECHNOL ASSES, V12, pR11; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rossillo A, 2008, J CARDIOVASC MED, V9, P51, DOI 10.2459/JCM.0b013e32801462d4; Rotter M, 2005, J CARDIOVASC ELECTR, V16, P1298, DOI 10.1111/j.1540-8167.2005.00225.x; Rotter M, 2005, EUR HEART J, V26, P1415, DOI 10.1093/eurheartj/ehi172; Saad EB, 2003, ANN INTERN MED, V138, P634, DOI 10.7326/0003-4819-138-8-200304150-00010; Sauer WH, 2006, CIRCULATION, V114, P191, DOI 10.1161/CIRCULATIONAHA.106.621896; Schwartzman D, 2003, J INTERV CARD ELECTR, V9, P295, DOI 10.1023/A:1026295202643; Shah DC, 2007, J CARDIOVASC ELECTR, V18, P926, DOI 10.1111/j.1540-8167.2007.00896.x; Sheikh I, 2006, J INTERV CARD ELECTR, V17, P103, DOI 10.1007/s10840-006-9066-9; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; Sra J, 2007, J CARDIOVASC ELECTR, V18, P409, DOI 10.1111/j.1540-8167.2006.00734.x; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Tamborero D, 2005, J INTERV CARD ELECTR, V14, P21, DOI 10.1007/s10840-005-4513-6; Tang K, 2008, CHINESE MED J-PEKING, V121, P508, DOI 10.1097/00029330-200803020-00007; Tang RB, 2006, J INTERV CARD ELECTR, V17, P41, DOI 10.1007/s10840-006-9049-x; Tao Hailong, 2008, Clin Cardiol, V31, P463, DOI 10.1002/clc.20340; Thomas L, 2004, AM J CARDIOL, V93, P165, DOI 10.1016/j.amjcard.2003.09.033; Tondo C, 2005, PACE, V28, pS102, DOI 10.1111/j.1540-8159.2005.00047.x; Tondo C, 2006, PACE, V29, P962, DOI 10.1111/j.1540-8159.2006.00471.x; Turco P, 2007, PACE, V30, pS112; Verma A, 2007, J CARDIOVASC ELECTR, V18, P151, DOI 10.1111/j.1540-8167.2006.00673.x; Walczak Franciszek, 2006, Kardiol Pol, V64, P26; Wang XH, 2008, EUROPACE, V10, P197, DOI 10.1093/europace/eum298; Wang XH, 2008, EUROPACE, V10, P600, DOI 10.1093/europace/eun077; Wang XH, 2007, EUROPACE, V9, P481, DOI 10.1093/europace/eum101; Wazni O, 2003, CIRCULATION, V108, P2479, DOI 10.1161/01.CIR.0000101684.88679.AB; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wazni OM, 2007, CIRCULATION, V116, P2531, DOI 10.1161/CIRCULATIONAHA.107.727784; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yamada T, 2006, INT HEART J, V47, P219, DOI 10.1536/ihj.47.219; Yamane T, 2002, J AM COLL CARDIOL, V39, P1337, DOI 10.1016/S0735-1097(02)01782-5; Yamane T, 2007, CIRC J, V71, P753, DOI 10.1253/circj.71.753; Zado E, 2008, J CARDIOVASC ELECTR, V19, P621, DOI 10.1111/j.1540-8167.2008.01183.x; Zhou JM, 2007, CHINESE MED J-PEKING, V120, P956, DOI 10.1097/00029330-200706010-00003	123	97	101	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					191	W43		10.7326/0003-4819-151-3-200908040-00131	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00131			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19581635				2022-12-28	WOS:000268947800006
J	Walensky, RP; Wolf, LL; Wood, R; Fofana, MO; Freedberg, KA; Martinson, NA; Paltiel, AD; Anglaret, X; Weinstein, MC; Losina, E				Walensky, Rochelle P.; Wolf, Lindsey L.; Wood, Robin; Fofana, Mariam O.; Freedberg, Kenneth A.; Martinson, Neil A.; Paltiel, A. David; Anglaret, Xavier; Weinstein, Milton C.; Losina, Elena		CEPAC Int Investigators	When to Start Antiretroviral Therapy in Resource-Limited Settings	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; OPPORTUNISTIC INFECTIONS; HIV TREATMENT; COTE-DIVOIRE; SOUTH-AFRICA; OUTCOMES; IMPACT; RECOMMENDATIONS; TUBERCULOSIS; PROPHYLAXIS	Background: The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years. Objective: To inform HIV treatment decisions about the optimal CD4 threshold at which to initiate ART in South Africa while awaiting the results of these trials. Design: Cost-effectiveness analysis by using a computer simulation model of HIV disease. Data Sources: Published data from randomized trials and observational cohorts in South Africa. Target Population: HIV-infected patients in South Africa. Time Horizon: 5-year and lifetime. Perspective: Modified societal. Intervention: No treatment, ART initiated at a CD4 count less than 0.250 x 10(9) cells/L, and ART initiated at a CD4 count less than 0.350 x 10(9) cells/L. Outcome Measures: Morbidity, mortality, life expectancy, medical costs, and cost-effectiveness. Results of Base-Case Analysis: If 10% to 100% of HIV-infected patients are identified and linked to care, a CD4 count threshold for ART initiation of 0.350 x 10(9) cells/L would reduce severe opportunistic diseases by 22000 to 221000 and deaths by 25000 to 253000 during the next 5 years compared with ART initiation at 0.250 x 10(9) cells/L; cost increases would range from $142 million (10%) to $1.4 billion (100%). Either ART initiation strategy would increase long-term survival by at least 7.9 years, with a mean per-person life expectancy of 3.8 years with no ART and 12.5 years with an initiation threshold of 0.350 x 10(9) cells/L. Compared with an initiation threshold of 0.250 x 10(9) cells/ L, a threshold of 0.350 x 10(9) cells/L has an incremental cost-effectiveness ratio of $1200 per year of life saved. Results of Sensitivity Analysis: Initiating ART at a CD4 count less than 0.350 x 10(9) cells/ L would remain cost-effective over the next 5 years even if the probability that the trial would demonstrate the superiority of earlier therapy is as low as 17%. Limitation: This model does not consider the possible benefits of initiating ART at a CD4 count greater than 0.350 x 10(9) cells/ L or of reduced HIV transmission. Conclusion: Earlier initiation of ART in South Africa will probably reduce morbidity and mortality, improve long-term survival, and be cost-effective. While awaiting trial results, treatment guidelines should be liberalized to allow initiation at CD4 counts less than 0.350 x 10(9) cells/ L, earlier than is currently recommended. Primary Funding Source: National Institute of Allergy and Infectious Diseases and the Doris Duke Charitable Foundation.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Massachusetts Gen Hosp,Sch Publ Hlth, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ Cape Town, ZA-7925 Cape Town, South Africa; Perinatal HIV Res Unit, Johannesburg, South Africa; Johns Hopkins Univ, Baltimore, MD USA; Yale Univ, Sch Med, New Haven, CT USA; Univ Bordeaux 2, Bordeaux, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Boston University; University of Cape Town; Johns Hopkins University; Yale University; UDICE-French Research Universities; Universite de Bordeaux	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Anglaret, Xavier/T-2757-2019; Anglaret, Xavier/F-7333-2013; Wood, Robin/G-8509-2011; Fofana, Mariam O./H-5208-2019	Fofana, Mariam O./0000-0002-2874-471X; Paltiel, A. David/0000-0002-4861-3290; Lipsitch, Marc/0000-0003-1504-9213; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Anglaret, Xavier/0000-0003-3319-8423	National Institute of Allergy and Infectious Diseases [R01 AI058736, K24 AI062476, P30 AI060354, U01 AI068634]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, U01AI068634, P30AI060354, K24AI062476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: By the National Institute of Allergy and Infectious Diseases (R01 AI058736, K24 AI062476, P30 AI060354, and U01 AI068634) and the Doris Duke Charitable Foundation (Clinical Scientist Development Award).	*ACT SOC S AFR, 2005, ASSA2003 SUMM STAT; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Bennett S, 2005, B WORLD HEALTH ORGAN, V83, P541; Bodri M, 2006, ANTIVIR THER, V11, P63; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; CLEARY S, 2004, COST EFFECTIVENESS A; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; *DOCT BORD, 2006, UNT WEB PRIC RED PRI; Edejer T, 2003, MAKING CHOICES HLTH; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; French National Agency for Research on AIDS and Viral Hepatitis, EARL ANT TREATM EARL; *GAUT DEP HLTH, 2004, GAUT HOSP NUM PHARM; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; IJUMBA P, 2005, S AFRICAN HLTH REV 2; KITAHATA MM, 2009, 16 C RETR OPP INF MO; Kress KD, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_3.S3; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lopez A. D., 2001, LIFE TABLES 191 COUN; Losina E, 2007, ANTIVIR THER, V12, P543; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Myer L, 2004, SAMJ S AFR MED J, V94, P273; *NIH, PREV SEX TRANSM HIV; *OAND CORP, 2009, FXHISTORY HIST CURR; *PRES EM PLAN AIDS, FY 2008 COUNTR PROF; *S AFR NAT DEP HLT, 2008, NAT HLTH REF PRIC LI; South African National Department of Health, 2004, NAT ANT TREATM GUID; STERNE J, 2009, 16 C RETR OPP INF MO; U.S. Preventive Services Task Force, 2008, GUID CLIN PREV SERV; UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance, 2001, GUID US HIV TEST TEC; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; *WHO, SUMM COUNTR PROF HIV; *WORLD BANK, 2006, WORLD DEV IND 2006; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	46	106	108	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					157	W38		10.7326/0003-4819-151-3-200908040-00138	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00138			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19620143	Green Accepted			2022-12-28	WOS:000268947800002
J	Rubenstein, LS; Annas, GJ				Rubenstein, Leonard S.; Annas, George J.			Medical ethics at Guantanamo Bay detention centre and in the US military: a time for reform	LANCET			English	Editorial Material							HUNGER STRIKES		[Annas, George J.] Boston Univ, Sch Publ Hlth, Hlth Law Bioeth & Human Rights Dept, Boston, MA 02118 USA; [Rubenstein, Leonard S.] US Inst Peace, Washington, DC USA; [Rubenstein, Leonard S.] Phys Human Rights, Cambridge, MA USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Bioeth & Human Rights Dept, 715 Albany St, Boston, MA 02118 USA.	annasgj@bu.edu		Annas, George/0000-0001-5836-7831				*AD HOC COMM MIL M, 2009, MIL MED ETH ISS REG; *AM MED ASS, 2006, AM MED ASS REIT OPP; *AM PSYCH ASS, 2006, AMA COUNC EHT JUD AF; American Psychiatric Association, 2006, PSYCH PART INT DET; Annas GJ, 2008, NEW ENGL J MED, V359, P1087, DOI 10.1056/NEJMp0805975; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; BUKOVSKY V, 2003, ACCOUNT TORTURE PRES, P218; *COMM ARM SERV, 2008, US SEN INQ TREATM DE; Crosby SS, 2007, JAMA-J AM MED ASSOC, V298, P563, DOI 10.1001/jama.298.5.563; *DEP ARM HEADQ US, 2006, 06029 OTSG MEDOM; *DEP DEF, 2006, INSTR 2310 E MED PRO; *ICRC, 2007, ICRC REP TRETAM 14 H; Mazzetti Mark, 2009, NY TIMES, pA1; *PHYS HUM RIGHTS, 2008, BROK LAWS BROK LIV; Physicians for Human Rights and University of Cape Town Health Sciences Faculty, 2003, DUAL LOYALT HUM RIGH; Rubenstein L, 2005, JAMA-J AM MED ASSOC, V294, P1544, DOI 10.1001/jama.294.12.1544; *US DEP DEF, 2009, REV DEP COMPL PRES E; *WHIT HOUS, 2009, EX ORD CLOS GUANT DE; *WORLD MED ASS, 2006, DECL HUNG STRIK; *WORLD MED ASS, 2006, DECL TOK GUID PHYS C; 2008, LANCET, V372, P777	21	17	17	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					353	355		10.1016/S0140-6736(09)60873-4	http://dx.doi.org/10.1016/S0140-6736(09)60873-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477GW	19632495				2022-12-28	WOS:000268508200033
J	Barabasi, AL				Barabasi, Albert-Laszlo			Scale-Free Networks: A Decade and Beyond	SCIENCE			English	Editorial Material							COMPLEX; INTERNET	For decades, we tacitly assumed that the components of such complex systems as the cell, the society, or the Internet are randomly wired together. In the past decade, an avalanche of research has shown that many real networks, independent of their age, function, and scope, converge to similar architectures, a universality that allowed researchers from different disciplines to embrace network theory as a common paradigm. The decade-old discovery of scale-free networks was one of those events that had helped catalyze the emergence of network science, a new research field with its distinct set of challenges and accomplishments.	[Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys Biol & Comp Sci, Ctr Complex Network Res, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Northeastern University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Barabasi, AL (corresponding author), Northeastern Univ, Dept Phys Biol & Comp Sci, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Xie, Jianjun/D-9838-2012; Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caldarelli G., 2007, SCALE FREE NETWORKS; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; KARINTHY F, 2006, STRUCTURE DYNAMICS N; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Newman M, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.3027989; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; PASLORSATORRAS R, 2001, PHYS REV LETT, V86, P3200; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Randolph M.F., 2001, INT J PHYS MODELL GE, V1, P1, DOI [10.1680/ijpmg.2001.010102, DOI 10.1680/IJPMG.2001.010102, DOI 10.1680/ijpmg.2001.010102]; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	26	1153	1237	8	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					412	413		10.1126/science.1173299	http://dx.doi.org/10.1126/science.1173299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628854				2022-12-28	WOS:000268255100038
J	Barnhart, KT				Barnhart, Kurt T.			Ectopic Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CROWN-RUMP LENGTH; TRANSVAGINAL SONOGRAPHY; INTRAUTERINE PREGNANCY; SYSTEMIC METHOTREXATE; EXPECTANT MANAGEMENT; MEDICAL-MANAGEMENT; CARDIAC ACTIVITY; RISK-FACTORS; SERUM HCG	A healthy 29-year-old woman who has been trying to conceive presents with vaginal spotting for the past 5 days and intermittent crampy abdominal pain in her left lower quadrant for the past 3 days. Although she normally has regular menstrual cycles, her last menstrual period was 6 weeks and 2 days before presentation. She has had a spontaneous vaginal delivery and an anembryonic gestation treated by dilation and curettage. How should this patient be evaluated and treated?	Univ Penn, Dept Obstet & Gynecol, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania	Barnhart, KT (corresponding author), Univ Penn, Dept Obstet & Gynecol, Med Ctr, 3701 Market St,8th Fl, Philadelphia, PA 19104 USA.	kbarnhart@obgyn.upenn.edu			National Institutes of Health [R01 HD36455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by a grant (R01 HD36455) from the National Institutes of Health.	Ailawadi M, 2005, FERTIL STERIL, V83, P376, DOI 10.1016/j.fertnstert.2004.06.068; Alleyassin A, 2006, FERTIL STERIL, V85, P1661, DOI 10.1016/j.fertnstert.2005.11.055; American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V111, P1479, DOI 10.1097/AOG.0b013e31817d201e; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Banerjee S, 1999, ULTRASOUND OBST GYN, V14, P231, DOI 10.1046/j.1469-0705.1999.14040231.x; Barnhart K, 2004, OBSTET GYNECOL, V104, P975, DOI 10.1097/01.AOG.0000142712.80407.fd; BARNHART K, 1994, OBSTET GYNECOL, V84, P1010; Barnhart KT, 2004, OBSTET GYNECOL, V104, P50, DOI 10.1097/01.AOG.0000128174.48843.12; Barnhart KT, 2003, OBSTET GYNECOL, V101, P778, DOI 10.1016/S0029-7844(02)03158-7; Barnhart KT, 2002, OBSTET GYNECOL, V100, P505, DOI 10.1016/S0029-7844(02)02142-7; Barnhart KT, 1999, OBSTET GYNECOL, V94, P583, DOI 10.1016/S0029-7844(99)00347-6; Barnhart K, 2007, FERTIL STERIL, V87, P250, DOI 10.1016/j.fertnstert.2006.06.054; Barnhart KT, 2006, FERTIL STERIL, V86, P36, DOI 10.1016/j.fertnstert.2005.12.023; Barnhart KT, 2008, OBSTET GYNECOL, V112, P1319, DOI 10.1097/AOG.0b013e31818eddcf; BRADLEY WG, 1982, RADIOLOGY, V143, P223, DOI 10.1148/radiology.143.1.7063730; BROWN DL, 1994, J ULTRAS MED, V13, P259, DOI 10.7863/jum.1994.13.4.259; BROWN DL, 1990, J ULTRAS MED, V9, P631; CACCIATORE B, 1990, BRIT J OBSTET GYNAEC, V97, P904, DOI 10.1111/j.1471-0528.1990.tb02445.x; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chung K, 2006, HUM REPROD, V21, P823, DOI 10.1093/humrep/dei389; Clayton HB, 2006, OBSTET GYNECOL, V107, P595, DOI 10.1097/01.AOG.0000196503.78126.62; Condous G, 2006, HUM REPROD, V21, P2706, DOI 10.1093/humrep/del223; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Condous G, 2004, INT J GYNECOL OBSTET, V86, P351, DOI 10.1016/j.ijgo.2004.04.004; Condous G, 2004, HUM REPROD, V19, P1900, DOI 10.1093/humrep/deh341; DORFMAN SF, 1983, OBSTET GYNECOL, V62, P334, DOI 10.1097/00006250-198309000-00014; GOLDSTEIN SR, 1992, OBSTET GYNECOL, V80, P670; GOLDSTEIN SR, 1994, J ULTRAS MED, V13, P27; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; KADAR N, 1981, OBSTET GYNECOL, V58, P162; Kirk E, 2006, ULTRASOUND OBST GYN, V27, P311, DOI 10.1002/uog.2702; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; LEVI CS, 1990, RADIOLOGY, V176, P71, DOI 10.1148/radiology.176.1.2191372; Maymon R, 1996, HUM REPROD UPDATE, V2, P541, DOI 10.1093/humupd/2.6.541; Menon S, 2007, FERTIL STERIL, V87, P481, DOI 10.1016/j.fertnstert.2006.10.007; Mol BWJ, 1999, AM J OBSTET GYNECOL, V181, P945, DOI 10.1016/S0002-9378(99)70330-3; Mol BWJ, 2002, ACTA OBSTET GYN SCAN, V81, P661, DOI 10.1034/j.1600-0412.2002.810713.x; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Mol F, 2008, HUM REPROD UPDATE, V14, P309, DOI 10.1093/humupd/dmn012; *PRACT COMM AM SOC, 2006, FERTIL STERIL S1, V86, pS96; ROMERO R, 1985, OBSTET GYNECOL, V66, P357; ROSSAVIK IK, 1988, FERTIL STERIL, V49, P1012; Seeber BE, 2006, OBSTET GYNECOL, V107, P955; Seeber BE, 2006, FERTIL STERIL, V86, P454, DOI 10.1016/j.fertnstert.2005.12.056; SEIFER DB, 1993, OBSTET GYNECOL, V81, P378; Shalev E, 1998, FERTIL STERIL, V69, P62, DOI 10.1016/S0015-0282(97)00425-1; Silva C, 2006, OBSTET GYNECOL, V107, P605, DOI 10.1097/01.AOG.0000198635.25135.e7; STOVALL TG, 1989, FERTIL STERIL, V51, P435; STOVALL TG, 1993, AM J OBSTET GYNECOL, V168, P1759, DOI 10.1016/0002-9378(93)90687-E; Van den Eeden SK, 2005, OBSTET GYNECOL, V105, P1052, DOI 10.1097/01.AOG.0000158860.26939.2d; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; YLOSTALO P, 1991, ANN NY ACAD SCI, V626, P516; 1995, MMWR MORB MORTAL WKL, V44, P46	54	281	303	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					379	387		10.1056/NEJMcp0810384	http://dx.doi.org/10.1056/NEJMcp0810384			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625718				2022-12-28	WOS:000268184500008
J	Baeten, JM; Celum, C; Coates, TJ				Baeten, Jared M.; Celum, Connie; Coates, Thomas J.			Male circumcision and HIV risks and benefits for women	LANCET			English	Editorial Material							PREVENTION; TRIAL; INFECTIONS; REDUCTION; UGANDA; RAKAI; MEN		[Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Coates, Thomas J.] Univ Calif Los Angeles, Div Infect Dis, UCLA Program Global Hlth, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.	jbaeten@u.washington.edu			NIAID NIH HHS [P30 AI027757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; GRAY RH, 2009, AM J OBSTET GYNECOL, V200; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Karim SA, 2009, 16 C RETR OPP INF MO; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; World Health Organization, 2007, NEW DAT MAL CIRC HIV	14	21	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 18	2009	374	9685					182	184		10.1016/S0140-6736(09)61311-8	http://dx.doi.org/10.1016/S0140-6736(09)61311-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474DP	19616704				2022-12-28	WOS:000268263000007
J	Liu, Z; Otto-Bliesner, BL; He, F; Brady, EC; Tomas, R; Clark, PU; Carlson, AE; Lynch-Stieglitz, J; Curry, W; Brook, E; Erickson, D; Jacob, R; Kutzbach, J; Cheng, J				Liu, Z.; Otto-Bliesner, B. L.; He, F.; Brady, E. C.; Tomas, R.; Clark, P. U.; Carlson, A. E.; Lynch-Stieglitz, J.; Curry, W.; Brook, E.; Erickson, D.; Jacob, R.; Kutzbach, J.; Cheng, J.			Transient Simulation of Last Deglaciation with a New Mechanism for Bolling-Allerod Warming	SCIENCE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; ABRUPT CLIMATE-CHANGE; PAST 20,000 YEARS; OVERTURNING CIRCULATION; SURFACE-TEMPERATURE; HEINRICH EVENTS; GLACIAL MAXIMUM; RAPID CHANGES; MODEL; OCEAN	We conducted the first synchronously coupled atmosphere-ocean general circulation model simulation from the Last Glacial Maximum to the Bolling-Allerod (BA) warming. Our model reproduces several major features of the deglacial climate evolution, suggesting a good agreement in climate sensitivity between the model and observations. In particular, our model simulates the abrupt BA warming as a transient response of the Atlantic meridional overturning circulation (AMOC) to a sudden termination of freshwater discharge to the North Atlantic before the BA. In contrast to previous mechanisms that invoke AMOC multiple equilibrium and Southern Hemisphere climate forcing, we propose that the BA transition is caused by the superposition of climatic responses to the transient CO2 forcing, the AMOC recovery from Heinrich Event 1, and an AMOC overshoot.	[Liu, Z.; Cheng, J.] Nanjing Univ Informat Sci & Technol, Key Lab Meteorol Disaster, Nanjing 210044, Peoples R China; [Liu, Z.] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Peoples R China; [Liu, Z.; He, F.; Kutzbach, J.; Cheng, J.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Z.; He, F.; Kutzbach, J.; Cheng, J.] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Otto-Bliesner, B. L.; Brady, E. C.; Tomas, R.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA; [Clark, P. U.; Brook, E.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; [Carlson, A. E.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Carlson, A. E.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Lynch-Stieglitz, J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Curry, W.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Erickson, D.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Jacob, R.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Nanjing University of Information Science & Technology; Chinese Academy of Sciences; Institute of Earth Environment, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Center Atmospheric Research (NCAR) - USA; Oregon State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia Institute of Technology; Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Liu, Z (corresponding author), Nanjing Univ Informat Sci & Technol, Key Lab Meteorol Disaster, Nanjing 210044, Peoples R China.	zliu3@wisc.edu	Lynch-Stieglitz, Jean/J-2277-2018; Cheng, Jun/G-4625-2013; Jacob, Robert/D-2580-2011; He, Feng/B-3583-2008; Brook, Edward/AAB-7807-2021; Otto-Bliesner, Bette/AAY-7691-2020	Lynch-Stieglitz, Jean/0000-0002-9353-1972; Jacob, Robert/0000-0002-9444-6593; He, Feng/0000-0002-3355-6406; Cheng, Jun/0000-0003-0168-1410	NSF; NCAR; Chinese NSF [NSFC40875058]; U.S. Department of Energy INCITE program and Abrupt Climate Change Program; Directorate For Geosciences [0936472] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NCAR(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Chinese NSF(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy INCITE program and Abrupt Climate Change Program(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported mainly by the Paleoclimate Program of NSF, NCAR, and Chinese NSF (NSFC40875058). The computing is supported by the U.S. Department of Energy INCITE program and Abrupt Climate Change Program. This paper is CCR contribution No. 980.	Abshagen J, 2004, J PHYS OCEANOGR, V34, P2756, DOI 10.1175/JPO2642.1; Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Davey MK, 2002, CLIM DYNAM, V18, P403, DOI 10.1007/s00382-001-0188-6; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Hostetler SW, 1999, J GEOPHYS RES-ATMOS, V104, P3947, DOI 10.1029/1998JD200067; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Knorr G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001604; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; LUNT D, 2006, CLIM PAST, V2, P267; Lynch-Stieglitz J, 2007, SCIENCE, V316, P66, DOI 10.1126/science.1137127; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mignot J, 2007, J CLIMATE, V20, P4884, DOI 10.1175/JCLI4280.1; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rahmstorf S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023655; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rasmussen TL, 2004, PALAEOGEOGR PALAEOCL, V210, P101, DOI 10.1016/j.palaeo.2004.04.005; Ruhlemann C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000948; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Shin SI, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015513; Skinner LC, 2006, QUATERNARY SCI REV, V25, P3312, DOI 10.1016/j.quascirev.2006.07.005; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Timm O, 2007, J CLIMATE, V20, P4377, DOI 10.1175/JCLI4237.1; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1; Waelbroeck C, 1998, PALEOCEANOGRAPHY, V13, P272, DOI 10.1029/98PA00071; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Weber SL, 2007, CLIM PAST, V3, P51, DOI 10.5194/cp-3-51-2007; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Yin JJ, 2007, J CLIMATE, V20, P4293, DOI 10.1175/JCLI4256.1; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	43	658	684	9	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					310	314		10.1126/science.1171041	http://dx.doi.org/10.1126/science.1171041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608916				2022-12-28	WOS:000268036600043
J	Palioura, S; Sherrer, RL; Steitz, TA; Soll, D; Simonovic, M				Palioura, Sotiria; Sherrer, R. Lynn; Steitz, Thomas A.; Soell, Dieter; Simonovic, Miljan			The Human SepSecS-tRNA(Sec) Complex Reveals the Mechanism of Selenocysteine Formation	SCIENCE			English	Article							TRANSFER-RNA; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; SYNTHASE; ARCHAEA	Selenocysteine is the only genetically encoded amino acid in humans whose biosynthesis occurs on its cognate transfer RNA (tRNA). O-Phosphoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS) catalyzes the final step of selenocysteine formation by a poorly understood tRNA-dependent mechanism. The crystal structure of human tRNA(Sec) in complex with SepSecS, phosphoserine, and thiophosphate, together with in vivo and in vitro enzyme assays, supports a pyridoxal phosphate-dependent mechanism of Sec-tRNA(Sec) formation. Two tRNA(Sec) molecules, with a fold distinct from other canonical tRNAs, bind to each SepSecS tetramer through their 13-base pair acceptor-T Psi C arm (where Psi indicates pseudouridine). The tRNA binding is likely to induce a conformational change in the enzyme's active site that allows a phosphoserine covalently attached to tRNA(Sec), but not free phosphoserine, to be oriented properly for the reaction to occur.	[Palioura, Sotiria; Sherrer, R. Lynn; Steitz, Thomas A.; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.; Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; msimon5@uic.edu	Steitz, Thomas A./C-6559-2009	Simonovic, Miljan/0000-0002-1576-2222; Sherrer, Lynn/0000-0001-9771-9035	DOE; NIGMS; HHMI, Yale University; Yale University School of Medicine MD/PhD Program; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI, Yale University(Howard Hughes Medical Institute); Yale University School of Medicine MD/PhD Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from DOE (to D.S.) and NIGMS (to T.A.S. and D.S.). In the initial phase of this study M.S. was supported by HHMI at Yale University. S.P. holds a fellowship of the Yale University School of Medicine MD/PhD Program. R.L.S. was supported by a Ruth L. Kirschstein National Research Service Award. Authors contributions, S.P. designed the research, collected and analyzed the data, and wrote the manuscript, R.L.S. did research and read the manuscript, T.A.S. designed the research and wrote the manuscript, D.S. designed the research and wrote the manuscript, M.S. designed the research, collected and analyzed the data, and wrote the manuscript.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOCK A, 2005, AMINOACYL TRNA SYNTH, P320; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Herkel Johannes, 2007, Hepatology, V46, P275, DOI 10.1002/hep.21807; Ioudovitch A, 1998, RNA, V4, P365; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; STURCHLER C, 1993, NUCLEIC ACIDS RES, V21, P1073, DOI 10.1093/nar/21.5.1073; Su D, 2009, IUBMB LIFE, V61, P35, DOI 10.1002/iub.136; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	22	111	116	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					321	325		10.1126/science.1173755	http://dx.doi.org/10.1126/science.1173755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608919	Green Accepted			2022-12-28	WOS:000268036600046
J	Williams, KM; Chien, JW; Gladwin, MT; Pavletic, SZ				Williams, Kirsten M.; Chien, Jason W.; Gladwin, Mark T.; Pavletic, Steven Z.			Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; AIR-FLOW OBSTRUCTION; WORKING GROUP-REPORT; NONINFECTIOUS PULMONARY COMPLICATIONS; LONG-TERM AZITHROMYCIN; LUNG TRANSPLANTATION; CLINICAL-TRIALS; RISK-FACTORS	With improvements in supportive care, both long-term survival following allogeneic hematopoietic stem cell transplantations (HSCTs) and the indications for this procedure have increased. As a result, the number of patients living with long-term toxic effects due to HSCT has increased. A once rare condition of the donor immune cells attacking healthy host tissues, termed chronic graft-vs-host disease, has become a more common phenomenon. When chronic graft-vs-host disease affects the lung tissue, bronchiolitis obliterans syndrome ensues. Recent data suggest that bronchiolitis obliterans syndrome may affect up to 6% of HSCT recipients and dramatically alters survival, with overall survival of only 13% at 5 years. These statistics have not improved since the first presentation of this disease over 20 years ago. Challenges to the progress of medical management of bronchiolitis obliterans syndrome include difficulties and delays in diagnosis and a paucity of data on pathogenesis to direct new therapies. This article critically evaluates the current diagnostic criteria for bronchiolitis obliterans syndrome and reviews the epidemiology, pathogenesis, and available treatments. Improvements in survival will likely require early disease recognition, allowing for therapeutic modulation of disease prior to the development of irreversible airway obliteration. JAMA. 2009; 302(3):306-314 www.jama.com	[Williams, Kirsten M.; Pavletic, Steven Z.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chien, Jason W.] Univ Washington, Div Clin Res, Fred Hutchinson Canc Res Ctr & Pulm & Crit Care, Seattle, WA 98195 USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Williams, KM (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bldg 10 CRC,Room 3-3288,10 Ctr Dr, Bethesda, MD 20892 USA.	williaki@mail.nih.gov		Williams, Kirsten/0000-0001-9372-5286	National Cancer Institute; National Institutes of Health; Intramural Research Program; Center for Cancer Research; National Institutes of Health [HL088201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088201] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported in part by the National Cancer Institute, National Institutes of Health, Intramural Research Program, Center for Cancer Research. Dr Chien is supported by research grant HL088201 from the National Institutes of Health.	Afessa B, 2001, BONE MARROW TRANSPL, V28, P425, DOI 10.1038/sj.bmt.1703142; Bankier AA, 2001, RADIOLOGY, V218, P533, DOI 10.1148/radiology.218.2.r01fe09533; Belperio JA, 2003, SEMIN RESP CRIT CARE, V24, P499; Besnier DP, 1997, TRANSPLANTATION, V64, P49, DOI 10.1097/00007890-199707150-00010; Bharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x; Bhushan V, 2003, JAMA-J AM MED ASSOC, V290, P2599, DOI 10.1001/jama.290.19.2599; Botturi K, 2008, EUR RESPIR J, V31, P1167, DOI 10.1183/09031936.00093207; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Chadwick C, 2004, BONE MARROW TRANSPL, V33, P451, DOI 10.1038/sj.bmt.1704370; CHAMBERLAIN D, 1994, J HEART LUNG TRANSPL, V13, P963; CHAN CK, 1987, MEDICINE, V66, P327, DOI 10.1097/00005792-198709000-00001; Chien JW, 2003, AM J RESP CRIT CARE, V168, P208, DOI 10.1164/rccm.200212-1468OC; Choi YW, 2003, J THORAC IMAG, V18, P72, DOI 10.1097/00005382-200304000-00003; CLARK JG, 1989, ANN INTERN MED, V111, P368, DOI 10.7326/0003-4819-111-5-368; CLARK JG, 1990, MAYO CLIN PROC, V65, P111, DOI 10.1016/S0025-6196(12)62115-6; CLARK JG, 1987, ANN INTERN MED, V107, P648, DOI 10.7326/0003-4819-107-5-648; Cohen J, 2007, CHEST, V132, P1198, DOI 10.1378/chest.06-2763; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P375, DOI 10.1016/j.bbmt.2006.02.003; CURTIS DJ, 1995, BONE MARROW TRANSPL, V16, P169; DEJONG PA, 2006, THORAX           MAY, P2; Dudek AZ, 2003, BIOL BLOOD MARROW TR, V9, P657, DOI 10.1016/S1083-8791(03)00242-8; Duncan CN, 2008, BONE MARROW TRANSPL, V41, P971, DOI 10.1038/bmt.2008.19; Duncan SR, 2002, AM J RESP CRIT CARE, V165, P1439, DOI 10.1164/rccm.2107009; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Fullmer JJ, 2005, PEDIATRICS, V116, P767, DOI 10.1542/peds.2005-0806; Gerhardt SG, 2003, AM J RESP CRIT CARE, V168, P121, DOI 10.1164/rccm.200212-1424BC; Gottlieb J, 2008, TRANSPLANTATION, V85, P36, DOI 10.1097/01.tp.0000295981.84633.bc; Gunn MLD, 2008, J THORAC IMAG, V23, P244, DOI 10.1097/RTI.0b013e3181809df0; GUTTADAURIA M, 1977, ARTHRITIS RHEUM, V20, P1071, DOI 10.1002/art.1780200506; Hansen JE, 2006, CHEST, V129, P369, DOI 10.1378/chest.129.2.369; HERRANZ AD, 1995, EUR RESPIR J, V8, P1812, DOI 10.1183/09031936.95.08101812; HOLLAND HK, 1988, BLOOD, V72, P621; Hollmen M, 2008, J HEART LUNG TRANSPL, V27, P856, DOI 10.1016/j.healun.2008.05.018; Ilhan O, 2004, TRANSFUS APHER SCI, V30, P185, DOI 10.1016/j.transci.2004.02.003; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Jaramillo A, 1999, TRANSPLANT P, V31, P185, DOI 10.1016/S0041-1345(98)01495-X; Johnson BA, 2003, AM J RESP CRIT CARE, V167, P1271, DOI 10.1164/rccm.200205-410OC; Khalid M, 2005, EUR RESPIR J, V25, P490, DOI 10.1183/09031936.05.00020804; Kumar S, 2001, ANN HEMATOL, V80, P430, DOI 10.1007/s002770100301; Lee Stephanie J, 2008, Hematology Am Soc Hematol Educ Program, P134, DOI 10.1182/asheducation-2008.1.134; Leung AN, 1998, CHEST, V113, P365, DOI 10.1378/chest.113.2.365; Mamessier E, 2007, TRANSPLANTATION, V84, P908, DOI 10.1097/01.tp.0000281408.20686.cb; Markopoulou KD, 2002, EUR RESPIR J, V19, P20, DOI 10.1183/09031936.02.00282001; Marras TK, 2004, BONE MARROW TRANSPL, V33, P509, DOI 10.1038/sj.bmt.1704377; Martin PJ, 2006, BIOL BLOOD MARROW TR, V12, P491, DOI 10.1016/j.bbmt.2006.03.004; Medoff BD, 2005, J EXP MED, V202, P97, DOI 10.1084/jem.20042481; Miller WT, 2001, J THORAC IMAG, V16, P76, DOI 10.1097/00005382-200104000-00002; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Nicod Laurent P, 2006, Proc Am Thorac Soc, V3, P444, DOI 10.1513/pats.200601-007AW; Or R, 2007, TRANSPLANTATION, V83, P577, DOI 10.1097/01.tp.0000255575.03795.df; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Pavletic SZ, 2006, BIOL BLOOD MARROW TR, V12, P252, DOI 10.1016/j.bbmt.2006.01.008; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PHILIT F, 1995, EUR RESPIR J, V8, P551; Porhownik NR, 2008, CAN RESPIR J, V15, P199, DOI 10.1155/2008/158681; Ratjen F, 2005, BONE MARROW TRANSPL, V36, P135, DOI 10.1038/sj.bmt.1705026; Reynaud-Gaubert M, 2000, AM J RESP CRIT CARE, V161, P1924, DOI 10.1164/ajrccm.161.6.9905060; Schulman LL, 2001, AM J RESP CRIT CARE, V163, P437, DOI 10.1164/ajrccm.163.2.2005031; Shitrit D, 2005, J HEART LUNG TRANSPL, V24, P1440, DOI 10.1016/j.healun.2004.08.006; Smith E P, 1998, Biol Blood Marrow Transplant, V4, P27; Snell GI, 1996, CHEST, V109, P874, DOI 10.1378/chest.109.4.874; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; SUTEDJA TG, 1988, THORAX, V43, P163, DOI 10.1136/thx.43.3.163; Suzuki T, 1999, BONE MARROW TRANSPL, V23, P829, DOI 10.1038/sj.bmt.1701660; Tomas LHS, 2005, CHEST, V128, P153, DOI 10.1378/chest.128.1.153; Vanaudenaerde BM, 2008, AM J TRANSPLANT, V8, P1911, DOI 10.1111/j.1600-6143.2008.02321.x; Vanaudenaerde BM, 2007, AM J TRANSPLANT, V7, P76, DOI 10.1111/j.1600-6143.2006.01586.x; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Verleden GM, 2005, J HEART LUNG TRANSPL, V24, P1155, DOI 10.1016/j.healun.2004.06.025; Verleden GM, 2004, TRANSPLANTATION, V77, P1465, DOI 10.1097/01.TP.0000122412.80864.43; Vogelsang GB, 2003, ANNU REV MED, V54, P29, DOI 10.1146/annurev.med.54.101601.152339; White DA, 2000, AM J RESP CRIT CARE, V161, P723, DOI 10.1164/ajrccm.161.3.9904016; Wilborn J, 1996, J CLIN INVEST, V97, P1827, DOI 10.1172/JCI118612; Yates B, 2005, AM J RESP CRIT CARE, V172, P772, DOI 10.1164/rccm.200411-1537OC; Yokoi T, 1997, VIRCHOWS ARCH, V431, P275, DOI 10.1007/s004280050099; Yoshihara S, 2007, BIOL BLOOD MARROW TR, V13, P749, DOI 10.1016/j.bbmt.2007.05.001; YOUSEM SA, 1995, HUM PATHOL, V26, P668, DOI 10.1016/0046-8177(95)90174-4	80	146	154	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 15	2009	302	3					306	314		10.1001/jama.2009.1018	http://dx.doi.org/10.1001/jama.2009.1018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BR	19602690	Green Accepted			2022-12-28	WOS:000267948100024
J	Gura, T				Gura, Trisha			Driving Biofuels from Field to Fuel Tank	CELL			English	Editorial Material								Rising oil prices, fears of global warming, and instability in oil-producing countries have ignited the rush to produce biofuels from plants. The science is progressing rapidly, driven by favorable policies and generous financing, but many hurdles remain before cars and trucks run on "gasohol" or "grassoline."											0	6	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 10	2009	138	1					9	12		10.1016/j.cell.2009.06.038	http://dx.doi.org/10.1016/j.cell.2009.06.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19596227	Bronze			2022-12-28	WOS:000267848600006
J	Hanson, K; Marchant, T; Nathan, R; Mponda, H; Jones, C; Bruce, J; Mshinda, H; Armstrong, J				Hanson, Kara; Marchant, Tanya; Nathan, Rose; Mponda, Hadji; Jones, Caroline; Bruce, Jane; Mshinda, Hassan; Armstrong, Joanna			Household ownership and use of insecticide treated nets among target groups after implementation of a national voucher programme in the United Republic of Tanzania: plausibility study using three annual cross sectional household surveys	BRITISH MEDICAL JOURNAL			English	Article							MALARIA CONTROL; SCALING-UP; BAGAMOYO DISTRICT; CHILD SURVIVAL; MOSQUITO NETS; BEDNETS; COVERAGE; AFRICA; CAMPAIGN; MORTALITY	Objectives To evaluate the impact of the Tanzania National Voucher Scheme on the coverage and equitable distribution of insecticide treated nets, used to prevent malaria, to pregnant women and their infants. Design Plausibility study using three nationally representative cross sectional household and health facility surveys, timed to take place early, mid-way, and at the end of the roll out of the national programme. Setting The Tanzania National Voucher Scheme was implemented in antenatal services, and phased in on a district by district basis from October 2004 covering all of mainland Tanzania in May 2006. Participants 6115, 6260, and 6198 households (in 2005, 2006, and 2007, respectively) in a representative sample of 21 districts (out of a total of 113). Interventions A voucher worth $2.45 (1.47 pound, (sic)1.74) to be used as part payment for the purchase of a net from a local shop was given to every pregnant woman attending antenatal services. Main outcome measures Insecticide treated net coverage was measured as household ownership of at least one net and use of a net the night before the survey. Socioeconomic distribution of nets was examined using an asset based index. Results Steady increases in net coverage indicators were observed over the three year study period. Between 2005 and 2007, household ownership of at least one net (untreated or insecticide treated) increased from 44% (2686/6115) to 65% (4006/6198; P<0.001), and ownership of at least one insecticide treated net doubled from 18% (1062/5961) to 36% (2229/6198) in the same period (P<0.001). Among infants under 1 year of age, use of any net increased from 33% (388/1180) to 56% (707/1272; P<0.001) and use of an insecticide treated net increased from 16% (188/1180) to 34% (436/1272; P<0.001). After adjusting for potential confounders, household ownership was positively associated with time since programme launch, although this association did not reach statistical significance (P=0.09). Each extra year of programme operation was associated with a 9 percentage point increase in household insecticide treated net ownership (95% confidence interval -1.6 to 20). In 2005, only 7% (78/1115) of nets in households with a child under 1 year of age had been purchased with a voucher; this value increased to 50% (608/1211) in 2007 (P<0.001). In 2007, infants under 1 year in the least poor quintile were more than three times more likely to have used an insecticide treated net than infants in the poorest quintile (54% v 16%; P<0.001). Conclusions The Tanzania National Voucher Scheme was associated with impressive increases in the coverage of insecticide treated nets over a two year period. Gaps in coverage remain, however, especially in the poorest groups. A voucher system that facilitates routine delivery of insecticide treated nets is a feasible option to "keep up" coverage.	[Hanson, Kara; Marchant, Tanya; Jones, Caroline; Armstrong, Joanna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Nathan, Rose; Mponda, Hadji; Mshinda, Hassan] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Mshinda, Hassan] Tanzania Commiss Sci & Technol, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute	Hanson, K (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	kara.hanson@lshtm.ac.uk		Marchant, Tanya/0000-0002-4228-4334; Schellenberg, Joanna/0000-0002-0708-3676	Ministry of Health; Gates Malaria Partnership; UK Department for International Development; Royal Netherlands Embassy; United States President's Malaria Initiative; National Malaria Control Programme	Ministry of Health; Gates Malaria Partnership; UK Department for International Development; Royal Netherlands Embassy; United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); National Malaria Control Programme	Funds for the 2005 and 2006 surveys were provided by the Ministry of Health through its Global Fund Round 1 grant and the Gates Malaria Partnership. The UK Department for International Development and the Royal Netherlands Embassy provided funds through their grants to Population Services International. The 2007 surveys were funded by the United States President's Malaria Initiative. Although the study was conceived in collaboration with the National Malaria Control Programme, the programme managers had no role in the collection, analysis or interpretation of the data, in the writing of the report, or in the decision to submit the paper for publication.	Abdullah S, 2007, AM J TROP MED HYG, V77, P99; Brentlinger PE, 2007, HEALTH POLICY PLANN, V22, P103, DOI 10.1093/heapol/czm002; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fraser-Hurt N, 1998, B WORLD HEALTH ORGAN, V76, P607; *GLOB FUND FIGHT A, 2008, ROLL CONT CHANN DOC; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hanson K, 2003, B WORLD HEALTH ORGAN, V81, P269; Hanson K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-205; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Miller JE, 1999, TROP MED INT HEALTH, V4, P167, DOI 10.1046/j.1365-3156.1999.43378.x; MULLIGAN J, 2008, MALARIA J, V15, P32; Mushi AK, 2003, HEALTH POLICY PLANN, V18, P163, DOI 10.1093/heapol/czg021; *NAT BUR STAT TANZ, 2005, TANZ DEM HLTH SURV 2; NJUNWA KJ, 1991, ACTA TROP, V49, P87, DOI 10.1016/0001-706X(91)90056-P; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Ousmane I., 2006, Morbidity and Mortality Weekly Report, V55, P913; PREMJI Z, 1995, TROP MED PARASITOL, V46, P147; *ROLL BACK MAL WOR, 2002, SCAL INS TREAT NETT; Roll Back Malaria, 2005, RBM GLOB STRAT PLAN; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sachs JD, 2007, SCI AM, V297, P42; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Winch PJ, 1997, TROP MED INT HEALTH, V2, P760, DOI 10.1046/j.1365-3156.1997.d01-376.x; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	38	61	61	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 2	2009	339								b2434	10.1136/bmj.b2434	http://dx.doi.org/10.1136/bmj.b2434			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QZ	19574316	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000267678700005
J	Nurieva, RI; Chung, Y; Martinez, GJ; Yang, XO; Tanaka, S; Matskevitch, TD; Wang, YH; Dong, C				Nurieva, Roza I.; Chung, Yeonseok; Martinez, Gustavo J.; Yang, Xuexian O.; Tanaka, Shinya; Matskevitch, Tatyana D.; Wang, Yi-Hong; Dong, Chen			Bcl6 Mediates the Development of T Follicular Helper Cells	SCIENCE			English	Article							GERMINAL-CENTER FORMATION; ROR-GAMMA; DIFFERENTIATION; INTERLEUKIN-21; INFLAMMATION; GENERATION; EXPRESSION; RESPONSES; LINEAGE	A fundamental function of CD4(+) helper T (T(H)) cells is the regulation of B cell-mediated humoral immunity. Development of T follicular helper (T(FH)) cells that provide help to B cells is mediated by the cytokines interleukin-6 and interleukin-21 but is independent of T(H)1, T(H)2, and T(H)17 effector cell lineages. Here, we characterize the function of Bcl6, a transcription factor selectively expressed in T(FH) cells. Bcl6 expression is regulated by interleukin-6 and interleukin-21. Bcl6 overexpression induced T(FH)-related gene expression and inhibited other T(H) lineage cell differentiation in a DNA binding-dependent manner. Moreover, Bcl6 deficiency in T cells resulted in impaired T(FH) cell development and germinal center reactions, and altered production of other effector T cell subsets. Our data thus illustrate that Bcl6 is required for programming of T(FH) cell generation.	[Nurieva, Roza I.; Chung, Yeonseok; Martinez, Gustavo J.; Yang, Xuexian O.; Tanaka, Shinya; Matskevitch, Tatyana D.; Wang, Yi-Hong; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Nurieva, RI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009	Tanaka, Shinya/0000-0001-6470-3301; Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Martinez, Gustavo/0000-0003-0178-3329; Chung, Yeonseok/0000-0001-5780-4841	NIH; M. D. Anderson Cancer Center; Leukemia and Lymphoma Society; Schissler Foundation; Korea Science and Engineering Foundation; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050746, R01AI083761, R01AI050761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Schissler Foundation; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by research grants from NIH (to C.D. and R.I.N.), M. D. Anderson Cancer Center, and Leukemia and Lymphoma Society (to C.D.). G.J.M. is a Schissler Foundation Fellow in cancer research. Y.C. is a recipient of a postdoctoral fellowship from the Korea Science and Engineering Foundation. R.N. is a recipient of a Scientist Development Grant from the American Heart Association, and C.D. is a Leukemia and Lymphoma Society Scholar and a Trust Fellow of the M. D. Anderson Cancer Center.	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	16	1040	1098	6	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					1001	1005		10.1126/science.1176676	http://dx.doi.org/10.1126/science.1176676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19628815	Green Accepted			2022-12-28	WOS:000269242800048
J	Wang, HH; Isaacs, FJ; Carr, PA; Sun, ZZ; Xu, G; Forest, CR; Church, GM				Wang, Harris H.; Isaacs, Farren J.; Carr, Peter A.; Sun, Zachary Z.; Xu, George; Forest, Craig R.; Church, George M.			Programming cells by multiplex genome engineering and accelerated evolution	NATURE			English	Article							ESCHERICHIA-COLI; LYCOPENE BIOSYNTHESIS; RECOMBINATION; GENES; IDENTIFICATION; MUTAGENESIS; IMPROVEMENT; EFFICIENCY; BACTERIA; PATHWAY	The breadth of genomic diversity found among organisms in nature allows populations to adapt to diverse environments(1,2). However, genomic diversity is difficult to generate in the laboratory and new phenotypes do not easily arise on practical timescales(3). Although in vitro and directed evolution methods(4-9) have created genetic variants with usefully altered phenotypes, these methods are limited to laborious and serial manipulation of single genes and are not used for parallel and continuous directed evolution of gene networks or genomes. Here, we describe multiplex automated genome engineering (MAGE) for large-scale programming and evolution of cells. MAGE simultaneously targets many locations on the chromosome for modification in a single cell or across a population of cells, thus producing combinatorial genomic diversity. Because the process is cyclical and scalable, we constructed prototype devices that automate the MAGE technology to facilitate rapid and continuous generation of a diverse set of genetic changes (mismatches, insertions, deletions). We applied MAGE to optimize the 1-deoxy-D-xylulose-5-phosphate (DXP) biosynthesis pathway in Escherichia coli to overproduce the industrially important isoprenoid lycopene. Twenty-four genetic components in the DXP pathway were modified simultaneously using a complex pool of synthetic DNA, creating over 4.3 billion combinatorial genomic variants per day. We isolated variants with more than fivefold increase in lycopene production within 3 days, a significant improvement over existing metabolic engineering techniques. Our multiplex approach embraces engineering in the context of evolution by expediting the design and evolution of organisms with new and improved properties.	[Wang, Harris H.; Isaacs, Farren J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wang, Harris H.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Wang, Harris H.] MIT, Harvard Mit Div Hlth Sci & Technol, Program Med Engn Med Phys, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Media Lab, Cambridge, MA 02139 USA; [Sun, Zachary Z.; Xu, George] Harvard Univ, Cambridge, MA 02138 USA; [Forest, Craig R.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; University System of Georgia; Georgia Institute of Technology	Wang, HH (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	hhwang@genetics.med.harvard.edu; farren@alumni.upenn.edu		church, george/0000-0001-6232-9969	NSF; DOE; DARPA; Wyss Institute for Biologically Inspired Engineering; NIH; NDSEG; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NDSEG; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Jacobson for his insights and advice throughout this work. We thank D. Court for his insights and sharing strain DY330, N. Reppas for advice and sharing strain EcNR2, F. X. Cunningham for sharing pAC- LYC, and B. H. Sterling for assistance in constructing the EcFI5 strain. Wealso thank M. Jewett, J. Aach, D. Bang, S. Kosuri and members of the Church laboratory for advice and discussions. We thank the NSF, DOE, DARPA, the Wyss Institute for Biologically Inspired Engineering and training fellowships from the NIH and NDSEG (H. H. W.) for supporting this research.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Cropp TA, 2004, TRENDS GENET, V20, P625, DOI 10.1016/j.tig.2004.09.013; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Nakayama M, 2005, BIOTECHNIQUES, V38, P917, DOI 10.2144/05386RR02; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a	32	998	1144	25	482	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					894	U133		10.1038/nature08187	http://dx.doi.org/10.1038/nature08187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19633652	Green Accepted			2022-12-28	WOS:000268938300039
J	Eberhardt, WEE; Stamatis, G; Stuschke, M				Eberhardt, Wilfried E. E.; Stamatis, Georgios; Stuschke, Martin			Surgery in stage III non-small-cell lung cancer	LANCET			English	Editorial Material							PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; TRIAL; CHEMORADIATION; SURVIVAL		[Eberhardt, Wilfried E. E.] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Canc Res, W German Tumour Ctr, D-45122 Essen, Germany; [Stamatis, Georgios] Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac Endoscopy & Thorac Surg, Ruhrlandklin, D-45122 Essen, Germany; [Stuschke, Martin] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiat Oncol, W German Tumour Ctr, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Eberhardt, WEE (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Med Canc Res, W German Tumour Ctr, D-45122 Essen, Germany.	wilfried.eberhardt@uni-essen.de		Eberhardt, Wilfried Ernst Erich/0000-0003-4284-3586				Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880, DOI 10.1200/JCO.1995.13.8.1880; Andre F, 2000, J CLIN ONCOL, V18, P2981, DOI 10.1200/JCO.2000.18.16.2981; Curran WJ, 2003, P AN M AM SOC CLIN, V22, P621; Eberhardt W, 1998, J CLIN ONCOL, V16, P622, DOI 10.1200/JCO.1998.16.2.622; Eberhardt WE, 2003, LUNG CANCER-J IASLC, V42, pS9, DOI 10.1016/S0169-5002(03)00300-3; Goldgewicht C, 2007, ENVIR RISQUES SANTE, V6, P14; Lorent N, 2004, ANN ONCOL, V15, P1645, DOI 10.1093/annonc/mdh435; POETTGEN C, 2009, INT J RAD BIOL PHYS; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; van Meerbeeck JP, 2007, JNCI-J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093; WEDEER W, 2009, AM ASS THOR SURG 89, V32	12	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					359	360		10.1016/S0140-6736(09)61026-6	http://dx.doi.org/10.1016/S0140-6736(09)61026-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19632715				2022-12-28	WOS:000268815200004
J	Hough, LE; Spannuth, M; Nakata, M; Coleman, DA; Jones, CD; Dantlgraber, G; Tschierske, C; Watanabe, J; Korblova, E; Walba, DM; Maclennan, JE; Glaser, MA; Clark, NA				Hough, L. E.; Spannuth, M.; Nakata, M.; Coleman, D. A.; Jones, C. D.; Dantlgraber, G.; Tschierske, C.; Watanabe, J.; Koerblova, E.; Walba, D. M.; Maclennan, J. E.; Glaser, M. A.; Clark, N. A.			Chiral Isotropic Liquids from Achiral Molecules	SCIENCE			English	Article							BANANA-SHAPED MOLECULES; SMECTIC PHASE; POLAR ORDER; CRYSTALS; MEMBRANES; LAMELLAR; MESOGENS	A variety of simple bent-core molecules exhibit smectic liquid crystal phases of planar fluid layers that are spontaneously both polar and chiral in the absence of crystalline order. We found that because of intralayer structural mismatch, such layers are also only marginally stable against spontaneous saddle splay deformation, which is incompatible with long-range order. This results in macroscopically isotropic fluids that possess only short-range orientational and positional order, in which the only macroscopically broken symmetry is chirality-even though the phases are formed from achiral molecules. Their conglomerate domains exhibit optical rotatory powers comparable to the highest ever found for isotropic fluids of chiral molecules.	[Hough, L. E.; Spannuth, M.; Nakata, M.; Coleman, D. A.; Jones, C. D.; Maclennan, J. E.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Hough, L. E.; Spannuth, M.; Nakata, M.; Coleman, D. A.; Jones, C. D.; Maclennan, J. E.; Glaser, M. A.; Clark, N. A.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Dantlgraber, G.; Tschierske, C.] Univ Halle Wittenberg, Inst Organ Chem, D-06120 Halle, Saale, Germany; [Watanabe, J.] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Koerblova, E.; Walba, D. M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Koerblova, E.; Walba, D. M.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Martin Luther University Halle Wittenberg; Tokyo Institute of Technology; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Hough, LE (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	hough@colorado.edu; noel.clark@colorado.edu	Walba, David/F-7284-2013; Clark, Noel A/AAP-9116-2020; Spannuth, Melissa/F-1212-2010; Korblova, Eva/AAC-3502-2021; Glaser, Matthew/H-2345-2016; Maclennan, Joseph E/A-9836-2013; Clark, Noel A./E-9011-2010	Korblova, Eva/0000-0002-3818-4373; Glaser, Matthew/0000-0002-8366-5598; Maclennan, Joseph E/0000-0002-3587-554X; Clark, Noel A./0000-0001-9301-5540; HOUGH, LOREN/0000-0002-1104-0126	NSF [DMR 0606528]; NSF Materials Research Science and Engineering Center [DMR 0820579]; U.S. Department of Energy, Divisions of Materials and Chemical Sciences	NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); U.S. Department of Energy, Divisions of Materials and Chemical Sciences(United States Department of Energy (DOE))	Supported by NSF grant DMR 0606528 (N.A.C.), NSF Materials Research Science and Engineering Center grant DMR 0820579 (N.A.C.), and an NSF Graduate Research Fellowship (L.E.H.). Use of the National Synchrotron Light Source was supported by the U.S. Department of Energy, Divisions of Materials and Chemical Sciences. We thank T. Giddings for technical assistance with the freeze-fracture TEM.	Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956; COSTELLO MJ, 1982, J MICROSC-OXFORD, V125, P125, DOI 10.1111/j.1365-2818.1982.tb00330.x; Dantlgraber G, 2002, ANGEW CHEM INT EDIT, V41, P2408, DOI 10.1002/1521-3773(20020703)41:13<2408::AID-ANIE2408>3.0.CO;2-M; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; DiDonna BA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215504; Eremin A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.020702; Etxebarria J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.042702; Etxebarria J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.079801; GLASER MA, 1994, J PHYS-CONDENS MAT, V6, pA261, DOI 10.1088/0953-8984/6/23A/041; Heppke G, 2000, LIQ CRYST, V27, P313, DOI 10.1080/026782900202750; Hough LE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107802; Hough LE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.079802; HUSE DA, 1988, J PHYS-PARIS, V49, P605, DOI 10.1051/jphys:01988004904060500; Jacques J., 1981, ENANTIOMERS RACEMATE; Keith C, 2007, J MATER CHEM, V17, P3796, DOI 10.1039/b706923e; Kleman M., 2003, SOFT MATTER PHYS INT; Lee SK, 2007, J PHYS CHEM B, V111, P8698, DOI 10.1021/jp0739014; Liao G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021710; Link DR, 1997, SCIENCE, V278, P1924, DOI 10.1126/science.278.5345.1924; Murthy HNS, 2002, LIQ CRYST, V29, P1223, DOI 10.1080/02678290210160114; Nakata M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011705; Nakata M, 2001, J MATER CHEM, V11, P2694, DOI 10.1039/b103506c; Navailles L, 1996, J PHYS II, V6, P1243, DOI 10.1051/jp2:1996128; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; Ortega J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011707; Pasteur L, 1848, CR HEBD ACAD SCI, V26, P535; PORTE G, 1992, J PHYS-CONDENS MAT, V4, P8649, DOI 10.1088/0953-8984/4/45/002; PORTE G, 1991, PHYSICA A, V176, P168, DOI 10.1016/0378-4371(91)90439-J; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; Reddy RA, 2003, LIQ CRYST, V30, P1031, DOI 10.1080/0267829031000152978; Takezoe H, 2006, JPN J APPL PHYS 1, V45, P597, DOI 10.1143/JJAP.45.597; Thisayukta J, 2000, J AM CHEM SOC, V122, P7441, DOI 10.1021/ja001370q; Walba DM, 2000, SCIENCE, V288, P2181, DOI 10.1126/science.288.5474.2181; Weissflog W, 2003, ADV MATER, V15, P630, DOI 10.1002/adma.200304570; WU ST, 1986, PHYS REV A, V33, P1270, DOI 10.1103/PhysRevA.33.1270; Yamamoto J, 2005, NATURE, V437, P525, DOI 10.1038/nature04034; ZASADZINSKI JAN, 1990, J PHYS-PARIS, V51, P747, DOI 10.1051/jphys:01990005108074700	37	226	227	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					452	456		10.1126/science.1170028	http://dx.doi.org/10.1126/science.1170028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19628863				2022-12-28	WOS:000268255100050
J	Watts, G				Watts, Geoff			Pandemic flu A/H1N1 influenza virus: the basics	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Gallaher WR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-51; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032	3	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2009	339								b3046	10.1136/bmj.b3046	http://dx.doi.org/10.1136/bmj.b3046			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IP	19633037				2022-12-28	WOS:000268352100005
J	Bersell, K; Arab, S; Haring, B; Kuhn, B				Bersell, Kevin; Arab, Shima; Haring, Bernhard; Kuehn, Bernhard			Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury	CELL			English	Article							STEM-CELLS; BETA-CELLS; ADULT; REGENERATION; KINASE; INHIBITION; EXPRESSION; RENEWAL; MITOSIS; GROWTH	Many organs rely on undifferentiated stem and progenitor cells for tissue regeneration. Whether differentiated cells themselves can contribute to cell replacement and tissue regeneration is a controversial question. Here, we show that differentiated heart muscle cells, cardiomyocytes, can be induced to proliferate and regenerate. We identify an underlying molecular mechanism for controlling this process that involves the growth factor neuregulin1 (NRG1) and its tyrosine kinase receptor, ErbB4. NRG1 induces mononucleated, but not binucleated, cardiomyocytes to divide. In vivo, genetic inactivation of ErbB4 reduces cardiomyocyte proliferation, whereas increasing ErbB4 expression enhances it. Injecting NRG1 in adult mice induces cardiomyocyte cell-cycle activity and promotes myocardial regeneration, leading to improved function after myocardial infarction. Undifferentiated progenitor cells did not contribute to NRG1-induced cardiomyocyte proliferation. Thus, increasing the activity of the NRG1/ErbB4 signaling pathway may provide a molecular strategy to promote myocardial regeneration.	[Bersell, Kevin; Arab, Shima; Haring, Bernhard; Kuehn, Bernhard] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Haring, Bernhard; Kuehn, Bernhard] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kuhn, B (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	bkuhn@enders.tch.harvard.edu			Mutant Mouse Repository (UC Davis); Department of Cardiology at Children's Hospital Boston; Charles Hood Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085143] Funding Source: NIH RePORTER	Mutant Mouse Repository (UC Davis); Department of Cardiology at Children's Hospital Boston; Charles Hood Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the Mutant Mouse Repository (UC Davis) for providing ErbB4<SUP>F/F</SUP> mice and Jackson Laboratories for providing alpha-MHC-MerCreMer and Rosa26R mice. We thank V. Bezzerides, R. Breitbart, D. Clapham, G. Corfas, C. Hug, and R. Liao (Harvard Medical School), R. Hajjar (Mount Sinai School of Medicine), and E. Oancea (Brown University) for stimulating discussions and E. Long (Children's Hospital) and S. Ngoy (Brigham and Women's Hospital) for technical assistance. This research was supported by the Department of Cardiology at Children's Hospital Boston, the Charles Hood Foundation, and the American Heart Association. B. K. is a founder of CardioHeal.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bettencourt-Dias M, 2003, J CELL SCI, V116, P4001, DOI 10.1242/jcs.00698; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; KATZ EB, 1992, AM J PHYSIOL, V262, pH1867, DOI 10.1152/ajpheart.1992.262.6.H1867; Keefe DL, 2002, CANCER-AM CANCER SOC, V95, P1592, DOI 10.1002/cncr.10854; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsuka M, 1998, CANCER RES, V58, P4811; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wang Z, 2009, MED BIOL ENG COMPUT, V47, P41, DOI 10.1007/s11517-008-0383-2; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363	34	664	712	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2009	138	2					257	270		10.1016/j.cell.2009.04.060	http://dx.doi.org/10.1016/j.cell.2009.04.060			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	474IM	19632177	Bronze			2022-12-28	WOS:000268277000009
J	Franco, LM; Skorupski, JC				Franco, Luis M.; Skorupski, Josh C.			Myotonic Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Franco, Luis M.; Skorupski, Josh C.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Franco, LM (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	lfranco@bcm.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					E4	E4		10.1056/NEJMicm0802903	http://dx.doi.org/10.1056/NEJMicm0802903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DC	19625713				2022-12-28	WOS:000268184500010
J	Vlopp, KG; Das, A				Vlopp, Kevin G.; Das, Anup			Comparative Effectiveness - Thinking beyond Medication A versus Medication B	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vlopp, Kevin G.; Das, Anup] Univ Penn, Philadelphia, PA 19104 USA; [Vlopp, Kevin G.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Vlopp, KG (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.			Volpp, Kevin/0000-0003-1423-4599				Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Hughes JR, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000031.PUB3; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Stead L. F., 2008, COCHRANE DATABASE SY, V1; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	5	47	48	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					331	333		10.1056/NEJMp0903496	http://dx.doi.org/10.1056/NEJMp0903496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DC	19625714	Green Published			2022-12-28	WOS:000268184500003
J	Forman, JP; Stampfer, MJ; Curhan, GC				Forman, John P.; Stampfer, Meir J.; Curhan, Gary C.			Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MODERATE ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; ANALGESIC USE; FOLLOW-UP; FREQUENCY; REPRODUCIBILITY; VALIDITY; PREVENTION	Context Hypertension is an important preventable risk factor for death among women. While several modifiable risk factors have been identified, their combined risk and distribution in the population have not been assessed. Objective To estimate the hypothetical fraction of hypertension incidence associated with dietary and lifestyle factors in women. Design, Setting, and Participants Prospective cohort study of 83 882 adult women aged 27 to 44 years in the second Nurses' Health Study who did not have hypertension, cardiovascular disease, diabetes, or cancer in 1991, and who had normal reported blood pressure (defined as systolic blood pressure of <= 120 mm Hg and diastolic blood pressure of <= 80 mm Hg), with follow-up for incident hypertension for 14 years through 2005. Six modifiable lifestyle and dietary factors for hypertension were identified. The 6 low-risk factors for hypertension were a body mass index (BMI) of less than 25, a daily mean of 30 minutes of vigorous exercise, a high score on the Dietary Approaches to Stop Hypertension (DASH) diet based on responses to a food frequency questionnaire, modest alcohol intake up to 10 g/d, use of nonnarcotic analgesics less than once per week, and intake of 400 mu g/d or more of supplemental folic acid. The association between combinations of 3 (normal BMI, daily vigorous exercise, and DASH-style diet), 4 (3 low-risk factors plus modest alcohol intake), 5 (4 low-risk factors plus avoidance of nonnarcotic analgesics), and 6 (folic acid supplementation >= 400 mu g/d) low-risk factors and the risk of developing hypertension was analyzed. Main Outcome Measures Adjusted hazard ratios for incident self-reported hypertension and population attributable risks (PARs). Results A total of 12 319 incident cases of hypertension were reported. All 6 modifiable risk factors were independently associated with the risk of developing hypertension during follow-up after also adjusting for age, race, family history of hypertension, smoking status, and use of oral contraceptives. For women who had all 6 low-risk factors (0.3% of the population), the hazard ratio for incident hypertension was 0.22 (95% confidence interval [CI], 0.10-0.51); the hypothetical PAR was 78% (95% CI, 49%-90%) for women who lacked these low-risk factors. The corresponding hypothetical absolute incidence rate difference (ARD) was 8.37 cases per 1000 person-years. The PARs were 72% (95% CI, 57%-82%; ARD, 7.76 cases per 1000 person-years) for 5 low-risk factors (0.8% of the population), 58% (95% CI, 46%-67%; ARD, 6.28 cases per 1000 person-years) for 4 low-risk factors (1.6% of the population), and 53% (95% CI, 45%-60%; ARD, 6.02 cases per 1000 person-years) for 3 low-risk factors (3.1% of the population). Body mass index alone was the most powerful predictor of hypertension, with a BMI of 25 or greater having an adjusted PAR of 40% (95% CI, 38%-41%) compared with a BMI of less than 25. Conclusions Adherence to low-risk dietary and lifestyle factors was associated with a significantly lower incidence of self-reported hypertension. Adopting low-risk dietary and lifestyle factors has the potential to prevent a large proportion of new-onset hypertension occurring among young women. JAMA. 2009;302(4):401-411	[Forman, John P.; Stampfer, Meir J.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Forman, John P.; Curhan, Gary C.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Forman, JP (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave,3rd Floor, Boston, MA 02115 USA.	jforman@partners.org			American Heart Association [0535401T]; National Institutes of Health [HL079929-01A2, CA50385]; NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079929] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by American Heart Association grant 0535401T and National Institutes of Health grants HL079929-01A2 and CA50385.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; [Anonymous], 1996, JAMA, V276, P241; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; CHALMERS JP, 1984, CLIN EXP HYPERTENS A, V6, P1077, DOI 10.3109/10641968409039582; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Dauchet L, 2007, AM J CLIN NUTR, V85, P1650, DOI 10.1093/ajcn/85.6.1650; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Forman JP, 2007, ARCH INTERN MED, V167, P394, DOI 10.1001/archinte.167.4.394; Forman JP, 2005, HYPERTENSION, V46, P500, DOI 10.1161/01.HYP.0000177437.07240.70; Forman JP, 2005, JAMA-J AM MED ASSOC, V293, P320, DOI 10.1001/jama.293.3.320; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gelber RP, 2007, AM J HYPERTENS, V20, P370, DOI 10.1016/j.amjhyper.2006.10.011; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Gu DF, 2007, J HYPERTENS, V25, P517, DOI 10.1097/HJH.0b013e328013e7f4; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; Mangoni AA, 2002, J INTERN MED, V252, P497, DOI 10.1046/j.1365-2796.2002.01059.x; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Parker ED, 2007, AM J PUBLIC HEALTH, V97, P703, DOI 10.2105/AJPH.2004.055889; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira MA, 1999, PREV MED, V28, P304, DOI 10.1006/pmed.1998.0431; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schulze MB, 2003, AM J EPIDEMIOL, V158, P365, DOI 10.1093/aje/kwg156; SELBY JV, 1989, AM J EPIDEMIOL, V129, P43, DOI 10.1093/oxfordjournals.aje.a115123; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Thadhani R, 2002, ARCH INTERN MED, V162, P569, DOI 10.1001/archinte.162.5.569; van Dijk RAJM, 2001, ARTERIOSCL THROM VAS, V21, P2072, DOI 10.1161/hq1201.100223; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WITTEMAN JCM, 1990, AM J CARDIOL, V65, P633, DOI 10.1016/0002-9149(90)91043-6; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	44	316	338	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					401	411		10.1001/jama.2009.1060	http://dx.doi.org/10.1001/jama.2009.1060			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NQ	19622819	Green Accepted			2022-12-28	WOS:000268139200023
J	Sorelli, PG; Thomas, D; Hoque, H				Sorelli, Paolo G.; Thomas, Daniel; Hoque, Happy			Endgames Picture quiz A surgical emergency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ILIAC ARTERY ANEURYSMS; ENDOVASCULAR TREATMENT; MANAGEMENT; RESUSCITATION; REPAIR		[Sorelli, Paolo G.; Thomas, Daniel; Hoque, Happy] Queen Marys Hosp, Dept Surg, Sidcup DA14 6LT, England		Sorelli, PG (corresponding author), Queen Marys Hosp, Dept Surg, Sidcup DA14 6LT, England.	paolosorelli@hotmail.com						American College of Surgeons, 1997, ADV TRAUM LIF SUPP D; Bolin T, 1988, EUR J VASCULAR SURG, V2, P214; BRIN BJ, 1982, ARCH SURG-CHICAGO, V117, P1329; Brown TK, 1934, AM J OBSTET GYNECOL, V27, P766, DOI 10.1016/S0002-9378(34)90700-6; BRUNKWALL J, 1989, J VASC SURG, V10, P381, DOI 10.1067/mva.1989.13733; Clarke MG, 2005, CARDIOVASC INTER RAD, V28, P364, DOI 10.1007/s00270-004-0254-7; Cormier F, 2000, ANN VASC SURG, V14, P561, DOI 10.1007/s100169910104; Cronenwett J, 2000, VASCULAR SURG, P1273; Dalainas I, 2008, CARDIOVASC INTER RAD, V31, P394, DOI 10.1007/s00270-006-0127-3; Ghosh J, 2009, EUR J VASC ENDOVASC, V37, P182, DOI 10.1016/j.ejvs.2008.11.001; Goff CD, 1999, AM SURGEON, V65, P421; Greaves I, 2002, J ROY COLL SURG EDIN, V47, P451; Hans SS, 2003, ARCH SURG-CHICAGO, V138, P898, DOI 10.1001/archsurg.138.8.898; Hobo R, 2008, J ENDOVASC THER, V15, P12, DOI 10.1583/07-2217.1; Kasirajan V, 1998, CARDIOVASC SURG, V6, P171, DOI 10.1016/S0967-2109(97)00136-1; Lucke B, 1921, J AMER MED ASSOC, V77, P935; Matsumoto K, 2004, WORLD J SURG, V28, P797, DOI 10.1007/s00268-004-7440-2; MCCREADY RA, 1983, SURGERY, V93, P688; Parry DJ, 2001, ANN ROY COLL SURG, V83, P302; RAZAVI MK, 1995, RADIOLOGY, V197, P801, DOI 10.1148/radiology.197.3.7480759; Revell M, 2003, J TRAUMA, V54, pS63, DOI 10.1097/01.TA.0000056157.94970.FA; RICHARDSON JW, 1988, J VASC SURG, V8, P165, DOI 10.1067/mva.1988.avs0080165; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Roberts K, 2006, EUR J VASC ENDOVASC, V31, P339, DOI 10.1016/j.ejvs.2005.11.003; SACKS NPM, 1992, J CARDIOVASC SURG, V33, P679; Sahgal A, 2001, J VASC SURG, V33, P289, DOI 10.1067/mva.2001.112702; Sakamoto I, 2003, J ENDOVASC THER, V10, P1075, DOI 10.1583/1545-1550(2003)010<1075:CEOIAA>2.0.CO;2; Sanada J, 2005, CARDIOVASC INTER RAD, V28, P83, DOI 10.1007/s00270-004-0005-9; Sandhu Rajdeep S, 2005, Semin Vasc Surg, V18, P209, DOI 10.1053/j.semvascsurg.2005.09.007; van Sambeek MRHM, 1998, EUR J VASC ENDOVASC, V15, P91, DOI 10.1016/S1078-5884(98)80127-5	30	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2009	339								b2302	10.1136/bmj.b2302	http://dx.doi.org/10.1136/bmj.b2302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475IL	19625350				2022-12-28	WOS:000268351700002
J	Schectman, J				Schectman, Joel			High consumption of red meat and processed meat was associated with increased risk for mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia Hlth Syst, Charlottesville, VA USA	University of Virginia	Schectman, J (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA USA.							GRADY D, 1992, ANN INTERN MED, V117, P1038	1	1	1	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2							JC1-15	10.7326/0003-4819-151-2-200907210-02015	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478RH	19620159				2022-12-28	WOS:000268605300023
J	Meltzoff, AN; Kuhl, PK; Movellan, J; Sejnowski, TJ				Meltzoff, Andrew N.; Kuhl, Patricia K.; Movellan, Javier; Sejnowski, Terrence J.			Foundations for a New Science of Learning	SCIENCE			English	Review							SOCIAL-INTERACTION; SPEECH-PERCEPTION; PHONETIC PERCEPTION; SCHOOL READINESS; JOINT ATTENTION; LANGUAGE; IMITATION; INFANTS; ACQUISITION; EXPERIENCE	Human learning is distinguished by the range and complexity of skills that can be learned and the degree of abstraction that can be achieved compared with those of other species. Homo sapiens is also the only species that has developed formal ways to enhance learning: teachers, schools, and curricula. Human infants have an intense interest in people and their behavior and possess powerful implicit learning mechanisms that are affected by social interaction. Neuroscientists are beginning to understand the brain mechanisms underlying learning and how shared brain systems for perception and action support social learning. Machine learning algorithms are being developed that allow robots and computers to learn autonomously. New insights from many different fields are converging to create a new science of learning that may transform educational practices.	[Meltzoff, Andrew N.; Kuhl, Patricia K.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Meltzoff, Andrew N.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Meltzoff, Andrew N.; Kuhl, Patricia K.] Univ Washington, LIFE Ctr, Seattle, WA 98195 USA; [Kuhl, Patricia K.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Movellan, Javier; Sejnowski, Terrence J.] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Movellan, Javier; Sejnowski, Terrence J.] Univ Calif San Diego, TDLC, La Jolla, CA 92093 USA; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Meltzoff, AN (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	Meltzoff@u.washington.edu	Sejnowski, Terrence/AAV-5558-2021; Meltzoff, Andrew N/GPC-8807-2022	Meltzoff, Andrew N/0000-0001-8683-0547	NSF Science of Learning Center; NIH [HD-22514, HD-37954]; Howard Hughes Medical Institute;  [SBE-0354453];  [SBE-0542013];  [IIS-0808767]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022514, R01HD037954, R37HD022514] Funding Source: NIH RePORTER	NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NSF Science of Learning Center grants SBE-0354453 (A.M. and P.K.) and SBE-0542013 (J.M. and T.S.), NIH grants HD-22514 (A.M.) and HD-37954 (P.K.), NSF IIS-0808767 (J.M.), and Howard Hughes Medical Institute (T.S.). The views in this article do not necessarily reflect those of NSF or NIH. We thank M. Asada for assistance with the robotic image in Fig. 1; A. Gopnik, J. Bongard, P. Marshall, S. Cheryan, P. Tallal, and J. Watson for valuable comments; and the members of the NSF Science of Learning Centers for helpful discussions.	Allman J.M., 1999, EVOLVING BRAINS; BAPTISTA LF, 1986, ANIM BEHAV, V34, P1359, DOI 10.1016/S0003-3472(86)80207-X; Bloom BS, 1984, EDUC RES, V13, P4, DOI DOI 10.3102/0013189X013006004; Brainard MS, 1998, J NEUROSCI, V18, P3929; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Bruner J. S., 1996, CULTURE ED; BUTKO NJ, 2006, P 5 IEEE INT C DEV L; Conboy BT, 2007, ADV CONSC RES, V68, P175; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Demiris Y, 2008, INFANT CHILD DEV, V17, P43, DOI 10.1002/icd.543; DOUGLAS R, FUTURE CHALLENGES SC; Doupe A., 2008, NEUROSCIENCE BIRDSON, P5; Doya K, 1996, ADV NEURAL INFORMATI, P101; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; FLOM R, 2007, GAZEZ FOLLOWING; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2007, DEVELOPMENTAL SCI, V10, P281, DOI 10.1111/j.1467-7687.2007.00584.x; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Imada T, 2006, NEUROREPORT, V17, P957, DOI 10.1097/01.wnr.0000223387.51704.89; Jacobs RA, 2003, NEURAL COMPUT, V15, P761, DOI 10.1162/08997660360581895; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Koedinger KR, 2007, EDUC PSYCHOL REV, V19, P239, DOI 10.1007/s10648-007-9049-0; KUHL P, OPPORTUNITIES CHALLE; Kuhl P, 2008, ANNU REV NEUROSCI, V31, P511, DOI 10.1146/annurev.neuro.30.051606.094321; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LAMM C, J COGN NEUR IN PRESS; Lee CD, 2008, EDUC RESEARCHER, V37, P267, DOI 10.3102/0013189X08322683; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.3.CO;2-I; Meltzoff AN, 2008, DEV PSYCHOL, V44, P1257, DOI 10.1037/a0012888; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Mitchell T.M, 2003, MACH LEARN; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Mottonen R, 2005, NEUROIMAGE, V24, P731, DOI 10.1016/j.neuroimage.2004.10.011; Movellan J., 2009, P 4 ACM IEEE INT C H, P307, DOI [DOI 10.1145/1514095.1514189, 10.1145/1514095.1514189]; Movellan JR, 2002, 2ND INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING, PROCEEDINGS, P34, DOI 10.1109/DEVLRN.2002.1011728; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Natl Res Council, 2009, LEARNING SCIENCE IN INFORMAL ENVIRONMENTS: PEOPLE, PLACES, AND PURSUITS, P1; Ng A.Y., 2000, MACHINE LEARNING, V1, P2; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Picard R. W., 1997, AFFECTIVE COMPUTING; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Raizada RDS, 2008, NEUROIMAGE, V40, P1392, DOI 10.1016/j.neuroimage.2008.01.021; Ramey CT, 2004, MERRILL PALMER QUART, V50, P471, DOI 10.1353/mpq.2004.0034; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Repacholi BM, 2008, DEV PSYCHOL, V44, P561, DOI 10.1037/0012-1649.44.2.561; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rogers SJ, 2006, IMITATION SOCIAL MIN; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Scassellati B, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION (RO-MAN), P585; Shon AP, 2007, INT J HUM ROBOT, V4, P387, DOI 10.1142/S0219843607001059; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stoel-Gammon C., 1992, PHONOLOGICAL DEV MOD, P273; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Tanaka F, 2007, P NATL ACAD SCI USA, V104, P17954, DOI 10.1073/pnas.0707769104; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; VERMA D, 2006, ADV NEURAL INFORM PR, P1393; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Williamson RA, 2008, DEV PSYCHOL, V44, P275, DOI 10.1037/0012-1649.44.1.275; ZAHNWAXLER C, 1979, CHILD DEV, V50, P319, DOI 10.1111/j.1467-8624.1979.tb04112.x; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	83	404	412	12	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					284	288		10.1126/science.1175626	http://dx.doi.org/10.1126/science.1175626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DZ	19608908	Green Published, Green Accepted			2022-12-28	WOS:000268036600035
J	Pfau, T; Spence, A; Starke, S; Ferrari, M; Wilson, A				Pfau, Thilo; Spence, Andrew; Starke, Sandra; Ferrari, Marta; Wilson, Alan			Modern Riding Style Improves Horse Racing Times	SCIENCE			English	Article							COST; LOCOMOTION; FORCE		[Pfau, Thilo; Spence, Andrew; Starke, Sandra; Ferrari, Marta; Wilson, Alan] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Pfau, T (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	tpfau@rvc.ac.uk		Starke, Sandra/0000-0002-1434-7094; Wilson, Alan/0000-0001-9914-3455	Horserace Betting Levy Board; Bremer Ausbildungs Partnerschaft; UK Biotechnology and Biological Sciences Research Council; Royal Society; EPSRC [EP/D07682X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [S20242] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500137/1, EP/D07682X/1] Funding Source: researchfish	Horserace Betting Levy Board; Bremer Ausbildungs Partnerschaft; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. J. Hobbs for the horses; T. Cox, the Cox Library, and T. Stanhope, Equine Action Images, for photographs; the Horserace Betting Levy Board for funding (T.P., A.S., and M.F.); and the Bremer Ausbildungs Partnerschaft (international LEONARDO program) for funding (S.S.). The UK Biotechnology and Biological Sciences Research Council funded the technology development. A.W. holds a Royal Society Wolfson Research Merit award. A.W. and T.P. have filed a patent application on monitoring of horses and jockeys during racing with methods similar to those described here.	Chang YH, 1999, J APPL PHYSIOL, V86, P1657, DOI 10.1152/jappl.1999.86.5.1657; Minetti AE, 1999, J EXP BIOL, V202, P2329; MORDIN N, 2002, WINNING THINKING DEF, P91; ORCHAND V, 1954, DERBY STAKES; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Schamhardt H.C., 1991, EQUINE EXERCISE PHYS, V3, P120; TAYLOR CR, 1980, J EXP BIOL, V86, P9; TROWBRIDGE EA, 1995, EUR J APPL PHYSIOL O, V70, P66, DOI 10.1007/BF00601810; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a	10	57	57	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					289	289		10.1126/science.1174605	http://dx.doi.org/10.1126/science.1174605			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19608909	Green Published			2022-12-28	WOS:000268036600036
J	[Anonymous]				[Anonymous]			Nowhere to hide	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 16	2009	460	7253					307	307		10.1038/460307b	http://dx.doi.org/10.1038/460307b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470MO	19606096	Bronze			2022-12-28	WOS:000267979000002
J	Beal, EJ; House, CH; Orphan, VJ				Beal, Emily J.; House, Christopher H.; Orphan, Victoria J.			Manganese- and Iron-Dependent Marine Methane Oxidation	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; MICROBIAL COMMUNITIES; COLD SEEPS; BLACK-SEA; ANAEROBIC OXIDATION; SEDIMENTS; REDUCTION; ARCHAEA; SOIL; DIVERSITY	Anaerobic methanotrophs help regulate Earth's climate and may have been an important part of the microbial ecosystem on the early Earth. The anaerobic oxidation of methane (AOM) is often thought of as a sulfate-dependent process, despite the fact that other electron acceptors are more energetically favorable. Here, we show that microorganisms from marine methane-seep sediment in the Eel River Basin in California are capable of using manganese (birnessite) and iron (ferrihydrite) to oxidize methane, revealing that marine AOM is coupled, either directly or indirectly, to a larger variety of oxidants than previously thought. Large amounts of manganese and iron are provided to oceans from rivers, indicating that manganese- and iron-dependent AOM have the potential to be globally important.	[Beal, Emily J.; House, Christopher H.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Beal, Emily J.; House, Christopher H.] Penn State Univ, Penn State Astrobiol Res Ctr, University Pk, PA 16802 USA; [Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; California Institute of Technology	Beal, EJ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	ejbeal@gmail.com; chrishouse@psu.edu	Orphan, Victoria J/K-1002-2014; Orphan, Victoria/AAS-5989-2020	Orphan, Victoria J/0000-0002-5374-6178; Orphan, Victoria/0000-0002-5374-6178	National Science Foundation [MCB-0348492]; National Aeronautics and Space Administration (NASA) Astrobiology Institute [NNA04CC06A]; Penn State Biogeochemical Research Initiative for Education (BRIE) [DGE-9972759]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA) Astrobiology Institute(National Aeronautics & Space Administration (NASA)); Penn State Biogeochemical Research Initiative for Education (BRIE)	Funding for this project has come from the National Science Foundation (MCB-0348492), National Aeronautics and Space Administration (NASA) Astrobiology Institute under NASA-Ames Cooperative Agreement NNA04CC06A, and the Penn State Biogeochemical Research Initiative for Education (BRIE) funded by NSF (IGERT) grant DGE-9972759. Sequences were submitted to GenBank and have accession numbers FJ264513 [GenBank] to FJ264602 [GenBank] and FJ264604 [GenBank] to FJ264884.	ALLER RC, 1988, GEOCHIM COSMOCHIM AC, V52, P751, DOI 10.1016/0016-7037(88)90335-3; ANBAR AD, 1992, GEOCHIM COSMOCHIM AC, V56, P2595, DOI 10.1016/0016-7037(92)90346-K; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; COLEMAN ML, 1993, NATURE, V361, P436, DOI 10.1038/361436a0; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Gillan DC, 2007, BIOFOULING, V23, P1, DOI 10.1080/08927010601108725; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; He JZ, 2008, GEOMICROBIOL J, V25, P14, DOI 10.1080/01490450701829014; HEIN JR, 1987, GEOLOGY, V15, P722, DOI 10.1130/0091-7613(1987)15<722:BMDOFC>2.0.CO;2; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Moran JJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000268; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Poulton SW, 2000, MAR CHEM, V72, P17, DOI 10.1016/S0304-4203(00)00060-8; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reitner J, 2005, FACIES, V51, P66, DOI 10.1007/s10347-005-0059-4; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x; Wheatcroft RA, 1997, GEOLOGY, V25, P163, DOI 10.1130/0091-7613(1997)025<0163:RAWDOF>2.3.CO;2; ZEHNDER AJB, 1980, APPL ENVIRON MICROB, V39, P194, DOI 10.1128/AEM.39.1.194-204.1980	36	643	718	26	660	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					184	187		10.1126/science.1169984	http://dx.doi.org/10.1126/science.1169984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19589998				2022-12-28	WOS:000267802000042
J	Migone, TS; Subramanian, GM; Zhong, J; Healey, LM; Corey, A; Devalaraja, M; Lo, L; Ullrich, S; Zimmerman, J; Chen, A; Lewis, M; Meister, G; Gillum, K; Sanford, D; Mott, J; Bolmer, SD				Migone, Thi-Sau; Subramanian, G. Mani; Zhong, John; Healey, Letha M.; Corey, Al; Devalaraja, Matt; Lo, Larry; Ullrich, Stephen; Zimmerman, Janelle; Chen, Andrew; Lewis, Maggie; Meister, Gabriel; Gillum, Karen; Sanford, Daniel; Mott, Jason; Bolmer, Sally D.			Raxibacumab for the Treatment of Inhalational Anthrax.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTECTIVE ANTIGEN; MONOCLONAL-ANTIBODY; RHESUS-MONKEY; PATHOLOGY; TOXIN; EFFICACY; MODEL	Background: Inhalational anthrax caused by Bacillus anthracis is associated with high mortality primarily due to toxin-mediated injury. Raxibacumab is a human IgG1(lamda) monoclonal antibody directed against protective antigen, a component of the anthrax toxin. Methods: We evaluated the efficacy of raxibacumab as a prophylactic agent and after disease onset in a total of four randomized, placebo-controlled studies conducted in rabbits and monkeys. Animals were exposed to an aerosolized target exposure of B. anthracis spores that was approximately 100 times (in the prophylactic studies) and 200 times (in the therapeutic-intervention studies) the median lethal dose. In the therapeutic-intervention studies, animals were monitored for the onset of symptoms. Animals with detectable protective antigen in serum, a significant increase in temperature, or both received a single intravenous bolus of placebo or raxibacumab at a dose of either 20 mg per kilogram of body weight or 40 mg per kilogram. The primary end point was survival at day 14 (in rabbits) or at day 28 (in monkeys). Safety studies were conducted with intravenous raxibacumab (40 mg per kilogram) in 333 healthy human volunteers. Results: In both rabbits and monkeys, the time to detection of protective antigen correlated with the time to bacteremia (r=0.9, P<0.001). In the therapeutic-intervention studies, the survival rate was significantly higher among rabbits that received raxibacumab at a dose of 40 mg per kilogram (44% [8 of 18]) than among rabbits that received placebo (0% [0 of 18]; P=0.003). Raxibacumab treatment also significantly increased survival in monkeys (64% [9 of 14], vs. 0% [0 of 12] with placebo; P<0.001). In human subjects, intravenous raxibacumab at a dose of 40 mg per kilogram had a half-life of 20 to 22 days and provided a maximum concentration of the drug in excess of levels that are protective in animals. Concentrations of raxibacumab provide a surrogate end point that should be predictive of clinical benefit. Conclusions: A single dose of raxibacumab improved survival in rabbits and monkeys with symptomatic inhalational anthrax. (ClinicalTrials.gov number, NCT00639678.) N Engl J Med 2009;361:135-44.	[Migone, Thi-Sau; Subramanian, G. Mani; Zhong, John; Healey, Letha M.; Corey, Al; Devalaraja, Matt; Lo, Larry; Ullrich, Stephen; Zimmerman, Janelle; Chen, Andrew; Lewis, Maggie; Bolmer, Sally D.] Human Genome Sci, Rockville, MD 20850 USA; [Meister, Gabriel; Gillum, Karen; Sanford, Daniel; Mott, Jason] Battelle Biomed Res Ctr, Columbus, OH USA	GlaxoSmithKline; Human Genome Sciences Inc	Migone, TS (corresponding author), Human Genome Sci, 14200 Shady Grove Rd, Rockville, MD 20850 USA.	thi_migone@hgsi.com; mani_subramanian@hgsi.com						ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; FRITZ DL, 1995, LAB INVEST, V73, P691; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; Holty JEC, 2006, ANN INTERN MED, V144, P270, DOI 10.7326/0003-4819-144-4-200602210-00009; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kao LM, 2006, ANTIMICROB AGENTS CH, V50, P3535, DOI 10.1128/AAC.00090-06; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Russell PK, 2007, CLIN INFECT DIS, V45, P68, DOI 10.1086/518151; Subramanian GM, 2005, CLIN INFECT DIS, V41, P12, DOI 10.1086/430708; Twenhafel NA, 2007, VET PATHOL, V44, P716, DOI 10.1354/vp.44-5-716; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	20	183	197	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					135	144		10.1056/NEJMoa0810603	http://dx.doi.org/10.1056/NEJMoa0810603			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19587338				2022-12-28	WOS:000267748900006
J	Singh, I; Rose, N				Singh, Ilina; Rose, Nikolas			Biomarkers in psychiatry	NATURE			English	Article							MENTAL-ILLNESS; PREVENTION; GENOTYPE; DISORDER; MEDICINE; GENETICS; GENOME; GENES; RISK; RACE		[Singh, Ilina; Rose, Nikolas] London Sch Econ, BIOS Ctr, London WC2A 2AE, England	University of London; London School Economics & Political Science	Singh, I (corresponding author), London Sch Econ, BIOS Ctr, Houghton St, London WC2A 2AE, England.	i.a.singh@lse.ac.uk	Rose, Nikolas S/D-1918-2010; Rose, Nikolas/A-4229-2013	Singh, Ilina/0000-0003-4497-3587; Rose, Nikolas/0000-0003-4007-5077	ESRC [ES/E020585/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020585/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Beauchaine TP, 2008, DEV PSYCHOPATHOL, V20, P745, DOI 10.1017/S0954579408000369; Beauchaine TP, 2009, BIOMARK MED, V3, P1, DOI 10.2217/17520363.3.1.1; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; BRUNNER HG, 2007, CIBA F SYMP, V194, P155; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Foster MW, 2006, J MED ETHICS, V32, P635, DOI 10.1136/jme.2005.013532; Foster MW, 2008, PERS MED, V5, P399, DOI 10.2217/17410541.5.4.399; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GOSWAMI U, 2005, PSYCHOL ED REV, V29, P2; Green MJ, 2003, ANN INTERN MED, V138, P571, DOI 10.7326/0003-4819-138-7-200304010-00013; HOLTZMAN P, 2000, BRAIN RES REV, V31, P350; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; HUNICHE L, 2001, OUTLINES CRIT SOC ST, V3, P35; Kirkwood TB., 2008, FORESIGHT MENTAL CAP; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Lock M, 2005, CURR ANTHROPOL, V46, pS47, DOI 10.1086/432452; Lock M, 2006, PUBLIC UNDERST SCI, V15, P277, DOI 10.1177/0963662506059259; MARONEY TA, 2009, GRUT I ANN C SQUAW V; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; Parens Erik, 2008, Child Adolesc Psychiatry Ment Health, V2, P5, DOI 10.1186/1753-2000-2-5; Phelan J, 2006, AM J MED GENET B, V141B, P688; Phelan JC, 2002, TRENDS NEUROSCI, V25, P430, DOI 10.1016/S0166-2236(02)02209-9; Prainsack B, 2008, NATURE, V456, P34, DOI 10.1038/456034a; Romeo R, 2006, BRIT J PSYCHIAT, V188, P547, DOI 10.1192/bjp.bp.104.007625; Rose N, 2008, BIOSOCIETIES, V3, P423, DOI 10.1017/S1745855208006339; Schick A, 2005, AM J BIOETHICS, V5, P36, DOI 10.1080/15265160590960410; SCHICK A, 2005, AM J BIOETHICS, V5, pW3; Seyffert M, 2005, CURR PEDIATR REV, V1, P17, DOI 10.2174/1573396052953453; Silverman C, 2008, BIOSOCIETIES, V3, P325, DOI 10.1017/S1745855208006236; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20.3.470; Zito JM, 2007, J CHILD ADOL PSYCHOP, V17, P195, DOI 10.1089/cap.2007.0006	41	219	223	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					202	207		10.1038/460202a	http://dx.doi.org/10.1038/460202a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	467RV	19587761				2022-12-28	WOS:000267761000030
J	Wang, JH; Gostissa, M; Yan, CT; Goff, P; Hickernell, T; Hansen, E; Difilippantonio, S; Wesemann, DR; Zarrin, AA; Rajewsky, K; Nussenzweig, A; Alt, FW				Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Difilippantonio, Simone; Wesemann, Duane R.; Zarrin, Ali A.; Rajewsky, Klaus; Nussenzweig, Andre; Alt, Frederick W.			Mechanisms promoting translocations in editing and switching peripheral B cells	NATURE			English	Article							END-JOINING PATHWAY; CHROMOSOMAL TRANSLOCATIONS; V(D)J RECOMBINATION; RECEPTOR REVISION; BONE-MARROW; DNA BREAKS; LYMPHOCYTE DEVELOPMENT; GENE-REGULATION; AID; EXPRESSION	Variable, diversity and joining gene segment (V(D) J) recombination assembles immunoglobulin heavy or light chain (IgH or IgL) variable region exons in developing bone marrow B cells, whereas class switch recombination (CSR) exchanges IgH constant region exons in peripheral B cells. Both processes use directed DNA double-strand breaks (DSBs) repaired by non-homologous end-joining (NHEJ). Errors in either V(D) J recombination or CSR can initiate chromosomal translocations, including oncogenic IgH locus (Igh) to c-myc (also known as Myc) translocations of peripheral B cell lymphomas. Collaboration between these processes has also been proposed to initiate translocations. However, the occurrence of V(D) J recombination in peripheral B cells is controversial. Here we show that activated NHEJ-deficient splenic B cells accumulate V(D) J-recombination-associated breaks at the lambda IgL locus (Igl), as well as CSR-associated Igh breaks, often in the same cell. Moreover, Igl and Igh breaks are frequently joined to form translocations, a phenomenon associated with specific Igh-Igl co-localization. Igh and c-myc also co-localize in these cells; correspondingly, the introduction of frequent c-myc DSBs robustly promotes Igh-c-myc translocations. Our studies show peripheral B cells that attempt secondary V(D) J recombination, and determine a role for mechanistic factors in promoting recurrent translocations in tumours.	[Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Rajewsky, Klaus; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Wang, Jing H.; Gostissa, Monica; Yan, Catherine T.; Goff, Peter; Hickernell, Thomas; Hansen, Erica; Wesemann, Duane R.; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Difilippantonio, Simone; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Wang, Jing Hong/M-7813-2015; Hickernell, Thomas R/ABG-2642-2021	Wang, Jing Hong/0000-0003-4343-2527; Hickernell, Thomas R/0000-0003-0897-8487; Goff, Peter/0000-0002-3488-4997; Rajewsky, Klaus/0000-0002-6633-6370; Wesemann, Duane/0000-0002-6690-944X	National Insitutes of Health (NIH) [5P01CA92625]; Leukemia and Lymphoma Society of America (LLS) SCORE; NCI; NATIONAL CANCER INSTITUTE [P01CA092625, T32CA009382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077595, R37AI077595] Funding Source: NIH RePORTER	National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCORE(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Alt laboratory members for discussions, and Y. L. Chen, J. M. Bianco and M. Moghimi for technical assistance. This work was supported by the National Insitutes of Health (NIH) grant 5P01CA92625 and a Leukemia and Lymphoma Society of America (LLS) SCORE grant to F. W. A. and K. R. M. G. is and J. H. W. was a Special Fellow of the LLS. J. H. W. and D. R. W. are supported by an NIH training grant and C. T. Y. was supported by an NCI training grant. A. N. is supported by the Intramural Research program of the NIH, NCI, Center for Cancer Research. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Goossens T, 2001, EUR J IMMUNOL, V31, P3638, DOI 10.1002/1521-4141(200112)31:12<3638::AID-IMMU3638>3.0.CO;2-G; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lahvis GP, 1997, J IMMUNOL, V159, P1783; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; PLESSIS A, 1992, GENETICS, V130, P451; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Roth DB, 2002, MOL CELL, V10, P1, DOI 10.1016/S1097-2765(02)00573-7; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Seagal J, 2002, CLIN IMMUNOL, V105, P1, DOI 10.1006/clim.2002.5290; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	50	101	103	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					231	U94		10.1038/nature08159	http://dx.doi.org/10.1038/nature08159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19587764	Green Accepted			2022-12-28	WOS:000267761000035
J	Miller, JD				Miller, James Dabney			FDA Performance Goals for Approving Drugs and Biologics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miller, JD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 4110 Greenway, Baltimore, MD 21218 USA.	jdmiller@jhsph.edu						Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; LEAVITT M, 2007, COMMUNICATION   0927; *US FDA, SUMM FDAS FY 2010 BU; *US FDA, 2005, GUID REV STAFF IND G; US Food and Drug Administration, PDUFA REAUTH PERF GO; 2008, FED REG, V73, P45017	6	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 8	2009	302	2					189	191		10.1001/jama.2009.974	http://dx.doi.org/10.1001/jama.2009.974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466WU	19584348				2022-12-28	WOS:000267696500028
J	Schmitz, D; Henn, W; Netzer, C				Schmitz, Dagmar; Henn, Wolfram; Netzer, Christian			Commentary: No risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing	BRITISH MEDICAL JOURNAL			English	Review									[Schmitz, Dagmar] Rhein Westfal TH Aachen, Inst Hist Theory & Eth Med, D-52074 Aachen, Germany; [Henn, Wolfram] Univ Saarland, Univ Hosp, Inst Human Genet, Dept Genet Counselling, D-66421 Homburg, Germany; [Netzer, Christian] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany	RWTH Aachen University; Saarland University; Universitatsklinikum des Saarlandes; University of Cologne	Schmitz, D (corresponding author), Rhein Westfal TH Aachen, Inst Hist Theory & Eth Med, Wendlingweg 2, D-52074 Aachen, Germany.	daschmitz@ukaachen.de	Henn, Wolfram/AAU-1608-2020					SCHMITZ D, 2009, NAT REV GENET   0623; Seavilleklein V, 2009, BIOETHICS, V23, P68, DOI 10.1111/j.1467-8519.2008.00674.x	2	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2009	339								b2690	10.1136/bmj.b2690	http://dx.doi.org/10.1136/bmj.b2690			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469KW	19581325				2022-12-28	WOS:000267898000003
